data_2mcf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mcf _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 mtp . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 121.363 0.601 . . . . 73.319999999999993 112.179 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -141.32 174.12 10.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.561 -1.274 . . . . 71.219999999999999 107.561 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.516 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 24.9 m-85 -120.35 134.96 55.17 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-O 121.325 0.583 . . . . 74.319999999999993 109.697 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.549 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 62.3 t0 -115.26 119.37 36.09 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.245 -1.343 . . . . 75.200000000000003 108.404 -175.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.6 125.7 50.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 115.673 -0.694 . . . . 75.439999999999998 111.393 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.484 ' HB ' HH21 ' A' ' 87' ' ' ARG . 7.7 p -112.39 115.84 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 N-CA-C 108.603 -0.888 . . . . 71.129999999999995 108.603 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.3 tt -104.02 124.45 58.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.482 -0.781 . . . . 70.319999999999993 108.952 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.1 mt -114.92 95.81 42.78 Favored Pre-proline 0 C--N 1.302 -1.457 0 CA-C-N 115.808 -0.633 . . . . 51.439999999999998 109.346 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.628 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 9.7 Cg_endo -89.45 126.6 1.58 Allowed 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.762 2.308 . . . . 71.129999999999995 110.173 176.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -150.67 127.67 11.12 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.615 0.722 . . . . 63.409999999999997 110.781 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.2 m -74.42 111.44 9.6 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.791 -1.189 . . . . 72.310000000000002 107.791 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.44 120.64 14.85 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.647 0.737 . . . . 73.140000000000001 112.948 -173.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -129.65 114.72 16.37 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 115.176 -0.92 . . . . 74.319999999999993 110.305 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -78.86 118.65 21.1 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 104.927 -2.249 . . . . 74.239999999999995 104.927 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -48.11 104.31 0.06 Allowed 'General case' 0 N--CA 1.424 -1.765 0 O-C-N 125.378 1.673 . . . . 73.409999999999997 110.578 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -84.8 -145.89 0.09 Allowed 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 112.685 -2.052 . . . . 40.32 108.292 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -63.05 -58.37 7.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 118.3 0.5 . . . . 73.150000000000006 111.369 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -137.3 -52.55 0.67 Allowed 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 118.866 -1.134 . . . . 74.319999999999993 113.833 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.53 ' O ' ' HG2' ' A' ' 20' ' ' MET . 10.5 t30 -108.27 80.95 1.41 Allowed 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 113.104 0.779 . . . . 74.349999999999994 113.104 -170.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.53 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 70.5 mmm -163.24 70.94 0.25 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.08 1.352 . . . . 75.129999999999995 109.287 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -146.21 89.89 1.91 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.319 -1.734 . . . . 63.25 106.319 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -113.25 118.03 33.5 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.201 -1.0 . . . . 74.230000000000004 111.08 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.5 mm -133.18 127.48 54.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.489 -0.778 . . . . 75.540000000000006 110.735 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.628 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 76.9 m -111.54 129.23 24.32 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 108.458 -0.941 . . . . 60.229999999999997 108.458 172.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.49 146.95 93.43 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.685 2.257 . . . . 74.219999999999999 112.725 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.86 147.93 92.02 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 123.68 2.92 . . . . 62.119999999999997 113.422 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.404 ' HG2' ' HB2' ' A' ' 99' ' ' ASN . 64.2 mtt -111.07 132.94 53.84 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.194 -1.039 . . . . 74.010000000000005 108.194 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.9 t -126.37 125.6 67.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 O-C-N 123.497 0.498 . . . . 71.549999999999997 110.457 -171.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.8 mm -138.21 116.17 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.748 0.819 . . . . 45.009999999999998 109.504 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -127.94 81.98 0.34 Allowed Glycine 0 CA--C 1.48 -2.139 0 C-N-CA 118.726 -1.702 . . . . 74.319999999999993 114.801 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.92 7.91 1.65 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.205 -0.598 . . . . 63.43 112.432 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.465 HH21 ' CG1' ' A' ' 103' ' ' VAL . 14.8 mmt85 -103.99 134.41 47.31 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.148 -0.621 . . . . 43.240000000000002 109.553 -169.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 p -78.19 163.76 25.52 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 107.678 -1.23 . . . . 71.120000000000005 107.678 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.516 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 63.3 t80 -51.42 -43.24 61.94 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 124.27 1.028 . . . . 75.219999999999999 111.22 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.99 -41.78 95.11 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.151 -0.931 . . . . 63.240000000000002 111.719 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.8 mt -79.29 -30.47 14.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.529 -0.545 . . . . 64.310000000000002 109.529 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.31 -45.8 89.68 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.353 -0.839 . . . . 75.030000000000001 110.098 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.08 -31.38 70.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 119.924 -0.711 . . . . 72.120000000000005 112.276 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.23 -45.07 67.28 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 119.495 -0.882 . . . . 74.329999999999998 110.508 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.4 tp -66.72 -40.9 87.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 C-N-CA 120.107 -0.637 . . . . 72.439999999999998 110.176 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.3 t -65.57 -42.67 93.5 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.008 0 CA-C-N 116.737 -0.21 . . . . 72.200000000000003 110.57 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -63.85 -40.73 97.26 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 120.761 0.315 . . . . 74.439999999999998 111.349 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.477 ' O ' HG21 ' A' ' 47' ' ' VAL . . . -66.85 -44.9 87.98 Favored Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 111.062 -0.815 . . . . 52.149999999999999 111.062 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.17 -39.85 86.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.649 -0.5 . . . . 73.239999999999995 109.649 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.45 ' OD2' ' HE2' ' A' ' 49' ' ' LYS . 23.2 t70 -57.75 -46.42 84.54 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 124.387 1.075 . . . . 61.409999999999997 110.653 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -67.42 -37.64 83.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.14 -0.482 . . . . 73.409999999999997 111.597 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 43' ' ' GLY . 62.3 t -68.36 -41.89 83.83 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 120.772 -0.371 . . . . 73.219999999999999 110.302 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 66.3 mt -66.01 -38.33 81.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 O-C-N 122.035 -0.416 . . . . 73.510000000000005 111.091 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.45 ' HE2' ' OD2' ' A' ' 45' ' ' ASP . 54.0 mtmt -76.57 -17.79 59.02 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.912 0.708 . . . . 74.409999999999997 112.912 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.02 -33.91 7.34 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 113.625 0.972 . . . . 65.450000000000003 113.625 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 t -87.4 -9.99 53.22 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.423 0.63 . . . . 75.25 110.053 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.604 ' CE2' ' HD2' ' A' ' 75' ' ' LYS . 12.3 m-85 -137.33 175.81 9.27 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 107.503 -1.295 . . . . 71.239999999999995 107.503 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -104.42 77.35 1.38 Allowed 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 105.462 -2.051 . . . . 72.129999999999995 105.462 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -114.46 136.44 53.01 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-N 115.158 -0.928 . . . . 73.430000000000007 112.532 -172.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 m -109.37 123.54 49.49 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.282 -1.377 . . . . 75.340000000000003 107.282 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 p -100.63 152.42 4.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 116.11 -0.495 . . . . 72.329999999999998 110.293 -173.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -142.13 140.08 32.36 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.691 -1.225 . . . . 73.040000000000006 107.691 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.96 136.32 49.42 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.34 0.59 . . . . 73.299999999999997 110.883 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mp -135.91 167.53 21.01 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.913 -1.143 . . . . 63.020000000000003 107.913 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -100.54 142.76 31.56 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.038 -1.468 . . . . 73.010000000000005 107.038 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.52 174.89 48.93 Favored Glycine 0 C--N 1.296 -1.681 0 C-N-CA 120.708 -0.758 . . . . 72.450000000000003 112.121 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.77 130.47 35.13 Favored 'General case' 0 C--O 1.179 -2.628 0 N-CA-C 108.188 -1.042 . . . . 51.039999999999999 108.188 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 13.64 -73.76 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 C-N-CA 128.241 2.616 . . . . 75.340000000000003 116.829 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 53.3 t -57.12 -37.75 72.43 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 124.151 0.98 . . . . 75.329999999999998 110.046 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 8.7 m-20 -86.18 124.4 32.54 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.601 -1.259 . . . . 71.099999999999994 107.601 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.4 t -93.83 -28.78 4.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-O 121.304 0.573 . . . . 72.439999999999998 111.717 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.6 tp -145.34 141.3 28.38 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.124 -0.695 . . . . 63.229999999999997 109.124 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.478 ' HH ' ' CG ' ' A' ' 83' ' ' HIS . 0.4 OUTLIER -130.28 108.96 10.4 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.199 -1.408 . . . . 74.420000000000002 107.199 179.208 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -104.79 114.77 29.19 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.279 -1.378 . . . . 75.439999999999998 107.279 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 36.1 ttmt -101.12 132.64 46.49 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.341 0.657 . . . . 74.150000000000006 109.295 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -126.4 125.24 41.86 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.716 -0.475 . . . . 74.310000000000002 109.716 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 m -98.38 113.49 25.49 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.999 -1.482 . . . . 74.319999999999993 106.999 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.48 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 4.2 mm? -98.38 139.99 33.32 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.573 0.583 . . . . 75.409999999999997 112.573 -172.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -140.13 127.95 21.92 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 105.715 -1.957 . . . . 73.239999999999995 105.715 170.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.604 ' HD2' ' CE2' ' A' ' 52' ' ' PHE . 49.2 tttm -134.79 -176.91 4.39 Favored 'General case' 0 C--N 1.273 -2.744 0 N-CA-C 104.933 -2.247 . . . . 61.509999999999998 104.933 177.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.424 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -55.97 92.25 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 114.568 1.322 . . . . 73.510000000000005 114.568 -175.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.7 17.6 74.99 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 114.903 -1.044 . . . . 62.130000000000003 113.146 175.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 44.4 mtmt -140.09 143.99 36.57 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.419 -0.586 . . . . 72.120000000000005 109.419 -175.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 73' ' ' LEU . 33.6 ttmt -146.79 139.31 24.98 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 110.033 -0.358 . . . . 73.420000000000002 110.033 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.62 174.4 35.71 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 110.902 -0.879 . . . . 61.119999999999997 110.902 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.9 tp -119.56 134.46 63.05 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 108.106 -1.072 . . . . 74.430000000000007 108.106 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.2 t -123.61 115.59 45.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.432 0.634 . . . . 75.319999999999993 109.673 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.478 ' CG ' ' HH ' ' A' ' 68' ' ' TYR . 36.4 m170 -107.15 116.67 32.33 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.257 -0.883 . . . . 63.32 110.512 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.58 110.0 30.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.737 -0.838 . . . . 75.430000000000007 108.737 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -118.27 137.4 53.07 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.891 -0.506 . . . . 72.540000000000006 111.336 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.7 mt -106.37 118.76 37.48 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.112 -0.495 . . . . 73.230000000000004 109.944 -171.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.484 HH21 ' HB ' ' A' ' 6' ' ' VAL . 28.5 mtm105 -97.15 141.14 30.65 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.025 0.441 . . . . 74.510000000000005 110.096 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 64' ' ' CYS . 49.7 pttt -80.23 98.11 7.23 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 109.301 -0.629 . . . . 71.209999999999994 109.301 173.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.0 tt -69.22 112.01 3.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-O 122.513 1.149 . . . . 74.439999999999998 109.636 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.6 p -140.68 -171.4 3.22 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 113.35 -1.75 . . . . 74.319999999999993 107.723 -170.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.47 -5.0 53.83 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.593 0.711 . . . . 62.020000000000003 110.658 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -99.74 -29.25 12.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.547 -0.751 . . . . 54.25 109.169 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 84.9 m -121.27 92.87 48.76 Favored Pre-proline 0 N--CA 1.431 -1.377 0 CA-C-N 115.429 -0.805 . . . . 54.109999999999999 109.719 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -76.48 167.79 24.97 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.189 1.926 . . . . 73.040000000000006 110.976 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.24 123.34 12.31 Favored 'Trans proline' 0 C--O 1.251 1.157 0 C-N-CA 122.032 1.821 . . . . 62.420000000000002 110.194 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 t -86.68 157.57 3.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.462 -0.57 . . . . 73.430000000000007 109.462 -176.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.47 137.49 32.31 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.96 -0.564 . . . . 74.200000000000003 110.299 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -177.1 -170.43 39.52 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 108.76 -1.736 . . . . 74.439999999999998 108.76 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.404 ' HB2' ' HG2' ' A' ' 27' ' ' MET . 94.1 m-20 -71.63 140.01 49.54 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.187 -0.671 . . . . 73.519999999999996 109.187 178.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -98.63 119.7 37.81 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.019 0.438 . . . . 71.439999999999998 111.133 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 41.1 t -73.2 139.04 46.0 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.553 -0.906 . . . . 72.219999999999999 108.553 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 m -74.03 91.15 2.03 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.494 0.664 . . . . 73.519999999999996 110.374 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.465 ' CG1' HH21 ' A' ' 32' ' ' ARG . 66.7 t -89.57 136.59 23.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 114.748 -1.115 . . . . 65.150000000000006 109.897 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 93.4 mt -148.48 -88.74 0.08 Allowed 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.099 -0.955 . . . . 61.549999999999997 109.606 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -120.58 166.9 13.0 Favored 'General case' 0 C--N 1.262 -3.239 0 N-CA-C 107.006 -1.479 . . . . 64.219999999999999 107.006 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -44.71 -46.74 10.54 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 124.172 0.92 . . . . 74.329999999999998 112.761 -178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.04 -31.54 72.14 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.477 -0.783 . . . . 72.030000000000001 112.271 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -81.47 -36.9 28.77 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.112 -0.699 . . . . 75.230000000000004 109.112 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.406 ' O ' HG12 ' A' ' 113' ' ' ILE . 44.2 m-20 -63.61 -45.39 90.51 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.11 -0.95 . . . . 71.540000000000006 109.198 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.407 ' O ' HG21 ' A' ' 114' ' ' VAL . 7.0 tp -67.69 -36.91 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 120.335 -0.546 . . . . 60.439999999999998 110.951 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.26 -33.18 75.17 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.266 -0.642 . . . . 70.319999999999993 109.266 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 41.6 t -65.09 -38.93 92.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.677 -0.692 . . . . 70.200000000000003 110.248 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 109' ' ' ASP . 51.5 mm -67.69 -43.57 86.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.906 -0.405 . . . . 75.319999999999993 109.906 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 110' ' ' ILE . 83.7 t -60.43 -43.65 94.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.024 -0.535 . . . . 73.329999999999998 111.037 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -66.92 -31.35 71.88 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 120.767 -0.373 . . . . 62.0 110.38 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.64 -45.58 71.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.017 0.437 . . . . 75.140000000000001 110.809 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.4 mt -68.1 -44.13 84.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.545 -0.752 . . . . 72.439999999999998 109.461 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.1 -31.48 71.99 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 112.398 0.518 . . . . 62.43 112.398 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.35 -43.0 61.57 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 119.416 -0.914 . . . . 74.150000000000006 110.012 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 2.6 t -70.36 -41.26 73.35 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.6 0.714 . . . . 62.329999999999998 109.556 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 10.4 mp -74.61 -35.68 62.95 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.75 -0.659 . . . . 74.400000000000006 111.994 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.15 -14.77 52.85 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 119.544 -0.863 . . . . 53.130000000000003 113.033 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.53 -34.59 58.54 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 118.232 -1.387 . . . . 71.519999999999996 111.733 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.48 -153.93 39.16 Favored Glycine 0 C--N 1.295 -1.701 0 CA-C-N 114.726 -1.124 . . . . 71.140000000000001 115.752 172.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--N 1.312 -1.057 0 C-N-CA 125.088 1.355 . . . . 75.329999999999998 112.494 -177.046 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' HE2' ' A' ' 1' ' ' MET . 2.7 tpt . . . . . 0 CA--C 1.511 -0.524 0 N-CA-C 109.402 -0.592 . . . . 52.329999999999998 109.402 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -128.84 170.77 12.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.362 -0.607 . . . . 70.319999999999993 109.362 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.484 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 16.6 m-85 -124.18 146.93 48.37 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.832 -0.622 . . . . 74.319999999999993 110.694 177.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.538 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 0.4 OUTLIER -99.03 102.44 14.16 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 125.27 1.428 . . . . 71.219999999999999 108.246 178.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.1 t -85.0 113.13 23.03 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 107.526 -1.287 . . . . 71.340000000000003 107.526 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -107.26 107.78 23.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.882 -1.155 . . . . 74.239999999999995 107.882 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.9 tt -110.91 110.06 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-O 122.064 0.935 . . . . 73.540000000000006 109.466 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.6 mt -106.77 104.71 52.57 Favored Pre-proline 0 C--N 1.293 -1.879 0 CA-C-N 114.245 -1.343 . . . . 75.519999999999996 110.143 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.695 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 5.9 Cg_exo -81.04 137.51 10.9 Favored 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 121.701 1.601 . . . . 73.109999999999999 108.463 170.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -139.27 156.59 46.95 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.001 -1.481 . . . . 73.219999999999999 107.001 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.406 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 35.7 m -104.58 126.47 51.69 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.397 -0.964 . . . . 73.120000000000005 108.397 175.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.516 ' CE1' ' HB3' ' A' ' 79' ' ' LYS 0.275 8.2 p90 -73.79 75.31 1.59 Allowed 'General case' 0 C--N 1.349 0.573 0 CA-C-O 122.723 1.249 . . . . 72.329999999999998 114.098 -176.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.622 ' NE2' ' HD2' ' A' ' 79' ' ' LYS . 50.3 m80 -128.46 111.41 13.26 Favored 'General case' 0 N--CA 1.414 -2.265 0 O-C-N 121.59 -0.694 . . . . 70.120000000000005 111.696 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -72.47 144.22 48.15 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.388 -1.278 . . . . 74.409999999999997 108.91 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -52.69 120.33 5.58 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 116.983 2.216 . . . . 73.319999999999993 116.983 -173.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.592 ' HB3' ' O ' ' A' ' 19' ' ' ASN . 9.5 t70 -100.45 168.22 9.88 Favored 'General case' 0 C--N 1.262 -3.203 0 CA-C-N 111.974 -2.376 . . . . 73.450000000000003 105.114 165.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -62.63 -32.84 73.94 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 122.63 0.372 . . . . 55.43 111.885 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -135.55 -35.68 0.8 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.901 0.704 . . . . 73.430000000000007 112.901 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.592 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 5.1 m-20 -95.84 -178.62 4.43 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.097 -0.501 . . . . 73.439999999999998 109.662 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 62.8 mtt 56.58 71.32 0.57 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 114.12 1.156 . . . . 71.510000000000005 114.12 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -165.72 116.45 1.05 Allowed 'General case' 0 N--CA 1.406 -2.658 0 N-CA-C 103.412 -2.811 . . . . 64.549999999999997 103.412 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -153.73 104.75 2.73 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-O 122.034 0.921 . . . . 65.310000000000002 110.77 171.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.5 mm -96.58 128.85 47.4 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.707 0 N-CA-C 104.076 -2.564 . . . . 75.150000000000006 104.076 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.695 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 59.3 m -107.81 159.06 31.82 Favored Pre-proline 0 C--N 1.288 -2.104 0 C-N-CA 119.812 -0.755 . . . . 72.120000000000005 110.426 -168.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.33 116.85 3.48 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.571 2.18 . . . . 73.150000000000006 112.741 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.52 128.87 5.55 Favored 'Trans proline' 0 C--O 1.256 1.39 0 C-N-CA 122.111 1.874 . . . . 74.349999999999994 111.501 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -91.44 126.26 36.47 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.723 -0.671 . . . . 74.219999999999999 110.594 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.6 t -123.14 115.24 45.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.555 -0.748 . . . . 71.409999999999997 108.994 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.3 mm -125.14 102.47 10.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 109.664 -0.495 . . . . 62.030000000000001 109.664 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -110.1 80.39 0.27 Allowed Glycine 0 CA--C 1.474 -2.505 0 C-N-CA 119.84 -1.172 . . . . 64.310000000000002 112.92 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -165.3 20.69 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.06 -1.07 . . . . 74.109999999999999 110.304 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -103.08 133.39 48.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.99 -1.855 . . . . 73.140000000000001 105.99 -173.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.0 p -77.93 165.92 23.5 Favored 'General case' 0 N--CA 1.408 -2.526 0 N-CA-C 107.929 -1.137 . . . . 61.32 107.929 174.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.484 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 59.7 t80 -52.76 -43.92 66.13 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 123.333 0.653 . . . . 71.239999999999995 111.029 -174.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.01 -31.33 68.95 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.019 -0.991 . . . . 72.230000000000004 112.889 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -81.63 -34.36 12.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.216 0.531 . . . . 75.430000000000007 109.601 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.04 -45.43 88.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.672 -0.695 . . . . 61.229999999999997 110.012 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.3 mmt -69.85 -29.72 67.03 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.891 0.376 . . . . 74.450000000000003 110.313 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -67.68 -44.71 77.14 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 115.789 -0.641 . . . . 74.219999999999999 110.31 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 44' ' ' VAL . 7.9 tp -69.93 -39.91 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 119.709 -0.797 . . . . 73.120000000000005 109.738 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.31 -42.09 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 116.602 -0.272 . . . . 53.439999999999998 110.931 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.547 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 46.3 t-20 -64.44 -42.42 96.01 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.494 -0.558 . . . . 65.150000000000006 109.494 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.463 ' HA3' ' CE1' ' A' ' 106' ' ' PHE . . . -67.53 -40.46 90.93 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.588 -0.815 . . . . 42.109999999999999 112.058 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 40' ' ' ILE . 72.1 t -65.22 -41.36 91.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.53 -0.545 . . . . 62.340000000000003 109.53 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -53.71 -47.22 70.74 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.481 1.112 . . . . 65.099999999999994 110.92 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 42' ' ' ASN . 88.0 mtt180 -69.5 -37.21 77.11 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.333 -0.848 . . . . 73.209999999999994 110.645 -177.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.2 t -71.12 -36.01 61.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.217 -0.447 . . . . 64.109999999999999 110.649 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.56 -45.63 97.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 122.6 0.36 . . . . 64.019999999999996 110.921 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -70.94 -25.32 62.69 Favored 'General case' 0 C--O 1.209 -1.064 0 CA-C-O 121.02 0.438 . . . . 74.420000000000002 110.82 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.6 -40.84 18.52 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.893 0.701 . . . . 63.130000000000003 112.893 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -92.23 -14.11 29.46 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 112.729 0.64 . . . . 74.150000000000006 112.729 -173.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -135.44 -175.71 4.03 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.505 0.669 . . . . 72.439999999999998 110.543 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -113.53 100.62 8.64 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 103.487 -2.783 . . . . 73.099999999999994 103.487 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.72 153.74 28.49 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 114.07 1.137 . . . . 62.32 114.07 -167.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.6 m -126.73 118.25 24.33 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 105.56 -2.015 . . . . 52.439999999999998 105.56 168.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.9 p -99.96 118.74 47.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.482 0.658 . . . . 75.439999999999998 109.953 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -114.83 122.23 45.72 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.569 -0.741 . . . . 61.32 109.075 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.13 141.33 28.71 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.972 -0.381 . . . . 64.0 109.972 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.57 168.57 19.4 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.563 0.697 . . . . 73.540000000000006 109.481 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -106.24 127.0 52.92 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.179 -1.415 . . . . 74.409999999999997 107.179 174.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.83 176.51 43.04 Favored Glycine 0 N--CA 1.422 -2.273 0 CA-C-N 115.742 -0.663 . . . . 53.149999999999999 112.672 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.23 174.64 1.54 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.271 1.028 . . . . 73.420000000000002 110.146 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -49.49 -40.65 38.24 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.081 0.952 . . . . 63.229999999999997 111.736 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.18 -20.25 48.9 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.566 -1.197 . . . . 53.520000000000003 111.999 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 85' ' ' LYS . 2.1 t70 -89.0 171.29 9.97 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.836 -0.54 . . . . 73.209999999999994 109.877 -174.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.7 t -114.19 -37.94 2.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 C-N-CA 123.857 0.863 . . . . 54.310000000000002 109.532 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.3 tp -167.3 131.57 1.89 Allowed 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.891 -0.595 . . . . 72.129999999999995 110.503 -171.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.28 133.68 52.56 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 107.41 -1.33 . . . . 72.120000000000005 107.41 -176.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -139.3 142.32 37.71 Favored 'General case' 0 C--N 1.28 -2.433 0 O-C-N 121.618 -0.676 . . . . 61.32 110.713 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -121.64 122.69 40.17 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.376 0.608 . . . . 62.520000000000003 109.522 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -97.57 119.85 36.89 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 107.177 -1.416 . . . . 74.319999999999993 107.177 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.7 m -94.35 116.17 28.5 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.305 -1.369 . . . . 52.020000000000003 107.305 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.94 142.2 47.61 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-O 121.04 0.448 . . . . 64.120000000000005 110.913 -173.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 26.6 tt0 -150.41 100.49 2.88 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 107.936 -1.135 . . . . 73.129999999999995 107.936 168.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -102.75 90.4 3.8 Favored 'General case' 0 N--CA 1.417 -2.078 0 C-N-CA 118.959 -1.096 . . . . 63.399999999999999 108.39 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 55.51 67.58 0.99 Allowed 'General case' 0 CA--C 1.545 0.771 0 O-C-N 124.707 1.254 . . . . 74.400000000000006 111.385 171.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.62 -23.5 19.22 Favored Glycine 0 C--N 1.308 -1.021 0 CA-C-N 115.483 -0.781 . . . . 73.409999999999997 113.341 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 53.2 mtmt -84.44 101.12 11.78 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.261 -1.015 . . . . 75.439999999999998 108.261 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.622 ' HD2' ' NE2' ' A' ' 13' ' ' HIS . 42.0 mttp -103.73 134.11 47.6 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 123.843 0.715 . . . . 72.549999999999997 110.187 -172.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -171.8 169.46 42.53 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.074 -1.06 . . . . 52.539999999999999 112.825 177.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.1 mt -131.62 138.22 53.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.147 -1.427 . . . . 71.109999999999999 107.147 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.8 t -115.18 110.34 31.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 109.084 -0.71 . . . . 74.409999999999997 109.084 176.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -97.27 105.83 18.05 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.664 -0.698 . . . . 74.230000000000004 109.827 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.2 t -101.29 115.44 43.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 107.927 -1.138 . . . . 72.540000000000006 107.927 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.471 ' HB2' ' OD2' ' A' ' 65' ' ' ASP . 21.7 ptmt -124.16 133.78 53.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.29 -0.633 . . . . 74.200000000000003 109.29 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.6 mt -107.33 112.91 25.97 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.863 -0.791 . . . . 72.340000000000003 108.863 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.5 mmm-85 -97.13 139.01 33.76 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.316 -0.994 . . . . 74.400000000000006 108.316 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.584 ' O ' ' HB2' ' A' ' 93' ' ' CYS . 21.8 pttm -92.06 98.98 11.89 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 120.208 -0.597 . . . . 74.450000000000003 111.464 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.2 tt -66.59 111.7 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 122.326 1.06 . . . . 73.129999999999995 109.494 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.3 p -145.67 -170.46 3.46 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.25 -1.341 . . . . 71.310000000000002 108.924 -169.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -72.73 -19.49 61.38 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.87 -1.159 . . . . 75.310000000000002 107.87 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.1 -36.84 17.88 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.253 -1.34 . . . . 73.239999999999995 109.556 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 86.3 m -122.36 125.43 26.53 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 113.463 0.912 . . . . 74.519999999999996 113.463 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.21 161.98 15.32 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.522 2.148 . . . . 75.450000000000003 110.905 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.12 142.99 89.34 Favored 'Trans proline' 0 C--O 1.262 1.71 0 C-N-CA 121.943 1.762 . . . . 71.439999999999998 109.667 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 t -87.98 159.42 3.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 109.576 -0.527 . . . . 72.230000000000004 109.576 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -109.51 131.15 55.33 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.782 -0.821 . . . . 72.329999999999998 108.782 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -174.6 -160.76 23.26 Favored Glycine 0 CA--C 1.479 -2.17 0 N-CA-C 110.731 -0.948 . . . . 71.530000000000001 110.731 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -79.73 125.75 30.06 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.207 -0.664 . . . . 72.340000000000003 109.207 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -87.72 105.87 17.66 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.891 0.853 . . . . 75.209999999999994 110.761 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 53.1 t -69.73 152.54 44.53 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.846 -1.525 . . . . 37.710000000000001 109.468 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.0 m -74.33 104.56 5.13 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.518 -0.919 . . . . 60.420000000000002 108.518 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.6 t -113.21 140.51 32.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 121.753 0.787 . . . . 74.439999999999998 110.518 -175.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.6 tp -149.76 -64.94 0.22 Allowed 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 114.452 -1.249 . . . . 75.150000000000006 108.164 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -158.42 162.04 37.55 Favored 'General case' 0 C--N 1.249 -3.787 0 CA-C-N 112.743 -2.026 . . . . 71.450000000000003 106.828 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.463 ' CE1' ' HA3' ' A' ' 43' ' ' GLY . 57.5 t80 -32.52 -55.03 0.34 Allowed 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 116.004 1.853 . . . . 53.200000000000003 116.004 -173.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.26 -28.13 69.52 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 113.669 0.988 . . . . 73.310000000000002 113.669 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -39.75 15.21 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.367 -1.346 . . . . 74.430000000000007 107.367 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.45 ' O ' HG12 ' A' ' 113' ' ' ILE . 11.9 m-20 -65.91 -46.51 78.02 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.603 -1.18 . . . . 74.019999999999996 108.629 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 16.2 tt -69.6 -25.86 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.536 -0.756 . . . . 73.209999999999994 110.504 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -65.34 -49.92 67.56 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 107.025 -1.472 . . . . 60.340000000000003 107.025 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 3.4 t -63.29 -39.82 95.63 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.688 -1.142 . . . . 55.530000000000001 111.27 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 109' ' ' ASP . 41.4 mm -64.89 -46.91 90.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.048 -0.524 . . . . 74.019999999999996 111.368 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 92.6 t -69.99 -33.64 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 C-N-CA 120.184 -0.607 . . . . 73.310000000000002 110.173 -176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -66.4 -37.75 85.94 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.827 -0.624 . . . . 75.329999999999998 110.79 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.55 -41.03 80.36 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.064 0.459 . . . . 65.25 110.403 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.39 -45.7 95.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.671 -0.695 . . . . 74.239999999999995 109.186 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.6 -38.15 89.04 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 115.928 -0.578 . . . . 73.340000000000003 112.1 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -68.7 -40.21 80.13 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.602 -0.439 . . . . 72.310000000000002 110.632 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 42.8 t -59.22 -49.84 76.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.359 0.6 . . . . 73.230000000000004 109.433 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 10.5 mp -74.68 -14.84 60.79 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.603 -0.726 . . . . 74.129999999999995 112.427 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.26 -33.68 25.97 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 110.243 -0.28 . . . . 62.539999999999999 110.243 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.54 -34.84 46.89 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.311 0.577 . . . . 70.209999999999994 109.815 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.22 -136.35 51.03 Favored Glycine 0 CA--C 1.474 -2.521 0 CA-C-N 114.094 -1.412 . . . . 55.539999999999999 114.594 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.469 ' HB3' ' CD2' ' A' ' 13' ' ' HIS . 1.3 pm0 . . . . . 0 C--N 1.262 -3.225 0 N-CA-C 114.934 1.457 . . . . 71.5 114.934 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.441 ' SD ' ' HE1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.504 -0.793 0 CA-C-O 120.807 0.337 . . . . 70.129999999999995 111.189 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -110.27 164.28 12.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.669 0.747 . . . . 51.549999999999997 111.986 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 11.3 m-85 -120.04 140.28 51.23 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.527 -1.215 . . . . 74.319999999999993 111.152 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.623 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 28.7 t70 -101.08 102.58 13.57 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 104.855 -2.276 . . . . 63.049999999999997 104.855 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.78 117.76 32.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.325 -0.852 . . . . 73.239999999999995 109.442 -172.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.19 116.72 52.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.028 -1.101 . . . . 74.519999999999996 108.028 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.3 tt -118.69 120.75 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 121.396 0.617 . . . . 74.25 109.732 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.436 HG12 ' HB3' ' A' ' 26' ' ' PRO . 5.5 mt -112.49 100.8 51.14 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 115.543 -0.753 . . . . 65.439999999999998 108.98 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.594 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 1.4 Cg_endo -85.53 120.53 2.11 Favored 'Trans proline' 0 N--CA 1.436 -1.87 0 N-CA-C 107.769 -1.666 . . . . 75.409999999999997 107.769 171.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -144.61 129.7 18.56 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 120.922 0.391 . . . . 70.340000000000003 110.431 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.511 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 37.5 m -73.08 120.39 18.63 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.65 -0.5 . . . . 74.439999999999998 109.65 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 2.7 p90 -61.52 110.89 1.6 Allowed 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 113.967 1.099 . . . . 72.109999999999999 113.967 -174.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -143.84 106.26 4.41 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 114.854 -1.066 . . . . 71.200000000000003 110.114 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -68.84 122.24 18.2 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.878 -1.897 . . . . 74.310000000000002 105.878 173.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.48 103.69 0.55 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 124.585 1.178 . . . . 73.349999999999994 109.77 -172.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 17' ' ' LYS . 14.0 t70 -89.1 -158.15 0.49 Allowed 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 114.02 -1.445 . . . . 55.420000000000002 110.492 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.472 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 23.3 tptm -72.46 -45.34 59.99 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.741 0.816 . . . . 74.150000000000006 111.694 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -132.62 -51.46 0.92 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.584 0.707 . . . . 73.209999999999994 110.249 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -96.36 -177.83 4.09 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 114.489 -1.232 . . . . 63.43 110.612 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 86.9 mtp 70.75 80.13 0.17 Allowed 'General case' 0 C--N 1.313 -0.99 0 O-C-N 124.572 1.17 . . . . 37.140000000000001 109.977 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -168.05 121.24 0.89 Allowed 'General case' 0 N--CA 1.403 -2.792 0 N-CA-C 105.083 -2.192 . . . . 70.530000000000001 105.083 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.441 ' NE2' ' HB3' ' A' ' 123' ' ' LYS . 18.5 t60 -168.42 84.28 0.17 Allowed 'General case' 0 C--N 1.282 -2.34 0 O-C-N 124.57 1.169 . . . . 75.230000000000004 110.334 165.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.5 mm -103.17 136.05 37.72 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 N-CA-C 107.165 -1.42 . . . . 74.450000000000003 107.165 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 79.0 m -107.25 145.49 31.29 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 110.126 -0.324 . . . . 74.439999999999998 110.126 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.49 136.27 73.12 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 123.424 2.749 . . . . 71.340000000000003 112.873 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.436 ' HB3' HG12 ' A' ' 8' ' ' ILE . 74.5 Cg_endo -73.05 140.66 31.64 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.887 2.391 . . . . 63.340000000000003 112.394 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 99' ' ' ASN . 53.8 mtt -98.12 139.56 33.74 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-N 116.233 -0.44 . . . . 74.319999999999993 109.84 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.6 t -130.12 116.7 37.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 116.524 -0.307 . . . . 71.099999999999994 110.448 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.25 102.39 9.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 107.188 -1.412 . . . . 63.420000000000002 107.188 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.623 ' CA ' ' HA ' ' A' ' 4' ' ' ASP . . . -121.85 81.7 0.34 Allowed Glycine 0 N--CA 1.42 -2.372 0 C-N-CA 119.056 -1.545 . . . . 53.329999999999998 115.262 -175.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -153.64 15.82 0.51 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.24 -0.98 . . . . 72.430000000000007 110.803 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -102.07 136.43 41.91 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.745 -0.835 . . . . 72.430000000000007 108.745 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 p -74.05 168.31 19.78 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 106.595 -1.632 . . . . 73.129999999999995 106.595 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.545 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 73.9 t80 -61.62 -38.69 88.57 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 118.425 0.557 . . . . 70.340000000000003 110.735 -174.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -59.65 -49.26 78.44 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.486 -0.779 . . . . 71.129999999999995 111.209 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.1 mt -70.83 -38.74 73.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.647 -0.706 . . . . 72.5 109.308 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.94 -41.64 91.06 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.635 -0.711 . . . . 74.430000000000007 110.703 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 11.7 tpt -68.94 -40.83 78.73 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.839 -0.43 . . . . 52.329999999999998 109.839 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -74.21 -32.71 63.14 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 112.744 0.646 . . . . 70.109999999999999 112.744 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.55 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -74.68 -42.66 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.601 -0.889 . . . . 55.229999999999997 108.601 178.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.4 t -69.75 -38.78 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 120.956 -0.298 . . . . 71.109999999999999 110.7 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.547 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -73.96 -26.75 60.64 Favored 'General case' 0 C--O 1.201 -1.479 0 C-N-CA 119.8 -0.76 . . . . 73.409999999999997 110.474 177.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.2 -46.33 80.39 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.133 -1.187 . . . . 54.25 110.133 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 40' ' ' ILE . 96.2 t -58.24 -45.07 89.11 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 N-CA-C 108.523 -0.917 . . . . 75.310000000000002 108.523 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.547 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 8.3 t70 -50.07 -49.27 51.89 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.646 1.578 . . . . 74.209999999999994 111.457 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 42' ' ' ASN . 45.4 mtt180 -67.36 -36.64 81.79 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.906 -1.043 . . . . 75.239999999999995 109.717 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.72 -38.85 67.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 123.358 0.411 . . . . 61.310000000000002 110.695 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 44' ' ' VAL . 70.3 mt -63.99 -46.1 94.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 C-N-CA 122.471 0.308 . . . . 52.310000000000002 110.614 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -78.68 -14.35 59.34 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.83 -0.748 . . . . 65.420000000000002 110.819 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.5 -49.27 10.1 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.948 -0.569 . . . . 73.209999999999994 111.126 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -91.8 -16.17 27.18 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 113.222 0.823 . . . . 74.219999999999999 113.222 -171.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -129.09 -177.26 4.15 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.583 0.706 . . . . 74.25 110.281 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 26.2 t-20 -109.81 108.23 18.48 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 104.352 -2.462 . . . . 73.120000000000005 104.352 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.66 157.97 45.27 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 115.963 -0.562 . . . . 71.239999999999995 112.202 -172.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 t -129.01 120.02 25.29 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.6 -1.63 . . . . 75.129999999999995 106.6 171.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.9 p -100.62 124.04 53.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.233 0.54 . . . . 73.340000000000003 110.612 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -122.73 146.92 47.07 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.791 -0.818 . . . . 75.239999999999995 108.791 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -119.68 127.67 53.1 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.955 0.883 . . . . 73.409999999999997 111.791 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.29 176.78 5.3 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.14 -1.43 . . . . 72.400000000000006 107.14 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -111.99 136.84 50.81 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.681 -0.859 . . . . 74.120000000000005 108.681 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -84.17 176.69 51.77 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 115.828 -0.624 . . . . 54.549999999999997 112.874 -175.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -74.68 133.04 42.13 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 123.328 0.651 . . . . 74.530000000000001 111.84 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t70 46.31 -84.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 126.298 1.839 . . . . 72.329999999999998 114.973 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.5 p -97.49 -1.6 43.78 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 113.556 0.947 . . . . 75.530000000000001 113.556 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 13.4 m-20 -76.96 117.78 18.89 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.659 -1.608 . . . . 75.310000000000002 106.659 172.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.0 t -85.31 -31.3 6.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-O 121.264 0.554 . . . . 72.25 112.235 -173.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 63.2 tp -148.67 133.91 18.38 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 109.409 -0.589 . . . . 74.25 109.409 -176.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.449 ' CE2' ' HD3' ' A' ' 85' ' ' LYS . 1.1 t80 -129.91 105.44 7.99 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.261 -1.385 . . . . 75.329999999999998 107.261 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -107.69 125.38 51.3 Favored 'General case' 0 C--N 1.281 -2.396 0 C-N-CA 120.191 -0.604 . . . . 74.340000000000003 111.732 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -103.0 115.14 30.03 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 125.201 1.4 . . . . 64.019999999999996 108.476 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 75.3 m-85 -102.56 118.04 36.0 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.606 -0.516 . . . . 74.099999999999994 109.606 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.0 m -87.87 123.15 32.33 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.804 -1.184 . . . . 71.25 107.804 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.404 HD12 HG22 ' A' ' 48' ' ' ILE . 4.3 mm? -111.14 138.46 47.55 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.972 0.909 . . . . 64.310000000000002 111.985 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 2.0 tm-20 -151.16 83.0 1.32 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.887 -1.051 . . . . 74.519999999999996 108.899 170.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.9 70.55 9.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.848 -0.797 . . . . 52.509999999999998 108.848 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 45.55 71.53 0.27 Allowed 'General case' 0 C--O 1.244 0.783 0 C-N-CA 125.255 1.422 . . . . 72.319999999999993 111.542 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.15 -24.1 33.08 Favored Glycine 0 C--N 1.304 -1.226 0 CA-C-N 115.466 -0.788 . . . . 45.32 112.207 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 99.0 mttt -88.53 103.13 15.6 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.417 -0.957 . . . . 71.420000000000002 108.417 175.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -106.78 146.96 30.24 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 120.307 -0.557 . . . . 72.420000000000002 110.515 -175.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . 177.72 177.42 46.52 Favored Glycine 0 CA--C 1.48 -2.148 0 C-N-CA 120.202 -0.999 . . . . 60.530000000000001 112.528 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 32.2 mt -132.22 145.19 35.09 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 106.796 -1.557 . . . . 73.019999999999996 106.796 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 100.0 t -122.5 109.22 23.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 108.208 -1.034 . . . . 73.319999999999993 108.208 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -95.05 106.54 18.55 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 123.868 0.867 . . . . 74.200000000000003 110.381 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.3 t -107.96 112.48 40.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.028 -0.73 . . . . 71.109999999999999 109.028 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.449 ' HD3' ' CE2' ' A' ' 68' ' ' TYR . 58.0 pttt -116.66 135.08 54.08 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 120.906 0.384 . . . . 63.030000000000001 110.867 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.3 mt -106.27 105.69 15.84 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.255 -1.387 . . . . 70.319999999999993 107.255 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 33.8 ttt85 -98.02 118.29 34.28 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.366 -0.605 . . . . 73.510000000000005 109.366 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -70.54 104.01 2.66 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.232 -0.655 . . . . 74.530000000000001 109.232 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.2 tt -78.44 111.26 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 CA-C-O 122.415 1.102 . . . . 63.240000000000002 108.989 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.4 t -138.77 -177.87 5.06 Favored 'General case' 0 N--CA 1.401 -2.903 0 N-CA-C 105.989 -1.856 . . . . 73.049999999999997 105.989 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -75.12 -21.74 58.67 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 118.799 0.727 . . . . 75.420000000000002 110.691 -173.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -96.74 11.37 35.8 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.592 -1.185 . . . . 73.219999999999999 109.686 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 41.3 t -139.92 116.46 8.16 Favored Pre-proline 0 C--N 1.319 -0.739 0 O-C-N 121.177 -0.952 . . . . 63.549999999999997 112.096 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -79.61 131.23 9.23 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.756 2.304 . . . . 71.030000000000001 110.876 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.14 164.15 36.18 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 123.108 2.538 . . . . 75.430000000000007 111.648 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.89 156.82 3.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.726 -0.842 . . . . 71.439999999999998 108.726 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -107.93 140.68 40.7 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.449 -0.945 . . . . 71.400000000000006 108.449 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.58 -171.29 40.12 Favored Glycine 0 CA--C 1.471 -2.67 0 N-CA-C 109.064 -1.614 . . . . 75.310000000000002 109.064 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 27' ' ' MET . 6.9 t-20 -63.63 103.78 0.58 Allowed 'General case' 0 N--CA 1.409 -2.486 0 C-N-CA 123.814 0.846 . . . . 65.010000000000005 110.018 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -89.32 103.08 15.74 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.141 -1.059 . . . . 72.230000000000004 108.141 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 42.6 t -71.19 175.2 5.49 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.054 -0.975 . . . . 72.219999999999999 111.136 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.9 p -60.72 110.3 1.27 Allowed 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.245 1.018 . . . . 61.109999999999999 110.949 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.22 139.12 17.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.884 -0.784 . . . . 64.310000000000002 108.884 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.542 ' HG ' ' H ' ' A' ' 105' ' ' GLU . 15.8 tp -178.72 -159.47 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 104.53 -2.396 . . . . 73.129999999999995 104.53 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.542 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 43.0 mt-10 -81.39 171.61 14.55 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 118.614 0.643 . . . . 75.120000000000005 111.259 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.405 ' O ' HG21 ' A' ' 110' ' ' ILE . 1.2 t80 -36.13 -48.5 0.62 Allowed 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 127.59 2.356 . . . . 64.299999999999997 113.351 -173.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.69 -28.5 68.67 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 123.85 0.86 . . . . 74.439999999999998 112.449 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.4 ' HA ' ' NE ' ' A' ' 108' ' ' ARG . 0.8 OUTLIER -87.38 -40.83 14.07 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.348 -0.541 . . . . 73.329999999999998 110.279 -178.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.576 ' O ' HG12 ' A' ' 113' ' ' ILE 0.328 18.5 p-10 -80.52 -26.01 38.37 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 119.377 -0.929 . . . . 61.140000000000001 112.211 -174.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.405 HG21 ' O ' ' A' ' 106' ' ' PHE . 8.6 tp -64.55 -38.97 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 109.457 -0.572 . . . . 74.430000000000007 109.457 173.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.41 -43.32 86.09 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.311 -0.626 . . . . 54.100000000000001 109.311 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 42.9 t -58.5 -44.32 89.4 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.816 -1.084 . . . . 74.120000000000005 111.612 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 109' ' ' ASP . 43.4 mm -65.25 -41.39 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 120.923 -0.311 . . . . 74.239999999999995 110.591 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.87 -42.87 97.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.544 -0.539 . . . . 64.340000000000003 109.544 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -61.47 -41.77 97.75 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.875 -0.602 . . . . 55.200000000000003 111.534 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.63 97.35 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 123.422 0.451 . . . . 54.210000000000001 111.444 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.3 mt -67.89 -44.79 85.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.165 -0.68 . . . . 72.329999999999998 109.165 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.92 -33.97 77.3 Favored 'General case' 0 C--O 1.211 -0.928 0 CA-C-N 115.702 -0.681 . . . . 75.329999999999998 111.64 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -69.97 -43.36 71.65 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.331 0.586 . . . . 72.310000000000002 110.64 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 5.3 t -70.22 -41.54 73.48 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.402 0.62 . . . . 62.539999999999999 109.594 -176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.5 mp -78.13 -15.7 58.62 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.503 -0.771 . . . . 74.200000000000003 111.77 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.41 -38.25 22.17 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 121.034 -0.266 . . . . 51.100000000000001 111.031 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.441 ' HB3' ' NE2' ' A' ' 22' ' ' HIS . 23.1 tptm -62.79 -47.52 83.14 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.264 0.554 . . . . 64.340000000000003 110.103 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.64 -164.21 53.05 Favored Glycine 0 C--N 1.286 -2.229 0 CA-C-N 114.326 -1.306 . . . . 73.140000000000001 114.341 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.246 0.907 0 C-N-CA 124.057 0.943 . . . . 72.420000000000002 110.258 -179.455 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mmm . . . . . 0 CA--C 1.494 -1.211 0 N-CA-C 111.965 0.357 . . . . 75.200000000000003 111.965 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -101.71 141.38 34.66 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.26 -1.015 . . . . 71.219999999999999 108.26 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.534 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 56.0 m-85 -118.06 142.79 47.03 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.64 -0.504 . . . . 74.109999999999999 109.64 174.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.495 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 32.0 t70 -104.31 115.58 30.64 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 124.475 1.11 . . . . 73.239999999999995 109.627 -172.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.82 117.32 48.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.917 -0.489 . . . . 45.530000000000001 109.861 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.52 124.27 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-O 121.357 0.599 . . . . 74.109999999999999 109.409 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.477 HG23 ' HB2' ' A' ' 27' ' ' MET . 7.1 tt -123.41 118.27 53.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-O 121.556 0.693 . . . . 74.120000000000005 111.062 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.437 HG12 ' HB3' ' A' ' 26' ' ' PRO . 61.9 mt -106.61 111.77 63.86 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 115.267 -0.878 . . . . 71.030000000000001 109.838 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.508 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 3.3 Cg_endo -87.34 123.79 1.94 Allowed 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.029 1.819 . . . . 72.219999999999999 109.205 171.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -142.74 119.35 11.07 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.484 0.659 . . . . 72.200000000000003 111.076 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 22' ' ' HIS . 49.4 m -77.36 116.65 18.14 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.233 -0.44 . . . . 70.209999999999994 110.298 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.679 ' CE1' ' HB2' ' A' ' 79' ' ' LYS . 1.8 p90 -65.46 123.99 21.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.65 0.738 . . . . 75.219999999999999 112.035 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 39.4 m80 -139.71 146.39 39.54 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.951 -1.022 . . . . 73.5 110.299 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -82.13 104.89 12.79 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-O 122.443 1.116 . . . . 72.409999999999997 109.927 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -67.47 100.7 0.88 Allowed 'General case' 0 N--CA 1.398 -3.036 0 CA-C-N 113.201 -1.818 . . . . 75.219999999999999 109.165 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -87.31 -94.48 0.09 Allowed 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.474 -0.785 . . . . 72.129999999999995 111.885 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -112.77 -57.8 2.24 Favored 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 119.32 -0.952 . . . . 73.349999999999994 112.729 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -121.98 -26.53 4.76 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 118.975 -1.09 . . . . 62.340000000000003 112.901 -169.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -137.34 169.9 17.0 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.333 -0.617 . . . . 74.5 109.333 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.405 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 64.2 mtm 82.19 70.85 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 126.159 1.783 . . . . 44.439999999999998 111.226 -176.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -161.76 96.33 1.02 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 105.046 -2.205 . . . . 74.25 105.046 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 11' ' ' SER . 39.1 t60 -114.15 89.91 3.21 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 119.24 -0.984 . . . . 73.299999999999997 112.041 -171.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mm -100.99 131.12 49.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 106.529 -1.656 . . . . 71.129999999999995 106.529 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 71.4 m -107.68 130.34 22.95 Favored Pre-proline 0 C--N 1.292 -1.918 0 C-N-CA 119.927 -0.709 . . . . 72.129999999999995 109.099 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -42.62 134.43 5.04 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 124.037 3.158 . . . . 52.210000000000001 113.915 -177.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.437 ' HB3' HG12 ' A' ' 8' ' ' ILE . 15.7 Cg_endo -59.29 136.77 74.46 Favored 'Trans proline' 0 C--O 1.256 1.393 0 C-N-CA 123.477 2.785 . . . . 75.409999999999997 114.073 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.514 ' HA ' ' O ' ' A' ' 99' ' ' ASN . 24.8 mmt -96.52 131.45 43.11 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 105.401 -2.074 . . . . 73.420000000000002 105.401 172.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.6 t -126.17 129.58 72.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 120.228 -0.589 . . . . 65.239999999999995 110.256 -175.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.3 mm -136.04 101.19 2.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 106.985 -1.487 . . . . 54.409999999999997 106.985 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.495 ' CA ' ' HA ' ' A' ' 4' ' ' ASP . . . -120.01 82.42 0.34 Allowed Glycine 0 CA--C 1.488 -1.604 0 C-N-CA 120.078 -1.058 . . . . 63.119999999999997 112.783 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -158.74 26.21 0.22 Allowed 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.982 -0.609 . . . . 75.209999999999994 111.46 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.486 HH22 HG11 ' A' ' 103' ' ' VAL . 21.3 mmt85 -118.04 141.97 47.9 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 107.828 -1.175 . . . . 74.230000000000004 107.828 -174.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.8 p -75.86 172.6 12.42 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 118.842 0.746 . . . . 74.019999999999996 109.481 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.534 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 60.1 t80 -55.19 -47.53 75.12 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.35 0.595 . . . . 72.430000000000007 112.139 -174.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.02 -40.01 78.9 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.343 -0.844 . . . . 63.329999999999998 111.197 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.72 -33.33 43.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.248 -0.433 . . . . 75.010000000000005 110.218 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.416 ' O ' HG22 ' A' ' 40' ' ' ILE . . . -65.28 -44.8 86.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.408 -0.36 . . . . 73.120000000000005 110.59 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.6 mtm -73.08 -33.34 65.57 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 118.912 -1.115 . . . . 74.209999999999994 111.06 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.11 -44.0 85.57 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.069 -0.514 . . . . 60.030000000000001 110.415 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 37' ' ' ALA . 8.5 tp -65.46 -38.92 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 109.807 -0.442 . . . . 71.219999999999999 109.807 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.8 t -69.29 -39.94 79.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 CA-C-N 116.213 -0.449 . . . . 74.030000000000001 110.196 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -67.84 -28.25 67.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.127 0.489 . . . . 72.019999999999996 110.183 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.43 -47.36 63.42 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.296 -1.121 . . . . 71.409999999999997 110.296 175.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 40' ' ' ILE . 92.9 t -62.7 -41.96 94.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.452 -0.573 . . . . 74.430000000000007 109.452 177.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -53.38 -53.05 56.71 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 125.265 1.426 . . . . 72.310000000000002 110.565 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.421 ' HA ' ' CD ' ' A' ' 49' ' ' LYS . 61.9 mtm180 -71.1 -23.77 62.17 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.511 -0.768 . . . . 75.219999999999999 112.523 -175.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 43' ' ' GLY . 94.3 t -78.2 -44.87 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 C-N-CA 120.522 -0.471 . . . . 70.239999999999995 110.47 175.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.9 mt -73.17 -33.77 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 120.537 -0.465 . . . . 72.439999999999998 111.456 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' CD ' ' HA ' ' A' ' 46' ' ' ARG . 13.3 ptmt -74.4 -16.22 60.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.391 0.615 . . . . 72.540000000000006 110.455 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.7 -49.79 5.21 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 115.318 -0.856 . . . . 64.209999999999994 111.081 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 t -77.07 -22.53 52.7 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 123.528 0.731 . . . . 64.319999999999993 112.649 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -127.7 -172.75 2.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.608 0.718 . . . . 71.310000000000002 110.8 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 18.6 t-20 -105.21 89.68 3.2 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 104.326 -2.472 . . . . 74.430000000000007 104.326 172.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -108.13 135.89 48.72 Favored 'General case' 0 N--CA 1.407 -2.599 0 CA-C-N 115.169 -0.923 . . . . 72.349999999999994 112.029 -172.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.5 m -115.6 110.73 19.62 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 106.171 -1.789 . . . . 54.149999999999999 106.171 172.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.85 118.72 46.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.54 -0.541 . . . . 72.019999999999996 109.54 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.541 ' CG ' ' HB2' ' A' ' 70' ' ' LYS . 9.2 pt-20 -120.88 122.32 40.0 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.123 -0.695 . . . . 73.430000000000007 109.123 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.402 ' HG2' ' HG2' ' A' ' 69' ' ' ARG . 42.7 mt-10 -95.28 130.44 42.04 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.814 -0.63 . . . . 75.140000000000001 111.37 -175.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.2 mp -125.52 176.5 6.8 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.437 -0.801 . . . . 72.209999999999994 109.324 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -105.27 139.14 40.36 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-O 121.198 0.523 . . . . 72.120000000000005 109.846 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.26 176.44 41.96 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 110.514 -1.034 . . . . 52.229999999999997 110.514 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.527 ' N ' ' HB2' ' A' ' 65' ' ' ASP . 26.7 mm-40 -65.51 -176.17 0.32 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 122.102 0.953 . . . . 72.319999999999993 111.67 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.69 -34.93 78.94 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.688 -1.142 . . . . 63.350000000000001 110.084 172.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.9 t -77.1 -22.06 53.31 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.591 -1.186 . . . . 64.519999999999996 108.997 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.527 ' HB2' ' N ' ' A' ' 62' ' ' GLU . 67.3 m-20 -93.53 172.46 8.25 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 109.024 -0.732 . . . . 75.530000000000001 109.024 177.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.1 t -117.7 -43.27 2.97 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 CA-C-O 121.513 0.673 . . . . 74.430000000000007 110.382 174.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.1 tp -157.34 149.1 22.28 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.73 -0.668 . . . . 65.230000000000004 109.724 -172.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.26 135.36 47.27 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.595 -0.891 . . . . 75.200000000000003 108.595 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.402 ' HG2' ' HG2' ' A' ' 58' ' ' GLU . 88.6 mtt180 -132.27 129.42 39.57 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.227 -0.296 . . . . 75.129999999999995 110.76 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.541 ' HB2' ' CG ' ' A' ' 57' ' ' GLU . 6.4 mtpm? -105.55 116.56 32.15 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 105.615 -1.995 . . . . 73.430000000000007 105.615 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -101.54 106.08 17.13 Favored 'General case' 0 C--N 1.263 -3.184 0 N-CA-C 107.678 -1.23 . . . . 74.120000000000005 107.678 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.3 m -91.93 112.44 24.37 Favored 'General case' 0 C--N 1.276 -2.628 0 N-CA-C 107.672 -1.233 . . . . 65.219999999999999 107.672 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.83 149.39 37.13 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.286 0.565 . . . . 65.340000000000003 111.023 -173.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.549 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 42.7 tt0 -150.25 98.26 2.65 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.991 -1.004 . . . . 74.439999999999998 109.8 168.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -105.91 88.66 2.86 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 115.872 -0.604 . . . . 65.239999999999995 109.674 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.295 5.7 pt-20 36.74 74.29 0.08 Allowed 'General case' 0 C--O 1.243 0.749 0 C-N-CA 125.825 1.65 . . . . 70.239999999999995 114.974 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.37 -23.91 34.37 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 113.604 -1.635 . . . . 71.219999999999999 112.47 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 57.9 mtmt -95.12 94.74 8.11 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 122.368 -0.489 . . . . 75.329999999999998 109.701 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.679 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 2.3 ptpp? -113.54 124.0 51.34 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.242 -0.89 . . . . 73.129999999999995 111.211 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.04 172.49 45.16 Favored Glycine 0 CA--C 1.491 -1.411 0 C-N-CA 120.967 -0.635 . . . . 61.130000000000003 112.0 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.9 mt -121.65 145.99 27.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.552 -0.907 . . . . 61.350000000000001 108.552 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 95.6 t -119.94 110.34 28.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 108.512 -0.921 . . . . 63.420000000000002 108.512 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.515 ' CD2' ' HG2' ' A' ' 70' ' ' LYS . 33.0 m170 -94.94 107.85 19.89 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.816 -0.629 . . . . 73.230000000000004 110.196 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.14 118.49 53.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 115.792 -0.64 . . . . 74.0 109.565 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -111.82 142.39 44.25 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.203 -0.666 . . . . 65.430000000000007 109.203 173.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.5 mt -107.37 123.94 49.1 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 103.549 -2.759 . . . . 54.43 103.549 172.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 41.6 mtp-105 -112.84 155.92 23.81 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 109.267 -0.642 . . . . 74.25 109.267 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -98.06 105.49 17.64 Favored 'General case' 0 C--N 1.282 -2.346 0 C-N-CA 120.327 -0.549 . . . . 64.329999999999998 110.485 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.458 ' C ' ' HG1' ' A' ' 90' ' ' THR . 1.8 tt -82.81 110.17 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 107.749 -1.204 . . . . 71.209999999999994 107.749 174.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.458 ' HG1' ' C ' ' A' ' 89' ' ' ILE . 2.2 m -145.85 -175.39 4.72 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 105.045 -2.206 . . . . 62.530000000000001 105.045 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -15.9 63.04 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 120.087 1.312 . . . . 71.329999999999998 110.458 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.07 -23.95 38.12 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.949 -1.023 . . . . 71.109999999999999 111.803 175.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 40.8 m -145.35 117.61 5.23 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 112.472 0.545 . . . . 64.439999999999998 112.472 -176.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.59 158.49 47.4 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 122.622 2.215 . . . . 64.310000000000002 110.499 175.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.3 160.37 49.03 Favored 'Trans proline' 0 C--O 1.255 1.337 0 C-N-CA 122.789 2.326 . . . . 74.030000000000001 110.65 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 t -82.93 149.46 4.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 107.24 -1.393 . . . . 53.509999999999998 107.24 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -112.38 112.81 24.65 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 106.75 -1.574 . . . . 70.209999999999994 106.75 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -151.51 -157.62 7.97 Favored Glycine 0 CA--C 1.461 -3.309 0 C-N-CA 120.165 -1.017 . . . . 62.439999999999998 112.018 -174.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 27' ' ' MET . 35.5 m-80 -76.58 104.23 6.98 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.798 -0.816 . . . . 71.209999999999994 108.798 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -83.11 112.32 19.7 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-O 121.651 0.739 . . . . 75.349999999999994 109.387 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.8 t -70.29 153.02 43.53 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.914 -1.513 . . . . 74.540000000000006 106.914 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.424 ' N ' ' SG ' ' A' ' 112' ' ' CYS . 15.5 m -69.84 77.63 0.46 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.426 1.107 . . . . 73.129999999999995 109.906 178.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.486 HG11 HH22 ' A' ' 32' ' ' ARG . 76.9 t -124.57 149.45 28.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 C-N-CA 125.429 1.491 . . . . 75.040000000000006 108.635 -173.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.2 mt -161.15 -82.61 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 125.625 1.57 . . . . 74.519999999999996 109.296 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -98.4 150.37 21.68 Favored 'General case' 0 C--N 1.262 -3.197 0 CA-C-N 114.109 -1.405 . . . . 75.340000000000003 108.948 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.439 ' HA ' ' HB3' ' A' ' 109' ' ' ASP . 74.6 t80 -46.34 -44.05 16.52 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.365 1.246 . . . . 72.519999999999996 114.365 -172.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -62.55 -35.61 79.99 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 112.587 0.588 . . . . 72.319999999999993 112.587 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -90.82 -30.7 16.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.441 0.639 . . . . 72.010000000000005 109.571 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.439 ' HB3' ' HA ' ' A' ' 106' ' ' PHE . 7.9 t0 -55.74 -55.15 35.7 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 125.731 1.613 . . . . 65.540000000000006 109.642 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.6 tp -59.78 -38.04 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 O-C-N 123.966 0.792 . . . . 63.049999999999997 110.865 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 40.3 mt-10 -69.5 -38.46 77.62 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 120.479 -0.488 . . . . 71.310000000000002 111.492 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 102' ' ' SER . 10.0 t -65.91 -40.77 91.78 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.0 -0.68 . . . . 72.209999999999994 109.36 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 117' ' ' ILE . 49.4 mm -64.41 -46.54 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 115.521 -0.763 . . . . 72.239999999999995 110.223 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 72.7 t -63.91 -41.88 93.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.52 -0.309 . . . . 64.030000000000001 110.732 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 111' ' ' GLU . 29.4 mtpp -67.19 -30.33 70.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 111.7 0.259 . . . . 75.230000000000004 111.7 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.37 -40.8 67.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.018 0.437 . . . . 53.329999999999998 110.298 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.557 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 83.0 mt -66.05 -45.78 89.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.137 -0.69 . . . . 73.409999999999997 109.137 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -57.57 -42.32 82.84 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.842 -0.617 . . . . 74.549999999999997 111.576 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -65.9 -41.9 90.91 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.539 -0.755 . . . . 74.400000000000006 110.288 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 15.1 t -70.17 -39.68 75.13 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.826 -0.435 . . . . 55.210000000000001 109.826 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 117' ' ' ILE . 61.4 mt -72.76 -37.39 67.68 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 116.423 -0.353 . . . . 73.420000000000002 111.359 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.89 -14.22 51.62 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 112.565 0.58 . . . . 61.340000000000003 112.565 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -66.63 -21.62 66.12 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.288 0.566 . . . . 74.439999999999998 112.432 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.88 -161.54 47.81 Favored Glycine 0 C--N 1.296 -1.681 0 CA-C-N 115.617 -0.72 . . . . 53.200000000000003 114.894 173.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 C--N 1.318 -0.799 0 CA-C-O 122.79 1.281 . . . . 65.099999999999994 112.498 -178.403 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.474 0 N-CA-C 106.803 -1.554 . . . . 73.239999999999995 106.803 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -138.63 163.24 32.6 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.433 0.635 . . . . 74.430000000000007 112.173 -172.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.489 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 46.2 m-85 -119.7 145.29 46.65 Favored 'General case' 0 C--O 1.251 1.144 0 C-N-CA 124.266 1.026 . . . . 74.439999999999998 110.616 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.514 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 30.6 t70 -115.44 111.23 20.47 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 125.542 1.537 . . . . 63.32 107.204 -175.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 p -96.65 127.87 48.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 122.119 -0.363 . . . . 65.340000000000003 110.916 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.418 HG21 HG22 ' A' ' 28' ' ' VAL . 4.8 p -117.9 127.48 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 115.923 -0.58 . . . . 60.310000000000002 111.177 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 tt -115.62 112.86 41.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.473 -0.785 . . . . 72.409999999999997 109.698 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.3 mp -98.92 109.2 52.93 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 108.247 -1.02 . . . . 74.230000000000004 108.247 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 17.7 Cg_endo -93.9 138.6 1.27 Allowed 'Trans proline' 0 N--CA 1.436 -1.895 0 C-N-CA 122.193 1.928 . . . . 64.439999999999998 110.684 173.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -159.13 130.61 6.29 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 110.189 -0.3 . . . . 61.43 110.189 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.426 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.3 m -69.82 121.37 17.14 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.001 -0.74 . . . . 72.150000000000006 109.001 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.557 ' CE1' ' HD3' ' A' ' 79' ' ' LYS . 21.3 p90 -70.01 101.58 1.83 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 112.529 0.566 . . . . 75.150000000000006 112.529 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.475 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 54.4 m80 -146.65 151.34 37.08 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.991 -0.549 . . . . 74.099999999999994 111.77 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -80.41 119.44 23.11 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 106.905 -1.517 . . . . 75.030000000000001 106.905 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -62.04 104.41 0.46 Allowed 'General case' 0 N--CA 1.406 -2.654 0 O-C-N 124.527 1.142 . . . . 72.420000000000002 109.383 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -87.22 -155.02 0.26 Allowed 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 113.957 -1.474 . . . . 54.340000000000003 108.668 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -81.56 -56.88 3.74 Favored 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 121.45 -0.781 . . . . 74.400000000000006 112.412 -175.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -136.12 15.01 3.28 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.824 0.821 . . . . 70.430000000000007 110.207 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -148.57 157.34 43.4 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.919 -1.141 . . . . 65.120000000000005 107.919 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.475 ' CG ' ' HB3' ' A' ' 13' ' ' HIS . 41.4 ttp 63.53 62.31 0.95 Allowed 'General case' 0 C--N 1.348 0.519 0 CA-C-O 122.848 1.308 . . . . 62.009999999999998 109.658 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -148.3 96.05 2.55 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.688 -1.596 . . . . 62.149999999999999 107.562 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.481 ' CG ' ' HA2' ' A' ' 124' ' ' GLY . 41.6 t60 -141.84 113.67 7.93 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.994 -1.083 . . . . 65.239999999999995 110.925 175.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.1 mm -126.93 126.91 69.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 106.394 -1.706 . . . . 73.450000000000003 106.394 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 46.6 m -107.68 149.85 39.46 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 112.264 0.468 . . . . 64.049999999999997 112.264 -171.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.3 129.74 23.55 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.27 2.647 . . . . 75.25 112.367 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -68.26 133.35 28.24 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.35 2.033 . . . . 75.120000000000005 112.199 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 25.0 mmt -86.96 131.32 34.13 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.67 -1.604 . . . . 74.219999999999999 106.67 174.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.418 HG22 HG21 ' A' ' 6' ' ' VAL . 19.0 t -127.64 127.91 69.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 109.503 -0.554 . . . . 62.539999999999999 109.503 -177.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.8 mm -126.65 114.4 37.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.561 -0.903 . . . . 74.439999999999998 108.561 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -127.87 82.14 0.34 Allowed Glycine 0 CA--C 1.48 -2.144 0 C-N-CA 119.06 -1.543 . . . . 50.210000000000001 114.531 -175.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -156.92 21.94 0.32 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.327 -0.936 . . . . 72.420000000000002 109.545 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.42 HH11 HD12 ' A' ' 40' ' ' ILE . 1.1 mmp_? -95.51 146.43 24.44 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.132 -1.433 . . . . 64.230000000000004 107.132 -172.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 p -85.07 175.6 8.92 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 105.947 -1.871 . . . . 72.299999999999997 105.947 168.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.489 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 76.8 t80 -60.41 -41.94 94.96 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 118.699 0.681 . . . . 72.120000000000005 110.695 -176.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -67.85 -41.58 82.72 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.48 -1.236 . . . . 63.340000000000003 111.197 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mm -74.01 -29.85 26.43 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 N-CA-C 109.613 -0.514 . . . . 73.109999999999999 109.613 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.42 -45.2 92.06 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.87 -0.605 . . . . 53.25 109.991 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.1 mmt -67.79 -39.46 84.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.225 -0.443 . . . . 73.420000000000002 110.713 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -69.43 -34.65 74.75 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.957 1.095 . . . . 65.109999999999999 113.957 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.502 ' O ' HG21 ' A' ' 44' ' ' VAL . 13.9 tt -70.46 -41.75 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 119.125 -1.03 . . . . 73.349999999999994 109.665 176.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 82.5 t -62.37 -44.1 98.85 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.369 0 N-CA-C 109.41 -0.589 . . . . 73.430000000000007 109.41 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -58.32 -41.84 85.42 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 123.119 0.568 . . . . 73.239999999999995 110.993 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.22 -43.55 92.79 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.62 -0.8 . . . . 74.25 111.401 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.502 HG21 ' O ' ' A' ' 40' ' ' ILE . 97.4 t -65.84 -41.32 89.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.31 -0.626 . . . . 71.010000000000005 109.31 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.93 -46.34 85.18 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 125.298 1.439 . . . . 63.310000000000002 110.717 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -64.8 -44.16 90.84 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.549 -1.205 . . . . 72.400000000000006 110.644 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.9 t -66.87 -38.95 82.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 116.266 -0.425 . . . . 70.340000000000003 110.759 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 73' ' ' LEU . 66.1 mt -68.79 -41.87 82.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 121.029 -0.268 . . . . 74.319999999999993 111.675 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -80.39 -17.8 50.81 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 118.749 -1.18 . . . . 65.450000000000003 110.993 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.63 -43.02 8.48 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 112.371 0.508 . . . . 65.430000000000007 112.371 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.3 m -83.27 -16.13 47.52 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 112.801 0.667 . . . . 43.020000000000003 112.801 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -138.13 -174.49 3.81 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.097 0.475 . . . . 72.230000000000004 110.351 -174.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -103.78 105.86 16.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.014 -1.847 . . . . 74.450000000000003 106.014 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.67 136.4 40.9 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 112.948 0.722 . . . . 72.239999999999995 112.948 -174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -100.49 115.52 30.27 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.329 -1.73 . . . . 74.230000000000004 106.329 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 p -100.98 123.07 53.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.26 0.552 . . . . 64.329999999999998 111.437 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -130.67 119.75 22.88 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.107 -0.497 . . . . 72.439999999999998 110.772 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -82.51 137.41 34.63 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.014 -0.539 . . . . 71.420000000000002 110.173 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.4 mt -134.25 171.83 13.71 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.661 -0.866 . . . . 74.209999999999994 108.661 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -99.35 162.04 13.27 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.499 -0.556 . . . . 74.319999999999993 109.499 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.75 177.48 16.43 Favored Glycine 0 C--N 1.278 -2.681 0 N-CA-C 109.292 -1.523 . . . . 52.009999999999998 109.292 178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.502 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 12.8 pt-20 -65.84 179.48 0.87 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.437 -0.579 . . . . 72.140000000000001 109.437 175.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.04 -27.56 69.19 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 122.09 0.948 . . . . 73.530000000000001 111.474 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.8 t -77.42 -16.66 58.7 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.703 -1.135 . . . . 70.430000000000007 109.869 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.502 ' OD2' ' HG2' ' A' ' 62' ' ' GLU . 78.2 m-20 -101.24 157.72 16.57 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 108.436 -0.949 . . . . 74.209999999999994 108.436 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.444 HG23 ' CE2' ' A' ' 3' ' ' TYR . 36.9 t -104.56 -44.2 8.57 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-O 121.579 0.704 . . . . 73.409999999999997 110.314 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.1 tp -163.0 153.08 15.99 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.826 -1.176 . . . . 53.299999999999997 107.826 -174.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -130.08 128.34 41.69 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 106.873 -1.529 . . . . 75.450000000000003 106.873 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -123.43 108.51 12.77 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 107.351 -1.352 . . . . 73.530000000000001 107.351 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -109.99 117.7 34.47 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.105 0.478 . . . . 71.140000000000001 110.218 -175.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -107.44 132.98 52.61 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.248 -0.649 . . . . 74.299999999999997 109.248 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.7 m -97.75 113.39 25.16 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 107.087 -1.449 . . . . 65.329999999999998 107.087 171.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.407 HD11 HG22 ' A' ' 48' ' ' ILE . 4.1 mm? -98.18 139.19 34.34 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 124.306 1.042 . . . . 73.329999999999998 113.51 -173.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -140.41 139.41 35.26 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-N 113.87 -1.514 . . . . 73.150000000000006 107.057 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.436 ' HZ1' ' CD ' ' A' ' 118' ' ' GLU . 82.0 tttt -132.68 176.52 8.38 Favored 'General case' 0 C--N 1.263 -3.185 0 N-CA-C 102.686 -3.079 . . . . 75.25 102.686 173.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.3 0.0 OUTLIER -62.86 90.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 115.112 1.523 . . . . 73.329999999999998 115.112 -177.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.26 2.19 77.55 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 114.709 -1.132 . . . . 72.510000000000005 112.8 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 55.3 mttp -130.22 143.38 50.75 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.753 -0.832 . . . . 72.030000000000001 108.753 -174.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.557 ' HD3' ' CE1' ' A' ' 12' ' ' PHE . 14.8 ptpt -151.69 156.2 39.86 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 112.737 0.643 . . . . 62.439999999999998 112.737 -169.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -177.65 170.68 43.17 Favored Glycine 0 C--O 1.2 -2.004 0 CA-C-N 115.372 -0.831 . . . . 73.109999999999999 111.383 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.9 mt -115.75 138.14 47.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 107.684 -1.228 . . . . 74.329999999999998 107.684 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.6 t -115.99 110.37 31.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 109.003 -0.74 . . . . 70.200000000000003 109.003 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -100.73 103.97 15.23 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.484 -0.78 . . . . 75.120000000000005 109.044 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.6 t -109.6 109.75 29.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.268 -0.641 . . . . 71.310000000000002 109.268 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -122.72 149.69 43.74 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 119.488 -0.885 . . . . 75.120000000000005 110.418 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.7 mt -99.16 126.54 44.95 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 107.736 -1.209 . . . . 75.049999999999997 107.736 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.5 ttt85 -115.95 134.52 54.89 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 108.273 -1.01 . . . . 75.219999999999999 108.273 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -81.06 98.3 7.92 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 116.295 -0.412 . . . . 73.109999999999999 111.482 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.6 tt -75.04 111.4 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 122.235 1.017 . . . . 62.119999999999997 108.825 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.5 p -145.15 -171.21 3.61 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-N 114.943 -1.026 . . . . 64.219999999999999 108.941 -172.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -78.79 -4.55 49.97 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.967 0.889 . . . . 72.340000000000003 109.279 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -98.8 -23.34 15.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.312 -0.858 . . . . 70.099999999999994 109.607 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 96.9 m -138.46 118.05 9.71 Favored Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 112.145 0.424 . . . . 52.130000000000003 112.145 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.58 157.48 36.15 Favored 'Trans proline' 0 C--O 1.25 1.119 0 C-N-CA 122.037 1.825 . . . . 75.109999999999999 109.651 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.97 160.7 32.55 Favored 'Trans proline' 0 C--O 1.255 1.329 0 C-N-CA 123.074 2.516 . . . . 73.340000000000003 112.502 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 t -81.2 144.71 10.02 Favored 'Isoleucine or valine' 0 C--O 1.252 1.201 0 N-CA-C 108.493 -0.928 . . . . 74.150000000000006 108.493 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -97.24 85.89 3.79 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 121.953 0.882 . . . . 74.329999999999998 110.809 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -129.37 -158.61 9.59 Favored Glycine 0 N--CA 1.412 -2.959 0 N-CA-C 109.362 -1.495 . . . . 70.219999999999999 109.362 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.91 98.43 7.88 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 108.274 -1.01 . . . . 52.140000000000001 108.274 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 64.2 mtp85 -86.63 93.63 9.26 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 108.064 -1.087 . . . . 75.519999999999996 108.064 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 19.3 t -72.51 168.38 18.67 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 113.854 -1.521 . . . . 44.409999999999997 113.144 -170.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.4 m -73.53 105.9 5.08 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 124.726 1.21 . . . . 73.030000000000001 111.028 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.9 t -84.89 155.03 3.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.799 -1.092 . . . . 71.420000000000002 108.866 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.5 tp -150.35 -68.59 0.19 Allowed 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.686 1.231 . . . . 74.319999999999993 109.177 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.32 165.61 35.34 Favored 'General case' 1 C--N 1.237 -4.297 0 N-CA-C 103.224 -2.88 . . . . 71.219999999999999 103.224 178.244 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' O ' HG22 ' A' ' 110' ' ' ILE . 91.6 t80 -45.98 -36.39 5.52 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.781 1.03 . . . . 75.310000000000002 113.781 -173.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -58.12 -40.45 81.25 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 113.341 0.867 . . . . 73.420000000000002 113.341 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -88.2 -30.41 19.76 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 119.929 -0.708 . . . . 71.109999999999999 109.337 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.44 -47.02 83.6 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.932 -1.031 . . . . 70.25 109.379 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 106' ' ' PHE . 10.3 tp -69.0 -31.71 51.55 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 CA-C-N 116.14 -0.482 . . . . 75.319999999999993 109.826 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -63.81 -41.86 97.79 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.699 -0.482 . . . . 75.420000000000002 109.699 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 53.6 t -70.2 -40.22 74.72 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.001 -0.545 . . . . 60.509999999999998 110.178 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.07 -45.18 99.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.81 -0.632 . . . . 62.420000000000002 111.379 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.27 -41.76 92.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.618 0.247 . . . . 61.350000000000001 110.37 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -69.73 -23.79 63.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.464 0.542 . . . . 72.329999999999998 112.464 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.62 -43.94 58.32 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.972 -0.381 . . . . 74.209999999999994 109.972 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.15 -45.45 98.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.359 -0.608 . . . . 75.329999999999998 109.359 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.436 ' CD ' ' HZ1' ' A' ' 75' ' ' LYS . 6.1 mm-40 -61.74 -38.23 87.19 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 116.059 -0.519 . . . . 74.329999999999998 111.541 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -64.11 -46.43 84.2 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 108.989 -0.745 . . . . 73.120000000000005 108.989 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 5.6 t -70.69 -29.88 66.3 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.387 -0.824 . . . . 55.420000000000002 111.25 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.29 -37.27 28.71 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.58 -0.7 . . . . 65.450000000000003 111.421 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . . . -76.78 -36.01 57.29 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 111.956 0.354 . . . . 54.450000000000003 111.956 -177.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 125' ' ' GLU . 9.9 mmmm -99.53 9.94 42.29 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 110.014 -0.365 . . . . 65.129999999999995 110.014 -175.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.481 ' HA2' ' CG ' ' A' ' 22' ' ' HIS . . . -71.7 33.37 0.59 Allowed Glycine 0 C--N 1.334 0.469 0 N-CA-C 117.304 1.682 . . . . 60.109999999999999 117.304 -171.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.268 -2.96 0 N-CA-C 106.365 -1.717 . . . . 72.519999999999996 106.365 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.635 0 N-CA-C 105.66 -1.978 . . . . 74.25 105.66 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.01 139.07 32.05 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.327 0.584 . . . . 71.209999999999994 112.055 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.646 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 62.9 m-85 -125.93 137.07 53.68 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.001 -1.0 . . . . 74.25 109.333 176.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.479 ' OD1' ' HB ' ' A' ' 89' ' ' ILE . 4.9 m-20 -101.83 122.1 43.34 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.477 -0.783 . . . . 73.510000000000005 108.898 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 p -95.53 109.14 22.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 108.339 -0.986 . . . . 73.540000000000006 108.339 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.425 ' HB ' ' CG ' ' A' ' 85' ' ' LYS . 61.0 t -102.96 106.28 19.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.921 -1.14 . . . . 70.129999999999995 107.921 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -105.67 118.48 53.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 CA-C-N 115.577 -0.738 . . . . 71.140000000000001 109.858 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.5 mp -106.18 108.18 61.22 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 107.927 -1.138 . . . . 74.400000000000006 107.927 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.64 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 28.5 Cg_endo -99.84 120.33 0.11 Allowed 'Trans proline' 0 N--CA 1.429 -2.314 0 C-N-CA 121.772 1.648 . . . . 74.299999999999997 110.908 171.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.733 ' HA ' ' SG ' ' A' ' 120' ' ' CYS . 0.7 OUTLIER -138.69 145.79 40.78 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.154 0.502 . . . . 64.400000000000006 109.901 174.06 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.472 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.6 p -81.76 129.99 34.91 Favored 'General case' 0 N--CA 1.398 -3.062 0 N-CA-C 107.468 -1.308 . . . . 62.530000000000001 107.468 175.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 79' ' ' LYS 0.284 0.0 OUTLIER -73.95 80.63 1.67 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 115.003 1.483 . . . . 75.329999999999998 115.003 -169.143 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -91.12 151.61 20.92 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.444 -1.253 . . . . 75.109999999999999 112.445 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -104.43 -158.25 0.65 Allowed 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 106.152 -1.795 . . . . 75.140000000000001 106.152 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -128.66 110.72 12.47 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 110.042 -0.355 . . . . 72.510000000000005 110.042 172.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -91.79 -104.99 0.11 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.136 -0.69 . . . . 72.340000000000003 109.136 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -113.35 -54.37 2.62 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.474 -0.935 . . . . 74.340000000000003 108.474 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -134.75 -29.55 1.15 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.322 -1.308 . . . . 74.150000000000006 108.443 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -63.04 133.56 54.73 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.217 -1.031 . . . . 72.310000000000002 108.217 171.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.2 mtt 74.32 99.12 0.07 Allowed 'General case' 0 C--N 1.313 -0.983 0 O-C-N 124.126 0.891 . . . . 70.109999999999999 112.139 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -174.1 82.18 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 125.662 1.585 . . . . 73.310000000000002 107.867 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -148.71 116.18 6.21 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-N 115.946 -0.57 . . . . 53.509999999999998 111.075 -175.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.9 mm -132.93 139.1 50.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.15 -1.426 . . . . 74.129999999999995 107.15 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 60.5 m -107.53 149.3 38.68 Favored Pre-proline 0 C--N 1.288 -2.087 0 N-CA-C 108.856 -0.794 . . . . 74.430000000000007 108.856 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.29 147.76 66.59 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.655 2.237 . . . . 73.409999999999997 113.551 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -64.45 136.69 51.83 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.117 2.544 . . . . 71.239999999999995 111.856 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.527 ' SD ' ' HB2' ' A' ' 101' ' ' CYS . 47.9 ttm -103.11 129.11 49.86 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.479 -0.934 . . . . 71.420000000000002 108.479 175.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.76 132.39 70.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 116.338 -0.392 . . . . 74.540000000000006 110.265 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.33 102.41 9.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 106.121 -1.807 . . . . 64.310000000000002 106.121 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' HA3' ' OD2' ' A' ' 4' ' ' ASP . . . -124.39 82.2 0.35 Allowed Glycine 0 C--N 1.285 -2.29 0 C-N-CA 120.025 -1.083 . . . . 60.340000000000003 114.587 -173.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -170.38 27.47 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.717 0.77 . . . . 73.400000000000006 109.276 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -105.04 154.0 20.71 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.765 -1.568 . . . . 74.329999999999998 106.765 -173.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.3 p -89.64 173.94 8.02 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 106.525 -1.657 . . . . 72.409999999999997 106.525 171.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.646 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 63.8 t80 -60.79 -46.15 91.64 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 118.603 0.638 . . . . 74.450000000000003 110.156 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.69 -42.3 95.42 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.569 -1.196 . . . . 62.140000000000001 111.567 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mm -69.66 -39.25 77.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 116.257 -0.429 . . . . 71.209999999999994 110.146 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.54 -44.7 81.68 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.857 -0.611 . . . . 61.109999999999999 110.077 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.6 mmt -65.88 -35.93 82.0 Favored 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 120.768 -0.373 . . . . 64.420000000000002 111.847 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.6 -41.61 92.6 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 120.555 -0.458 . . . . 63.0 111.509 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.435 ' O ' HG22 ' A' ' 44' ' ' VAL . 8.9 tt -71.96 -41.79 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 118.605 -1.238 . . . . 72.420000000000002 110.527 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.438 HG12 ' NH2' ' A' ' 69' ' ' ARG . 91.3 t -66.77 -38.37 81.38 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 CA-C-N 116.726 -0.216 . . . . 64.299999999999997 110.953 -177.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -67.47 -37.95 83.69 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.067 0.46 . . . . 73.430000000000007 110.277 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.449 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -65.72 -48.04 70.85 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.355 -0.926 . . . . 61.340000000000003 111.12 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 40' ' ' ILE . 92.0 t -64.81 -39.67 86.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.206 0.527 . . . . 73.510000000000005 109.78 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.07 -42.91 91.5 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.788 0.835 . . . . 74.109999999999999 112.117 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -79.63 -26.13 41.23 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 120.162 -0.615 . . . . 72.219999999999999 111.178 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 43' ' ' GLY . 79.5 t -70.03 -44.84 78.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 110.126 -0.324 . . . . 73.230000000000004 110.126 174.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 72.1 mt -65.1 -40.48 89.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 111.972 0.36 . . . . 75.319999999999993 111.972 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -80.27 -10.75 59.76 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.067 -1.053 . . . . 75.439999999999998 112.175 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -98.81 -47.87 5.14 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.29 -0.414 . . . . 74.349999999999994 111.164 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.7 m -81.09 -18.12 47.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.629 0.603 . . . . 60.32 112.629 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.643 ' CE2' ' HD2' ' A' ' 75' ' ' LYS . 1.8 m-85 -127.68 175.2 8.48 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.333 -0.988 . . . . 73.319999999999993 108.333 -176.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -105.03 91.7 3.91 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 105.716 -1.957 . . . . 52.310000000000002 105.716 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -132.25 136.39 46.94 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 112.998 0.74 . . . . 41.210000000000001 112.998 -172.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 71' ' ' TYR . 23.3 t -94.46 159.77 14.95 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.856 -1.535 . . . . 72.239999999999995 106.856 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.0 130.9 55.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 120.909 0.385 . . . . 75.319999999999993 109.988 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -135.61 112.22 10.02 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.59 -0.522 . . . . 64.230000000000004 109.59 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -87.88 136.13 33.1 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.635 -0.426 . . . . 75.230000000000004 110.411 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.0 mt -133.59 171.65 13.81 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.436 -0.802 . . . . 74.310000000000002 108.898 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -85.37 143.78 28.43 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.329 -0.989 . . . . 44.240000000000002 108.329 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -96.67 175.43 31.46 Favored Glycine 0 N--CA 1.414 -2.777 0 N-CA-C 110.394 -1.082 . . . . 63.119999999999997 110.394 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.412 ' HG2' ' CG ' ' A' ' 65' ' ' ASP . 11.2 pt-20 -70.39 179.84 2.32 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 122.767 0.427 . . . . 73.439999999999998 110.03 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.4 -38.16 76.78 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.724 0.773 . . . . 72.420000000000002 112.795 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 76.9 m -83.78 -5.19 59.14 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.504 -0.771 . . . . 72.340000000000003 111.908 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.496 ' OD2' ' HB2' ' A' ' 85' ' ' LYS . 13.4 m-20 -95.8 171.6 8.55 Favored 'General case' 0 CA--C 1.49 -1.365 0 CA-C-N 115.396 -0.82 . . . . 72.230000000000004 110.091 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.15 -42.65 3.58 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.447 0 CA-C-N 114.651 -1.159 . . . . 73.400000000000006 109.089 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.1 tp -163.21 151.77 14.12 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 106.901 -1.518 . . . . 74.329999999999998 106.901 -176.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.58 118.36 21.88 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.483 -1.673 . . . . 73.099999999999994 106.483 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.438 ' NH2' HG12 ' A' ' 41' ' ' VAL . 36.3 ttp180 -122.72 124.2 42.84 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.23 -0.988 . . . . 73.140000000000001 110.43 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -98.42 145.11 27.06 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 124.367 1.067 . . . . 72.439999999999998 108.986 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 55' ' ' SER . 95.4 m-85 -131.76 137.74 48.32 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.878 -1.156 . . . . 74.150000000000006 107.878 175.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 32.0 m -113.86 111.85 22.4 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.698 -0.853 . . . . 74.129999999999995 108.698 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.9 139.96 32.16 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 113.273 0.842 . . . . 63.200000000000003 113.273 -171.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -143.85 89.75 2.08 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 105.038 -2.208 . . . . 54.399999999999999 105.038 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.643 ' HD2' ' CE2' ' A' ' 52' ' ' PHE . 63.9 tttm -105.34 96.34 6.45 Favored 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.766 -0.584 . . . . 71.349999999999994 109.632 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 13.6 pt-20 53.5 35.51 20.92 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.618 1.167 . . . . 72.5 113.092 173.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.54 -8.64 56.8 Favored Glycine 0 CA--C 1.506 -0.505 0 C-N-CA 121.165 -0.54 . . . . 74.439999999999998 112.764 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HE3' ' HA ' ' A' ' 122' ' ' ALA . 50.4 mtpt -98.86 102.72 14.55 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.392 -1.707 . . . . 62.119999999999997 106.392 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.47 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . 58.9 mttp -101.53 153.96 19.26 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.792 -0.64 . . . . 72.030000000000001 112.176 -174.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -173.04 176.58 45.78 Favored Glycine 0 N--CA 1.417 -2.596 0 N-CA-C 110.599 -1.0 . . . . 60.039999999999999 110.599 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.3 tt -133.78 149.36 30.68 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.039 0 N-CA-C 106.948 -1.501 . . . . 54.219999999999999 106.948 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.0 t -132.34 127.52 57.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.252 -0.648 . . . . 75.329999999999998 109.252 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -113.86 113.72 25.28 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.322 -0.621 . . . . 74.129999999999995 109.322 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.54 110.59 30.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.879 -0.786 . . . . 61.210000000000001 108.879 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.496 ' HB2' ' OD2' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -110.67 126.53 54.61 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.03 -1.1 . . . . 70.219999999999999 108.03 178.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.0 mt -100.22 125.94 46.45 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.995 -1.854 . . . . 60.039999999999999 105.995 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.442 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 70.1 mtp85 -112.36 141.8 45.64 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-O 121.091 0.472 . . . . 72.040000000000006 110.927 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -94.29 98.71 11.11 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 115.309 -0.86 . . . . 71.129999999999995 109.373 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.479 ' HB ' ' OD1' ' A' ' 4' ' ' ASP . 10.9 tt -65.38 111.72 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 122.44 1.114 . . . . 70.109999999999999 109.141 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.7 p -137.8 176.75 8.43 Favored 'General case' 0 N--CA 1.39 -3.44 0 CA-C-N 114.685 -1.143 . . . . 55.399999999999999 109.807 -174.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -71.38 -17.78 62.39 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.895 -1.048 . . . . 72.030000000000001 109.32 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -98.06 -32.12 11.79 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.665 -1.152 . . . . 73.530000000000001 110.817 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 42.3 m -133.69 108.46 11.96 Favored Pre-proline 0 N--CA 1.432 -1.349 0 N-CA-C 113.695 0.998 . . . . 74.299999999999997 113.695 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -90.4 144.92 4.03 Favored 'Trans proline' 0 N--CA 1.438 -1.785 0 C-N-CA 122.465 2.11 . . . . 37.530000000000001 111.236 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -82.87 158.93 15.97 Favored 'Trans proline' 0 C--O 1.255 1.37 0 C-N-CA 122.378 2.052 . . . . 75.239999999999995 111.518 172.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 t -98.73 150.13 5.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 105.252 -2.129 . . . . 75.409999999999997 105.252 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -107.13 146.31 31.43 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.788 0.804 . . . . 75.439999999999998 112.162 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -138.59 -147.58 5.17 Favored Glycine 0 CA--C 1.476 -2.344 0 CA-C-N 114.071 -1.422 . . . . 72.109999999999999 110.079 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -60.84 125.84 25.18 Favored 'General case' 0 C--N 1.288 -2.093 0 O-C-N 124.286 0.639 . . . . 74.340000000000003 110.007 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -97.7 131.43 44.25 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.213 0.53 . . . . 73.439999999999998 110.395 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.527 ' HB2' ' SD ' ' A' ' 27' ' ' MET . 44.3 t -73.35 154.91 39.89 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.558 -1.201 . . . . 64.400000000000006 109.919 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.3 t -80.96 74.97 7.94 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.519 -1.289 . . . . 74.420000000000002 107.519 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.94 140.05 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 114.866 -1.061 . . . . 75.420000000000002 109.803 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.9 tp -153.7 -121.87 0.03 OUTLIER 'General case' 0 C--N 1.257 -3.453 0 N-CA-C 103.866 -2.642 . . . . 74.239999999999995 103.866 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.62 168.59 10.07 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 107.817 -1.179 . . . . 63.240000000000002 107.817 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.447 ' O ' HG22 ' A' ' 110' ' ' ILE . 74.5 t80 -43.25 -36.64 1.87 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.57 1.148 . . . . 73.319999999999993 114.071 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -56.84 -37.63 71.53 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.707 0.803 . . . . 63.420000000000002 112.249 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -90.62 -34.69 15.37 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.687 -0.486 . . . . 75.319999999999993 109.687 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -62.55 -46.87 86.37 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.15 -0.932 . . . . 74.519999999999996 110.613 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.447 HG22 ' O ' ' A' ' 106' ' ' PHE . 9.1 tp -64.59 -39.75 86.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 N-CA-C 109.963 -0.384 . . . . 72.209999999999994 109.963 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.96 -41.5 82.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.774 -0.648 . . . . 75.219999999999999 110.671 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 7.8 t -63.0 -44.25 96.54 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.693 -0.685 . . . . 75.109999999999999 111.259 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 47.0 mm -68.25 -41.46 83.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.994 -0.372 . . . . 61.340000000000003 109.994 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 51.6 t -64.22 -43.06 97.23 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 CA-C-N 116.029 -0.532 . . . . 73.340000000000003 110.366 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -61.9 -40.47 95.56 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 122.826 0.45 . . . . 75.25 111.19 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.59 84.33 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.183 0.516 . . . . 70.329999999999998 111.412 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.416 ' O ' HD12 ' A' ' 121' ' ' LEU . 79.0 mt -71.3 -43.28 74.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.364 -0.606 . . . . 72.329999999999998 109.364 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 114' ' ' VAL . 1.7 tm-20 -62.63 -40.49 97.18 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.484 -0.78 . . . . 63.539999999999999 110.448 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.74 -36.78 76.12 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 120.069 -0.652 . . . . 74.319999999999993 110.669 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.733 ' SG ' ' HA ' ' A' ' 10' ' ' GLU . 10.8 t -67.96 -34.05 75.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.657 0.741 . . . . 75.099999999999994 109.665 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 117' ' ' ILE . 9.3 mp -75.79 -35.34 60.12 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.474 -0.784 . . . . 73.319999999999993 111.247 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.448 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . . . -69.67 -33.77 73.02 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.991 0.424 . . . . 74.230000000000004 111.144 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -80.55 10.32 4.9 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.7 -0.682 . . . . 71.349999999999994 111.556 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -53.71 124.15 28.57 Favored Glycine 0 C--O 1.249 1.044 0 CA-C-N 116.111 -0.495 . . . . 50.25 112.817 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 . . . . . 0 C--N 1.318 -0.784 0 C-N-CA 125.706 1.602 . . . . 74.310000000000002 112.259 -177.555 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.252 0 N-CA-C 106.764 -1.569 . . . . 72.140000000000001 106.764 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -120.45 128.89 53.59 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.905 0.383 . . . . 63.240000000000002 110.405 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.609 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 28.8 m-85 -117.69 148.95 41.51 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.395 0.617 . . . . 74.549999999999997 111.377 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -121.36 107.47 12.54 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.222 -2.14 . . . . 60.229999999999997 105.222 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -93.23 114.91 30.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 116.186 -0.461 . . . . 71.420000000000002 110.23 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.401 ' HB ' ' HG3' ' A' ' 85' ' ' LYS . 46.9 t -104.87 112.89 40.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 108.432 -0.951 . . . . 63.200000000000003 108.432 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' A' ' 27' ' ' MET . 3.7 tt -114.34 108.34 25.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.835 0.826 . . . . 75.25 108.847 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.9 mt -104.06 106.4 53.08 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 114.991 -1.004 . . . . 75.519999999999996 111.799 -171.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.584 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 7.1 Cg_endo -92.9 140.05 1.8 Allowed 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 122.419 2.079 . . . . 63.219999999999999 110.572 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -164.08 155.87 16.53 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 122.468 0.307 . . . . 71.140000000000001 110.76 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.9 m -91.57 135.19 34.04 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.707 -0.479 . . . . 74.5 109.707 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.15 68.65 10.0 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 113.551 0.945 . . . . 75.200000000000003 113.551 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -122.82 138.21 54.71 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.126 -1.064 . . . . 74.519999999999996 108.126 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.407 ' N ' ' HD2' ' A' ' 14' ' ' ARG . 9.0 mpt_? -82.39 134.98 35.25 Favored 'General case' 0 CA--C 1.475 -1.938 0 N-CA-C 108.998 -0.742 . . . . 73.200000000000003 108.998 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -62.67 110.44 1.72 Allowed 'General case' 0 N--CA 1.405 -2.702 0 O-C-N 124.688 1.242 . . . . 73.519999999999996 111.131 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.411 ' HB2' ' HE1' ' A' ' 20' ' ' MET . 35.7 t70 -84.72 -99.31 0.06 Allowed 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 114.603 -1.18 . . . . 71.530000000000001 109.623 173.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -113.79 -58.45 2.15 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.033 0.444 . . . . 62.119999999999997 109.956 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -138.12 -51.91 0.6 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.085 0.945 . . . . 74.239999999999995 109.813 173.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -84.99 67.41 10.2 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.851 -1.068 . . . . 70.200000000000003 112.74 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.411 ' HE1' ' HB2' ' A' ' 16' ' ' ASP . 48.1 ttp 159.42 88.75 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.384 0 C-N-CA 128.169 2.588 . . . . 73.510000000000005 105.359 171.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 168.98 121.8 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.323 -2.103 . . . . 73.230000000000004 105.323 -173.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.417 ' HB2' ' H ' ' A' ' 125' ' ' GLU . 77.1 t60 -156.81 113.46 3.05 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.804 -0.758 . . . . 74.439999999999998 112.592 172.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.3 mm -113.64 132.5 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 N-CA-C 107.272 -1.381 . . . . 73.319999999999993 107.272 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 9.1 m -109.6 138.63 20.66 Favored Pre-proline 0 C--N 1.273 -2.723 0 N-CA-C 107.353 -1.351 . . . . 72.030000000000001 107.353 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -53.88 128.96 31.81 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 122.797 2.331 . . . . 70.409999999999997 112.427 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.88 130.43 26.0 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.489 2.126 . . . . 72.109999999999999 110.343 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.435 ' HB2' HG21 ' A' ' 7' ' ' ILE . 73.0 mtm -88.82 138.97 30.94 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 109.849 -0.426 . . . . 43.520000000000003 109.849 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.3 119.99 53.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.3 0.571 . . . . 74.430000000000007 110.04 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 30.6 mm -113.13 100.87 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 105.783 -1.932 . . . . 74.510000000000005 105.783 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.2 165.04 13.1 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 119.6 -1.286 . . . . 65.0 112.132 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.6 t70 65.72 70.05 0.45 Allowed 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 125.339 1.456 . . . . 62.049999999999997 110.634 -175.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -138.34 136.05 35.99 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 105.364 -2.088 . . . . 75.349999999999994 105.364 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.6 p -77.95 163.73 25.73 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 106.558 -1.645 . . . . 63.020000000000003 106.558 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.609 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 74.7 t80 -59.13 -37.26 76.81 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.609 0.718 . . . . 71.430000000000007 110.393 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -63.56 -47.17 82.62 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.309 -1.314 . . . . 54.420000000000002 110.857 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.1 mt -73.13 -38.52 55.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.935 -0.765 . . . . 71.120000000000005 108.935 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.82 98.9 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.866 -1.061 . . . . 43.329999999999998 110.893 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.4 tpp -67.69 -39.9 84.39 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.624 -0.831 . . . . 75.319999999999993 110.545 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -70.52 -34.48 72.35 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 119.838 -0.745 . . . . 71.400000000000006 112.745 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.517 ' O ' HG23 ' A' ' 44' ' ' VAL . 7.0 tp -73.79 -43.01 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 119.484 -0.886 . . . . 43.039999999999999 110.57 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t -68.57 -39.65 80.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 121.249 -0.18 . . . . 71.129999999999995 111.159 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -70.51 -29.38 65.87 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.272 -0.64 . . . . 65.219999999999999 109.272 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' HG21 ' A' ' 47' ' ' VAL . . . -65.29 -47.54 78.89 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 110.42 -1.072 . . . . 71.549999999999997 110.42 174.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 40' ' ' ILE . 90.5 t -57.59 -46.06 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 109.146 -0.687 . . . . 73.239999999999995 109.146 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -55.86 -39.4 71.43 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 125.231 1.412 . . . . 75.010000000000005 113.108 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -79.02 -31.04 44.53 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.305 -0.407 . . . . 74.319999999999993 111.2 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 43' ' ' GLY . 82.5 t -71.8 -38.06 64.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.289 -0.634 . . . . 63.439999999999998 109.289 176.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.5 mt -60.73 -46.6 95.69 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.852 0 CA-C-N 116.091 -0.504 . . . . 75.109999999999999 111.558 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -76.7 -15.93 59.65 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.6 -0.84 . . . . 74.409999999999997 112.114 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.4 -40.19 12.21 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.213 -0.449 . . . . 75.040000000000006 112.055 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 t -91.61 -20.61 21.46 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 112.463 0.542 . . . . 73.409999999999997 112.463 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -128.35 -179.97 5.31 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.6 0.714 . . . . 74.049999999999997 110.45 -174.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -105.54 106.52 17.06 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 104.155 -2.535 . . . . 71.319999999999993 104.155 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -118.2 135.63 54.13 Favored 'General case' 0 N--CA 1.404 -2.759 0 C-N-CA 119.533 -0.867 . . . . 64.439999999999998 113.114 -172.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.438 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 29.4 m -99.16 106.88 19.11 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 104.418 -2.438 . . . . 63.409999999999997 104.418 166.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 p -99.16 118.13 45.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.452 -0.944 . . . . 71.25 108.452 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' CD ' ' HZ2' ' A' ' 70' ' ' LYS . 27.5 mt-10 -116.33 129.13 56.1 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.072 -0.967 . . . . 73.209999999999994 109.952 -174.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -85.56 118.19 24.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.68 -0.691 . . . . 71.310000000000002 109.747 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mp -119.3 167.22 12.09 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 109.018 -0.734 . . . . 75.129999999999995 109.018 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -109.74 147.96 32.26 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 108.103 -1.073 . . . . 74.5 108.103 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.16 176.09 35.5 Favored Glycine 0 N--CA 1.407 -3.265 0 CA-C-N 115.512 -0.767 . . . . 73.150000000000006 112.725 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.437 ' N ' ' HB2' ' A' ' 65' ' ' ASP . 44.4 mt-10 -66.02 -173.33 0.18 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 124.893 1.277 . . . . 65.420000000000002 110.347 174.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -58.01 -44.7 87.42 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.462 0.648 . . . . 61.039999999999999 111.791 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 90.2 m -80.08 -23.45 41.3 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.6 -0.727 . . . . 74.299999999999997 111.757 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.437 ' HB2' ' N ' ' A' ' 62' ' ' GLU . 9.6 m-20 -90.87 123.23 34.23 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 119.342 -0.943 . . . . 73.430000000000007 111.013 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.7 t -84.43 -33.27 8.56 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 115.849 -0.614 . . . . 74.030000000000001 111.791 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.9 tp -151.58 139.9 20.39 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.441 -0.577 . . . . 73.030000000000001 109.441 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -130.8 121.41 25.31 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 107.622 -1.251 . . . . 74.239999999999995 107.622 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -118.72 123.66 45.42 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.665 -1.235 . . . . 70.5 107.665 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.407 ' HZ2' ' CD ' ' A' ' 57' ' ' GLU . 28.1 ttpp -103.63 109.96 21.85 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.268 -1.012 . . . . 72.209999999999994 108.268 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -96.43 119.17 34.44 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.01 -1.107 . . . . 75.349999999999994 108.01 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 16.9 m -98.95 115.93 30.02 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 106.527 -1.657 . . . . 62.240000000000002 106.527 174.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -108.59 151.04 26.66 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 113.537 0.94 . . . . 73.120000000000005 113.537 -170.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 36.6 tt0 -147.28 125.79 12.44 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 113.421 -1.718 . . . . 72.239999999999995 106.831 169.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -128.16 81.73 2.04 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 108.116 -1.068 . . . . 74.109999999999999 108.116 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 45.22 76.65 0.09 Allowed 'General case' 0 C--O 1.244 0.79 0 C-N-CA 126.239 1.816 . . . . 71.329999999999998 113.586 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.36 -23.18 28.78 Favored Glycine 0 C--N 1.309 -0.93 0 CA-C-N 115.777 -0.647 . . . . 52.210000000000001 112.933 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 14.2 mptt -96.01 129.42 43.28 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.551 -1.278 . . . . 65.329999999999998 107.551 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -145.97 138.49 25.53 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-O 121.132 0.492 . . . . 65.540000000000006 111.76 -173.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.3 179.76 42.28 Favored Glycine 0 CA--C 1.493 -1.285 0 N-CA-C 110.472 -1.051 . . . . 53.140000000000001 110.472 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 29.7 mt -120.1 145.96 25.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 109.404 -0.591 . . . . 70.239999999999995 109.404 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 83.8 t -126.45 112.64 30.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.716 -0.846 . . . . 72.510000000000005 108.716 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -98.87 107.54 20.0 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.309 -0.997 . . . . 75.239999999999995 108.309 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 44.0 t -102.58 110.47 29.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.696 -0.483 . . . . 74.099999999999994 109.696 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.401 ' HG3' ' HB ' ' A' ' 6' ' ' VAL . 8.1 ptpt -116.68 135.55 53.69 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 120.766 0.317 . . . . 72.0 110.677 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.1 mt -103.62 109.92 21.79 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 106.667 -1.605 . . . . 75.230000000000004 106.667 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.429 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 13.4 mtp180 -98.0 140.53 32.2 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 119.686 -0.806 . . . . 75.219999999999999 109.329 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -84.86 113.05 21.09 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 107.891 -1.151 . . . . 64.120000000000005 107.891 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 tt -87.26 111.64 22.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.79 -0.818 . . . . 71.540000000000006 108.79 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -128.18 174.59 9.13 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.505 -1.295 . . . . 72.129999999999995 107.505 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -78.2 0.16 26.12 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 120.282 -0.567 . . . . 75.030000000000001 112.322 -173.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -119.01 10.58 12.21 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.847 -0.615 . . . . 65.109999999999999 110.683 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.8 t -146.91 118.82 4.76 Favored Pre-proline 0 N--CA 1.446 -0.635 0 O-C-N 122.09 -0.381 . . . . 72.200000000000003 110.3 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.65 148.13 22.66 Favored 'Trans proline' 0 C--O 1.249 1.067 0 C-N-CA 123.209 2.606 . . . . 62.299999999999997 113.947 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.72 164.39 33.78 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 123.567 2.845 . . . . 64.439999999999998 110.217 175.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.5 t -100.51 156.48 4.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.742 -1.207 . . . . 72.200000000000003 107.742 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.89 116.34 24.96 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 122.024 0.916 . . . . 74.129999999999995 112.371 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.37 -160.5 8.34 Favored Glycine 0 N--CA 1.415 -2.748 0 N-CA-C 109.634 -1.387 . . . . 62.420000000000002 109.634 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -60.64 104.8 0.38 Allowed 'General case' 0 N--CA 1.398 -3.066 0 C-N-CA 124.792 1.237 . . . . 61.130000000000003 110.011 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -82.39 105.74 13.69 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 106.643 -1.614 . . . . 53.329999999999998 106.643 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.69 -179.23 5.21 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.421 -0.809 . . . . 72.5 109.207 -174.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.3 m -74.14 93.82 2.35 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.045 -0.724 . . . . 73.430000000000007 109.045 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.42 HG11 ' OD2' ' A' ' 109' ' ' ASP . 31.7 t -98.98 143.8 12.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.562 -0.903 . . . . 70.319999999999993 108.562 -177.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.4 tp -161.57 -75.31 0.05 Allowed 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 122.133 0.968 . . . . 73.230000000000004 109.654 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -151.0 169.46 21.74 Favored 'General case' 0 C--N 1.259 -3.343 0 CA-C-N 112.945 -1.934 . . . . 72.230000000000004 108.193 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.419 ' O ' HG22 ' A' ' 110' ' ' ILE . 70.1 t80 -33.16 -63.47 0.23 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 115.559 1.689 . . . . 73.329999999999998 115.559 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.62 -42.62 93.1 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.914 0.709 . . . . 70.209999999999994 112.914 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.64 -36.18 62.88 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.256 -0.577 . . . . 54.520000000000003 109.714 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.534 ' O ' HG12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -64.88 -50.71 65.49 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 124.024 0.828 . . . . 63.43 110.134 177.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 106' ' ' PHE . 7.6 tp -63.55 -36.25 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-O 120.914 0.388 . . . . 75.439999999999998 110.116 -176.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.37 -48.06 83.38 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.545 -0.752 . . . . 75.129999999999995 110.387 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 6.4 t -67.36 -36.31 81.13 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 116.065 -0.516 . . . . 71.230000000000004 109.782 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 109' ' ' ASP . 49.9 mm -64.89 -47.2 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.592 -0.731 . . . . 70.209999999999994 110.167 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 77.0 t -63.39 -41.0 91.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-O 121.113 0.483 . . . . 74.150000000000006 110.174 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.33 -42.95 99.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.505 -0.77 . . . . 71.030000000000001 111.13 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.01 -38.06 79.03 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 123.191 0.307 . . . . 65.209999999999994 111.373 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.418 ' O ' HD12 ' A' ' 121' ' ' LEU . 77.8 mt -64.77 -45.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.543 -0.54 . . . . 65.530000000000001 109.543 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -71.75 -31.14 66.35 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 119.19 -1.004 . . . . 72.409999999999997 112.307 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.62 -43.75 88.6 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 109.156 -0.683 . . . . 74.109999999999999 109.156 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 52.1 t -58.66 -46.87 86.24 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.531 -0.758 . . . . 71.439999999999998 110.64 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 117' ' ' ILE . 9.0 mp -73.26 -26.64 61.18 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.022 0.439 . . . . 73.230000000000004 111.811 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.68 -32.47 28.11 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 111.945 0.35 . . . . 72.349999999999994 111.945 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -87.73 9.93 19.96 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.486 0.55 . . . . 72.209999999999994 112.486 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -52.43 127.57 33.78 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.076 -0.511 . . . . 37.5 112.142 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.417 ' H ' ' HB2' ' A' ' 22' ' ' HIS 0.326 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 C-N-CA 125.742 1.617 . . . . 72.530000000000001 113.608 -178.086 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 tpt . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.22 0.533 . . . . 74.010000000000005 110.282 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.49 157.71 16.98 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.164 -1.05 . . . . 54.420000000000002 108.164 175.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 73.4 m-85 -111.62 136.24 51.11 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.363 -0.977 . . . . 74.030000000000001 108.363 174.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -113.15 114.29 26.58 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.967 -1.015 . . . . 63.229999999999997 108.491 -173.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -90.28 113.88 27.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 109.509 -0.552 . . . . 75.340000000000003 109.509 -174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.29 111.92 38.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 108.73 -0.841 . . . . 75.120000000000005 108.73 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.466 HG22 ' HB2' ' A' ' 27' ' ' MET . 4.5 tt -104.17 121.24 55.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 CA-C-N 115.754 -0.657 . . . . 75.329999999999998 110.26 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 19.8 mm -99.58 106.32 39.16 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 107.861 -1.163 . . . . 74.310000000000002 107.861 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 18.4 Cg_endo -94.35 137.84 1.06 Allowed 'Trans proline' 0 N--CA 1.437 -1.836 0 C-N-CA 122.283 1.989 . . . . 73.329999999999998 111.432 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -146.89 154.98 41.94 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.155 -0.683 . . . . 71.25 109.155 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.521 ' OG ' ' HB3' ' A' ' 22' ' ' HIS . 90.0 p -79.85 156.1 27.52 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 107.296 -1.372 . . . . 73.230000000000004 107.296 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.47 ' HB3' ' CG ' ' A' ' 79' ' ' LYS . 53.7 t80 -81.63 76.89 8.53 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 109.16 -0.681 . . . . 75.239999999999995 109.16 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.403 ' CD2' ' HB3' ' A' ' 125' ' ' GLU . 71.5 m80 -150.82 101.96 2.95 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-N 114.761 -1.109 . . . . 75.450000000000003 110.439 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -88.1 155.77 19.62 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 106.863 -1.532 . . . . 74.120000000000005 106.863 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -55.82 99.84 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 115.527 1.677 . . . . 75.540000000000006 115.527 -173.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 17' ' ' LYS . 23.4 t70 -85.63 -152.23 0.16 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 113.088 -1.869 . . . . 52.310000000000002 106.799 172.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.473 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 9.3 tmtt? -69.82 -58.76 3.5 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.282 -1.007 . . . . 73.409999999999997 108.282 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -138.77 -51.78 0.56 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.514 -0.874 . . . . 72.519999999999996 112.451 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -90.12 55.2 3.02 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.581 1.326 . . . . 73.310000000000002 114.581 -166.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 61.1 mtt -162.85 90.74 0.71 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 125.682 1.593 . . . . 72.319999999999993 107.263 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -175.37 118.19 0.17 Allowed 'General case' 0 N--CA 1.424 -1.762 0 C-N-CA 124.741 1.217 . . . . 62.310000000000002 108.345 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.521 ' HB3' ' OG ' ' A' ' 11' ' ' SER . 10.8 t60 -169.78 110.92 0.44 Allowed 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.419 -0.81 . . . . 74.310000000000002 110.037 170.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.3 mm -112.19 139.69 35.54 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 105.04 -2.207 . . . . 70.319999999999993 105.04 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 50.9 m -108.17 145.85 32.32 Favored Pre-proline 0 C--N 1.274 -2.684 0 N-CA-C 109.008 -0.738 . . . . 75.519999999999996 109.008 -178.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.88 150.43 83.48 Favored 'Trans proline' 0 C--O 1.248 0.99 0 C-N-CA 122.455 2.103 . . . . 63.5 112.072 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.45 137.75 47.9 Favored 'Trans proline' 0 CA--C 1.503 -1.039 0 C-N-CA 122.998 2.465 . . . . 72.319999999999993 111.344 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.466 ' HB2' HG22 ' A' ' 7' ' ' ILE . 48.2 mtp -99.81 128.85 45.88 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 105.922 -1.881 . . . . 75.549999999999997 105.922 173.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.7 t -111.4 123.73 67.52 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 C-N-CA 119.786 -0.766 . . . . 53.539999999999999 109.373 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.2 mp -122.31 102.31 11.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.763 -1.569 . . . . 74.150000000000006 106.763 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.18 -169.01 14.21 Favored Glycine 0 C--N 1.276 -2.804 0 C-N-CA 119.225 -1.465 . . . . 75.299999999999997 114.178 -172.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.1 t70 57.37 43.26 23.58 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 123.043 1.402 . . . . 65.129999999999995 110.156 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -116.92 136.14 53.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 105.708 -1.96 . . . . 75.209999999999994 105.708 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 p -79.83 169.63 17.65 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 119.211 0.914 . . . . 75.030000000000001 108.645 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.605 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 68.0 t80 -57.48 -45.67 84.59 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 123.188 0.595 . . . . 74.430000000000007 111.573 -172.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -66.87 -42.15 86.09 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 114.735 -1.12 . . . . 74.409999999999997 110.725 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.7 mt -72.97 -36.86 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 115.325 -0.852 . . . . 72.299999999999997 109.865 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.401 ' HA ' HG23 ' A' ' 40' ' ' ILE . . . -64.06 -41.16 97.46 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.954 -0.566 . . . . 73.030000000000001 110.324 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.2 ttm -70.3 -37.95 74.89 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 120.139 -0.624 . . . . 62.0 110.819 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -73.12 -36.0 66.64 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.428 0.899 . . . . 72.420000000000002 113.428 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.412 ' O ' HG22 ' A' ' 44' ' ' VAL . 11.6 tt -68.31 -40.87 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 119.842 -0.743 . . . . 72.409999999999997 109.28 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.4 t -65.42 -43.82 94.56 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.864 0 N-CA-C 109.57 -0.53 . . . . 72.340000000000003 109.57 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -59.42 -39.24 82.86 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.595 0.358 . . . . 72.329999999999998 111.82 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.8 -44.0 95.37 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.714 -0.755 . . . . 74.109999999999999 111.369 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 40' ' ' ILE . 56.6 t -71.06 -39.09 74.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.378 -0.601 . . . . 61.420000000000002 109.378 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.433 ' OD2' HG22 ' A' ' 56' ' ' VAL . 14.1 t70 -56.68 -46.93 80.85 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.752 1.621 . . . . 64.450000000000003 109.966 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -64.73 -40.56 95.52 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.157 -0.929 . . . . 75.140000000000001 109.917 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.1 t -66.77 -39.29 83.32 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 CA-C-N 116.311 -0.404 . . . . 62.229999999999997 111.139 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 72.9 mt -69.44 -40.74 80.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 110.66 -0.126 . . . . 73.209999999999994 110.66 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -71.92 -30.79 65.72 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.337 -0.545 . . . . 74.25 110.607 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.2 -45.66 11.8 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 112.545 0.572 . . . . 73.349999999999994 112.545 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.5 m -85.44 -20.01 30.44 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.885 0.698 . . . . 73.209999999999994 112.885 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 48' ' ' ILE . 6.4 m-85 -123.15 157.08 33.74 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-O 121.145 0.498 . . . . 72.519999999999996 109.683 -175.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.552 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 45.1 t30 -85.86 87.35 7.4 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 104.367 -2.457 . . . . 60.030000000000001 104.367 172.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -133.5 136.25 44.95 Favored 'General case' 0 N--CA 1.397 -3.112 0 CA-C-N 115.434 -0.803 . . . . 72.310000000000002 111.975 -173.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 72' ' ' THR . 41.0 p -95.8 122.77 38.94 Favored 'General case' 0 N--CA 1.404 -2.731 0 N-CA-C 106.727 -1.582 . . . . 62.0 106.727 171.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.433 HG22 ' OD2' ' A' ' 45' ' ' ASP . 3.2 p -99.68 119.34 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 N-CA-C 108.126 -1.065 . . . . 71.329999999999998 108.126 177.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -117.61 112.28 20.33 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 114.12 -1.4 . . . . 64.109999999999999 108.584 -174.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -94.21 122.36 36.66 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.406 0.622 . . . . 72.129999999999995 111.464 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mp -121.94 178.11 5.02 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 115.197 -0.91 . . . . 54.329999999999998 109.193 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -95.61 140.8 29.91 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.325 -0.852 . . . . 72.019999999999996 108.748 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.12 175.69 41.57 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 115.574 -0.739 . . . . 54.539999999999999 113.089 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -72.52 174.87 6.85 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 123.995 0.918 . . . . 70.420000000000002 108.595 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -49.73 -41.33 43.39 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 124.613 1.165 . . . . 72.109999999999999 113.034 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.01 -8.54 57.88 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.124 -0.944 . . . . 70.010000000000005 111.644 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -99.15 159.08 15.23 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 107.667 -1.234 . . . . 74.209999999999994 107.667 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.75 -37.64 3.67 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.638 0 CA-C-O 121.57 0.7 . . . . 74.030000000000001 110.212 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.7 tp -156.88 144.24 18.9 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.798 -1.186 . . . . 73.120000000000005 107.798 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -131.32 107.12 8.73 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.857 -0.794 . . . . 74.319999999999993 108.857 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -116.19 129.33 56.25 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.017 -1.073 . . . . 74.430000000000007 111.262 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -109.32 128.89 55.45 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.532 -0.758 . . . . 53.420000000000002 109.447 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -105.91 134.72 48.58 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 107.255 -1.387 . . . . 74.230000000000004 107.255 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 30.6 m -109.18 107.3 17.53 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 106.578 -1.638 . . . . 62.229999999999997 106.578 173.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.66 140.13 41.16 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 120.954 0.407 . . . . 74.319999999999993 111.865 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.552 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 44.3 tt0 -147.81 86.82 1.6 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.627 -0.715 . . . . 74.299999999999997 109.073 168.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -95.91 104.0 15.91 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.922 -0.581 . . . . 72.25 110.556 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 56.9 34.81 25.43 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.804 0.69 . . . . 74.150000000000006 112.46 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.94 -7.88 57.47 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 120.754 -0.736 . . . . 55.539999999999999 113.086 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 53.4 mtpt -92.37 102.11 14.59 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.108 -1.071 . . . . 73.200000000000003 108.108 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.542 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -102.09 138.19 39.37 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.576 -0.738 . . . . 75.420000000000002 111.21 -173.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.434 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . -164.03 164.48 36.55 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.438 -0.411 . . . . 54.43 112.751 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 34.0 mm -120.13 134.63 63.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 105.584 -2.006 . . . . 74.200000000000003 105.584 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.6 t -127.57 120.3 54.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.879 -0.513 . . . . 62.310000000000002 110.25 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.414 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 67.1 m-70 -105.62 104.14 13.8 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.328 -0.619 . . . . 65.099999999999994 109.328 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.3 t -100.11 110.59 27.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 109.669 -0.493 . . . . 74.140000000000001 109.669 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -112.55 140.54 47.22 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.042 0.449 . . . . 72.510000000000005 110.406 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.2 mt -97.78 125.7 42.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 105.831 -1.915 . . . . 73.140000000000001 105.831 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -104.55 141.54 36.23 Favored 'General case' 0 C--N 1.273 -2.761 0 N-CA-C 108.017 -1.105 . . . . 73.510000000000005 108.017 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 51.0 pttt -90.0 98.04 11.54 Favored 'General case' 0 C--N 1.279 -2.48 0 C-N-CA 119.294 -0.962 . . . . 64.510000000000005 108.958 172.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.3 tt -74.13 112.31 10.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 121.261 -0.899 . . . . 61.25 110.39 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.34 177.14 8.46 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.084 -1.08 . . . . 62.149999999999999 108.084 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -77.99 -13.83 59.74 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 118.774 0.715 . . . . 61.140000000000001 111.119 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -109.02 9.82 26.31 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.124 -0.943 . . . . 62.310000000000002 110.156 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 42.1 t -147.84 102.07 3.66 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 109.075 -0.713 . . . . 74.439999999999998 109.075 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.56 139.65 25.77 Favored 'Trans proline' 0 C--O 1.252 1.224 0 C-N-CA 122.429 2.086 . . . . 63.210000000000001 113.851 -174.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.62 161.07 28.08 Favored 'Trans proline' 0 N--CA 1.439 -1.71 0 C-N-CA 122.45 2.1 . . . . 70.319999999999993 108.78 173.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.3 t -91.68 157.92 2.92 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.559 0 N-CA-C 107.232 -1.396 . . . . 73.420000000000002 107.232 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -109.82 133.48 53.1 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.09 -1.078 . . . . 71.239999999999995 108.09 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -155.52 -144.88 4.03 Favored Glycine 0 N--CA 1.413 -2.867 0 C-N-CA 119.842 -1.171 . . . . 72.5 112.244 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -64.9 127.01 29.81 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 113.456 -1.372 . . . . 53.229999999999997 109.521 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -77.11 99.33 5.33 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.549 -1.278 . . . . 74.349999999999994 107.549 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 44.1 t -79.96 152.59 29.43 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 115.404 -0.816 . . . . 72.239999999999995 109.565 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.8 m -76.6 86.4 3.28 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.232 -1.025 . . . . 63.119999999999997 108.232 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 28.8 t -115.51 138.0 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.515 -174.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 103' ' ' VAL . 25.6 mt -170.55 -49.98 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 126.556 1.943 . . . . 65.400000000000006 110.948 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.6 142.37 17.8 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 113.996 -1.456 . . . . 75.530000000000001 107.537 -172.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -32.96 -44.43 0.11 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.145 2.178 . . . . 74.200000000000003 116.552 -170.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -54.84 -53.72 51.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.373 0.606 . . . . 73.25 112.567 -175.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -80.72 -30.14 36.31 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.989 -0.55 . . . . 71.049999999999997 110.041 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.94 -47.88 81.33 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.944 -1.026 . . . . 75.420000000000002 109.477 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.7 tt -65.53 -37.0 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.552 -0.295 . . . . 52.310000000000002 110.523 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.28 -48.32 82.25 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 109.655 -0.498 . . . . 73.109999999999999 109.655 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 21.5 t -62.81 -39.25 93.71 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.514 -0.767 . . . . 70.129999999999995 111.632 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 75.9 mt -70.18 -45.71 74.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 120.505 -0.478 . . . . 74.439999999999998 110.846 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.6 t -70.19 -38.86 75.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.264 -0.574 . . . . 64.209999999999994 110.72 -176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -74.53 -22.05 59.22 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 112.291 0.478 . . . . 75.200000000000003 112.291 -176.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.465 ' HB3' ' SD ' ' A' ' 27' ' ' MET . . . -83.04 -37.69 23.56 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 119.073 -1.051 . . . . 63.299999999999997 110.486 175.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.511 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 81.6 mt -62.48 -45.37 98.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 108.968 -0.752 . . . . 55.549999999999997 108.968 175.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -54.4 -43.64 71.63 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 123.575 0.75 . . . . 60.450000000000003 112.382 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 22.5 mm-40 -65.7 -44.11 87.13 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.818 0.699 . . . . 74.450000000000003 110.93 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 36.5 t -62.4 -40.94 98.15 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.198 0.523 . . . . 43.0 110.163 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 117' ' ' ILE . 70.6 mt -71.82 -29.14 64.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.977 -0.556 . . . . 74.019999999999996 110.656 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.08 -31.81 39.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 112.727 0.64 . . . . 74.540000000000006 112.727 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 119' ' ' GLU . 72.3 mmtt -65.56 -40.25 92.62 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 119.841 -0.743 . . . . 63.520000000000003 109.933 -177.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.62 -154.3 50.76 Favored Glycine 0 C--N 1.291 -1.966 0 CA-C-N 114.44 -1.254 . . . . 63.219999999999999 114.798 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 13' ' ' HIS . 9.2 pt-20 . . . . . 0 C--N 1.294 -1.846 0 C-N-CA 124.703 1.201 . . . . 61.109999999999999 112.799 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptm . . . . . 0 CA--C 1.515 -0.388 0 N-CA-C 109.375 -0.602 . . . . 65.239999999999995 109.375 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 31' ' ' ASP . 87.5 tttt -122.3 136.96 54.99 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.072 0.463 . . . . 73.299999999999997 111.499 -173.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.586 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 19.2 m-85 -117.24 152.44 34.82 Favored 'General case' 0 C--O 1.251 1.169 0 C-N-CA 125.0 1.32 . . . . 74.340000000000003 109.338 173.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.629 ' OD1' ' HA3' ' A' ' 30' ' ' GLY . 24.6 t70 -123.67 108.77 12.93 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.581 -1.637 . . . . 55.450000000000003 106.581 -177.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.44 127.05 48.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.195 0.522 . . . . 62.119999999999997 111.927 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' A' ' 85' ' ' LYS . 4.8 p -115.15 121.66 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.621 0 N-CA-C 108.156 -1.053 . . . . 75.340000000000003 108.156 176.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.466 HG23 ' CG ' ' A' ' 27' ' ' MET . 1.9 tt -122.2 123.48 68.95 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 CA-C-N 115.392 -0.822 . . . . 73.099999999999994 109.878 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.527 ' CG1' ' HB2' ' A' ' 83' ' ' HIS . 40.2 pt -108.06 118.59 52.27 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.864 -0.607 . . . . 53.049999999999997 110.463 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 11.5 Cg_endo -90.94 142.7 3.21 Favored 'Trans proline' 0 N--CA 1.431 -2.152 0 C-N-CA 122.153 1.902 . . . . 72.019999999999996 109.726 170.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -151.41 146.95 26.32 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 108.909 -0.774 . . . . 72.5 108.909 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.621 ' OG ' ' HB3' ' A' ' 22' ' ' HIS . 86.5 p -90.4 143.9 26.32 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.302 -1.37 . . . . 72.420000000000002 107.302 175.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.534 ' CE1' ' HB2' ' A' ' 79' ' ' LYS 0.351 1.6 p90 -80.61 87.5 5.76 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 118.098 -1.441 . . . . 74.230000000000004 113.189 178.379 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -130.14 99.53 5.09 Favored 'General case' 0 N--CA 1.414 -2.271 0 CA-C-N 113.729 -1.578 . . . . 63.210000000000001 110.833 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.92 118.05 9.86 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 122.305 1.05 . . . . 63.340000000000003 109.395 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 20' ' ' MET . 56.1 t80 -60.71 111.62 1.69 Allowed 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 112.208 -2.269 . . . . 74.019999999999996 111.074 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -85.69 -105.04 0.06 Allowed 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 113.433 -1.712 . . . . 73.25 110.218 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -112.35 -57.31 2.29 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.451 0.644 . . . . 72.540000000000006 110.627 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -124.92 -23.28 4.31 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.497 -0.774 . . . . 75.540000000000006 109.909 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -103.07 157.41 17.01 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.554 -0.748 . . . . 75.129999999999995 111.654 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 83.1 mtp 72.96 76.7 0.14 Allowed 'General case' 0 C--O 1.209 -1.038 0 O-C-N 124.829 1.331 . . . . 71.439999999999998 114.085 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -161.2 99.39 1.19 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.305 -0.998 . . . . 73.109999999999999 108.305 171.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.621 ' HB3' ' OG ' ' A' ' 11' ' ' SER . 47.0 t60 -136.63 93.04 2.82 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.651 -0.87 . . . . 72.439999999999998 108.651 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.2 mm -109.01 138.53 35.73 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 106.126 -1.805 . . . . 72.219999999999999 106.126 176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 62.9 m -106.81 122.73 40.79 Favored Pre-proline 0 C--N 1.273 -2.736 0 C-N-CA 120.278 -0.569 . . . . 63.009999999999998 110.078 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -49.55 143.35 21.66 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.976 3.117 . . . . 50.43 113.733 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.85 133.05 55.75 Favored 'Trans proline' 0 CA--C 1.509 -0.727 0 C-N-CA 123.792 2.995 . . . . 73.129999999999995 113.051 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.466 ' CG ' HG23 ' A' ' 7' ' ' ILE . 22.1 ptp -106.07 141.55 37.25 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.652 -1.611 . . . . 74.409999999999997 106.652 172.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.412 ' O ' HD11 ' A' ' 29' ' ' ILE . 39.8 t -133.86 127.75 52.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 120.229 -0.588 . . . . 51.210000000000001 110.91 -169.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.412 HD11 ' O ' ' A' ' 28' ' ' VAL . 45.3 mm -129.17 103.8 9.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.715 -1.217 . . . . 75.319999999999993 107.715 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.629 ' HA3' ' OD1' ' A' ' 4' ' ' ASP . . . -123.04 88.91 0.41 Allowed Glycine 0 N--CA 1.419 -2.461 0 C-N-CA 118.919 -1.61 . . . . 72.420000000000002 113.618 -175.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.42 ' HA ' ' HE3' ' A' ' 2' ' ' LYS . 5.9 p-10 -165.52 29.29 0.05 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.991 0.901 . . . . 74.349999999999994 109.118 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -118.32 136.98 53.39 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-N 115.572 -0.74 . . . . 74.340000000000003 109.21 -170.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.4 p -76.31 169.66 17.8 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 106.765 -1.568 . . . . 65.150000000000006 106.765 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.586 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 84.8 t80 -59.0 -39.21 81.15 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.465 0.65 . . . . 74.329999999999998 110.758 -177.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.15 -50.31 72.38 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.144 -1.389 . . . . 72.109999999999999 110.755 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.3 mt -69.99 -37.19 71.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.5 -0.555 . . . . 63.43 109.5 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.1 94.01 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.612 -0.722 . . . . 70.329999999999998 110.8 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.6 tpp -69.76 -41.15 75.57 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 120.103 -0.639 . . . . 41.25 110.16 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.4 -38.03 80.92 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 112.489 0.552 . . . . 73.019999999999996 112.489 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.463 ' O ' HG21 ' A' ' 44' ' ' VAL . 14.4 tt -69.52 -39.39 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 119.516 -0.874 . . . . 72.25 110.114 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.7 t -67.95 -40.41 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 120.544 -0.462 . . . . 55.539999999999999 109.964 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -69.55 -25.91 64.24 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.77 0.319 . . . . 72.209999999999994 111.559 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.59 -46.51 39.3 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 110.541 -1.024 . . . . 73.049999999999997 110.541 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 48' ' ' ILE . 86.3 t -61.1 -42.62 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 109.21 -0.663 . . . . 64.530000000000001 109.21 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -49.92 -52.36 33.87 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 125.912 1.685 . . . . 72.439999999999998 111.057 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -68.28 -35.19 77.48 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.773 -1.103 . . . . 73.310000000000002 110.387 -175.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 91.6 t -71.73 -36.56 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 116.075 -0.511 . . . . 71.439999999999998 111.253 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 44' ' ' VAL . 60.4 mt -68.35 -38.76 79.89 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.959 0 N-CA-C 109.541 -0.54 . . . . 74.450000000000003 109.541 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -66.62 -33.84 76.55 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.803 0.335 . . . . 74.209999999999994 111.682 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.99 -25.5 34.7 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.452 0.538 . . . . 73.409999999999997 112.452 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.9 m -99.48 -23.96 14.93 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.164 0.801 . . . . 75.120000000000005 113.164 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -133.24 -172.52 2.96 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.792 0.806 . . . . 74.450000000000003 111.6 -173.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -106.93 100.25 9.77 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 104.287 -2.486 . . . . 71.319999999999993 104.287 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -114.69 144.49 43.36 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 113.343 0.868 . . . . 72.319999999999993 113.343 -169.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -123.68 112.15 17.04 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.798 -1.556 . . . . 73.109999999999999 106.798 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -100.55 137.2 28.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.127 0.489 . . . . 74.310000000000002 109.993 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -136.32 117.96 14.96 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.223 -1.029 . . . . 73.340000000000003 108.223 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -97.65 129.25 44.75 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.55 -0.86 . . . . 71.120000000000005 111.366 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.2 mp -122.51 177.44 5.41 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.744 -1.116 . . . . 37.469999999999999 108.072 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -101.58 161.83 13.35 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.389 -1.337 . . . . 73.040000000000006 107.389 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.39 176.63 19.7 Favored Glycine 0 N--CA 1.413 -2.85 0 N-CA-C 111.052 -0.819 . . . . 53.530000000000001 111.052 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.468 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 11.9 pt-20 -65.23 -178.33 0.47 Allowed 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 123.403 0.681 . . . . 61.109999999999999 110.418 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -50.13 -38.45 39.15 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 114.442 1.275 . . . . 75.409999999999997 114.442 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 44.0 t -92.96 -0.93 57.11 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 121.687 0.756 . . . . 75.340000000000003 110.558 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.506 ' OD1' ' HG2' ' A' ' 87' ' ' ARG . 88.0 m-20 -100.75 152.82 20.03 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-N 115.974 -0.557 . . . . 74.349999999999994 110.077 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -113.45 -24.89 3.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-O 121.288 0.566 . . . . 63.329999999999998 111.893 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.2 tp -154.36 141.73 19.63 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 109.141 -0.688 . . . . 73.129999999999995 109.141 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -130.34 102.13 6.06 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 106.655 -1.609 . . . . 74.239999999999995 106.655 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -111.24 124.63 52.61 Favored 'General case' 0 C--N 1.281 -2.38 0 C-N-CA 119.436 -0.906 . . . . 74.439999999999998 109.642 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -105.74 143.27 34.13 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.284 -0.636 . . . . 73.109999999999999 109.284 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -127.88 126.26 41.22 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.384 -0.969 . . . . 72.450000000000003 108.384 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.0 m -103.28 117.0 33.52 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.112 -1.81 . . . . 65.209999999999994 106.112 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.55 144.31 49.17 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.415 0.626 . . . . 75.5 112.393 -170.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 22.2 mt-10 -147.55 160.4 42.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.574 1.178 . . . . 63.420000000000002 111.134 171.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -154.29 157.44 38.68 Favored 'General case' 0 C--N 1.258 -3.409 0 N-CA-C 102.327 -3.212 . . . . 75.040000000000006 102.327 165.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -53.06 99.59 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.994 0.902 . . . . 52.520000000000003 112.726 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.72 0.51 56.46 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.401 -0.818 . . . . 71.219999999999999 112.648 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 95.6 mttt -134.33 108.55 8.26 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.047 -1.094 . . . . 53.420000000000002 108.047 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.534 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 16.5 ptpt -131.64 132.66 44.19 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.397 0.517 . . . . 71.340000000000003 112.397 -174.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.87 177.27 43.99 Favored Glycine 0 C--O 1.215 -1.036 0 C-N-CA 119.955 -1.117 . . . . 65.430000000000007 113.819 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.0 mt -129.22 148.81 33.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 106.884 -1.524 . . . . 62.539999999999999 106.884 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.25 123.86 51.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.634 -0.506 . . . . 64.349999999999994 109.634 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.527 ' HB2' ' CG1' ' A' ' 8' ' ' ILE . 11.9 m170 -110.7 112.44 24.32 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.641 -0.503 . . . . 74.019999999999996 109.641 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.47 114.51 42.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.514 -0.921 . . . . 74.140000000000001 108.514 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.418 ' HB3' HG11 ' A' ' 6' ' ' VAL . 59.9 tttp -115.72 118.28 32.63 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.958 -1.127 . . . . 74.420000000000002 107.958 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.5 mt -98.16 114.63 26.9 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 107.232 -1.395 . . . . 74.120000000000005 107.232 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.506 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 76.0 mtp85 -102.42 139.62 37.78 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.581 0.705 . . . . 71.519999999999996 110.073 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -90.71 98.27 11.68 Favored 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 115.089 -0.96 . . . . 73.439999999999998 108.49 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 tt -75.14 110.81 10.49 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-O 122.824 1.297 . . . . 70.209999999999994 109.173 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.1 p -123.31 -170.81 2.18 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 113.773 -1.558 . . . . 74.310000000000002 107.744 -174.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -82.63 -0.46 47.21 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.672 -0.862 . . . . 75.230000000000004 108.672 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -112.51 -5.05 14.07 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.974 -1.012 . . . . 72.140000000000001 110.18 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.2 m -137.97 113.97 9.15 Favored Pre-proline 0 C--N 1.311 -1.087 0 C-N-CA 123.202 0.601 . . . . 75.129999999999995 110.814 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.48 163.34 29.79 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 122.015 1.81 . . . . 64.049999999999997 110.552 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.96 163.2 29.32 Favored 'Trans proline' 0 C--O 1.247 0.952 0 C-N-CA 122.885 2.39 . . . . 63.030000000000001 112.048 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 t -93.41 156.54 3.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.582 -0.896 . . . . 71.430000000000007 108.582 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -106.41 141.54 37.55 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.272 -1.01 . . . . 72.510000000000005 108.272 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.42 -163.83 31.51 Favored Glycine 0 N--CA 1.419 -2.466 0 C-N-CA 120.149 -1.024 . . . . 55.109999999999999 111.714 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -69.58 139.23 53.68 Favored 'General case' 0 N--CA 1.417 -2.124 0 C-N-CA 125.205 1.402 . . . . 75.239999999999995 107.921 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -102.59 123.54 46.5 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 119.655 -0.818 . . . . 72.439999999999998 111.803 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.1 t -79.34 137.92 37.5 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.311 -1.366 . . . . 71.530000000000001 107.311 172.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.5 m -75.33 95.47 3.21 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.647 0.737 . . . . 64.019999999999996 110.191 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.426 HG13 ' CG ' ' A' ' 109' ' ' ASP . 57.7 t -97.89 147.55 6.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.778 -1.101 . . . . 54.420000000000002 109.369 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 47.1 tp -149.56 -74.1 0.17 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.289 -0.869 . . . . 70.420000000000002 109.56 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -143.56 151.41 40.18 Favored 'General case' 0 C--N 1.258 -3.385 0 N-CA-C 106.831 -1.544 . . . . 54.100000000000001 106.831 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.458 ' O ' HG21 ' A' ' 110' ' ' ILE . 79.9 t80 -35.78 -42.08 0.24 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.512 1.671 . . . . 74.219999999999999 115.512 -172.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -55.26 -47.75 74.99 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 122.804 0.442 . . . . 71.530000000000001 112.015 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.89 -34.22 30.11 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 107.672 -1.232 . . . . 63.329999999999998 107.672 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.426 ' CG ' HG13 ' A' ' 103' ' ' VAL . 26.2 m-20 -62.37 -46.8 87.0 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.476 -0.784 . . . . 74.349999999999994 110.218 -176.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 106' ' ' PHE . 8.5 tp -65.56 -41.36 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 115.571 -0.74 . . . . 73.310000000000002 110.612 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -26.37 60.32 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 120.285 -0.566 . . . . 72.340000000000003 111.572 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 12.0 t -68.26 -48.01 66.21 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 116.585 -0.28 . . . . 71.209999999999994 110.382 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.73 -42.93 93.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.216 -0.447 . . . . 72.450000000000003 110.087 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 70.9 t -64.65 -40.9 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 116.207 -0.451 . . . . 73.450000000000003 110.306 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -61.55 -44.09 97.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.351 -0.386 . . . . 74.430000000000007 111.355 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.417 ' CB ' ' HE2' ' A' ' 27' ' ' MET . . . -69.49 -35.64 75.76 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.847 0.356 . . . . 37.469999999999999 111.573 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.461 ' O ' HD12 ' A' ' 121' ' ' LEU . 80.8 mt -69.33 -44.57 80.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 109.587 -0.523 . . . . 72.439999999999998 109.587 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -60.37 -45.22 94.3 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.886 -0.783 . . . . 63.219999999999999 108.886 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 44.5 mt-10 -68.57 -33.74 74.6 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 112.081 0.4 . . . . 64.219999999999999 112.081 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 9' ' ' PRO . 30.3 t -67.42 -31.3 71.41 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.417 0.627 . . . . 60.210000000000001 109.818 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 117' ' ' ILE . 9.0 mp -81.33 -37.84 27.69 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 121.151 0.501 . . . . 71.549999999999997 110.812 176.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.4 -16.71 41.76 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 115.579 1.696 . . . . 75.430000000000007 115.579 -175.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 62.9 mttm -75.81 -3.88 37.52 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 119.884 1.22 . . . . 75.340000000000003 113.603 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.07 -157.45 20.08 Favored Glycine 0 N--CA 1.422 -2.263 0 C-N-CA 119.943 -1.122 . . . . 74.329999999999998 113.429 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 20' ' ' MET . 10.0 pt-20 . . . . . 0 C--N 1.286 -2.189 0 CA-C-N 114.421 -0.889 . . . . 73.129999999999995 111.214 -174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.415 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 2.0 mmt . . . . . 0 CA--C 1.506 -0.732 0 CA-C-O 121.367 0.603 . . . . 71.439999999999998 112.194 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -126.18 143.77 51.01 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.671 -1.233 . . . . 55.43 107.671 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 11.8 m-85 -114.7 145.34 42.16 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 122.002 0.906 . . . . 72.099999999999994 112.778 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.558 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 35.4 t70 -106.12 100.89 10.41 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 127.026 2.131 . . . . 64.239999999999995 105.541 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -92.42 124.6 44.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.638 -0.664 . . . . 54.140000000000001 109.334 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.9 t -113.51 119.05 59.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.288 -1.004 . . . . 73.239999999999995 108.288 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.469 HG21 ' HB2' ' A' ' 27' ' ' MET . 7.7 tt -114.29 116.55 52.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 121.504 0.669 . . . . 61.140000000000001 109.391 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 20.7 mt -106.61 106.72 58.58 Favored Pre-proline 0 C--N 1.3 -1.551 0 CA-C-N 115.56 -0.745 . . . . 72.219999999999999 110.056 -175.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.533 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 25.3 Cg_endo -95.42 137.22 0.74 Allowed 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.507 2.138 . . . . 73.420000000000002 111.185 173.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -158.55 137.45 11.29 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 121.845 -0.534 . . . . 71.409999999999997 111.065 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -84.5 106.92 16.45 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.21 -0.45 . . . . 50.409999999999997 109.853 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.62 ' CE1' ' HB2' ' A' ' 79' ' ' LYS . 2.0 p90 -63.26 106.98 0.97 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.103 1.149 . . . . 73.299999999999997 114.103 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 73.7 m80 -142.24 156.36 45.3 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.96 -1.018 . . . . 74.319999999999993 108.704 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -98.26 120.68 39.1 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 108.0 -1.111 . . . . 71.430000000000007 108.0 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -60.04 111.08 1.36 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 124.754 1.284 . . . . 75.349999999999994 110.603 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.07 -100.53 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.576 -1.193 . . . . 72.299999999999997 108.355 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -113.19 -60.31 1.9 Allowed 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 106.862 -1.533 . . . . 75.5 106.862 167.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.435 ' HA ' ' OE1' ' A' ' 21' ' ' GLU . 7.2 p-80 -138.5 34.56 2.26 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 113.797 -1.547 . . . . 74.25 110.005 175.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -135.29 152.61 51.66 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 106.619 -1.622 . . . . 61.310000000000002 106.619 -178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.428 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 0.0 OUTLIER 60.99 58.09 2.38 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.512 1.149 . . . . 62.520000000000003 110.009 -175.239 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.435 ' OE1' ' HA ' ' A' ' 18' ' ' HIS . 7.4 pt-20 -141.06 88.22 2.16 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 113.47 -1.695 . . . . 64.5 110.684 -176.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -128.75 104.65 7.75 Favored 'General case' 0 C--N 1.285 -2.22 0 O-C-N 121.68 -0.638 . . . . 72.420000000000002 109.456 174.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.6 mm -116.51 136.68 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.733 0 N-CA-C 107.02 -1.474 . . . . 70.430000000000007 107.02 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 70.2 m -108.38 145.63 31.94 Favored Pre-proline 0 C--N 1.281 -2.397 0 N-CA-C 107.335 -1.357 . . . . 73.430000000000007 107.335 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.42 152.01 33.9 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 121.902 1.734 . . . . 63.119999999999997 112.451 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.02 125.2 17.49 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.631 2.221 . . . . 64.439999999999998 111.261 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.469 ' HB2' HG21 ' A' ' 7' ' ' ILE . 38.9 mtt -95.56 134.45 38.41 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.454 -1.684 . . . . 74.129999999999995 106.454 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -131.33 136.86 56.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.383 -0.527 . . . . 65.230000000000004 110.954 -168.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.4 mp -133.65 109.17 12.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.201 -1.037 . . . . 72.129999999999995 108.201 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -119.08 81.19 0.32 Allowed Glycine 0 C--N 1.3 -1.465 0 C-N-CA 119.209 -1.472 . . . . 42.329999999999998 115.137 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -176.06 31.03 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 124.555 1.142 . . . . 53.5 112.268 172.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.65 133.23 53.36 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 106.228 -1.767 . . . . 71.329999999999998 106.228 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 p -75.13 161.48 29.36 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 119.471 1.032 . . . . 72.25 109.509 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.564 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 61.9 t80 -58.89 -43.63 90.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.499 0.666 . . . . 74.150000000000006 111.263 -173.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -70.08 -34.96 73.82 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.841 -1.072 . . . . 73.140000000000001 112.098 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.5 -35.79 17.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.404 -0.591 . . . . 52.100000000000001 109.404 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.8 -45.72 93.31 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-N 115.497 -0.774 . . . . 51.030000000000001 109.997 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 18.4 mmt -62.99 -38.11 89.87 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 116.504 -0.316 . . . . 70.109999999999999 111.249 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -65.54 -45.26 84.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.396 -0.365 . . . . 63.200000000000003 111.035 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 44' ' ' VAL . 10.4 tt -71.79 -39.73 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 119.146 -1.022 . . . . 65.299999999999997 110.541 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 83.5 t -67.8 -33.73 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 121.133 -0.227 . . . . 63.409999999999997 110.615 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -67.83 -40.94 83.7 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.86 -0.422 . . . . 75.219999999999999 109.86 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -65.34 -45.05 92.34 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-N 115.64 -0.709 . . . . 62.32 111.342 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 40' ' ' ILE . 69.7 t -61.7 -42.7 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.012 0.434 . . . . 74.519999999999996 109.875 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.56 -46.21 80.85 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 124.306 1.042 . . . . 72.239999999999995 111.225 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -71.54 -35.32 70.62 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.059 -0.973 . . . . 71.340000000000003 110.323 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 43' ' ' GLY . 97.7 t -67.73 -40.6 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 121.051 -0.259 . . . . 75.030000000000001 110.445 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 44' ' ' VAL . 74.8 mt -64.15 -39.6 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.958 0.409 . . . . 74.200000000000003 109.9 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -74.89 -19.28 60.21 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 115.973 -0.558 . . . . 75.319999999999993 111.321 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.72 -14.74 16.54 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 112.874 0.694 . . . . 73.430000000000007 112.874 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 m -108.23 -23.42 11.94 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 112.429 0.529 . . . . 70.409999999999997 112.429 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -133.97 177.93 7.35 Favored 'General case' 0 CA--C 1.484 -1.564 0 CA-C-O 121.461 0.648 . . . . 72.150000000000006 110.069 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.51 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 38.4 t30 -98.93 95.89 7.47 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 104.938 -2.245 . . . . 73.25 104.938 175.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -117.41 135.25 54.02 Favored 'General case' 0 N--CA 1.402 -2.859 0 CA-C-N 115.427 -0.806 . . . . 44.43 112.408 -173.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.4 m -109.72 121.26 44.82 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 106.812 -1.551 . . . . 74.129999999999995 106.812 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.35 128.82 51.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-O 121.294 0.568 . . . . 74.310000000000002 110.539 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -122.37 112.33 17.96 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.879 -1.526 . . . . 71.209999999999994 106.879 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.16 119.13 34.09 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.814 0.34 . . . . 61.130000000000003 110.818 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.48 174.4 6.57 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.291 0.567 . . . . 71.230000000000004 109.824 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -95.98 155.18 16.86 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.2 -1.408 . . . . 65.319999999999993 107.2 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.66 175.73 24.6 Favored Glycine 0 C--N 1.277 -2.749 0 C-N-CA 120.519 -0.848 . . . . 73.150000000000006 112.891 -176.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.503 ' HB3' ' OD2' ' A' ' 65' ' ' ASP . 11.6 tp10 -65.91 177.05 1.42 Allowed 'General case' 0 C--O 1.21 -1.025 0 C-N-CA 124.735 1.214 . . . . 72.140000000000001 108.813 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -45.25 -49.11 12.69 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 113.813 1.042 . . . . 74.420000000000002 113.813 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 76.8 m -82.03 -15.07 54.86 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.758 -0.655 . . . . 75.209999999999994 111.712 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 12.3 m-20 -98.87 118.09 34.85 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.1 -0.64 . . . . 73.219999999999999 110.618 -176.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.0 t -80.73 -36.21 15.47 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.508 0 CA-C-N 116.062 -0.517 . . . . 61.200000000000003 112.272 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.8 tp -146.48 140.68 26.4 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.896 -1.15 . . . . 75.439999999999998 107.896 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.79 102.01 6.13 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 107.374 -1.343 . . . . 65.519999999999996 107.374 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -109.43 114.53 28.25 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.83 0.824 . . . . 63.009999999999998 110.372 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -98.49 139.33 34.39 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.811 -1.086 . . . . 72.420000000000002 109.012 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.84 128.48 51.7 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 107.257 -1.386 . . . . 72.530000000000001 107.257 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.3 m -103.42 119.17 38.37 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 106.78 -1.563 . . . . 75.409999999999997 106.78 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.57 137.71 44.07 Favored 'General case' 0 CA--C 1.495 -1.156 0 CA-C-O 121.084 0.468 . . . . 61.240000000000002 112.182 -173.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.51 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -142.45 83.55 1.83 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.145 -1.428 . . . . 74.109999999999999 107.145 173.125 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -85.62 66.79 9.83 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.063 -0.517 . . . . 75.409999999999997 109.831 -177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 51.56 64.1 1.98 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.507 -1.224 . . . . 74.5 111.427 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.93 -11.8 62.39 Favored Glycine 0 C--N 1.314 -0.667 0 C-N-CA 120.666 -0.778 . . . . 74.109999999999999 112.856 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -108.64 107.7 18.28 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.38 -1.341 . . . . 64.109999999999999 107.38 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.62 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -121.63 142.65 49.92 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 113.14 0.793 . . . . 70.239999999999995 113.14 -165.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.98 171.29 43.77 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.967 -0.56 . . . . 41.409999999999997 111.877 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.4 mt -116.53 147.0 20.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.759 -1.2 . . . . 75.329999999999998 107.759 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.3 t -130.18 110.44 19.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.588 -0.893 . . . . 74.510000000000005 108.588 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 7' ' ' ILE . 38.6 m-70 -98.89 106.32 18.57 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.294 -0.632 . . . . 63.299999999999997 109.294 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.6 t -104.66 109.87 28.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.603 -0.888 . . . . 64.340000000000003 108.603 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -119.76 139.44 52.3 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.61 -0.515 . . . . 72.5 109.61 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.7 mt -102.52 106.22 16.9 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 107.385 -1.339 . . . . 74.120000000000005 107.385 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 60.0 ttt-85 -98.05 141.55 30.86 Favored 'General case' 0 C--N 1.263 -3.17 0 N-CA-C 108.843 -0.799 . . . . 64.340000000000003 108.843 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -93.59 108.35 20.08 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 109.346 -0.613 . . . . 73.0 109.346 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 tt -83.15 116.12 26.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.29 0.567 . . . . 73.420000000000002 109.68 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.8 p -115.79 -172.04 2.09 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 107.957 -1.127 . . . . 72.409999999999997 107.957 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -87.76 -13.2 42.97 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.464 0.65 . . . . 73.109999999999999 109.977 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -95.49 -38.23 10.54 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.919 -1.037 . . . . 65.430000000000007 109.63 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 49.3 t -101.52 104.3 33.25 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 109.465 -0.568 . . . . 63.039999999999999 109.465 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.85 146.97 33.96 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.219 2.612 . . . . 70.129999999999995 113.017 -176.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.16 162.18 27.45 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 123.782 2.988 . . . . 73.239999999999995 113.447 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 t -92.22 159.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 107.339 -1.356 . . . . 64.040000000000006 107.339 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.48 141.34 48.66 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.316 -0.624 . . . . 61.240000000000002 109.316 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.09 -169.9 41.41 Favored Glycine 0 CA--C 1.467 -2.927 0 N-CA-C 108.762 -1.735 . . . . 64.510000000000005 108.762 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.416 ' HB3' ' HG2' ' A' ' 27' ' ' MET . 4.4 t-20 -56.31 111.0 0.86 Allowed 'General case' 0 N--CA 1.426 -1.634 0 O-C-N 124.234 0.608 . . . . 72.450000000000003 109.788 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -87.16 126.17 34.63 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 108.344 -0.984 . . . . 74.219999999999999 108.344 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.11 151.97 44.87 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.305 -0.861 . . . . 73.340000000000003 110.435 -175.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.9 m -78.93 81.92 5.17 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.523 0.677 . . . . 74.549999999999997 109.766 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.525 HG12 ' OD2' ' A' ' 109' ' ' ASP . 49.3 t -80.74 143.72 11.86 Favored 'Isoleucine or valine' 0 C--O 1.251 1.137 0 CA-C-N 114.705 -1.134 . . . . 54.310000000000002 109.64 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -154.67 -67.98 0.13 Allowed 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.44 -1.319 . . . . 72.329999999999998 107.44 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -158.6 163.06 37.32 Favored 'General case' 1 C--N 1.24 -4.189 0 CA-C-N 112.54 -2.118 . . . . 64.030000000000001 105.62 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -39.35 -43.12 1.14 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.336 1.606 . . . . 73.0 115.336 -172.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -60.36 -49.76 76.29 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.025 0.379 . . . . 71.120000000000005 112.025 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -74.71 -33.87 62.48 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.295 -0.562 . . . . 71.329999999999998 110.645 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.525 ' OD2' HG12 ' A' ' 103' ' ' VAL . 0.9 OUTLIER -62.29 -48.37 80.2 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.387 -0.824 . . . . 64.439999999999998 110.423 178.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 10.5 tp -66.68 -37.99 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 120.711 -0.396 . . . . 71.099999999999994 110.452 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -63.58 -42.21 98.31 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.685 -0.406 . . . . 74.140000000000001 110.44 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 2.7 t -63.59 -41.32 98.36 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.164 -0.471 . . . . 73.120000000000005 111.907 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 117' ' ' ILE . 47.6 mm -70.54 -45.19 75.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 121.085 -0.246 . . . . 73.299999999999997 110.644 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 70.7 t -64.69 -42.91 96.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.333 -0.394 . . . . 72.129999999999995 110.912 -177.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.57 -27.35 62.14 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.173 -0.611 . . . . 53.149999999999999 111.163 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.18 84.8 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.47 -0.567 . . . . 53.310000000000002 109.47 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 113' ' ' ILE . 72.4 mt -63.8 -45.8 96.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.398 -0.819 . . . . 73.530000000000001 109.184 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 114' ' ' VAL . 80.6 mt-10 -60.71 -40.35 91.97 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 116.276 -0.42 . . . . 72.510000000000005 111.283 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -70.43 -35.22 73.26 Favored 'General case' 0 C--O 1.202 -1.438 0 C-N-CA 120.632 -0.427 . . . . 74.439999999999998 111.149 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 8.1 t -73.54 -37.15 65.68 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.196 -0.602 . . . . 73.140000000000001 110.483 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.3 mp -77.58 -42.67 34.38 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.866 -0.734 . . . . 75.319999999999993 111.211 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.29 -19.88 29.22 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 116.29 1.959 . . . . 65.019999999999996 116.29 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.4 30.4 mttp -59.63 -47.76 84.33 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 116.73 2.122 . . . . 72.200000000000003 116.73 -172.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 155.34 149.84 5.41 Favored Glycine 0 C--N 1.264 -3.431 0 C-N-CA 119.405 -1.378 . . . . 63.439999999999998 113.017 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 . . . . . 0 C--N 1.297 -1.698 0 C-N-CA 124.424 1.09 . . . . 71.530000000000001 111.128 -176.261 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 N-CA-C 107.022 -1.473 . . . . 74.400000000000006 107.022 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 98.3 mttt -88.06 155.29 19.88 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.673 0.749 . . . . 63.25 112.195 -178.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.618 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 7.6 m-85 -122.95 151.86 41.4 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.957 -1.02 . . . . 74.239999999999995 111.856 178.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.536 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 32.3 t70 -103.32 101.55 11.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 105.753 -1.943 . . . . 74.230000000000004 105.753 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -90.41 120.91 40.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.643 0.735 . . . . 73.140000000000001 109.335 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.0 t -110.69 112.39 40.35 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 107.664 -1.236 . . . . 71.530000000000001 107.664 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 27' ' ' MET . 4.7 tt -120.08 108.83 24.19 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 CA-C-O 121.938 0.875 . . . . 74.430000000000007 109.903 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.0 mt -110.27 117.25 51.82 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-N 114.799 -1.091 . . . . 73.549999999999997 108.553 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.609 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 44.6 Cg_endo -93.67 140.25 1.55 Allowed 'Trans proline' 0 N--CA 1.431 -2.171 0 C-N-CA 121.51 1.473 . . . . 73.530000000000001 110.728 171.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.55 124.49 8.61 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.187 0.518 . . . . 74.329999999999998 111.054 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.473 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 57.4 m -67.51 114.64 6.33 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 122.108 -0.37 . . . . 73.120000000000005 110.143 177.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 2.7 p90 -57.39 115.17 2.55 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 113.726 1.009 . . . . 72.430000000000007 113.726 -176.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -146.45 162.79 37.5 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 114.275 -1.329 . . . . 72.409999999999997 108.324 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -133.63 149.5 51.58 Favored 'General case' 0 N--CA 1.401 -2.896 0 N-CA-C 104.945 -2.243 . . . . 71.430000000000007 104.945 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -61.12 115.93 4.15 Favored 'General case' 0 N--CA 1.413 -2.316 0 O-C-N 124.214 0.946 . . . . 74.450000000000003 110.806 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -91.27 -159.31 0.62 Allowed 'General case' 0 C--N 1.266 -3.064 0 N-CA-C 105.504 -2.036 . . . . 73.349999999999994 105.504 172.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -70.64 -52.84 18.57 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 119.466 1.03 . . . . 64.430000000000007 110.599 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -136.16 5.47 3.02 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.546 0.689 . . . . 74.140000000000001 110.511 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -125.82 170.95 11.1 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.486 -0.561 . . . . 75.150000000000006 109.486 -175.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 57.9 mtt 66.2 85.19 0.14 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.86 1.264 . . . . 65.150000000000006 113.347 175.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -161.73 98.72 1.11 Allowed 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.854 -1.165 . . . . 70.530000000000001 107.854 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -149.62 134.21 17.61 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.919 -0.488 . . . . 73.519999999999996 111.391 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 23' ' ' ILE . 3.2 mp -128.86 144.72 37.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 104.572 -2.381 . . . . 72.349999999999994 104.572 172.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.609 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 37.4 m -107.15 160.0 27.99 Favored Pre-proline 0 C--N 1.277 -2.547 0 N-CA-C 108.584 -0.895 . . . . 52.109999999999999 108.584 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.89 119.81 7.1 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.228 2.619 . . . . 71.129999999999995 114.182 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.59 125.14 10.35 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.64 2.227 . . . . 62.420000000000002 110.925 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.476 ' HB3' HG21 ' A' ' 7' ' ' ILE . 39.0 tpp -101.15 128.19 47.36 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.899 -1.149 . . . . 70.400000000000006 107.899 -175.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.7 t -129.31 129.34 67.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.449 -0.574 . . . . 72.109999999999999 109.449 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.7 mm -134.39 106.59 8.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.062 0.458 . . . . 74.430000000000007 110.684 178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -104.47 81.12 0.32 Allowed Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 119.875 -1.155 . . . . 61.219999999999999 112.091 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -170.04 31.12 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.895 0.855 . . . . 65.349999999999994 111.023 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 -124.61 133.94 53.09 Favored 'General case' 0 C--O 1.201 -1.457 0 N-CA-C 107.667 -1.235 . . . . 72.209999999999994 107.667 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 2.3 p -84.44 155.25 22.32 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 118.524 0.602 . . . . 73.319999999999993 110.553 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.618 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 90.3 t80 -48.9 -53.74 18.3 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 124.464 1.106 . . . . 72.120000000000005 113.315 -172.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 25.5 m-20 -70.18 -35.43 73.96 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.749 -1.114 . . . . 73.109999999999999 111.06 -174.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.8 mt -76.28 -38.23 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 109.619 -0.512 . . . . 71.109999999999999 109.619 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.01 -44.96 95.61 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.716 -0.675 . . . . 71.340000000000003 110.414 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.8 ttm -66.45 -38.38 87.24 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 119.968 -0.693 . . . . 74.25 110.674 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 35' ' ' ASP . 55.9 mm-40 -67.82 -40.14 83.85 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.494 -0.482 . . . . 65.129999999999995 111.752 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.52 ' O ' HG21 ' A' ' 44' ' ' VAL . 14.6 tt -73.38 -38.36 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 119.464 -0.894 . . . . 73.340000000000003 110.736 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.87 -39.23 84.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 110.193 -0.299 . . . . 74.140000000000001 110.193 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -71.31 -16.59 62.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.031 0.443 . . . . 65.109999999999999 111.822 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.79 -43.47 6.79 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 110.233 -1.147 . . . . 74.530000000000001 110.233 173.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.52 HG21 ' O ' ' A' ' 40' ' ' ILE . 77.4 t -59.8 -38.26 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.045 -1.095 . . . . 62.149999999999999 108.045 177.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -51.09 -50.08 59.44 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 126.051 1.74 . . . . 72.439999999999998 111.069 176.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -67.26 -38.19 84.74 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.753 -0.832 . . . . 73.319999999999993 108.753 -177.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -62.32 -45.4 98.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.07 -0.514 . . . . 72.230000000000004 110.696 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 44' ' ' VAL . 61.6 mt -69.42 -38.35 76.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.912 0.386 . . . . 73.219999999999999 110.397 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -79.58 -14.29 58.93 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.245 0.545 . . . . 74.510000000000005 112.263 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.65 -38.46 7.9 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.722 -0.611 . . . . 65.310000000000002 112.009 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -84.72 -14.08 49.42 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.663 0.744 . . . . 70.140000000000001 110.377 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -141.19 -175.58 4.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.58 -1.267 . . . . 74.420000000000002 107.58 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -106.78 100.1 9.63 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 105.609 -1.997 . . . . 63.409999999999997 105.609 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -129.46 136.04 49.4 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-O 121.194 0.521 . . . . 74.25 111.952 -175.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.411 ' OG ' ' HB ' ' A' ' 72' ' ' THR . 5.5 p -116.87 127.57 54.4 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.725 -1.213 . . . . 73.099999999999994 107.725 175.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 p -101.03 119.1 48.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 119.805 -0.758 . . . . 72.219999999999999 111.77 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -95.91 111.11 23.19 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.806 -1.924 . . . . 70.010000000000005 105.806 171.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -103.24 108.51 19.75 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 122.069 0.937 . . . . 73.519999999999996 112.315 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mp -111.85 177.56 4.61 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.888 -1.506 . . . . 74.120000000000005 109.422 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.42 161.82 14.07 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.427 -0.953 . . . . 63.450000000000003 108.427 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.1 176.52 24.66 Favored Glycine 0 C--N 1.285 -2.298 0 N-CA-C 110.345 -1.102 . . . . 54.149999999999999 110.345 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -65.19 -179.47 0.58 Allowed 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 116.973 0.386 . . . . 73.120000000000005 110.126 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -52.05 -31.9 32.1 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 113.273 0.842 . . . . 74.400000000000006 113.273 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 51.8 t -87.67 -15.6 36.71 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.765 -0.652 . . . . 74.230000000000004 111.463 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 11.5 m-20 -105.64 156.81 17.9 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-O 121.244 0.545 . . . . 73.329999999999998 110.141 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.6 t -112.22 -31.94 2.17 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 120.497 -0.481 . . . . 74.530000000000001 111.857 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.3 tp -151.15 138.64 19.55 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.071 -0.652 . . . . 61.240000000000002 109.764 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.478 ' HH ' ' CG ' ' A' ' 83' ' ' HIS . 0.5 OUTLIER -131.2 104.18 6.91 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.392 -0.596 . . . . 73.329999999999998 109.392 -179.297 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -104.62 116.58 32.3 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.482 -0.932 . . . . 72.319999999999993 108.482 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -98.72 110.27 22.9 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.669 -1.234 . . . . 75.230000000000004 107.669 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -94.93 123.04 38.17 Favored 'General case' 0 C--N 1.264 -3.122 0 N-CA-C 109.713 -0.477 . . . . 64.5 109.713 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.411 ' HB ' ' OG ' ' A' ' 55' ' ' SER . 29.9 m -94.26 122.38 36.74 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.452 -1.314 . . . . 72.439999999999998 107.452 176.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.47 136.78 50.15 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 114.391 1.256 . . . . 73.340000000000003 114.391 -172.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -133.62 135.68 44.35 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.91 -1.885 . . . . 74.519999999999996 105.91 170.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 80.1 tttt -139.82 172.62 12.52 Favored 'General case' 0 C--N 1.27 -2.886 0 N-CA-C 104.422 -2.436 . . . . 71.510000000000005 104.422 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 8.2 pt-20 -47.2 87.67 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.907 0.883 . . . . 74.140000000000001 112.942 176.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.32 19.16 78.63 Favored Glycine 0 N--CA 1.432 -1.623 0 CA-C-N 115.175 -0.921 . . . . 61.240000000000002 112.482 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 59.2 mmtt -127.86 156.43 42.58 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.725 -1.583 . . . . 74.310000000000002 106.725 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -156.85 140.77 16.21 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 123.262 0.351 . . . . 74.329999999999998 110.349 -178.164 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -170.5 177.46 43.66 Favored Glycine 0 C--O 1.205 -1.692 0 C-N-CA 120.113 -1.041 . . . . 71.120000000000005 113.432 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 60.8 mt -123.79 151.5 28.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 106.493 -1.669 . . . . 75.120000000000005 106.493 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.1 t -134.64 109.9 12.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.324 -0.991 . . . . 72.530000000000001 108.324 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.478 ' CG ' ' HH ' ' A' ' 68' ' ' TYR . 62.2 m-70 -89.4 104.22 16.79 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.693 -0.484 . . . . 72.519999999999996 109.693 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.2 t -105.13 109.81 28.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.385 -0.969 . . . . 72.219999999999999 108.385 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -122.68 144.22 49.28 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 120.111 -0.635 . . . . 65.439999999999998 110.014 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.4 mt -105.81 109.47 21.44 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 107.226 -1.398 . . . . 52.240000000000002 107.226 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.512 ' HD3' ' OD2' ' A' ' 4' ' ' ASP . 36.6 ttt180 -98.51 141.34 31.48 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.4 -0.963 . . . . 75.439999999999998 108.4 -177.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -85.01 111.18 19.48 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 120.346 -0.542 . . . . 75.420000000000002 109.925 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.9 tt -74.47 112.13 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-O 122.168 0.985 . . . . 71.510000000000005 108.993 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -135.31 -177.95 4.89 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 106.235 -1.765 . . . . 73.239999999999995 106.235 -171.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -80.91 -13.75 58.63 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.472 1.13 . . . . 64.319999999999993 108.987 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -79.34 -33.39 43.09 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 113.849 -1.523 . . . . 71.25 108.474 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 95.9 m -129.76 94.22 32.44 Favored Pre-proline 0 N--CA 1.439 -1.002 0 CA-C-N 115.209 -0.905 . . . . 74.239999999999995 110.403 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.6 153.39 43.86 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 122.529 2.153 . . . . 51.520000000000003 112.269 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.34 138.48 60.85 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.171 2.581 . . . . 53.130000000000003 111.762 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.4 t -97.27 153.26 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.307 -0.997 . . . . 73.219999999999999 108.307 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -105.64 92.27 4.11 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 108.364 -0.976 . . . . 71.140000000000001 108.364 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -109.96 -149.67 12.68 Favored Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 109.741 -1.344 . . . . 61.149999999999999 109.741 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -72.9 118.27 15.64 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 107.426 -1.324 . . . . 73.040000000000006 107.426 172.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -94.78 121.6 36.54 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.519 0.676 . . . . 71.129999999999995 109.201 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 20.8 t -69.37 151.48 46.11 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.673 -1.149 . . . . 74.209999999999994 110.261 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 m -77.34 88.74 3.74 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.75 -0.833 . . . . 51.039999999999999 108.75 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -106.0 148.29 10.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 114.924 -1.035 . . . . 65.219999999999999 110.976 -172.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.0 tp -157.83 -61.45 0.08 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.628 1.204 . . . . 74.150000000000006 107.887 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -146.43 167.2 24.22 Favored 'General case' 0 C--N 1.256 -3.475 0 CA-C-N 112.243 -2.253 . . . . 74.230000000000004 108.192 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.536 ' O ' HG23 ' A' ' 110' ' ' ILE . 63.8 t80 -46.59 -49.17 19.33 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 124.627 1.204 . . . . 71.140000000000001 113.611 -175.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -58.73 -28.93 66.32 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.061 0.458 . . . . 74.329999999999998 112.063 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -87.11 -40.44 14.65 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 116.323 -0.399 . . . . 72.239999999999995 111.366 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.436 ' O ' HG12 ' A' ' 113' ' ' ILE 0.367 4.5 p30 -78.26 -28.34 47.7 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 118.788 -1.165 . . . . 73.299999999999997 112.954 -176.113 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 106' ' ' PHE . 8.2 tp -67.59 -40.3 83.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 109.482 -0.562 . . . . 72.019999999999996 109.482 175.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -66.91 -41.01 87.85 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 108.95 -0.759 . . . . 75.219999999999999 108.95 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 8.5 t -64.19 -41.87 96.9 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.13 -0.941 . . . . 74.540000000000006 111.744 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 109' ' ' ASP . 35.8 mm -68.16 -42.0 84.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 120.494 0.188 . . . . 65.340000000000003 110.596 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 93.1 t -67.03 -41.23 87.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.396 -0.594 . . . . 73.420000000000002 109.396 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -60.6 -39.91 89.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.936 -0.574 . . . . 73.439999999999998 110.964 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.45 98.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.86 0.362 . . . . 73.109999999999999 110.711 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 77.3 mt -68.8 -43.52 82.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.326 -0.62 . . . . 73.0 109.326 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -58.25 -46.18 86.45 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 123.817 0.847 . . . . 61.229999999999997 111.618 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -69.86 -36.05 75.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.533 -0.758 . . . . 65.109999999999999 109.464 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 52.7 t -65.21 -47.2 77.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.699 -0.682 . . . . 53.219999999999999 110.193 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.3 mp -68.88 -30.41 68.91 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.157 -0.474 . . . . 73.200000000000003 111.596 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.12 -35.32 56.35 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.66 -0.7 . . . . 72.140000000000001 111.128 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -87.05 -12.93 45.8 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.52 0.676 . . . . 75.319999999999993 110.781 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.35 60.51 4.51 Favored Glycine 0 C--N 1.304 -1.203 0 CA-C-N 115.306 -0.861 . . . . 70.120000000000005 113.265 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--N 1.268 -2.973 0 C-N-CA 124.733 1.213 . . . . 74.140000000000001 108.479 178.644 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.1 mmm . . . . . 0 CA--C 1.499 -1.002 0 CA-C-O 121.011 0.434 . . . . 64.140000000000001 110.291 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -99.56 143.47 29.76 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.976 -0.556 . . . . 74.219999999999999 109.962 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.594 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 21.0 m-85 -116.49 141.04 48.7 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.62 -0.718 . . . . 74.409999999999997 110.008 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.534 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 33.2 t70 -111.92 108.63 18.05 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 125.418 1.487 . . . . 43.520000000000003 109.988 -174.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 p -88.87 116.04 29.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 115.894 -0.594 . . . . 74.230000000000004 109.962 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.21 116.8 50.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.412 -1.329 . . . . 73.439999999999998 107.412 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.422 HG22 ' HB3' ' A' ' 27' ' ' MET . 4.9 tt -121.32 115.86 47.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-O 121.305 0.574 . . . . 61.520000000000003 110.551 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.8 tt -110.42 110.3 58.02 Favored Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 116.028 -0.533 . . . . 74.120000000000005 110.298 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.557 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 72.4 Cg_endo -91.62 147.4 3.35 Favored 'Trans proline' 0 N--CA 1.435 -1.952 0 C-N-CA 122.301 2.001 . . . . 64.299999999999997 110.112 173.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.61 177.66 9.83 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.933 -0.766 . . . . 64.340000000000003 108.933 177.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.424 ' HB2' ' HB3' ' A' ' 22' ' ' HIS . 52.1 m -122.6 104.29 9.25 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 109.019 -0.734 . . . . 64.230000000000004 109.019 173.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 24.0 p90 -49.56 95.61 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 115.131 1.53 . . . . 73.049999999999997 115.131 -176.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.486 ' CE1' ' HB3' ' A' ' 125' ' ' GLU . 76.6 m80 -145.85 168.89 19.71 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.42 -0.809 . . . . 74.310000000000002 109.299 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.75 147.23 46.57 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 104.322 -2.473 . . . . 73.049999999999997 104.322 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -70.43 93.36 0.87 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 123.77 0.669 . . . . 65.120000000000005 109.265 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.5 -84.28 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.212 -0.904 . . . . 71.150000000000006 110.529 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -107.61 -59.91 1.77 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.61 -0.515 . . . . 64.299999999999997 109.61 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -138.06 -52.43 0.62 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.066 -1.087 . . . . 73.239999999999995 108.066 173.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -74.97 174.92 8.65 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 113.114 -1.857 . . . . 60.219999999999999 111.083 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.433 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 4.5 mpp? 74.0 72.16 0.11 Allowed 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 124.881 1.363 . . . . 74.5 108.567 -175.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 5.1 pt-20 -148.84 93.29 2.09 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 113.804 -1.544 . . . . 65.439999999999998 109.249 -171.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 11' ' ' SER . 19.0 t60 -160.96 107.47 1.45 Allowed 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.143 -1.423 . . . . 55.539999999999999 113.616 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -123.34 136.63 59.33 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 105.27 -2.122 . . . . 73.109999999999999 105.27 172.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 64.0 m -108.3 153.73 41.78 Favored Pre-proline 0 C--N 1.294 -1.83 0 O-C-N 123.109 0.256 . . . . 72.409999999999997 110.791 -176.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.83 143.18 72.51 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 123.244 2.629 . . . . 64.099999999999994 113.849 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.97 130.45 13.31 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.905 2.403 . . . . 61.210000000000001 112.002 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.422 ' HB3' HG22 ' A' ' 7' ' ' ILE . 50.3 ttm -92.42 135.3 34.15 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.941 -1.133 . . . . 64.540000000000006 107.941 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 83.9 t -131.09 116.4 33.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 O-C-N 123.238 0.337 . . . . 73.329999999999998 110.786 -171.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.2 mm -129.2 106.06 13.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 120.638 0.256 . . . . 71.430000000000007 111.357 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -112.83 80.91 0.28 Allowed Glycine 0 CA--C 1.476 -2.396 0 C-N-CA 120.27 -0.966 . . . . 72.450000000000003 112.139 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -144.33 1.58 1.08 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.648 0.981 . . . . 51.100000000000001 113.648 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.42 HH21 ' CG ' ' A' ' 109' ' ' ASP . 33.3 mmt180 -107.33 134.57 50.2 Favored 'General case' 0 C--N 1.285 -2.204 0 O-C-N 121.025 -1.047 . . . . 71.150000000000006 108.304 -172.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 p -74.65 164.48 26.53 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 107.569 -1.271 . . . . 61.229999999999997 107.569 173.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.594 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 82.1 t80 -55.3 -45.48 76.24 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 120.789 0.328 . . . . 75.209999999999994 111.848 -173.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.85 -39.24 93.24 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.272 -0.876 . . . . 43.210000000000001 111.498 -176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.9 mm -74.31 -43.19 50.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.754 -0.832 . . . . 74.120000000000005 108.754 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.92 -43.38 98.95 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 115.539 -0.755 . . . . 74.109999999999999 111.074 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.3 tpt -68.81 -38.0 79.6 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.972 -0.291 . . . . 61.340000000000003 110.871 -175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -84.36 -21.43 30.89 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 118.905 -1.118 . . . . 74.219999999999999 112.594 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 44' ' ' VAL . 17.6 tt -82.6 -40.25 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 C-N-CA 119.005 -1.078 . . . . 73.25 109.78 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.36 -36.28 71.3 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.876 0 C-N-CA 121.095 -0.242 . . . . 71.340000000000003 110.439 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -64.05 -31.98 73.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.147 0.499 . . . . 71.25 110.158 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.439 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -69.41 -44.78 63.27 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.714 -0.955 . . . . 52.219999999999999 110.714 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 40' ' ' ILE . 63.3 t -60.14 -44.93 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.282 -0.636 . . . . 73.409999999999997 109.282 177.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.8 -43.42 80.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.848 1.259 . . . . 70.430000000000007 110.862 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -68.96 -38.5 79.44 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.478 -0.783 . . . . 65.209999999999994 109.78 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 43' ' ' GLY . 92.9 t -66.41 -42.27 90.17 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.361 0 CA-C-N 116.513 -0.312 . . . . 73.409999999999997 110.674 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.446 ' CG2' HD11 ' A' ' 73' ' ' LEU . 72.7 mt -66.81 -41.81 88.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 121.287 0.565 . . . . 71.530000000000001 110.496 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -78.22 -11.38 59.92 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.499 -0.773 . . . . 72.200000000000003 110.583 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.9 -41.94 5.06 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 113.192 0.812 . . . . 72.430000000000007 113.192 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.5 m -91.03 -6.44 53.9 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.583 0.586 . . . . 64.439999999999998 112.583 -175.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -136.47 168.91 18.56 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 108.33 -0.989 . . . . 74.140000000000001 108.33 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -96.15 100.17 11.84 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 105.588 -2.004 . . . . 73.439999999999998 105.588 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.19 136.23 55.01 Favored 'General case' 0 N--CA 1.408 -2.542 0 C-N-CA 120.079 -0.648 . . . . 75.040000000000006 112.626 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 11.6 m -99.45 106.46 18.51 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 103.737 -2.69 . . . . 71.519999999999996 103.737 167.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.423 ' CG2' ' HD2' ' A' ' 69' ' ' ARG . 5.1 p -99.86 121.76 50.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-O 121.661 0.743 . . . . 45.420000000000002 111.419 -171.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -116.25 135.93 53.46 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.293 -0.867 . . . . 75.019999999999996 109.505 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.475 ' HB3' ' NH1' ' A' ' 69' ' ' ARG . 8.5 pt-20 -98.78 136.36 38.93 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.382 -0.372 . . . . 74.120000000000005 110.025 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.6 mt -142.02 175.41 9.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.234 0.54 . . . . 64.409999999999997 111.021 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.37 161.78 13.44 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.466 -1.679 . . . . 72.329999999999998 106.466 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' HA3' ' CB ' ' A' ' 65' ' ' ASP . . . -114.69 175.22 15.93 Favored Glycine 0 C--N 1.284 -2.306 0 C-N-CA 119.714 -1.231 . . . . 61.409999999999997 113.061 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -93.53 134.05 36.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 123.07 0.548 . . . . 74.019999999999996 111.19 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 52.17 -88.67 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.629 1.714 . . . . 71.340000000000003 115.629 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 73.9 m -89.26 -12.96 39.21 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.546 -0.752 . . . . 53.340000000000003 112.069 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.508 ' CB ' ' HA3' ' A' ' 61' ' ' GLY . 14.0 m-20 -69.24 125.87 28.02 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.799 -1.186 . . . . 70.129999999999995 107.799 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.4 t -92.53 -31.8 4.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 121.279 0.561 . . . . 72.129999999999995 110.491 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.2 tp -151.76 145.22 24.84 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.124 -1.065 . . . . 71.25 108.124 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -130.12 122.21 27.83 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 107.938 -1.134 . . . . 74.420000000000002 107.938 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.475 ' NH1' ' HB3' ' A' ' 58' ' ' GLU . 22.0 tpp180 -120.1 119.07 32.24 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.406 -1.331 . . . . 74.439999999999998 107.406 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -108.83 136.26 48.68 Favored 'General case' 0 C--N 1.282 -2.327 0 C-N-CA 123.624 0.77 . . . . 73.510000000000005 109.215 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -126.31 131.87 51.76 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.329 -0.619 . . . . 75.109999999999999 109.329 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 18.6 m -103.02 109.51 21.08 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.663 -1.606 . . . . 72.150000000000006 106.663 172.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.446 HD11 ' CG2' ' A' ' 48' ' ' ILE . 3.3 mm? -98.67 140.51 32.78 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 113.027 0.751 . . . . 52.520000000000003 113.027 -172.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -135.71 95.9 3.33 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.279 -1.328 . . . . 65.430000000000007 108.493 171.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -92.08 76.36 5.41 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.082 -1.822 . . . . 72.0 106.082 179.066 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.333 0.7 OUTLIER 30.45 76.92 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.917 1.687 . . . . 75.409999999999997 115.417 -175.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.76 -23.51 35.44 Favored Glycine 0 C--O 1.236 0.273 0 C-N-CA 121.333 -0.46 . . . . 52.530000000000001 112.415 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 61.5 mttp -98.47 144.39 27.87 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 105.301 -2.111 . . . . 74.430000000000007 105.301 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 5.3 ptpp? -145.59 150.52 36.52 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 120.216 -0.594 . . . . 73.450000000000003 109.929 -168.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.82 156.2 11.82 Favored Glycine 0 C--N 1.309 -0.951 0 C-N-CA 120.53 -0.843 . . . . 72.450000000000003 112.79 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 27.4 mt -103.57 139.22 25.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.504 -0.924 . . . . 63.409999999999997 108.504 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.3 t -118.53 116.45 51.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.342 -0.984 . . . . 74.420000000000002 108.342 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -104.34 109.5 21.37 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.568 -0.901 . . . . 74.430000000000007 108.568 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.08 119.53 55.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.028 -0.73 . . . . 74.239999999999995 109.028 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -121.47 140.24 52.43 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.23 -0.655 . . . . 63.409999999999997 109.23 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.0 mt -106.48 109.75 21.75 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.148 -1.427 . . . . 75.519999999999996 107.148 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -97.05 148.28 23.16 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-O 121.788 0.804 . . . . 73.239999999999995 111.014 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -92.18 105.5 17.7 Favored 'General case' 0 C--N 1.259 -3.352 0 CA-C-N 114.83 -1.077 . . . . 73.329999999999998 108.613 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 tt -91.34 112.34 25.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.412 0.625 . . . . 53.310000000000002 109.384 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.3 p -131.94 -171.01 2.52 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.815 -0.63 . . . . 74.430000000000007 109.993 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.47 -14.34 46.37 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.755 0.788 . . . . 62.32 108.905 176.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -90.41 -39.87 12.39 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.968 -1.015 . . . . 65.140000000000001 109.708 176.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 42.5 t -85.5 132.61 44.23 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 109.538 -0.541 . . . . 65.040000000000006 109.538 176.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 93' ' ' CYS . 5.4 Cg_exo -77.33 117.1 4.27 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.877 2.384 . . . . 72.239999999999995 111.88 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.34 122.31 11.12 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.836 2.357 . . . . 75.230000000000004 111.717 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.7 t -88.9 157.68 3.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 107.636 -1.246 . . . . 74.25 107.636 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -122.76 161.5 23.82 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.59 -0.893 . . . . 72.239999999999995 108.59 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -173.68 -166.24 31.63 Favored Glycine 0 CA--C 1.458 -3.486 0 N-CA-C 106.718 -2.553 . . . . 61.140000000000001 106.718 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.401 ' HB3' ' HA ' ' A' ' 27' ' ' MET . 3.2 t-20 -56.01 102.98 0.09 Allowed 'General case' 0 N--CA 1.409 -2.49 0 O-C-N 124.411 0.712 . . . . 71.200000000000003 109.584 176.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -85.66 114.15 22.42 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.943 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 41.7 t -78.53 141.26 38.29 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.422 -1.325 . . . . 53.25 107.422 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.5 m -64.79 117.32 7.34 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.399 -0.963 . . . . 54.509999999999998 108.399 177.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.7 t -76.01 141.26 16.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.445 0.64 . . . . 74.310000000000002 110.539 -172.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.498 ' HG ' ' H ' ' A' ' 105' ' ' GLU . 15.2 tp -161.7 -159.46 0.62 Allowed 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.053 -2.203 . . . . 72.310000000000002 105.053 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.498 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 36.3 mt-10 -89.14 173.05 8.65 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 119.134 0.879 . . . . 61.509999999999998 112.038 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.481 ' O ' HG22 ' A' ' 110' ' ' ILE . 71.6 t80 -32.82 -58.05 0.36 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.517 1.927 . . . . 75.120000000000005 116.201 -171.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -68.64 -21.54 64.46 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 113.052 0.76 . . . . 74.150000000000006 113.052 -170.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -87.73 -42.39 12.65 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 119.671 -0.812 . . . . 75.310000000000002 111.001 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.481 ' O ' HG12 ' A' ' 113' ' ' ILE 0.262 17.1 p-10 -77.94 -30.08 50.29 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 118.684 -1.206 . . . . 60.039999999999999 111.783 -175.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 106' ' ' PHE . 16.5 tt -69.65 -38.78 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 119.225 -0.99 . . . . 72.319999999999993 109.829 175.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.25 -36.51 83.2 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 109.154 -0.684 . . . . 64.319999999999993 109.154 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 43.5 t -60.17 -45.49 92.9 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.798 -0.637 . . . . 62.25 109.703 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 109' ' ' ASP . 46.4 mm -61.28 -46.27 96.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 122.954 0.501 . . . . 74.150000000000006 109.891 175.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 110' ' ' ILE . 80.9 t -61.38 -42.77 95.01 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 CA-C-N 115.608 -0.723 . . . . 64.329999999999998 109.996 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -67.64 -32.19 72.71 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 112.139 0.422 . . . . 53.340000000000003 112.139 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.99 -39.37 83.28 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.284 -0.566 . . . . 71.109999999999999 110.044 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.5 mt -69.92 -47.12 71.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.856 -0.611 . . . . 72.200000000000003 110.11 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -64.7 -40.53 95.53 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 116.253 -0.431 . . . . 71.409999999999997 110.987 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.67 -17.72 58.97 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 120.298 -0.561 . . . . 73.129999999999995 112.154 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 27.4 t -78.24 -48.14 16.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.144 -1.058 . . . . 72.439999999999998 108.144 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 11.2 mp -69.37 -36.74 77.13 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.502 -0.772 . . . . 70.519999999999996 111.918 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.93 -13.57 53.13 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 114.002 1.112 . . . . 74.310000000000002 114.002 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -74.93 -12.39 60.34 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.255 -0.978 . . . . 74.519999999999996 110.893 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.92 169.01 42.29 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 115.113 -0.949 . . . . 55.340000000000003 111.12 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.486 ' HB3' ' CE1' ' A' ' 13' ' ' HIS . 0.7 OUTLIER . . . . . 0 C--N 1.293 -1.859 0 O-C-N 122.152 -0.616 . . . . 71.120000000000005 112.04 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 mtm . . . . . 0 CA--C 1.494 -1.185 0 N-CA-C 108.808 -0.812 . . . . 65.530000000000001 108.808 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -92.87 145.42 24.4 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.659 -0.497 . . . . 62.219999999999999 109.659 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 21.9 m-85 -112.48 142.68 44.73 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 121.564 0.697 . . . . 73.549999999999997 111.466 177.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.527 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 31.9 t70 -111.26 102.66 11.05 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 105.793 -1.929 . . . . 73.099999999999994 105.793 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.65 119.3 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 CA-C-O 122.087 0.946 . . . . 62.520000000000003 110.865 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -105.99 116.58 50.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-N 114.083 -1.417 . . . . 73.230000000000004 107.848 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.437 HG23 ' HB3' ' A' ' 27' ' ' MET . 6.2 tt -115.3 114.85 47.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 CA-C-O 121.348 0.594 . . . . 75.450000000000003 109.614 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mp -104.0 106.61 53.88 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 108.936 -0.764 . . . . 70.030000000000001 108.936 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.626 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 2.0 Cg_endo -84.87 139.16 7.29 Favored 'Trans proline' 0 N--CA 1.44 -1.646 0 C-N-CA 121.964 1.776 . . . . 65.540000000000006 109.199 172.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -157.78 133.65 9.26 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.056 0.455 . . . . 74.329999999999998 110.524 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.7 m -84.26 118.56 24.26 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.588 -0.523 . . . . 60.299999999999997 109.588 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 3.7 p90 -61.77 109.84 1.35 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.257 1.206 . . . . 63.350000000000001 114.257 -174.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -139.29 128.65 24.18 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.494 -0.776 . . . . 74.019999999999996 111.416 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -81.37 104.09 11.58 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 105.68 -1.97 . . . . 73.510000000000005 105.68 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 20' ' ' MET . 49.3 t80 -45.99 103.0 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 O-C-N 125.84 1.963 . . . . 74.200000000000003 109.662 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.25 -103.96 0.1 Allowed 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.134 -1.393 . . . . 73.310000000000002 113.688 -173.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -111.96 -58.99 2.05 Favored 'General case' 0 N--CA 1.434 -1.256 0 O-C-N 122.041 -0.412 . . . . 63.530000000000001 110.61 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -136.62 -36.76 0.7 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.405 -0.591 . . . . 74.400000000000006 109.405 176.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -102.04 163.25 12.35 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.766 -1.198 . . . . 74.340000000000003 107.766 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 1.8 mpt? 72.73 80.17 0.14 Allowed 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 124.28 1.032 . . . . 74.200000000000003 110.389 -173.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 178.03 132.4 0.07 Allowed 'General case' 0 N--CA 1.407 -2.605 0 N-CA-C 104.042 -2.577 . . . . 72.519999999999996 104.042 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 67.2 t60 179.41 92.37 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.804 0 O-C-N 124.336 1.023 . . . . 73.299999999999997 112.275 174.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mm -100.88 139.82 21.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 N-CA-C 105.692 -1.966 . . . . 55.310000000000002 105.692 171.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 42.0 m -106.58 153.92 40.31 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 109.708 -0.479 . . . . 71.409999999999997 109.708 -174.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.75 151.1 74.61 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 122.812 2.341 . . . . 73.120000000000005 112.718 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -72.63 151.55 52.51 Favored 'Trans proline' 0 C--O 1.255 1.356 0 C-N-CA 123.178 2.586 . . . . 70.109999999999999 114.107 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.531 ' SD ' ' HB3' ' A' ' 99' ' ' ASN . 2.4 tpt -114.56 134.99 54.62 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 104.606 -2.368 . . . . 74.409999999999997 104.606 176.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -130.73 130.43 64.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 119.088 0.858 . . . . 74.140000000000001 110.731 -176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.8 mm -124.1 102.51 11.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 106.961 -1.496 . . . . 73.239999999999995 106.961 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -126.31 81.13 0.36 Allowed Glycine 0 CA--C 1.476 -2.344 0 C-N-CA 117.586 -2.245 . . . . 63.509999999999998 114.198 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -161.15 18.45 0.12 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.438 -0.881 . . . . 62.43 111.372 176.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -115.25 134.14 55.4 Favored 'General case' 0 C--O 1.2 -1.514 0 N-CA-C 108.209 -1.034 . . . . 71.329999999999998 108.209 -171.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -72.88 163.38 28.22 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.13 -1.063 . . . . 72.519999999999996 108.13 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.605 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 83.0 t80 -52.09 -47.97 64.95 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.936 0.494 . . . . 62.030000000000001 112.092 -172.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.68 -40.66 92.98 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.176 -0.92 . . . . 73.439999999999998 111.302 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.4 mt -76.25 -37.88 32.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.343 -0.614 . . . . 63.240000000000002 109.343 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.6 99.74 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.483 -0.78 . . . . 53.420000000000002 110.008 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.434 ' HE1' ' HA ' ' A' ' 38' ' ' MET . 0.8 OUTLIER -67.26 -36.35 81.41 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.251 -0.431 . . . . 64.439999999999998 110.066 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -68.64 -42.51 77.92 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.23 -0.441 . . . . 73.319999999999993 110.888 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.451 ' O ' HG21 ' A' ' 44' ' ' VAL . 8.1 tp -71.1 -37.52 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.277 -0.569 . . . . 64.120000000000005 110.337 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.9 t -67.09 -37.19 78.79 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 N-CA-C 109.808 -0.441 . . . . 72.439999999999998 109.808 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.12 -33.54 76.27 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 109.643 -0.503 . . . . 74.319999999999993 109.643 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.22 -43.71 78.79 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 111.42 -0.672 . . . . 64.140000000000001 111.42 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 40' ' ' ILE . 99.4 t -62.03 -46.1 97.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.747 -0.835 . . . . 73.329999999999998 108.747 177.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -53.85 -46.27 71.19 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 125.498 1.519 . . . . 74.530000000000001 110.927 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -66.86 -41.08 87.93 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 114.391 -1.277 . . . . 71.409999999999997 110.316 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 88.8 t -71.25 -35.0 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 116.036 -0.529 . . . . 62.439999999999998 110.005 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 64.8 mt -65.12 -45.84 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 110.091 -0.337 . . . . 55.32 110.091 175.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -62.78 -35.4 79.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.21 0.448 . . . . 61.420000000000002 112.21 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.32 -33.74 22.01 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 113.445 0.905 . . . . 73.340000000000003 113.445 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -97.03 -16.32 20.62 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 113.564 0.95 . . . . 61.539999999999999 113.564 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -128.16 -177.02 3.98 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.204 -0.665 . . . . 72.109999999999999 109.204 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -107.76 100.25 9.65 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 103.719 -2.697 . . . . 65.209999999999994 103.719 171.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.05 144.95 30.62 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 114.759 1.392 . . . . 50.219999999999999 114.759 -168.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.4 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 1.9 m -123.34 103.47 8.52 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 103.983 -2.599 . . . . 60.399999999999999 103.983 169.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 p -100.66 119.26 48.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-O 121.649 0.738 . . . . 72.420000000000002 111.351 -174.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -120.0 122.45 41.18 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.383 -0.826 . . . . 74.209999999999994 111.469 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -89.25 140.97 28.94 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.802 -0.444 . . . . 73.219999999999999 109.802 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 mp -136.49 172.42 13.04 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.106 -1.442 . . . . 74.239999999999995 107.106 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.49 147.81 24.47 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.255 -0.578 . . . . 73.420000000000002 109.716 176.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.44 148.79 41.09 Favored Glycine 0 C--N 1.293 -1.835 0 CA-C-N 115.29 -0.868 . . . . 38.090000000000003 111.137 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.92 132.74 34.33 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-O 121.158 0.504 . . . . 63.119999999999997 110.789 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.0 t70 52.31 -84.14 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 126.137 1.775 . . . . 74.439999999999998 113.681 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.5 t -110.54 -0.55 17.31 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.171 0.51 . . . . 51.310000000000002 111.786 -176.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.517 ' OD1' ' HB3' ' A' ' 87' ' ' ARG . 23.1 m-20 -74.24 138.21 43.52 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 106.664 -1.606 . . . . 74.329999999999998 106.664 172.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.8 t -93.81 -29.93 4.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 112.698 0.629 . . . . 65.129999999999995 112.698 -173.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.3 tp -150.29 140.24 21.94 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 108.669 -0.863 . . . . 73.230000000000004 108.669 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -130.68 133.7 46.31 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 107.054 -1.461 . . . . 74.200000000000003 107.054 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -137.05 120.34 16.84 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.492 -1.299 . . . . 73.150000000000006 107.492 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -111.94 118.09 34.53 Favored 'General case' 0 N--CA 1.413 -2.294 0 C-N-CA 118.828 -1.149 . . . . 74.030000000000001 108.612 175.068 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -94.11 125.68 38.89 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 114.658 -1.155 . . . . 73.209999999999994 108.624 -177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.4 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 19.5 m -100.06 113.99 27.0 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.78 -1.563 . . . . 74.109999999999999 106.78 175.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.41 152.4 37.97 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 113.538 0.94 . . . . 55.240000000000002 113.538 -170.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -135.32 140.81 45.4 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.222 -1.808 . . . . 72.430000000000007 106.807 170.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.538 ' HG2' ' OE1' ' A' ' 76' ' ' GLU . 51.6 tttm -139.47 -178.64 5.48 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 104.988 -2.227 . . . . 75.099999999999994 104.988 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.538 ' OE1' ' HG2' ' A' ' 75' ' ' LYS 0.26 0.0 OUTLIER -59.87 86.25 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 115.233 1.568 . . . . 70.120000000000005 115.233 -177.568 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.15 19.33 67.28 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 114.798 -1.092 . . . . 64.129999999999995 111.263 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HZ2' ' CD ' ' A' ' 118' ' ' GLU . 44.7 mtpt -132.74 135.9 46.03 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.306 -0.998 . . . . 73.409999999999997 108.306 -176.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -137.94 138.65 39.19 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.982 -0.747 . . . . 74.439999999999998 108.982 -175.488 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -174.04 172.12 45.06 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 119.414 -1.374 . . . . 63.420000000000002 113.612 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.5 mt -124.43 143.68 37.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 106.996 -1.483 . . . . 71.230000000000004 106.996 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 97.4 t -124.03 110.1 24.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.085 -0.709 . . . . 74.109999999999999 109.085 177.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -94.15 104.18 16.21 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.002 -0.545 . . . . 74.409999999999997 109.648 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.3 t -105.62 115.07 46.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 109.245 -0.65 . . . . 75.329999999999998 109.245 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -125.34 134.94 52.02 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.019 -0.673 . . . . 71.439999999999998 110.185 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.8 mp -112.1 108.1 17.26 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 109.115 -0.698 . . . . 64.349999999999994 109.115 -173.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.517 ' HB3' ' OD1' ' A' ' 65' ' ' ASP . 12.3 ptp180 -102.14 151.42 22.2 Favored 'General case' 0 CA--C 1.468 -2.196 0 C-N-CA 119.333 -0.947 . . . . 74.519999999999996 112.28 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -84.29 98.45 10.0 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.885 -1.052 . . . . 62.43 109.557 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.3 tt -74.11 114.95 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-O 122.16 0.981 . . . . 72.340000000000003 109.959 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.5 p -133.04 -171.84 2.78 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 107.695 -1.224 . . . . 62.200000000000003 107.695 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -83.03 -5.83 59.25 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.235 0.54 . . . . 54.399999999999999 110.093 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -98.91 -39.93 8.33 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.989 -0.745 . . . . 74.340000000000003 108.989 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 62.7 m -104.35 120.69 49.88 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 116.494 -0.321 . . . . 74.319999999999993 111.615 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.37 142.79 19.07 Favored 'Trans proline' 0 CA--C 1.555 1.569 0 C-N-CA 123.069 2.512 . . . . 70.420000000000002 113.859 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.69 164.72 34.1 Favored 'Trans proline' 0 C--O 1.248 1.025 0 C-N-CA 124.016 3.144 . . . . 75.310000000000002 111.883 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.5 t -101.11 159.67 3.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 107.989 -1.115 . . . . 75.540000000000006 107.989 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -112.66 111.5 22.35 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.185 0.517 . . . . 73.349999999999994 110.7 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -128.49 -163.5 11.31 Favored Glycine 0 CA--C 1.487 -1.712 0 N-CA-C 110.462 -1.055 . . . . 74.510000000000005 110.462 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.531 ' HB3' ' SD ' ' A' ' 27' ' ' MET . 2.6 t-20 -75.19 140.91 43.6 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 122.446 0.298 . . . . 64.540000000000006 110.37 177.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -83.92 97.69 9.38 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 122.083 0.944 . . . . 64.409999999999997 110.581 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.19 151.99 44.77 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 113.422 -1.717 . . . . 73.439999999999998 108.978 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -76.83 93.27 3.7 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.839 0.828 . . . . 75.099999999999994 110.69 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.25 146.16 6.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 114.923 -1.035 . . . . 73.310000000000002 109.866 -175.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.7 mt -156.9 -90.8 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 126.116 1.766 . . . . 75.319999999999993 107.934 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.44 173.72 11.23 Favored 'General case' 0 C--N 1.255 -3.515 0 N-CA-C 105.944 -1.873 . . . . 75.209999999999994 105.944 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.456 ' O ' HG21 ' A' ' 110' ' ' ILE . 90.6 t80 -33.01 -46.39 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.682 1.734 . . . . 72.209999999999994 115.682 -172.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -56.1 -55.39 33.62 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 123.087 0.555 . . . . 74.150000000000006 112.204 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -78.83 -30.86 45.51 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.818 -0.628 . . . . 74.510000000000005 109.49 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.409 ' O ' HG12 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -65.76 -49.16 69.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.259 -0.882 . . . . 62.229999999999997 110.425 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.456 HG21 ' O ' ' A' ' 106' ' ' PHE . 9.9 tp -68.3 -35.76 72.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 121.365 0.603 . . . . 74.120000000000005 109.498 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -65.11 -44.68 87.97 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 115.205 -0.907 . . . . 75.409999999999997 110.12 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 27.0 t -67.55 -39.32 84.97 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 123.448 0.468 . . . . 63.5 110.974 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.556 ' O ' HG12 ' A' ' 117' ' ' ILE . 44.4 mm -66.01 -45.09 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 116.494 -0.321 . . . . 74.219999999999999 110.593 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.77 -35.5 74.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 N-CA-C 109.88 -0.415 . . . . 74.430000000000007 109.88 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 119' ' ' GLU . 60.1 tttp -60.1 -47.11 87.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.652 -0.703 . . . . 73.150000000000006 110.28 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.42 95.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.167 -0.47 . . . . 72.439999999999998 110.958 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 113' ' ' ILE . 43.0 mm -66.84 -44.03 89.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.742 -0.466 . . . . 64.120000000000005 109.742 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.454 ' CD ' ' HZ2' ' A' ' 78' ' ' LYS . 6.6 mm-40 -65.78 -36.59 83.98 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.973 -0.558 . . . . 74.140000000000001 112.288 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 54.5 mm-40 -68.45 -45.54 72.21 Favored 'General case' 0 C--O 1.221 -0.441 0 O-C-N 123.727 0.642 . . . . 65.400000000000006 110.034 176.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 44.6 t -56.63 -46.27 81.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.938 -0.574 . . . . 72.299999999999997 111.233 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.7 mp -78.6 -19.86 51.77 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.26 -0.576 . . . . 74.129999999999995 111.777 -177.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.63 -29.8 41.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.053 0.454 . . . . 70.400000000000006 109.928 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -83.13 -1.97 54.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.884 -0.598 . . . . 73.430000000000007 111.032 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -53.86 131.1 43.99 Favored Glycine 0 C--O 1.245 0.808 0 N-CA-C 110.814 -0.915 . . . . 71.329999999999998 110.814 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 N--CA 1.468 0.427 0 C-N-CA 124.63 1.172 . . . . 74.120000000000005 109.937 -171.611 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 CA--C 1.489 -1.392 0 N-CA-C 108.305 -0.998 . . . . 75.230000000000004 108.305 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.67 153.47 51.08 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.043 -1.095 . . . . 74.510000000000005 108.043 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 14.4 m-85 -112.95 145.67 40.38 Favored 'General case' 0 C--N 1.283 -2.313 0 C-N-CA 123.387 0.675 . . . . 75.209999999999994 109.508 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.522 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 15.7 t70 -103.08 110.67 22.69 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.532 -1.285 . . . . 73.140000000000001 107.532 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -93.11 111.46 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 CA-C-O 121.897 0.856 . . . . 74.230000000000004 108.721 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 p -109.29 110.97 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.76 0 CA-C-N 114.778 -1.101 . . . . 73.209999999999994 109.284 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.491 HG21 ' HB2' ' A' ' 27' ' ' MET . 4.3 tt -103.93 125.36 58.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.868 -1.06 . . . . 52.329999999999998 110.372 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.2 mt -118.93 103.31 48.27 Favored Pre-proline 0 N--CA 1.425 -1.723 0 CA-C-N 115.52 -0.764 . . . . 72.409999999999997 109.275 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.555 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 3.1 Cg_exo -82.39 140.58 10.89 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.175 1.917 . . . . 75.439999999999998 109.582 173.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -156.97 114.27 3.12 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.949 0.881 . . . . 71.329999999999998 110.677 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 m -80.42 128.39 33.52 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.811 -0.632 . . . . 62.539999999999999 109.619 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.481 ' HD2' ' CD1' ' A' ' 81' ' ' ILE . 2.2 p90 -59.18 105.18 0.31 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 114.632 1.345 . . . . 74.439999999999998 114.632 -175.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -141.14 106.73 5.08 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.395 -1.275 . . . . 73.540000000000006 109.538 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -69.08 159.14 33.44 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 106.86 -1.533 . . . . 72.430000000000007 106.86 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -82.91 92.16 7.26 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.012 -1.075 . . . . 72.349999999999994 110.462 176.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.533 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 16.9 t70 -66.76 -102.0 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.76 -1.109 . . . . 74.329999999999998 109.43 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -113.32 -60.36 1.89 Allowed 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 108.269 -1.011 . . . . 63.340000000000003 108.269 171.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -139.5 -53.08 0.54 Allowed 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.677 0.751 . . . . 74.109999999999999 112.205 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -86.1 74.47 10.07 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.376 -0.829 . . . . 73.120000000000005 111.109 -174.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.533 ' SD ' ' HB2' ' A' ' 16' ' ' ASP . 53.0 ttm 173.87 93.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.719 2.007 . . . . 74.349999999999994 105.614 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 10.0 pt-20 -176.16 115.99 0.13 Allowed 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.082 -1.451 . . . . 63.43 107.082 -175.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -157.44 98.23 1.67 Allowed 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 119.326 -0.95 . . . . 73.310000000000002 111.429 172.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.4 mm -120.05 131.04 73.49 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 105.832 -1.914 . . . . 75.310000000000002 105.832 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 73.5 m -107.47 129.03 24.82 Favored Pre-proline 0 C--N 1.293 -1.885 0 C-N-CA 119.764 -0.775 . . . . 65.319999999999993 110.745 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -56.17 146.15 72.58 Favored 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 123.217 2.612 . . . . 63.530000000000001 112.537 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -57.8 145.11 91.88 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 123.684 2.922 . . . . 50.340000000000003 114.265 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.491 ' HB2' HG21 ' A' ' 7' ' ' ILE . 62.9 mtp -103.41 131.13 50.75 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 104.994 -2.224 . . . . 64.219999999999999 104.994 173.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.6 t -120.66 123.23 69.9 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 O-C-N 123.133 0.27 . . . . 74.150000000000006 110.355 -173.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.68 107.5 15.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 107.389 -1.338 . . . . 72.209999999999994 107.389 176.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -127.13 81.77 0.35 Allowed Glycine 0 CA--C 1.475 -2.429 0 C-N-CA 118.019 -2.039 . . . . 75.540000000000006 115.416 -173.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -174.38 37.92 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.979 0.895 . . . . 74.049999999999997 111.126 173.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -113.7 133.34 55.39 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 106.423 -1.695 . . . . 37.119999999999997 106.423 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 p -76.71 163.49 26.78 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 119.139 0.881 . . . . 72.340000000000003 109.089 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.494 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 63.2 t80 -52.55 -43.32 65.11 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 123.758 0.823 . . . . 74.239999999999995 111.689 -174.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -68.14 -40.23 82.47 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.008 -0.996 . . . . 72.400000000000006 111.331 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.2 mm -73.65 -39.35 53.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.131 -0.692 . . . . 73.140000000000001 109.131 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.78 95.14 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.936 -1.029 . . . . 74.329999999999998 110.331 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.1 mmt -65.67 -36.04 82.5 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.495 -0.482 . . . . 74.129999999999995 111.287 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -68.42 -43.58 76.88 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 120.634 -0.426 . . . . 74.409999999999997 111.285 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.7 tt -70.32 -39.33 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 C-N-CA 119.826 -0.75 . . . . 54.340000000000003 110.464 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.3 -45.09 99.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-N 116.737 -0.21 . . . . 74.209999999999994 110.868 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -68.44 -32.59 72.71 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 119.977 -0.689 . . . . 53.450000000000003 111.4 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.435 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -69.78 -46.05 55.29 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 110.983 -0.847 . . . . 74.010000000000005 110.983 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.35 -41.11 90.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.729 -0.471 . . . . 63.409999999999997 109.729 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.446 ' CG ' HH21 ' A' ' 69' ' ' ARG . 16.4 t70 -58.48 -46.67 86.19 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.919 -1.037 . . . . 70.219999999999999 110.346 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -40.77 96.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.633 -0.712 . . . . 64.409999999999997 110.817 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 43' ' ' GLY . 98.3 t -63.75 -43.22 97.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.531 -0.304 . . . . 74.25 111.067 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.8 mt -69.9 -39.59 77.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.561 0.219 . . . . 73.319999999999993 110.922 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -74.92 -24.72 58.55 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 120.903 0.382 . . . . 74.340000000000003 110.912 -175.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.39 -42.15 9.94 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 112.502 0.556 . . . . 72.519999999999996 112.502 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.1 m -83.9 -17.93 39.12 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.199 0.523 . . . . 74.329999999999998 111.737 -174.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -134.58 179.34 6.35 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 121.533 0.682 . . . . 73.540000000000006 109.995 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 26.7 t-20 -98.8 102.66 14.47 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.007 -1.849 . . . . 75.25 106.007 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -133.98 135.94 43.8 Favored 'General case' 0 N--CA 1.412 -2.357 0 C-N-CA 119.595 -0.842 . . . . 72.420000000000002 112.446 -175.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.9 m -102.1 111.89 24.34 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 105.24 -2.133 . . . . 74.150000000000006 105.24 171.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.403 HG21 ' OD1' ' A' ' 45' ' ' ASP . 7.4 p -100.64 142.74 15.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 120.699 0.285 . . . . 63.420000000000002 110.778 -174.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -139.88 151.74 45.89 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.634 -0.876 . . . . 73.239999999999995 108.634 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -125.63 106.46 9.75 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.983 0.897 . . . . 61.32 110.068 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -99.08 172.49 7.36 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.854 -1.067 . . . . 72.219999999999999 109.148 -175.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -109.03 137.84 46.3 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.059 -0.518 . . . . 72.230000000000004 109.687 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -98.29 176.83 30.65 Favored Glycine 0 C--N 1.294 -1.784 0 CA-C-N 115.196 -0.911 . . . . 60.200000000000003 112.671 -174.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.72 166.74 8.36 Favored 'General case' 0 C--O 1.19 -2.047 0 N-CA-C 107.388 -1.338 . . . . 65.109999999999999 107.388 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -42.6 -39.77 2.46 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 115.311 1.597 . . . . 72.430000000000007 115.311 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 51.5 t -73.71 -29.64 62.38 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.082 0.468 . . . . 63.200000000000003 111.518 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.422 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 8.0 m-20 -98.26 115.17 27.82 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.545 -0.909 . . . . 63.240000000000002 108.545 -176.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.0 t -83.67 -32.57 8.96 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 N-CA-C 113.29 0.848 . . . . 74.340000000000003 113.29 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.1 tp -148.79 140.8 23.85 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.238 -1.023 . . . . 73.439999999999998 108.238 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -129.72 126.11 37.49 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.962 -1.495 . . . . 75.530000000000001 106.962 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.446 HH21 ' CG ' ' A' ' 45' ' ' ASP . 10.8 tpt180 -113.73 138.8 49.74 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 107.529 -1.286 . . . . 65.540000000000006 107.529 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -123.96 130.64 52.92 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.981 -1.118 . . . . 52.219999999999999 107.981 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -125.56 115.82 20.78 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.234 -0.654 . . . . 70.0 109.234 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 39.5 m -88.26 110.3 20.63 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.974 -1.121 . . . . 74.329999999999998 107.974 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.0 142.23 28.47 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.13 0.572 . . . . 74.239999999999995 112.317 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 36.7 tt0 -144.32 93.9 2.5 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.917 -1.038 . . . . 63.140000000000001 109.041 171.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.508 ' HG2' ' H ' ' A' ' 76' ' ' GLU . 49.8 tttt -99.53 -176.04 3.17 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 105.968 -1.864 . . . . 64.0 105.968 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.508 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 8.6 pt-20 -48.83 91.26 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.092 1.357 . . . . 70.140000000000001 113.271 177.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.24 17.27 68.0 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.188 -0.914 . . . . 62.32 113.414 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 53.7 mtmt -138.78 122.41 17.44 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.48 -0.933 . . . . 73.140000000000001 108.48 -177.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -145.24 145.58 31.35 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 120.698 0.285 . . . . 72.540000000000006 111.298 -173.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.92 171.9 41.81 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 110.47 -1.052 . . . . 71.530000000000001 110.47 -176.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.481 ' CD1' ' HD2' ' A' ' 12' ' ' PHE . 3.7 mp -105.03 143.87 15.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 117.888 0.844 . . . . 72.099999999999994 109.669 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.4 t -119.6 110.27 28.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.967 -0.753 . . . . 73.319999999999993 108.967 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -93.89 131.3 39.45 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 124.006 0.922 . . . . 74.439999999999998 110.017 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.14 109.92 18.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.235 -1.024 . . . . 63.32 108.235 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -118.45 146.27 44.61 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.936 -1.106 . . . . 62.399999999999999 111.338 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.5 mt -105.52 107.89 19.12 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.502 -1.296 . . . . 73.549999999999997 107.502 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 37.3 ptt180 -103.84 135.89 44.54 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.403 -0.962 . . . . 74.129999999999995 108.403 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -76.73 108.34 9.68 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.447 0.641 . . . . 74.239999999999995 110.81 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 tt -82.82 111.42 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.276 1.036 . . . . 74.420000000000002 108.564 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 91' ' ' GLU . 3.6 m -144.53 -171.95 3.71 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 104.27 -2.493 . . . . 73.319999999999993 104.27 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.488 ' H ' HG22 ' A' ' 90' ' ' THR . 3.8 mp0 -60.82 -24.34 65.78 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 119.112 0.869 . . . . 74.5 111.765 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -76.45 -39.92 52.0 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.544 -0.753 . . . . 73.540000000000006 110.665 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 73.9 m -119.21 89.87 40.61 Favored Pre-proline 0 N--CA 1.431 -1.4 0 CA-C-N 116.459 -0.337 . . . . 73.109999999999999 110.627 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.24 152.75 56.17 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 121.809 1.673 . . . . 70.120000000000005 110.575 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.96 141.98 91.24 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.213 2.608 . . . . 44.140000000000001 113.317 -175.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.25 155.62 16.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 106.619 -1.622 . . . . 72.420000000000002 106.619 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.92 144.97 27.36 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 120.958 0.409 . . . . 74.439999999999998 110.183 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -157.24 -159.74 9.7 Favored Glycine 0 CA--C 1.464 -3.14 0 N-CA-C 107.992 -2.043 . . . . 45.039999999999999 107.992 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -69.45 108.99 3.99 Favored 'General case' 0 N--CA 1.395 -3.206 0 N-CA-C 107.652 -1.24 . . . . 70.420000000000002 107.652 171.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -83.29 109.62 17.41 Favored 'General case' 0 N--CA 1.416 -2.164 0 N-CA-C 107.894 -1.15 . . . . 74.409999999999997 107.894 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 36.7 t -69.32 156.74 38.3 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.856 -1.066 . . . . 65.109999999999999 109.723 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -79.43 94.58 5.58 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.982 -1.118 . . . . 61.049999999999997 107.982 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.7 t -96.31 129.96 45.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.339 -0.846 . . . . 63.43 110.297 -172.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 mp -139.64 -90.42 0.19 Allowed 'General case' 0 C--N 1.269 -2.905 0 CA-C-N 114.746 -1.116 . . . . 73.510000000000005 108.569 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -139.41 163.14 33.29 Favored 'General case' 0 C--N 1.251 -3.684 0 CA-C-N 113.587 -1.642 . . . . 70.409999999999997 106.873 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -34.35 -49.99 0.4 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.284 1.433 . . . . 74.5 114.843 -172.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 111' ' ' GLU . 27.9 tt0 -61.08 -46.5 90.41 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.095 0.406 . . . . 63.25 112.095 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -78.08 -31.16 50.02 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.494 -0.321 . . . . 61.329999999999998 110.555 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 113' ' ' ILE . 2.3 m-20 -66.43 -45.99 77.99 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.324 -0.853 . . . . 74.230000000000004 110.127 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.2 tp -63.35 -38.08 81.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 116.558 -0.292 . . . . 74.230000000000004 110.729 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 107' ' ' GLU . 44.9 mt-10 -60.14 -46.13 90.7 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.835 -0.431 . . . . 63.420000000000002 109.835 177.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 18.6 t -61.5 -41.1 96.78 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.497 -0.774 . . . . 71.099999999999994 111.137 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.451 ' O ' HG13 ' A' ' 117' ' ' ILE . 46.3 mm -65.42 -46.33 90.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.312 -0.404 . . . . 75.010000000000005 110.377 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 80.1 t -64.88 -39.97 87.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.158 -0.474 . . . . 75.109999999999999 110.554 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -67.46 -32.28 73.02 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 116.366 -0.379 . . . . 71.219999999999999 111.252 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.53 -34.67 53.87 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 120.641 0.258 . . . . 61.229999999999997 111.338 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 113' ' ' ILE . 82.4 mt -64.17 -48.12 87.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.791 -1.189 . . . . 71.430000000000007 107.791 174.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -62.77 -29.73 70.91 Favored 'General case' 0 C--O 1.192 -1.933 0 CA-C-N 115.447 -0.797 . . . . 72.450000000000003 111.633 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -67.59 -35.55 79.19 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.234 0.54 . . . . 54.219999999999999 109.795 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 4.5 t -84.47 -31.15 24.7 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.143 0.973 . . . . 75.349999999999994 109.537 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.6 mp -78.54 -39.34 38.16 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.859 -0.609 . . . . 72.219999999999999 111.98 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.67 -15.55 44.95 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 114.826 1.417 . . . . 43.439999999999998 114.826 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 123' ' ' LYS 0.346 34.0 mmtp -84.14 -3.93 58.45 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 116.271 1.952 . . . . 62.130000000000003 116.271 -175.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.33 -163.45 53.92 Favored Glycine 0 C--O 1.215 -1.075 0 C-N-CA 120.442 -0.885 . . . . 62.210000000000001 113.44 173.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.287 -2.135 0 CA-C-O 121.86 0.838 . . . . 74.439999999999998 112.823 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 tmm? . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 107.816 -1.179 . . . . 61.409999999999997 107.816 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -110.93 165.72 11.63 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.821 0.819 . . . . 71.340000000000003 113.193 -169.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.462 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 7.5 m-85 -121.65 145.81 47.62 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.684 -1.144 . . . . 73.549999999999997 110.28 177.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.432 ' OD1' ' HA3' ' A' ' 30' ' ' GLY . 32.4 t70 -115.13 120.75 40.84 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.762 -1.57 . . . . 73.450000000000003 106.762 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -99.91 116.78 43.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 109.63 -0.507 . . . . 63.130000000000003 109.63 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.411 ' HB ' ' CG ' ' A' ' 85' ' ' LYS . 46.6 t -108.48 117.46 54.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 107.862 -1.162 . . . . 60.409999999999997 107.862 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.413 HG22 ' HB2' ' A' ' 27' ' ' MET . 7.7 tt -117.95 123.09 71.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 121.376 0.608 . . . . 62.420000000000002 110.306 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.2 mp -114.27 98.24 48.04 Favored Pre-proline 0 N--CA 1.422 -1.849 0 CA-C-N 115.648 -0.705 . . . . 51.509999999999998 109.138 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.69 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 5.8 Cg_exo -81.49 130.36 6.95 Favored 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 122.009 1.806 . . . . 74.230000000000004 107.427 171.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.37 131.08 12.36 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.285 0.564 . . . . 72.099999999999994 110.697 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -73.53 122.17 21.77 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 107.672 -1.233 . . . . 74.400000000000006 107.672 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.497 ' HD1' ' O ' ' A' ' 12' ' ' PHE 0.255 0.1 OUTLIER -68.02 105.68 2.11 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.981 0.896 . . . . 65.430000000000007 113.08 -175.256 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -126.75 126.29 43.19 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 113.942 1.09 . . . . 74.120000000000005 113.942 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -76.64 129.18 36.02 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 103.171 -2.9 . . . . 73.5 103.171 165.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.65 111.46 9.86 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-O 121.602 0.715 . . . . 73.319999999999993 110.026 -169.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.57 -164.17 0.61 Allowed 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 114.36 -1.291 . . . . 38.009999999999998 107.967 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -100.88 -29.9 11.97 Favored 'General case' 0 N--CA 1.411 -2.381 0 O-C-N 121.499 -0.751 . . . . 72.209999999999994 110.745 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.1 t60 -135.05 -51.08 0.77 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 118.776 -1.169 . . . . 65.430000000000007 113.357 -175.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -122.22 139.08 54.19 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 109.358 -0.608 . . . . 72.140000000000001 109.358 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.303 59.3 mtm 96.64 73.35 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 126.338 1.855 . . . . 65.019999999999996 111.295 -175.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -156.41 94.07 1.46 Allowed 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 112.696 -2.047 . . . . 42.539999999999999 107.44 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -142.17 120.55 12.37 Favored 'General case' 0 CA--C 1.47 -2.116 0 O-C-N 121.577 -0.702 . . . . 71.540000000000006 109.462 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mm -133.05 143.67 38.72 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.799 0 N-CA-C 104.225 -2.509 . . . . 74.349999999999994 104.225 175.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.69 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 60.5 m -107.77 150.1 39.82 Favored Pre-proline 0 C--N 1.274 -2.7 0 N-CA-C 109.989 -0.374 . . . . 73.420000000000002 109.989 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -65.29 142.5 73.26 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.239 2.626 . . . . 63.32 114.255 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.06 126.49 18.05 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 123.104 2.536 . . . . 41.119999999999997 110.994 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.413 ' HB2' HG22 ' A' ' 7' ' ' ILE . 84.3 mtp -101.23 145.29 29.03 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.333 -0.988 . . . . 60.140000000000001 108.333 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 62.2 t -130.76 121.21 49.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.417 -0.586 . . . . 65.25 109.417 -178.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.6 mp -131.14 102.18 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.772 0 N-CA-C 106.205 -1.776 . . . . 73.099999999999994 106.205 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.432 ' HA3' ' OD1' ' A' ' 4' ' ' ASP . . . -117.53 -172.75 16.09 Favored Glycine 0 C--N 1.269 -3.146 0 C-N-CA 119.902 -1.142 . . . . 55.030000000000001 112.773 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.447 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 9.0 t70 71.7 67.6 0.15 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 125.636 1.574 . . . . 71.140000000000001 110.515 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.492 HH22 ' CG1' ' A' ' 103' ' ' VAL . 3.8 mpt_? -140.25 143.92 36.21 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 104.818 -2.29 . . . . 74.25 104.818 172.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 t -78.53 -179.71 6.56 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.78 -1.168 . . . . 62.149999999999999 108.07 174.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.462 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 88.3 t80 -55.98 -52.91 62.5 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 123.094 0.558 . . . . 70.349999999999994 112.394 -174.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 46.2 m-20 -68.04 -39.9 82.96 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.008 -0.997 . . . . 64.310000000000002 110.136 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.0 mt -65.03 -38.32 82.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.305 -0.861 . . . . 75.25 109.925 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.16 -42.47 88.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.791 -0.448 . . . . 72.129999999999995 109.791 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 24.0 mmt -64.77 -41.32 95.95 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.037 -0.529 . . . . 74.099999999999994 110.825 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 35' ' ' ASP . 40.1 mt-10 -66.27 -40.29 90.02 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 112.337 0.495 . . . . 73.349999999999994 112.337 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.566 ' O ' HG22 ' A' ' 44' ' ' VAL . 15.0 tt -72.58 -41.49 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 119.198 -1.001 . . . . 74.450000000000003 110.609 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.6 t -72.15 -37.15 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 120.468 -0.493 . . . . 62.219999999999999 111.309 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -74.31 -23.89 59.14 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.611 -0.436 . . . . 74.219999999999999 111.057 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.87 -45.93 40.24 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.196 -1.161 . . . . 38.009999999999998 110.196 175.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 40' ' ' ILE . 61.5 t -63.3 -41.97 94.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 N-CA-C 108.981 -0.748 . . . . 75.319999999999993 108.981 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.68 -52.34 31.76 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 125.372 1.469 . . . . 65.25 110.793 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -63.93 -40.25 96.02 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.789 -1.096 . . . . 71.310000000000002 110.732 -177.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.93 -36.62 74.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.215 -0.448 . . . . 72.420000000000002 110.592 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.4 mt -67.62 -43.74 86.69 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.171 0 N-CA-C 109.901 -0.407 . . . . 73.450000000000003 109.901 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.443 ' HZ1' ' HB3' ' A' ' 49' ' ' LYS . 7.9 mtpm? -74.26 -15.75 60.97 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.628 0.603 . . . . 75.109999999999999 112.628 -177.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.76 -33.99 13.38 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 112.177 0.436 . . . . 45.130000000000003 112.177 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -96.52 -19.21 19.27 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.258 0.551 . . . . 72.040000000000006 112.359 -176.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.409 ' CD2' ' HD2' ' A' ' 75' ' ' LYS . 22.4 m-85 -137.23 -176.36 4.36 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.686 -1.227 . . . . 71.310000000000002 107.686 -176.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -107.49 117.78 34.99 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.985 -1.487 . . . . 73.109999999999999 106.985 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -138.24 134.98 35.09 Favored 'General case' 0 N--CA 1.405 -2.71 0 C-N-CA 119.892 -0.723 . . . . 72.230000000000004 110.934 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.6 m -108.18 120.04 41.21 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 105.754 -1.943 . . . . 73.040000000000006 105.754 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.32 127.36 53.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.185 0.517 . . . . 64.129999999999995 110.767 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -121.72 116.6 24.82 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.748 -1.205 . . . . 64.140000000000001 107.748 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -100.49 118.18 36.17 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 120.872 0.368 . . . . 72.319999999999993 111.634 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mp -121.32 178.13 4.9 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.69 -0.855 . . . . 62.219999999999999 108.69 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -87.59 149.61 24.21 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.746 -0.835 . . . . 75.549999999999997 108.746 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.458 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -92.35 175.17 37.47 Favored Glycine 0 C--N 1.292 -1.908 0 N-CA-C 110.316 -1.114 . . . . 71.109999999999999 110.316 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -92.5 133.81 35.57 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 118.079 0.939 . . . . 74.209999999999994 112.749 -175.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.3 t70 59.26 -76.59 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.918 1.687 . . . . 62.109999999999999 114.53 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.9 t -119.38 5.53 11.16 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.425 0.631 . . . . 75.409999999999997 110.748 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.458 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 65.3 m-20 -81.43 124.17 29.2 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.943 -1.873 . . . . 73.150000000000006 105.943 173.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.8 t -83.75 -37.15 13.0 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 112.457 0.54 . . . . 74.5 112.457 -173.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 59.2 tp -142.18 137.85 31.13 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 109.169 -0.678 . . . . 64.409999999999997 109.169 -175.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.06 103.59 6.85 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.097 -1.446 . . . . 70.230000000000004 107.097 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -107.67 119.81 40.46 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 122.047 0.927 . . . . 74.420000000000002 111.226 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -98.71 108.69 21.44 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 113.704 -1.589 . . . . 74.340000000000003 108.036 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -97.21 131.38 44.0 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.882 -0.784 . . . . 74.319999999999993 108.882 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 15.4 m -96.13 118.58 32.99 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.662 -1.607 . . . . 63.130000000000003 106.662 173.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.24 134.74 47.84 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 112.976 0.732 . . . . 73.510000000000005 112.976 -173.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -136.45 137.04 40.01 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.155 -1.384 . . . . 75.519999999999996 108.105 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -141.79 85.88 1.96 Allowed 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.141 -1.429 . . . . 62.210000000000001 107.141 175.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.278 15.5 pt-20 32.95 69.62 0.12 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.919 1.687 . . . . 75.230000000000004 114.572 -174.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.19 -23.33 35.18 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.035 -0.984 . . . . 52.219999999999999 112.565 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.558 ' N ' ' HE3' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -85.88 124.25 32.14 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.064 -1.828 . . . . 74.209999999999994 106.064 178.801 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.439 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -132.2 146.51 52.07 Favored 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 120.057 -0.657 . . . . 71.420000000000002 111.745 -172.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.24 176.56 38.61 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.196 -0.911 . . . . 73.049999999999997 111.174 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.4 tp -129.47 138.0 55.44 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 106.668 -1.604 . . . . 73.420000000000002 106.668 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.44 110.32 24.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.467 -0.771 . . . . 73.010000000000005 110.083 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -96.92 106.36 18.67 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 123.838 0.855 . . . . 73.140000000000001 110.411 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.2 t -107.09 115.46 48.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.048 -0.723 . . . . 72.150000000000006 109.048 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 18.3 ptpt -110.45 140.42 44.71 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.819 -0.437 . . . . 70.140000000000001 109.819 177.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.4 mt -107.8 108.02 19.04 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 105.399 -2.074 . . . . 72.430000000000007 105.399 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 43.9 ttt85 -97.81 133.13 42.74 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 109.057 -0.72 . . . . 72.439999999999998 109.057 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -79.34 112.82 16.95 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.42 -0.955 . . . . 72.299999999999997 108.42 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.5 tt -91.08 111.44 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-O 122.373 1.082 . . . . 74.420000000000002 109.023 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.6 m -133.53 172.6 12.51 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 105.206 -2.146 . . . . 73.25 105.206 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -64.55 -20.89 66.5 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 118.872 0.76 . . . . 70.140000000000001 110.485 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -94.48 -5.83 45.27 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.039 -0.982 . . . . 74.340000000000003 111.59 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 70.3 m -133.32 109.52 12.51 Favored Pre-proline 0 C--N 1.314 -0.94 0 O-C-N 122.124 -0.36 . . . . 73.019999999999996 111.046 -175.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.56 138.86 24.79 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.143 1.895 . . . . 53.420000000000002 112.387 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.95 164.66 33.9 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 123.414 2.742 . . . . 51.340000000000003 111.13 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.7 t -94.11 155.7 3.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.988 -0.745 . . . . 72.549999999999997 108.988 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -106.19 122.08 45.48 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.512 -0.767 . . . . 70.209999999999994 109.086 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -158.13 -159.65 9.74 Favored Glycine 0 CA--C 1.468 -2.85 0 N-CA-C 110.229 -1.148 . . . . 54.0 110.229 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -76.29 93.0 3.36 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-O 121.828 0.823 . . . . 71.129999999999995 111.375 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 62.9 ttt180 -73.89 122.01 21.84 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.252 -1.34 . . . . 72.109999999999999 108.037 177.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 38.7 t -88.97 163.79 15.4 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.896 -0.722 . . . . 73.329999999999998 109.846 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.7 m -75.31 107.75 7.63 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 122.934 0.494 . . . . 75.340000000000003 109.902 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.492 ' CG1' HH22 ' A' ' 32' ' ' ARG . 36.5 t -85.01 135.91 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-O 122.132 0.967 . . . . 74.129999999999995 110.277 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.0 mt -153.18 -163.84 1.78 Allowed 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 104.805 -2.294 . . . . 73.099999999999994 104.805 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -54.05 145.93 15.76 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 118.405 0.548 . . . . 75.219999999999999 111.406 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.429 ' O ' HG23 ' A' ' 110' ' ' ILE . 13.9 t80 -32.91 -48.57 0.21 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.425 2.29 . . . . 75.230000000000004 113.707 -173.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.562 ' O ' ' HG3' ' A' ' 111' ' ' GLU . 43.3 tt0 -57.4 -43.87 84.05 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 112.349 0.5 . . . . 74.319999999999993 112.349 -176.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 -72.09 -31.4 66.04 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.145 -0.622 . . . . 61.409999999999997 111.501 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -71.38 -44.7 64.46 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.879 -1.055 . . . . 74.200000000000003 108.412 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 106' ' ' PHE . 12.7 tt -68.37 -36.79 76.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 C-N-CA 120.479 -0.489 . . . . 74.099999999999994 110.681 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.562 ' HG3' ' O ' ' A' ' 107' ' ' GLU . 52.6 mt-10 -61.56 -35.94 79.22 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.874 0.368 . . . . 74.140000000000001 110.064 176.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 44.5 t -64.98 -43.44 92.62 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.005 -0.543 . . . . 75.439999999999998 109.953 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.6 mm -64.58 -46.66 91.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.513 -0.767 . . . . 73.430000000000007 110.301 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 92.3 t -63.29 -39.2 84.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.456 -0.338 . . . . 73.319999999999993 110.53 -177.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -62.64 -38.7 91.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.052 0.453 . . . . 74.120000000000005 110.4 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.89 -42.32 90.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.132 -0.486 . . . . 71.030000000000001 110.326 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.78 -42.75 93.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.008 -0.542 . . . . 75.209999999999994 110.569 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 114' ' ' VAL . 52.8 mt-10 -61.12 -44.81 96.77 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 121.319 -0.152 . . . . 75.129999999999995 110.618 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -65.07 -46.59 80.55 Favored 'General case' 0 C--O 1.181 -2.502 0 C-N-CA 119.685 -0.806 . . . . 72.439999999999998 110.336 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 2.7 t -68.84 -22.71 64.21 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.324 0.583 . . . . 61.310000000000002 111.616 -172.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.2 mp -81.96 -47.1 13.12 Favored 'General case' 0 N--CA 1.428 -1.553 0 O-C-N 121.999 -0.438 . . . . 71.109999999999999 111.473 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.16 -25.59 31.71 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.855 0.687 . . . . 51.100000000000001 112.855 -172.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -102.65 9.92 38.98 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.431 -1.322 . . . . 71.209999999999994 107.431 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.11 57.35 2.75 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 114.445 -1.252 . . . . 61.210000000000001 115.329 -174.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--N 1.272 -2.765 0 C-N-CA 125.233 1.413 . . . . 72.25 107.228 172.68 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 mtp . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 121.363 0.601 . . . . 73.319999999999993 112.179 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -141.32 174.12 10.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.561 -1.274 . . . . 71.219999999999999 107.561 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.516 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 24.9 m-85 -120.35 134.96 55.17 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-O 121.325 0.583 . . . . 74.319999999999993 109.697 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.549 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 62.3 t0 -115.26 119.37 36.09 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.245 -1.343 . . . . 75.200000000000003 108.404 -175.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.6 125.7 50.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 115.673 -0.694 . . . . 75.439999999999998 111.393 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.484 ' HB ' HH21 ' A' ' 87' ' ' ARG . 7.7 p -112.39 115.84 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 N-CA-C 108.603 -0.888 . . . . 71.129999999999995 108.603 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.3 tt -104.02 124.45 58.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.482 -0.781 . . . . 70.319999999999993 108.952 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.1 mt -114.92 95.81 42.78 Favored Pre-proline 0 C--N 1.302 -1.457 0 CA-C-N 115.808 -0.633 . . . . 51.439999999999998 109.346 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.628 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 9.7 Cg_endo -89.45 126.6 1.58 Allowed 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.762 2.308 . . . . 71.129999999999995 110.173 176.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -150.67 127.67 11.12 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.615 0.722 . . . . 63.409999999999997 110.781 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.2 m -74.42 111.44 9.6 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.791 -1.189 . . . . 72.310000000000002 107.791 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.44 120.64 14.85 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.647 0.737 . . . . 73.140000000000001 112.948 -173.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -129.65 114.72 16.37 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 115.176 -0.92 . . . . 74.319999999999993 110.305 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -78.86 118.65 21.1 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 104.927 -2.249 . . . . 74.239999999999995 104.927 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -48.11 104.31 0.06 Allowed 'General case' 0 N--CA 1.424 -1.765 0 O-C-N 125.378 1.673 . . . . 73.409999999999997 110.578 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -84.8 -145.89 0.09 Allowed 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 112.685 -2.052 . . . . 40.32 108.292 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -63.05 -58.37 7.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 118.3 0.5 . . . . 73.150000000000006 111.369 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -137.3 -52.55 0.67 Allowed 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 118.866 -1.134 . . . . 74.319999999999993 113.833 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.53 ' O ' ' HG2' ' A' ' 20' ' ' MET . 10.5 t30 -108.27 80.95 1.41 Allowed 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 113.104 0.779 . . . . 74.349999999999994 113.104 -170.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.53 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 70.5 mmm -163.24 70.94 0.25 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.08 1.352 . . . . 75.129999999999995 109.287 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -146.21 89.89 1.91 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.319 -1.734 . . . . 63.25 106.319 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -113.25 118.03 33.5 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.201 -1.0 . . . . 74.230000000000004 111.08 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 132' ' ' GLY . 21.5 mm -133.18 127.48 54.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.489 -0.778 . . . . 75.540000000000006 110.735 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.628 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 76.9 m -111.54 129.23 24.32 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 108.458 -0.941 . . . . 60.229999999999997 108.458 172.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.49 146.95 93.43 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.685 2.257 . . . . 74.219999999999999 112.725 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.86 147.93 92.02 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 123.68 2.92 . . . . 62.119999999999997 113.422 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.404 ' HG2' ' HB2' ' A' ' 99' ' ' ASN . 64.2 mtt -111.07 132.94 53.84 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.194 -1.039 . . . . 74.010000000000005 108.194 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.9 t -126.37 125.6 67.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 O-C-N 123.497 0.498 . . . . 71.549999999999997 110.457 -171.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.8 mm -138.21 116.17 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.748 0.819 . . . . 45.009999999999998 109.504 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -127.94 81.98 0.34 Allowed Glycine 0 CA--C 1.48 -2.139 0 C-N-CA 118.726 -1.702 . . . . 74.319999999999993 114.801 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.92 7.91 1.65 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.205 -0.598 . . . . 63.43 112.432 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.465 HH21 ' CG1' ' A' ' 103' ' ' VAL . 14.8 mmt85 -103.99 134.41 47.31 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.148 -0.621 . . . . 43.240000000000002 109.553 -169.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 p -78.19 163.76 25.52 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 107.678 -1.23 . . . . 71.120000000000005 107.678 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.516 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 63.3 t80 -51.42 -43.24 61.94 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 124.27 1.028 . . . . 75.219999999999999 111.22 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.99 -41.78 95.11 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.151 -0.931 . . . . 63.240000000000002 111.719 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.8 mt -79.29 -30.47 14.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.529 -0.545 . . . . 64.310000000000002 109.529 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.31 -45.8 89.68 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.353 -0.839 . . . . 75.030000000000001 110.098 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.08 -31.38 70.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 119.924 -0.711 . . . . 72.120000000000005 112.276 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.23 -45.07 67.28 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 119.495 -0.882 . . . . 74.329999999999998 110.508 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.4 tp -66.72 -40.9 87.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 C-N-CA 120.107 -0.637 . . . . 72.439999999999998 110.176 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.3 t -65.57 -42.67 93.5 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.008 0 CA-C-N 116.737 -0.21 . . . . 72.200000000000003 110.57 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -63.85 -40.73 97.26 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 120.761 0.315 . . . . 74.439999999999998 111.349 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.477 ' O ' HG21 ' A' ' 47' ' ' VAL . . . -66.85 -44.9 87.98 Favored Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 111.062 -0.815 . . . . 52.149999999999999 111.062 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.17 -39.85 86.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.649 -0.5 . . . . 73.239999999999995 109.649 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.45 ' OD2' ' HE2' ' A' ' 49' ' ' LYS . 23.2 t70 -57.75 -46.42 84.54 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 124.387 1.075 . . . . 61.409999999999997 110.653 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -67.42 -37.64 83.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.14 -0.482 . . . . 73.409999999999997 111.597 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 43' ' ' GLY . 62.3 t -68.36 -41.89 83.83 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 120.772 -0.371 . . . . 73.219999999999999 110.302 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 66.3 mt -66.01 -38.33 81.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 O-C-N 122.035 -0.416 . . . . 73.510000000000005 111.091 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 142' ' ' LEU . 54.0 mtmt -76.57 -17.79 59.02 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.912 0.708 . . . . 74.409999999999997 112.912 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.02 -33.91 7.34 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 113.625 0.972 . . . . 65.450000000000003 113.625 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 t -87.4 -9.99 53.22 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.423 0.63 . . . . 75.25 110.053 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.604 ' CE2' ' HD2' ' A' ' 75' ' ' LYS . 12.3 m-85 -137.33 175.81 9.27 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 107.503 -1.295 . . . . 71.239999999999995 107.503 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -104.42 77.35 1.38 Allowed 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 105.462 -2.051 . . . . 72.129999999999995 105.462 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -114.46 136.44 53.01 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-N 115.158 -0.928 . . . . 73.430000000000007 112.532 -172.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 m -109.37 123.54 49.49 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.282 -1.377 . . . . 75.340000000000003 107.282 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 p -100.63 152.42 4.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 116.11 -0.495 . . . . 72.329999999999998 110.293 -173.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -142.13 140.08 32.36 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.691 -1.225 . . . . 73.040000000000006 107.691 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.96 136.32 49.42 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.34 0.59 . . . . 73.299999999999997 110.883 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mp -135.91 167.53 21.01 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.913 -1.143 . . . . 63.020000000000003 107.913 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -100.54 142.76 31.56 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.038 -1.468 . . . . 73.010000000000005 107.038 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.52 174.89 48.93 Favored Glycine 0 C--N 1.296 -1.681 0 C-N-CA 120.708 -0.758 . . . . 72.450000000000003 112.121 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.77 130.47 35.13 Favored 'General case' 0 C--O 1.179 -2.628 0 N-CA-C 108.188 -1.042 . . . . 51.039999999999999 108.188 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 13.64 -73.76 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 C-N-CA 128.241 2.616 . . . . 75.340000000000003 116.829 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 53.3 t -57.12 -37.75 72.43 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 124.151 0.98 . . . . 75.329999999999998 110.046 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 8.7 m-20 -86.18 124.4 32.54 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.601 -1.259 . . . . 71.099999999999994 107.601 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.4 t -93.83 -28.78 4.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-O 121.304 0.573 . . . . 72.439999999999998 111.717 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.6 tp -145.34 141.3 28.38 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.124 -0.695 . . . . 63.229999999999997 109.124 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.478 ' HH ' ' CG ' ' A' ' 83' ' ' HIS . 0.4 OUTLIER -130.28 108.96 10.4 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.199 -1.408 . . . . 74.420000000000002 107.199 179.208 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -104.79 114.77 29.19 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.279 -1.378 . . . . 75.439999999999998 107.279 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 36.1 ttmt -101.12 132.64 46.49 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.341 0.657 . . . . 74.150000000000006 109.295 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -126.4 125.24 41.86 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.716 -0.475 . . . . 74.310000000000002 109.716 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 m -98.38 113.49 25.49 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.999 -1.482 . . . . 74.319999999999993 106.999 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.48 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 4.2 mm? -98.38 139.99 33.32 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.573 0.583 . . . . 75.409999999999997 112.573 -172.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -140.13 127.95 21.92 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 105.715 -1.957 . . . . 73.239999999999995 105.715 170.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.604 ' HD2' ' CE2' ' A' ' 52' ' ' PHE . 49.2 tttm -134.79 -176.91 4.39 Favored 'General case' 0 C--N 1.273 -2.744 0 N-CA-C 104.933 -2.247 . . . . 61.509999999999998 104.933 177.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.424 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -55.97 92.25 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 114.568 1.322 . . . . 73.510000000000005 114.568 -175.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.7 17.6 74.99 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 114.903 -1.044 . . . . 62.130000000000003 113.146 175.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 44.4 mtmt -140.09 143.99 36.57 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.419 -0.586 . . . . 72.120000000000005 109.419 -175.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 73' ' ' LEU . 33.6 ttmt -146.79 139.31 24.98 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 110.033 -0.358 . . . . 73.420000000000002 110.033 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.62 174.4 35.71 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 110.902 -0.879 . . . . 61.119999999999997 110.902 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.9 tp -119.56 134.46 63.05 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 108.106 -1.072 . . . . 74.430000000000007 108.106 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.2 t -123.61 115.59 45.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.432 0.634 . . . . 75.319999999999993 109.673 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.478 ' CG ' ' HH ' ' A' ' 68' ' ' TYR . 36.4 m170 -107.15 116.67 32.33 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.257 -0.883 . . . . 63.32 110.512 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.58 110.0 30.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.737 -0.838 . . . . 75.430000000000007 108.737 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -118.27 137.4 53.07 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.891 -0.506 . . . . 72.540000000000006 111.336 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.7 mt -106.37 118.76 37.48 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.112 -0.495 . . . . 73.230000000000004 109.944 -171.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.484 HH21 ' HB ' ' A' ' 6' ' ' VAL . 28.5 mtm105 -97.15 141.14 30.65 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.025 0.441 . . . . 74.510000000000005 110.096 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 64' ' ' CYS . 49.7 pttt -80.23 98.11 7.23 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 109.301 -0.629 . . . . 71.209999999999994 109.301 173.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.0 tt -69.22 112.01 3.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-O 122.513 1.149 . . . . 74.439999999999998 109.636 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.6 p -140.68 -171.4 3.22 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 113.35 -1.75 . . . . 74.319999999999993 107.723 -170.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.47 -5.0 53.83 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.593 0.711 . . . . 62.020000000000003 110.658 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -99.74 -29.25 12.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.547 -0.751 . . . . 54.25 109.169 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 84.9 m -121.27 92.87 48.76 Favored Pre-proline 0 N--CA 1.431 -1.377 0 CA-C-N 115.429 -0.805 . . . . 54.109999999999999 109.719 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -76.48 167.79 24.97 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.189 1.926 . . . . 73.040000000000006 110.976 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.24 123.34 12.31 Favored 'Trans proline' 0 C--O 1.251 1.157 0 C-N-CA 122.032 1.821 . . . . 62.420000000000002 110.194 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 t -86.68 157.57 3.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.462 -0.57 . . . . 73.430000000000007 109.462 -176.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.47 137.49 32.31 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.96 -0.564 . . . . 74.200000000000003 110.299 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -177.1 -170.43 39.52 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 108.76 -1.736 . . . . 74.439999999999998 108.76 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.404 ' HB2' ' HG2' ' A' ' 27' ' ' MET . 94.1 m-20 -71.63 140.01 49.54 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.187 -0.671 . . . . 73.519999999999996 109.187 178.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -98.63 119.7 37.81 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.019 0.438 . . . . 71.439999999999998 111.133 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 41.1 t -73.2 139.04 46.0 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.553 -0.906 . . . . 72.219999999999999 108.553 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 m -74.03 91.15 2.03 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.494 0.664 . . . . 73.519999999999996 110.374 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.465 ' CG1' HH21 ' A' ' 32' ' ' ARG . 66.7 t -89.57 136.59 23.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 114.748 -1.115 . . . . 65.150000000000006 109.897 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 93.4 mt -148.48 -88.74 0.08 Allowed 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.099 -0.955 . . . . 61.549999999999997 109.606 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -120.58 166.9 13.0 Favored 'General case' 0 C--N 1.262 -3.239 0 N-CA-C 107.006 -1.479 . . . . 64.219999999999999 107.006 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -44.71 -46.74 10.54 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 124.172 0.92 . . . . 74.329999999999998 112.761 -178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.04 -31.54 72.14 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.477 -0.783 . . . . 72.030000000000001 112.271 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -81.47 -36.9 28.77 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.112 -0.699 . . . . 75.230000000000004 109.112 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.406 ' O ' HG12 ' A' ' 113' ' ' ILE . 44.2 m-20 -63.61 -45.39 90.51 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.11 -0.95 . . . . 71.540000000000006 109.198 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.407 ' O ' HG21 ' A' ' 114' ' ' VAL . 7.0 tp -67.69 -36.91 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 120.335 -0.546 . . . . 60.439999999999998 110.951 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.26 -33.18 75.17 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.266 -0.642 . . . . 70.319999999999993 109.266 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 41.6 t -65.09 -38.93 92.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.677 -0.692 . . . . 70.200000000000003 110.248 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 109' ' ' ASP . 51.5 mm -67.69 -43.57 86.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.906 -0.405 . . . . 75.319999999999993 109.906 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 110' ' ' ILE . 83.7 t -60.43 -43.65 94.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.024 -0.535 . . . . 73.329999999999998 111.037 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -66.92 -31.35 71.88 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 120.767 -0.373 . . . . 62.0 110.38 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.64 -45.58 71.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.017 0.437 . . . . 75.140000000000001 110.809 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.4 mt -68.1 -44.13 84.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.545 -0.752 . . . . 72.439999999999998 109.461 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.1 -31.48 71.99 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 112.398 0.518 . . . . 62.43 112.398 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.35 -43.0 61.57 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 119.416 -0.914 . . . . 74.150000000000006 110.012 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 2.6 t -70.36 -41.26 73.35 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.6 0.714 . . . . 62.329999999999998 109.556 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 10.4 mp -74.61 -35.68 62.95 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.75 -0.659 . . . . 74.400000000000006 111.994 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.15 -14.77 52.85 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 119.544 -0.863 . . . . 53.130000000000003 113.033 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.53 -34.59 58.54 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 118.232 -1.387 . . . . 71.519999999999996 111.733 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.48 -153.93 39.16 Favored Glycine 0 C--N 1.295 -1.701 0 CA-C-N 114.726 -1.124 . . . . 71.140000000000001 115.752 172.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -51.39 103.77 0.07 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 125.088 1.355 . . . . 75.329999999999998 112.494 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.89 -178.74 5.96 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 106.883 -1.525 . . . . 75.219999999999999 106.883 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -110.13 139.17 45.56 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.453 -0.943 . . . . 72.150000000000006 108.453 172.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.8 t -155.5 -164.66 1.8 Allowed 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.874 -1.158 . . . . 73.120000000000005 107.874 -174.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -56.1 144.37 29.52 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.204 1.002 . . . . 62.119999999999997 109.913 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -80.34 88.9 5.53 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.436 0.636 . . . . 72.040000000000006 109.949 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -151.82 -164.87 2.08 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 105.352 -2.092 . . . . 73.120000000000005 105.352 173.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.509 ' O ' ' HD3' ' A' ' 134' ' ' PRO . . . 121.46 106.19 1.97 Allowed Glycine 0 CA--C 1.474 -2.479 0 N-CA-C 109.778 -1.329 . . . . 63.219999999999999 109.778 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -102.57 100.93 17.5 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-O 121.535 0.683 . . . . 60.25 111.772 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 132' ' ' GLY . 1.6 Cg_endo -81.88 85.72 1.66 Allowed 'Trans proline' 0 N--CA 1.43 -2.26 0 C-N-CA 122.162 1.908 . . . . 73.519999999999996 109.649 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 46.0 mm -87.85 110.31 34.06 Favored Pre-proline 0 N--CA 1.417 -2.102 0 N-CA-C 108.716 -0.846 . . . . 75.400000000000006 108.716 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.35 134.64 39.66 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 122.99 2.46 . . . . 70.420000000000002 111.959 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -127.48 112.39 21.07 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 107.532 -1.284 . . . . 75.239999999999995 107.532 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -68.12 -11.37 31.82 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.963 2.442 . . . . 74.450000000000003 113.658 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.47 123.25 40.07 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.869 -0.419 . . . . 74.219999999999999 109.869 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mp -125.52 89.66 3.08 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.028 -0.73 . . . . 62.549999999999997 109.028 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.93 151.31 12.1 Favored Glycine 0 C--N 1.304 -1.24 0 C-N-CA 120.545 -0.836 . . . . 62.229999999999997 111.549 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 2.5 pt? -96.43 -178.62 4.35 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.698 -0.482 . . . . 72.319999999999993 109.698 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' A' ' 49' ' ' LYS . 22.8 t0 -130.29 112.13 13.04 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.18 -0.674 . . . . 63.32 109.18 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 24.2 m -64.04 117.47 7.11 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.297 -0.865 . . . . 64.329999999999998 112.75 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.1 m -162.28 93.57 0.87 Allowed 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.448 -1.316 . . . . 65.120000000000005 107.448 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -85.23 149.32 25.57 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.913 -1.143 . . . . 74.040000000000006 107.913 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.9 m -77.7 130.05 36.3 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.409 -0.96 . . . . 70.310000000000002 108.409 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.472 0 N-CA-C 109.895 -1.282 . . . . 41.32 109.895 -177.69 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HE2' ' HA ' ' A' ' 1' ' ' MET . 2.7 tpt . . . . . 0 CA--C 1.511 -0.524 0 N-CA-C 109.402 -0.592 . . . . 52.329999999999998 109.402 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -128.84 170.77 12.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.362 -0.607 . . . . 70.319999999999993 109.362 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.484 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 16.6 m-85 -124.18 146.93 48.37 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.832 -0.622 . . . . 74.319999999999993 110.694 177.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.538 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 0.4 OUTLIER -99.03 102.44 14.16 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 125.27 1.428 . . . . 71.219999999999999 108.246 178.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.1 t -85.0 113.13 23.03 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 107.526 -1.287 . . . . 71.340000000000003 107.526 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -107.26 107.78 23.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.882 -1.155 . . . . 74.239999999999995 107.882 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.9 tt -110.91 110.06 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-O 122.064 0.935 . . . . 73.540000000000006 109.466 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.6 mt -106.77 104.71 52.57 Favored Pre-proline 0 C--N 1.293 -1.879 0 CA-C-N 114.245 -1.343 . . . . 75.519999999999996 110.143 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.695 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 5.9 Cg_exo -81.04 137.51 10.9 Favored 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 121.701 1.601 . . . . 73.109999999999999 108.463 170.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -139.27 156.59 46.95 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.001 -1.481 . . . . 73.219999999999999 107.001 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.406 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 35.7 m -104.58 126.47 51.69 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.397 -0.964 . . . . 73.120000000000005 108.397 175.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.516 ' CE1' ' HB3' ' A' ' 79' ' ' LYS 0.275 8.2 p90 -73.79 75.31 1.59 Allowed 'General case' 0 C--N 1.349 0.573 0 CA-C-O 122.723 1.249 . . . . 72.329999999999998 114.098 -176.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.622 ' NE2' ' HD2' ' A' ' 79' ' ' LYS . 50.3 m80 -128.46 111.41 13.26 Favored 'General case' 0 N--CA 1.414 -2.265 0 O-C-N 121.59 -0.694 . . . . 70.120000000000005 111.696 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -72.47 144.22 48.15 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.388 -1.278 . . . . 74.409999999999997 108.91 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -52.69 120.33 5.58 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 116.983 2.216 . . . . 73.319999999999993 116.983 -173.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.592 ' HB3' ' O ' ' A' ' 19' ' ' ASN . 9.5 t70 -100.45 168.22 9.88 Favored 'General case' 0 C--N 1.262 -3.203 0 CA-C-N 111.974 -2.376 . . . . 73.450000000000003 105.114 165.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -62.63 -32.84 73.94 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 122.63 0.372 . . . . 55.43 111.885 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -135.55 -35.68 0.8 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.901 0.704 . . . . 73.430000000000007 112.901 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.592 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 5.1 m-20 -95.84 -178.62 4.43 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.097 -0.501 . . . . 73.439999999999998 109.662 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 62.8 mtt 56.58 71.32 0.57 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 114.12 1.156 . . . . 71.510000000000005 114.12 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -165.72 116.45 1.05 Allowed 'General case' 0 N--CA 1.406 -2.658 0 N-CA-C 103.412 -2.811 . . . . 64.549999999999997 103.412 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.625 ' ND1' ' HB3' ' A' ' 127' ' ' ASN . 3.6 t60 -153.73 104.75 2.73 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-O 122.034 0.921 . . . . 65.310000000000002 110.77 171.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.5 mm -96.58 128.85 47.4 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.707 0 N-CA-C 104.076 -2.564 . . . . 75.150000000000006 104.076 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.695 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 59.3 m -107.81 159.06 31.82 Favored Pre-proline 0 C--N 1.288 -2.104 0 C-N-CA 119.812 -0.755 . . . . 72.120000000000005 110.426 -168.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.33 116.85 3.48 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.571 2.18 . . . . 73.150000000000006 112.741 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.52 128.87 5.55 Favored 'Trans proline' 0 C--O 1.256 1.39 0 C-N-CA 122.111 1.874 . . . . 74.349999999999994 111.501 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -91.44 126.26 36.47 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.723 -0.671 . . . . 74.219999999999999 110.594 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.6 t -123.14 115.24 45.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.555 -0.748 . . . . 71.409999999999997 108.994 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.3 mm -125.14 102.47 10.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 109.664 -0.495 . . . . 62.030000000000001 109.664 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -110.1 80.39 0.27 Allowed Glycine 0 CA--C 1.474 -2.505 0 C-N-CA 119.84 -1.172 . . . . 64.310000000000002 112.92 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -165.3 20.69 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.06 -1.07 . . . . 74.109999999999999 110.304 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -103.08 133.39 48.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.99 -1.855 . . . . 73.140000000000001 105.99 -173.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.0 p -77.93 165.92 23.5 Favored 'General case' 0 N--CA 1.408 -2.526 0 N-CA-C 107.929 -1.137 . . . . 61.32 107.929 174.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.484 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 59.7 t80 -52.76 -43.92 66.13 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 123.333 0.653 . . . . 71.239999999999995 111.029 -174.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.01 -31.33 68.95 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.019 -0.991 . . . . 72.230000000000004 112.889 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -81.63 -34.36 12.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.216 0.531 . . . . 75.430000000000007 109.601 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.04 -45.43 88.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.672 -0.695 . . . . 61.229999999999997 110.012 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.3 mmt -69.85 -29.72 67.03 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.891 0.376 . . . . 74.450000000000003 110.313 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -67.68 -44.71 77.14 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 115.789 -0.641 . . . . 74.219999999999999 110.31 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 44' ' ' VAL . 7.9 tp -69.93 -39.91 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 119.709 -0.797 . . . . 73.120000000000005 109.738 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.31 -42.09 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 116.602 -0.272 . . . . 53.439999999999998 110.931 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.547 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 46.3 t-20 -64.44 -42.42 96.01 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.494 -0.558 . . . . 65.150000000000006 109.494 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.463 ' HA3' ' CE1' ' A' ' 106' ' ' PHE . . . -67.53 -40.46 90.93 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.588 -0.815 . . . . 42.109999999999999 112.058 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 40' ' ' ILE . 72.1 t -65.22 -41.36 91.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.53 -0.545 . . . . 62.340000000000003 109.53 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -53.71 -47.22 70.74 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.481 1.112 . . . . 65.099999999999994 110.92 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 42' ' ' ASN . 88.0 mtt180 -69.5 -37.21 77.11 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.333 -0.848 . . . . 73.209999999999994 110.645 -177.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.2 t -71.12 -36.01 61.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.217 -0.447 . . . . 64.109999999999999 110.649 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.56 -45.63 97.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 122.6 0.36 . . . . 64.019999999999996 110.921 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -70.94 -25.32 62.69 Favored 'General case' 0 C--O 1.209 -1.064 0 CA-C-O 121.02 0.438 . . . . 74.420000000000002 110.82 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.419 ' HB1' ' H ' ' A' ' 148' ' ' GLY . . . -83.6 -40.84 18.52 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.893 0.701 . . . . 63.130000000000003 112.893 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -92.23 -14.11 29.46 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 112.729 0.64 . . . . 74.150000000000006 112.729 -173.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -135.44 -175.71 4.03 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.505 0.669 . . . . 72.439999999999998 110.543 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.471 ' HA ' ' OD1' ' A' ' 143' ' ' ASP . 2.9 t-20 -113.53 100.62 8.64 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 103.487 -2.783 . . . . 73.099999999999994 103.487 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.72 153.74 28.49 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 114.07 1.137 . . . . 62.32 114.07 -167.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.6 m -126.73 118.25 24.33 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 105.56 -2.015 . . . . 52.439999999999998 105.56 168.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.9 p -99.96 118.74 47.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.482 0.658 . . . . 75.439999999999998 109.953 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -114.83 122.23 45.72 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.569 -0.741 . . . . 61.32 109.075 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.13 141.33 28.71 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.972 -0.381 . . . . 64.0 109.972 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.57 168.57 19.4 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.563 0.697 . . . . 73.540000000000006 109.481 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -106.24 127.0 52.92 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.179 -1.415 . . . . 74.409999999999997 107.179 174.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.83 176.51 43.04 Favored Glycine 0 N--CA 1.422 -2.273 0 CA-C-N 115.742 -0.663 . . . . 53.149999999999999 112.672 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.23 174.64 1.54 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.271 1.028 . . . . 73.420000000000002 110.146 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -49.49 -40.65 38.24 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.081 0.952 . . . . 63.229999999999997 111.736 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.18 -20.25 48.9 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.566 -1.197 . . . . 53.520000000000003 111.999 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 85' ' ' LYS . 2.1 t70 -89.0 171.29 9.97 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.836 -0.54 . . . . 73.209999999999994 109.877 -174.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.7 t -114.19 -37.94 2.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 C-N-CA 123.857 0.863 . . . . 54.310000000000002 109.532 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.3 tp -167.3 131.57 1.89 Allowed 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.891 -0.595 . . . . 72.129999999999995 110.503 -171.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.28 133.68 52.56 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 107.41 -1.33 . . . . 72.120000000000005 107.41 -176.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -139.3 142.32 37.71 Favored 'General case' 0 C--N 1.28 -2.433 0 O-C-N 121.618 -0.676 . . . . 61.32 110.713 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -121.64 122.69 40.17 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.376 0.608 . . . . 62.520000000000003 109.522 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -97.57 119.85 36.89 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 107.177 -1.416 . . . . 74.319999999999993 107.177 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.7 m -94.35 116.17 28.5 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.305 -1.369 . . . . 52.020000000000003 107.305 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.94 142.2 47.61 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-O 121.04 0.448 . . . . 64.120000000000005 110.913 -173.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 26.6 tt0 -150.41 100.49 2.88 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 107.936 -1.135 . . . . 73.129999999999995 107.936 168.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -102.75 90.4 3.8 Favored 'General case' 0 N--CA 1.417 -2.078 0 C-N-CA 118.959 -1.096 . . . . 63.399999999999999 108.39 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 55.51 67.58 0.99 Allowed 'General case' 0 CA--C 1.545 0.771 0 O-C-N 124.707 1.254 . . . . 74.400000000000006 111.385 171.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.62 -23.5 19.22 Favored Glycine 0 C--N 1.308 -1.021 0 CA-C-N 115.483 -0.781 . . . . 73.409999999999997 113.341 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 53.2 mtmt -84.44 101.12 11.78 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.261 -1.015 . . . . 75.439999999999998 108.261 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.622 ' HD2' ' NE2' ' A' ' 13' ' ' HIS . 42.0 mttp -103.73 134.11 47.6 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 123.843 0.715 . . . . 72.549999999999997 110.187 -172.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -171.8 169.46 42.53 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.074 -1.06 . . . . 52.539999999999999 112.825 177.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.1 mt -131.62 138.22 53.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.147 -1.427 . . . . 71.109999999999999 107.147 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.8 t -115.18 110.34 31.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 109.084 -0.71 . . . . 74.409999999999997 109.084 176.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -97.27 105.83 18.05 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.664 -0.698 . . . . 74.230000000000004 109.827 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.2 t -101.29 115.44 43.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 107.927 -1.138 . . . . 72.540000000000006 107.927 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.471 ' HB2' ' OD2' ' A' ' 65' ' ' ASP . 21.7 ptmt -124.16 133.78 53.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.29 -0.633 . . . . 74.200000000000003 109.29 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.6 mt -107.33 112.91 25.97 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.863 -0.791 . . . . 72.340000000000003 108.863 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.5 mmm-85 -97.13 139.01 33.76 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.316 -0.994 . . . . 74.400000000000006 108.316 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.584 ' O ' ' HB2' ' A' ' 93' ' ' CYS . 21.8 pttm -92.06 98.98 11.89 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 120.208 -0.597 . . . . 74.450000000000003 111.464 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.2 tt -66.59 111.7 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 122.326 1.06 . . . . 73.129999999999995 109.494 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.3 p -145.67 -170.46 3.46 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.25 -1.341 . . . . 71.310000000000002 108.924 -169.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -72.73 -19.49 61.38 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.87 -1.159 . . . . 75.310000000000002 107.87 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.1 -36.84 17.88 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.253 -1.34 . . . . 73.239999999999995 109.556 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 86.3 m -122.36 125.43 26.53 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 113.463 0.912 . . . . 74.519999999999996 113.463 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.21 161.98 15.32 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.522 2.148 . . . . 75.450000000000003 110.905 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.12 142.99 89.34 Favored 'Trans proline' 0 C--O 1.262 1.71 0 C-N-CA 121.943 1.762 . . . . 71.439999999999998 109.667 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 t -87.98 159.42 3.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 109.576 -0.527 . . . . 72.230000000000004 109.576 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -109.51 131.15 55.33 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.782 -0.821 . . . . 72.329999999999998 108.782 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -174.6 -160.76 23.26 Favored Glycine 0 CA--C 1.479 -2.17 0 N-CA-C 110.731 -0.948 . . . . 71.530000000000001 110.731 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -79.73 125.75 30.06 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.207 -0.664 . . . . 72.340000000000003 109.207 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -87.72 105.87 17.66 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.891 0.853 . . . . 75.209999999999994 110.761 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 53.1 t -69.73 152.54 44.53 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.846 -1.525 . . . . 37.710000000000001 109.468 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.0 m -74.33 104.56 5.13 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.518 -0.919 . . . . 60.420000000000002 108.518 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.6 t -113.21 140.51 32.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 121.753 0.787 . . . . 74.439999999999998 110.518 -175.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.6 tp -149.76 -64.94 0.22 Allowed 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 114.452 -1.249 . . . . 75.150000000000006 108.164 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -158.42 162.04 37.55 Favored 'General case' 0 C--N 1.249 -3.787 0 CA-C-N 112.743 -2.026 . . . . 71.450000000000003 106.828 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.463 ' CE1' ' HA3' ' A' ' 43' ' ' GLY . 57.5 t80 -32.52 -55.03 0.34 Allowed 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 116.004 1.853 . . . . 53.200000000000003 116.004 -173.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.26 -28.13 69.52 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 113.669 0.988 . . . . 73.310000000000002 113.669 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -39.75 15.21 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.367 -1.346 . . . . 74.430000000000007 107.367 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.45 ' O ' HG12 ' A' ' 113' ' ' ILE . 11.9 m-20 -65.91 -46.51 78.02 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.603 -1.18 . . . . 74.019999999999996 108.629 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 16.2 tt -69.6 -25.86 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.536 -0.756 . . . . 73.209999999999994 110.504 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -65.34 -49.92 67.56 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 107.025 -1.472 . . . . 60.340000000000003 107.025 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 3.4 t -63.29 -39.82 95.63 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.688 -1.142 . . . . 55.530000000000001 111.27 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 109' ' ' ASP . 41.4 mm -64.89 -46.91 90.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.048 -0.524 . . . . 74.019999999999996 111.368 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 92.6 t -69.99 -33.64 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 C-N-CA 120.184 -0.607 . . . . 73.310000000000002 110.173 -176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -66.4 -37.75 85.94 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.827 -0.624 . . . . 75.329999999999998 110.79 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.55 -41.03 80.36 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.064 0.459 . . . . 65.25 110.403 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.39 -45.7 95.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.671 -0.695 . . . . 74.239999999999995 109.186 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.6 -38.15 89.04 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 115.928 -0.578 . . . . 73.340000000000003 112.1 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -68.7 -40.21 80.13 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.602 -0.439 . . . . 72.310000000000002 110.632 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 42.8 t -59.22 -49.84 76.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.359 0.6 . . . . 73.230000000000004 109.433 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 10.5 mp -74.68 -14.84 60.79 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.603 -0.726 . . . . 74.129999999999995 112.427 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.26 -33.68 25.97 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 110.243 -0.28 . . . . 62.539999999999999 110.243 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.54 -34.84 46.89 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.311 0.577 . . . . 70.209999999999994 109.815 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.22 -136.35 51.03 Favored Glycine 0 CA--C 1.474 -2.521 0 CA-C-N 114.094 -1.412 . . . . 55.539999999999999 114.594 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.469 ' HB3' ' CD2' ' A' ' 13' ' ' HIS . 1.3 pm0 -73.66 38.72 0.1 Allowed 'General case' 0 C--N 1.262 -3.225 0 N-CA-C 114.934 1.457 . . . . 71.5 114.934 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 127' ' ' ASN . 48.5 mt -159.35 86.53 0.81 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 114.369 1.248 . . . . 74.140000000000001 114.369 -178.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.625 ' HB3' ' ND1' ' A' ' 22' ' ' HIS . 16.5 t-20 174.28 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.687 0.795 . . . . 74.420000000000002 110.78 166.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.0 t -78.12 125.52 29.48 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.596 -1.183 . . . . 75.319999999999993 110.497 -177.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -173.83 89.15 0.07 Allowed 'General case' 0 C--O 1.247 0.964 0 N-CA-C 113.648 0.981 . . . . 74.010000000000005 113.648 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.0 tp 65.58 87.61 0.12 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.597 1.159 . . . . 63.299999999999997 113.93 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -104.01 115.76 31.02 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.178 -1.045 . . . . 75.040000000000006 108.178 175.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -151.38 46.56 0.6 Allowed Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 109.156 -1.578 . . . . 62.149999999999999 109.156 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -159.84 95.43 1.61 Allowed Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-N 115.511 -0.345 . . . . 72.400000000000006 110.138 -174.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -79.83 117.26 3.58 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.655 2.237 . . . . 72.430000000000007 110.62 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 48.0 mm -124.55 103.11 32.11 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-O 120.715 0.293 . . . . 64.439999999999998 111.521 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -77.43 162.93 30.35 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.479 2.119 . . . . 62.140000000000001 110.756 172.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -122.38 95.51 46.93 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-O 120.837 0.351 . . . . 62.240000000000002 110.494 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -73.7 -22.54 17.79 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.892 2.395 . . . . 74.019999999999996 112.492 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 53.5 tp -111.79 122.44 47.81 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.66 0.743 . . . . 62.409999999999997 112.469 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.5 mp -117.3 79.61 1.37 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.586 -1.635 . . . . 75.530000000000001 106.586 169.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.56 -146.3 11.34 Favored Glycine 0 N--CA 1.42 -2.374 0 C-N-CA 120.303 -0.951 . . . . 71.430000000000007 110.894 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -163.79 167.18 21.21 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.761 -0.829 . . . . 71.040000000000006 108.761 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.471 ' OD1' ' HA ' ' A' ' 53' ' ' ASN . 6.7 p-10 -97.8 175.25 6.23 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.134 -1.062 . . . . 73.409999999999997 108.134 177.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.3 m -144.33 61.06 1.35 Allowed 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 107.332 -1.358 . . . . 75.239999999999995 107.332 171.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 89.7 m -130.93 131.03 44.21 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.47 -1.241 . . . . 63.140000000000001 110.002 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.76 161.97 27.29 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.29 -1.004 . . . . 72.430000000000007 108.29 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.8 m -71.73 92.51 1.2 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.221 0.534 . . . . 74.329999999999998 110.404 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.419 ' H ' ' HB1' ' A' ' 50' ' ' ALA . . . . . . . . 0 N--CA 1.426 -1.982 0 N-CA-C 109.246 -1.542 . . . . 75.129999999999995 109.246 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.441 ' SD ' ' HE1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.504 -0.793 0 CA-C-O 120.807 0.337 . . . . 70.129999999999995 111.189 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -110.27 164.28 12.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.669 0.747 . . . . 51.549999999999997 111.986 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 11.3 m-85 -120.04 140.28 51.23 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.527 -1.215 . . . . 74.319999999999993 111.152 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.623 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 28.7 t70 -101.08 102.58 13.57 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 104.855 -2.276 . . . . 63.049999999999997 104.855 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.78 117.76 32.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.325 -0.852 . . . . 73.239999999999995 109.442 -172.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.19 116.72 52.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.028 -1.101 . . . . 74.519999999999996 108.028 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.3 tt -118.69 120.75 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 121.396 0.617 . . . . 74.25 109.732 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.436 HG12 ' HB3' ' A' ' 26' ' ' PRO . 5.5 mt -112.49 100.8 51.14 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 115.543 -0.753 . . . . 65.439999999999998 108.98 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.594 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 1.4 Cg_endo -85.53 120.53 2.11 Favored 'Trans proline' 0 N--CA 1.436 -1.87 0 N-CA-C 107.769 -1.666 . . . . 75.409999999999997 107.769 171.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -144.61 129.7 18.56 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 120.922 0.391 . . . . 70.340000000000003 110.431 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.511 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 37.5 m -73.08 120.39 18.63 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.65 -0.5 . . . . 74.439999999999998 109.65 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 2.7 p90 -61.52 110.89 1.6 Allowed 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 113.967 1.099 . . . . 72.109999999999999 113.967 -174.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -143.84 106.26 4.41 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 114.854 -1.066 . . . . 71.200000000000003 110.114 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -68.84 122.24 18.2 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.878 -1.897 . . . . 74.310000000000002 105.878 173.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.48 103.69 0.55 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 124.585 1.178 . . . . 73.349999999999994 109.77 -172.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 17' ' ' LYS . 14.0 t70 -89.1 -158.15 0.49 Allowed 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 114.02 -1.445 . . . . 55.420000000000002 110.492 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.472 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 23.3 tptm -72.46 -45.34 59.99 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.741 0.816 . . . . 74.150000000000006 111.694 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -132.62 -51.46 0.92 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.584 0.707 . . . . 73.209999999999994 110.249 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -96.36 -177.83 4.09 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 114.489 -1.232 . . . . 63.43 110.612 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 86.9 mtp 70.75 80.13 0.17 Allowed 'General case' 0 C--N 1.313 -0.99 0 O-C-N 124.572 1.17 . . . . 37.140000000000001 109.977 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.423 ' OE1' ' HA ' ' A' ' 127' ' ' ASN . 2.2 tm-20 -168.05 121.24 0.89 Allowed 'General case' 0 N--CA 1.403 -2.792 0 N-CA-C 105.083 -2.192 . . . . 70.530000000000001 105.083 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.441 ' NE2' ' HB3' ' A' ' 123' ' ' LYS . 18.5 t60 -168.42 84.28 0.17 Allowed 'General case' 0 C--N 1.282 -2.34 0 O-C-N 124.57 1.169 . . . . 75.230000000000004 110.334 165.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 131' ' ' GLU . 46.5 mm -103.17 136.05 37.72 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 N-CA-C 107.165 -1.42 . . . . 74.450000000000003 107.165 175.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 79.0 m -107.25 145.49 31.29 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 110.126 -0.324 . . . . 74.439999999999998 110.126 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.49 136.27 73.12 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 123.424 2.749 . . . . 71.340000000000003 112.873 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.436 ' HB3' HG12 ' A' ' 8' ' ' ILE . 74.5 Cg_endo -73.05 140.66 31.64 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.887 2.391 . . . . 63.340000000000003 112.394 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 99' ' ' ASN . 53.8 mtt -98.12 139.56 33.74 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-N 116.233 -0.44 . . . . 74.319999999999993 109.84 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.6 t -130.12 116.7 37.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 116.524 -0.307 . . . . 71.099999999999994 110.448 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.25 102.39 9.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 107.188 -1.412 . . . . 63.420000000000002 107.188 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.623 ' CA ' ' HA ' ' A' ' 4' ' ' ASP . . . -121.85 81.7 0.34 Allowed Glycine 0 N--CA 1.42 -2.372 0 C-N-CA 119.056 -1.545 . . . . 53.329999999999998 115.262 -175.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -153.64 15.82 0.51 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.24 -0.98 . . . . 72.430000000000007 110.803 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -102.07 136.43 41.91 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.745 -0.835 . . . . 72.430000000000007 108.745 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 p -74.05 168.31 19.78 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 106.595 -1.632 . . . . 73.129999999999995 106.595 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.545 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 73.9 t80 -61.62 -38.69 88.57 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 118.425 0.557 . . . . 70.340000000000003 110.735 -174.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -59.65 -49.26 78.44 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.486 -0.779 . . . . 71.129999999999995 111.209 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.1 mt -70.83 -38.74 73.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.647 -0.706 . . . . 72.5 109.308 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.94 -41.64 91.06 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.635 -0.711 . . . . 74.430000000000007 110.703 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 11.7 tpt -68.94 -40.83 78.73 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.839 -0.43 . . . . 52.329999999999998 109.839 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -74.21 -32.71 63.14 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 112.744 0.646 . . . . 70.109999999999999 112.744 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.55 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -74.68 -42.66 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.601 -0.889 . . . . 55.229999999999997 108.601 178.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.4 t -69.75 -38.78 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 120.956 -0.298 . . . . 71.109999999999999 110.7 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.547 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -73.96 -26.75 60.64 Favored 'General case' 0 C--O 1.201 -1.479 0 C-N-CA 119.8 -0.76 . . . . 73.409999999999997 110.474 177.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.2 -46.33 80.39 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.133 -1.187 . . . . 54.25 110.133 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 40' ' ' ILE . 96.2 t -58.24 -45.07 89.11 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 N-CA-C 108.523 -0.917 . . . . 75.310000000000002 108.523 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.547 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 8.3 t70 -50.07 -49.27 51.89 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.646 1.578 . . . . 74.209999999999994 111.457 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 42' ' ' ASN . 45.4 mtt180 -67.36 -36.64 81.79 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.906 -1.043 . . . . 75.239999999999995 109.717 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.72 -38.85 67.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 123.358 0.411 . . . . 61.310000000000002 110.695 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 44' ' ' VAL . 70.3 mt -63.99 -46.1 94.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 C-N-CA 122.471 0.308 . . . . 52.310000000000002 110.614 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -78.68 -14.35 59.34 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.83 -0.748 . . . . 65.420000000000002 110.819 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 147' ' ' THR . . . -82.5 -49.27 10.1 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.948 -0.569 . . . . 73.209999999999994 111.126 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -91.8 -16.17 27.18 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 113.222 0.823 . . . . 74.219999999999999 113.222 -171.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -129.09 -177.26 4.15 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.583 0.706 . . . . 74.25 110.281 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 26.2 t-20 -109.81 108.23 18.48 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 104.352 -2.462 . . . . 73.120000000000005 104.352 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.66 157.97 45.27 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 115.963 -0.562 . . . . 71.239999999999995 112.202 -172.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 t -129.01 120.02 25.29 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.6 -1.63 . . . . 75.129999999999995 106.6 171.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.9 p -100.62 124.04 53.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.233 0.54 . . . . 73.340000000000003 110.612 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -122.73 146.92 47.07 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.791 -0.818 . . . . 75.239999999999995 108.791 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -119.68 127.67 53.1 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.955 0.883 . . . . 73.409999999999997 111.791 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.29 176.78 5.3 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.14 -1.43 . . . . 72.400000000000006 107.14 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -111.99 136.84 50.81 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.681 -0.859 . . . . 74.120000000000005 108.681 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -84.17 176.69 51.77 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 115.828 -0.624 . . . . 54.549999999999997 112.874 -175.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -74.68 133.04 42.13 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 123.328 0.651 . . . . 74.530000000000001 111.84 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t70 46.31 -84.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 126.298 1.839 . . . . 72.329999999999998 114.973 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.5 p -97.49 -1.6 43.78 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 113.556 0.947 . . . . 75.530000000000001 113.556 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 13.4 m-20 -76.96 117.78 18.89 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.659 -1.608 . . . . 75.310000000000002 106.659 172.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.0 t -85.31 -31.3 6.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-O 121.264 0.554 . . . . 72.25 112.235 -173.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 63.2 tp -148.67 133.91 18.38 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 109.409 -0.589 . . . . 74.25 109.409 -176.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.449 ' CE2' ' HD3' ' A' ' 85' ' ' LYS . 1.1 t80 -129.91 105.44 7.99 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.261 -1.385 . . . . 75.329999999999998 107.261 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -107.69 125.38 51.3 Favored 'General case' 0 C--N 1.281 -2.396 0 C-N-CA 120.191 -0.604 . . . . 74.340000000000003 111.732 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -103.0 115.14 30.03 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 125.201 1.4 . . . . 64.019999999999996 108.476 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 75.3 m-85 -102.56 118.04 36.0 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.606 -0.516 . . . . 74.099999999999994 109.606 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.0 m -87.87 123.15 32.33 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.804 -1.184 . . . . 71.25 107.804 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.404 HD12 HG22 ' A' ' 48' ' ' ILE . 4.3 mm? -111.14 138.46 47.55 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.972 0.909 . . . . 64.310000000000002 111.985 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 2.0 tm-20 -151.16 83.0 1.32 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.887 -1.051 . . . . 74.519999999999996 108.899 170.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.9 70.55 9.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.848 -0.797 . . . . 52.509999999999998 108.848 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 45.55 71.53 0.27 Allowed 'General case' 0 C--O 1.244 0.783 0 C-N-CA 125.255 1.422 . . . . 72.319999999999993 111.542 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.15 -24.1 33.08 Favored Glycine 0 C--N 1.304 -1.226 0 CA-C-N 115.466 -0.788 . . . . 45.32 112.207 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 99.0 mttt -88.53 103.13 15.6 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.417 -0.957 . . . . 71.420000000000002 108.417 175.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -106.78 146.96 30.24 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 120.307 -0.557 . . . . 72.420000000000002 110.515 -175.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . 177.72 177.42 46.52 Favored Glycine 0 CA--C 1.48 -2.148 0 C-N-CA 120.202 -0.999 . . . . 60.530000000000001 112.528 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 32.2 mt -132.22 145.19 35.09 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 106.796 -1.557 . . . . 73.019999999999996 106.796 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 100.0 t -122.5 109.22 23.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 108.208 -1.034 . . . . 73.319999999999993 108.208 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -95.05 106.54 18.55 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 123.868 0.867 . . . . 74.200000000000003 110.381 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.3 t -107.96 112.48 40.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.028 -0.73 . . . . 71.109999999999999 109.028 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.449 ' HD3' ' CE2' ' A' ' 68' ' ' TYR . 58.0 pttt -116.66 135.08 54.08 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 120.906 0.384 . . . . 63.030000000000001 110.867 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.3 mt -106.27 105.69 15.84 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.255 -1.387 . . . . 70.319999999999993 107.255 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 33.8 ttt85 -98.02 118.29 34.28 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.366 -0.605 . . . . 73.510000000000005 109.366 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -70.54 104.01 2.66 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.232 -0.655 . . . . 74.530000000000001 109.232 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.2 tt -78.44 111.26 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 CA-C-O 122.415 1.102 . . . . 63.240000000000002 108.989 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.4 t -138.77 -177.87 5.06 Favored 'General case' 0 N--CA 1.401 -2.903 0 N-CA-C 105.989 -1.856 . . . . 73.049999999999997 105.989 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -75.12 -21.74 58.67 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 118.799 0.727 . . . . 75.420000000000002 110.691 -173.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -96.74 11.37 35.8 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.592 -1.185 . . . . 73.219999999999999 109.686 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 41.3 t -139.92 116.46 8.16 Favored Pre-proline 0 C--N 1.319 -0.739 0 O-C-N 121.177 -0.952 . . . . 63.549999999999997 112.096 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -79.61 131.23 9.23 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.756 2.304 . . . . 71.030000000000001 110.876 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.14 164.15 36.18 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 123.108 2.538 . . . . 75.430000000000007 111.648 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.89 156.82 3.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.726 -0.842 . . . . 71.439999999999998 108.726 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -107.93 140.68 40.7 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.449 -0.945 . . . . 71.400000000000006 108.449 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.58 -171.29 40.12 Favored Glycine 0 CA--C 1.471 -2.67 0 N-CA-C 109.064 -1.614 . . . . 75.310000000000002 109.064 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 27' ' ' MET . 6.9 t-20 -63.63 103.78 0.58 Allowed 'General case' 0 N--CA 1.409 -2.486 0 C-N-CA 123.814 0.846 . . . . 65.010000000000005 110.018 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -89.32 103.08 15.74 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.141 -1.059 . . . . 72.230000000000004 108.141 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 42.6 t -71.19 175.2 5.49 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.054 -0.975 . . . . 72.219999999999999 111.136 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.9 p -60.72 110.3 1.27 Allowed 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.245 1.018 . . . . 61.109999999999999 110.949 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.22 139.12 17.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.884 -0.784 . . . . 64.310000000000002 108.884 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.542 ' HG ' ' H ' ' A' ' 105' ' ' GLU . 15.8 tp -178.72 -159.47 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 104.53 -2.396 . . . . 73.129999999999995 104.53 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.542 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 43.0 mt-10 -81.39 171.61 14.55 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 118.614 0.643 . . . . 75.120000000000005 111.259 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.405 ' O ' HG21 ' A' ' 110' ' ' ILE . 1.2 t80 -36.13 -48.5 0.62 Allowed 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 127.59 2.356 . . . . 64.299999999999997 113.351 -173.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.69 -28.5 68.67 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 123.85 0.86 . . . . 74.439999999999998 112.449 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.4 ' HA ' ' NE ' ' A' ' 108' ' ' ARG . 0.8 OUTLIER -87.38 -40.83 14.07 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.348 -0.541 . . . . 73.329999999999998 110.279 -178.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.576 ' O ' HG12 ' A' ' 113' ' ' ILE 0.328 18.5 p-10 -80.52 -26.01 38.37 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 119.377 -0.929 . . . . 61.140000000000001 112.211 -174.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.405 HG21 ' O ' ' A' ' 106' ' ' PHE . 8.6 tp -64.55 -38.97 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 109.457 -0.572 . . . . 74.430000000000007 109.457 173.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.41 -43.32 86.09 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.311 -0.626 . . . . 54.100000000000001 109.311 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 42.9 t -58.5 -44.32 89.4 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.816 -1.084 . . . . 74.120000000000005 111.612 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 109' ' ' ASP . 43.4 mm -65.25 -41.39 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 120.923 -0.311 . . . . 74.239999999999995 110.591 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.87 -42.87 97.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.544 -0.539 . . . . 64.340000000000003 109.544 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -61.47 -41.77 97.75 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.875 -0.602 . . . . 55.200000000000003 111.534 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.63 97.35 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 123.422 0.451 . . . . 54.210000000000001 111.444 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.3 mt -67.89 -44.79 85.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.165 -0.68 . . . . 72.329999999999998 109.165 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.92 -33.97 77.3 Favored 'General case' 0 C--O 1.211 -0.928 0 CA-C-N 115.702 -0.681 . . . . 75.329999999999998 111.64 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -69.97 -43.36 71.65 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.331 0.586 . . . . 72.310000000000002 110.64 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 5.3 t -70.22 -41.54 73.48 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.402 0.62 . . . . 62.539999999999999 109.594 -176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.5 mp -78.13 -15.7 58.62 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.503 -0.771 . . . . 74.200000000000003 111.77 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.41 -38.25 22.17 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 121.034 -0.266 . . . . 51.100000000000001 111.031 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.441 ' HB3' ' NE2' ' A' ' 22' ' ' HIS . 23.1 tptm -62.79 -47.52 83.14 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.264 0.554 . . . . 64.340000000000003 110.103 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.64 -164.21 53.05 Favored Glycine 0 C--N 1.286 -2.229 0 CA-C-N 114.326 -1.306 . . . . 73.140000000000001 114.341 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -63.92 104.78 0.74 Allowed 'General case' 0 C--O 1.246 0.907 0 C-N-CA 124.057 0.943 . . . . 72.420000000000002 110.258 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -175.05 107.62 0.1 Allowed 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 106.434 -1.691 . . . . 64.230000000000004 106.434 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.423 ' HA ' ' OE1' ' A' ' 21' ' ' GLU . 3.0 t-20 -54.41 112.07 0.92 Allowed 'General case' 0 N--CA 1.469 0.521 0 O-C-N 124.154 0.908 . . . . 64.450000000000003 109.235 177.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 22.8 t -142.13 16.4 2.08 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.868 0.842 . . . . 43.509999999999998 110.846 -173.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -170.61 174.75 4.91 Favored 'General case' 0 C--N 1.271 -2.838 0 N-CA-C 107.383 -1.34 . . . . 72.140000000000001 107.383 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.2 tp -129.19 84.76 2.25 Favored 'General case' 0 N--CA 1.413 -2.288 0 O-C-N 121.677 -0.639 . . . . 74.140000000000001 109.942 176.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 18.4 mm-40 -116.0 85.86 2.37 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.173 -0.921 . . . . 72.549999999999997 110.415 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.54 62.43 3.08 Favored Glycine 0 N--CA 1.426 -1.981 0 CA-C-N 115.377 -0.828 . . . . 60.240000000000002 112.323 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -104.28 121.05 48.8 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 108.915 -0.772 . . . . 73.219999999999999 108.915 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.53 131.19 22.47 Favored 'Trans proline' 0 C--O 1.244 0.802 0 C-N-CA 122.493 2.129 . . . . 73.439999999999998 112.336 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.6 mm -126.14 102.32 27.63 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 108.582 -0.895 . . . . 75.319999999999993 108.582 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.58 132.09 18.37 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.356 2.038 . . . . 62.329999999999998 111.098 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 60.66 85.57 0.18 Allowed Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 124.094 0.957 . . . . 74.010000000000005 112.34 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -72.59 -27.06 15.86 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.251 1.967 . . . . 73.219999999999999 110.775 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.6 pp -131.63 132.53 44.11 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 107.604 -1.258 . . . . 73.349999999999994 107.604 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 24.6 tp -151.23 133.66 15.46 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.324 -0.991 . . . . 53.420000000000002 108.324 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 61.64 -160.34 29.17 Favored Glycine 0 C--O 1.254 1.398 0 O-C-N 123.985 0.803 . . . . 73.420000000000002 113.26 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 47.5 tp -161.23 79.98 0.6 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.433 -0.58 . . . . 52.25 109.433 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -97.59 91.1 5.26 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.627 -0.879 . . . . 74.420000000000002 108.627 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.1 m -107.89 74.49 0.95 Allowed 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 108.895 -0.78 . . . . 75.200000000000003 108.895 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 18.2 p -94.69 133.84 37.92 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.723 -1.126 . . . . 72.140000000000001 108.213 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 145' ' ' THR . 25.2 mmm180 78.36 158.8 0.18 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.944 0.897 . . . . 72.510000000000005 111.962 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 10.2 t -162.42 157.79 22.98 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 105.507 -2.034 . . . . 75.109999999999999 105.507 174.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.115 0 N-CA-C 110.026 -1.23 . . . . 51.219999999999999 110.026 -179.69 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mmm . . . . . 0 CA--C 1.494 -1.211 0 N-CA-C 111.965 0.357 . . . . 75.200000000000003 111.965 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -101.71 141.38 34.66 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.26 -1.015 . . . . 71.219999999999999 108.26 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.534 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 56.0 m-85 -118.06 142.79 47.03 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.64 -0.504 . . . . 74.109999999999999 109.64 174.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.495 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 32.0 t70 -104.31 115.58 30.64 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 124.475 1.11 . . . . 73.239999999999995 109.627 -172.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.82 117.32 48.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.917 -0.489 . . . . 45.530000000000001 109.861 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.52 124.27 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-O 121.357 0.599 . . . . 74.109999999999999 109.409 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.477 HG23 ' HB2' ' A' ' 27' ' ' MET . 7.1 tt -123.41 118.27 53.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-O 121.556 0.693 . . . . 74.120000000000005 111.062 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.437 HG12 ' HB3' ' A' ' 26' ' ' PRO . 61.9 mt -106.61 111.77 63.86 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 115.267 -0.878 . . . . 71.030000000000001 109.838 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.508 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 3.3 Cg_endo -87.34 123.79 1.94 Allowed 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.029 1.819 . . . . 72.219999999999999 109.205 171.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -142.74 119.35 11.07 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.484 0.659 . . . . 72.200000000000003 111.076 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 22' ' ' HIS . 49.4 m -77.36 116.65 18.14 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.233 -0.44 . . . . 70.209999999999994 110.298 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.679 ' CE1' ' HB2' ' A' ' 79' ' ' LYS . 1.8 p90 -65.46 123.99 21.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.65 0.738 . . . . 75.219999999999999 112.035 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 39.4 m80 -139.71 146.39 39.54 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.951 -1.022 . . . . 73.5 110.299 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -82.13 104.89 12.79 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-O 122.443 1.116 . . . . 72.409999999999997 109.927 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -67.47 100.7 0.88 Allowed 'General case' 0 N--CA 1.398 -3.036 0 CA-C-N 113.201 -1.818 . . . . 75.219999999999999 109.165 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -87.31 -94.48 0.09 Allowed 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.474 -0.785 . . . . 72.129999999999995 111.885 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -112.77 -57.8 2.24 Favored 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 119.32 -0.952 . . . . 73.349999999999994 112.729 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -121.98 -26.53 4.76 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 118.975 -1.09 . . . . 62.340000000000003 112.901 -169.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -137.34 169.9 17.0 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.333 -0.617 . . . . 74.5 109.333 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.405 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 64.2 mtm 82.19 70.85 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 126.159 1.783 . . . . 44.439999999999998 111.226 -176.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -161.76 96.33 1.02 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 105.046 -2.205 . . . . 74.25 105.046 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 11' ' ' SER . 39.1 t60 -114.15 89.91 3.21 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 119.24 -0.984 . . . . 73.299999999999997 112.041 -171.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mm -100.99 131.12 49.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 106.529 -1.656 . . . . 71.129999999999995 106.529 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 71.4 m -107.68 130.34 22.95 Favored Pre-proline 0 C--N 1.292 -1.918 0 C-N-CA 119.927 -0.709 . . . . 72.129999999999995 109.099 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -42.62 134.43 5.04 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 124.037 3.158 . . . . 52.210000000000001 113.915 -177.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.437 ' HB3' HG12 ' A' ' 8' ' ' ILE . 15.7 Cg_endo -59.29 136.77 74.46 Favored 'Trans proline' 0 C--O 1.256 1.393 0 C-N-CA 123.477 2.785 . . . . 75.409999999999997 114.073 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.514 ' HA ' ' O ' ' A' ' 99' ' ' ASN . 24.8 mmt -96.52 131.45 43.11 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 105.401 -2.074 . . . . 73.420000000000002 105.401 172.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.6 t -126.17 129.58 72.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 120.228 -0.589 . . . . 65.239999999999995 110.256 -175.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.3 mm -136.04 101.19 2.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 106.985 -1.487 . . . . 54.409999999999997 106.985 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.495 ' CA ' ' HA ' ' A' ' 4' ' ' ASP . . . -120.01 82.42 0.34 Allowed Glycine 0 CA--C 1.488 -1.604 0 C-N-CA 120.078 -1.058 . . . . 63.119999999999997 112.783 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -158.74 26.21 0.22 Allowed 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.982 -0.609 . . . . 75.209999999999994 111.46 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.486 HH22 HG11 ' A' ' 103' ' ' VAL . 21.3 mmt85 -118.04 141.97 47.9 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 107.828 -1.175 . . . . 74.230000000000004 107.828 -174.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.8 p -75.86 172.6 12.42 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 118.842 0.746 . . . . 74.019999999999996 109.481 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.534 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 60.1 t80 -55.19 -47.53 75.12 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.35 0.595 . . . . 72.430000000000007 112.139 -174.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.02 -40.01 78.9 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.343 -0.844 . . . . 63.329999999999998 111.197 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.72 -33.33 43.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.248 -0.433 . . . . 75.010000000000005 110.218 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.416 ' O ' HG22 ' A' ' 40' ' ' ILE . . . -65.28 -44.8 86.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.408 -0.36 . . . . 73.120000000000005 110.59 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.6 mtm -73.08 -33.34 65.57 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 118.912 -1.115 . . . . 74.209999999999994 111.06 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.11 -44.0 85.57 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.069 -0.514 . . . . 60.030000000000001 110.415 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 37' ' ' ALA . 8.5 tp -65.46 -38.92 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 109.807 -0.442 . . . . 71.219999999999999 109.807 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.8 t -69.29 -39.94 79.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 CA-C-N 116.213 -0.449 . . . . 74.030000000000001 110.196 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -67.84 -28.25 67.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.127 0.489 . . . . 72.019999999999996 110.183 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.43 -47.36 63.42 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.296 -1.121 . . . . 71.409999999999997 110.296 175.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 40' ' ' ILE . 92.9 t -62.7 -41.96 94.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.452 -0.573 . . . . 74.430000000000007 109.452 177.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -53.38 -53.05 56.71 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 125.265 1.426 . . . . 72.310000000000002 110.565 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.421 ' HA ' ' CD ' ' A' ' 49' ' ' LYS . 61.9 mtm180 -71.1 -23.77 62.17 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.511 -0.768 . . . . 75.219999999999999 112.523 -175.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 43' ' ' GLY . 94.3 t -78.2 -44.87 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 C-N-CA 120.522 -0.471 . . . . 70.239999999999995 110.47 175.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.9 mt -73.17 -33.77 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 120.537 -0.465 . . . . 72.439999999999998 111.456 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' CD ' ' HA ' ' A' ' 46' ' ' ARG . 13.3 ptmt -74.4 -16.22 60.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.391 0.615 . . . . 72.540000000000006 110.455 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 144' ' ' SER . . . -95.7 -49.79 5.21 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 115.318 -0.856 . . . . 64.209999999999994 111.081 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 t -77.07 -22.53 52.7 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 123.528 0.731 . . . . 64.319999999999993 112.649 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -127.7 -172.75 2.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.608 0.718 . . . . 71.310000000000002 110.8 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 18.6 t-20 -105.21 89.68 3.2 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 104.326 -2.472 . . . . 74.430000000000007 104.326 172.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -108.13 135.89 48.72 Favored 'General case' 0 N--CA 1.407 -2.599 0 CA-C-N 115.169 -0.923 . . . . 72.349999999999994 112.029 -172.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.5 m -115.6 110.73 19.62 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 106.171 -1.789 . . . . 54.149999999999999 106.171 172.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.85 118.72 46.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.54 -0.541 . . . . 72.019999999999996 109.54 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.541 ' CG ' ' HB2' ' A' ' 70' ' ' LYS . 9.2 pt-20 -120.88 122.32 40.0 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.123 -0.695 . . . . 73.430000000000007 109.123 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.402 ' HG2' ' HG2' ' A' ' 69' ' ' ARG . 42.7 mt-10 -95.28 130.44 42.04 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.814 -0.63 . . . . 75.140000000000001 111.37 -175.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.2 mp -125.52 176.5 6.8 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.437 -0.801 . . . . 72.209999999999994 109.324 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -105.27 139.14 40.36 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-O 121.198 0.523 . . . . 72.120000000000005 109.846 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.26 176.44 41.96 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 110.514 -1.034 . . . . 52.229999999999997 110.514 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.527 ' N ' ' HB2' ' A' ' 65' ' ' ASP . 26.7 mm-40 -65.51 -176.17 0.32 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 122.102 0.953 . . . . 72.319999999999993 111.67 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.69 -34.93 78.94 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.688 -1.142 . . . . 63.350000000000001 110.084 172.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.9 t -77.1 -22.06 53.31 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.591 -1.186 . . . . 64.519999999999996 108.997 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.527 ' HB2' ' N ' ' A' ' 62' ' ' GLU . 67.3 m-20 -93.53 172.46 8.25 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 109.024 -0.732 . . . . 75.530000000000001 109.024 177.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.1 t -117.7 -43.27 2.97 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 CA-C-O 121.513 0.673 . . . . 74.430000000000007 110.382 174.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.1 tp -157.34 149.1 22.28 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.73 -0.668 . . . . 65.230000000000004 109.724 -172.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.26 135.36 47.27 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.595 -0.891 . . . . 75.200000000000003 108.595 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.402 ' HG2' ' HG2' ' A' ' 58' ' ' GLU . 88.6 mtt180 -132.27 129.42 39.57 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.227 -0.296 . . . . 75.129999999999995 110.76 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.541 ' HB2' ' CG ' ' A' ' 57' ' ' GLU . 6.4 mtpm? -105.55 116.56 32.15 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 105.615 -1.995 . . . . 73.430000000000007 105.615 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -101.54 106.08 17.13 Favored 'General case' 0 C--N 1.263 -3.184 0 N-CA-C 107.678 -1.23 . . . . 74.120000000000005 107.678 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.3 m -91.93 112.44 24.37 Favored 'General case' 0 C--N 1.276 -2.628 0 N-CA-C 107.672 -1.233 . . . . 65.219999999999999 107.672 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.83 149.39 37.13 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.286 0.565 . . . . 65.340000000000003 111.023 -173.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.549 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 42.7 tt0 -150.25 98.26 2.65 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.991 -1.004 . . . . 74.439999999999998 109.8 168.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -105.91 88.66 2.86 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 115.872 -0.604 . . . . 65.239999999999995 109.674 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.295 5.7 pt-20 36.74 74.29 0.08 Allowed 'General case' 0 C--O 1.243 0.749 0 C-N-CA 125.825 1.65 . . . . 70.239999999999995 114.974 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.37 -23.91 34.37 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 113.604 -1.635 . . . . 71.219999999999999 112.47 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 57.9 mtmt -95.12 94.74 8.11 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 122.368 -0.489 . . . . 75.329999999999998 109.701 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.679 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 2.3 ptpp? -113.54 124.0 51.34 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.242 -0.89 . . . . 73.129999999999995 111.211 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.04 172.49 45.16 Favored Glycine 0 CA--C 1.491 -1.411 0 C-N-CA 120.967 -0.635 . . . . 61.130000000000003 112.0 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.9 mt -121.65 145.99 27.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.552 -0.907 . . . . 61.350000000000001 108.552 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 95.6 t -119.94 110.34 28.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 108.512 -0.921 . . . . 63.420000000000002 108.512 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.515 ' CD2' ' HG2' ' A' ' 70' ' ' LYS . 33.0 m170 -94.94 107.85 19.89 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.816 -0.629 . . . . 73.230000000000004 110.196 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.14 118.49 53.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 115.792 -0.64 . . . . 74.0 109.565 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -111.82 142.39 44.25 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.203 -0.666 . . . . 65.430000000000007 109.203 173.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.5 mt -107.37 123.94 49.1 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 103.549 -2.759 . . . . 54.43 103.549 172.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 41.6 mtp-105 -112.84 155.92 23.81 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 109.267 -0.642 . . . . 74.25 109.267 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -98.06 105.49 17.64 Favored 'General case' 0 C--N 1.282 -2.346 0 C-N-CA 120.327 -0.549 . . . . 64.329999999999998 110.485 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.458 ' C ' ' HG1' ' A' ' 90' ' ' THR . 1.8 tt -82.81 110.17 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 107.749 -1.204 . . . . 71.209999999999994 107.749 174.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.458 ' HG1' ' C ' ' A' ' 89' ' ' ILE . 2.2 m -145.85 -175.39 4.72 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 105.045 -2.206 . . . . 62.530000000000001 105.045 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -15.9 63.04 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 120.087 1.312 . . . . 71.329999999999998 110.458 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.07 -23.95 38.12 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.949 -1.023 . . . . 71.109999999999999 111.803 175.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 40.8 m -145.35 117.61 5.23 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 112.472 0.545 . . . . 64.439999999999998 112.472 -176.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.59 158.49 47.4 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 122.622 2.215 . . . . 64.310000000000002 110.499 175.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.3 160.37 49.03 Favored 'Trans proline' 0 C--O 1.255 1.337 0 C-N-CA 122.789 2.326 . . . . 74.030000000000001 110.65 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 t -82.93 149.46 4.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 107.24 -1.393 . . . . 53.509999999999998 107.24 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -112.38 112.81 24.65 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 106.75 -1.574 . . . . 70.209999999999994 106.75 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -151.51 -157.62 7.97 Favored Glycine 0 CA--C 1.461 -3.309 0 C-N-CA 120.165 -1.017 . . . . 62.439999999999998 112.018 -174.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 27' ' ' MET . 35.5 m-80 -76.58 104.23 6.98 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.798 -0.816 . . . . 71.209999999999994 108.798 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -83.11 112.32 19.7 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-O 121.651 0.739 . . . . 75.349999999999994 109.387 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.8 t -70.29 153.02 43.53 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.914 -1.513 . . . . 74.540000000000006 106.914 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.424 ' N ' ' SG ' ' A' ' 112' ' ' CYS . 15.5 m -69.84 77.63 0.46 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.426 1.107 . . . . 73.129999999999995 109.906 178.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.486 HG11 HH22 ' A' ' 32' ' ' ARG . 76.9 t -124.57 149.45 28.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 C-N-CA 125.429 1.491 . . . . 75.040000000000006 108.635 -173.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.2 mt -161.15 -82.61 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 125.625 1.57 . . . . 74.519999999999996 109.296 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -98.4 150.37 21.68 Favored 'General case' 0 C--N 1.262 -3.197 0 CA-C-N 114.109 -1.405 . . . . 75.340000000000003 108.948 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.439 ' HA ' ' HB3' ' A' ' 109' ' ' ASP . 74.6 t80 -46.34 -44.05 16.52 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.365 1.246 . . . . 72.519999999999996 114.365 -172.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -62.55 -35.61 79.99 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 112.587 0.588 . . . . 72.319999999999993 112.587 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -90.82 -30.7 16.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.441 0.639 . . . . 72.010000000000005 109.571 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.439 ' HB3' ' HA ' ' A' ' 106' ' ' PHE . 7.9 t0 -55.74 -55.15 35.7 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 125.731 1.613 . . . . 65.540000000000006 109.642 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.6 tp -59.78 -38.04 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 O-C-N 123.966 0.792 . . . . 63.049999999999997 110.865 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 40.3 mt-10 -69.5 -38.46 77.62 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 120.479 -0.488 . . . . 71.310000000000002 111.492 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 102' ' ' SER . 10.0 t -65.91 -40.77 91.78 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.0 -0.68 . . . . 72.209999999999994 109.36 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 117' ' ' ILE . 49.4 mm -64.41 -46.54 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 115.521 -0.763 . . . . 72.239999999999995 110.223 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 72.7 t -63.91 -41.88 93.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.52 -0.309 . . . . 64.030000000000001 110.732 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 111' ' ' GLU . 29.4 mtpp -67.19 -30.33 70.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 111.7 0.259 . . . . 75.230000000000004 111.7 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.37 -40.8 67.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.018 0.437 . . . . 53.329999999999998 110.298 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.557 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 83.0 mt -66.05 -45.78 89.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.137 -0.69 . . . . 73.409999999999997 109.137 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -57.57 -42.32 82.84 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.842 -0.617 . . . . 74.549999999999997 111.576 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -65.9 -41.9 90.91 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.539 -0.755 . . . . 74.400000000000006 110.288 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 15.1 t -70.17 -39.68 75.13 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.826 -0.435 . . . . 55.210000000000001 109.826 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 117' ' ' ILE . 61.4 mt -72.76 -37.39 67.68 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 116.423 -0.353 . . . . 73.420000000000002 111.359 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.89 -14.22 51.62 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 112.565 0.58 . . . . 61.340000000000003 112.565 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -66.63 -21.62 66.12 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.288 0.566 . . . . 74.439999999999998 112.432 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.88 -161.54 47.81 Favored Glycine 0 C--N 1.296 -1.681 0 CA-C-N 115.617 -0.72 . . . . 53.200000000000003 114.894 173.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.77 83.43 3.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.79 1.281 . . . . 65.099999999999994 112.498 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -128.17 123.26 33.9 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.544 -2.021 . . . . 73.430000000000007 105.544 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -76.13 126.04 30.25 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.429 -0.908 . . . . 73.140000000000001 111.753 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.3 t -135.82 97.39 3.63 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 105.714 -1.958 . . . . 72.200000000000003 105.714 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -90.7 103.78 16.44 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 114.628 -1.169 . . . . 75.019999999999996 110.783 -171.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.3 tp -149.08 172.9 14.02 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 107.713 -1.218 . . . . 65.030000000000001 107.713 -176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -70.71 109.65 5.06 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.186 0.517 . . . . 74.239999999999995 112.219 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -144.09 -161.9 9.17 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 107.076 -2.41 . . . . 63.420000000000002 107.076 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -163.81 75.62 1.73 Allowed Pre-proline 0 C--N 1.306 -1.315 0 CA-C-N 118.108 0.954 . . . . 75.219999999999999 109.927 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.95 92.94 0.33 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.841 2.361 . . . . 63.109999999999999 113.352 -176.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.442 ' HB ' ' HE3' ' A' ' 70' ' ' LYS . 47.5 mm -115.99 102.9 53.84 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 107.542 -1.281 . . . . 73.540000000000006 107.542 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.82 170.79 9.55 Favored 'Trans proline' 0 C--O 1.252 1.212 0 C-N-CA 123.744 2.963 . . . . 55.530000000000001 114.11 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.442 ' O ' HD23 ' A' ' 139' ' ' LEU . 21.8 t-20 -137.11 150.26 68.76 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 105.181 -2.155 . . . . 72.519999999999996 105.181 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.5 -0.06 6.96 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 122.253 1.969 . . . . 72.109999999999999 113.24 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 137' ' ' ASN . 3.4 mm? 71.82 113.09 0.06 Allowed 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.221 1.409 . . . . 72.329999999999998 112.602 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -138.01 98.32 3.61 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.27 -1.382 . . . . 75.019999999999996 107.27 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -170.47 175.79 44.24 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 109.722 -1.351 . . . . 75.420000000000002 109.722 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.4 tp -161.06 136.79 8.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 117.517 0.659 . . . . 70.230000000000004 109.348 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.44 110.58 0.8 Allowed 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 123.932 0.77 . . . . 74.340000000000003 110.479 176.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 7.6 m -115.42 84.67 2.13 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 106.846 -1.538 . . . . 71.230000000000004 106.846 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.5 m -67.11 -18.17 65.19 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.337 -0.847 . . . . 74.519999999999996 112.372 -172.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 67.47 -171.65 0.19 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.893 0.877 . . . . 73.120000000000005 108.847 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.1 t -81.77 97.7 8.09 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.956 0.884 . . . . 73.519999999999996 109.779 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.257 0 N-CA-C 108.854 -1.698 . . . . 71.430000000000007 108.854 -178.594 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.474 0 N-CA-C 106.803 -1.554 . . . . 73.239999999999995 106.803 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -138.63 163.24 32.6 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.433 0.635 . . . . 74.430000000000007 112.173 -172.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.489 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 46.2 m-85 -119.7 145.29 46.65 Favored 'General case' 0 C--O 1.251 1.144 0 C-N-CA 124.266 1.026 . . . . 74.439999999999998 110.616 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.514 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 30.6 t70 -115.44 111.23 20.47 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 125.542 1.537 . . . . 63.32 107.204 -175.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 p -96.65 127.87 48.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 122.119 -0.363 . . . . 65.340000000000003 110.916 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.418 HG21 HG22 ' A' ' 28' ' ' VAL . 4.8 p -117.9 127.48 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 115.923 -0.58 . . . . 60.310000000000002 111.177 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 tt -115.62 112.86 41.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.473 -0.785 . . . . 72.409999999999997 109.698 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.3 mp -98.92 109.2 52.93 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 108.247 -1.02 . . . . 74.230000000000004 108.247 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 17.7 Cg_endo -93.9 138.6 1.27 Allowed 'Trans proline' 0 N--CA 1.436 -1.895 0 C-N-CA 122.193 1.928 . . . . 64.439999999999998 110.684 173.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -159.13 130.61 6.29 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 110.189 -0.3 . . . . 61.43 110.189 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.426 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.3 m -69.82 121.37 17.14 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.001 -0.74 . . . . 72.150000000000006 109.001 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.557 ' CE1' ' HD3' ' A' ' 79' ' ' LYS . 21.3 p90 -70.01 101.58 1.83 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 112.529 0.566 . . . . 75.150000000000006 112.529 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.475 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 54.4 m80 -146.65 151.34 37.08 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.991 -0.549 . . . . 74.099999999999994 111.77 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -80.41 119.44 23.11 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 106.905 -1.517 . . . . 75.030000000000001 106.905 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -62.04 104.41 0.46 Allowed 'General case' 0 N--CA 1.406 -2.654 0 O-C-N 124.527 1.142 . . . . 72.420000000000002 109.383 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -87.22 -155.02 0.26 Allowed 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 113.957 -1.474 . . . . 54.340000000000003 108.668 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -81.56 -56.88 3.74 Favored 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 121.45 -0.781 . . . . 74.400000000000006 112.412 -175.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -136.12 15.01 3.28 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.824 0.821 . . . . 70.430000000000007 110.207 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -148.57 157.34 43.4 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.919 -1.141 . . . . 65.120000000000005 107.919 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.475 ' CG ' ' HB3' ' A' ' 13' ' ' HIS . 41.4 ttp 63.53 62.31 0.95 Allowed 'General case' 0 C--N 1.348 0.519 0 CA-C-O 122.848 1.308 . . . . 62.009999999999998 109.658 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -148.3 96.05 2.55 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.688 -1.596 . . . . 62.149999999999999 107.562 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.485 ' CE1' ' HB2' ' A' ' 128' ' ' SER . 41.6 t60 -141.84 113.67 7.93 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.994 -1.083 . . . . 65.239999999999995 110.925 175.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.1 mm -126.93 126.91 69.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 106.394 -1.706 . . . . 73.450000000000003 106.394 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 46.6 m -107.68 149.85 39.46 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 112.264 0.468 . . . . 64.049999999999997 112.264 -171.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.3 129.74 23.55 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.27 2.647 . . . . 75.25 112.367 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -68.26 133.35 28.24 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.35 2.033 . . . . 75.120000000000005 112.199 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 25.0 mmt -86.96 131.32 34.13 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.67 -1.604 . . . . 74.219999999999999 106.67 174.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.418 HG22 HG21 ' A' ' 6' ' ' VAL . 19.0 t -127.64 127.91 69.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 109.503 -0.554 . . . . 62.539999999999999 109.503 -177.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.8 mm -126.65 114.4 37.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.561 -0.903 . . . . 74.439999999999998 108.561 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -127.87 82.14 0.34 Allowed Glycine 0 CA--C 1.48 -2.144 0 C-N-CA 119.06 -1.543 . . . . 50.210000000000001 114.531 -175.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -156.92 21.94 0.32 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.327 -0.936 . . . . 72.420000000000002 109.545 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.42 HH11 HD12 ' A' ' 40' ' ' ILE . 1.1 mmp_? -95.51 146.43 24.44 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.132 -1.433 . . . . 64.230000000000004 107.132 -172.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 p -85.07 175.6 8.92 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 105.947 -1.871 . . . . 72.299999999999997 105.947 168.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.489 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 76.8 t80 -60.41 -41.94 94.96 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 118.699 0.681 . . . . 72.120000000000005 110.695 -176.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -67.85 -41.58 82.72 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.48 -1.236 . . . . 63.340000000000003 111.197 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mm -74.01 -29.85 26.43 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 N-CA-C 109.613 -0.514 . . . . 73.109999999999999 109.613 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.42 -45.2 92.06 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.87 -0.605 . . . . 53.25 109.991 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.1 mmt -67.79 -39.46 84.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.225 -0.443 . . . . 73.420000000000002 110.713 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -69.43 -34.65 74.75 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.957 1.095 . . . . 65.109999999999999 113.957 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.502 ' O ' HG21 ' A' ' 44' ' ' VAL . 13.9 tt -70.46 -41.75 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 119.125 -1.03 . . . . 73.349999999999994 109.665 176.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 82.5 t -62.37 -44.1 98.85 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.369 0 N-CA-C 109.41 -0.589 . . . . 73.430000000000007 109.41 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -58.32 -41.84 85.42 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 123.119 0.568 . . . . 73.239999999999995 110.993 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.22 -43.55 92.79 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.62 -0.8 . . . . 74.25 111.401 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.502 HG21 ' O ' ' A' ' 40' ' ' ILE . 97.4 t -65.84 -41.32 89.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.31 -0.626 . . . . 71.010000000000005 109.31 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.93 -46.34 85.18 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 125.298 1.439 . . . . 63.310000000000002 110.717 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -64.8 -44.16 90.84 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.549 -1.205 . . . . 72.400000000000006 110.644 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.9 t -66.87 -38.95 82.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 116.266 -0.425 . . . . 70.340000000000003 110.759 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 73' ' ' LEU . 66.1 mt -68.79 -41.87 82.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 121.029 -0.268 . . . . 74.319999999999993 111.675 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -80.39 -17.8 50.81 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 118.749 -1.18 . . . . 65.450000000000003 110.993 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.63 -43.02 8.48 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 112.371 0.508 . . . . 65.430000000000007 112.371 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.3 m -83.27 -16.13 47.52 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 112.801 0.667 . . . . 43.020000000000003 112.801 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -138.13 -174.49 3.81 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.097 0.475 . . . . 72.230000000000004 110.351 -174.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -103.78 105.86 16.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.014 -1.847 . . . . 74.450000000000003 106.014 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.67 136.4 40.9 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 112.948 0.722 . . . . 72.239999999999995 112.948 -174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -100.49 115.52 30.27 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.329 -1.73 . . . . 74.230000000000004 106.329 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 p -100.98 123.07 53.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.26 0.552 . . . . 64.329999999999998 111.437 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -130.67 119.75 22.88 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.107 -0.497 . . . . 72.439999999999998 110.772 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -82.51 137.41 34.63 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.014 -0.539 . . . . 71.420000000000002 110.173 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.4 mt -134.25 171.83 13.71 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.661 -0.866 . . . . 74.209999999999994 108.661 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -99.35 162.04 13.27 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.499 -0.556 . . . . 74.319999999999993 109.499 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.75 177.48 16.43 Favored Glycine 0 C--N 1.278 -2.681 0 N-CA-C 109.292 -1.523 . . . . 52.009999999999998 109.292 178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.502 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 12.8 pt-20 -65.84 179.48 0.87 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.437 -0.579 . . . . 72.140000000000001 109.437 175.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.04 -27.56 69.19 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 122.09 0.948 . . . . 73.530000000000001 111.474 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.8 t -77.42 -16.66 58.7 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.703 -1.135 . . . . 70.430000000000007 109.869 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.502 ' OD2' ' HG2' ' A' ' 62' ' ' GLU . 78.2 m-20 -101.24 157.72 16.57 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 108.436 -0.949 . . . . 74.209999999999994 108.436 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.444 HG23 ' CE2' ' A' ' 3' ' ' TYR . 36.9 t -104.56 -44.2 8.57 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-O 121.579 0.704 . . . . 73.409999999999997 110.314 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.1 tp -163.0 153.08 15.99 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.826 -1.176 . . . . 53.299999999999997 107.826 -174.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -130.08 128.34 41.69 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 106.873 -1.529 . . . . 75.450000000000003 106.873 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -123.43 108.51 12.77 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 107.351 -1.352 . . . . 73.530000000000001 107.351 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -109.99 117.7 34.47 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.105 0.478 . . . . 71.140000000000001 110.218 -175.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -107.44 132.98 52.61 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.248 -0.649 . . . . 74.299999999999997 109.248 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.7 m -97.75 113.39 25.16 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 107.087 -1.449 . . . . 65.329999999999998 107.087 171.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.407 HD11 HG22 ' A' ' 48' ' ' ILE . 4.1 mm? -98.18 139.19 34.34 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 124.306 1.042 . . . . 73.329999999999998 113.51 -173.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -140.41 139.41 35.26 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-N 113.87 -1.514 . . . . 73.150000000000006 107.057 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.436 ' HZ1' ' CD ' ' A' ' 118' ' ' GLU . 82.0 tttt -132.68 176.52 8.38 Favored 'General case' 0 C--N 1.263 -3.185 0 N-CA-C 102.686 -3.079 . . . . 75.25 102.686 173.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.3 0.0 OUTLIER -62.86 90.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 115.112 1.523 . . . . 73.329999999999998 115.112 -177.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.26 2.19 77.55 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 114.709 -1.132 . . . . 72.510000000000005 112.8 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 55.3 mttp -130.22 143.38 50.75 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.753 -0.832 . . . . 72.030000000000001 108.753 -174.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.557 ' HD3' ' CE1' ' A' ' 12' ' ' PHE . 14.8 ptpt -151.69 156.2 39.86 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 112.737 0.643 . . . . 62.439999999999998 112.737 -169.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -177.65 170.68 43.17 Favored Glycine 0 C--O 1.2 -2.004 0 CA-C-N 115.372 -0.831 . . . . 73.109999999999999 111.383 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.9 mt -115.75 138.14 47.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 107.684 -1.228 . . . . 74.329999999999998 107.684 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.6 t -115.99 110.37 31.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 109.003 -0.74 . . . . 70.200000000000003 109.003 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -100.73 103.97 15.23 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.484 -0.78 . . . . 75.120000000000005 109.044 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.6 t -109.6 109.75 29.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.268 -0.641 . . . . 71.310000000000002 109.268 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -122.72 149.69 43.74 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 119.488 -0.885 . . . . 75.120000000000005 110.418 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.7 mt -99.16 126.54 44.95 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 107.736 -1.209 . . . . 75.049999999999997 107.736 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.5 ttt85 -115.95 134.52 54.89 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 108.273 -1.01 . . . . 75.219999999999999 108.273 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -81.06 98.3 7.92 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 116.295 -0.412 . . . . 73.109999999999999 111.482 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.6 tt -75.04 111.4 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 122.235 1.017 . . . . 62.119999999999997 108.825 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.5 p -145.15 -171.21 3.61 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-N 114.943 -1.026 . . . . 64.219999999999999 108.941 -172.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -78.79 -4.55 49.97 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.967 0.889 . . . . 72.340000000000003 109.279 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -98.8 -23.34 15.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.312 -0.858 . . . . 70.099999999999994 109.607 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 96.9 m -138.46 118.05 9.71 Favored Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 112.145 0.424 . . . . 52.130000000000003 112.145 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.58 157.48 36.15 Favored 'Trans proline' 0 C--O 1.25 1.119 0 C-N-CA 122.037 1.825 . . . . 75.109999999999999 109.651 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.97 160.7 32.55 Favored 'Trans proline' 0 C--O 1.255 1.329 0 C-N-CA 123.074 2.516 . . . . 73.340000000000003 112.502 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 t -81.2 144.71 10.02 Favored 'Isoleucine or valine' 0 C--O 1.252 1.201 0 N-CA-C 108.493 -0.928 . . . . 74.150000000000006 108.493 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -97.24 85.89 3.79 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 121.953 0.882 . . . . 74.329999999999998 110.809 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -129.37 -158.61 9.59 Favored Glycine 0 N--CA 1.412 -2.959 0 N-CA-C 109.362 -1.495 . . . . 70.219999999999999 109.362 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.91 98.43 7.88 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 108.274 -1.01 . . . . 52.140000000000001 108.274 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 64.2 mtp85 -86.63 93.63 9.26 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 108.064 -1.087 . . . . 75.519999999999996 108.064 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 19.3 t -72.51 168.38 18.67 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 113.854 -1.521 . . . . 44.409999999999997 113.144 -170.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.4 m -73.53 105.9 5.08 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 124.726 1.21 . . . . 73.030000000000001 111.028 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.9 t -84.89 155.03 3.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.799 -1.092 . . . . 71.420000000000002 108.866 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.5 tp -150.35 -68.59 0.19 Allowed 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.686 1.231 . . . . 74.319999999999993 109.177 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.32 165.61 35.34 Favored 'General case' 1 C--N 1.237 -4.297 0 N-CA-C 103.224 -2.88 . . . . 71.219999999999999 103.224 178.244 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' O ' HG22 ' A' ' 110' ' ' ILE . 91.6 t80 -45.98 -36.39 5.52 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.781 1.03 . . . . 75.310000000000002 113.781 -173.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -58.12 -40.45 81.25 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 113.341 0.867 . . . . 73.420000000000002 113.341 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -88.2 -30.41 19.76 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 119.929 -0.708 . . . . 71.109999999999999 109.337 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.44 -47.02 83.6 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.932 -1.031 . . . . 70.25 109.379 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 106' ' ' PHE . 10.3 tp -69.0 -31.71 51.55 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 CA-C-N 116.14 -0.482 . . . . 75.319999999999993 109.826 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -63.81 -41.86 97.79 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.699 -0.482 . . . . 75.420000000000002 109.699 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 53.6 t -70.2 -40.22 74.72 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.001 -0.545 . . . . 60.509999999999998 110.178 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.07 -45.18 99.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.81 -0.632 . . . . 62.420000000000002 111.379 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.27 -41.76 92.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.618 0.247 . . . . 61.350000000000001 110.37 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -69.73 -23.79 63.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.464 0.542 . . . . 72.329999999999998 112.464 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.62 -43.94 58.32 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.972 -0.381 . . . . 74.209999999999994 109.972 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.15 -45.45 98.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.359 -0.608 . . . . 75.329999999999998 109.359 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.436 ' CD ' ' HZ1' ' A' ' 75' ' ' LYS . 6.1 mm-40 -61.74 -38.23 87.19 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 116.059 -0.519 . . . . 74.329999999999998 111.541 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -64.11 -46.43 84.2 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 108.989 -0.745 . . . . 73.120000000000005 108.989 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 5.6 t -70.69 -29.88 66.3 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.387 -0.824 . . . . 55.420000000000002 111.25 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.29 -37.27 28.71 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.58 -0.7 . . . . 65.450000000000003 111.421 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . . . -76.78 -36.01 57.29 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 111.956 0.354 . . . . 54.450000000000003 111.956 -177.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 125' ' ' GLU . 9.9 mmmm -99.53 9.94 42.29 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 110.014 -0.365 . . . . 65.129999999999995 110.014 -175.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.481 ' HA2' ' CG ' ' A' ' 22' ' ' HIS . . . -71.7 33.37 0.59 Allowed Glycine 0 C--N 1.334 0.469 0 N-CA-C 117.304 1.682 . . . . 60.109999999999999 117.304 -171.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -166.94 54.54 0.08 Allowed 'General case' 0 C--N 1.268 -2.96 0 N-CA-C 106.365 -1.717 . . . . 72.519999999999996 106.365 177.041 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -155.62 134.58 12.08 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 104.258 -2.497 . . . . 42.219999999999999 104.258 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -69.25 93.62 0.64 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.244 1.021 . . . . 73.340000000000003 113.233 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.485 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 49.6 m -134.46 123.88 24.72 Favored 'General case' 0 N--CA 1.395 -3.18 0 N-CA-C 103.318 -2.845 . . . . 61.149999999999999 103.318 171.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -153.09 109.0 3.32 Favored 'General case' 0 N--CA 1.412 -2.357 0 C-N-CA 119.243 -0.983 . . . . 74.420000000000002 111.845 -171.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.5 tp -94.36 93.55 7.76 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.546 -2.02 . . . . 62.450000000000003 105.546 168.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -66.48 115.99 6.98 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.166 -0.924 . . . . 75.299999999999997 111.105 -172.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.47 170.59 26.77 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 114.069 -1.423 . . . . 75.010000000000005 114.135 -175.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -123.24 152.11 63.38 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.009 -0.737 . . . . 71.150000000000006 109.009 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.78 95.28 0.88 Allowed 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 121.843 1.695 . . . . 75.109999999999999 110.68 176.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.4 mm -83.67 121.75 76.37 Favored Pre-proline 0 N--CA 1.41 -2.429 0 N-CA-C 106.267 -1.753 . . . . 73.430000000000007 106.267 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -60.09 157.25 35.35 Favored 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 123.248 2.632 . . . . 64.120000000000005 111.692 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -122.28 85.48 47.18 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 109.344 -0.613 . . . . 62.100000000000001 109.344 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.447 ' HD2' ' OE1' ' A' ' 62' ' ' GLU . 12.1 Cg_exo -74.06 100.54 1.3 Allowed 'Trans proline' 0 N--CA 1.433 -2.08 0 C-N-CA 121.811 1.674 . . . . 65.120000000000005 110.905 175.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.02 136.6 35.22 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.069 -1.456 . . . . 72.219999999999999 107.069 171.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 66.28 104.35 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.156 0.983 . . . . 75.409999999999997 111.392 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -137.6 -65.12 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 110.437 -1.065 . . . . 74.230000000000004 110.437 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.8 tp -148.71 102.17 3.27 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.843 0.354 . . . . 50.509999999999998 110.835 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -114.57 -5.2 12.78 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.998 0.428 . . . . 73.099999999999994 109.928 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.5 m -59.97 108.38 0.76 Allowed 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 123.787 0.835 . . . . 72.299999999999997 113.187 -175.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.9 t -144.31 27.5 1.4 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.195 -1.409 . . . . 74.239999999999995 107.195 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.3 97.02 7.35 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 106.23 -1.767 . . . . 73.209999999999994 106.23 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 32.8 m 73.36 105.7 0.07 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.695 1.198 . . . . 70.109999999999999 111.372 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.144 0 N-CA-C 110.634 -0.986 . . . . 37.579999999999998 110.634 179.21 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.635 0 N-CA-C 105.66 -1.978 . . . . 74.25 105.66 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.01 139.07 32.05 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.327 0.584 . . . . 71.209999999999994 112.055 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.646 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 62.9 m-85 -125.93 137.07 53.68 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.001 -1.0 . . . . 74.25 109.333 176.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.479 ' OD1' ' HB ' ' A' ' 89' ' ' ILE . 4.9 m-20 -101.83 122.1 43.34 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.477 -0.783 . . . . 73.510000000000005 108.898 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 p -95.53 109.14 22.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 108.339 -0.986 . . . . 73.540000000000006 108.339 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.425 ' HB ' ' CG ' ' A' ' 85' ' ' LYS . 61.0 t -102.96 106.28 19.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.921 -1.14 . . . . 70.129999999999995 107.921 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -105.67 118.48 53.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 CA-C-N 115.577 -0.738 . . . . 71.140000000000001 109.858 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.5 mp -106.18 108.18 61.22 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 107.927 -1.138 . . . . 74.400000000000006 107.927 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.64 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 28.5 Cg_endo -99.84 120.33 0.11 Allowed 'Trans proline' 0 N--CA 1.429 -2.314 0 C-N-CA 121.772 1.648 . . . . 74.299999999999997 110.908 171.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.733 ' HA ' ' SG ' ' A' ' 120' ' ' CYS . 0.7 OUTLIER -138.69 145.79 40.78 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.154 0.502 . . . . 64.400000000000006 109.901 174.06 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.472 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.6 p -81.76 129.99 34.91 Favored 'General case' 0 N--CA 1.398 -3.062 0 N-CA-C 107.468 -1.308 . . . . 62.530000000000001 107.468 175.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 79' ' ' LYS 0.284 0.0 OUTLIER -73.95 80.63 1.67 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 115.003 1.483 . . . . 75.329999999999998 115.003 -169.143 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -91.12 151.61 20.92 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.444 -1.253 . . . . 75.109999999999999 112.445 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -104.43 -158.25 0.65 Allowed 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 106.152 -1.795 . . . . 75.140000000000001 106.152 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -128.66 110.72 12.47 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 110.042 -0.355 . . . . 72.510000000000005 110.042 172.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -91.79 -104.99 0.11 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.136 -0.69 . . . . 72.340000000000003 109.136 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -113.35 -54.37 2.62 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.474 -0.935 . . . . 74.340000000000003 108.474 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -134.75 -29.55 1.15 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.322 -1.308 . . . . 74.150000000000006 108.443 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -63.04 133.56 54.73 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.217 -1.031 . . . . 72.310000000000002 108.217 171.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.2 mtt 74.32 99.12 0.07 Allowed 'General case' 0 C--N 1.313 -0.983 0 O-C-N 124.126 0.891 . . . . 70.109999999999999 112.139 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -174.1 82.18 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 125.662 1.585 . . . . 73.310000000000002 107.867 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.464 ' ND1' ' HB2' ' A' ' 128' ' ' SER . 41.6 t60 -148.71 116.18 6.21 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-N 115.946 -0.57 . . . . 53.509999999999998 111.075 -175.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.9 mm -132.93 139.1 50.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.15 -1.426 . . . . 74.129999999999995 107.15 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 60.5 m -107.53 149.3 38.68 Favored Pre-proline 0 C--N 1.288 -2.087 0 N-CA-C 108.856 -0.794 . . . . 74.430000000000007 108.856 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.29 147.76 66.59 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.655 2.237 . . . . 73.409999999999997 113.551 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -64.45 136.69 51.83 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.117 2.544 . . . . 71.239999999999995 111.856 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.527 ' SD ' ' HB2' ' A' ' 101' ' ' CYS . 47.9 ttm -103.11 129.11 49.86 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.479 -0.934 . . . . 71.420000000000002 108.479 175.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.76 132.39 70.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 116.338 -0.392 . . . . 74.540000000000006 110.265 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.33 102.41 9.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 106.121 -1.807 . . . . 64.310000000000002 106.121 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' HA3' ' OD2' ' A' ' 4' ' ' ASP . . . -124.39 82.2 0.35 Allowed Glycine 0 C--N 1.285 -2.29 0 C-N-CA 120.025 -1.083 . . . . 60.340000000000003 114.587 -173.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -170.38 27.47 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.717 0.77 . . . . 73.400000000000006 109.276 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -105.04 154.0 20.71 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.765 -1.568 . . . . 74.329999999999998 106.765 -173.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.3 p -89.64 173.94 8.02 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 106.525 -1.657 . . . . 72.409999999999997 106.525 171.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.646 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 63.8 t80 -60.79 -46.15 91.64 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 118.603 0.638 . . . . 74.450000000000003 110.156 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.69 -42.3 95.42 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.569 -1.196 . . . . 62.140000000000001 111.567 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mm -69.66 -39.25 77.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 116.257 -0.429 . . . . 71.209999999999994 110.146 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.54 -44.7 81.68 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.857 -0.611 . . . . 61.109999999999999 110.077 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.6 mmt -65.88 -35.93 82.0 Favored 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 120.768 -0.373 . . . . 64.420000000000002 111.847 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.6 -41.61 92.6 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 120.555 -0.458 . . . . 63.0 111.509 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.435 ' O ' HG22 ' A' ' 44' ' ' VAL . 8.9 tt -71.96 -41.79 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 118.605 -1.238 . . . . 72.420000000000002 110.527 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.438 HG12 ' NH2' ' A' ' 69' ' ' ARG . 91.3 t -66.77 -38.37 81.38 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 CA-C-N 116.726 -0.216 . . . . 64.299999999999997 110.953 -177.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -67.47 -37.95 83.69 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.067 0.46 . . . . 73.430000000000007 110.277 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.449 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -65.72 -48.04 70.85 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.355 -0.926 . . . . 61.340000000000003 111.12 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 40' ' ' ILE . 92.0 t -64.81 -39.67 86.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.206 0.527 . . . . 73.510000000000005 109.78 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.07 -42.91 91.5 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.788 0.835 . . . . 74.109999999999999 112.117 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -79.63 -26.13 41.23 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 120.162 -0.615 . . . . 72.219999999999999 111.178 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 43' ' ' GLY . 79.5 t -70.03 -44.84 78.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 110.126 -0.324 . . . . 73.230000000000004 110.126 174.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 72.1 mt -65.1 -40.48 89.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 111.972 0.36 . . . . 75.319999999999993 111.972 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -80.27 -10.75 59.76 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.067 -1.053 . . . . 75.439999999999998 112.175 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -98.81 -47.87 5.14 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.29 -0.414 . . . . 74.349999999999994 111.164 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.7 m -81.09 -18.12 47.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.629 0.603 . . . . 60.32 112.629 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.643 ' CE2' ' HD2' ' A' ' 75' ' ' LYS . 1.8 m-85 -127.68 175.2 8.48 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.333 -0.988 . . . . 73.319999999999993 108.333 -176.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.473 ' HA ' HD22 ' A' ' 142' ' ' LEU . 6.4 t-20 -105.03 91.7 3.91 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 105.716 -1.957 . . . . 52.310000000000002 105.716 174.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -132.25 136.39 46.94 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 112.998 0.74 . . . . 41.210000000000001 112.998 -172.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.553 ' OG ' ' HA ' ' A' ' 140' ' ' LEU . 23.3 t -94.46 159.77 14.95 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.856 -1.535 . . . . 72.239999999999995 106.856 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.0 130.9 55.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 120.909 0.385 . . . . 75.319999999999993 109.988 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -135.61 112.22 10.02 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.59 -0.522 . . . . 64.230000000000004 109.59 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -87.88 136.13 33.1 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.635 -0.426 . . . . 75.230000000000004 110.411 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.0 mt -133.59 171.65 13.81 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.436 -0.802 . . . . 74.310000000000002 108.898 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -85.37 143.78 28.43 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.329 -0.989 . . . . 44.240000000000002 108.329 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -96.67 175.43 31.46 Favored Glycine 0 N--CA 1.414 -2.777 0 N-CA-C 110.394 -1.082 . . . . 63.119999999999997 110.394 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.412 ' HG2' ' CG ' ' A' ' 65' ' ' ASP . 11.2 pt-20 -70.39 179.84 2.32 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 122.767 0.427 . . . . 73.439999999999998 110.03 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.4 -38.16 76.78 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.724 0.773 . . . . 72.420000000000002 112.795 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 76.9 m -83.78 -5.19 59.14 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.504 -0.771 . . . . 72.340000000000003 111.908 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.496 ' OD2' ' HB2' ' A' ' 85' ' ' LYS . 13.4 m-20 -95.8 171.6 8.55 Favored 'General case' 0 CA--C 1.49 -1.365 0 CA-C-N 115.396 -0.82 . . . . 72.230000000000004 110.091 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.15 -42.65 3.58 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.447 0 CA-C-N 114.651 -1.159 . . . . 73.400000000000006 109.089 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.1 tp -163.21 151.77 14.12 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 106.901 -1.518 . . . . 74.329999999999998 106.901 -176.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.58 118.36 21.88 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.483 -1.673 . . . . 73.099999999999994 106.483 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.438 ' NH2' HG12 ' A' ' 41' ' ' VAL . 36.3 ttp180 -122.72 124.2 42.84 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.23 -0.988 . . . . 73.140000000000001 110.43 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -98.42 145.11 27.06 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 124.367 1.067 . . . . 72.439999999999998 108.986 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 55' ' ' SER . 95.4 m-85 -131.76 137.74 48.32 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.878 -1.156 . . . . 74.150000000000006 107.878 175.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 32.0 m -113.86 111.85 22.4 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.698 -0.853 . . . . 74.129999999999995 108.698 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.9 139.96 32.16 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 113.273 0.842 . . . . 63.200000000000003 113.273 -171.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -143.85 89.75 2.08 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 105.038 -2.208 . . . . 54.399999999999999 105.038 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.643 ' HD2' ' CE2' ' A' ' 52' ' ' PHE . 63.9 tttm -105.34 96.34 6.45 Favored 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.766 -0.584 . . . . 71.349999999999994 109.632 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 13.6 pt-20 53.5 35.51 20.92 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.618 1.167 . . . . 72.5 113.092 173.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.54 -8.64 56.8 Favored Glycine 0 CA--C 1.506 -0.505 0 C-N-CA 121.165 -0.54 . . . . 74.439999999999998 112.764 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HE3' ' HA ' ' A' ' 122' ' ' ALA . 50.4 mtpt -98.86 102.72 14.55 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.392 -1.707 . . . . 62.119999999999997 106.392 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.47 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . 58.9 mttp -101.53 153.96 19.26 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.792 -0.64 . . . . 72.030000000000001 112.176 -174.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -173.04 176.58 45.78 Favored Glycine 0 N--CA 1.417 -2.596 0 N-CA-C 110.599 -1.0 . . . . 60.039999999999999 110.599 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.3 tt -133.78 149.36 30.68 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.039 0 N-CA-C 106.948 -1.501 . . . . 54.219999999999999 106.948 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.0 t -132.34 127.52 57.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.252 -0.648 . . . . 75.329999999999998 109.252 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -113.86 113.72 25.28 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.322 -0.621 . . . . 74.129999999999995 109.322 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.54 110.59 30.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.879 -0.786 . . . . 61.210000000000001 108.879 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.496 ' HB2' ' OD2' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -110.67 126.53 54.61 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.03 -1.1 . . . . 70.219999999999999 108.03 178.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.0 mt -100.22 125.94 46.45 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.995 -1.854 . . . . 60.039999999999999 105.995 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.442 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 70.1 mtp85 -112.36 141.8 45.64 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-O 121.091 0.472 . . . . 72.040000000000006 110.927 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -94.29 98.71 11.11 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 115.309 -0.86 . . . . 71.129999999999995 109.373 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.479 ' HB ' ' OD1' ' A' ' 4' ' ' ASP . 10.9 tt -65.38 111.72 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 122.44 1.114 . . . . 70.109999999999999 109.141 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.7 p -137.8 176.75 8.43 Favored 'General case' 0 N--CA 1.39 -3.44 0 CA-C-N 114.685 -1.143 . . . . 55.399999999999999 109.807 -174.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -71.38 -17.78 62.39 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.895 -1.048 . . . . 72.030000000000001 109.32 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -98.06 -32.12 11.79 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.665 -1.152 . . . . 73.530000000000001 110.817 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 42.3 m -133.69 108.46 11.96 Favored Pre-proline 0 N--CA 1.432 -1.349 0 N-CA-C 113.695 0.998 . . . . 74.299999999999997 113.695 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -90.4 144.92 4.03 Favored 'Trans proline' 0 N--CA 1.438 -1.785 0 C-N-CA 122.465 2.11 . . . . 37.530000000000001 111.236 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -82.87 158.93 15.97 Favored 'Trans proline' 0 C--O 1.255 1.37 0 C-N-CA 122.378 2.052 . . . . 75.239999999999995 111.518 172.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 t -98.73 150.13 5.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 105.252 -2.129 . . . . 75.409999999999997 105.252 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -107.13 146.31 31.43 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.788 0.804 . . . . 75.439999999999998 112.162 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -138.59 -147.58 5.17 Favored Glycine 0 CA--C 1.476 -2.344 0 CA-C-N 114.071 -1.422 . . . . 72.109999999999999 110.079 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -60.84 125.84 25.18 Favored 'General case' 0 C--N 1.288 -2.093 0 O-C-N 124.286 0.639 . . . . 74.340000000000003 110.007 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -97.7 131.43 44.25 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.213 0.53 . . . . 73.439999999999998 110.395 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.527 ' HB2' ' SD ' ' A' ' 27' ' ' MET . 44.3 t -73.35 154.91 39.89 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.558 -1.201 . . . . 64.400000000000006 109.919 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.3 t -80.96 74.97 7.94 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.519 -1.289 . . . . 74.420000000000002 107.519 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.94 140.05 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 114.866 -1.061 . . . . 75.420000000000002 109.803 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.9 tp -153.7 -121.87 0.03 OUTLIER 'General case' 0 C--N 1.257 -3.453 0 N-CA-C 103.866 -2.642 . . . . 74.239999999999995 103.866 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.62 168.59 10.07 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 107.817 -1.179 . . . . 63.240000000000002 107.817 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.447 ' O ' HG22 ' A' ' 110' ' ' ILE . 74.5 t80 -43.25 -36.64 1.87 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.57 1.148 . . . . 73.319999999999993 114.071 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -56.84 -37.63 71.53 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.707 0.803 . . . . 63.420000000000002 112.249 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -90.62 -34.69 15.37 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.687 -0.486 . . . . 75.319999999999993 109.687 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -62.55 -46.87 86.37 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.15 -0.932 . . . . 74.519999999999996 110.613 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.447 HG22 ' O ' ' A' ' 106' ' ' PHE . 9.1 tp -64.59 -39.75 86.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 N-CA-C 109.963 -0.384 . . . . 72.209999999999994 109.963 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.96 -41.5 82.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.774 -0.648 . . . . 75.219999999999999 110.671 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 7.8 t -63.0 -44.25 96.54 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.693 -0.685 . . . . 75.109999999999999 111.259 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 47.0 mm -68.25 -41.46 83.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.994 -0.372 . . . . 61.340000000000003 109.994 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 51.6 t -64.22 -43.06 97.23 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 CA-C-N 116.029 -0.532 . . . . 73.340000000000003 110.366 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -61.9 -40.47 95.56 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 122.826 0.45 . . . . 75.25 111.19 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.59 84.33 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.183 0.516 . . . . 70.329999999999998 111.412 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.416 ' O ' HD12 ' A' ' 121' ' ' LEU . 79.0 mt -71.3 -43.28 74.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.364 -0.606 . . . . 72.329999999999998 109.364 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 114' ' ' VAL . 1.7 tm-20 -62.63 -40.49 97.18 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.484 -0.78 . . . . 63.539999999999999 110.448 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.74 -36.78 76.12 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 120.069 -0.652 . . . . 74.319999999999993 110.669 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.733 ' SG ' ' HA ' ' A' ' 10' ' ' GLU . 10.8 t -67.96 -34.05 75.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.657 0.741 . . . . 75.099999999999994 109.665 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 117' ' ' ILE . 9.3 mp -75.79 -35.34 60.12 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.474 -0.784 . . . . 73.319999999999993 111.247 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.448 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . . . -69.67 -33.77 73.02 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.991 0.424 . . . . 74.230000000000004 111.144 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -80.55 10.32 4.9 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.7 -0.682 . . . . 71.349999999999994 111.556 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -53.71 124.15 28.57 Favored Glycine 0 C--O 1.249 1.044 0 CA-C-N 116.111 -0.495 . . . . 50.25 112.817 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 68.04 57.98 0.48 Allowed 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 125.706 1.602 . . . . 74.310000000000002 112.259 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.2 mt -142.77 135.87 28.31 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.497 -1.229 . . . . 70.439999999999998 108.827 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -58.63 100.31 0.06 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.388 1.075 . . . . 71.239999999999995 112.0 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.464 ' HB2' ' ND1' ' A' ' 22' ' ' HIS . 58.2 m -155.55 105.83 2.47 Favored 'General case' 0 N--CA 1.422 -1.86 0 C-N-CA 124.416 1.086 . . . . 73.219999999999999 110.058 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm 68.5 103.06 0.05 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.855 1.262 . . . . 44.340000000000003 112.634 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . 0.289 0.6 OUTLIER -76.45 73.02 3.19 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 123.058 1.408 . . . . 62.049999999999997 112.83 176.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -134.28 151.49 51.3 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.308 -1.367 . . . . 73.140000000000001 107.308 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -119.76 142.18 16.09 Favored Glycine 0 N--CA 1.428 -1.866 0 C-N-CA 120.051 -1.071 . . . . 72.030000000000001 111.717 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.51 ' HE3' ' OE2' ' A' ' 10' ' ' GLU . 19.7 tptp -118.97 87.17 33.18 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 106.45 -1.685 . . . . 73.099999999999994 106.45 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -84.01 72.51 5.24 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.693 2.262 . . . . 61.119999999999997 112.699 -173.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.1 mt -128.5 100.6 22.17 Favored Pre-proline 0 N--CA 1.42 -1.972 0 CA-C-N 115.297 -0.865 . . . . 64.420000000000002 108.989 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -87.36 129.89 2.79 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.086 1.857 . . . . 64.519999999999996 110.234 172.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -120.66 102.77 44.44 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 109.149 -0.685 . . . . 70.409999999999997 109.149 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -86.66 -5.22 8.13 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.242 1.961 . . . . 73.109999999999999 112.651 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 tt -95.92 102.37 14.16 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 107.947 -1.131 . . . . 74.310000000000002 107.947 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.553 ' HA ' ' OG ' ' A' ' 55' ' ' SER 0.284 1.6 pp -125.16 115.32 20.26 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 113.081 0.771 . . . . 71.340000000000003 113.081 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -153.52 152.91 24.46 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.554 -1.018 . . . . 42.530000000000001 110.554 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 54' ' ' ALA . 5.5 mp -126.99 143.65 51.23 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 117.072 0.436 . . . . 75.010000000000005 111.149 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -144.26 92.16 2.28 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.788 -0.642 . . . . 74.239999999999995 109.581 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.8 m -165.45 100.21 0.71 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.441 1.096 . . . . 73.019999999999996 109.074 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.8 t -82.4 67.55 8.47 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.774 0.797 . . . . 72.510000000000005 110.542 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 62.23 -175.63 0.14 Allowed 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.239 -1.346 . . . . 65.299999999999997 110.71 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.4 m -66.7 125.16 24.95 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.488 -0.56 . . . . 63.25 109.488 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.285 0 N-CA-C 109.028 -1.629 . . . . 62.049999999999997 109.028 -177.84 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.252 0 N-CA-C 106.764 -1.569 . . . . 72.140000000000001 106.764 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -120.45 128.89 53.59 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.905 0.383 . . . . 63.240000000000002 110.405 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.609 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 28.8 m-85 -117.69 148.95 41.51 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.395 0.617 . . . . 74.549999999999997 111.377 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -121.36 107.47 12.54 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.222 -2.14 . . . . 60.229999999999997 105.222 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -93.23 114.91 30.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 116.186 -0.461 . . . . 71.420000000000002 110.23 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.401 ' HB ' ' HG3' ' A' ' 85' ' ' LYS . 46.9 t -104.87 112.89 40.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 108.432 -0.951 . . . . 63.200000000000003 108.432 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' A' ' 27' ' ' MET . 3.7 tt -114.34 108.34 25.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.835 0.826 . . . . 75.25 108.847 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.9 mt -104.06 106.4 53.08 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 114.991 -1.004 . . . . 75.519999999999996 111.799 -171.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.584 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 7.1 Cg_endo -92.9 140.05 1.8 Allowed 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 122.419 2.079 . . . . 63.219999999999999 110.572 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -164.08 155.87 16.53 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 122.468 0.307 . . . . 71.140000000000001 110.76 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.9 m -91.57 135.19 34.04 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.707 -0.479 . . . . 74.5 109.707 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.15 68.65 10.0 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 113.551 0.945 . . . . 75.200000000000003 113.551 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -122.82 138.21 54.71 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.126 -1.064 . . . . 74.519999999999996 108.126 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.407 ' N ' ' HD2' ' A' ' 14' ' ' ARG . 9.0 mpt_? -82.39 134.98 35.25 Favored 'General case' 0 CA--C 1.475 -1.938 0 N-CA-C 108.998 -0.742 . . . . 73.200000000000003 108.998 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -62.67 110.44 1.72 Allowed 'General case' 0 N--CA 1.405 -2.702 0 O-C-N 124.688 1.242 . . . . 73.519999999999996 111.131 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.411 ' HB2' ' HE1' ' A' ' 20' ' ' MET . 35.7 t70 -84.72 -99.31 0.06 Allowed 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 114.603 -1.18 . . . . 71.530000000000001 109.623 173.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -113.79 -58.45 2.15 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.033 0.444 . . . . 62.119999999999997 109.956 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -138.12 -51.91 0.6 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.085 0.945 . . . . 74.239999999999995 109.813 173.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -84.99 67.41 10.2 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.851 -1.068 . . . . 70.200000000000003 112.74 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.411 ' HE1' ' HB2' ' A' ' 16' ' ' ASP . 48.1 ttp 159.42 88.75 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.384 0 C-N-CA 128.169 2.588 . . . . 73.510000000000005 105.359 171.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 168.98 121.8 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.323 -2.103 . . . . 73.230000000000004 105.323 -173.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.417 ' HB2' ' H ' ' A' ' 125' ' ' GLU . 77.1 t60 -156.81 113.46 3.05 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.804 -0.758 . . . . 74.439999999999998 112.592 172.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.3 mm -113.64 132.5 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 N-CA-C 107.272 -1.381 . . . . 73.319999999999993 107.272 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 9.1 m -109.6 138.63 20.66 Favored Pre-proline 0 C--N 1.273 -2.723 0 N-CA-C 107.353 -1.351 . . . . 72.030000000000001 107.353 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -53.88 128.96 31.81 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 122.797 2.331 . . . . 70.409999999999997 112.427 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.88 130.43 26.0 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.489 2.126 . . . . 72.109999999999999 110.343 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.435 ' HB2' HG21 ' A' ' 7' ' ' ILE . 73.0 mtm -88.82 138.97 30.94 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 109.849 -0.426 . . . . 43.520000000000003 109.849 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.3 119.99 53.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.3 0.571 . . . . 74.430000000000007 110.04 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 30.6 mm -113.13 100.87 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 105.783 -1.932 . . . . 74.510000000000005 105.783 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.2 165.04 13.1 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 119.6 -1.286 . . . . 65.0 112.132 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.6 t70 65.72 70.05 0.45 Allowed 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 125.339 1.456 . . . . 62.049999999999997 110.634 -175.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -138.34 136.05 35.99 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 105.364 -2.088 . . . . 75.349999999999994 105.364 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.6 p -77.95 163.73 25.73 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 106.558 -1.645 . . . . 63.020000000000003 106.558 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.609 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 74.7 t80 -59.13 -37.26 76.81 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.609 0.718 . . . . 71.430000000000007 110.393 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -63.56 -47.17 82.62 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.309 -1.314 . . . . 54.420000000000002 110.857 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.1 mt -73.13 -38.52 55.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.935 -0.765 . . . . 71.120000000000005 108.935 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.82 98.9 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.866 -1.061 . . . . 43.329999999999998 110.893 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.4 tpp -67.69 -39.9 84.39 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.624 -0.831 . . . . 75.319999999999993 110.545 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -70.52 -34.48 72.35 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 119.838 -0.745 . . . . 71.400000000000006 112.745 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.517 ' O ' HG23 ' A' ' 44' ' ' VAL . 7.0 tp -73.79 -43.01 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 119.484 -0.886 . . . . 43.039999999999999 110.57 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t -68.57 -39.65 80.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 121.249 -0.18 . . . . 71.129999999999995 111.159 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -70.51 -29.38 65.87 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.272 -0.64 . . . . 65.219999999999999 109.272 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' HG21 ' A' ' 47' ' ' VAL . . . -65.29 -47.54 78.89 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 110.42 -1.072 . . . . 71.549999999999997 110.42 174.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 40' ' ' ILE . 90.5 t -57.59 -46.06 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 109.146 -0.687 . . . . 73.239999999999995 109.146 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -55.86 -39.4 71.43 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 125.231 1.412 . . . . 75.010000000000005 113.108 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -79.02 -31.04 44.53 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.305 -0.407 . . . . 74.319999999999993 111.2 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 43' ' ' GLY . 82.5 t -71.8 -38.06 64.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.289 -0.634 . . . . 63.439999999999998 109.289 176.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.5 mt -60.73 -46.6 95.69 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.852 0 CA-C-N 116.091 -0.504 . . . . 75.109999999999999 111.558 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -76.7 -15.93 59.65 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.6 -0.84 . . . . 74.409999999999997 112.114 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.4 -40.19 12.21 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.213 -0.449 . . . . 75.040000000000006 112.055 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 t -91.61 -20.61 21.46 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 112.463 0.542 . . . . 73.409999999999997 112.463 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -128.35 -179.97 5.31 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.6 0.714 . . . . 74.049999999999997 110.45 -174.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -105.54 106.52 17.06 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 104.155 -2.535 . . . . 71.319999999999993 104.155 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -118.2 135.63 54.13 Favored 'General case' 0 N--CA 1.404 -2.759 0 C-N-CA 119.533 -0.867 . . . . 64.439999999999998 113.114 -172.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.438 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 29.4 m -99.16 106.88 19.11 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 104.418 -2.438 . . . . 63.409999999999997 104.418 166.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 p -99.16 118.13 45.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.452 -0.944 . . . . 71.25 108.452 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' CD ' ' HZ2' ' A' ' 70' ' ' LYS . 27.5 mt-10 -116.33 129.13 56.1 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.072 -0.967 . . . . 73.209999999999994 109.952 -174.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -85.56 118.19 24.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.68 -0.691 . . . . 71.310000000000002 109.747 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mp -119.3 167.22 12.09 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 109.018 -0.734 . . . . 75.129999999999995 109.018 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -109.74 147.96 32.26 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 108.103 -1.073 . . . . 74.5 108.103 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.16 176.09 35.5 Favored Glycine 0 N--CA 1.407 -3.265 0 CA-C-N 115.512 -0.767 . . . . 73.150000000000006 112.725 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.437 ' N ' ' HB2' ' A' ' 65' ' ' ASP . 44.4 mt-10 -66.02 -173.33 0.18 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 124.893 1.277 . . . . 65.420000000000002 110.347 174.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -58.01 -44.7 87.42 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.462 0.648 . . . . 61.039999999999999 111.791 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 90.2 m -80.08 -23.45 41.3 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.6 -0.727 . . . . 74.299999999999997 111.757 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.437 ' HB2' ' N ' ' A' ' 62' ' ' GLU . 9.6 m-20 -90.87 123.23 34.23 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 119.342 -0.943 . . . . 73.430000000000007 111.013 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.7 t -84.43 -33.27 8.56 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 115.849 -0.614 . . . . 74.030000000000001 111.791 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.9 tp -151.58 139.9 20.39 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.441 -0.577 . . . . 73.030000000000001 109.441 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -130.8 121.41 25.31 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 107.622 -1.251 . . . . 74.239999999999995 107.622 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -118.72 123.66 45.42 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.665 -1.235 . . . . 70.5 107.665 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.407 ' HZ2' ' CD ' ' A' ' 57' ' ' GLU . 28.1 ttpp -103.63 109.96 21.85 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.268 -1.012 . . . . 72.209999999999994 108.268 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -96.43 119.17 34.44 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.01 -1.107 . . . . 75.349999999999994 108.01 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 16.9 m -98.95 115.93 30.02 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 106.527 -1.657 . . . . 62.240000000000002 106.527 174.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -108.59 151.04 26.66 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 113.537 0.94 . . . . 73.120000000000005 113.537 -170.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 36.6 tt0 -147.28 125.79 12.44 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 113.421 -1.718 . . . . 72.239999999999995 106.831 169.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -128.16 81.73 2.04 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 108.116 -1.068 . . . . 74.109999999999999 108.116 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 45.22 76.65 0.09 Allowed 'General case' 0 C--O 1.244 0.79 0 C-N-CA 126.239 1.816 . . . . 71.329999999999998 113.586 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.36 -23.18 28.78 Favored Glycine 0 C--N 1.309 -0.93 0 CA-C-N 115.777 -0.647 . . . . 52.210000000000001 112.933 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 14.2 mptt -96.01 129.42 43.28 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.551 -1.278 . . . . 65.329999999999998 107.551 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -145.97 138.49 25.53 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-O 121.132 0.492 . . . . 65.540000000000006 111.76 -173.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.3 179.76 42.28 Favored Glycine 0 CA--C 1.493 -1.285 0 N-CA-C 110.472 -1.051 . . . . 53.140000000000001 110.472 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 29.7 mt -120.1 145.96 25.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 109.404 -0.591 . . . . 70.239999999999995 109.404 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 83.8 t -126.45 112.64 30.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.716 -0.846 . . . . 72.510000000000005 108.716 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -98.87 107.54 20.0 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.309 -0.997 . . . . 75.239999999999995 108.309 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 44.0 t -102.58 110.47 29.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.696 -0.483 . . . . 74.099999999999994 109.696 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.401 ' HG3' ' HB ' ' A' ' 6' ' ' VAL . 8.1 ptpt -116.68 135.55 53.69 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 120.766 0.317 . . . . 72.0 110.677 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.1 mt -103.62 109.92 21.79 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 106.667 -1.605 . . . . 75.230000000000004 106.667 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.429 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 13.4 mtp180 -98.0 140.53 32.2 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 119.686 -0.806 . . . . 75.219999999999999 109.329 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -84.86 113.05 21.09 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 107.891 -1.151 . . . . 64.120000000000005 107.891 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 tt -87.26 111.64 22.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.79 -0.818 . . . . 71.540000000000006 108.79 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -128.18 174.59 9.13 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.505 -1.295 . . . . 72.129999999999995 107.505 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -78.2 0.16 26.12 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 120.282 -0.567 . . . . 75.030000000000001 112.322 -173.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -119.01 10.58 12.21 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.847 -0.615 . . . . 65.109999999999999 110.683 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.8 t -146.91 118.82 4.76 Favored Pre-proline 0 N--CA 1.446 -0.635 0 O-C-N 122.09 -0.381 . . . . 72.200000000000003 110.3 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.65 148.13 22.66 Favored 'Trans proline' 0 C--O 1.249 1.067 0 C-N-CA 123.209 2.606 . . . . 62.299999999999997 113.947 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.72 164.39 33.78 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 123.567 2.845 . . . . 64.439999999999998 110.217 175.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.5 t -100.51 156.48 4.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.742 -1.207 . . . . 72.200000000000003 107.742 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.89 116.34 24.96 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 122.024 0.916 . . . . 74.129999999999995 112.371 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.37 -160.5 8.34 Favored Glycine 0 N--CA 1.415 -2.748 0 N-CA-C 109.634 -1.387 . . . . 62.420000000000002 109.634 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -60.64 104.8 0.38 Allowed 'General case' 0 N--CA 1.398 -3.066 0 C-N-CA 124.792 1.237 . . . . 61.130000000000003 110.011 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -82.39 105.74 13.69 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 106.643 -1.614 . . . . 53.329999999999998 106.643 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.69 -179.23 5.21 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.421 -0.809 . . . . 72.5 109.207 -174.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.3 m -74.14 93.82 2.35 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.045 -0.724 . . . . 73.430000000000007 109.045 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.42 HG11 ' OD2' ' A' ' 109' ' ' ASP . 31.7 t -98.98 143.8 12.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.562 -0.903 . . . . 70.319999999999993 108.562 -177.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.4 tp -161.57 -75.31 0.05 Allowed 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 122.133 0.968 . . . . 73.230000000000004 109.654 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -151.0 169.46 21.74 Favored 'General case' 0 C--N 1.259 -3.343 0 CA-C-N 112.945 -1.934 . . . . 72.230000000000004 108.193 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.419 ' O ' HG22 ' A' ' 110' ' ' ILE . 70.1 t80 -33.16 -63.47 0.23 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 115.559 1.689 . . . . 73.329999999999998 115.559 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.62 -42.62 93.1 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.914 0.709 . . . . 70.209999999999994 112.914 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.64 -36.18 62.88 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.256 -0.577 . . . . 54.520000000000003 109.714 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.534 ' O ' HG12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -64.88 -50.71 65.49 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 124.024 0.828 . . . . 63.43 110.134 177.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 106' ' ' PHE . 7.6 tp -63.55 -36.25 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-O 120.914 0.388 . . . . 75.439999999999998 110.116 -176.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.37 -48.06 83.38 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.545 -0.752 . . . . 75.129999999999995 110.387 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 6.4 t -67.36 -36.31 81.13 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 116.065 -0.516 . . . . 71.230000000000004 109.782 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 109' ' ' ASP . 49.9 mm -64.89 -47.2 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.592 -0.731 . . . . 70.209999999999994 110.167 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 77.0 t -63.39 -41.0 91.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-O 121.113 0.483 . . . . 74.150000000000006 110.174 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.33 -42.95 99.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.505 -0.77 . . . . 71.030000000000001 111.13 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.01 -38.06 79.03 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 123.191 0.307 . . . . 65.209999999999994 111.373 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.418 ' O ' HD12 ' A' ' 121' ' ' LEU . 77.8 mt -64.77 -45.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.543 -0.54 . . . . 65.530000000000001 109.543 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -71.75 -31.14 66.35 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 119.19 -1.004 . . . . 72.409999999999997 112.307 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.62 -43.75 88.6 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 109.156 -0.683 . . . . 74.109999999999999 109.156 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 52.1 t -58.66 -46.87 86.24 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.531 -0.758 . . . . 71.439999999999998 110.64 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 117' ' ' ILE . 9.0 mp -73.26 -26.64 61.18 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.022 0.439 . . . . 73.230000000000004 111.811 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.68 -32.47 28.11 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 111.945 0.35 . . . . 72.349999999999994 111.945 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -87.73 9.93 19.96 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.486 0.55 . . . . 72.209999999999994 112.486 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -52.43 127.57 33.78 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.076 -0.511 . . . . 37.5 112.142 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.417 ' H ' ' HB2' ' A' ' 22' ' ' HIS 0.326 0.7 OUTLIER 86.2 22.32 0.07 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.742 1.617 . . . . 72.530000000000001 113.608 -178.086 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.2 mt -135.42 86.27 2.23 Favored 'General case' 0 C--N 1.264 -3.135 0 CA-C-N 112.861 -1.972 . . . . 74.099999999999994 106.603 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -153.26 155.6 36.88 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.38 -0.528 . . . . 62.210000000000001 110.424 -173.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 25.0 m -127.35 101.9 6.67 Favored 'General case' 0 N--CA 1.393 -3.317 0 N-CA-C 109.068 -0.716 . . . . 73.409999999999997 109.068 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 83.1 112.87 0.06 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.928 1.291 . . . . 74.430000000000007 113.433 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 31.3 tp -66.03 156.34 34.03 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 115.075 -0.966 . . . . 70.239999999999995 110.563 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -145.32 119.4 9.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.652 -1.24 . . . . 70.219999999999999 107.652 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.76 -167.81 46.71 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 120.61 -0.805 . . . . 71.409999999999997 111.607 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -138.68 137.92 20.93 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.771 -0.826 . . . . 74.239999999999995 108.771 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -49.3 124.19 11.41 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.728 2.952 . . . . 75.120000000000005 113.529 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 50.2 mm -87.84 128.83 52.73 Favored Pre-proline 0 N--CA 1.421 -1.902 0 N-CA-C 108.854 -0.795 . . . . 64.019999999999996 108.854 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.19 170.93 7.03 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 124.374 3.382 . . . . 72.209999999999994 114.081 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -151.51 157.05 34.95 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 108.24 -1.022 . . . . 72.420000000000002 108.24 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.93 -6.57 10.45 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 121.978 1.785 . . . . 74.120000000000005 111.129 175.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 55.5 tp 64.96 101.01 0.04 OUTLIER 'General case' 0 C--N 1.346 0.434 0 C-N-CA 124.789 1.236 . . . . 73.040000000000006 109.756 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.5 tp -118.92 117.29 28.43 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.948 -0.569 . . . . 61.140000000000001 110.338 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -106.82 98.2 1.3 Allowed Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 109.913 -1.275 . . . . 74.219999999999999 109.913 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.48 157.32 19.08 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.454 0.645 . . . . 72.519999999999996 111.59 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -103.12 91.97 4.33 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.21 -0.663 . . . . 74.129999999999995 109.21 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 20.4 m -140.16 35.47 1.91 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 123.252 1.501 . . . . 72.519999999999996 108.037 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.5 m -97.24 84.88 3.56 Favored 'General case' 0 C--N 1.265 -3.075 0 CA-C-N 112.021 -2.354 . . . . 74.409999999999997 106.713 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -135.62 149.47 49.36 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.986 -1.006 . . . . 70.420000000000002 109.393 -173.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 55.5 m -146.18 150.13 35.26 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.357 -1.349 . . . . 73.310000000000002 107.357 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.528 0 C-N-CA 120.422 -0.894 . . . . 44.210000000000001 110.897 179.057 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 tpt . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.22 0.533 . . . . 74.010000000000005 110.282 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.49 157.71 16.98 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.164 -1.05 . . . . 54.420000000000002 108.164 175.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 73.4 m-85 -111.62 136.24 51.11 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.363 -0.977 . . . . 74.030000000000001 108.363 174.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -113.15 114.29 26.58 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.967 -1.015 . . . . 63.229999999999997 108.491 -173.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -90.28 113.88 27.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 109.509 -0.552 . . . . 75.340000000000003 109.509 -174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.29 111.92 38.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 108.73 -0.841 . . . . 75.120000000000005 108.73 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.466 HG22 ' HB2' ' A' ' 27' ' ' MET . 4.5 tt -104.17 121.24 55.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 CA-C-N 115.754 -0.657 . . . . 75.329999999999998 110.26 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 19.8 mm -99.58 106.32 39.16 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 107.861 -1.163 . . . . 74.310000000000002 107.861 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 18.4 Cg_endo -94.35 137.84 1.06 Allowed 'Trans proline' 0 N--CA 1.437 -1.836 0 C-N-CA 122.283 1.989 . . . . 73.329999999999998 111.432 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -146.89 154.98 41.94 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.155 -0.683 . . . . 71.25 109.155 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.521 ' OG ' ' HB3' ' A' ' 22' ' ' HIS . 90.0 p -79.85 156.1 27.52 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 107.296 -1.372 . . . . 73.230000000000004 107.296 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.47 ' HB3' ' CG ' ' A' ' 79' ' ' LYS . 53.7 t80 -81.63 76.89 8.53 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 109.16 -0.681 . . . . 75.239999999999995 109.16 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.403 ' CD2' ' HB3' ' A' ' 125' ' ' GLU . 71.5 m80 -150.82 101.96 2.95 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-N 114.761 -1.109 . . . . 75.450000000000003 110.439 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -88.1 155.77 19.62 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 106.863 -1.532 . . . . 74.120000000000005 106.863 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -55.82 99.84 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 115.527 1.677 . . . . 75.540000000000006 115.527 -173.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 17' ' ' LYS . 23.4 t70 -85.63 -152.23 0.16 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 113.088 -1.869 . . . . 52.310000000000002 106.799 172.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.473 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 9.3 tmtt? -69.82 -58.76 3.5 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.282 -1.007 . . . . 73.409999999999997 108.282 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -138.77 -51.78 0.56 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.514 -0.874 . . . . 72.519999999999996 112.451 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -90.12 55.2 3.02 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.581 1.326 . . . . 73.310000000000002 114.581 -166.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 61.1 mtt -162.85 90.74 0.71 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 125.682 1.593 . . . . 72.319999999999993 107.263 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -175.37 118.19 0.17 Allowed 'General case' 0 N--CA 1.424 -1.762 0 C-N-CA 124.741 1.217 . . . . 62.310000000000002 108.345 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.521 ' HB3' ' OG ' ' A' ' 11' ' ' SER . 10.8 t60 -169.78 110.92 0.44 Allowed 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.419 -0.81 . . . . 74.310000000000002 110.037 170.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.404 HG21 ' CA ' ' A' ' 132' ' ' GLY . 45.3 mm -112.19 139.69 35.54 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 105.04 -2.207 . . . . 70.319999999999993 105.04 175.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 50.9 m -108.17 145.85 32.32 Favored Pre-proline 0 C--N 1.274 -2.684 0 N-CA-C 109.008 -0.738 . . . . 75.519999999999996 109.008 -178.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.88 150.43 83.48 Favored 'Trans proline' 0 C--O 1.248 0.99 0 C-N-CA 122.455 2.103 . . . . 63.5 112.072 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.516 ' HD3' ' OE1' ' A' ' 131' ' ' GLU . 22.9 Cg_exo -66.45 137.75 47.9 Favored 'Trans proline' 0 CA--C 1.503 -1.039 0 C-N-CA 122.998 2.465 . . . . 72.319999999999993 111.344 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.466 ' HB2' HG22 ' A' ' 7' ' ' ILE . 48.2 mtp -99.81 128.85 45.88 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 105.922 -1.881 . . . . 75.549999999999997 105.922 173.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.7 t -111.4 123.73 67.52 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 C-N-CA 119.786 -0.766 . . . . 53.539999999999999 109.373 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.2 mp -122.31 102.31 11.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.763 -1.569 . . . . 74.150000000000006 106.763 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.18 -169.01 14.21 Favored Glycine 0 C--N 1.276 -2.804 0 C-N-CA 119.225 -1.465 . . . . 75.299999999999997 114.178 -172.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.1 t70 57.37 43.26 23.58 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 123.043 1.402 . . . . 65.129999999999995 110.156 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -116.92 136.14 53.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 105.708 -1.96 . . . . 75.209999999999994 105.708 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 p -79.83 169.63 17.65 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 119.211 0.914 . . . . 75.030000000000001 108.645 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.605 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 68.0 t80 -57.48 -45.67 84.59 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 123.188 0.595 . . . . 74.430000000000007 111.573 -172.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -66.87 -42.15 86.09 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 114.735 -1.12 . . . . 74.409999999999997 110.725 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.7 mt -72.97 -36.86 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 115.325 -0.852 . . . . 72.299999999999997 109.865 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.401 ' HA ' HG23 ' A' ' 40' ' ' ILE . . . -64.06 -41.16 97.46 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.954 -0.566 . . . . 73.030000000000001 110.324 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.2 ttm -70.3 -37.95 74.89 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 120.139 -0.624 . . . . 62.0 110.819 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -73.12 -36.0 66.64 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.428 0.899 . . . . 72.420000000000002 113.428 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.412 ' O ' HG22 ' A' ' 44' ' ' VAL . 11.6 tt -68.31 -40.87 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 119.842 -0.743 . . . . 72.409999999999997 109.28 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.4 t -65.42 -43.82 94.56 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.864 0 N-CA-C 109.57 -0.53 . . . . 72.340000000000003 109.57 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -59.42 -39.24 82.86 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.595 0.358 . . . . 72.329999999999998 111.82 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.8 -44.0 95.37 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.714 -0.755 . . . . 74.109999999999999 111.369 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 40' ' ' ILE . 56.6 t -71.06 -39.09 74.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.378 -0.601 . . . . 61.420000000000002 109.378 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.433 ' OD2' HG22 ' A' ' 56' ' ' VAL . 14.1 t70 -56.68 -46.93 80.85 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.752 1.621 . . . . 64.450000000000003 109.966 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -64.73 -40.56 95.52 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.157 -0.929 . . . . 75.140000000000001 109.917 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.1 t -66.77 -39.29 83.32 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 CA-C-N 116.311 -0.404 . . . . 62.229999999999997 111.139 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 72.9 mt -69.44 -40.74 80.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 110.66 -0.126 . . . . 73.209999999999994 110.66 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -71.92 -30.79 65.72 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.337 -0.545 . . . . 74.25 110.607 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.2 -45.66 11.8 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 112.545 0.572 . . . . 73.349999999999994 112.545 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.5 m -85.44 -20.01 30.44 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.885 0.698 . . . . 73.209999999999994 112.885 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 48' ' ' ILE . 6.4 m-85 -123.15 157.08 33.74 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-O 121.145 0.498 . . . . 72.519999999999996 109.683 -175.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.552 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 45.1 t30 -85.86 87.35 7.4 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 104.367 -2.457 . . . . 60.030000000000001 104.367 172.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -133.5 136.25 44.95 Favored 'General case' 0 N--CA 1.397 -3.112 0 CA-C-N 115.434 -0.803 . . . . 72.310000000000002 111.975 -173.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 72' ' ' THR . 41.0 p -95.8 122.77 38.94 Favored 'General case' 0 N--CA 1.404 -2.731 0 N-CA-C 106.727 -1.582 . . . . 62.0 106.727 171.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.433 HG22 ' OD2' ' A' ' 45' ' ' ASP . 3.2 p -99.68 119.34 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 N-CA-C 108.126 -1.065 . . . . 71.329999999999998 108.126 177.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.414 ' HG2' HD22 ' A' ' 139' ' ' LEU . 28.3 mt-10 -117.61 112.28 20.33 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 114.12 -1.4 . . . . 64.109999999999999 108.584 -174.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -94.21 122.36 36.66 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.406 0.622 . . . . 72.129999999999995 111.464 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mp -121.94 178.11 5.02 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 115.197 -0.91 . . . . 54.329999999999998 109.193 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -95.61 140.8 29.91 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.325 -0.852 . . . . 72.019999999999996 108.748 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.12 175.69 41.57 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 115.574 -0.739 . . . . 54.539999999999999 113.089 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -72.52 174.87 6.85 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 123.995 0.918 . . . . 70.420000000000002 108.595 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -49.73 -41.33 43.39 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 124.613 1.165 . . . . 72.109999999999999 113.034 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.01 -8.54 57.88 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.124 -0.944 . . . . 70.010000000000005 111.644 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -99.15 159.08 15.23 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 107.667 -1.234 . . . . 74.209999999999994 107.667 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.75 -37.64 3.67 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.638 0 CA-C-O 121.57 0.7 . . . . 74.030000000000001 110.212 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.7 tp -156.88 144.24 18.9 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.798 -1.186 . . . . 73.120000000000005 107.798 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -131.32 107.12 8.73 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.857 -0.794 . . . . 74.319999999999993 108.857 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -116.19 129.33 56.25 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.017 -1.073 . . . . 74.430000000000007 111.262 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -109.32 128.89 55.45 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.532 -0.758 . . . . 53.420000000000002 109.447 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -105.91 134.72 48.58 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 107.255 -1.387 . . . . 74.230000000000004 107.255 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 30.6 m -109.18 107.3 17.53 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 106.578 -1.638 . . . . 62.229999999999997 106.578 173.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.66 140.13 41.16 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 120.954 0.407 . . . . 74.319999999999993 111.865 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.552 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 44.3 tt0 -147.81 86.82 1.6 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.627 -0.715 . . . . 74.299999999999997 109.073 168.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -95.91 104.0 15.91 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.922 -0.581 . . . . 72.25 110.556 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 56.9 34.81 25.43 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.804 0.69 . . . . 74.150000000000006 112.46 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.94 -7.88 57.47 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 120.754 -0.736 . . . . 55.539999999999999 113.086 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 53.4 mtpt -92.37 102.11 14.59 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.108 -1.071 . . . . 73.200000000000003 108.108 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.542 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -102.09 138.19 39.37 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.576 -0.738 . . . . 75.420000000000002 111.21 -173.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.434 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . -164.03 164.48 36.55 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.438 -0.411 . . . . 54.43 112.751 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 34.0 mm -120.13 134.63 63.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 105.584 -2.006 . . . . 74.200000000000003 105.584 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.6 t -127.57 120.3 54.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.879 -0.513 . . . . 62.310000000000002 110.25 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.414 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 67.1 m-70 -105.62 104.14 13.8 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.328 -0.619 . . . . 65.099999999999994 109.328 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.3 t -100.11 110.59 27.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 109.669 -0.493 . . . . 74.140000000000001 109.669 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -112.55 140.54 47.22 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.042 0.449 . . . . 72.510000000000005 110.406 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.2 mt -97.78 125.7 42.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 105.831 -1.915 . . . . 73.140000000000001 105.831 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -104.55 141.54 36.23 Favored 'General case' 0 C--N 1.273 -2.761 0 N-CA-C 108.017 -1.105 . . . . 73.510000000000005 108.017 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 51.0 pttt -90.0 98.04 11.54 Favored 'General case' 0 C--N 1.279 -2.48 0 C-N-CA 119.294 -0.962 . . . . 64.510000000000005 108.958 172.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.3 tt -74.13 112.31 10.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 121.261 -0.899 . . . . 61.25 110.39 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.34 177.14 8.46 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.084 -1.08 . . . . 62.149999999999999 108.084 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -77.99 -13.83 59.74 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 118.774 0.715 . . . . 61.140000000000001 111.119 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -109.02 9.82 26.31 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.124 -0.943 . . . . 62.310000000000002 110.156 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 42.1 t -147.84 102.07 3.66 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 109.075 -0.713 . . . . 74.439999999999998 109.075 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.56 139.65 25.77 Favored 'Trans proline' 0 C--O 1.252 1.224 0 C-N-CA 122.429 2.086 . . . . 63.210000000000001 113.851 -174.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.62 161.07 28.08 Favored 'Trans proline' 0 N--CA 1.439 -1.71 0 C-N-CA 122.45 2.1 . . . . 70.319999999999993 108.78 173.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.3 t -91.68 157.92 2.92 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.559 0 N-CA-C 107.232 -1.396 . . . . 73.420000000000002 107.232 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -109.82 133.48 53.1 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.09 -1.078 . . . . 71.239999999999995 108.09 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -155.52 -144.88 4.03 Favored Glycine 0 N--CA 1.413 -2.867 0 C-N-CA 119.842 -1.171 . . . . 72.5 112.244 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -64.9 127.01 29.81 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 113.456 -1.372 . . . . 53.229999999999997 109.521 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -77.11 99.33 5.33 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.549 -1.278 . . . . 74.349999999999994 107.549 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 44.1 t -79.96 152.59 29.43 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 115.404 -0.816 . . . . 72.239999999999995 109.565 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.8 m -76.6 86.4 3.28 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.232 -1.025 . . . . 63.119999999999997 108.232 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 28.8 t -115.51 138.0 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.515 -174.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 103' ' ' VAL . 25.6 mt -170.55 -49.98 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 126.556 1.943 . . . . 65.400000000000006 110.948 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.6 142.37 17.8 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 113.996 -1.456 . . . . 75.530000000000001 107.537 -172.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -32.96 -44.43 0.11 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.145 2.178 . . . . 74.200000000000003 116.552 -170.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -54.84 -53.72 51.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.373 0.606 . . . . 73.25 112.567 -175.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -80.72 -30.14 36.31 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.989 -0.55 . . . . 71.049999999999997 110.041 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.94 -47.88 81.33 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.944 -1.026 . . . . 75.420000000000002 109.477 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.7 tt -65.53 -37.0 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.552 -0.295 . . . . 52.310000000000002 110.523 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.28 -48.32 82.25 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 109.655 -0.498 . . . . 73.109999999999999 109.655 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 21.5 t -62.81 -39.25 93.71 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.514 -0.767 . . . . 70.129999999999995 111.632 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 75.9 mt -70.18 -45.71 74.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 120.505 -0.478 . . . . 74.439999999999998 110.846 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.6 t -70.19 -38.86 75.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.264 -0.574 . . . . 64.209999999999994 110.72 -176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -74.53 -22.05 59.22 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 112.291 0.478 . . . . 75.200000000000003 112.291 -176.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.465 ' HB3' ' SD ' ' A' ' 27' ' ' MET . . . -83.04 -37.69 23.56 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 119.073 -1.051 . . . . 63.299999999999997 110.486 175.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.511 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 81.6 mt -62.48 -45.37 98.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 108.968 -0.752 . . . . 55.549999999999997 108.968 175.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -54.4 -43.64 71.63 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 123.575 0.75 . . . . 60.450000000000003 112.382 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 22.5 mm-40 -65.7 -44.11 87.13 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.818 0.699 . . . . 74.450000000000003 110.93 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 36.5 t -62.4 -40.94 98.15 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.198 0.523 . . . . 43.0 110.163 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 117' ' ' ILE . 70.6 mt -71.82 -29.14 64.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.977 -0.556 . . . . 74.019999999999996 110.656 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.08 -31.81 39.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 112.727 0.64 . . . . 74.540000000000006 112.727 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 119' ' ' GLU . 72.3 mmtt -65.56 -40.25 92.62 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 119.841 -0.743 . . . . 63.520000000000003 109.933 -177.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.62 -154.3 50.76 Favored Glycine 0 C--N 1.291 -1.966 0 CA-C-N 114.44 -1.254 . . . . 63.219999999999999 114.798 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 13' ' ' HIS . 9.2 pt-20 -63.8 133.12 52.86 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 124.703 1.201 . . . . 61.109999999999999 112.799 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp 74.03 80.23 0.12 Allowed 'General case' 0 C--O 1.244 0.795 0 C-N-CA 124.983 1.313 . . . . 72.030000000000001 111.783 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -161.38 165.96 28.13 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.106 -1.072 . . . . 71.319999999999993 108.106 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.5 m -41.97 128.16 3.47 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.075 1.75 . . . . 64.030000000000001 114.753 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' A' ' 129' ' ' LYS . 1.2 pptp? -145.8 142.37 28.81 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.348 -0.982 . . . . 52.149999999999999 108.348 173.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 46.0 tp -158.0 25.96 0.26 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.326 1.06 . . . . 75.25 108.457 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.516 ' OE1' ' HD3' ' A' ' 26' ' ' PRO . 14.3 pt-20 -177.37 -171.81 0.35 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.326 -1.307 . . . . 74.129999999999995 107.749 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.404 ' CA ' HG21 ' A' ' 23' ' ' ILE . . . 131.28 151.15 6.9 Favored Glycine 0 N--CA 1.431 -1.64 0 O-C-N 123.868 0.73 . . . . 50.219999999999999 112.551 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -143.35 70.24 17.83 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 107.167 -1.42 . . . . 64.5 107.167 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.73 104.85 1.87 Allowed 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 122.466 2.111 . . . . 52.109999999999999 111.468 -173.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 7.4 tp -127.31 102.07 24.2 Favored Pre-proline 0 N--CA 1.42 -1.971 0 CA-C-O 121.823 0.82 . . . . 62.310000000000002 110.919 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.95 160.66 27.14 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.707 2.271 . . . . 73.319999999999993 111.537 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -162.87 125.69 1.73 Allowed Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 108.523 -0.917 . . . . 74.340000000000003 108.523 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -69.05 -15.82 40.05 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.746 2.298 . . . . 75.239999999999995 112.657 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.414 HD22 ' HG2' ' A' ' 57' ' ' GLU . 25.2 tp 71.51 153.33 0.12 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.132 1.373 . . . . 53.119999999999997 111.46 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.3 tp -68.41 122.04 17.58 Favored 'General case' 0 C--O 1.249 1.046 0 N-CA-C 108.464 -0.939 . . . . 64.430000000000007 108.464 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.71 77.98 1.55 Allowed Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 115.716 -0.674 . . . . 37.509999999999998 112.656 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 tt -116.18 101.59 8.85 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 104.963 -2.236 . . . . 64.439999999999998 104.963 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -88.94 158.32 18.09 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.191 0.519 . . . . 65.329999999999998 110.616 -175.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.4 m -114.25 98.97 7.26 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 115.508 -0.769 . . . . 64.319999999999993 109.105 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 87.3 m -98.56 88.65 4.15 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.694 -1.224 . . . . 72.430000000000007 107.694 173.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -108.88 137.4 46.87 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.043 -1.435 . . . . 74.519999999999996 109.488 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.2 m -84.42 81.98 8.59 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 108.365 -0.976 . . . . 70.209999999999994 108.365 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.349 0 N-CA-C 109.806 -1.318 . . . . 42.43 109.806 -178.781 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptm . . . . . 0 CA--C 1.515 -0.388 0 N-CA-C 109.375 -0.602 . . . . 65.239999999999995 109.375 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 31' ' ' ASP . 87.5 tttt -122.3 136.96 54.99 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.072 0.463 . . . . 73.299999999999997 111.499 -173.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.586 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 19.2 m-85 -117.24 152.44 34.82 Favored 'General case' 0 C--O 1.251 1.169 0 C-N-CA 125.0 1.32 . . . . 74.340000000000003 109.338 173.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.629 ' OD1' ' HA3' ' A' ' 30' ' ' GLY . 24.6 t70 -123.67 108.77 12.93 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.581 -1.637 . . . . 55.450000000000003 106.581 -177.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.44 127.05 48.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.195 0.522 . . . . 62.119999999999997 111.927 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' A' ' 85' ' ' LYS . 4.8 p -115.15 121.66 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.621 0 N-CA-C 108.156 -1.053 . . . . 75.340000000000003 108.156 176.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.466 HG23 ' CG ' ' A' ' 27' ' ' MET . 1.9 tt -122.2 123.48 68.95 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 CA-C-N 115.392 -0.822 . . . . 73.099999999999994 109.878 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.527 ' CG1' ' HB2' ' A' ' 83' ' ' HIS . 40.2 pt -108.06 118.59 52.27 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.864 -0.607 . . . . 53.049999999999997 110.463 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 11.5 Cg_endo -90.94 142.7 3.21 Favored 'Trans proline' 0 N--CA 1.431 -2.152 0 C-N-CA 122.153 1.902 . . . . 72.019999999999996 109.726 170.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -151.41 146.95 26.32 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 108.909 -0.774 . . . . 72.5 108.909 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.621 ' OG ' ' HB3' ' A' ' 22' ' ' HIS . 86.5 p -90.4 143.9 26.32 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.302 -1.37 . . . . 72.420000000000002 107.302 175.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.534 ' CE1' ' HB2' ' A' ' 79' ' ' LYS 0.351 1.6 p90 -80.61 87.5 5.76 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 118.098 -1.441 . . . . 74.230000000000004 113.189 178.379 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -130.14 99.53 5.09 Favored 'General case' 0 N--CA 1.414 -2.271 0 CA-C-N 113.729 -1.578 . . . . 63.210000000000001 110.833 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.92 118.05 9.86 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 122.305 1.05 . . . . 63.340000000000003 109.395 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 20' ' ' MET . 56.1 t80 -60.71 111.62 1.69 Allowed 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 112.208 -2.269 . . . . 74.019999999999996 111.074 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -85.69 -105.04 0.06 Allowed 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 113.433 -1.712 . . . . 73.25 110.218 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -112.35 -57.31 2.29 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.451 0.644 . . . . 72.540000000000006 110.627 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -124.92 -23.28 4.31 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.497 -0.774 . . . . 75.540000000000006 109.909 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -103.07 157.41 17.01 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.554 -0.748 . . . . 75.129999999999995 111.654 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 83.1 mtp 72.96 76.7 0.14 Allowed 'General case' 0 C--O 1.209 -1.038 0 O-C-N 124.829 1.331 . . . . 71.439999999999998 114.085 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -161.2 99.39 1.19 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.305 -0.998 . . . . 73.109999999999999 108.305 171.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.621 ' HB3' ' OG ' ' A' ' 11' ' ' SER . 47.0 t60 -136.63 93.04 2.82 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.651 -0.87 . . . . 72.439999999999998 108.651 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.2 mm -109.01 138.53 35.73 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 106.126 -1.805 . . . . 72.219999999999999 106.126 176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 62.9 m -106.81 122.73 40.79 Favored Pre-proline 0 C--N 1.273 -2.736 0 C-N-CA 120.278 -0.569 . . . . 63.009999999999998 110.078 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -49.55 143.35 21.66 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.976 3.117 . . . . 50.43 113.733 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.85 133.05 55.75 Favored 'Trans proline' 0 CA--C 1.509 -0.727 0 C-N-CA 123.792 2.995 . . . . 73.129999999999995 113.051 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.466 ' CG ' HG23 ' A' ' 7' ' ' ILE . 22.1 ptp -106.07 141.55 37.25 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.652 -1.611 . . . . 74.409999999999997 106.652 172.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.412 ' O ' HD11 ' A' ' 29' ' ' ILE . 39.8 t -133.86 127.75 52.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 120.229 -0.588 . . . . 51.210000000000001 110.91 -169.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.412 HD11 ' O ' ' A' ' 28' ' ' VAL . 45.3 mm -129.17 103.8 9.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.715 -1.217 . . . . 75.319999999999993 107.715 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.629 ' HA3' ' OD1' ' A' ' 4' ' ' ASP . . . -123.04 88.91 0.41 Allowed Glycine 0 N--CA 1.419 -2.461 0 C-N-CA 118.919 -1.61 . . . . 72.420000000000002 113.618 -175.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.42 ' HA ' ' HE3' ' A' ' 2' ' ' LYS . 5.9 p-10 -165.52 29.29 0.05 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.991 0.901 . . . . 74.349999999999994 109.118 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -118.32 136.98 53.39 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-N 115.572 -0.74 . . . . 74.340000000000003 109.21 -170.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.4 p -76.31 169.66 17.8 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 106.765 -1.568 . . . . 65.150000000000006 106.765 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.586 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 84.8 t80 -59.0 -39.21 81.15 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.465 0.65 . . . . 74.329999999999998 110.758 -177.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.15 -50.31 72.38 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.144 -1.389 . . . . 72.109999999999999 110.755 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.3 mt -69.99 -37.19 71.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.5 -0.555 . . . . 63.43 109.5 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.1 94.01 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.612 -0.722 . . . . 70.329999999999998 110.8 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.6 tpp -69.76 -41.15 75.57 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 120.103 -0.639 . . . . 41.25 110.16 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.4 -38.03 80.92 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 112.489 0.552 . . . . 73.019999999999996 112.489 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.463 ' O ' HG21 ' A' ' 44' ' ' VAL . 14.4 tt -69.52 -39.39 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 119.516 -0.874 . . . . 72.25 110.114 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.7 t -67.95 -40.41 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 120.544 -0.462 . . . . 55.539999999999999 109.964 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -69.55 -25.91 64.24 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.77 0.319 . . . . 72.209999999999994 111.559 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.59 -46.51 39.3 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 110.541 -1.024 . . . . 73.049999999999997 110.541 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 48' ' ' ILE . 86.3 t -61.1 -42.62 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 109.21 -0.663 . . . . 64.530000000000001 109.21 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -49.92 -52.36 33.87 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 125.912 1.685 . . . . 72.439999999999998 111.057 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -68.28 -35.19 77.48 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.773 -1.103 . . . . 73.310000000000002 110.387 -175.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 91.6 t -71.73 -36.56 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 116.075 -0.511 . . . . 71.439999999999998 111.253 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 44' ' ' VAL . 60.4 mt -68.35 -38.76 79.89 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.959 0 N-CA-C 109.541 -0.54 . . . . 74.450000000000003 109.541 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -66.62 -33.84 76.55 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.803 0.335 . . . . 74.209999999999994 111.682 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.99 -25.5 34.7 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.452 0.538 . . . . 73.409999999999997 112.452 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.9 m -99.48 -23.96 14.93 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.164 0.801 . . . . 75.120000000000005 113.164 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -133.24 -172.52 2.96 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.792 0.806 . . . . 74.450000000000003 111.6 -173.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -106.93 100.25 9.77 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 104.287 -2.486 . . . . 71.319999999999993 104.287 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -114.69 144.49 43.36 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 113.343 0.868 . . . . 72.319999999999993 113.343 -169.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -123.68 112.15 17.04 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.798 -1.556 . . . . 73.109999999999999 106.798 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -100.55 137.2 28.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.127 0.489 . . . . 74.310000000000002 109.993 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -136.32 117.96 14.96 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.223 -1.029 . . . . 73.340000000000003 108.223 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -97.65 129.25 44.75 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.55 -0.86 . . . . 71.120000000000005 111.366 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.2 mp -122.51 177.44 5.41 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.744 -1.116 . . . . 37.469999999999999 108.072 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -101.58 161.83 13.35 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.389 -1.337 . . . . 73.040000000000006 107.389 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.39 176.63 19.7 Favored Glycine 0 N--CA 1.413 -2.85 0 N-CA-C 111.052 -0.819 . . . . 53.530000000000001 111.052 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.468 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 11.9 pt-20 -65.23 -178.33 0.47 Allowed 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 123.403 0.681 . . . . 61.109999999999999 110.418 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -50.13 -38.45 39.15 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 114.442 1.275 . . . . 75.409999999999997 114.442 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 44.0 t -92.96 -0.93 57.11 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 121.687 0.756 . . . . 75.340000000000003 110.558 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.506 ' OD1' ' HG2' ' A' ' 87' ' ' ARG . 88.0 m-20 -100.75 152.82 20.03 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-N 115.974 -0.557 . . . . 74.349999999999994 110.077 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -113.45 -24.89 3.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-O 121.288 0.566 . . . . 63.329999999999998 111.893 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.2 tp -154.36 141.73 19.63 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 109.141 -0.688 . . . . 73.129999999999995 109.141 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -130.34 102.13 6.06 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 106.655 -1.609 . . . . 74.239999999999995 106.655 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -111.24 124.63 52.61 Favored 'General case' 0 C--N 1.281 -2.38 0 C-N-CA 119.436 -0.906 . . . . 74.439999999999998 109.642 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -105.74 143.27 34.13 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.284 -0.636 . . . . 73.109999999999999 109.284 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -127.88 126.26 41.22 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.384 -0.969 . . . . 72.450000000000003 108.384 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.0 m -103.28 117.0 33.52 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.112 -1.81 . . . . 65.209999999999994 106.112 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.55 144.31 49.17 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.415 0.626 . . . . 75.5 112.393 -170.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.497 ' OE2' ' HG ' ' A' ' 140' ' ' LEU . 22.2 mt-10 -147.55 160.4 42.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.574 1.178 . . . . 63.420000000000002 111.134 171.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -154.29 157.44 38.68 Favored 'General case' 0 C--N 1.258 -3.409 0 N-CA-C 102.327 -3.212 . . . . 75.040000000000006 102.327 165.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -53.06 99.59 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.994 0.902 . . . . 52.520000000000003 112.726 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.72 0.51 56.46 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.401 -0.818 . . . . 71.219999999999999 112.648 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 95.6 mttt -134.33 108.55 8.26 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.047 -1.094 . . . . 53.420000000000002 108.047 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.534 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 16.5 ptpt -131.64 132.66 44.19 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.397 0.517 . . . . 71.340000000000003 112.397 -174.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.87 177.27 43.99 Favored Glycine 0 C--O 1.215 -1.036 0 C-N-CA 119.955 -1.117 . . . . 65.430000000000007 113.819 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.0 mt -129.22 148.81 33.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 106.884 -1.524 . . . . 62.539999999999999 106.884 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.25 123.86 51.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.634 -0.506 . . . . 64.349999999999994 109.634 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.527 ' HB2' ' CG1' ' A' ' 8' ' ' ILE . 11.9 m170 -110.7 112.44 24.32 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.641 -0.503 . . . . 74.019999999999996 109.641 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.47 114.51 42.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.514 -0.921 . . . . 74.140000000000001 108.514 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.418 ' HB3' HG11 ' A' ' 6' ' ' VAL . 59.9 tttp -115.72 118.28 32.63 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.958 -1.127 . . . . 74.420000000000002 107.958 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.5 mt -98.16 114.63 26.9 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 107.232 -1.395 . . . . 74.120000000000005 107.232 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.506 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 76.0 mtp85 -102.42 139.62 37.78 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.581 0.705 . . . . 71.519999999999996 110.073 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -90.71 98.27 11.68 Favored 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 115.089 -0.96 . . . . 73.439999999999998 108.49 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 tt -75.14 110.81 10.49 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-O 122.824 1.297 . . . . 70.209999999999994 109.173 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.1 p -123.31 -170.81 2.18 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 113.773 -1.558 . . . . 74.310000000000002 107.744 -174.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -82.63 -0.46 47.21 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.672 -0.862 . . . . 75.230000000000004 108.672 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -112.51 -5.05 14.07 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.974 -1.012 . . . . 72.140000000000001 110.18 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.2 m -137.97 113.97 9.15 Favored Pre-proline 0 C--N 1.311 -1.087 0 C-N-CA 123.202 0.601 . . . . 75.129999999999995 110.814 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.48 163.34 29.79 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 122.015 1.81 . . . . 64.049999999999997 110.552 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.96 163.2 29.32 Favored 'Trans proline' 0 C--O 1.247 0.952 0 C-N-CA 122.885 2.39 . . . . 63.030000000000001 112.048 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 t -93.41 156.54 3.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.582 -0.896 . . . . 71.430000000000007 108.582 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -106.41 141.54 37.55 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.272 -1.01 . . . . 72.510000000000005 108.272 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.42 -163.83 31.51 Favored Glycine 0 N--CA 1.419 -2.466 0 C-N-CA 120.149 -1.024 . . . . 55.109999999999999 111.714 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -69.58 139.23 53.68 Favored 'General case' 0 N--CA 1.417 -2.124 0 C-N-CA 125.205 1.402 . . . . 75.239999999999995 107.921 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -102.59 123.54 46.5 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 119.655 -0.818 . . . . 72.439999999999998 111.803 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.1 t -79.34 137.92 37.5 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.311 -1.366 . . . . 71.530000000000001 107.311 172.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.5 m -75.33 95.47 3.21 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.647 0.737 . . . . 64.019999999999996 110.191 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.426 HG13 ' CG ' ' A' ' 109' ' ' ASP . 57.7 t -97.89 147.55 6.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.778 -1.101 . . . . 54.420000000000002 109.369 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 47.1 tp -149.56 -74.1 0.17 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.289 -0.869 . . . . 70.420000000000002 109.56 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -143.56 151.41 40.18 Favored 'General case' 0 C--N 1.258 -3.385 0 N-CA-C 106.831 -1.544 . . . . 54.100000000000001 106.831 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.458 ' O ' HG21 ' A' ' 110' ' ' ILE . 79.9 t80 -35.78 -42.08 0.24 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.512 1.671 . . . . 74.219999999999999 115.512 -172.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -55.26 -47.75 74.99 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 122.804 0.442 . . . . 71.530000000000001 112.015 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.89 -34.22 30.11 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 107.672 -1.232 . . . . 63.329999999999998 107.672 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.426 ' CG ' HG13 ' A' ' 103' ' ' VAL . 26.2 m-20 -62.37 -46.8 87.0 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.476 -0.784 . . . . 74.349999999999994 110.218 -176.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 106' ' ' PHE . 8.5 tp -65.56 -41.36 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 115.571 -0.74 . . . . 73.310000000000002 110.612 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -26.37 60.32 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 120.285 -0.566 . . . . 72.340000000000003 111.572 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 12.0 t -68.26 -48.01 66.21 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 116.585 -0.28 . . . . 71.209999999999994 110.382 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.73 -42.93 93.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.216 -0.447 . . . . 72.450000000000003 110.087 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 70.9 t -64.65 -40.9 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 116.207 -0.451 . . . . 73.450000000000003 110.306 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -61.55 -44.09 97.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.351 -0.386 . . . . 74.430000000000007 111.355 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.417 ' CB ' ' HE2' ' A' ' 27' ' ' MET . . . -69.49 -35.64 75.76 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.847 0.356 . . . . 37.469999999999999 111.573 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.461 ' O ' HD12 ' A' ' 121' ' ' LEU . 80.8 mt -69.33 -44.57 80.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 109.587 -0.523 . . . . 72.439999999999998 109.587 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -60.37 -45.22 94.3 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.886 -0.783 . . . . 63.219999999999999 108.886 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 44.5 mt-10 -68.57 -33.74 74.6 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 112.081 0.4 . . . . 64.219999999999999 112.081 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 9' ' ' PRO . 30.3 t -67.42 -31.3 71.41 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.417 0.627 . . . . 60.210000000000001 109.818 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 117' ' ' ILE . 9.0 mp -81.33 -37.84 27.69 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 121.151 0.501 . . . . 71.549999999999997 110.812 176.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.4 -16.71 41.76 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 115.579 1.696 . . . . 75.430000000000007 115.579 -175.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 62.9 mttm -75.81 -3.88 37.52 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 119.884 1.22 . . . . 75.340000000000003 113.603 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.07 -157.45 20.08 Favored Glycine 0 N--CA 1.422 -2.263 0 C-N-CA 119.943 -1.122 . . . . 74.329999999999998 113.429 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 20' ' ' MET . 10.0 pt-20 -102.93 30.77 4.57 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.421 -0.889 . . . . 73.129999999999995 111.214 -174.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.9 mt -138.56 104.02 5.02 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 114.674 -1.148 . . . . 71.010000000000005 113.723 -171.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 t30 179.46 96.54 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.791 1.636 . . . . 71.209999999999994 106.682 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.6 m -59.26 172.22 0.65 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 125.278 1.431 . . . . 61.109999999999999 114.603 -171.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 57.2 tptt 83.77 93.6 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.683 1.993 . . . . 72.540000000000006 111.742 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.2 mt -76.04 81.48 2.89 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.218 -0.901 . . . . 73.120000000000005 111.163 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -105.76 11.89 31.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 123.765 1.745 . . . . 74.420000000000002 107.974 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -137.76 145.82 17.52 Favored Glycine 0 N--CA 1.413 -2.849 0 N-CA-C 105.044 -3.223 . . . . 72.109999999999999 105.044 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -121.15 93.8 48.83 Favored Pre-proline 0 C--N 1.286 -2.18 0 CA-C-N 117.982 0.891 . . . . 64.439999999999998 109.084 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.69 120.33 7.7 Favored 'Trans proline' 0 C--O 1.244 0.776 0 C-N-CA 122.868 2.379 . . . . 65.430000000000007 113.634 -171.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.9 tp -127.55 104.23 21.74 Favored Pre-proline 0 N--CA 1.428 -1.533 0 CA-C-N 115.302 -0.863 . . . . 73.5 110.634 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -67.6 132.62 27.53 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 121.789 1.659 . . . . 61.219999999999999 110.672 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -96.09 163.01 21.91 Favored Pre-proline 0 C--N 1.306 -1.306 0 CA-C-N 116.368 -0.378 . . . . 74.140000000000001 110.39 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.09 -25.09 77.12 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.741 2.294 . . . . 74.219999999999999 111.335 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 80.4 mt -85.8 104.04 15.12 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 105.747 -1.946 . . . . 55.450000000000003 105.747 173.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.497 ' HG ' ' OE2' ' A' ' 74' ' ' GLU . 13.8 tp -132.74 150.24 52.18 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.081 -1.081 . . . . 75.200000000000003 108.081 -171.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 74' ' ' GLU . . . -81.89 84.09 1.5 Allowed Glycine 0 CA--C 1.503 -0.68 0 C-N-CA 121.167 -0.54 . . . . 71.109999999999999 112.35 -173.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -84.5 32.11 0.51 Allowed 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 123.074 0.549 . . . . 72.549999999999997 112.018 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -104.78 162.37 13.37 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.846 0.832 . . . . 73.319999999999993 111.444 -176.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.7 t -151.62 46.94 0.8 Allowed 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 104.364 -2.458 . . . . 75.310000000000002 104.364 172.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.2 m -75.83 94.82 3.38 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 112.699 -2.046 . . . . 73.329999999999998 108.626 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -94.3 90.36 6.26 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.364 -0.835 . . . . 75.329999999999998 109.387 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.1 p -80.73 126.88 31.85 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-O 121.814 0.816 . . . . 73.230000000000004 112.434 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.663 0 N-CA-C 107.645 -2.182 . . . . 73.129999999999995 107.645 177.571 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 2.0 mmt . . . . . 0 CA--C 1.506 -0.732 0 CA-C-O 121.367 0.603 . . . . 71.439999999999998 112.194 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -126.18 143.77 51.01 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.671 -1.233 . . . . 55.43 107.671 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 11.8 m-85 -114.7 145.34 42.16 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 122.002 0.906 . . . . 72.099999999999994 112.778 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.558 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 35.4 t70 -106.12 100.89 10.41 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 127.026 2.131 . . . . 64.239999999999995 105.541 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -92.42 124.6 44.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.638 -0.664 . . . . 54.140000000000001 109.334 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.9 t -113.51 119.05 59.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.288 -1.004 . . . . 73.239999999999995 108.288 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.469 HG21 ' HB2' ' A' ' 27' ' ' MET . 7.7 tt -114.29 116.55 52.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 121.504 0.669 . . . . 61.140000000000001 109.391 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 20.7 mt -106.61 106.72 58.58 Favored Pre-proline 0 C--N 1.3 -1.551 0 CA-C-N 115.56 -0.745 . . . . 72.219999999999999 110.056 -175.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.533 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 25.3 Cg_endo -95.42 137.22 0.74 Allowed 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.507 2.138 . . . . 73.420000000000002 111.185 173.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' CD ' ' HZ3' ' A' ' 133' ' ' LYS . 10.1 pt-20 -158.55 137.45 11.29 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 121.845 -0.534 . . . . 71.409999999999997 111.065 177.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -84.5 106.92 16.45 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.21 -0.45 . . . . 50.409999999999997 109.853 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.62 ' CE1' ' HB2' ' A' ' 79' ' ' LYS . 2.0 p90 -63.26 106.98 0.97 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.103 1.149 . . . . 73.299999999999997 114.103 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 73.7 m80 -142.24 156.36 45.3 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.96 -1.018 . . . . 74.319999999999993 108.704 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -98.26 120.68 39.1 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 108.0 -1.111 . . . . 71.430000000000007 108.0 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -60.04 111.08 1.36 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 124.754 1.284 . . . . 75.349999999999994 110.603 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.07 -100.53 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.576 -1.193 . . . . 72.299999999999997 108.355 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -113.19 -60.31 1.9 Allowed 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 106.862 -1.533 . . . . 75.5 106.862 167.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.435 ' HA ' ' OE1' ' A' ' 21' ' ' GLU . 7.2 p-80 -138.5 34.56 2.26 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 113.797 -1.547 . . . . 74.25 110.005 175.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -135.29 152.61 51.66 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 106.619 -1.622 . . . . 61.310000000000002 106.619 -178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.428 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 0.0 OUTLIER 60.99 58.09 2.38 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.512 1.149 . . . . 62.520000000000003 110.009 -175.239 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.435 ' OE1' ' HA ' ' A' ' 18' ' ' HIS . 7.4 pt-20 -141.06 88.22 2.16 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 113.47 -1.695 . . . . 64.5 110.684 -176.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -128.75 104.65 7.75 Favored 'General case' 0 C--N 1.285 -2.22 0 O-C-N 121.68 -0.638 . . . . 72.420000000000002 109.456 174.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.6 mm -116.51 136.68 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.733 0 N-CA-C 107.02 -1.474 . . . . 70.430000000000007 107.02 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 70.2 m -108.38 145.63 31.94 Favored Pre-proline 0 C--N 1.281 -2.397 0 N-CA-C 107.335 -1.357 . . . . 73.430000000000007 107.335 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.42 152.01 33.9 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 121.902 1.734 . . . . 63.119999999999997 112.451 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.02 125.2 17.49 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.631 2.221 . . . . 64.439999999999998 111.261 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.469 ' HB2' HG21 ' A' ' 7' ' ' ILE . 38.9 mtt -95.56 134.45 38.41 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.454 -1.684 . . . . 74.129999999999995 106.454 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -131.33 136.86 56.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.383 -0.527 . . . . 65.230000000000004 110.954 -168.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.4 mp -133.65 109.17 12.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.201 -1.037 . . . . 72.129999999999995 108.201 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -119.08 81.19 0.32 Allowed Glycine 0 C--N 1.3 -1.465 0 C-N-CA 119.209 -1.472 . . . . 42.329999999999998 115.137 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -176.06 31.03 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 124.555 1.142 . . . . 53.5 112.268 172.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.65 133.23 53.36 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 106.228 -1.767 . . . . 71.329999999999998 106.228 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 p -75.13 161.48 29.36 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 119.471 1.032 . . . . 72.25 109.509 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.564 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 61.9 t80 -58.89 -43.63 90.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.499 0.666 . . . . 74.150000000000006 111.263 -173.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -70.08 -34.96 73.82 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.841 -1.072 . . . . 73.140000000000001 112.098 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.5 -35.79 17.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.404 -0.591 . . . . 52.100000000000001 109.404 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.8 -45.72 93.31 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-N 115.497 -0.774 . . . . 51.030000000000001 109.997 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 18.4 mmt -62.99 -38.11 89.87 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 116.504 -0.316 . . . . 70.109999999999999 111.249 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -65.54 -45.26 84.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.396 -0.365 . . . . 63.200000000000003 111.035 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 44' ' ' VAL . 10.4 tt -71.79 -39.73 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 119.146 -1.022 . . . . 65.299999999999997 110.541 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 83.5 t -67.8 -33.73 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 121.133 -0.227 . . . . 63.409999999999997 110.615 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -67.83 -40.94 83.7 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.86 -0.422 . . . . 75.219999999999999 109.86 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -65.34 -45.05 92.34 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-N 115.64 -0.709 . . . . 62.32 111.342 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 40' ' ' ILE . 69.7 t -61.7 -42.7 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.012 0.434 . . . . 74.519999999999996 109.875 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.56 -46.21 80.85 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 124.306 1.042 . . . . 72.239999999999995 111.225 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -71.54 -35.32 70.62 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.059 -0.973 . . . . 71.340000000000003 110.323 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 43' ' ' GLY . 97.7 t -67.73 -40.6 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 121.051 -0.259 . . . . 75.030000000000001 110.445 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 44' ' ' VAL . 74.8 mt -64.15 -39.6 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.958 0.409 . . . . 74.200000000000003 109.9 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -74.89 -19.28 60.21 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 115.973 -0.558 . . . . 75.319999999999993 111.321 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.72 -14.74 16.54 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 112.874 0.694 . . . . 73.430000000000007 112.874 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 m -108.23 -23.42 11.94 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 112.429 0.529 . . . . 70.409999999999997 112.429 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -133.97 177.93 7.35 Favored 'General case' 0 CA--C 1.484 -1.564 0 CA-C-O 121.461 0.648 . . . . 72.150000000000006 110.069 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.51 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 38.4 t30 -98.93 95.89 7.47 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 104.938 -2.245 . . . . 73.25 104.938 175.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -117.41 135.25 54.02 Favored 'General case' 0 N--CA 1.402 -2.859 0 CA-C-N 115.427 -0.806 . . . . 44.43 112.408 -173.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.4 m -109.72 121.26 44.82 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 106.812 -1.551 . . . . 74.129999999999995 106.812 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.35 128.82 51.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-O 121.294 0.568 . . . . 74.310000000000002 110.539 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -122.37 112.33 17.96 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.879 -1.526 . . . . 71.209999999999994 106.879 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.16 119.13 34.09 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.814 0.34 . . . . 61.130000000000003 110.818 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.48 174.4 6.57 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.291 0.567 . . . . 71.230000000000004 109.824 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -95.98 155.18 16.86 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.2 -1.408 . . . . 65.319999999999993 107.2 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.66 175.73 24.6 Favored Glycine 0 C--N 1.277 -2.749 0 C-N-CA 120.519 -0.848 . . . . 73.150000000000006 112.891 -176.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.503 ' HB3' ' OD2' ' A' ' 65' ' ' ASP . 11.6 tp10 -65.91 177.05 1.42 Allowed 'General case' 0 C--O 1.21 -1.025 0 C-N-CA 124.735 1.214 . . . . 72.140000000000001 108.813 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -45.25 -49.11 12.69 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 113.813 1.042 . . . . 74.420000000000002 113.813 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 76.8 m -82.03 -15.07 54.86 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.758 -0.655 . . . . 75.209999999999994 111.712 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 12.3 m-20 -98.87 118.09 34.85 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.1 -0.64 . . . . 73.219999999999999 110.618 -176.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.0 t -80.73 -36.21 15.47 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.508 0 CA-C-N 116.062 -0.517 . . . . 61.200000000000003 112.272 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.8 tp -146.48 140.68 26.4 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.896 -1.15 . . . . 75.439999999999998 107.896 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.79 102.01 6.13 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 107.374 -1.343 . . . . 65.519999999999996 107.374 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -109.43 114.53 28.25 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.83 0.824 . . . . 63.009999999999998 110.372 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -98.49 139.33 34.39 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.811 -1.086 . . . . 72.420000000000002 109.012 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.84 128.48 51.7 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 107.257 -1.386 . . . . 72.530000000000001 107.257 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.3 m -103.42 119.17 38.37 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 106.78 -1.563 . . . . 75.409999999999997 106.78 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.57 137.71 44.07 Favored 'General case' 0 CA--C 1.495 -1.156 0 CA-C-O 121.084 0.468 . . . . 61.240000000000002 112.182 -173.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.51 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -142.45 83.55 1.83 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.145 -1.428 . . . . 74.109999999999999 107.145 173.125 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -85.62 66.79 9.83 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.063 -0.517 . . . . 75.409999999999997 109.831 -177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 51.56 64.1 1.98 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.507 -1.224 . . . . 74.5 111.427 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.93 -11.8 62.39 Favored Glycine 0 C--N 1.314 -0.667 0 C-N-CA 120.666 -0.778 . . . . 74.109999999999999 112.856 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -108.64 107.7 18.28 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.38 -1.341 . . . . 64.109999999999999 107.38 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.62 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -121.63 142.65 49.92 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 113.14 0.793 . . . . 70.239999999999995 113.14 -165.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.98 171.29 43.77 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.967 -0.56 . . . . 41.409999999999997 111.877 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.4 mt -116.53 147.0 20.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.759 -1.2 . . . . 75.329999999999998 107.759 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.3 t -130.18 110.44 19.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.588 -0.893 . . . . 74.510000000000005 108.588 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 7' ' ' ILE . 38.6 m-70 -98.89 106.32 18.57 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.294 -0.632 . . . . 63.299999999999997 109.294 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.6 t -104.66 109.87 28.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.603 -0.888 . . . . 64.340000000000003 108.603 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -119.76 139.44 52.3 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.61 -0.515 . . . . 72.5 109.61 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.7 mt -102.52 106.22 16.9 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 107.385 -1.339 . . . . 74.120000000000005 107.385 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 60.0 ttt-85 -98.05 141.55 30.86 Favored 'General case' 0 C--N 1.263 -3.17 0 N-CA-C 108.843 -0.799 . . . . 64.340000000000003 108.843 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -93.59 108.35 20.08 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 109.346 -0.613 . . . . 73.0 109.346 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 tt -83.15 116.12 26.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.29 0.567 . . . . 73.420000000000002 109.68 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.8 p -115.79 -172.04 2.09 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 107.957 -1.127 . . . . 72.409999999999997 107.957 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -87.76 -13.2 42.97 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.464 0.65 . . . . 73.109999999999999 109.977 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -95.49 -38.23 10.54 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.919 -1.037 . . . . 65.430000000000007 109.63 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 49.3 t -101.52 104.3 33.25 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 109.465 -0.568 . . . . 63.039999999999999 109.465 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.85 146.97 33.96 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.219 2.612 . . . . 70.129999999999995 113.017 -176.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.16 162.18 27.45 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 123.782 2.988 . . . . 73.239999999999995 113.447 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 t -92.22 159.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 107.339 -1.356 . . . . 64.040000000000006 107.339 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.48 141.34 48.66 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.316 -0.624 . . . . 61.240000000000002 109.316 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.09 -169.9 41.41 Favored Glycine 0 CA--C 1.467 -2.927 0 N-CA-C 108.762 -1.735 . . . . 64.510000000000005 108.762 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.416 ' HB3' ' HG2' ' A' ' 27' ' ' MET . 4.4 t-20 -56.31 111.0 0.86 Allowed 'General case' 0 N--CA 1.426 -1.634 0 O-C-N 124.234 0.608 . . . . 72.450000000000003 109.788 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -87.16 126.17 34.63 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 108.344 -0.984 . . . . 74.219999999999999 108.344 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.11 151.97 44.87 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.305 -0.861 . . . . 73.340000000000003 110.435 -175.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.9 m -78.93 81.92 5.17 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.523 0.677 . . . . 74.549999999999997 109.766 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.525 HG12 ' OD2' ' A' ' 109' ' ' ASP . 49.3 t -80.74 143.72 11.86 Favored 'Isoleucine or valine' 0 C--O 1.251 1.137 0 CA-C-N 114.705 -1.134 . . . . 54.310000000000002 109.64 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -154.67 -67.98 0.13 Allowed 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.44 -1.319 . . . . 72.329999999999998 107.44 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -158.6 163.06 37.32 Favored 'General case' 1 C--N 1.24 -4.189 0 CA-C-N 112.54 -2.118 . . . . 64.030000000000001 105.62 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -39.35 -43.12 1.14 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.336 1.606 . . . . 73.0 115.336 -172.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -60.36 -49.76 76.29 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.025 0.379 . . . . 71.120000000000005 112.025 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -74.71 -33.87 62.48 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.295 -0.562 . . . . 71.329999999999998 110.645 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.525 ' OD2' HG12 ' A' ' 103' ' ' VAL . 0.9 OUTLIER -62.29 -48.37 80.2 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.387 -0.824 . . . . 64.439999999999998 110.423 178.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 10.5 tp -66.68 -37.99 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 120.711 -0.396 . . . . 71.099999999999994 110.452 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -63.58 -42.21 98.31 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.685 -0.406 . . . . 74.140000000000001 110.44 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 2.7 t -63.59 -41.32 98.36 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.164 -0.471 . . . . 73.120000000000005 111.907 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 117' ' ' ILE . 47.6 mm -70.54 -45.19 75.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 121.085 -0.246 . . . . 73.299999999999997 110.644 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 70.7 t -64.69 -42.91 96.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.333 -0.394 . . . . 72.129999999999995 110.912 -177.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.57 -27.35 62.14 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.173 -0.611 . . . . 53.149999999999999 111.163 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.18 84.8 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.47 -0.567 . . . . 53.310000000000002 109.47 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 113' ' ' ILE . 72.4 mt -63.8 -45.8 96.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.398 -0.819 . . . . 73.530000000000001 109.184 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 114' ' ' VAL . 80.6 mt-10 -60.71 -40.35 91.97 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 116.276 -0.42 . . . . 72.510000000000005 111.283 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -70.43 -35.22 73.26 Favored 'General case' 0 C--O 1.202 -1.438 0 C-N-CA 120.632 -0.427 . . . . 74.439999999999998 111.149 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 8.1 t -73.54 -37.15 65.68 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.196 -0.602 . . . . 73.140000000000001 110.483 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.3 mp -77.58 -42.67 34.38 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.866 -0.734 . . . . 75.319999999999993 111.211 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.29 -19.88 29.22 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 116.29 1.959 . . . . 65.019999999999996 116.29 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.4 30.4 mttp -59.63 -47.76 84.33 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 116.73 2.122 . . . . 72.200000000000003 116.73 -172.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 155.34 149.84 5.41 Favored Glycine 0 C--N 1.264 -3.431 0 C-N-CA 119.405 -1.378 . . . . 63.439999999999998 113.017 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -83.17 48.78 1.43 Allowed 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 124.424 1.09 . . . . 71.530000000000001 111.128 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.5 tp 176.95 101.85 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 125.2 1.4 . . . . 71.230000000000004 109.67 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 34.6 t30 177.41 113.34 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.668 1.187 . . . . 71.420000000000002 109.665 174.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.9 m 55.58 94.84 0.02 OUTLIER 'General case' 0 N--CA 1.421 -1.917 0 C-N-CA 125.824 1.65 . . . . 50.210000000000001 114.539 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -82.03 114.5 20.64 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 115.044 -0.98 . . . . 72.420000000000002 110.424 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 98.8 mt -128.68 -174.9 3.37 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.989 -1.856 . . . . 74.230000000000004 105.989 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.61 120.38 16.14 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.648 -0.501 . . . . 74.409999999999997 109.648 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -133.08 160.47 23.91 Favored Glycine 0 CA--C 1.482 -1.982 0 N-CA-C 109.533 -1.427 . . . . 62.109999999999999 109.533 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.472 ' HZ3' ' CD ' ' A' ' 10' ' ' GLU . 3.0 mppt? -110.49 109.28 58.25 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 117.366 0.583 . . . . 74.329999999999998 110.254 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.83 112.07 3.3 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 121.849 1.699 . . . . 75.209999999999994 109.139 174.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.432 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 49.6 mm -106.9 110.15 63.47 Favored Pre-proline 0 N--CA 1.421 -1.89 0 CA-C-N 116.32 -0.4 . . . . 74.010000000000005 110.354 -176.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 135' ' ' ILE . 55.8 Cg_endo -74.01 150.04 42.71 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.294 1.996 . . . . 61.030000000000001 109.304 170.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.1 m120 66.03 87.44 0.12 Allowed Pre-proline 0 C--N 1.32 -0.703 0 C-N-CA 124.073 0.949 . . . . 74.329999999999998 111.672 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -81.85 -10.96 11.5 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.558 2.172 . . . . 71.439999999999998 111.658 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 66.03 100.32 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 124.851 1.26 . . . . 74.420000000000002 111.167 -176.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.7 mp -86.34 69.6 10.44 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 121.444 0.64 . . . . 62.32 109.427 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.63 -36.55 58.41 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 115.185 -0.916 . . . . 55.310000000000002 111.078 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.8 tt 66.64 94.14 0.07 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.922 1.289 . . . . 72.129999999999995 109.075 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -130.62 109.68 10.83 Favored 'General case' 0 CA--C 1.469 -2.155 0 CA-C-N 114.491 -1.231 . . . . 73.310000000000002 109.558 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 66.6 m -161.88 71.84 0.37 Allowed 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.213 -1.403 . . . . 54.539999999999999 107.213 174.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.4 m -78.65 86.71 4.61 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.566 -0.743 . . . . 61.409999999999997 109.249 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -169.83 132.88 1.18 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.378 -1.712 . . . . 72.030000000000001 106.378 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.6 m -88.22 98.4 11.55 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.943 -0.762 . . . . 74.510000000000005 108.943 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.459 0 N-CA-C 109.672 -1.371 . . . . 62.329999999999998 109.672 -178.665 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 N-CA-C 107.022 -1.473 . . . . 74.400000000000006 107.022 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 98.3 mttt -88.06 155.29 19.88 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.673 0.749 . . . . 63.25 112.195 -178.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.618 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 7.6 m-85 -122.95 151.86 41.4 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.957 -1.02 . . . . 74.239999999999995 111.856 178.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.536 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 32.3 t70 -103.32 101.55 11.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 105.753 -1.943 . . . . 74.230000000000004 105.753 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -90.41 120.91 40.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.643 0.735 . . . . 73.140000000000001 109.335 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.0 t -110.69 112.39 40.35 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 107.664 -1.236 . . . . 71.530000000000001 107.664 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 27' ' ' MET . 4.7 tt -120.08 108.83 24.19 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 CA-C-O 121.938 0.875 . . . . 74.430000000000007 109.903 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.0 mt -110.27 117.25 51.82 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-N 114.799 -1.091 . . . . 73.549999999999997 108.553 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.609 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 44.6 Cg_endo -93.67 140.25 1.55 Allowed 'Trans proline' 0 N--CA 1.431 -2.171 0 C-N-CA 121.51 1.473 . . . . 73.530000000000001 110.728 171.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.55 124.49 8.61 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.187 0.518 . . . . 74.329999999999998 111.054 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.473 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 57.4 m -67.51 114.64 6.33 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 122.108 -0.37 . . . . 73.120000000000005 110.143 177.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 2.7 p90 -57.39 115.17 2.55 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 113.726 1.009 . . . . 72.430000000000007 113.726 -176.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -146.45 162.79 37.5 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 114.275 -1.329 . . . . 72.409999999999997 108.324 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -133.63 149.5 51.58 Favored 'General case' 0 N--CA 1.401 -2.896 0 N-CA-C 104.945 -2.243 . . . . 71.430000000000007 104.945 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -61.12 115.93 4.15 Favored 'General case' 0 N--CA 1.413 -2.316 0 O-C-N 124.214 0.946 . . . . 74.450000000000003 110.806 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -91.27 -159.31 0.62 Allowed 'General case' 0 C--N 1.266 -3.064 0 N-CA-C 105.504 -2.036 . . . . 73.349999999999994 105.504 172.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -70.64 -52.84 18.57 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 119.466 1.03 . . . . 64.430000000000007 110.599 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -136.16 5.47 3.02 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.546 0.689 . . . . 74.140000000000001 110.511 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -125.82 170.95 11.1 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.486 -0.561 . . . . 75.150000000000006 109.486 -175.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 57.9 mtt 66.2 85.19 0.14 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.86 1.264 . . . . 65.150000000000006 113.347 175.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -161.73 98.72 1.11 Allowed 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.854 -1.165 . . . . 70.530000000000001 107.854 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -149.62 134.21 17.61 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.919 -0.488 . . . . 73.519999999999996 111.391 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 23' ' ' ILE . 3.2 mp -128.86 144.72 37.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 104.572 -2.381 . . . . 72.349999999999994 104.572 172.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.609 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 37.4 m -107.15 160.0 27.99 Favored Pre-proline 0 C--N 1.277 -2.547 0 N-CA-C 108.584 -0.895 . . . . 52.109999999999999 108.584 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.89 119.81 7.1 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.228 2.619 . . . . 71.129999999999995 114.182 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.59 125.14 10.35 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.64 2.227 . . . . 62.420000000000002 110.925 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.476 ' HB3' HG21 ' A' ' 7' ' ' ILE . 39.0 tpp -101.15 128.19 47.36 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.899 -1.149 . . . . 70.400000000000006 107.899 -175.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.7 t -129.31 129.34 67.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.449 -0.574 . . . . 72.109999999999999 109.449 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.7 mm -134.39 106.59 8.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.062 0.458 . . . . 74.430000000000007 110.684 178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -104.47 81.12 0.32 Allowed Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 119.875 -1.155 . . . . 61.219999999999999 112.091 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -170.04 31.12 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.895 0.855 . . . . 65.349999999999994 111.023 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 -124.61 133.94 53.09 Favored 'General case' 0 C--O 1.201 -1.457 0 N-CA-C 107.667 -1.235 . . . . 72.209999999999994 107.667 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 2.3 p -84.44 155.25 22.32 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 118.524 0.602 . . . . 73.319999999999993 110.553 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.618 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 90.3 t80 -48.9 -53.74 18.3 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 124.464 1.106 . . . . 72.120000000000005 113.315 -172.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 25.5 m-20 -70.18 -35.43 73.96 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.749 -1.114 . . . . 73.109999999999999 111.06 -174.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.8 mt -76.28 -38.23 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 109.619 -0.512 . . . . 71.109999999999999 109.619 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.01 -44.96 95.61 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.716 -0.675 . . . . 71.340000000000003 110.414 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.8 ttm -66.45 -38.38 87.24 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 119.968 -0.693 . . . . 74.25 110.674 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 35' ' ' ASP . 55.9 mm-40 -67.82 -40.14 83.85 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.494 -0.482 . . . . 65.129999999999995 111.752 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.52 ' O ' HG21 ' A' ' 44' ' ' VAL . 14.6 tt -73.38 -38.36 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 119.464 -0.894 . . . . 73.340000000000003 110.736 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.87 -39.23 84.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 110.193 -0.299 . . . . 74.140000000000001 110.193 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -71.31 -16.59 62.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.031 0.443 . . . . 65.109999999999999 111.822 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.79 -43.47 6.79 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 110.233 -1.147 . . . . 74.530000000000001 110.233 173.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.52 HG21 ' O ' ' A' ' 40' ' ' ILE . 77.4 t -59.8 -38.26 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.045 -1.095 . . . . 62.149999999999999 108.045 177.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -51.09 -50.08 59.44 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 126.051 1.74 . . . . 72.439999999999998 111.069 176.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -67.26 -38.19 84.74 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.753 -0.832 . . . . 73.319999999999993 108.753 -177.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -62.32 -45.4 98.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.07 -0.514 . . . . 72.230000000000004 110.696 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 44' ' ' VAL . 61.6 mt -69.42 -38.35 76.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.912 0.386 . . . . 73.219999999999999 110.397 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -79.58 -14.29 58.93 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.245 0.545 . . . . 74.510000000000005 112.263 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.65 -38.46 7.9 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.722 -0.611 . . . . 65.310000000000002 112.009 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -84.72 -14.08 49.42 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.663 0.744 . . . . 70.140000000000001 110.377 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -141.19 -175.58 4.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.58 -1.267 . . . . 74.420000000000002 107.58 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -106.78 100.1 9.63 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 105.609 -1.997 . . . . 63.409999999999997 105.609 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -129.46 136.04 49.4 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-O 121.194 0.521 . . . . 74.25 111.952 -175.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.499 ' OG ' ' HA2' ' A' ' 141' ' ' GLY . 5.5 p -116.87 127.57 54.4 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.725 -1.213 . . . . 73.099999999999994 107.725 175.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 p -101.03 119.1 48.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 119.805 -0.758 . . . . 72.219999999999999 111.77 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -95.91 111.11 23.19 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.806 -1.924 . . . . 70.010000000000005 105.806 171.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -103.24 108.51 19.75 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 122.069 0.937 . . . . 73.519999999999996 112.315 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mp -111.85 177.56 4.61 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.888 -1.506 . . . . 74.120000000000005 109.422 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.42 161.82 14.07 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.427 -0.953 . . . . 63.450000000000003 108.427 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.1 176.52 24.66 Favored Glycine 0 C--N 1.285 -2.298 0 N-CA-C 110.345 -1.102 . . . . 54.149999999999999 110.345 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -65.19 -179.47 0.58 Allowed 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 116.973 0.386 . . . . 73.120000000000005 110.126 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -52.05 -31.9 32.1 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 113.273 0.842 . . . . 74.400000000000006 113.273 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 51.8 t -87.67 -15.6 36.71 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.765 -0.652 . . . . 74.230000000000004 111.463 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 11.5 m-20 -105.64 156.81 17.9 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-O 121.244 0.545 . . . . 73.329999999999998 110.141 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.6 t -112.22 -31.94 2.17 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 120.497 -0.481 . . . . 74.530000000000001 111.857 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.3 tp -151.15 138.64 19.55 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.071 -0.652 . . . . 61.240000000000002 109.764 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.478 ' HH ' ' CG ' ' A' ' 83' ' ' HIS . 0.5 OUTLIER -131.2 104.18 6.91 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.392 -0.596 . . . . 73.329999999999998 109.392 -179.297 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -104.62 116.58 32.3 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.482 -0.932 . . . . 72.319999999999993 108.482 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.448 ' HZ3' ' ND2' ' A' ' 137' ' ' ASN . 25.1 ttmt -98.72 110.27 22.9 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.669 -1.234 . . . . 75.230000000000004 107.669 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -94.93 123.04 38.17 Favored 'General case' 0 C--N 1.264 -3.122 0 N-CA-C 109.713 -0.477 . . . . 64.5 109.713 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.411 ' HB ' ' OG ' ' A' ' 55' ' ' SER . 29.9 m -94.26 122.38 36.74 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.452 -1.314 . . . . 72.439999999999998 107.452 176.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.47 136.78 50.15 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 114.391 1.256 . . . . 73.340000000000003 114.391 -172.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -133.62 135.68 44.35 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.91 -1.885 . . . . 74.519999999999996 105.91 170.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 80.1 tttt -139.82 172.62 12.52 Favored 'General case' 0 C--N 1.27 -2.886 0 N-CA-C 104.422 -2.436 . . . . 71.510000000000005 104.422 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 8.2 pt-20 -47.2 87.67 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.907 0.883 . . . . 74.140000000000001 112.942 176.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.32 19.16 78.63 Favored Glycine 0 N--CA 1.432 -1.623 0 CA-C-N 115.175 -0.921 . . . . 61.240000000000002 112.482 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 59.2 mmtt -127.86 156.43 42.58 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.725 -1.583 . . . . 74.310000000000002 106.725 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -156.85 140.77 16.21 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 123.262 0.351 . . . . 74.329999999999998 110.349 -178.164 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -170.5 177.46 43.66 Favored Glycine 0 C--O 1.205 -1.692 0 C-N-CA 120.113 -1.041 . . . . 71.120000000000005 113.432 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 60.8 mt -123.79 151.5 28.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 106.493 -1.669 . . . . 75.120000000000005 106.493 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.1 t -134.64 109.9 12.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.324 -0.991 . . . . 72.530000000000001 108.324 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.478 ' CG ' ' HH ' ' A' ' 68' ' ' TYR . 62.2 m-70 -89.4 104.22 16.79 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.693 -0.484 . . . . 72.519999999999996 109.693 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.2 t -105.13 109.81 28.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.385 -0.969 . . . . 72.219999999999999 108.385 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -122.68 144.22 49.28 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 120.111 -0.635 . . . . 65.439999999999998 110.014 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.4 mt -105.81 109.47 21.44 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 107.226 -1.398 . . . . 52.240000000000002 107.226 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.512 ' HD3' ' OD2' ' A' ' 4' ' ' ASP . 36.6 ttt180 -98.51 141.34 31.48 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.4 -0.963 . . . . 75.439999999999998 108.4 -177.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -85.01 111.18 19.48 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 120.346 -0.542 . . . . 75.420000000000002 109.925 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.9 tt -74.47 112.13 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-O 122.168 0.985 . . . . 71.510000000000005 108.993 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -135.31 -177.95 4.89 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 106.235 -1.765 . . . . 73.239999999999995 106.235 -171.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -80.91 -13.75 58.63 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.472 1.13 . . . . 64.319999999999993 108.987 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -79.34 -33.39 43.09 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 113.849 -1.523 . . . . 71.25 108.474 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 95.9 m -129.76 94.22 32.44 Favored Pre-proline 0 N--CA 1.439 -1.002 0 CA-C-N 115.209 -0.905 . . . . 74.239999999999995 110.403 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.6 153.39 43.86 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 122.529 2.153 . . . . 51.520000000000003 112.269 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.34 138.48 60.85 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.171 2.581 . . . . 53.130000000000003 111.762 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.4 t -97.27 153.26 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.307 -0.997 . . . . 73.219999999999999 108.307 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -105.64 92.27 4.11 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 108.364 -0.976 . . . . 71.140000000000001 108.364 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -109.96 -149.67 12.68 Favored Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 109.741 -1.344 . . . . 61.149999999999999 109.741 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -72.9 118.27 15.64 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 107.426 -1.324 . . . . 73.040000000000006 107.426 172.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -94.78 121.6 36.54 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.519 0.676 . . . . 71.129999999999995 109.201 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 20.8 t -69.37 151.48 46.11 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.673 -1.149 . . . . 74.209999999999994 110.261 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 m -77.34 88.74 3.74 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.75 -0.833 . . . . 51.039999999999999 108.75 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -106.0 148.29 10.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 114.924 -1.035 . . . . 65.219999999999999 110.976 -172.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.0 tp -157.83 -61.45 0.08 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.628 1.204 . . . . 74.150000000000006 107.887 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -146.43 167.2 24.22 Favored 'General case' 0 C--N 1.256 -3.475 0 CA-C-N 112.243 -2.253 . . . . 74.230000000000004 108.192 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.536 ' O ' HG23 ' A' ' 110' ' ' ILE . 63.8 t80 -46.59 -49.17 19.33 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 124.627 1.204 . . . . 71.140000000000001 113.611 -175.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -58.73 -28.93 66.32 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.061 0.458 . . . . 74.329999999999998 112.063 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -87.11 -40.44 14.65 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 116.323 -0.399 . . . . 72.239999999999995 111.366 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.436 ' O ' HG12 ' A' ' 113' ' ' ILE 0.367 4.5 p30 -78.26 -28.34 47.7 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 118.788 -1.165 . . . . 73.299999999999997 112.954 -176.113 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 106' ' ' PHE . 8.2 tp -67.59 -40.3 83.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 109.482 -0.562 . . . . 72.019999999999996 109.482 175.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -66.91 -41.01 87.85 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 108.95 -0.759 . . . . 75.219999999999999 108.95 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 8.5 t -64.19 -41.87 96.9 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.13 -0.941 . . . . 74.540000000000006 111.744 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 109' ' ' ASP . 35.8 mm -68.16 -42.0 84.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 120.494 0.188 . . . . 65.340000000000003 110.596 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 93.1 t -67.03 -41.23 87.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.396 -0.594 . . . . 73.420000000000002 109.396 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -60.6 -39.91 89.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.936 -0.574 . . . . 73.439999999999998 110.964 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.45 98.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.86 0.362 . . . . 73.109999999999999 110.711 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 77.3 mt -68.8 -43.52 82.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.326 -0.62 . . . . 73.0 109.326 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -58.25 -46.18 86.45 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 123.817 0.847 . . . . 61.229999999999997 111.618 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -69.86 -36.05 75.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.533 -0.758 . . . . 65.109999999999999 109.464 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 52.7 t -65.21 -47.2 77.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.699 -0.682 . . . . 53.219999999999999 110.193 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.3 mp -68.88 -30.41 68.91 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.157 -0.474 . . . . 73.200000000000003 111.596 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.12 -35.32 56.35 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.66 -0.7 . . . . 72.140000000000001 111.128 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -87.05 -12.93 45.8 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.52 0.676 . . . . 75.319999999999993 110.781 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.35 60.51 4.51 Favored Glycine 0 C--N 1.304 -1.203 0 CA-C-N 115.306 -0.861 . . . . 70.120000000000005 113.265 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -130.54 108.35 9.88 Favored 'General case' 0 C--N 1.268 -2.973 0 C-N-CA 124.733 1.213 . . . . 74.140000000000001 108.479 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.7 mp 66.51 -178.65 0.2 Allowed 'General case' 0 C--O 1.242 0.702 0 O-C-N 124.265 0.978 . . . . 71.319999999999993 110.917 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -62.89 127.79 32.88 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.512 -1.292 . . . . 74.319999999999993 107.512 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.7 m -127.1 161.18 29.06 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 109.04 -0.726 . . . . 72.319999999999993 109.04 -176.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.449 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 22.3 ttmm -80.38 77.63 7.13 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 122.499 1.142 . . . . 62.219999999999999 112.332 -178.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 129' ' ' LYS . 20.6 mt -171.21 54.15 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 129.893 3.277 . . . . 62.530000000000001 103.511 174.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -75.29 175.88 7.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.353 -2.203 . . . . 52.399999999999999 111.37 -173.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 138.95 -137.53 8.72 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 108.787 -1.725 . . . . 62.020000000000003 108.787 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -116.99 110.64 41.44 Favored Pre-proline 0 C--N 1.305 -1.357 0 CA-C-N 117.088 0.444 . . . . 71.019999999999996 110.087 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.61 173.71 13.87 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.563 2.175 . . . . 75.310000000000002 110.79 176.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 46.5 mm -111.22 102.76 53.77 Favored Pre-proline 0 N--CA 1.432 -1.359 0 CA-C-O 121.164 0.507 . . . . 75.299999999999997 110.075 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -88.18 138.84 4.19 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 123.017 2.478 . . . . 64.409999999999997 112.073 172.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.448 ' ND2' ' HZ3' ' A' ' 70' ' ' LYS . 16.3 m120 -136.78 173.73 5.22 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 107.521 -1.288 . . . . 74.439999999999998 107.521 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 137' ' ' ASN . 23.5 Cg_endo -66.58 -18.01 53.58 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 121.535 1.49 . . . . 74.439999999999998 112.333 174.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.9 mp 73.65 102.14 0.07 Allowed 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.539 1.136 . . . . 74.430000000000007 112.51 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.1 mt -112.64 101.54 9.67 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.173 -1.417 . . . . 73.310000000000002 107.173 173.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.499 ' HA2' ' OG ' ' A' ' 55' ' ' SER . . . -127.68 4.73 7.05 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.478 -0.868 . . . . 74.010000000000005 113.21 -175.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.1 mp -89.17 76.06 7.75 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.275 1.036 . . . . 65.340000000000003 112.313 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -143.07 31.87 1.38 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 104.319 -2.475 . . . . 73.120000000000005 104.319 175.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.3 m -41.42 111.08 0.19 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 111.621 -2.536 . . . . 73.409999999999997 114.752 -172.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.3 p -128.98 147.69 50.88 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.045 -1.094 . . . . 75.109999999999999 108.045 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -146.32 141.86 27.69 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.216 0.532 . . . . 75.019999999999996 111.553 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 49.2 m -145.07 101.55 3.64 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.281 -1.007 . . . . 64.109999999999999 108.281 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.04 0 N-CA-C 109.503 -1.439 . . . . 37.969999999999999 109.503 -179.789 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.1 mmm . . . . . 0 CA--C 1.499 -1.002 0 CA-C-O 121.011 0.434 . . . . 64.140000000000001 110.291 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -99.56 143.47 29.76 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.976 -0.556 . . . . 74.219999999999999 109.962 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.594 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 21.0 m-85 -116.49 141.04 48.7 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.62 -0.718 . . . . 74.409999999999997 110.008 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.534 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 33.2 t70 -111.92 108.63 18.05 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 125.418 1.487 . . . . 43.520000000000003 109.988 -174.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 p -88.87 116.04 29.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 115.894 -0.594 . . . . 74.230000000000004 109.962 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.21 116.8 50.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.412 -1.329 . . . . 73.439999999999998 107.412 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.422 HG22 ' HB3' ' A' ' 27' ' ' MET . 4.9 tt -121.32 115.86 47.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-O 121.305 0.574 . . . . 61.520000000000003 110.551 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.8 tt -110.42 110.3 58.02 Favored Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 116.028 -0.533 . . . . 74.120000000000005 110.298 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.557 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 72.4 Cg_endo -91.62 147.4 3.35 Favored 'Trans proline' 0 N--CA 1.435 -1.952 0 C-N-CA 122.301 2.001 . . . . 64.299999999999997 110.112 173.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.61 177.66 9.83 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.933 -0.766 . . . . 64.340000000000003 108.933 177.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.424 ' HB2' ' HB3' ' A' ' 22' ' ' HIS . 52.1 m -122.6 104.29 9.25 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 109.019 -0.734 . . . . 64.230000000000004 109.019 173.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 24.0 p90 -49.56 95.61 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 115.131 1.53 . . . . 73.049999999999997 115.131 -176.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.486 ' CE1' ' HB3' ' A' ' 125' ' ' GLU . 76.6 m80 -145.85 168.89 19.71 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.42 -0.809 . . . . 74.310000000000002 109.299 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.75 147.23 46.57 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 104.322 -2.473 . . . . 73.049999999999997 104.322 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -70.43 93.36 0.87 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 123.77 0.669 . . . . 65.120000000000005 109.265 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.5 -84.28 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.212 -0.904 . . . . 71.150000000000006 110.529 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -107.61 -59.91 1.77 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.61 -0.515 . . . . 64.299999999999997 109.61 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -138.06 -52.43 0.62 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.066 -1.087 . . . . 73.239999999999995 108.066 173.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -74.97 174.92 8.65 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 113.114 -1.857 . . . . 60.219999999999999 111.083 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.433 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 4.5 mpp? 74.0 72.16 0.11 Allowed 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 124.881 1.363 . . . . 74.5 108.567 -175.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 5.1 pt-20 -148.84 93.29 2.09 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 113.804 -1.544 . . . . 65.439999999999998 109.249 -171.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 11' ' ' SER . 19.0 t60 -160.96 107.47 1.45 Allowed 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.143 -1.423 . . . . 55.539999999999999 113.616 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -123.34 136.63 59.33 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 105.27 -2.122 . . . . 73.109999999999999 105.27 172.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 64.0 m -108.3 153.73 41.78 Favored Pre-proline 0 C--N 1.294 -1.83 0 O-C-N 123.109 0.256 . . . . 72.409999999999997 110.791 -176.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.83 143.18 72.51 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 123.244 2.629 . . . . 64.099999999999994 113.849 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.97 130.45 13.31 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.905 2.403 . . . . 61.210000000000001 112.002 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.422 ' HB3' HG22 ' A' ' 7' ' ' ILE . 50.3 ttm -92.42 135.3 34.15 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.941 -1.133 . . . . 64.540000000000006 107.941 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 83.9 t -131.09 116.4 33.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 O-C-N 123.238 0.337 . . . . 73.329999999999998 110.786 -171.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.2 mm -129.2 106.06 13.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 120.638 0.256 . . . . 71.430000000000007 111.357 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -112.83 80.91 0.28 Allowed Glycine 0 CA--C 1.476 -2.396 0 C-N-CA 120.27 -0.966 . . . . 72.450000000000003 112.139 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -144.33 1.58 1.08 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.648 0.981 . . . . 51.100000000000001 113.648 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.42 HH21 ' CG ' ' A' ' 109' ' ' ASP . 33.3 mmt180 -107.33 134.57 50.2 Favored 'General case' 0 C--N 1.285 -2.204 0 O-C-N 121.025 -1.047 . . . . 71.150000000000006 108.304 -172.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 p -74.65 164.48 26.53 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 107.569 -1.271 . . . . 61.229999999999997 107.569 173.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.594 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 82.1 t80 -55.3 -45.48 76.24 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 120.789 0.328 . . . . 75.209999999999994 111.848 -173.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.85 -39.24 93.24 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.272 -0.876 . . . . 43.210000000000001 111.498 -176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.9 mm -74.31 -43.19 50.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.754 -0.832 . . . . 74.120000000000005 108.754 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.92 -43.38 98.95 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 115.539 -0.755 . . . . 74.109999999999999 111.074 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.3 tpt -68.81 -38.0 79.6 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.972 -0.291 . . . . 61.340000000000003 110.871 -175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -84.36 -21.43 30.89 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 118.905 -1.118 . . . . 74.219999999999999 112.594 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 44' ' ' VAL . 17.6 tt -82.6 -40.25 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 C-N-CA 119.005 -1.078 . . . . 73.25 109.78 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.36 -36.28 71.3 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.876 0 C-N-CA 121.095 -0.242 . . . . 71.340000000000003 110.439 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -64.05 -31.98 73.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.147 0.499 . . . . 71.25 110.158 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.439 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -69.41 -44.78 63.27 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.714 -0.955 . . . . 52.219999999999999 110.714 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 40' ' ' ILE . 63.3 t -60.14 -44.93 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.282 -0.636 . . . . 73.409999999999997 109.282 177.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.8 -43.42 80.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.848 1.259 . . . . 70.430000000000007 110.862 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -68.96 -38.5 79.44 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.478 -0.783 . . . . 65.209999999999994 109.78 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 43' ' ' GLY . 92.9 t -66.41 -42.27 90.17 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.361 0 CA-C-N 116.513 -0.312 . . . . 73.409999999999997 110.674 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.446 ' CG2' HD11 ' A' ' 73' ' ' LEU . 72.7 mt -66.81 -41.81 88.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 121.287 0.565 . . . . 71.530000000000001 110.496 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -78.22 -11.38 59.92 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.499 -0.773 . . . . 72.200000000000003 110.583 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.9 -41.94 5.06 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 113.192 0.812 . . . . 72.430000000000007 113.192 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.5 m -91.03 -6.44 53.9 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.583 0.586 . . . . 64.439999999999998 112.583 -175.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -136.47 168.91 18.56 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 108.33 -0.989 . . . . 74.140000000000001 108.33 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -96.15 100.17 11.84 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 105.588 -2.004 . . . . 73.439999999999998 105.588 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.19 136.23 55.01 Favored 'General case' 0 N--CA 1.408 -2.542 0 C-N-CA 120.079 -0.648 . . . . 75.040000000000006 112.626 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 11.6 m -99.45 106.46 18.51 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 103.737 -2.69 . . . . 71.519999999999996 103.737 167.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.423 ' CG2' ' HD2' ' A' ' 69' ' ' ARG . 5.1 p -99.86 121.76 50.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-O 121.661 0.743 . . . . 45.420000000000002 111.419 -171.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -116.25 135.93 53.46 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.293 -0.867 . . . . 75.019999999999996 109.505 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.475 ' HB3' ' NH1' ' A' ' 69' ' ' ARG . 8.5 pt-20 -98.78 136.36 38.93 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.382 -0.372 . . . . 74.120000000000005 110.025 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.6 mt -142.02 175.41 9.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.234 0.54 . . . . 64.409999999999997 111.021 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.37 161.78 13.44 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.466 -1.679 . . . . 72.329999999999998 106.466 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' HA3' ' CB ' ' A' ' 65' ' ' ASP . . . -114.69 175.22 15.93 Favored Glycine 0 C--N 1.284 -2.306 0 C-N-CA 119.714 -1.231 . . . . 61.409999999999997 113.061 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -93.53 134.05 36.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 123.07 0.548 . . . . 74.019999999999996 111.19 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 52.17 -88.67 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.629 1.714 . . . . 71.340000000000003 115.629 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 73.9 m -89.26 -12.96 39.21 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.546 -0.752 . . . . 53.340000000000003 112.069 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.508 ' CB ' ' HA3' ' A' ' 61' ' ' GLY . 14.0 m-20 -69.24 125.87 28.02 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.799 -1.186 . . . . 70.129999999999995 107.799 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.4 t -92.53 -31.8 4.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 121.279 0.561 . . . . 72.129999999999995 110.491 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.2 tp -151.76 145.22 24.84 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.124 -1.065 . . . . 71.25 108.124 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -130.12 122.21 27.83 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 107.938 -1.134 . . . . 74.420000000000002 107.938 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.475 ' NH1' ' HB3' ' A' ' 58' ' ' GLU . 22.0 tpp180 -120.1 119.07 32.24 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.406 -1.331 . . . . 74.439999999999998 107.406 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -108.83 136.26 48.68 Favored 'General case' 0 C--N 1.282 -2.327 0 C-N-CA 123.624 0.77 . . . . 73.510000000000005 109.215 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -126.31 131.87 51.76 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.329 -0.619 . . . . 75.109999999999999 109.329 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 18.6 m -103.02 109.51 21.08 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.663 -1.606 . . . . 72.150000000000006 106.663 172.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.446 HD11 ' CG2' ' A' ' 48' ' ' ILE . 3.3 mm? -98.67 140.51 32.78 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 113.027 0.751 . . . . 52.520000000000003 113.027 -172.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -135.71 95.9 3.33 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.279 -1.328 . . . . 65.430000000000007 108.493 171.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -92.08 76.36 5.41 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.082 -1.822 . . . . 72.0 106.082 179.066 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.333 0.7 OUTLIER 30.45 76.92 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.917 1.687 . . . . 75.409999999999997 115.417 -175.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.76 -23.51 35.44 Favored Glycine 0 C--O 1.236 0.273 0 C-N-CA 121.333 -0.46 . . . . 52.530000000000001 112.415 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 61.5 mttp -98.47 144.39 27.87 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 105.301 -2.111 . . . . 74.430000000000007 105.301 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 5.3 ptpp? -145.59 150.52 36.52 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 120.216 -0.594 . . . . 73.450000000000003 109.929 -168.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.82 156.2 11.82 Favored Glycine 0 C--N 1.309 -0.951 0 C-N-CA 120.53 -0.843 . . . . 72.450000000000003 112.79 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 27.4 mt -103.57 139.22 25.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.504 -0.924 . . . . 63.409999999999997 108.504 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.3 t -118.53 116.45 51.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.342 -0.984 . . . . 74.420000000000002 108.342 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -104.34 109.5 21.37 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.568 -0.901 . . . . 74.430000000000007 108.568 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.08 119.53 55.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.028 -0.73 . . . . 74.239999999999995 109.028 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -121.47 140.24 52.43 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.23 -0.655 . . . . 63.409999999999997 109.23 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.0 mt -106.48 109.75 21.75 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.148 -1.427 . . . . 75.519999999999996 107.148 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -97.05 148.28 23.16 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-O 121.788 0.804 . . . . 73.239999999999995 111.014 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -92.18 105.5 17.7 Favored 'General case' 0 C--N 1.259 -3.352 0 CA-C-N 114.83 -1.077 . . . . 73.329999999999998 108.613 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 tt -91.34 112.34 25.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.412 0.625 . . . . 53.310000000000002 109.384 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.3 p -131.94 -171.01 2.52 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.815 -0.63 . . . . 74.430000000000007 109.993 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.47 -14.34 46.37 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.755 0.788 . . . . 62.32 108.905 176.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -90.41 -39.87 12.39 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.968 -1.015 . . . . 65.140000000000001 109.708 176.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 42.5 t -85.5 132.61 44.23 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 109.538 -0.541 . . . . 65.040000000000006 109.538 176.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 93' ' ' CYS . 5.4 Cg_exo -77.33 117.1 4.27 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.877 2.384 . . . . 72.239999999999995 111.88 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.34 122.31 11.12 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.836 2.357 . . . . 75.230000000000004 111.717 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.7 t -88.9 157.68 3.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 107.636 -1.246 . . . . 74.25 107.636 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -122.76 161.5 23.82 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.59 -0.893 . . . . 72.239999999999995 108.59 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -173.68 -166.24 31.63 Favored Glycine 0 CA--C 1.458 -3.486 0 N-CA-C 106.718 -2.553 . . . . 61.140000000000001 106.718 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.401 ' HB3' ' HA ' ' A' ' 27' ' ' MET . 3.2 t-20 -56.01 102.98 0.09 Allowed 'General case' 0 N--CA 1.409 -2.49 0 O-C-N 124.411 0.712 . . . . 71.200000000000003 109.584 176.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -85.66 114.15 22.42 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.943 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 41.7 t -78.53 141.26 38.29 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.422 -1.325 . . . . 53.25 107.422 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.5 m -64.79 117.32 7.34 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.399 -0.963 . . . . 54.509999999999998 108.399 177.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.7 t -76.01 141.26 16.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.445 0.64 . . . . 74.310000000000002 110.539 -172.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.498 ' HG ' ' H ' ' A' ' 105' ' ' GLU . 15.2 tp -161.7 -159.46 0.62 Allowed 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.053 -2.203 . . . . 72.310000000000002 105.053 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.498 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 36.3 mt-10 -89.14 173.05 8.65 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 119.134 0.879 . . . . 61.509999999999998 112.038 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.481 ' O ' HG22 ' A' ' 110' ' ' ILE . 71.6 t80 -32.82 -58.05 0.36 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.517 1.927 . . . . 75.120000000000005 116.201 -171.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -68.64 -21.54 64.46 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 113.052 0.76 . . . . 74.150000000000006 113.052 -170.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -87.73 -42.39 12.65 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 119.671 -0.812 . . . . 75.310000000000002 111.001 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.481 ' O ' HG12 ' A' ' 113' ' ' ILE 0.262 17.1 p-10 -77.94 -30.08 50.29 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 118.684 -1.206 . . . . 60.039999999999999 111.783 -175.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 106' ' ' PHE . 16.5 tt -69.65 -38.78 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 119.225 -0.99 . . . . 72.319999999999993 109.829 175.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.25 -36.51 83.2 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 109.154 -0.684 . . . . 64.319999999999993 109.154 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 43.5 t -60.17 -45.49 92.9 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.798 -0.637 . . . . 62.25 109.703 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 109' ' ' ASP . 46.4 mm -61.28 -46.27 96.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 122.954 0.501 . . . . 74.150000000000006 109.891 175.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 110' ' ' ILE . 80.9 t -61.38 -42.77 95.01 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 CA-C-N 115.608 -0.723 . . . . 64.329999999999998 109.996 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -67.64 -32.19 72.71 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 112.139 0.422 . . . . 53.340000000000003 112.139 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.99 -39.37 83.28 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.284 -0.566 . . . . 71.109999999999999 110.044 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.5 mt -69.92 -47.12 71.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.856 -0.611 . . . . 72.200000000000003 110.11 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -64.7 -40.53 95.53 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 116.253 -0.431 . . . . 71.409999999999997 110.987 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.67 -17.72 58.97 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 120.298 -0.561 . . . . 73.129999999999995 112.154 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 27.4 t -78.24 -48.14 16.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.144 -1.058 . . . . 72.439999999999998 108.144 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 11.2 mp -69.37 -36.74 77.13 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.502 -0.772 . . . . 70.519999999999996 111.918 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.93 -13.57 53.13 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 114.002 1.112 . . . . 74.310000000000002 114.002 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -74.93 -12.39 60.34 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.255 -0.978 . . . . 74.519999999999996 110.893 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.92 169.01 42.29 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 115.113 -0.949 . . . . 55.340000000000003 111.12 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.486 ' HB3' ' CE1' ' A' ' 13' ' ' HIS . 0.7 OUTLIER -83.98 51.87 2.16 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 122.152 -0.616 . . . . 71.120000000000005 112.04 -178.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -137.19 80.41 1.81 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.918 -1.037 . . . . 74.340000000000003 112.338 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.6 t30 177.93 100.62 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.097 1.359 . . . . 73.200000000000003 109.751 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 63.9 m -67.07 119.38 11.91 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.692 0.758 . . . . 62.310000000000002 112.337 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -158.13 136.82 11.23 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 102.235 -3.246 . . . . 63.219999999999999 102.235 173.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -150.0 108.63 3.83 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 119.148 0.885 . . . . 70.140000000000001 113.243 -175.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.18 92.99 0.51 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 104.4 -2.445 . . . . 50.439999999999998 104.4 173.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 147.86 176.82 21.75 Favored Glycine 0 C--N 1.289 -2.071 0 N-CA-C 107.831 -2.108 . . . . 72.349999999999994 107.831 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -148.08 108.85 3.7 Favored Pre-proline 0 C--N 1.302 -1.497 0 CA-C-N 118.087 0.943 . . . . 73.420000000000002 110.025 -177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.98 110.7 1.78 Allowed 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 122.498 2.132 . . . . 65.120000000000005 112.033 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 48.1 mm -116.17 100.68 53.69 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 108.322 -0.992 . . . . 72.040000000000006 108.322 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.34 130.28 8.01 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 122.867 2.378 . . . . 44.109999999999999 112.366 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -126.97 120.59 22.67 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 107.029 -1.471 . . . . 74.209999999999994 107.029 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.93 61.82 5.68 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 122.777 2.318 . . . . 75.200000000000003 113.669 -175.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.5 tp -95.44 53.77 1.52 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.495 -1.668 . . . . 74.010000000000005 106.495 174.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -85.45 151.1 24.23 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 113.285 -1.78 . . . . 73.540000000000006 111.052 -173.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 104.99 -20.46 38.37 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.703 -0.76 . . . . 52.32 111.967 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 30.7 tp -76.19 85.35 3.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 122.152 0.977 . . . . 72.129999999999995 109.668 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -120.94 147.55 45.3 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.426 -1.716 . . . . 72.109999999999999 108.929 -173.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 67.9 p -124.53 93.68 3.98 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.414 -0.958 . . . . 71.319999999999993 108.414 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 40.7 m -63.18 106.32 0.85 Allowed 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.631 0.729 . . . . 74.439999999999998 111.656 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -137.78 115.62 11.48 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.05 -1.093 . . . . 72.430000000000007 108.05 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.3 t -131.51 128.85 40.21 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.389 0.614 . . . . 74.129999999999995 109.99 175.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.509 0 N-CA-C 108.333 -1.907 . . . . 53.210000000000001 108.333 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 mtm . . . . . 0 CA--C 1.494 -1.185 0 N-CA-C 108.808 -0.812 . . . . 65.530000000000001 108.808 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -92.87 145.42 24.4 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.659 -0.497 . . . . 62.219999999999999 109.659 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 21.9 m-85 -112.48 142.68 44.73 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 121.564 0.697 . . . . 73.549999999999997 111.466 177.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.527 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 31.9 t70 -111.26 102.66 11.05 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 105.793 -1.929 . . . . 73.099999999999994 105.793 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.65 119.3 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 CA-C-O 122.087 0.946 . . . . 62.520000000000003 110.865 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -105.99 116.58 50.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-N 114.083 -1.417 . . . . 73.230000000000004 107.848 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.437 HG23 ' HB3' ' A' ' 27' ' ' MET . 6.2 tt -115.3 114.85 47.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 CA-C-O 121.348 0.594 . . . . 75.450000000000003 109.614 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mp -104.0 106.61 53.88 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 108.936 -0.764 . . . . 70.030000000000001 108.936 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.626 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 2.0 Cg_endo -84.87 139.16 7.29 Favored 'Trans proline' 0 N--CA 1.44 -1.646 0 C-N-CA 121.964 1.776 . . . . 65.540000000000006 109.199 172.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.527 ' CD ' ' HZ3' ' A' ' 133' ' ' LYS . 11.5 pt-20 -157.78 133.65 9.26 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.056 0.455 . . . . 74.329999999999998 110.524 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.7 m -84.26 118.56 24.26 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.588 -0.523 . . . . 60.299999999999997 109.588 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 3.7 p90 -61.77 109.84 1.35 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.257 1.206 . . . . 63.350000000000001 114.257 -174.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -139.29 128.65 24.18 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.494 -0.776 . . . . 74.019999999999996 111.416 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -81.37 104.09 11.58 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 105.68 -1.97 . . . . 73.510000000000005 105.68 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 20' ' ' MET . 49.3 t80 -45.99 103.0 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 O-C-N 125.84 1.963 . . . . 74.200000000000003 109.662 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.25 -103.96 0.1 Allowed 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.134 -1.393 . . . . 73.310000000000002 113.688 -173.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -111.96 -58.99 2.05 Favored 'General case' 0 N--CA 1.434 -1.256 0 O-C-N 122.041 -0.412 . . . . 63.530000000000001 110.61 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -136.62 -36.76 0.7 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.405 -0.591 . . . . 74.400000000000006 109.405 176.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -102.04 163.25 12.35 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.766 -1.198 . . . . 74.340000000000003 107.766 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 1.8 mpt? 72.73 80.17 0.14 Allowed 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 124.28 1.032 . . . . 74.200000000000003 110.389 -173.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 178.03 132.4 0.07 Allowed 'General case' 0 N--CA 1.407 -2.605 0 N-CA-C 104.042 -2.577 . . . . 72.519999999999996 104.042 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 67.2 t60 179.41 92.37 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.804 0 O-C-N 124.336 1.023 . . . . 73.299999999999997 112.275 174.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mm -100.88 139.82 21.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 N-CA-C 105.692 -1.966 . . . . 55.310000000000002 105.692 171.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 42.0 m -106.58 153.92 40.31 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 109.708 -0.479 . . . . 71.409999999999997 109.708 -174.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.75 151.1 74.61 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 122.812 2.341 . . . . 73.120000000000005 112.718 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -72.63 151.55 52.51 Favored 'Trans proline' 0 C--O 1.255 1.356 0 C-N-CA 123.178 2.586 . . . . 70.109999999999999 114.107 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.531 ' SD ' ' HB3' ' A' ' 99' ' ' ASN . 2.4 tpt -114.56 134.99 54.62 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 104.606 -2.368 . . . . 74.409999999999997 104.606 176.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -130.73 130.43 64.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 119.088 0.858 . . . . 74.140000000000001 110.731 -176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.8 mm -124.1 102.51 11.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 106.961 -1.496 . . . . 73.239999999999995 106.961 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -126.31 81.13 0.36 Allowed Glycine 0 CA--C 1.476 -2.344 0 C-N-CA 117.586 -2.245 . . . . 63.509999999999998 114.198 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -161.15 18.45 0.12 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.438 -0.881 . . . . 62.43 111.372 176.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -115.25 134.14 55.4 Favored 'General case' 0 C--O 1.2 -1.514 0 N-CA-C 108.209 -1.034 . . . . 71.329999999999998 108.209 -171.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -72.88 163.38 28.22 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.13 -1.063 . . . . 72.519999999999996 108.13 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.605 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 83.0 t80 -52.09 -47.97 64.95 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.936 0.494 . . . . 62.030000000000001 112.092 -172.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.68 -40.66 92.98 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.176 -0.92 . . . . 73.439999999999998 111.302 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.4 mt -76.25 -37.88 32.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.343 -0.614 . . . . 63.240000000000002 109.343 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.6 99.74 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.483 -0.78 . . . . 53.420000000000002 110.008 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.434 ' HE1' ' HA ' ' A' ' 38' ' ' MET . 0.8 OUTLIER -67.26 -36.35 81.41 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.251 -0.431 . . . . 64.439999999999998 110.066 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -68.64 -42.51 77.92 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.23 -0.441 . . . . 73.319999999999993 110.888 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.451 ' O ' HG21 ' A' ' 44' ' ' VAL . 8.1 tp -71.1 -37.52 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.277 -0.569 . . . . 64.120000000000005 110.337 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.9 t -67.09 -37.19 78.79 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 N-CA-C 109.808 -0.441 . . . . 72.439999999999998 109.808 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.12 -33.54 76.27 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 109.643 -0.503 . . . . 74.319999999999993 109.643 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.22 -43.71 78.79 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 111.42 -0.672 . . . . 64.140000000000001 111.42 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 40' ' ' ILE . 99.4 t -62.03 -46.1 97.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.747 -0.835 . . . . 73.329999999999998 108.747 177.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -53.85 -46.27 71.19 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 125.498 1.519 . . . . 74.530000000000001 110.927 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -66.86 -41.08 87.93 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 114.391 -1.277 . . . . 71.409999999999997 110.316 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 88.8 t -71.25 -35.0 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 116.036 -0.529 . . . . 62.439999999999998 110.005 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 64.8 mt -65.12 -45.84 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 110.091 -0.337 . . . . 55.32 110.091 175.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -62.78 -35.4 79.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.21 0.448 . . . . 61.420000000000002 112.21 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.32 -33.74 22.01 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 113.445 0.905 . . . . 73.340000000000003 113.445 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -97.03 -16.32 20.62 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 113.564 0.95 . . . . 61.539999999999999 113.564 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -128.16 -177.02 3.98 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.204 -0.665 . . . . 72.109999999999999 109.204 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -107.76 100.25 9.65 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 103.719 -2.697 . . . . 65.209999999999994 103.719 171.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.05 144.95 30.62 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 114.759 1.392 . . . . 50.219999999999999 114.759 -168.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.4 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 1.9 m -123.34 103.47 8.52 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 103.983 -2.599 . . . . 60.399999999999999 103.983 169.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 p -100.66 119.26 48.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-O 121.649 0.738 . . . . 72.420000000000002 111.351 -174.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -120.0 122.45 41.18 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.383 -0.826 . . . . 74.209999999999994 111.469 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -89.25 140.97 28.94 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.802 -0.444 . . . . 73.219999999999999 109.802 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 mp -136.49 172.42 13.04 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.106 -1.442 . . . . 74.239999999999995 107.106 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.49 147.81 24.47 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.255 -0.578 . . . . 73.420000000000002 109.716 176.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.44 148.79 41.09 Favored Glycine 0 C--N 1.293 -1.835 0 CA-C-N 115.29 -0.868 . . . . 38.090000000000003 111.137 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.92 132.74 34.33 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-O 121.158 0.504 . . . . 63.119999999999997 110.789 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.0 t70 52.31 -84.14 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 126.137 1.775 . . . . 74.439999999999998 113.681 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.5 t -110.54 -0.55 17.31 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.171 0.51 . . . . 51.310000000000002 111.786 -176.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.517 ' OD1' ' HB3' ' A' ' 87' ' ' ARG . 23.1 m-20 -74.24 138.21 43.52 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 106.664 -1.606 . . . . 74.329999999999998 106.664 172.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.8 t -93.81 -29.93 4.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 112.698 0.629 . . . . 65.129999999999995 112.698 -173.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.3 tp -150.29 140.24 21.94 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 108.669 -0.863 . . . . 73.230000000000004 108.669 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -130.68 133.7 46.31 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 107.054 -1.461 . . . . 74.200000000000003 107.054 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -137.05 120.34 16.84 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.492 -1.299 . . . . 73.150000000000006 107.492 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -111.94 118.09 34.53 Favored 'General case' 0 N--CA 1.413 -2.294 0 C-N-CA 118.828 -1.149 . . . . 74.030000000000001 108.612 175.068 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -94.11 125.68 38.89 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 114.658 -1.155 . . . . 73.209999999999994 108.624 -177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.4 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 19.5 m -100.06 113.99 27.0 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.78 -1.563 . . . . 74.109999999999999 106.78 175.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.41 152.4 37.97 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 113.538 0.94 . . . . 55.240000000000002 113.538 -170.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -135.32 140.81 45.4 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.222 -1.808 . . . . 72.430000000000007 106.807 170.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.538 ' HG2' ' OE1' ' A' ' 76' ' ' GLU . 51.6 tttm -139.47 -178.64 5.48 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 104.988 -2.227 . . . . 75.099999999999994 104.988 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.538 ' OE1' ' HG2' ' A' ' 75' ' ' LYS 0.26 0.0 OUTLIER -59.87 86.25 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 115.233 1.568 . . . . 70.120000000000005 115.233 -177.568 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.15 19.33 67.28 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 114.798 -1.092 . . . . 64.129999999999995 111.263 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HZ2' ' CD ' ' A' ' 118' ' ' GLU . 44.7 mtpt -132.74 135.9 46.03 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.306 -0.998 . . . . 73.409999999999997 108.306 -176.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -137.94 138.65 39.19 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.982 -0.747 . . . . 74.439999999999998 108.982 -175.488 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -174.04 172.12 45.06 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 119.414 -1.374 . . . . 63.420000000000002 113.612 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.5 mt -124.43 143.68 37.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 106.996 -1.483 . . . . 71.230000000000004 106.996 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 97.4 t -124.03 110.1 24.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.085 -0.709 . . . . 74.109999999999999 109.085 177.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -94.15 104.18 16.21 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.002 -0.545 . . . . 74.409999999999997 109.648 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.3 t -105.62 115.07 46.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 109.245 -0.65 . . . . 75.329999999999998 109.245 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -125.34 134.94 52.02 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.019 -0.673 . . . . 71.439999999999998 110.185 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.8 mp -112.1 108.1 17.26 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 109.115 -0.698 . . . . 64.349999999999994 109.115 -173.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.517 ' HB3' ' OD1' ' A' ' 65' ' ' ASP . 12.3 ptp180 -102.14 151.42 22.2 Favored 'General case' 0 CA--C 1.468 -2.196 0 C-N-CA 119.333 -0.947 . . . . 74.519999999999996 112.28 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -84.29 98.45 10.0 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.885 -1.052 . . . . 62.43 109.557 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.3 tt -74.11 114.95 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-O 122.16 0.981 . . . . 72.340000000000003 109.959 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.5 p -133.04 -171.84 2.78 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 107.695 -1.224 . . . . 62.200000000000003 107.695 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -83.03 -5.83 59.25 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.235 0.54 . . . . 54.399999999999999 110.093 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -98.91 -39.93 8.33 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.989 -0.745 . . . . 74.340000000000003 108.989 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 62.7 m -104.35 120.69 49.88 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 116.494 -0.321 . . . . 74.319999999999993 111.615 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.37 142.79 19.07 Favored 'Trans proline' 0 CA--C 1.555 1.569 0 C-N-CA 123.069 2.512 . . . . 70.420000000000002 113.859 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.69 164.72 34.1 Favored 'Trans proline' 0 C--O 1.248 1.025 0 C-N-CA 124.016 3.144 . . . . 75.310000000000002 111.883 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.5 t -101.11 159.67 3.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 107.989 -1.115 . . . . 75.540000000000006 107.989 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -112.66 111.5 22.35 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.185 0.517 . . . . 73.349999999999994 110.7 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -128.49 -163.5 11.31 Favored Glycine 0 CA--C 1.487 -1.712 0 N-CA-C 110.462 -1.055 . . . . 74.510000000000005 110.462 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.531 ' HB3' ' SD ' ' A' ' 27' ' ' MET . 2.6 t-20 -75.19 140.91 43.6 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 122.446 0.298 . . . . 64.540000000000006 110.37 177.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -83.92 97.69 9.38 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 122.083 0.944 . . . . 64.409999999999997 110.581 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.19 151.99 44.77 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 113.422 -1.717 . . . . 73.439999999999998 108.978 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -76.83 93.27 3.7 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.839 0.828 . . . . 75.099999999999994 110.69 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.25 146.16 6.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 114.923 -1.035 . . . . 73.310000000000002 109.866 -175.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.7 mt -156.9 -90.8 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 126.116 1.766 . . . . 75.319999999999993 107.934 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.44 173.72 11.23 Favored 'General case' 0 C--N 1.255 -3.515 0 N-CA-C 105.944 -1.873 . . . . 75.209999999999994 105.944 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.456 ' O ' HG21 ' A' ' 110' ' ' ILE . 90.6 t80 -33.01 -46.39 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.682 1.734 . . . . 72.209999999999994 115.682 -172.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -56.1 -55.39 33.62 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 123.087 0.555 . . . . 74.150000000000006 112.204 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -78.83 -30.86 45.51 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.818 -0.628 . . . . 74.510000000000005 109.49 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.409 ' O ' HG12 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -65.76 -49.16 69.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.259 -0.882 . . . . 62.229999999999997 110.425 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.456 HG21 ' O ' ' A' ' 106' ' ' PHE . 9.9 tp -68.3 -35.76 72.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 121.365 0.603 . . . . 74.120000000000005 109.498 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -65.11 -44.68 87.97 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 115.205 -0.907 . . . . 75.409999999999997 110.12 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 27.0 t -67.55 -39.32 84.97 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 123.448 0.468 . . . . 63.5 110.974 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.556 ' O ' HG12 ' A' ' 117' ' ' ILE . 44.4 mm -66.01 -45.09 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 116.494 -0.321 . . . . 74.219999999999999 110.593 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.77 -35.5 74.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 N-CA-C 109.88 -0.415 . . . . 74.430000000000007 109.88 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 119' ' ' GLU . 60.1 tttp -60.1 -47.11 87.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.652 -0.703 . . . . 73.150000000000006 110.28 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.42 95.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.167 -0.47 . . . . 72.439999999999998 110.958 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 113' ' ' ILE . 43.0 mm -66.84 -44.03 89.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.742 -0.466 . . . . 64.120000000000005 109.742 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.454 ' CD ' ' HZ2' ' A' ' 78' ' ' LYS . 6.6 mm-40 -65.78 -36.59 83.98 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.973 -0.558 . . . . 74.140000000000001 112.288 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 54.5 mm-40 -68.45 -45.54 72.21 Favored 'General case' 0 C--O 1.221 -0.441 0 O-C-N 123.727 0.642 . . . . 65.400000000000006 110.034 176.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 44.6 t -56.63 -46.27 81.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.938 -0.574 . . . . 72.299999999999997 111.233 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.7 mp -78.6 -19.86 51.77 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.26 -0.576 . . . . 74.129999999999995 111.777 -177.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.63 -29.8 41.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.053 0.454 . . . . 70.400000000000006 109.928 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -83.13 -1.97 54.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.884 -0.598 . . . . 73.430000000000007 111.032 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -53.86 131.1 43.99 Favored Glycine 0 C--O 1.245 0.808 0 N-CA-C 110.814 -0.915 . . . . 71.329999999999998 110.814 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 73.9 74.66 0.12 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.63 1.172 . . . . 74.120000000000005 109.937 -171.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.1 tp -131.88 149.22 52.51 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 106.141 -1.8 . . . . 74.329999999999998 106.141 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -81.31 104.49 11.8 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 119.026 -1.069 . . . . 52.450000000000003 110.839 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.5 t -151.19 171.88 16.69 Favored 'General case' 0 N--CA 1.409 -2.52 0 N-CA-C 103.996 -2.594 . . . . 72.120000000000005 103.996 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.68 123.57 8.68 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.19 -0.604 . . . . 62.229999999999997 112.421 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.24 -157.64 0.52 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.636 -1.616 . . . . 74.400000000000006 106.636 174.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -98.89 93.41 6.02 Favored 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 120.052 -0.659 . . . . 73.340000000000003 111.724 176.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.21 159.11 37.5 Favored Glycine 0 C--O 1.249 1.05 0 CA-C-N 115.146 -0.933 . . . . 52.310000000000002 111.904 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.527 ' HZ3' ' CD ' ' A' ' 10' ' ' GLU . 88.4 mttt -98.94 131.19 25.96 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 112.475 0.546 . . . . 44.439999999999998 112.475 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.78 156.48 63.2 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.275 1.983 . . . . 74.409999999999997 108.403 168.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.59 101.41 54.21 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.712 -0.477 . . . . 73.420000000000002 109.712 -175.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -79.1 131.7 10.02 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 N-CA-C 107.849 -1.635 . . . . 74.420000000000002 107.849 168.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -81.65 117.0 66.54 Favored Pre-proline 0 C--N 1.296 -1.724 0 C-N-CA 119.847 -0.741 . . . . 72.019999999999996 111.282 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.53 -24.77 25.78 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.344 2.03 . . . . 64.099999999999994 111.589 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 82.4 mt 58.72 67.23 0.95 Allowed 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 123.024 1.392 . . . . 62.210000000000001 109.862 -175.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 68.2 tp -148.56 115.32 6.0 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 112.76 -2.018 . . . . 72.129999999999995 106.311 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -177.2 -129.69 1.28 Allowed Glycine 0 N--CA 1.419 -2.499 0 C-N-CA 119.38 -1.39 . . . . 61.539999999999999 111.918 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.7 mp 63.88 28.88 14.66 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.702 0.763 . . . . 75.510000000000005 109.301 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -85.84 98.81 10.97 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.428 -1.323 . . . . 71.340000000000003 107.428 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.8 m -93.21 147.92 22.48 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-N 115.165 -0.925 . . . . 74.219999999999999 111.421 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -148.48 170.06 18.87 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 106.978 -1.49 . . . . 72.310000000000002 106.978 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -139.16 98.53 3.54 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.401 -0.963 . . . . 63.130000000000003 108.401 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 62.9 m -150.34 142.76 24.36 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.643 -0.873 . . . . 73.530000000000001 108.643 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.212 0 N-CA-C 109.073 -1.611 . . . . 61.210000000000001 109.073 -179.676 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 CA--C 1.489 -1.392 0 N-CA-C 108.305 -0.998 . . . . 75.230000000000004 108.305 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.67 153.47 51.08 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.043 -1.095 . . . . 74.510000000000005 108.043 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 14.4 m-85 -112.95 145.67 40.38 Favored 'General case' 0 C--N 1.283 -2.313 0 C-N-CA 123.387 0.675 . . . . 75.209999999999994 109.508 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.522 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 15.7 t70 -103.08 110.67 22.69 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.532 -1.285 . . . . 73.140000000000001 107.532 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -93.11 111.46 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 CA-C-O 121.897 0.856 . . . . 74.230000000000004 108.721 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 p -109.29 110.97 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.76 0 CA-C-N 114.778 -1.101 . . . . 73.209999999999994 109.284 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.491 HG21 ' HB2' ' A' ' 27' ' ' MET . 4.3 tt -103.93 125.36 58.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.868 -1.06 . . . . 52.329999999999998 110.372 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.2 mt -118.93 103.31 48.27 Favored Pre-proline 0 N--CA 1.425 -1.723 0 CA-C-N 115.52 -0.764 . . . . 72.409999999999997 109.275 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.555 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 3.1 Cg_exo -82.39 140.58 10.89 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.175 1.917 . . . . 75.439999999999998 109.582 173.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -156.97 114.27 3.12 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.949 0.881 . . . . 71.329999999999998 110.677 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 m -80.42 128.39 33.52 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.811 -0.632 . . . . 62.539999999999999 109.619 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.481 ' HD2' ' CD1' ' A' ' 81' ' ' ILE . 2.2 p90 -59.18 105.18 0.31 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 114.632 1.345 . . . . 74.439999999999998 114.632 -175.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -141.14 106.73 5.08 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.395 -1.275 . . . . 73.540000000000006 109.538 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -69.08 159.14 33.44 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 106.86 -1.533 . . . . 72.430000000000007 106.86 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -82.91 92.16 7.26 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.012 -1.075 . . . . 72.349999999999994 110.462 176.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.533 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 16.9 t70 -66.76 -102.0 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.76 -1.109 . . . . 74.329999999999998 109.43 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -113.32 -60.36 1.89 Allowed 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 108.269 -1.011 . . . . 63.340000000000003 108.269 171.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -139.5 -53.08 0.54 Allowed 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.677 0.751 . . . . 74.109999999999999 112.205 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -86.1 74.47 10.07 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.376 -0.829 . . . . 73.120000000000005 111.109 -174.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.533 ' SD ' ' HB2' ' A' ' 16' ' ' ASP . 53.0 ttm 173.87 93.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.719 2.007 . . . . 74.349999999999994 105.614 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 10.0 pt-20 -176.16 115.99 0.13 Allowed 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.082 -1.451 . . . . 63.43 107.082 -175.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -157.44 98.23 1.67 Allowed 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 119.326 -0.95 . . . . 73.310000000000002 111.429 172.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.4 mm -120.05 131.04 73.49 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 105.832 -1.914 . . . . 75.310000000000002 105.832 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 73.5 m -107.47 129.03 24.82 Favored Pre-proline 0 C--N 1.293 -1.885 0 C-N-CA 119.764 -0.775 . . . . 65.319999999999993 110.745 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -56.17 146.15 72.58 Favored 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 123.217 2.612 . . . . 63.530000000000001 112.537 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -57.8 145.11 91.88 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 123.684 2.922 . . . . 50.340000000000003 114.265 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.491 ' HB2' HG21 ' A' ' 7' ' ' ILE . 62.9 mtp -103.41 131.13 50.75 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 104.994 -2.224 . . . . 64.219999999999999 104.994 173.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.6 t -120.66 123.23 69.9 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 O-C-N 123.133 0.27 . . . . 74.150000000000006 110.355 -173.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.68 107.5 15.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 107.389 -1.338 . . . . 72.209999999999994 107.389 176.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -127.13 81.77 0.35 Allowed Glycine 0 CA--C 1.475 -2.429 0 C-N-CA 118.019 -2.039 . . . . 75.540000000000006 115.416 -173.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -174.38 37.92 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.979 0.895 . . . . 74.049999999999997 111.126 173.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -113.7 133.34 55.39 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 106.423 -1.695 . . . . 37.119999999999997 106.423 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 p -76.71 163.49 26.78 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 119.139 0.881 . . . . 72.340000000000003 109.089 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.494 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 63.2 t80 -52.55 -43.32 65.11 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 123.758 0.823 . . . . 74.239999999999995 111.689 -174.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -68.14 -40.23 82.47 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.008 -0.996 . . . . 72.400000000000006 111.331 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.2 mm -73.65 -39.35 53.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.131 -0.692 . . . . 73.140000000000001 109.131 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.78 95.14 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.936 -1.029 . . . . 74.329999999999998 110.331 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.1 mmt -65.67 -36.04 82.5 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.495 -0.482 . . . . 74.129999999999995 111.287 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -68.42 -43.58 76.88 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 120.634 -0.426 . . . . 74.409999999999997 111.285 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.7 tt -70.32 -39.33 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 C-N-CA 119.826 -0.75 . . . . 54.340000000000003 110.464 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.3 -45.09 99.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-N 116.737 -0.21 . . . . 74.209999999999994 110.868 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -68.44 -32.59 72.71 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 119.977 -0.689 . . . . 53.450000000000003 111.4 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.435 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -69.78 -46.05 55.29 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 110.983 -0.847 . . . . 74.010000000000005 110.983 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.35 -41.11 90.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.729 -0.471 . . . . 63.409999999999997 109.729 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.446 ' CG ' HH21 ' A' ' 69' ' ' ARG . 16.4 t70 -58.48 -46.67 86.19 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.919 -1.037 . . . . 70.219999999999999 110.346 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -40.77 96.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.633 -0.712 . . . . 64.409999999999997 110.817 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 43' ' ' GLY . 98.3 t -63.75 -43.22 97.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.531 -0.304 . . . . 74.25 111.067 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.8 mt -69.9 -39.59 77.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.561 0.219 . . . . 73.319999999999993 110.922 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -74.92 -24.72 58.55 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 120.903 0.382 . . . . 74.340000000000003 110.912 -175.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.39 -42.15 9.94 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 112.502 0.556 . . . . 72.519999999999996 112.502 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.1 m -83.9 -17.93 39.12 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.199 0.523 . . . . 74.329999999999998 111.737 -174.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -134.58 179.34 6.35 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 121.533 0.682 . . . . 73.540000000000006 109.995 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 26.7 t-20 -98.8 102.66 14.47 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.007 -1.849 . . . . 75.25 106.007 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -133.98 135.94 43.8 Favored 'General case' 0 N--CA 1.412 -2.357 0 C-N-CA 119.595 -0.842 . . . . 72.420000000000002 112.446 -175.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.9 m -102.1 111.89 24.34 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 105.24 -2.133 . . . . 74.150000000000006 105.24 171.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.403 HG21 ' OD1' ' A' ' 45' ' ' ASP . 7.4 p -100.64 142.74 15.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 120.699 0.285 . . . . 63.420000000000002 110.778 -174.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HB2' ' ND2' ' A' ' 137' ' ' ASN . 10.0 tp10 -139.88 151.74 45.89 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.634 -0.876 . . . . 73.239999999999995 108.634 175.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -125.63 106.46 9.75 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.983 0.897 . . . . 61.32 110.068 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -99.08 172.49 7.36 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.854 -1.067 . . . . 72.219999999999999 109.148 -175.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -109.03 137.84 46.3 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.059 -0.518 . . . . 72.230000000000004 109.687 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -98.29 176.83 30.65 Favored Glycine 0 C--N 1.294 -1.784 0 CA-C-N 115.196 -0.911 . . . . 60.200000000000003 112.671 -174.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.72 166.74 8.36 Favored 'General case' 0 C--O 1.19 -2.047 0 N-CA-C 107.388 -1.338 . . . . 65.109999999999999 107.388 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -42.6 -39.77 2.46 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 115.311 1.597 . . . . 72.430000000000007 115.311 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 51.5 t -73.71 -29.64 62.38 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.082 0.468 . . . . 63.200000000000003 111.518 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.422 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 8.0 m-20 -98.26 115.17 27.82 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.545 -0.909 . . . . 63.240000000000002 108.545 -176.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.0 t -83.67 -32.57 8.96 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 N-CA-C 113.29 0.848 . . . . 74.340000000000003 113.29 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.1 tp -148.79 140.8 23.85 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.238 -1.023 . . . . 73.439999999999998 108.238 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -129.72 126.11 37.49 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.962 -1.495 . . . . 75.530000000000001 106.962 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.446 HH21 ' CG ' ' A' ' 45' ' ' ASP . 10.8 tpt180 -113.73 138.8 49.74 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 107.529 -1.286 . . . . 65.540000000000006 107.529 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -123.96 130.64 52.92 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.981 -1.118 . . . . 52.219999999999999 107.981 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -125.56 115.82 20.78 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.234 -0.654 . . . . 70.0 109.234 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 39.5 m -88.26 110.3 20.63 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.974 -1.121 . . . . 74.329999999999998 107.974 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.0 142.23 28.47 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.13 0.572 . . . . 74.239999999999995 112.317 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 36.7 tt0 -144.32 93.9 2.5 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.917 -1.038 . . . . 63.140000000000001 109.041 171.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.508 ' HG2' ' H ' ' A' ' 76' ' ' GLU . 49.8 tttt -99.53 -176.04 3.17 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 105.968 -1.864 . . . . 64.0 105.968 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.508 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 8.6 pt-20 -48.83 91.26 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.092 1.357 . . . . 70.140000000000001 113.271 177.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.24 17.27 68.0 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.188 -0.914 . . . . 62.32 113.414 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 53.7 mtmt -138.78 122.41 17.44 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.48 -0.933 . . . . 73.140000000000001 108.48 -177.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -145.24 145.58 31.35 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 120.698 0.285 . . . . 72.540000000000006 111.298 -173.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.92 171.9 41.81 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 110.47 -1.052 . . . . 71.530000000000001 110.47 -176.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.481 ' CD1' ' HD2' ' A' ' 12' ' ' PHE . 3.7 mp -105.03 143.87 15.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 117.888 0.844 . . . . 72.099999999999994 109.669 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.4 t -119.6 110.27 28.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.967 -0.753 . . . . 73.319999999999993 108.967 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -93.89 131.3 39.45 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 124.006 0.922 . . . . 74.439999999999998 110.017 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.14 109.92 18.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.235 -1.024 . . . . 63.32 108.235 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -118.45 146.27 44.61 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.936 -1.106 . . . . 62.399999999999999 111.338 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.5 mt -105.52 107.89 19.12 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.502 -1.296 . . . . 73.549999999999997 107.502 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 37.3 ptt180 -103.84 135.89 44.54 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.403 -0.962 . . . . 74.129999999999995 108.403 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -76.73 108.34 9.68 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.447 0.641 . . . . 74.239999999999995 110.81 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 tt -82.82 111.42 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.276 1.036 . . . . 74.420000000000002 108.564 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 91' ' ' GLU . 3.6 m -144.53 -171.95 3.71 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 104.27 -2.493 . . . . 73.319999999999993 104.27 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.488 ' H ' HG22 ' A' ' 90' ' ' THR . 3.8 mp0 -60.82 -24.34 65.78 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 119.112 0.869 . . . . 74.5 111.765 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -76.45 -39.92 52.0 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.544 -0.753 . . . . 73.540000000000006 110.665 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 73.9 m -119.21 89.87 40.61 Favored Pre-proline 0 N--CA 1.431 -1.4 0 CA-C-N 116.459 -0.337 . . . . 73.109999999999999 110.627 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.24 152.75 56.17 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 121.809 1.673 . . . . 70.120000000000005 110.575 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.96 141.98 91.24 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.213 2.608 . . . . 44.140000000000001 113.317 -175.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.25 155.62 16.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 106.619 -1.622 . . . . 72.420000000000002 106.619 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.92 144.97 27.36 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 120.958 0.409 . . . . 74.439999999999998 110.183 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -157.24 -159.74 9.7 Favored Glycine 0 CA--C 1.464 -3.14 0 N-CA-C 107.992 -2.043 . . . . 45.039999999999999 107.992 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -69.45 108.99 3.99 Favored 'General case' 0 N--CA 1.395 -3.206 0 N-CA-C 107.652 -1.24 . . . . 70.420000000000002 107.652 171.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -83.29 109.62 17.41 Favored 'General case' 0 N--CA 1.416 -2.164 0 N-CA-C 107.894 -1.15 . . . . 74.409999999999997 107.894 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 36.7 t -69.32 156.74 38.3 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.856 -1.066 . . . . 65.109999999999999 109.723 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -79.43 94.58 5.58 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.982 -1.118 . . . . 61.049999999999997 107.982 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.7 t -96.31 129.96 45.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.339 -0.846 . . . . 63.43 110.297 -172.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 mp -139.64 -90.42 0.19 Allowed 'General case' 0 C--N 1.269 -2.905 0 CA-C-N 114.746 -1.116 . . . . 73.510000000000005 108.569 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -139.41 163.14 33.29 Favored 'General case' 0 C--N 1.251 -3.684 0 CA-C-N 113.587 -1.642 . . . . 70.409999999999997 106.873 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -34.35 -49.99 0.4 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.284 1.433 . . . . 74.5 114.843 -172.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 111' ' ' GLU . 27.9 tt0 -61.08 -46.5 90.41 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.095 0.406 . . . . 63.25 112.095 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -78.08 -31.16 50.02 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.494 -0.321 . . . . 61.329999999999998 110.555 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 113' ' ' ILE . 2.3 m-20 -66.43 -45.99 77.99 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.324 -0.853 . . . . 74.230000000000004 110.127 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.2 tp -63.35 -38.08 81.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 116.558 -0.292 . . . . 74.230000000000004 110.729 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 107' ' ' GLU . 44.9 mt-10 -60.14 -46.13 90.7 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.835 -0.431 . . . . 63.420000000000002 109.835 177.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 18.6 t -61.5 -41.1 96.78 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.497 -0.774 . . . . 71.099999999999994 111.137 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.451 ' O ' HG13 ' A' ' 117' ' ' ILE . 46.3 mm -65.42 -46.33 90.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.312 -0.404 . . . . 75.010000000000005 110.377 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 80.1 t -64.88 -39.97 87.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.158 -0.474 . . . . 75.109999999999999 110.554 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -67.46 -32.28 73.02 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 116.366 -0.379 . . . . 71.219999999999999 111.252 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.53 -34.67 53.87 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 120.641 0.258 . . . . 61.229999999999997 111.338 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 113' ' ' ILE . 82.4 mt -64.17 -48.12 87.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.791 -1.189 . . . . 71.430000000000007 107.791 174.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -62.77 -29.73 70.91 Favored 'General case' 0 C--O 1.192 -1.933 0 CA-C-N 115.447 -0.797 . . . . 72.450000000000003 111.633 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -67.59 -35.55 79.19 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.234 0.54 . . . . 54.219999999999999 109.795 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 4.5 t -84.47 -31.15 24.7 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.143 0.973 . . . . 75.349999999999994 109.537 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.6 mp -78.54 -39.34 38.16 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.859 -0.609 . . . . 72.219999999999999 111.98 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.67 -15.55 44.95 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 114.826 1.417 . . . . 43.439999999999998 114.826 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 123' ' ' LYS 0.346 34.0 mmtp -84.14 -3.93 58.45 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 116.271 1.952 . . . . 62.130000000000003 116.271 -175.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.33 -163.45 53.92 Favored Glycine 0 C--O 1.215 -1.075 0 C-N-CA 120.442 -0.885 . . . . 62.210000000000001 113.44 173.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.1 88.63 6.6 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-O 121.86 0.838 . . . . 74.439999999999998 112.823 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 127' ' ' ASN . 6.2 tt -161.84 140.65 9.52 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 105.996 -1.853 . . . . 70.420000000000002 105.996 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.438 ' N ' HD22 ' A' ' 126' ' ' LEU . 6.3 t30 78.16 113.27 0.07 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.251 1.204 . . . . 73.299999999999997 114.251 177.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.2 p -144.0 104.52 4.15 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 114.76 -1.109 . . . . 72.340000000000003 108.267 173.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -107.42 32.56 4.57 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.993 0.901 . . . . 72.129999999999995 110.464 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.0 tp -171.72 135.15 0.85 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 113.717 -1.583 . . . . 65.400000000000006 107.14 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.09 105.91 18.14 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.236 -1.764 . . . . 73.340000000000003 106.236 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -145.59 154.39 25.9 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 110.546 -1.022 . . . . 70.310000000000002 110.546 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -114.68 105.3 53.61 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 109.905 -0.406 . . . . 73.129999999999995 109.905 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.22 121.3 8.28 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.502 2.135 . . . . 51.350000000000001 110.68 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 49.3 mm -104.89 102.94 38.38 Favored Pre-proline 0 N--CA 1.436 -1.128 0 N-CA-C 109.074 -0.713 . . . . 74.129999999999995 109.074 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.26 143.32 63.92 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.449 2.099 . . . . 71.129999999999995 110.352 175.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.442 ' ND2' ' HB2' ' A' ' 57' ' ' GLU . 27.2 p-10 -101.78 135.4 19.75 Favored Pre-proline 0 C--N 1.298 -1.641 0 C-N-CA 120.019 -0.672 . . . . 63.109999999999999 110.131 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.72 -52.37 2.4 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.347 2.031 . . . . 71.239999999999995 110.654 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 55.4 tp 66.18 123.1 0.02 OUTLIER 'General case' 0 C--O 1.242 0.677 0 C-N-CA 125.532 1.533 . . . . 72.540000000000006 112.517 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.0 tp -84.66 78.31 9.88 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.22 -1.4 . . . . 71.140000000000001 107.22 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -121.07 122.77 5.32 Favored Glycine 0 N--CA 1.412 -2.935 0 CA-C-N 114.903 -1.044 . . . . 62.43 111.63 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -123.91 27.33 7.27 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.662 -1.607 . . . . 71.230000000000004 106.662 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -95.6 93.15 6.98 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.77 -1.559 . . . . 75.420000000000002 111.019 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.8 m -125.92 93.35 3.8 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.067 -1.457 . . . . 73.129999999999995 107.067 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.7 t -153.99 138.71 17.01 Favored 'General case' 0 N--CA 1.411 -2.382 0 N-CA-C 108.152 -1.055 . . . . 74.200000000000003 108.152 -176.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.52 100.93 4.64 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 106.366 -1.716 . . . . 71.310000000000002 106.366 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.5 t -138.29 135.68 35.7 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.543 -0.91 . . . . 72.450000000000003 108.543 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.489 0 N-CA-C 107.453 -2.259 . . . . 74.109999999999999 107.453 -175.267 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 tmm? . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 107.816 -1.179 . . . . 61.409999999999997 107.816 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -110.93 165.72 11.63 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.821 0.819 . . . . 71.340000000000003 113.193 -169.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.462 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 7.5 m-85 -121.65 145.81 47.62 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.684 -1.144 . . . . 73.549999999999997 110.28 177.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.432 ' OD1' ' HA3' ' A' ' 30' ' ' GLY . 32.4 t70 -115.13 120.75 40.84 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.762 -1.57 . . . . 73.450000000000003 106.762 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -99.91 116.78 43.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 109.63 -0.507 . . . . 63.130000000000003 109.63 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.411 ' HB ' ' CG ' ' A' ' 85' ' ' LYS . 46.6 t -108.48 117.46 54.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 107.862 -1.162 . . . . 60.409999999999997 107.862 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.413 HG22 ' HB2' ' A' ' 27' ' ' MET . 7.7 tt -117.95 123.09 71.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 121.376 0.608 . . . . 62.420000000000002 110.306 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.2 mp -114.27 98.24 48.04 Favored Pre-proline 0 N--CA 1.422 -1.849 0 CA-C-N 115.648 -0.705 . . . . 51.509999999999998 109.138 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.69 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 5.8 Cg_exo -81.49 130.36 6.95 Favored 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 122.009 1.806 . . . . 74.230000000000004 107.427 171.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.37 131.08 12.36 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.285 0.564 . . . . 72.099999999999994 110.697 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -73.53 122.17 21.77 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 107.672 -1.233 . . . . 74.400000000000006 107.672 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.497 ' HD1' ' O ' ' A' ' 12' ' ' PHE 0.255 0.1 OUTLIER -68.02 105.68 2.11 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.981 0.896 . . . . 65.430000000000007 113.08 -175.256 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -126.75 126.29 43.19 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 113.942 1.09 . . . . 74.120000000000005 113.942 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -76.64 129.18 36.02 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 103.171 -2.9 . . . . 73.5 103.171 165.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.65 111.46 9.86 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-O 121.602 0.715 . . . . 73.319999999999993 110.026 -169.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.57 -164.17 0.61 Allowed 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 114.36 -1.291 . . . . 38.009999999999998 107.967 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -100.88 -29.9 11.97 Favored 'General case' 0 N--CA 1.411 -2.381 0 O-C-N 121.499 -0.751 . . . . 72.209999999999994 110.745 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.1 t60 -135.05 -51.08 0.77 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 118.776 -1.169 . . . . 65.430000000000007 113.357 -175.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -122.22 139.08 54.19 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 109.358 -0.608 . . . . 72.140000000000001 109.358 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.303 59.3 mtm 96.64 73.35 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 126.338 1.855 . . . . 65.019999999999996 111.295 -175.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -156.41 94.07 1.46 Allowed 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 112.696 -2.047 . . . . 42.539999999999999 107.44 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -142.17 120.55 12.37 Favored 'General case' 0 CA--C 1.47 -2.116 0 O-C-N 121.577 -0.702 . . . . 71.540000000000006 109.462 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.414 HG13 ' H ' ' A' ' 132' ' ' GLY . 41.6 mm -133.05 143.67 38.72 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.799 0 N-CA-C 104.225 -2.509 . . . . 74.349999999999994 104.225 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.69 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 60.5 m -107.77 150.1 39.82 Favored Pre-proline 0 C--N 1.274 -2.7 0 N-CA-C 109.989 -0.374 . . . . 73.420000000000002 109.989 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -65.29 142.5 73.26 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.239 2.626 . . . . 63.32 114.255 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.06 126.49 18.05 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 123.104 2.536 . . . . 41.119999999999997 110.994 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.413 ' HB2' HG22 ' A' ' 7' ' ' ILE . 84.3 mtp -101.23 145.29 29.03 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.333 -0.988 . . . . 60.140000000000001 108.333 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 62.2 t -130.76 121.21 49.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.417 -0.586 . . . . 65.25 109.417 -178.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.6 mp -131.14 102.18 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.772 0 N-CA-C 106.205 -1.776 . . . . 73.099999999999994 106.205 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.432 ' HA3' ' OD1' ' A' ' 4' ' ' ASP . . . -117.53 -172.75 16.09 Favored Glycine 0 C--N 1.269 -3.146 0 C-N-CA 119.902 -1.142 . . . . 55.030000000000001 112.773 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.447 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 9.0 t70 71.7 67.6 0.15 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 125.636 1.574 . . . . 71.140000000000001 110.515 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.492 HH22 ' CG1' ' A' ' 103' ' ' VAL . 3.8 mpt_? -140.25 143.92 36.21 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 104.818 -2.29 . . . . 74.25 104.818 172.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 t -78.53 -179.71 6.56 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.78 -1.168 . . . . 62.149999999999999 108.07 174.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.462 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 88.3 t80 -55.98 -52.91 62.5 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 123.094 0.558 . . . . 70.349999999999994 112.394 -174.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 46.2 m-20 -68.04 -39.9 82.96 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.008 -0.997 . . . . 64.310000000000002 110.136 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.0 mt -65.03 -38.32 82.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.305 -0.861 . . . . 75.25 109.925 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.16 -42.47 88.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.791 -0.448 . . . . 72.129999999999995 109.791 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 24.0 mmt -64.77 -41.32 95.95 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.037 -0.529 . . . . 74.099999999999994 110.825 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 35' ' ' ASP . 40.1 mt-10 -66.27 -40.29 90.02 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 112.337 0.495 . . . . 73.349999999999994 112.337 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.566 ' O ' HG22 ' A' ' 44' ' ' VAL . 15.0 tt -72.58 -41.49 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 119.198 -1.001 . . . . 74.450000000000003 110.609 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.6 t -72.15 -37.15 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 120.468 -0.493 . . . . 62.219999999999999 111.309 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -74.31 -23.89 59.14 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.611 -0.436 . . . . 74.219999999999999 111.057 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.87 -45.93 40.24 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.196 -1.161 . . . . 38.009999999999998 110.196 175.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 40' ' ' ILE . 61.5 t -63.3 -41.97 94.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 N-CA-C 108.981 -0.748 . . . . 75.319999999999993 108.981 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.68 -52.34 31.76 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 125.372 1.469 . . . . 65.25 110.793 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -63.93 -40.25 96.02 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.789 -1.096 . . . . 71.310000000000002 110.732 -177.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.93 -36.62 74.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.215 -0.448 . . . . 72.420000000000002 110.592 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.4 mt -67.62 -43.74 86.69 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.171 0 N-CA-C 109.901 -0.407 . . . . 73.450000000000003 109.901 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.443 ' HZ1' ' HB3' ' A' ' 49' ' ' LYS . 7.9 mtpm? -74.26 -15.75 60.97 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.628 0.603 . . . . 75.109999999999999 112.628 -177.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.76 -33.99 13.38 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 112.177 0.436 . . . . 45.130000000000003 112.177 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -96.52 -19.21 19.27 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.258 0.551 . . . . 72.040000000000006 112.359 -176.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.409 ' CD2' ' HD2' ' A' ' 75' ' ' LYS . 22.4 m-85 -137.23 -176.36 4.36 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.686 -1.227 . . . . 71.310000000000002 107.686 -176.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -107.49 117.78 34.99 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.985 -1.487 . . . . 73.109999999999999 106.985 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -138.24 134.98 35.09 Favored 'General case' 0 N--CA 1.405 -2.71 0 C-N-CA 119.892 -0.723 . . . . 72.230000000000004 110.934 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.6 m -108.18 120.04 41.21 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 105.754 -1.943 . . . . 73.040000000000006 105.754 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.32 127.36 53.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.185 0.517 . . . . 64.129999999999995 110.767 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -121.72 116.6 24.82 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.748 -1.205 . . . . 64.140000000000001 107.748 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -100.49 118.18 36.17 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 120.872 0.368 . . . . 72.319999999999993 111.634 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mp -121.32 178.13 4.9 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.69 -0.855 . . . . 62.219999999999999 108.69 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -87.59 149.61 24.21 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.746 -0.835 . . . . 75.549999999999997 108.746 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.458 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -92.35 175.17 37.47 Favored Glycine 0 C--N 1.292 -1.908 0 N-CA-C 110.316 -1.114 . . . . 71.109999999999999 110.316 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -92.5 133.81 35.57 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 118.079 0.939 . . . . 74.209999999999994 112.749 -175.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.3 t70 59.26 -76.59 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.918 1.687 . . . . 62.109999999999999 114.53 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.9 t -119.38 5.53 11.16 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.425 0.631 . . . . 75.409999999999997 110.748 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.458 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 65.3 m-20 -81.43 124.17 29.2 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.943 -1.873 . . . . 73.150000000000006 105.943 173.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.8 t -83.75 -37.15 13.0 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 112.457 0.54 . . . . 74.5 112.457 -173.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 59.2 tp -142.18 137.85 31.13 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 109.169 -0.678 . . . . 64.409999999999997 109.169 -175.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.06 103.59 6.85 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.097 -1.446 . . . . 70.230000000000004 107.097 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -107.67 119.81 40.46 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 122.047 0.927 . . . . 74.420000000000002 111.226 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -98.71 108.69 21.44 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 113.704 -1.589 . . . . 74.340000000000003 108.036 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -97.21 131.38 44.0 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.882 -0.784 . . . . 74.319999999999993 108.882 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 15.4 m -96.13 118.58 32.99 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.662 -1.607 . . . . 63.130000000000003 106.662 173.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.24 134.74 47.84 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 112.976 0.732 . . . . 73.510000000000005 112.976 -173.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -136.45 137.04 40.01 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.155 -1.384 . . . . 75.519999999999996 108.105 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -141.79 85.88 1.96 Allowed 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.141 -1.429 . . . . 62.210000000000001 107.141 175.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.278 15.5 pt-20 32.95 69.62 0.12 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.919 1.687 . . . . 75.230000000000004 114.572 -174.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.19 -23.33 35.18 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.035 -0.984 . . . . 52.219999999999999 112.565 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.558 ' N ' ' HE3' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -85.88 124.25 32.14 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.064 -1.828 . . . . 74.209999999999994 106.064 178.801 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.439 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -132.2 146.51 52.07 Favored 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 120.057 -0.657 . . . . 71.420000000000002 111.745 -172.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.24 176.56 38.61 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.196 -0.911 . . . . 73.049999999999997 111.174 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.4 tp -129.47 138.0 55.44 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 106.668 -1.604 . . . . 73.420000000000002 106.668 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.44 110.32 24.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.467 -0.771 . . . . 73.010000000000005 110.083 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -96.92 106.36 18.67 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 123.838 0.855 . . . . 73.140000000000001 110.411 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.2 t -107.09 115.46 48.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.048 -0.723 . . . . 72.150000000000006 109.048 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 18.3 ptpt -110.45 140.42 44.71 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.819 -0.437 . . . . 70.140000000000001 109.819 177.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.4 mt -107.8 108.02 19.04 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 105.399 -2.074 . . . . 72.430000000000007 105.399 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 43.9 ttt85 -97.81 133.13 42.74 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 109.057 -0.72 . . . . 72.439999999999998 109.057 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -79.34 112.82 16.95 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.42 -0.955 . . . . 72.299999999999997 108.42 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.5 tt -91.08 111.44 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-O 122.373 1.082 . . . . 74.420000000000002 109.023 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.6 m -133.53 172.6 12.51 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 105.206 -2.146 . . . . 73.25 105.206 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -64.55 -20.89 66.5 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 118.872 0.76 . . . . 70.140000000000001 110.485 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -94.48 -5.83 45.27 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.039 -0.982 . . . . 74.340000000000003 111.59 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 70.3 m -133.32 109.52 12.51 Favored Pre-proline 0 C--N 1.314 -0.94 0 O-C-N 122.124 -0.36 . . . . 73.019999999999996 111.046 -175.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.56 138.86 24.79 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.143 1.895 . . . . 53.420000000000002 112.387 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.95 164.66 33.9 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 123.414 2.742 . . . . 51.340000000000003 111.13 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.7 t -94.11 155.7 3.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.988 -0.745 . . . . 72.549999999999997 108.988 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -106.19 122.08 45.48 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.512 -0.767 . . . . 70.209999999999994 109.086 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -158.13 -159.65 9.74 Favored Glycine 0 CA--C 1.468 -2.85 0 N-CA-C 110.229 -1.148 . . . . 54.0 110.229 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -76.29 93.0 3.36 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-O 121.828 0.823 . . . . 71.129999999999995 111.375 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 62.9 ttt180 -73.89 122.01 21.84 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.252 -1.34 . . . . 72.109999999999999 108.037 177.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 38.7 t -88.97 163.79 15.4 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.896 -0.722 . . . . 73.329999999999998 109.846 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.7 m -75.31 107.75 7.63 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 122.934 0.494 . . . . 75.340000000000003 109.902 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.492 ' CG1' HH22 ' A' ' 32' ' ' ARG . 36.5 t -85.01 135.91 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-O 122.132 0.967 . . . . 74.129999999999995 110.277 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.0 mt -153.18 -163.84 1.78 Allowed 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 104.805 -2.294 . . . . 73.099999999999994 104.805 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -54.05 145.93 15.76 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 118.405 0.548 . . . . 75.219999999999999 111.406 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.429 ' O ' HG23 ' A' ' 110' ' ' ILE . 13.9 t80 -32.91 -48.57 0.21 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.425 2.29 . . . . 75.230000000000004 113.707 -173.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.562 ' O ' ' HG3' ' A' ' 111' ' ' GLU . 43.3 tt0 -57.4 -43.87 84.05 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 112.349 0.5 . . . . 74.319999999999993 112.349 -176.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 -72.09 -31.4 66.04 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.145 -0.622 . . . . 61.409999999999997 111.501 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -71.38 -44.7 64.46 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.879 -1.055 . . . . 74.200000000000003 108.412 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 106' ' ' PHE . 12.7 tt -68.37 -36.79 76.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 C-N-CA 120.479 -0.489 . . . . 74.099999999999994 110.681 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.562 ' HG3' ' O ' ' A' ' 107' ' ' GLU . 52.6 mt-10 -61.56 -35.94 79.22 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.874 0.368 . . . . 74.140000000000001 110.064 176.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 44.5 t -64.98 -43.44 92.62 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.005 -0.543 . . . . 75.439999999999998 109.953 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.6 mm -64.58 -46.66 91.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.513 -0.767 . . . . 73.430000000000007 110.301 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 92.3 t -63.29 -39.2 84.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.456 -0.338 . . . . 73.319999999999993 110.53 -177.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -62.64 -38.7 91.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.052 0.453 . . . . 74.120000000000005 110.4 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.89 -42.32 90.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.132 -0.486 . . . . 71.030000000000001 110.326 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.78 -42.75 93.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.008 -0.542 . . . . 75.209999999999994 110.569 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 114' ' ' VAL . 52.8 mt-10 -61.12 -44.81 96.77 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 121.319 -0.152 . . . . 75.129999999999995 110.618 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -65.07 -46.59 80.55 Favored 'General case' 0 C--O 1.181 -2.502 0 C-N-CA 119.685 -0.806 . . . . 72.439999999999998 110.336 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 2.7 t -68.84 -22.71 64.21 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.324 0.583 . . . . 61.310000000000002 111.616 -172.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.2 mp -81.96 -47.1 13.12 Favored 'General case' 0 N--CA 1.428 -1.553 0 O-C-N 121.999 -0.438 . . . . 71.109999999999999 111.473 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.16 -25.59 31.71 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.855 0.687 . . . . 51.100000000000001 112.855 -172.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -102.65 9.92 38.98 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.431 -1.322 . . . . 71.209999999999994 107.431 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.11 57.35 2.75 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 114.445 -1.252 . . . . 61.210000000000001 115.329 -174.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -173.26 98.5 0.12 Allowed 'General case' 0 C--N 1.272 -2.765 0 C-N-CA 125.233 1.413 . . . . 72.25 107.228 172.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.81 -178.38 4.85 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 115.598 -0.728 . . . . 71.129999999999995 110.022 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -134.1 159.46 40.78 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 126.02 1.728 . . . . 71.120000000000005 106.467 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.8 t 63.56 34.66 12.37 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 122.033 0.921 . . . . 72.400000000000006 110.996 177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -122.69 107.54 12.06 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.594 -1.185 . . . . 70.519999999999996 111.004 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.6 tp -65.42 144.79 56.84 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.349 -0.841 . . . . 72.230000000000004 109.308 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.4 165.66 13.83 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.167 -0.924 . . . . 74.010000000000005 112.232 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.414 ' H ' HG13 ' A' ' 23' ' ' ILE . . . -120.56 -74.3 0.38 Allowed Glycine 0 N--CA 1.42 -2.368 0 N-CA-C 105.232 -3.147 . . . . 73.239999999999995 105.232 170.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -117.97 119.49 33.59 Favored Pre-proline 0 N--CA 1.427 -1.605 0 N-CA-C 106.82 -1.548 . . . . 73.549999999999997 106.82 170.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.7 106.43 1.98 Allowed 'Trans proline' 0 N--CA 1.446 -1.285 0 N-CA-C 107.598 -1.732 . . . . 73.340000000000003 107.598 172.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 49.3 mm -112.27 102.12 53.43 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 120.825 -0.35 . . . . 71.319999999999993 111.184 -174.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.57 132.72 7.97 Favored 'Trans proline' 0 N--CA 1.436 -1.878 0 C-N-CA 122.001 1.801 . . . . 75.040000000000006 107.695 167.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -136.79 98.73 10.58 Favored Pre-proline 0 C--N 1.289 -2.037 0 C-N-CA 119.287 -0.965 . . . . 64.400000000000006 108.99 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.76 75.93 4.54 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 122.314 2.009 . . . . 74.219999999999999 112.867 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.53 162.03 36.92 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.399 -0.819 . . . . 60.509999999999998 111.016 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.77 97.95 6.89 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.016 -0.735 . . . . 62.140000000000001 109.016 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.12 129.79 41.13 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 111.329 -0.708 . . . . 62.119999999999997 111.329 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.6 tt -123.98 98.3 5.73 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.685 -0.858 . . . . 73.129999999999995 108.685 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -141.08 139.82 34.09 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.463 -0.79 . . . . 61.549999999999997 110.495 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 t -147.46 47.27 1.12 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.378 1.085 . . . . 73.340000000000003 108.611 175.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 20.9 p -88.89 116.57 27.27 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 107.781 -1.192 . . . . 71.129999999999995 107.781 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 50.2 ttp85 -53.06 112.11 0.8 Allowed 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.765 0.826 . . . . 62.0 111.952 -172.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.2 m -80.95 120.48 24.81 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.479 -0.782 . . . . 74.450000000000003 109.967 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.422 0 N-CA-C 109.829 -1.309 . . . . 73.549999999999997 109.829 178.282 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 mtp . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 121.363 0.601 . . . . 73.319999999999993 112.179 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -141.32 174.12 10.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.561 -1.274 . . . . 71.219999999999999 107.561 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 24.9 m-85 -120.35 134.96 55.17 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-O 121.325 0.583 . . . . 71.439999999999998 109.697 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.672 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 62.3 t0 -115.26 119.37 36.09 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.245 -1.343 . . . . 74.420000000000002 108.404 -175.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.6 125.7 50.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 115.673 -0.694 . . . . 75.439999999999998 111.393 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.498 ' HB ' HH21 ' A' ' 87' ' ' ARG . 7.7 p -112.39 115.84 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 N-CA-C 108.603 -0.888 . . . . 71.129999999999995 108.603 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.454 HG23 ' HB2' ' A' ' 27' ' ' MET . 8.3 tt -104.02 124.45 58.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.482 -0.781 . . . . 70.319999999999993 108.952 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.1 mt -114.92 95.81 42.78 Favored Pre-proline 0 C--N 1.302 -1.457 0 CA-C-N 115.808 -0.633 . . . . 51.439999999999998 109.346 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.635 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 9.7 Cg_endo -89.45 126.6 1.58 Allowed 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.762 2.308 . . . . 71.129999999999995 110.173 176.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -150.67 127.67 11.12 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.615 0.722 . . . . 63.409999999999997 110.781 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.2 m -74.42 111.44 9.6 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.791 -1.189 . . . . 72.310000000000002 107.791 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.44 120.64 14.85 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.647 0.737 . . . . 73.140000000000001 112.948 -173.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -129.65 114.72 16.37 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 115.176 -0.92 . . . . 74.319999999999993 110.305 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -78.86 118.65 21.1 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 104.927 -2.249 . . . . 74.239999999999995 104.927 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -48.11 104.31 0.06 Allowed 'General case' 0 N--CA 1.424 -1.765 0 O-C-N 125.378 1.673 . . . . 73.409999999999997 110.578 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.451 ' H ' ' HB2' ' A' ' 20' ' ' MET . 12.9 t70 -84.8 -145.89 0.09 Allowed 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 112.685 -2.052 . . . . 40.32 108.292 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -63.05 -58.37 7.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 118.3 0.5 . . . . 61.210000000000001 111.369 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -137.3 -52.55 0.67 Allowed 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 118.866 -1.134 . . . . 74.319999999999993 113.833 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.52 ' O ' ' HG2' ' A' ' 20' ' ' MET . 10.5 t30 -108.27 80.95 1.41 Allowed 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 113.104 0.779 . . . . 74.349999999999994 113.104 -170.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 70.5 mmm -163.24 70.94 0.25 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.08 1.352 . . . . 75.129999999999995 109.287 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -146.21 89.89 1.91 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.319 -1.734 . . . . 62.299999999999997 106.319 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -113.25 118.03 33.5 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.201 -1.0 . . . . 74.230000000000004 111.08 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.5 mm -133.18 127.48 54.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.489 -0.778 . . . . 63.399999999999999 110.735 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 76.9 m -111.54 129.23 24.32 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 108.458 -0.941 . . . . 60.229999999999997 108.458 172.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.4 ' HB2' ' ND2' ' A' ' 99' ' ' ASN . 27.0 Cg_exo -63.49 146.95 93.43 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.685 2.257 . . . . 74.219999999999999 112.725 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.86 147.93 92.02 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 123.68 2.92 . . . . 62.119999999999997 113.422 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.502 ' HG2' ' HB2' ' A' ' 99' ' ' ASN . 64.2 mtt -111.07 132.94 53.84 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.194 -1.039 . . . . 74.010000000000005 108.194 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.9 t -126.37 125.6 67.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 O-C-N 123.497 0.498 . . . . 71.510000000000005 110.457 -171.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.8 mm -138.21 116.17 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.748 0.819 . . . . 45.009999999999998 109.504 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.672 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -127.94 81.98 0.34 Allowed Glycine 0 CA--C 1.48 -2.139 0 C-N-CA 118.726 -1.702 . . . . 74.319999999999993 114.801 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.92 7.91 1.65 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.205 -0.598 . . . . 63.43 112.432 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.459 HH21 ' CG1' ' A' ' 103' ' ' VAL . 14.8 mmt85 -103.99 134.41 47.31 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.148 -0.621 . . . . 43.240000000000002 109.553 -169.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 p -78.19 163.76 25.52 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 107.678 -1.23 . . . . 71.120000000000005 107.678 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.513 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 63.3 t80 -51.42 -43.24 61.94 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 124.27 1.028 . . . . 75.219999999999999 111.22 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.99 -41.78 95.11 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.151 -0.931 . . . . 63.240000000000002 111.719 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.8 mt -79.29 -30.47 14.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.529 -0.545 . . . . 64.310000000000002 109.529 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.31 -45.8 89.68 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.353 -0.839 . . . . 75.030000000000001 110.098 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.08 -31.38 70.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 119.924 -0.711 . . . . 72.120000000000005 112.276 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.23 -45.07 67.28 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 119.495 -0.882 . . . . 74.329999999999998 110.508 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.4 tp -66.72 -40.9 87.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 C-N-CA 120.107 -0.637 . . . . 72.439999999999998 110.176 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.3 t -65.57 -42.67 93.5 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.008 0 CA-C-N 116.737 -0.21 . . . . 72.200000000000003 110.57 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -63.85 -40.73 97.26 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 120.761 0.315 . . . . 74.439999999999998 111.349 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -66.85 -44.9 87.98 Favored Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 111.062 -0.815 . . . . 52.149999999999999 111.062 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.17 -39.85 86.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.649 -0.5 . . . . 73.239999999999995 109.649 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.447 ' OD2' ' HE2' ' A' ' 49' ' ' LYS . 23.2 t70 -57.75 -46.42 84.54 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 124.387 1.075 . . . . 61.409999999999997 110.653 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 46' ' ' ARG . 29.7 mmt180 -67.42 -37.64 83.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.14 -0.482 . . . . 73.409999999999997 111.597 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 43' ' ' GLY . 62.3 t -68.36 -41.89 83.83 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 120.772 -0.371 . . . . 60.130000000000003 110.302 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.49 HG23 HD11 ' A' ' 73' ' ' LEU . 66.3 mt -66.01 -38.33 81.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 O-C-N 122.035 -0.416 . . . . 73.510000000000005 111.091 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.447 ' HE2' ' OD2' ' A' ' 45' ' ' ASP . 54.0 mtmt -76.57 -17.79 59.02 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.912 0.708 . . . . 74.409999999999997 112.912 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.02 -33.91 7.34 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 113.625 0.972 . . . . 65.450000000000003 113.625 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 t -87.4 -9.99 53.22 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.423 0.63 . . . . 61.25 110.053 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.615 ' CE2' ' HD2' ' A' ' 75' ' ' LYS . 12.3 m-85 -137.33 175.81 9.27 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 107.503 -1.295 . . . . 71.239999999999995 107.503 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -104.42 77.35 1.38 Allowed 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 105.462 -2.051 . . . . 72.129999999999995 105.462 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.499 ' HB2' HD13 ' A' ' 73' ' ' LEU . . . -114.46 136.44 53.01 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-N 115.158 -0.928 . . . . 73.430000000000007 112.532 -172.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 m -109.37 123.54 49.49 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.282 -1.377 . . . . 75.340000000000003 107.282 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 p -100.63 152.42 4.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 116.11 -0.495 . . . . 31.23 110.293 -173.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -142.13 140.08 32.36 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.691 -1.225 . . . . 73.040000000000006 107.691 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.96 136.32 49.42 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.34 0.59 . . . . 73.299999999999997 110.883 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mp -135.91 167.53 21.01 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.913 -1.143 . . . . 63.020000000000003 107.913 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -100.54 142.76 31.56 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.038 -1.468 . . . . 73.010000000000005 107.038 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.52 174.89 48.93 Favored Glycine 0 C--N 1.296 -1.681 0 C-N-CA 120.708 -0.758 . . . . 72.450000000000003 112.121 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.77 130.47 35.13 Favored 'General case' 0 C--O 1.179 -2.628 0 N-CA-C 108.188 -1.042 . . . . 51.039999999999999 108.188 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 13.64 -73.76 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 C-N-CA 128.241 2.616 . . . . 75.340000000000003 116.829 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 53.3 t -57.12 -37.75 72.43 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 124.151 0.98 . . . . 75.329999999999998 110.046 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 8.7 m-20 -86.18 124.4 32.54 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.601 -1.259 . . . . 62.5 107.601 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.4 t -93.83 -28.78 4.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-O 121.304 0.573 . . . . 72.439999999999998 111.717 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.6 tp -145.34 141.3 28.38 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.124 -0.695 . . . . 63.229999999999997 109.124 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.28 108.96 10.4 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.199 -1.408 . . . . 74.420000000000002 107.199 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -104.79 114.77 29.19 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.279 -1.378 . . . . 75.439999999999998 107.279 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 36.1 ttmt -101.12 132.64 46.49 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.341 0.657 . . . . 74.150000000000006 109.295 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -126.4 125.24 41.86 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.716 -0.475 . . . . 74.310000000000002 109.716 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 m -98.38 113.49 25.49 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.999 -1.482 . . . . 74.319999999999993 106.999 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.499 HD13 ' HB2' ' A' ' 54' ' ' ALA . 4.2 mm? -98.38 139.99 33.32 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.573 0.583 . . . . 75.409999999999997 112.573 -172.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HB2' ' HE2' ' A' ' 79' ' ' LYS . 42.9 tt0 -140.13 127.95 21.92 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 105.715 -1.957 . . . . 73.239999999999995 105.715 170.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.615 ' HD2' ' CE2' ' A' ' 52' ' ' PHE . 49.2 tttm -134.79 -176.91 4.39 Favored 'General case' 0 C--N 1.273 -2.744 0 N-CA-C 104.933 -2.247 . . . . 61.509999999999998 104.933 177.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.428 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -55.97 92.25 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 114.568 1.322 . . . . 73.510000000000005 114.568 -175.691 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.7 17.6 74.99 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 114.903 -1.044 . . . . 62.130000000000003 113.146 175.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 44.4 mtmt -140.09 143.99 36.57 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.419 -0.586 . . . . 72.120000000000005 109.419 -175.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 73' ' ' LEU . 33.6 ttmt -146.79 139.31 24.98 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 110.033 -0.358 . . . . 73.420000000000002 110.033 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.62 174.4 35.71 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 110.902 -0.879 . . . . 61.119999999999997 110.902 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.9 tp -119.56 134.46 63.05 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 108.106 -1.072 . . . . 74.430000000000007 108.106 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.2 t -123.61 115.59 45.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.432 0.634 . . . . 75.319999999999993 109.673 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.409 ' CD2' ' HG3' ' A' ' 70' ' ' LYS . 36.4 m170 -107.15 116.67 32.33 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.257 -0.883 . . . . 63.32 110.512 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.58 110.0 30.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.737 -0.838 . . . . 75.430000000000007 108.737 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -118.27 137.4 53.07 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.891 -0.506 . . . . 72.540000000000006 111.336 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.7 mt -106.37 118.76 37.48 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.112 -0.495 . . . . 73.230000000000004 109.944 -171.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.498 HH21 ' HB ' ' A' ' 6' ' ' VAL . 28.5 mtm105 -97.15 141.14 30.65 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.025 0.441 . . . . 73.510000000000005 110.096 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 64' ' ' CYS . 49.7 pttt -80.23 98.11 7.23 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 109.301 -0.629 . . . . 71.209999999999994 109.301 173.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.0 tt -69.22 112.01 3.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-O 122.513 1.149 . . . . 74.439999999999998 109.636 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.6 p -140.68 -171.4 3.22 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 113.35 -1.75 . . . . 51.020000000000003 107.723 -170.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.47 -5.0 53.83 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.593 0.711 . . . . 62.020000000000003 110.658 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -99.74 -29.25 12.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.547 -0.751 . . . . 54.25 109.169 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 84.9 m -121.27 92.87 48.76 Favored Pre-proline 0 N--CA 1.431 -1.377 0 CA-C-N 115.429 -0.805 . . . . 54.109999999999999 109.719 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -76.48 167.79 24.97 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.189 1.926 . . . . 73.040000000000006 110.976 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.24 123.34 12.31 Favored 'Trans proline' 0 C--O 1.251 1.157 0 C-N-CA 122.032 1.821 . . . . 62.420000000000002 110.194 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 t -86.68 157.57 3.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.462 -0.57 . . . . 73.430000000000007 109.462 -176.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.47 137.49 32.31 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.96 -0.564 . . . . 74.200000000000003 110.299 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -177.1 -170.43 39.52 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 108.76 -1.736 . . . . 74.439999999999998 108.76 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.502 ' HB2' ' HG2' ' A' ' 27' ' ' MET . 94.1 m-20 -71.63 140.01 49.54 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.187 -0.671 . . . . 62.140000000000001 109.187 178.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -98.63 119.7 37.81 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.019 0.438 . . . . 71.439999999999998 111.133 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 41.1 t -73.2 139.04 46.0 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.553 -0.906 . . . . 72.219999999999999 108.553 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 m -74.03 91.15 2.03 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.494 0.664 . . . . 73.519999999999996 110.374 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.459 ' CG1' HH21 ' A' ' 32' ' ' ARG . 66.7 t -89.57 136.59 23.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 114.748 -1.115 . . . . 65.150000000000006 109.897 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 93.4 mt -148.48 -88.74 0.08 Allowed 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.099 -0.955 . . . . 61.549999999999997 109.606 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -120.58 166.9 13.0 Favored 'General case' 0 C--N 1.262 -3.239 0 N-CA-C 107.006 -1.479 . . . . 64.219999999999999 107.006 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -44.71 -46.74 10.54 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 124.172 0.92 . . . . 74.329999999999998 112.761 -178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.04 -31.54 72.14 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.477 -0.783 . . . . 72.010000000000005 112.271 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -81.47 -36.9 28.77 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.112 -0.699 . . . . 75.230000000000004 109.112 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.415 ' O ' HG12 ' A' ' 113' ' ' ILE . 44.2 m-20 -63.61 -45.39 90.51 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.11 -0.95 . . . . 71.540000000000006 109.198 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 114' ' ' VAL . 7.0 tp -67.69 -36.91 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 120.335 -0.546 . . . . 60.439999999999998 110.951 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.26 -33.18 75.17 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.266 -0.642 . . . . 70.319999999999993 109.266 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 41.6 t -65.09 -38.93 92.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.677 -0.692 . . . . 60.229999999999997 110.248 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 109' ' ' ASP . 51.5 mm -67.69 -43.57 86.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.906 -0.405 . . . . 75.319999999999993 109.906 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 110' ' ' ILE . 83.7 t -60.43 -43.65 94.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.024 -0.535 . . . . 73.329999999999998 111.037 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -66.92 -31.35 71.88 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 120.767 -0.373 . . . . 41.43 110.38 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.64 -45.58 71.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.017 0.437 . . . . 75.140000000000001 110.809 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.4 mt -68.1 -44.13 84.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.545 -0.752 . . . . 72.439999999999998 109.461 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.1 -31.48 71.99 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 112.398 0.518 . . . . 62.43 112.398 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.35 -43.0 61.57 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 119.416 -0.914 . . . . 74.150000000000006 110.012 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 2.6 t -70.36 -41.26 73.35 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.6 0.714 . . . . 62.329999999999998 109.556 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 10.4 mp -74.61 -35.68 62.95 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.75 -0.659 . . . . 74.400000000000006 111.994 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.15 -14.77 52.85 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 119.544 -0.863 . . . . 44.200000000000003 113.033 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.53 -34.59 58.54 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 118.232 -1.387 . . . . 71.519999999999996 111.733 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.48 -153.93 39.16 Favored Glycine 0 C--N 1.295 -1.701 0 CA-C-N 114.726 -1.124 . . . . 71.140000000000001 115.752 172.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--N 1.312 -1.057 0 C-N-CA 125.088 1.355 . . . . 75.329999999999998 112.494 -177.046 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 tpt . . . . . 0 CA--C 1.511 -0.524 0 N-CA-C 109.402 -0.592 . . . . 52.329999999999998 109.402 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -128.84 170.77 12.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.362 -0.607 . . . . 70.319999999999993 109.362 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.484 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 16.6 m-85 -124.18 146.93 48.37 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.832 -0.622 . . . . 74.319999999999993 110.694 177.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.645 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 0.4 OUTLIER -99.03 102.44 14.16 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 125.27 1.428 . . . . 71.219999999999999 108.246 178.173 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.1 t -85.0 113.13 23.03 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 107.526 -1.287 . . . . 71.340000000000003 107.526 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.442 HG13 HG22 ' A' ' 28' ' ' VAL . 60.0 t -107.26 107.78 23.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.882 -1.155 . . . . 74.239999999999995 107.882 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.9 tt -110.91 110.06 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-O 122.064 0.935 . . . . 73.540000000000006 109.466 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.406 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 45.6 mt -106.77 104.71 52.57 Favored Pre-proline 0 C--N 1.293 -1.879 0 CA-C-N 114.245 -1.343 . . . . 75.519999999999996 110.143 -174.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.693 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 5.9 Cg_exo -81.04 137.51 10.9 Favored 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 121.701 1.601 . . . . 73.109999999999999 108.463 170.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -139.27 156.59 46.95 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.001 -1.481 . . . . 73.219999999999999 107.001 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.458 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 35.7 m -104.58 126.47 51.69 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.397 -0.964 . . . . 73.120000000000005 108.397 175.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.523 ' CE1' ' HB3' ' A' ' 79' ' ' LYS 0.275 8.2 p90 -73.79 75.31 1.59 Allowed 'General case' 0 C--N 1.349 0.573 0 CA-C-O 122.723 1.249 . . . . 72.329999999999998 114.098 -176.504 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.635 ' NE2' ' HD2' ' A' ' 79' ' ' LYS . 50.3 m80 -128.46 111.41 13.26 Favored 'General case' 0 N--CA 1.414 -2.265 0 O-C-N 121.59 -0.694 . . . . 70.120000000000005 111.696 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -72.47 144.22 48.15 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.388 -1.278 . . . . 74.409999999999997 108.91 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -52.69 120.33 5.58 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 116.983 2.216 . . . . 73.319999999999993 116.983 -173.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.595 ' HB3' ' O ' ' A' ' 19' ' ' ASN . 9.5 t70 -100.45 168.22 9.88 Favored 'General case' 0 C--N 1.262 -3.203 0 CA-C-N 111.974 -2.376 . . . . 70.239999999999995 105.114 165.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -62.63 -32.84 73.94 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 122.63 0.372 . . . . 55.43 111.885 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -135.55 -35.68 0.8 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.901 0.704 . . . . 73.430000000000007 112.901 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.595 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 5.1 m-20 -95.84 -178.62 4.43 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.097 -0.501 . . . . 73.439999999999998 109.662 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 62.8 mtt 56.58 71.32 0.57 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 114.12 1.156 . . . . 71.510000000000005 114.12 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -165.72 116.45 1.05 Allowed 'General case' 0 N--CA 1.406 -2.658 0 N-CA-C 103.412 -2.811 . . . . 64.549999999999997 103.412 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -153.73 104.75 2.73 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-O 122.034 0.921 . . . . 62.43 110.77 171.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.5 mm -96.58 128.85 47.4 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.707 0 N-CA-C 104.076 -2.564 . . . . 75.150000000000006 104.076 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.693 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 59.3 m -107.81 159.06 31.82 Favored Pre-proline 0 C--N 1.288 -2.104 0 C-N-CA 119.812 -0.755 . . . . 72.120000000000005 110.426 -168.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.33 116.85 3.48 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.571 2.18 . . . . 73.150000000000006 112.741 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.52 128.87 5.55 Favored 'Trans proline' 0 C--O 1.256 1.39 0 C-N-CA 122.111 1.874 . . . . 74.349999999999994 111.501 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -91.44 126.26 36.47 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.723 -0.671 . . . . 74.219999999999999 110.594 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.449 HG11 ' HB ' ' A' ' 96' ' ' VAL . 94.6 t -123.14 115.24 45.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.555 -0.748 . . . . 53.43 108.994 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.475 HD11 ' H ' ' A' ' 101' ' ' CYS . 45.3 mm -125.14 102.47 10.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 109.664 -0.495 . . . . 52.399999999999999 109.664 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.645 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -110.1 80.39 0.27 Allowed Glycine 0 CA--C 1.474 -2.505 0 C-N-CA 119.84 -1.172 . . . . 64.310000000000002 112.92 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -165.3 20.69 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.06 -1.07 . . . . 74.109999999999999 110.304 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -103.08 133.39 48.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.99 -1.855 . . . . 73.140000000000001 105.99 -173.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.0 p -77.93 165.92 23.5 Favored 'General case' 0 N--CA 1.408 -2.526 0 N-CA-C 107.929 -1.137 . . . . 61.32 107.929 174.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.484 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 59.7 t80 -52.76 -43.92 66.13 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 123.333 0.653 . . . . 71.140000000000001 111.029 -174.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.01 -31.33 68.95 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.019 -0.991 . . . . 60.109999999999999 112.889 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -81.63 -34.36 12.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.216 0.531 . . . . 75.430000000000007 109.601 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.04 -45.43 88.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.672 -0.695 . . . . 61.229999999999997 110.012 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.3 mmt -69.85 -29.72 67.03 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.891 0.376 . . . . 74.450000000000003 110.313 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -67.68 -44.71 77.14 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 115.789 -0.641 . . . . 74.219999999999999 110.31 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 44' ' ' VAL . 7.9 tp -69.93 -39.91 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 119.709 -0.797 . . . . 73.120000000000005 109.738 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.31 -42.09 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 116.602 -0.272 . . . . 53.439999999999998 110.931 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.554 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 46.3 t-20 -64.44 -42.42 96.01 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.494 -0.558 . . . . 34.329999999999998 109.494 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.474 ' HA3' ' CE1' ' A' ' 106' ' ' PHE . . . -67.53 -40.46 90.93 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.588 -0.815 . . . . 42.109999999999999 112.058 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 40' ' ' ILE . 72.1 t -65.22 -41.36 91.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.53 -0.545 . . . . 62.340000000000003 109.53 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -53.71 -47.22 70.74 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.481 1.112 . . . . 65.099999999999994 110.92 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 42' ' ' ASN . 88.0 mtt180 -69.5 -37.21 77.11 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.333 -0.848 . . . . 73.209999999999994 110.645 -177.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.2 t -71.12 -36.01 61.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.217 -0.447 . . . . 51.119999999999997 110.649 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.56 -45.63 97.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 122.6 0.36 . . . . 64.019999999999996 110.921 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -70.94 -25.32 62.69 Favored 'General case' 0 C--O 1.209 -1.064 0 CA-C-O 121.02 0.438 . . . . 74.420000000000002 110.82 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.6 -40.84 18.52 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.893 0.701 . . . . 63.130000000000003 112.893 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -92.23 -14.11 29.46 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 112.729 0.64 . . . . 74.150000000000006 112.729 -173.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -135.44 -175.71 4.03 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.505 0.669 . . . . 72.439999999999998 110.543 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -113.53 100.62 8.64 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 103.487 -2.783 . . . . 73.099999999999994 103.487 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.72 153.74 28.49 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 114.07 1.137 . . . . 62.32 114.07 -167.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.6 m -126.73 118.25 24.33 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 105.56 -2.015 . . . . 52.439999999999998 105.56 168.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.9 p -99.96 118.74 47.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.482 0.658 . . . . 75.439999999999998 109.953 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HB2' ' HG3' ' A' ' 70' ' ' LYS . 39.2 mt-10 -114.83 122.23 45.72 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.569 -0.741 . . . . 61.32 109.075 -177.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.13 141.33 28.71 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.972 -0.381 . . . . 64.0 109.972 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.57 168.57 19.4 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.563 0.697 . . . . 53.009999999999998 109.481 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -106.24 127.0 52.92 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.179 -1.415 . . . . 74.310000000000002 107.179 174.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' A' ' 65' ' ' ASP . . . -72.83 176.51 43.04 Favored Glycine 0 N--CA 1.422 -2.273 0 CA-C-N 115.742 -0.663 . . . . 53.149999999999999 112.672 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' A' ' 65' ' ' ASP . 9.4 pt-20 -64.23 174.64 1.54 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.271 1.028 . . . . 73.420000000000002 110.146 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -49.49 -40.65 38.24 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.081 0.952 . . . . 63.229999999999997 111.736 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.18 -20.25 48.9 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.566 -1.197 . . . . 53.520000000000003 111.999 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.47 ' OD2' ' HB2' ' A' ' 85' ' ' LYS . 2.1 t70 -89.0 171.29 9.97 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.836 -0.54 . . . . 73.209999999999994 109.877 -174.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.7 t -114.19 -37.94 2.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 C-N-CA 123.857 0.863 . . . . 54.310000000000002 109.532 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.3 tp -167.3 131.57 1.89 Allowed 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.891 -0.595 . . . . 52.409999999999997 110.503 -171.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.28 133.68 52.56 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 107.41 -1.33 . . . . 72.120000000000005 107.41 -176.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -139.3 142.32 37.71 Favored 'General case' 0 C--N 1.28 -2.433 0 O-C-N 121.618 -0.676 . . . . 61.32 110.713 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HG3' ' HB2' ' A' ' 57' ' ' GLU . 14.4 ptmm? -121.64 122.69 40.17 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.376 0.608 . . . . 62.520000000000003 109.522 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -97.57 119.85 36.89 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 107.177 -1.416 . . . . 74.319999999999993 107.177 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.7 m -94.35 116.17 28.5 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.305 -1.369 . . . . 52.020000000000003 107.305 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.94 142.2 47.61 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-O 121.04 0.448 . . . . 64.120000000000005 110.913 -173.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 26.6 tt0 -150.41 100.49 2.88 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 107.936 -1.135 . . . . 73.129999999999995 107.936 168.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -102.75 90.4 3.8 Favored 'General case' 0 N--CA 1.417 -2.078 0 C-N-CA 118.959 -1.096 . . . . 54.210000000000001 108.39 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 55.51 67.58 0.99 Allowed 'General case' 0 CA--C 1.545 0.771 0 O-C-N 124.707 1.254 . . . . 70.099999999999994 111.385 171.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.62 -23.5 19.22 Favored Glycine 0 C--N 1.308 -1.021 0 CA-C-N 115.483 -0.781 . . . . 73.409999999999997 113.341 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 53.2 mtmt -84.44 101.12 11.78 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.261 -1.015 . . . . 74.129999999999995 108.261 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.635 ' HD2' ' NE2' ' A' ' 13' ' ' HIS . 42.0 mttp -103.73 134.11 47.6 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 123.843 0.715 . . . . 72.549999999999997 110.187 -172.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -171.8 169.46 42.53 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.074 -1.06 . . . . 52.539999999999999 112.825 177.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.1 mt -131.62 138.22 53.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.147 -1.427 . . . . 71.109999999999999 107.147 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.8 t -115.18 110.34 31.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 109.084 -0.71 . . . . 74.409999999999997 109.084 176.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 88.4 m-70 -97.27 105.83 18.05 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.664 -0.698 . . . . 74.230000000000004 109.827 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.2 t -101.29 115.44 43.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 107.927 -1.138 . . . . 72.540000000000006 107.927 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.47 ' HB2' ' OD2' ' A' ' 65' ' ' ASP . 21.7 ptmt -124.16 133.78 53.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.29 -0.633 . . . . 74.200000000000003 109.29 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.6 mt -107.33 112.91 25.97 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.863 -0.791 . . . . 70.519999999999996 108.863 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.472 ' HB2' ' HB2' ' A' ' 4' ' ' ASP . 45.5 mmm-85 -97.13 139.01 33.76 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.316 -0.994 . . . . 74.400000000000006 108.316 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 93' ' ' CYS . 21.8 pttm -92.06 98.98 11.89 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 120.208 -0.597 . . . . 74.450000000000003 111.464 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.2 tt -66.59 111.7 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 122.326 1.06 . . . . 73.129999999999995 109.494 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.3 p -145.67 -170.46 3.46 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.25 -1.341 . . . . 64.310000000000002 108.924 -169.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -72.73 -19.49 61.38 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.87 -1.159 . . . . 75.310000000000002 107.87 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.1 -36.84 17.88 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.253 -1.34 . . . . 73.239999999999995 109.556 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 86.3 m -122.36 125.43 26.53 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 113.463 0.912 . . . . 54.32 113.463 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.21 161.98 15.32 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.522 2.148 . . . . 75.450000000000003 110.905 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.12 142.99 89.34 Favored 'Trans proline' 0 C--O 1.262 1.71 0 C-N-CA 121.943 1.762 . . . . 71.439999999999998 109.667 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.449 ' HB ' HG11 ' A' ' 28' ' ' VAL . 13.7 t -87.98 159.42 3.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 109.576 -0.527 . . . . 71.200000000000003 109.576 -176.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -109.51 131.15 55.33 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.782 -0.821 . . . . 72.329999999999998 108.782 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -174.6 -160.76 23.26 Favored Glycine 0 CA--C 1.479 -2.17 0 N-CA-C 110.731 -0.948 . . . . 71.530000000000001 110.731 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -79.73 125.75 30.06 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.207 -0.664 . . . . 72.340000000000003 109.207 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -87.72 105.87 17.66 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.891 0.853 . . . . 75.209999999999994 110.761 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.475 ' H ' HD11 ' A' ' 29' ' ' ILE . 53.1 t -69.73 152.54 44.53 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.846 -1.525 . . . . 31.210000000000001 109.468 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.0 m -74.33 104.56 5.13 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.518 -0.919 . . . . 60.420000000000002 108.518 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.6 t -113.21 140.51 32.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 121.753 0.787 . . . . 74.439999999999998 110.518 -175.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.6 tp -149.76 -64.94 0.22 Allowed 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 114.452 -1.249 . . . . 75.150000000000006 108.164 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -158.42 162.04 37.55 Favored 'General case' 0 C--N 1.249 -3.787 0 CA-C-N 112.743 -2.026 . . . . 71.450000000000003 106.828 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.474 ' CE1' ' HA3' ' A' ' 43' ' ' GLY . 57.5 t80 -32.52 -55.03 0.34 Allowed 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 116.004 1.853 . . . . 53.200000000000003 116.004 -173.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.26 -28.13 69.52 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 113.669 0.988 . . . . 73.310000000000002 113.669 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -39.75 15.21 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.367 -1.346 . . . . 74.0 107.367 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 113' ' ' ILE . 11.9 m-20 -65.91 -46.51 78.02 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.603 -1.18 . . . . 74.019999999999996 108.629 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.428 HG13 HG22 ' A' ' 44' ' ' VAL . 16.2 tt -69.6 -25.86 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.536 -0.756 . . . . 73.209999999999994 110.504 -176.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -65.34 -49.92 67.56 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 107.025 -1.472 . . . . 60.340000000000003 107.025 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 3.4 t -63.29 -39.82 95.63 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.688 -1.142 . . . . 55.530000000000001 111.27 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 109' ' ' ASP . 41.4 mm -64.89 -46.91 90.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.048 -0.524 . . . . 74.019999999999996 111.368 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 92.6 t -69.99 -33.64 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 C-N-CA 120.184 -0.607 . . . . 73.310000000000002 110.173 -176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -66.4 -37.75 85.94 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.827 -0.624 . . . . 75.329999999999998 110.79 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.55 -41.03 80.36 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.064 0.459 . . . . 65.25 110.403 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.39 -45.7 95.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.671 -0.695 . . . . 71.409999999999997 109.186 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.6 -38.15 89.04 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 115.928 -0.578 . . . . 73.340000000000003 112.1 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -68.7 -40.21 80.13 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.602 -0.439 . . . . 72.310000000000002 110.632 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 42.8 t -59.22 -49.84 76.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.359 0.6 . . . . 62.219999999999999 109.433 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 10.5 mp -74.68 -14.84 60.79 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.603 -0.726 . . . . 74.129999999999995 112.427 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.26 -33.68 25.97 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 110.243 -0.28 . . . . 62.539999999999999 110.243 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.54 -34.84 46.89 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.311 0.577 . . . . 70.209999999999994 109.815 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.22 -136.35 51.03 Favored Glycine 0 CA--C 1.474 -2.521 0 CA-C-N 114.094 -1.412 . . . . 55.539999999999999 114.594 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.479 ' HB3' ' CD2' ' A' ' 13' ' ' HIS . 1.3 pm0 . . . . . 0 C--N 1.262 -3.225 0 N-CA-C 114.934 1.457 . . . . 71.5 114.934 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.436 ' SD ' ' HE1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.504 -0.793 0 CA-C-O 120.807 0.337 . . . . 70.129999999999995 111.189 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -110.27 164.28 12.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.669 0.747 . . . . 51.549999999999997 111.986 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 11.3 m-85 -120.04 140.28 51.23 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.527 -1.215 . . . . 74.319999999999993 111.152 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.649 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 28.7 t70 -101.08 102.58 13.57 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 104.855 -2.276 . . . . 63.049999999999997 104.855 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.78 117.76 32.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.325 -0.852 . . . . 73.239999999999995 109.442 -172.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.19 116.72 52.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.028 -1.101 . . . . 74.519999999999996 108.028 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.409 HD13 HD12 ' A' ' 113' ' ' ILE . 10.3 tt -118.69 120.75 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 121.396 0.617 . . . . 74.25 109.732 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.493 HG12 ' HB3' ' A' ' 26' ' ' PRO . 5.5 mt -112.49 100.8 51.14 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 115.543 -0.753 . . . . 65.439999999999998 108.98 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.603 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 1.4 Cg_endo -85.53 120.53 2.11 Favored 'Trans proline' 0 N--CA 1.436 -1.87 0 N-CA-C 107.769 -1.666 . . . . 75.409999999999997 107.769 171.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -144.61 129.7 18.56 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 120.922 0.391 . . . . 70.340000000000003 110.431 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.653 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 37.5 m -73.08 120.39 18.63 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.65 -0.5 . . . . 62.100000000000001 109.65 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.601 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 2.7 p90 -61.52 110.89 1.6 Allowed 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 113.967 1.099 . . . . 72.109999999999999 113.967 -174.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -143.84 106.26 4.41 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 114.854 -1.066 . . . . 65.049999999999997 110.114 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -68.84 122.24 18.2 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.878 -1.897 . . . . 74.310000000000002 105.878 173.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.48 103.69 0.55 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 124.585 1.178 . . . . 73.349999999999994 109.77 -172.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 17' ' ' LYS . 14.0 t70 -89.1 -158.15 0.49 Allowed 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 114.02 -1.445 . . . . 55.420000000000002 110.492 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.447 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 23.3 tptm -72.46 -45.34 59.99 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.741 0.816 . . . . 74.150000000000006 111.694 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -132.62 -51.46 0.92 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.584 0.707 . . . . 51.100000000000001 110.249 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -96.36 -177.83 4.09 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 114.489 -1.232 . . . . 63.43 110.612 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 86.9 mtp 70.75 80.13 0.17 Allowed 'General case' 0 C--N 1.313 -0.99 0 O-C-N 124.572 1.17 . . . . 32.149999999999999 109.977 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -168.05 121.24 0.89 Allowed 'General case' 0 N--CA 1.403 -2.792 0 N-CA-C 105.083 -2.192 . . . . 70.530000000000001 105.083 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.45 ' NE2' ' HB3' ' A' ' 123' ' ' LYS . 18.5 t60 -168.42 84.28 0.17 Allowed 'General case' 0 C--N 1.282 -2.34 0 O-C-N 124.57 1.169 . . . . 75.230000000000004 110.334 165.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.5 mm -103.17 136.05 37.72 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 N-CA-C 107.165 -1.42 . . . . 74.450000000000003 107.165 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 79.0 m -107.25 145.49 31.29 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 110.126 -0.324 . . . . 74.439999999999998 110.126 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 24' ' ' CYS . 52.5 Cg_exo -55.49 136.27 73.12 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 123.424 2.749 . . . . 71.340000000000003 112.873 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.493 ' HB3' HG12 ' A' ' 8' ' ' ILE . 74.5 Cg_endo -73.05 140.66 31.64 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.887 2.391 . . . . 63.340000000000003 112.394 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 99' ' ' ASN . 53.8 mtt -98.12 139.56 33.74 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-N 116.233 -0.44 . . . . 74.319999999999993 109.84 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.6 t -130.12 116.7 37.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 116.524 -0.307 . . . . 71.099999999999994 110.448 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.25 102.39 9.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 107.188 -1.412 . . . . 63.420000000000002 107.188 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.649 ' CA ' ' HA ' ' A' ' 4' ' ' ASP . . . -121.85 81.7 0.34 Allowed Glycine 0 N--CA 1.42 -2.372 0 C-N-CA 119.056 -1.545 . . . . 53.329999999999998 115.262 -175.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -153.64 15.82 0.51 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.24 -0.98 . . . . 71.329999999999998 110.803 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -102.07 136.43 41.91 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.745 -0.835 . . . . 72.430000000000007 108.745 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 p -74.05 168.31 19.78 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 106.595 -1.632 . . . . 73.129999999999995 106.595 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.562 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 73.9 t80 -61.62 -38.69 88.57 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 118.425 0.557 . . . . 41.130000000000003 110.735 -174.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -59.65 -49.26 78.44 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.486 -0.779 . . . . 71.129999999999995 111.209 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.1 mt -70.83 -38.74 73.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.647 -0.706 . . . . 72.5 109.308 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.401 ' HA ' HG22 ' A' ' 40' ' ' ILE . . . -65.94 -41.64 91.06 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.635 -0.711 . . . . 74.430000000000007 110.703 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 11.7 tpt -68.94 -40.83 78.73 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.839 -0.43 . . . . 52.329999999999998 109.839 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -74.21 -32.71 63.14 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 112.744 0.646 . . . . 70.109999999999999 112.744 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.557 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -74.68 -42.66 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.601 -0.889 . . . . 55.229999999999997 108.601 178.369 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.404 HG21 HD21 ' A' ' 86' ' ' LEU . 73.4 t -69.75 -38.78 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 120.956 -0.298 . . . . 71.109999999999999 110.7 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.549 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 4.0 m-20 -73.96 -26.75 60.64 Favored 'General case' 0 C--O 1.201 -1.479 0 C-N-CA 119.8 -0.76 . . . . 73.409999999999997 110.474 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.407 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -66.2 -46.33 80.39 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.133 -1.187 . . . . 54.25 110.133 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 40' ' ' ILE . 96.2 t -58.24 -45.07 89.11 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 N-CA-C 108.523 -0.917 . . . . 71.319999999999993 108.523 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 8.3 t70 -50.07 -49.27 51.89 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.646 1.578 . . . . 74.209999999999994 111.457 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 42' ' ' ASN . 45.4 mtt180 -67.36 -36.64 81.79 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.906 -1.043 . . . . 75.239999999999995 109.717 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 43' ' ' GLY . 60.9 t -71.72 -38.85 67.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 123.358 0.411 . . . . 61.310000000000002 110.695 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.455 HG23 HD11 ' A' ' 73' ' ' LEU . 70.3 mt -63.99 -46.1 94.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 C-N-CA 122.471 0.308 . . . . 52.310000000000002 110.614 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -78.68 -14.35 59.34 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.83 -0.748 . . . . 65.420000000000002 110.819 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.5 -49.27 10.1 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.948 -0.569 . . . . 61.119999999999997 111.126 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -91.8 -16.17 27.18 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 113.222 0.823 . . . . 74.219999999999999 113.222 -171.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.416 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 9.6 m-85 -129.09 -177.26 4.15 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.583 0.706 . . . . 74.25 110.281 -175.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 26.2 t-20 -109.81 108.23 18.48 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 104.352 -2.462 . . . . 73.120000000000005 104.352 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.66 157.97 45.27 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 115.963 -0.562 . . . . 71.239999999999995 112.202 -172.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 t -129.01 120.02 25.29 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.6 -1.63 . . . . 75.129999999999995 106.6 171.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.9 p -100.62 124.04 53.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.233 0.54 . . . . 73.340000000000003 110.612 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -122.73 146.92 47.07 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.791 -0.818 . . . . 75.239999999999995 108.791 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -119.68 127.67 53.1 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.955 0.883 . . . . 73.409999999999997 111.791 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.29 176.78 5.3 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.14 -1.43 . . . . 72.400000000000006 107.14 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -111.99 136.84 50.81 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.681 -0.859 . . . . 71.219999999999999 108.681 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.565 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -84.17 176.69 51.77 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 115.828 -0.624 . . . . 54.549999999999997 112.874 -175.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -74.68 133.04 42.13 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 123.328 0.651 . . . . 74.530000000000001 111.84 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t70 46.31 -84.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 126.298 1.839 . . . . 72.329999999999998 114.973 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.5 p -97.49 -1.6 43.78 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 113.556 0.947 . . . . 75.530000000000001 113.556 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.565 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 13.4 m-20 -76.96 117.78 18.89 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.659 -1.608 . . . . 75.310000000000002 106.659 172.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.0 t -85.31 -31.3 6.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-O 121.264 0.554 . . . . 52.329999999999998 112.235 -173.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 63.2 tp -148.67 133.91 18.38 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 109.409 -0.589 . . . . 60.130000000000003 109.409 -176.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.462 ' CE2' ' HD3' ' A' ' 85' ' ' LYS . 1.1 t80 -129.91 105.44 7.99 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.261 -1.385 . . . . 75.329999999999998 107.261 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -107.69 125.38 51.3 Favored 'General case' 0 C--N 1.281 -2.396 0 C-N-CA 120.191 -0.604 . . . . 74.340000000000003 111.732 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -103.0 115.14 30.03 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 125.201 1.4 . . . . 64.019999999999996 108.476 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 75.3 m-85 -102.56 118.04 36.0 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.606 -0.516 . . . . 74.099999999999994 109.606 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.0 m -87.87 123.15 32.33 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.804 -1.184 . . . . 71.25 107.804 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.455 HD11 HG23 ' A' ' 48' ' ' ILE . 4.3 mm? -111.14 138.46 47.55 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.972 0.909 . . . . 64.310000000000002 111.985 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 2.0 tm-20 -151.16 83.0 1.32 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.887 -1.051 . . . . 74.519999999999996 108.899 170.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -87.9 70.55 9.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.848 -0.797 . . . . 44.039999999999999 108.848 178.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 45.55 71.53 0.27 Allowed 'General case' 0 C--O 1.244 0.783 0 C-N-CA 125.255 1.422 . . . . 72.319999999999993 111.542 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.15 -24.1 33.08 Favored Glycine 0 C--N 1.304 -1.226 0 CA-C-N 115.466 -0.788 . . . . 45.32 112.207 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 99.0 mttt -88.53 103.13 15.6 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.417 -0.957 . . . . 71.420000000000002 108.417 175.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -106.78 146.96 30.24 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 120.307 -0.557 . . . . 72.420000000000002 110.515 -175.799 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . 177.72 177.42 46.52 Favored Glycine 0 CA--C 1.48 -2.148 0 C-N-CA 120.202 -0.999 . . . . 60.530000000000001 112.528 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 32.2 mt -132.22 145.19 35.09 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 106.796 -1.557 . . . . 73.019999999999996 106.796 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 100.0 t -122.5 109.22 23.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 108.208 -1.034 . . . . 53.530000000000001 108.208 172.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -95.05 106.54 18.55 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 123.868 0.867 . . . . 74.200000000000003 110.381 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.3 t -107.96 112.48 40.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.028 -0.73 . . . . 71.109999999999999 109.028 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.462 ' HD3' ' CE2' ' A' ' 68' ' ' TYR . 58.0 pttt -116.66 135.08 54.08 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 120.906 0.384 . . . . 63.030000000000001 110.867 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.404 HD21 HG21 ' A' ' 41' ' ' VAL . 56.3 mt -106.27 105.69 15.84 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.255 -1.387 . . . . 70.319999999999993 107.255 -175.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 33.8 ttt85 -98.02 118.29 34.28 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.366 -0.605 . . . . 72.340000000000003 109.366 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -70.54 104.01 2.66 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.232 -0.655 . . . . 74.530000000000001 109.232 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.2 tt -78.44 111.26 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 CA-C-O 122.415 1.102 . . . . 52.240000000000002 108.989 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.4 t -138.77 -177.87 5.06 Favored 'General case' 0 N--CA 1.401 -2.903 0 N-CA-C 105.989 -1.856 . . . . 73.049999999999997 105.989 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -75.12 -21.74 58.67 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 118.799 0.727 . . . . 73.340000000000003 110.691 -173.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -96.74 11.37 35.8 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.592 -1.185 . . . . 73.109999999999999 109.686 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 41.3 t -139.92 116.46 8.16 Favored Pre-proline 0 C--N 1.319 -0.739 0 O-C-N 121.177 -0.952 . . . . 63.549999999999997 112.096 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -79.61 131.23 9.23 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.756 2.304 . . . . 71.030000000000001 110.876 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.14 164.15 36.18 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 123.108 2.538 . . . . 75.430000000000007 111.648 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.89 156.82 3.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.726 -0.842 . . . . 71.439999999999998 108.726 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -107.93 140.68 40.7 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.449 -0.945 . . . . 71.400000000000006 108.449 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.58 -171.29 40.12 Favored Glycine 0 CA--C 1.471 -2.67 0 N-CA-C 109.064 -1.614 . . . . 75.310000000000002 109.064 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 27' ' ' MET . 6.9 t-20 -63.63 103.78 0.58 Allowed 'General case' 0 N--CA 1.409 -2.486 0 C-N-CA 123.814 0.846 . . . . 65.010000000000005 110.018 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -89.32 103.08 15.74 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.141 -1.059 . . . . 72.230000000000004 108.141 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 42.6 t -71.19 175.2 5.49 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.054 -0.975 . . . . 72.219999999999999 111.136 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.9 p -60.72 110.3 1.27 Allowed 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.245 1.018 . . . . 61.109999999999999 110.949 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.22 139.12 17.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.884 -0.784 . . . . 64.310000000000002 108.884 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.586 ' HG ' ' H ' ' A' ' 105' ' ' GLU . 15.8 tp -178.72 -159.47 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 104.53 -2.396 . . . . 61.539999999999999 104.53 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.586 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 43.0 mt-10 -81.39 171.61 14.55 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 118.614 0.643 . . . . 75.120000000000005 111.259 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' O ' HG22 ' A' ' 110' ' ' ILE . 1.2 t80 -36.13 -48.5 0.62 Allowed 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 127.59 2.356 . . . . 64.299999999999997 113.351 -173.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.69 -28.5 68.67 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 123.85 0.86 . . . . 74.439999999999998 112.449 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.451 ' HA ' ' NE ' ' A' ' 108' ' ' ARG . 0.8 OUTLIER -87.38 -40.83 14.07 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.348 -0.541 . . . . 73.329999999999998 110.279 -178.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.592 ' O ' HG12 ' A' ' 113' ' ' ILE 0.328 18.5 p-10 -80.52 -26.01 38.37 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 119.377 -0.929 . . . . 61.140000000000001 112.211 -174.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 106' ' ' PHE . 8.6 tp -64.55 -38.97 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 109.457 -0.572 . . . . 74.430000000000007 109.457 173.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.41 -43.32 86.09 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.311 -0.626 . . . . 54.100000000000001 109.311 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 42.9 t -58.5 -44.32 89.4 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.816 -1.084 . . . . 74.120000000000005 111.612 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 109' ' ' ASP . 43.4 mm -65.25 -41.39 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 120.923 -0.311 . . . . 74.239999999999995 110.591 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 110' ' ' ILE . 86.0 t -63.87 -42.87 97.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.544 -0.539 . . . . 64.340000000000003 109.544 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -61.47 -41.77 97.75 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.875 -0.602 . . . . 55.200000000000003 111.534 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.63 97.35 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 123.422 0.451 . . . . 54.210000000000001 111.444 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.3 mt -67.89 -44.79 85.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.165 -0.68 . . . . 72.329999999999998 109.165 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.92 -33.97 77.3 Favored 'General case' 0 C--O 1.211 -0.928 0 CA-C-N 115.702 -0.681 . . . . 70.450000000000003 111.64 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -69.97 -43.36 71.65 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.331 0.586 . . . . 72.310000000000002 110.64 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 5.3 t -70.22 -41.54 73.48 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.402 0.62 . . . . 62.539999999999999 109.594 -176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.422 HD23 ' HB3' ' A' ' 78' ' ' LYS . 9.5 mp -78.13 -15.7 58.62 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.503 -0.771 . . . . 74.200000000000003 111.77 -177.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.41 -38.25 22.17 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 121.034 -0.266 . . . . 51.100000000000001 111.031 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB3' ' NE2' ' A' ' 22' ' ' HIS . 23.1 tptm -62.79 -47.52 83.14 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.264 0.554 . . . . 64.340000000000003 110.103 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.64 -164.21 53.05 Favored Glycine 0 C--N 1.286 -2.229 0 CA-C-N 114.326 -1.306 . . . . 73.140000000000001 114.341 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.246 0.907 0 C-N-CA 124.057 0.943 . . . . 72.420000000000002 110.258 -179.455 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.434 ' HE2' ' HB3' ' A' ' 1' ' ' MET . 62.0 mmm . . . . . 0 CA--C 1.494 -1.211 0 N-CA-C 111.965 0.357 . . . . 75.200000000000003 111.965 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -101.71 141.38 34.66 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.26 -1.015 . . . . 71.219999999999999 108.26 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 56.0 m-85 -118.06 142.79 47.03 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.64 -0.504 . . . . 63.219999999999999 109.64 174.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.627 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 32.0 t70 -104.31 115.58 30.64 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 124.475 1.11 . . . . 73.239999999999995 109.627 -172.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.82 117.32 48.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.917 -0.489 . . . . 45.530000000000001 109.861 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.506 HG23 HG22 ' A' ' 28' ' ' VAL . 7.3 p -111.52 124.27 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-O 121.357 0.599 . . . . 74.109999999999999 109.409 176.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 27' ' ' MET . 7.1 tt -123.41 118.27 53.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-O 121.556 0.693 . . . . 74.120000000000005 111.062 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.484 HG12 ' HB3' ' A' ' 26' ' ' PRO . 61.9 mt -106.61 111.77 63.86 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 115.267 -0.878 . . . . 71.030000000000001 109.838 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.509 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 3.3 Cg_endo -87.34 123.79 1.94 Allowed 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.029 1.819 . . . . 72.219999999999999 109.205 171.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -142.74 119.35 11.07 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.484 0.659 . . . . 72.200000000000003 111.076 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 22' ' ' HIS . 49.4 m -77.36 116.65 18.14 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.233 -0.44 . . . . 70.209999999999994 110.298 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.689 ' CE1' ' HB2' ' A' ' 79' ' ' LYS . 1.8 p90 -65.46 123.99 21.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.65 0.738 . . . . 75.219999999999999 112.035 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 39.4 m80 -139.71 146.39 39.54 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.951 -1.022 . . . . 73.439999999999998 110.299 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -82.13 104.89 12.79 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-O 122.443 1.116 . . . . 72.409999999999997 109.927 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -67.47 100.7 0.88 Allowed 'General case' 0 N--CA 1.398 -3.036 0 CA-C-N 113.201 -1.818 . . . . 61.329999999999998 109.165 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -87.31 -94.48 0.09 Allowed 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.474 -0.785 . . . . 72.129999999999995 111.885 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 1.8 tmtp? -112.77 -57.8 2.24 Favored 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 119.32 -0.952 . . . . 73.349999999999994 112.729 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -121.98 -26.53 4.76 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 118.975 -1.09 . . . . 62.340000000000003 112.901 -169.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -137.34 169.9 17.0 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.333 -0.617 . . . . 74.5 109.333 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.435 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 64.2 mtm 82.19 70.85 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 126.159 1.783 . . . . 44.439999999999998 111.226 -176.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -161.76 96.33 1.02 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 105.046 -2.205 . . . . 74.25 105.046 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 11' ' ' SER . 39.1 t60 -114.15 89.91 3.21 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 119.24 -0.984 . . . . 73.299999999999997 112.041 -171.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mm -100.99 131.12 49.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 106.529 -1.656 . . . . 71.129999999999995 106.529 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 71.4 m -107.68 130.34 22.95 Favored Pre-proline 0 C--N 1.292 -1.918 0 C-N-CA 119.927 -0.709 . . . . 72.129999999999995 109.099 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -42.62 134.43 5.04 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 124.037 3.158 . . . . 43.509999999999998 113.915 -177.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HB3' HG12 ' A' ' 8' ' ' ILE . 15.7 Cg_endo -59.29 136.77 74.46 Favored 'Trans proline' 0 C--O 1.256 1.393 0 C-N-CA 123.477 2.785 . . . . 75.409999999999997 114.073 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.534 ' HB2' HG23 ' A' ' 7' ' ' ILE . 24.8 mmt -96.52 131.45 43.11 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 105.401 -2.074 . . . . 73.420000000000002 105.401 172.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 6' ' ' VAL . 29.6 t -126.17 129.58 72.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 120.228 -0.589 . . . . 65.239999999999995 110.256 -175.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.3 mm -136.04 101.19 2.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 106.985 -1.487 . . . . 54.409999999999997 106.985 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.627 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -120.01 82.42 0.34 Allowed Glycine 0 CA--C 1.488 -1.604 0 C-N-CA 120.078 -1.058 . . . . 63.119999999999997 112.783 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -158.74 26.21 0.22 Allowed 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.982 -0.609 . . . . 75.209999999999994 111.46 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.56 HH22 HG12 ' A' ' 103' ' ' VAL . 21.3 mmt85 -118.04 141.97 47.9 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 107.828 -1.175 . . . . 74.230000000000004 107.828 -174.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.8 p -75.86 172.6 12.42 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 118.842 0.746 . . . . 73.120000000000005 109.481 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.532 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 60.1 t80 -55.19 -47.53 75.12 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.35 0.595 . . . . 65.049999999999997 112.139 -174.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.02 -40.01 78.9 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.343 -0.844 . . . . 63.329999999999998 111.197 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.72 -33.33 43.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.248 -0.433 . . . . 65.329999999999998 110.218 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.417 ' O ' HG22 ' A' ' 40' ' ' ILE . . . -65.28 -44.8 86.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.408 -0.36 . . . . 73.120000000000005 110.59 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.6 mtm -73.08 -33.34 65.57 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 118.912 -1.115 . . . . 74.209999999999994 111.06 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.11 -44.0 85.57 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.069 -0.514 . . . . 60.030000000000001 110.415 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 37' ' ' ALA . 8.5 tp -65.46 -38.92 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 109.807 -0.442 . . . . 71.219999999999999 109.807 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.448 HG21 HD21 ' A' ' 86' ' ' LEU . 96.8 t -69.29 -39.94 79.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 CA-C-N 116.213 -0.449 . . . . 65.209999999999994 110.196 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -67.84 -28.25 67.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.127 0.489 . . . . 72.019999999999996 110.183 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.43 -47.36 63.42 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.296 -1.121 . . . . 71.409999999999997 110.296 175.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 40' ' ' ILE . 92.9 t -62.7 -41.96 94.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.452 -0.573 . . . . 74.430000000000007 109.452 177.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -53.38 -53.05 56.71 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 125.265 1.426 . . . . 72.310000000000002 110.565 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.42 ' HA ' ' CD ' ' A' ' 49' ' ' LYS . 61.9 mtm180 -71.1 -23.77 62.17 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.511 -0.768 . . . . 75.219999999999999 112.523 -175.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 43' ' ' GLY . 94.3 t -78.2 -44.87 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 C-N-CA 120.522 -0.471 . . . . 70.239999999999995 110.47 175.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.429 HG22 ' HB2' ' A' ' 54' ' ' ALA . 54.9 mt -73.17 -33.77 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 120.537 -0.465 . . . . 72.439999999999998 111.456 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 13.3 ptmt -74.4 -16.22 60.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.391 0.615 . . . . 61.149999999999999 110.455 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.7 -49.79 5.21 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 115.318 -0.856 . . . . 64.209999999999994 111.081 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 t -77.07 -22.53 52.7 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 123.528 0.731 . . . . 64.319999999999993 112.649 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -127.7 -172.75 2.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.608 0.718 . . . . 64.140000000000001 110.8 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 18.6 t-20 -105.21 89.68 3.2 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 104.326 -2.472 . . . . 74.430000000000007 104.326 172.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' A' ' 49' ' ' LYS . . . -108.13 135.89 48.72 Favored 'General case' 0 N--CA 1.407 -2.599 0 CA-C-N 115.169 -0.923 . . . . 72.349999999999994 112.029 -172.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.5 m -115.6 110.73 19.62 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 106.171 -1.789 . . . . 54.149999999999999 106.171 172.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.85 118.72 46.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.54 -0.541 . . . . 72.019999999999996 109.54 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.56 ' HG3' ' HB2' ' A' ' 70' ' ' LYS . 9.2 pt-20 -120.88 122.32 40.0 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.123 -0.695 . . . . 73.430000000000007 109.123 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.449 ' HG2' ' HG2' ' A' ' 69' ' ' ARG . 42.7 mt-10 -95.28 130.44 42.04 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.814 -0.63 . . . . 75.140000000000001 111.37 -175.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.2 mp -125.52 176.5 6.8 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.437 -0.801 . . . . 72.209999999999994 109.324 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -105.27 139.14 40.36 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-O 121.198 0.523 . . . . 72.120000000000005 109.846 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.26 176.44 41.96 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 110.514 -1.034 . . . . 52.229999999999997 110.514 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.518 ' N ' ' HB2' ' A' ' 65' ' ' ASP . 26.7 mm-40 -65.51 -176.17 0.32 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 122.102 0.953 . . . . 65.010000000000005 111.67 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.69 -34.93 78.94 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.688 -1.142 . . . . 63.350000000000001 110.084 172.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.9 t -77.1 -22.06 53.31 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.591 -1.186 . . . . 62.539999999999999 108.997 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.518 ' HB2' ' N ' ' A' ' 62' ' ' GLU . 67.3 m-20 -93.53 172.46 8.25 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 109.024 -0.732 . . . . 74.319999999999993 109.024 177.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.1 t -117.7 -43.27 2.97 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 CA-C-O 121.513 0.673 . . . . 74.430000000000007 110.382 174.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.1 tp -157.34 149.1 22.28 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.73 -0.668 . . . . 65.230000000000004 109.724 -172.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.26 135.36 47.27 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.595 -0.891 . . . . 75.200000000000003 108.595 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.449 ' HG2' ' HG2' ' A' ' 58' ' ' GLU . 88.6 mtt180 -132.27 129.42 39.57 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.227 -0.296 . . . . 75.129999999999995 110.76 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.56 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . 6.4 mtpm? -105.55 116.56 32.15 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 105.615 -1.995 . . . . 73.430000000000007 105.615 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.425 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 71.6 m-85 -101.54 106.08 17.13 Favored 'General case' 0 C--N 1.263 -3.184 0 N-CA-C 107.678 -1.23 . . . . 74.120000000000005 107.678 174.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.3 m -91.93 112.44 24.37 Favored 'General case' 0 C--N 1.276 -2.628 0 N-CA-C 107.672 -1.233 . . . . 65.219999999999999 107.672 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.83 149.39 37.13 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.286 0.565 . . . . 65.340000000000003 111.023 -173.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 42.7 tt0 -150.25 98.26 2.65 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.991 -1.004 . . . . 74.439999999999998 109.8 168.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -105.91 88.66 2.86 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 115.872 -0.604 . . . . 65.239999999999995 109.674 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.295 5.7 pt-20 36.74 74.29 0.08 Allowed 'General case' 0 C--O 1.243 0.749 0 C-N-CA 125.825 1.65 . . . . 70.239999999999995 114.974 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.37 -23.91 34.37 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 113.604 -1.635 . . . . 71.219999999999999 112.47 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 57.9 mtmt -95.12 94.74 8.11 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 122.368 -0.489 . . . . 75.329999999999998 109.701 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.689 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 2.3 ptpp? -113.54 124.0 51.34 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.242 -0.89 . . . . 73.129999999999995 111.211 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.416 ' HA2' ' H ' ' A' ' 12' ' ' PHE . . . -173.04 172.49 45.16 Favored Glycine 0 CA--C 1.491 -1.411 0 C-N-CA 120.967 -0.635 . . . . 61.130000000000003 112.0 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.9 mt -121.65 145.99 27.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.552 -0.907 . . . . 61.350000000000001 108.552 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 95.6 t -119.94 110.34 28.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 108.512 -0.921 . . . . 63.420000000000002 108.512 174.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.518 ' CD2' ' HG2' ' A' ' 70' ' ' LYS . 33.0 m170 -94.94 107.85 19.89 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.816 -0.629 . . . . 73.230000000000004 110.196 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.14 118.49 53.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 115.792 -0.64 . . . . 74.0 109.565 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -111.82 142.39 44.25 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.203 -0.666 . . . . 65.430000000000007 109.203 173.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.448 HD21 HG21 ' A' ' 41' ' ' VAL . 92.5 mt -107.37 123.94 49.1 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 103.549 -2.759 . . . . 51.210000000000001 103.549 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 41.6 mtp-105 -112.84 155.92 23.81 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 109.267 -0.642 . . . . 74.25 109.267 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -98.06 105.49 17.64 Favored 'General case' 0 C--N 1.282 -2.346 0 C-N-CA 120.327 -0.549 . . . . 64.329999999999998 110.485 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 tt -82.81 110.17 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 107.749 -1.204 . . . . 71.109999999999999 107.749 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 m -145.85 -175.39 4.72 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 105.045 -2.206 . . . . 62.530000000000001 105.045 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -15.9 63.04 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 120.087 1.312 . . . . 71.329999999999998 110.458 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -81.07 -23.95 38.12 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.949 -1.023 . . . . 71.109999999999999 111.803 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 40.8 m -145.35 117.61 5.23 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 112.472 0.545 . . . . 64.439999999999998 112.472 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 93' ' ' CYS . 2.7 Cg_exo -73.59 158.49 47.4 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 122.622 2.215 . . . . 64.310000000000002 110.499 175.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.3 160.37 49.03 Favored 'Trans proline' 0 C--O 1.255 1.337 0 C-N-CA 122.789 2.326 . . . . 64.140000000000001 110.65 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 t -82.93 149.46 4.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 107.24 -1.393 . . . . 53.509999999999998 107.24 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -112.38 112.81 24.65 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 106.75 -1.574 . . . . 70.209999999999994 106.75 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -151.51 -157.62 7.97 Favored Glycine 0 CA--C 1.461 -3.309 0 C-N-CA 120.165 -1.017 . . . . 62.439999999999998 112.018 -174.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' A' ' 27' ' ' MET . 35.5 m-80 -76.58 104.23 6.98 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.798 -0.816 . . . . 65.25 108.798 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -83.11 112.32 19.7 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-O 121.651 0.739 . . . . 75.349999999999994 109.387 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.488 ' HB3' HG23 ' A' ' 103' ' ' VAL . 4.8 t -70.29 153.02 43.53 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.914 -1.513 . . . . 74.540000000000006 106.914 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.424 ' N ' ' SG ' ' A' ' 112' ' ' CYS . 15.5 m -69.84 77.63 0.46 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.426 1.107 . . . . 73.129999999999995 109.906 178.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.56 HG12 HH22 ' A' ' 32' ' ' ARG . 76.9 t -124.57 149.45 28.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 C-N-CA 125.429 1.491 . . . . 75.040000000000006 108.635 -173.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.2 mt -161.15 -82.61 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 125.625 1.57 . . . . 74.519999999999996 109.296 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -98.4 150.37 21.68 Favored 'General case' 0 C--N 1.262 -3.197 0 CA-C-N 114.109 -1.405 . . . . 75.340000000000003 108.948 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.518 ' HA ' ' HB3' ' A' ' 109' ' ' ASP . 74.6 t80 -46.34 -44.05 16.52 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.365 1.246 . . . . 70.219999999999999 114.365 -172.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -62.55 -35.61 79.99 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 112.587 0.588 . . . . 72.319999999999993 112.587 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -90.82 -30.7 16.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.441 0.639 . . . . 72.010000000000005 109.571 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.518 ' HB3' ' HA ' ' A' ' 106' ' ' PHE . 7.9 t0 -55.74 -55.15 35.7 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 125.731 1.613 . . . . 65.540000000000006 109.642 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.6 tp -59.78 -38.04 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 O-C-N 123.966 0.792 . . . . 63.049999999999997 110.865 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 40.3 mt-10 -69.5 -38.46 77.62 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 120.479 -0.488 . . . . 71.310000000000002 111.492 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 102' ' ' SER . 10.0 t -65.91 -40.77 91.78 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.0 -0.68 . . . . 44.229999999999997 109.36 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 117' ' ' ILE . 49.4 mm -64.41 -46.54 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 115.521 -0.763 . . . . 72.239999999999995 110.223 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 72.7 t -63.91 -41.88 93.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.52 -0.309 . . . . 64.030000000000001 110.732 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 111' ' ' GLU . 29.4 mtpp -67.19 -30.33 70.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 111.7 0.259 . . . . 75.230000000000004 111.7 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.37 -40.8 67.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.018 0.437 . . . . 53.329999999999998 110.298 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.57 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 83.0 mt -66.05 -45.78 89.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.137 -0.69 . . . . 73.409999999999997 109.137 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -57.57 -42.32 82.84 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.842 -0.617 . . . . 74.549999999999997 111.576 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -65.9 -41.9 90.91 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.539 -0.755 . . . . 74.400000000000006 110.288 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 15.1 t -70.17 -39.68 75.13 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.826 -0.435 . . . . 55.210000000000001 109.826 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 117' ' ' ILE . 61.4 mt -72.76 -37.39 67.68 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 116.423 -0.353 . . . . 73.420000000000002 111.359 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.89 -14.22 51.62 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 112.565 0.58 . . . . 61.340000000000003 112.565 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -66.63 -21.62 66.12 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.288 0.566 . . . . 74.439999999999998 112.432 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.88 -161.54 47.81 Favored Glycine 0 C--N 1.296 -1.681 0 CA-C-N 115.617 -0.72 . . . . 53.200000000000003 114.894 173.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 C--N 1.318 -0.799 0 CA-C-O 122.79 1.281 . . . . 65.099999999999994 112.498 -178.403 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.474 0 N-CA-C 106.803 -1.554 . . . . 73.239999999999995 106.803 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -138.63 163.24 32.6 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.433 0.635 . . . . 74.430000000000007 112.173 -172.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 46.2 m-85 -119.7 145.29 46.65 Favored 'General case' 0 C--O 1.251 1.144 0 C-N-CA 124.266 1.026 . . . . 74.409999999999997 110.616 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.604 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 30.6 t70 -115.44 111.23 20.47 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 125.542 1.537 . . . . 63.32 107.204 -175.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 p -96.65 127.87 48.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 122.119 -0.363 . . . . 65.340000000000003 110.916 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.577 HG23 HG22 ' A' ' 28' ' ' VAL . 4.8 p -117.9 127.48 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 115.923 -0.58 . . . . 60.310000000000002 111.177 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.429 HG23 ' HB2' ' A' ' 27' ' ' MET . 3.2 tt -115.62 112.86 41.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.473 -0.785 . . . . 72.409999999999997 109.698 176.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.436 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 3.3 mp -98.92 109.2 52.93 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 108.247 -1.02 . . . . 41.340000000000003 108.247 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 17.7 Cg_endo -93.9 138.6 1.27 Allowed 'Trans proline' 0 N--CA 1.436 -1.895 0 C-N-CA 122.193 1.928 . . . . 64.439999999999998 110.684 173.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -159.13 130.61 6.29 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 110.189 -0.3 . . . . 50.130000000000003 110.189 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.526 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.3 m -69.82 121.37 17.14 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.001 -0.74 . . . . 72.150000000000006 109.001 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.561 ' CE1' ' HD3' ' A' ' 79' ' ' LYS . 21.3 p90 -70.01 101.58 1.83 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 112.529 0.566 . . . . 64.239999999999995 112.529 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.482 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 81.9 m-70 -146.65 151.34 37.08 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.991 -0.549 . . . . 74.099999999999994 111.77 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -80.41 119.44 23.11 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 106.905 -1.517 . . . . 73.230000000000004 106.905 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -62.04 104.41 0.46 Allowed 'General case' 0 N--CA 1.406 -2.654 0 O-C-N 124.527 1.142 . . . . 72.420000000000002 109.383 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -87.22 -155.02 0.26 Allowed 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 113.957 -1.474 . . . . 54.340000000000003 108.668 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -81.56 -56.88 3.74 Favored 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 121.45 -0.781 . . . . 74.400000000000006 112.412 -175.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -136.12 15.01 3.28 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.824 0.821 . . . . 63.119999999999997 110.207 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -148.57 157.34 43.4 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.919 -1.141 . . . . 65.120000000000005 107.919 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.482 ' CG ' ' HB3' ' A' ' 13' ' ' HIS . 41.4 ttp 63.53 62.31 0.95 Allowed 'General case' 0 C--N 1.348 0.519 0 CA-C-O 122.848 1.308 . . . . 62.009999999999998 109.658 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -148.3 96.05 2.55 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.688 -1.596 . . . . 62.149999999999999 107.562 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.473 ' CG ' ' HA2' ' A' ' 124' ' ' GLY . 20.5 t-80 -141.84 113.67 7.93 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.994 -1.083 . . . . 62.409999999999997 110.925 175.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.1 mm -126.93 126.91 69.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 106.394 -1.706 . . . . 73.450000000000003 106.394 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 46.6 m -107.68 149.85 39.46 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 112.264 0.468 . . . . 64.049999999999997 112.264 -171.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 33.3 Cg_endo -65.3 129.74 23.55 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.27 2.647 . . . . 75.25 112.367 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 20.1 Cg_exo -68.26 133.35 28.24 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.35 2.033 . . . . 75.120000000000005 112.199 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.429 ' HB2' HG23 ' A' ' 7' ' ' ILE . 25.0 mmt -86.96 131.32 34.13 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.67 -1.604 . . . . 74.219999999999999 106.67 174.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.577 HG22 HG23 ' A' ' 6' ' ' VAL . 19.0 t -127.64 127.91 69.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 109.503 -0.554 . . . . 62.539999999999999 109.503 -177.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.8 mm -126.65 114.4 37.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.561 -0.903 . . . . 74.439999999999998 108.561 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -127.87 82.14 0.34 Allowed Glycine 0 CA--C 1.48 -2.144 0 C-N-CA 119.06 -1.543 . . . . 50.210000000000001 114.531 -175.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -156.92 21.94 0.32 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.327 -0.936 . . . . 72.420000000000002 109.545 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.437 HH11 HD12 ' A' ' 40' ' ' ILE . 1.1 mmp_? -95.51 146.43 24.44 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.132 -1.433 . . . . 64.230000000000004 107.132 -172.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 p -85.07 175.6 8.92 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 105.947 -1.871 . . . . 72.299999999999997 105.947 168.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.491 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 76.8 t80 -60.41 -41.94 94.96 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 118.699 0.681 . . . . 72.120000000000005 110.695 -176.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -67.85 -41.58 82.72 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.48 -1.236 . . . . 63.340000000000003 111.197 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mm -74.01 -29.85 26.43 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 N-CA-C 109.613 -0.514 . . . . 71.150000000000006 109.613 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.407 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -63.42 -45.2 92.06 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.87 -0.605 . . . . 44.039999999999999 109.991 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.1 mmt -67.79 -39.46 84.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.225 -0.443 . . . . 73.420000000000002 110.713 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -69.43 -34.65 74.75 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.957 1.095 . . . . 65.109999999999999 113.957 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.52 ' O ' HG23 ' A' ' 44' ' ' VAL . 13.9 tt -70.46 -41.75 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 119.125 -1.03 . . . . 73.349999999999994 109.665 176.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 82.5 t -62.37 -44.1 98.85 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.369 0 N-CA-C 109.41 -0.589 . . . . 73.430000000000007 109.41 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -58.32 -41.84 85.42 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 123.119 0.568 . . . . 73.239999999999995 110.993 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.22 -43.55 92.79 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.62 -0.8 . . . . 74.25 111.401 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 40' ' ' ILE . 97.4 t -65.84 -41.32 89.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.31 -0.626 . . . . 71.010000000000005 109.31 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.93 -46.34 85.18 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 125.298 1.439 . . . . 63.310000000000002 110.717 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -64.8 -44.16 90.84 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.549 -1.205 . . . . 72.400000000000006 110.644 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.9 t -66.87 -38.95 82.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 116.266 -0.425 . . . . 65.340000000000003 110.759 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.487 HG23 HD11 ' A' ' 73' ' ' LEU . 66.1 mt -68.79 -41.87 82.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 121.029 -0.268 . . . . 74.319999999999993 111.675 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -80.39 -17.8 50.81 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 118.749 -1.18 . . . . 65.450000000000003 110.993 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.63 -43.02 8.48 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 112.371 0.508 . . . . 65.430000000000007 112.371 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.3 m -83.27 -16.13 47.52 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 112.801 0.667 . . . . 43.020000000000003 112.801 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -138.13 -174.49 3.81 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.097 0.475 . . . . 71.129999999999995 110.351 -174.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -103.78 105.86 16.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.014 -1.847 . . . . 74.450000000000003 106.014 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.67 136.4 40.9 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 112.948 0.722 . . . . 72.239999999999995 112.948 -174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -100.49 115.52 30.27 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.329 -1.73 . . . . 74.230000000000004 106.329 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 p -100.98 123.07 53.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.26 0.552 . . . . 64.329999999999998 111.437 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -130.67 119.75 22.88 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.107 -0.497 . . . . 72.439999999999998 110.772 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -82.51 137.41 34.63 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.014 -0.539 . . . . 61.340000000000003 110.173 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.4 mt -134.25 171.83 13.71 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.661 -0.866 . . . . 74.209999999999994 108.661 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -99.35 162.04 13.27 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.499 -0.556 . . . . 74.319999999999993 109.499 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.75 177.48 16.43 Favored Glycine 0 C--N 1.278 -2.681 0 N-CA-C 109.292 -1.523 . . . . 52.009999999999998 109.292 178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.509 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 12.8 pt-20 -65.84 179.48 0.87 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.437 -0.579 . . . . 72.140000000000001 109.437 175.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.04 -27.56 69.19 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 122.09 0.948 . . . . 73.530000000000001 111.474 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.8 t -77.42 -16.66 58.7 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.703 -1.135 . . . . 70.430000000000007 109.869 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.509 ' OD2' ' HG2' ' A' ' 62' ' ' GLU . 78.2 m-20 -101.24 157.72 16.57 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 108.436 -0.949 . . . . 74.209999999999994 108.436 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.471 HG21 ' CE2' ' A' ' 3' ' ' TYR . 36.9 t -104.56 -44.2 8.57 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-O 121.579 0.704 . . . . 73.409999999999997 110.314 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.1 tp -163.0 153.08 15.99 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.826 -1.176 . . . . 53.299999999999997 107.826 -174.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -130.08 128.34 41.69 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 106.873 -1.529 . . . . 75.450000000000003 106.873 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -123.43 108.51 12.77 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 107.351 -1.352 . . . . 73.530000000000001 107.351 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.439 ' HE3' ' HB3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -109.99 117.7 34.47 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.105 0.478 . . . . 71.140000000000001 110.218 -175.212 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -107.44 132.98 52.61 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.248 -0.649 . . . . 74.299999999999997 109.248 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.7 m -97.75 113.39 25.16 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 107.087 -1.449 . . . . 65.329999999999998 107.087 171.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.487 HD11 HG23 ' A' ' 48' ' ' ILE . 4.1 mm? -98.18 139.19 34.34 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 124.306 1.042 . . . . 73.329999999999998 113.51 -173.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -140.41 139.41 35.26 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-N 113.87 -1.514 . . . . 73.150000000000006 107.057 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -132.68 176.52 8.38 Favored 'General case' 0 C--N 1.263 -3.185 0 N-CA-C 102.686 -3.079 . . . . 75.25 102.686 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.3 0.0 OUTLIER -62.86 90.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 115.112 1.523 . . . . 73.329999999999998 115.112 -177.24 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.26 2.19 77.55 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 114.709 -1.132 . . . . 72.510000000000005 112.8 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 55.3 mttp -130.22 143.38 50.75 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.753 -0.832 . . . . 72.030000000000001 108.753 -174.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.561 ' HD3' ' CE1' ' A' ' 12' ' ' PHE . 14.8 ptpt -151.69 156.2 39.86 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 112.737 0.643 . . . . 62.439999999999998 112.737 -169.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -177.65 170.68 43.17 Favored Glycine 0 C--O 1.2 -2.004 0 CA-C-N 115.372 -0.831 . . . . 73.109999999999999 111.383 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.9 mt -115.75 138.14 47.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 107.684 -1.228 . . . . 74.329999999999998 107.684 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.6 t -115.99 110.37 31.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 109.003 -0.74 . . . . 70.200000000000003 109.003 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 31.2 m-70 -100.73 103.97 15.23 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.484 -0.78 . . . . 75.120000000000005 109.044 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.6 t -109.6 109.75 29.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.268 -0.641 . . . . 71.310000000000002 109.268 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -122.72 149.69 43.74 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 119.488 -0.885 . . . . 75.120000000000005 110.418 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.407 HD22 ' HB1' ' A' ' 37' ' ' ALA . 92.7 mt -99.16 126.54 44.95 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 107.736 -1.209 . . . . 75.049999999999997 107.736 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.5 ttt85 -115.95 134.52 54.89 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 108.273 -1.01 . . . . 75.219999999999999 108.273 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.501 ' HG2' HG23 ' A' ' 90' ' ' THR . 38.4 ttmt -81.06 98.3 7.92 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 116.295 -0.412 . . . . 73.109999999999999 111.482 -176.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.6 tt -75.04 111.4 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 122.235 1.017 . . . . 62.119999999999997 108.825 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.501 HG23 ' HG2' ' A' ' 88' ' ' LYS . 4.5 p -145.15 -171.21 3.61 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-N 114.943 -1.026 . . . . 64.219999999999999 108.941 -172.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -78.79 -4.55 49.97 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.967 0.889 . . . . 72.340000000000003 109.279 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -98.8 -23.34 15.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.312 -0.858 . . . . 70.099999999999994 109.607 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 96.9 m -138.46 118.05 9.71 Favored Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 112.145 0.424 . . . . 52.130000000000003 112.145 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.58 157.48 36.15 Favored 'Trans proline' 0 C--O 1.25 1.119 0 C-N-CA 122.037 1.825 . . . . 75.109999999999999 109.651 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.97 160.7 32.55 Favored 'Trans proline' 0 C--O 1.255 1.329 0 C-N-CA 123.074 2.516 . . . . 73.340000000000003 112.502 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 t -81.2 144.71 10.02 Favored 'Isoleucine or valine' 0 C--O 1.252 1.201 0 N-CA-C 108.493 -0.928 . . . . 74.150000000000006 108.493 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -97.24 85.89 3.79 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 121.953 0.882 . . . . 74.329999999999998 110.809 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -129.37 -158.61 9.59 Favored Glycine 0 N--CA 1.412 -2.959 0 N-CA-C 109.362 -1.495 . . . . 70.219999999999999 109.362 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -80.91 98.43 7.88 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 108.274 -1.01 . . . . 52.140000000000001 108.274 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 64.2 mtp85 -86.63 93.63 9.26 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 108.064 -1.087 . . . . 75.519999999999996 108.064 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 19.3 t -72.51 168.38 18.67 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 113.854 -1.521 . . . . 44.409999999999997 113.144 -170.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.4 m -73.53 105.9 5.08 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 124.726 1.21 . . . . 73.030000000000001 111.028 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.9 t -84.89 155.03 3.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.799 -1.092 . . . . 65.230000000000004 108.866 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.5 tp -150.35 -68.59 0.19 Allowed 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.686 1.231 . . . . 70.439999999999998 109.177 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.32 165.61 35.34 Favored 'General case' 1 C--N 1.237 -4.297 0 N-CA-C 103.224 -2.88 . . . . 55.43 103.224 178.244 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' O ' HG22 ' A' ' 110' ' ' ILE . 91.6 t80 -45.98 -36.39 5.52 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.781 1.03 . . . . 74.109999999999999 113.781 -173.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -58.12 -40.45 81.25 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 113.341 0.867 . . . . 73.420000000000002 113.341 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -88.2 -30.41 19.76 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 119.929 -0.708 . . . . 71.109999999999999 109.337 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.44 -47.02 83.6 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.932 -1.031 . . . . 70.25 109.379 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 106' ' ' PHE . 10.3 tp -69.0 -31.71 51.55 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 CA-C-N 116.14 -0.482 . . . . 74.329999999999998 109.826 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -63.81 -41.86 97.79 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.699 -0.482 . . . . 75.420000000000002 109.699 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 53.6 t -70.2 -40.22 74.72 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.001 -0.545 . . . . 45.43 110.178 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.07 -45.18 99.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.81 -0.632 . . . . 62.420000000000002 111.379 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.27 -41.76 92.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.618 0.247 . . . . 61.350000000000001 110.37 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -69.73 -23.79 63.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.464 0.542 . . . . 72.329999999999998 112.464 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.62 -43.94 58.32 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.972 -0.381 . . . . 74.209999999999994 109.972 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.15 -45.45 98.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.359 -0.608 . . . . 75.329999999999998 109.359 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -61.74 -38.23 87.19 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 116.059 -0.519 . . . . 74.329999999999998 111.541 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -64.11 -46.43 84.2 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 108.989 -0.745 . . . . 73.120000000000005 108.989 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 5.6 t -70.69 -29.88 66.3 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.387 -0.824 . . . . 55.420000000000002 111.25 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.29 -37.27 28.71 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.58 -0.7 . . . . 65.450000000000003 111.421 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . . . -76.78 -36.01 57.29 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 111.956 0.354 . . . . 52.210000000000001 111.956 -177.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -99.53 9.94 42.29 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 110.014 -0.365 . . . . 65.129999999999995 110.014 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.473 ' HA2' ' CG ' ' A' ' 22' ' ' HIS . . . -71.7 33.37 0.59 Allowed Glycine 0 C--N 1.334 0.469 0 N-CA-C 117.304 1.682 . . . . 60.109999999999999 117.304 -171.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.268 -2.96 0 N-CA-C 106.365 -1.717 . . . . 72.519999999999996 106.365 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.635 0 N-CA-C 105.66 -1.978 . . . . 74.25 105.66 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.01 139.07 32.05 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.327 0.584 . . . . 71.209999999999994 112.055 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.654 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 62.9 m-85 -125.93 137.07 53.68 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.001 -1.0 . . . . 74.25 109.333 176.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.481 ' OD1' ' HB ' ' A' ' 89' ' ' ILE . 4.9 m-20 -101.83 122.1 43.34 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.477 -0.783 . . . . 73.510000000000005 108.898 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 p -95.53 109.14 22.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 108.339 -0.986 . . . . 64.120000000000005 108.339 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 28' ' ' VAL . 61.0 t -102.96 106.28 19.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.921 -1.14 . . . . 70.129999999999995 107.921 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -105.67 118.48 53.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 CA-C-N 115.577 -0.738 . . . . 71.140000000000001 109.858 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.401 HG13 ' HB3' ' A' ' 26' ' ' PRO . 3.5 mp -106.18 108.18 61.22 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 107.927 -1.138 . . . . 74.120000000000005 107.927 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.648 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 28.5 Cg_endo -99.84 120.33 0.11 Allowed 'Trans proline' 0 N--CA 1.429 -2.314 0 C-N-CA 121.772 1.648 . . . . 74.299999999999997 110.908 171.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.713 ' HA ' ' SG ' ' A' ' 120' ' ' CYS . 0.7 OUTLIER -138.69 145.79 40.78 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.154 0.502 . . . . 64.400000000000006 109.901 174.06 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.598 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.6 p -81.76 129.99 34.91 Favored 'General case' 0 N--CA 1.398 -3.062 0 N-CA-C 107.468 -1.308 . . . . 60.439999999999998 107.468 175.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.505 ' CE1' ' HB3' ' A' ' 79' ' ' LYS 0.284 0.0 OUTLIER -73.95 80.63 1.67 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 115.003 1.483 . . . . 75.329999999999998 115.003 -169.143 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -91.12 151.61 20.92 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.444 -1.253 . . . . 75.109999999999999 112.445 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -104.43 -158.25 0.65 Allowed 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 106.152 -1.795 . . . . 75.140000000000001 106.152 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -128.66 110.72 12.47 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 110.042 -0.355 . . . . 70.5 110.042 172.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -91.79 -104.99 0.11 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.136 -0.69 . . . . 72.340000000000003 109.136 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -113.35 -54.37 2.62 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.474 -0.935 . . . . 74.340000000000003 108.474 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -134.75 -29.55 1.15 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.322 -1.308 . . . . 60.299999999999997 108.443 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -63.04 133.56 54.73 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.217 -1.031 . . . . 72.310000000000002 108.217 171.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.2 mtt 74.32 99.12 0.07 Allowed 'General case' 0 C--N 1.313 -0.983 0 O-C-N 124.126 0.891 . . . . 70.109999999999999 112.139 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -174.1 82.18 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 125.662 1.585 . . . . 73.310000000000002 107.867 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -148.71 116.18 6.21 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-N 115.946 -0.57 . . . . 52.329999999999998 111.075 -175.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.9 mm -132.93 139.1 50.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.15 -1.426 . . . . 74.129999999999995 107.15 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 60.5 m -107.53 149.3 38.68 Favored Pre-proline 0 C--N 1.288 -2.087 0 N-CA-C 108.856 -0.794 . . . . 74.430000000000007 108.856 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 55.1 Cg_endo -69.29 147.76 66.59 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.655 2.237 . . . . 73.409999999999997 113.551 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 33.5 Cg_exo -64.45 136.69 51.83 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.117 2.544 . . . . 71.239999999999995 111.856 178.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.522 ' SD ' ' HB2' ' A' ' 101' ' ' CYS . 47.9 ttm -103.11 129.11 49.86 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.479 -0.934 . . . . 71.420000000000002 108.479 175.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 6' ' ' VAL . 58.9 t -120.76 132.39 70.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 116.338 -0.392 . . . . 74.540000000000006 110.265 -174.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.33 102.41 9.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 106.121 -1.807 . . . . 64.310000000000002 106.121 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -124.39 82.2 0.35 Allowed Glycine 0 C--N 1.285 -2.29 0 C-N-CA 120.025 -1.083 . . . . 60.340000000000003 114.587 -173.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -170.38 27.47 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.717 0.77 . . . . 73.400000000000006 109.276 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -105.04 154.0 20.71 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.765 -1.568 . . . . 74.329999999999998 106.765 -173.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.3 p -89.64 173.94 8.02 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 106.525 -1.657 . . . . 72.409999999999997 106.525 171.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.654 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 63.8 t80 -60.79 -46.15 91.64 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 118.603 0.638 . . . . 74.450000000000003 110.156 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.69 -42.3 95.42 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.569 -1.196 . . . . 62.140000000000001 111.567 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mm -69.66 -39.25 77.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 116.257 -0.429 . . . . 71.209999999999994 110.146 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.54 -44.7 81.68 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.857 -0.611 . . . . 61.109999999999999 110.077 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.6 mmt -65.88 -35.93 82.0 Favored 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 120.768 -0.373 . . . . 64.420000000000002 111.847 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.6 -41.61 92.6 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 120.555 -0.458 . . . . 63.0 111.509 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 44' ' ' VAL . 8.9 tt -71.96 -41.79 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 118.605 -1.238 . . . . 72.420000000000002 110.527 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.448 HG12 ' NH2' ' A' ' 69' ' ' ARG . 91.3 t -66.77 -38.37 81.38 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 CA-C-N 116.726 -0.216 . . . . 64.299999999999997 110.953 -177.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -67.47 -37.95 83.69 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.067 0.46 . . . . 73.430000000000007 110.277 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.464 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.72 -48.04 70.85 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.355 -0.926 . . . . 61.340000000000003 111.12 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 40' ' ' ILE . 92.0 t -64.81 -39.67 86.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.206 0.527 . . . . 73.510000000000005 109.78 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.07 -42.91 91.5 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.788 0.835 . . . . 74.109999999999999 112.117 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -79.63 -26.13 41.23 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 120.162 -0.615 . . . . 72.219999999999999 111.178 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 43' ' ' GLY . 79.5 t -70.03 -44.84 78.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 110.126 -0.324 . . . . 73.230000000000004 110.126 174.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 72.1 mt -65.1 -40.48 89.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 111.972 0.36 . . . . 75.319999999999993 111.972 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -80.27 -10.75 59.76 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.067 -1.053 . . . . 75.439999999999998 112.175 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -98.81 -47.87 5.14 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.29 -0.414 . . . . 74.349999999999994 111.164 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.7 m -81.09 -18.12 47.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.629 0.603 . . . . 50.350000000000001 112.629 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.657 ' CE2' ' HD2' ' A' ' 75' ' ' LYS . 1.8 m-85 -127.68 175.2 8.48 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.333 -0.988 . . . . 73.319999999999993 108.333 -176.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -105.03 91.7 3.91 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 105.716 -1.957 . . . . 52.310000000000002 105.716 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.558 ' HB2' HD13 ' A' ' 73' ' ' LEU . . . -132.25 136.39 46.94 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 112.998 0.74 . . . . 41.210000000000001 112.998 -172.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 71' ' ' TYR . 23.3 t -94.46 159.77 14.95 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.856 -1.535 . . . . 53.049999999999997 106.856 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.0 130.9 55.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 120.909 0.385 . . . . 75.319999999999993 109.988 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -135.61 112.22 10.02 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.59 -0.522 . . . . 64.230000000000004 109.59 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -87.88 136.13 33.1 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.635 -0.426 . . . . 75.230000000000004 110.411 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.0 mt -133.59 171.65 13.81 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.436 -0.802 . . . . 74.310000000000002 108.898 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -85.37 143.78 28.43 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.329 -0.989 . . . . 44.240000000000002 108.329 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -96.67 175.43 31.46 Favored Glycine 0 N--CA 1.414 -2.777 0 N-CA-C 110.394 -1.082 . . . . 63.119999999999997 110.394 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.428 ' HG2' ' CG ' ' A' ' 65' ' ' ASP . 11.2 pt-20 -70.39 179.84 2.32 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 122.767 0.427 . . . . 73.439999999999998 110.03 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.4 -38.16 76.78 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.724 0.773 . . . . 72.319999999999993 112.795 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 76.9 m -83.78 -5.19 59.14 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.504 -0.771 . . . . 72.340000000000003 111.908 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 85' ' ' LYS . 13.4 m-20 -95.8 171.6 8.55 Favored 'General case' 0 CA--C 1.49 -1.365 0 CA-C-N 115.396 -0.82 . . . . 72.230000000000004 110.091 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.15 -42.65 3.58 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.447 0 CA-C-N 114.651 -1.159 . . . . 73.400000000000006 109.089 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.1 tp -163.21 151.77 14.12 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 106.901 -1.518 . . . . 74.329999999999998 106.901 -176.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.58 118.36 21.88 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.483 -1.673 . . . . 73.099999999999994 106.483 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.448 ' NH2' HG12 ' A' ' 41' ' ' VAL . 36.3 ttp180 -122.72 124.2 42.84 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.23 -0.988 . . . . 73.140000000000001 110.43 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -98.42 145.11 27.06 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 124.367 1.067 . . . . 72.439999999999998 108.986 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 95.4 m-85 -131.76 137.74 48.32 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.878 -1.156 . . . . 74.150000000000006 107.878 175.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 32.0 m -113.86 111.85 22.4 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.698 -0.853 . . . . 72.439999999999998 108.698 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 54' ' ' ALA . 4.2 mm? -96.9 139.96 32.16 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 113.273 0.842 . . . . 60.109999999999999 113.273 -171.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -143.85 89.75 2.08 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 105.038 -2.208 . . . . 54.399999999999999 105.038 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.657 ' HD2' ' CE2' ' A' ' 52' ' ' PHE . 63.9 tttm -105.34 96.34 6.45 Favored 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.766 -0.584 . . . . 71.349999999999994 109.632 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 13.6 pt-20 53.5 35.51 20.92 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.618 1.167 . . . . 72.5 113.092 173.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.54 -8.64 56.8 Favored Glycine 0 CA--C 1.506 -0.505 0 C-N-CA 121.165 -0.54 . . . . 74.439999999999998 112.764 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HE3' ' HA ' ' A' ' 122' ' ' ALA . 50.4 mtpt -98.86 102.72 14.55 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.392 -1.707 . . . . 62.119999999999997 106.392 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.505 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . 58.9 mttp -101.53 153.96 19.26 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.792 -0.64 . . . . 72.030000000000001 112.176 -174.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -173.04 176.58 45.78 Favored Glycine 0 N--CA 1.417 -2.596 0 N-CA-C 110.599 -1.0 . . . . 60.039999999999999 110.599 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.3 tt -133.78 149.36 30.68 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.039 0 N-CA-C 106.948 -1.501 . . . . 54.219999999999999 106.948 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 91.0 t -132.34 127.52 57.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.252 -0.648 . . . . 75.329999999999998 109.252 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -113.86 113.72 25.28 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.322 -0.621 . . . . 74.129999999999995 109.322 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.54 110.59 30.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.879 -0.786 . . . . 61.210000000000001 108.879 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.511 ' HB2' ' OD2' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -110.67 126.53 54.61 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.03 -1.1 . . . . 64.129999999999995 108.03 178.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.0 mt -100.22 125.94 46.45 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.995 -1.854 . . . . 60.039999999999999 105.995 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.456 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 70.1 mtp85 -112.36 141.8 45.64 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-O 121.091 0.472 . . . . 72.040000000000006 110.927 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -94.29 98.71 11.11 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 115.309 -0.86 . . . . 71.129999999999995 109.373 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.481 ' HB ' ' OD1' ' A' ' 4' ' ' ASP . 10.9 tt -65.38 111.72 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 122.44 1.114 . . . . 70.109999999999999 109.141 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.7 p -137.8 176.75 8.43 Favored 'General case' 0 N--CA 1.39 -3.44 0 CA-C-N 114.685 -1.143 . . . . 55.399999999999999 109.807 -174.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -71.38 -17.78 62.39 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.895 -1.048 . . . . 72.030000000000001 109.32 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -98.06 -32.12 11.79 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.665 -1.152 . . . . 73.530000000000001 110.817 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 42.3 m -133.69 108.46 11.96 Favored Pre-proline 0 N--CA 1.432 -1.349 0 N-CA-C 113.695 0.998 . . . . 74.299999999999997 113.695 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -90.4 144.92 4.03 Favored 'Trans proline' 0 N--CA 1.438 -1.785 0 C-N-CA 122.465 2.11 . . . . 32.420000000000002 111.236 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -82.87 158.93 15.97 Favored 'Trans proline' 0 C--O 1.255 1.37 0 C-N-CA 122.378 2.052 . . . . 74.239999999999995 111.518 172.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 t -98.73 150.13 5.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 105.252 -2.129 . . . . 75.409999999999997 105.252 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -107.13 146.31 31.43 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.788 0.804 . . . . 73.219999999999999 112.162 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -138.59 -147.58 5.17 Favored Glycine 0 CA--C 1.476 -2.344 0 CA-C-N 114.071 -1.422 . . . . 72.109999999999999 110.079 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -60.84 125.84 25.18 Favored 'General case' 0 C--N 1.288 -2.093 0 O-C-N 124.286 0.639 . . . . 74.340000000000003 110.007 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -97.7 131.43 44.25 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.213 0.53 . . . . 60.450000000000003 110.395 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.522 ' HB2' ' SD ' ' A' ' 27' ' ' MET . 44.3 t -73.35 154.91 39.89 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.558 -1.201 . . . . 64.400000000000006 109.919 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.3 t -80.96 74.97 7.94 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.519 -1.289 . . . . 64.319999999999993 107.519 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.94 140.05 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 114.866 -1.061 . . . . 75.420000000000002 109.803 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.9 tp -153.7 -121.87 0.03 OUTLIER 'General case' 0 C--N 1.257 -3.453 0 N-CA-C 103.866 -2.642 . . . . 74.239999999999995 103.866 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.62 168.59 10.07 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 107.817 -1.179 . . . . 63.240000000000002 107.817 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.457 ' O ' HG22 ' A' ' 110' ' ' ILE . 74.5 t80 -43.25 -36.64 1.87 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.57 1.148 . . . . 73.319999999999993 114.071 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -56.84 -37.63 71.53 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.707 0.803 . . . . 63.420000000000002 112.249 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -90.62 -34.69 15.37 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.687 -0.486 . . . . 75.319999999999993 109.687 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 26.0 m-20 -62.55 -46.87 86.37 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.15 -0.932 . . . . 74.519999999999996 110.613 -176.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 106' ' ' PHE . 9.1 tp -64.59 -39.75 86.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 N-CA-C 109.963 -0.384 . . . . 72.209999999999994 109.963 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.96 -41.5 82.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.774 -0.648 . . . . 75.219999999999999 110.671 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 7.8 t -63.0 -44.25 96.54 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.693 -0.685 . . . . 74.310000000000002 111.259 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 47.0 mm -68.25 -41.46 83.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.994 -0.372 . . . . 54.439999999999998 109.994 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 51.6 t -64.22 -43.06 97.23 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 CA-C-N 116.029 -0.532 . . . . 61.219999999999999 110.366 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -61.9 -40.47 95.56 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 122.826 0.45 . . . . 75.25 111.19 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.59 84.33 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.183 0.516 . . . . 70.329999999999998 111.412 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.415 ' O ' HD13 ' A' ' 121' ' ' LEU . 79.0 mt -71.3 -43.28 74.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.364 -0.606 . . . . 72.329999999999998 109.364 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 114' ' ' VAL . 1.7 tm-20 -62.63 -40.49 97.18 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.484 -0.78 . . . . 63.539999999999999 110.448 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.74 -36.78 76.12 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 120.069 -0.652 . . . . 74.319999999999993 110.669 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.713 ' SG ' ' HA ' ' A' ' 10' ' ' GLU . 10.8 t -67.96 -34.05 75.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.657 0.741 . . . . 75.099999999999994 109.665 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.3 mp -75.79 -35.34 60.12 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.474 -0.784 . . . . 73.319999999999993 111.247 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.477 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . . . -69.67 -33.77 73.02 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.991 0.424 . . . . 74.230000000000004 111.144 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -80.55 10.32 4.9 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.7 -0.682 . . . . 70.319999999999993 111.556 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -53.71 124.15 28.57 Favored Glycine 0 C--O 1.249 1.044 0 CA-C-N 116.111 -0.495 . . . . 50.25 112.817 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 . . . . . 0 C--N 1.318 -0.784 0 C-N-CA 125.706 1.602 . . . . 74.310000000000002 112.259 -177.555 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.252 0 N-CA-C 106.764 -1.569 . . . . 72.140000000000001 106.764 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -120.45 128.89 53.59 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.905 0.383 . . . . 41.43 110.405 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.623 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 28.8 m-85 -117.69 148.95 41.51 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.395 0.617 . . . . 74.549999999999997 111.377 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.477 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 29.4 t70 -121.36 107.47 12.54 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.222 -2.14 . . . . 60.229999999999997 105.222 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -93.23 114.91 30.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 116.186 -0.461 . . . . 64.5 110.23 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.444 ' HB ' ' HG3' ' A' ' 85' ' ' LYS . 46.9 t -104.87 112.89 40.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 108.432 -0.951 . . . . 63.200000000000003 108.432 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.506 HG23 ' HB2' ' A' ' 27' ' ' MET . 3.7 tt -114.34 108.34 25.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.835 0.826 . . . . 75.25 108.847 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.9 mt -104.06 106.4 53.08 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 114.991 -1.004 . . . . 75.519999999999996 111.799 -171.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.584 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 7.1 Cg_endo -92.9 140.05 1.8 Allowed 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 122.419 2.079 . . . . 63.219999999999999 110.572 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -164.08 155.87 16.53 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 122.468 0.307 . . . . 71.140000000000001 110.76 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.9 m -91.57 135.19 34.04 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.707 -0.479 . . . . 52.009999999999998 109.707 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.15 68.65 10.0 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 113.551 0.945 . . . . 75.200000000000003 113.551 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -122.82 138.21 54.71 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.126 -1.064 . . . . 74.519999999999996 108.126 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.415 ' N ' ' HD2' ' A' ' 14' ' ' ARG . 9.0 mpt_? -82.39 134.98 35.25 Favored 'General case' 0 CA--C 1.475 -1.938 0 N-CA-C 108.998 -0.742 . . . . 73.200000000000003 108.998 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 20' ' ' MET . 7.1 t80 -62.67 110.44 1.72 Allowed 'General case' 0 N--CA 1.405 -2.702 0 O-C-N 124.688 1.242 . . . . 73.519999999999996 111.131 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.72 -99.31 0.06 Allowed 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 114.603 -1.18 . . . . 71.530000000000001 109.623 173.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -113.79 -58.45 2.15 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.033 0.444 . . . . 62.119999999999997 109.956 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -138.12 -51.91 0.6 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.085 0.945 . . . . 62.310000000000002 109.813 173.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -84.99 67.41 10.2 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.851 -1.068 . . . . 64.450000000000003 112.74 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 48.1 ttp 159.42 88.75 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.384 0 C-N-CA 128.169 2.588 . . . . 73.510000000000005 105.359 171.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 168.98 121.8 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.323 -2.103 . . . . 73.230000000000004 105.323 -173.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.474 ' HB2' ' H ' ' A' ' 125' ' ' GLU . 77.1 t60 -156.81 113.46 3.05 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.804 -0.758 . . . . 74.439999999999998 112.592 172.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.3 mm -113.64 132.5 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 N-CA-C 107.272 -1.381 . . . . 73.319999999999993 107.272 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 9.1 m -109.6 138.63 20.66 Favored Pre-proline 0 C--N 1.273 -2.723 0 N-CA-C 107.353 -1.351 . . . . 72.030000000000001 107.353 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -53.88 128.96 31.81 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 122.797 2.331 . . . . 70.409999999999997 112.427 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.88 130.43 26.0 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.489 2.126 . . . . 72.109999999999999 110.343 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.506 ' HB2' HG23 ' A' ' 7' ' ' ILE . 73.0 mtm -88.82 138.97 30.94 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 109.849 -0.426 . . . . 43.520000000000003 109.849 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.3 119.99 53.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.3 0.571 . . . . 74.430000000000007 110.04 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 30.6 mm -113.13 100.87 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 105.783 -1.932 . . . . 64.230000000000004 105.783 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -107.2 165.04 13.1 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 119.6 -1.286 . . . . 65.0 112.132 -176.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.6 t70 65.72 70.05 0.45 Allowed 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 125.339 1.456 . . . . 62.049999999999997 110.634 -175.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -138.34 136.05 35.99 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 105.364 -2.088 . . . . 75.349999999999994 105.364 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.6 p -77.95 163.73 25.73 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 106.558 -1.645 . . . . 63.020000000000003 106.558 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.623 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 74.7 t80 -59.13 -37.26 76.81 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.609 0.718 . . . . 71.430000000000007 110.393 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -63.56 -47.17 82.62 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.309 -1.314 . . . . 54.420000000000002 110.857 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.1 mt -73.13 -38.52 55.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.935 -0.765 . . . . 71.120000000000005 108.935 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.82 98.9 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.866 -1.061 . . . . 43.329999999999998 110.893 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.4 tpp -67.69 -39.9 84.39 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.624 -0.831 . . . . 75.319999999999993 110.545 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -70.52 -34.48 72.35 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 119.838 -0.745 . . . . 71.400000000000006 112.745 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 44' ' ' VAL . 7.0 tp -73.79 -43.01 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 119.484 -0.886 . . . . 42.520000000000003 110.57 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t -68.57 -39.65 80.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 121.249 -0.18 . . . . 63.219999999999999 111.159 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -70.51 -29.38 65.87 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.272 -0.64 . . . . 65.219999999999999 109.272 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.29 -47.54 78.89 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 110.42 -1.072 . . . . 71.549999999999997 110.42 174.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 40' ' ' ILE . 90.5 t -57.59 -46.06 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 109.146 -0.687 . . . . 73.239999999999995 109.146 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -55.86 -39.4 71.43 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 125.231 1.412 . . . . 75.010000000000005 113.108 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 46' ' ' ARG . 25.8 mtp180 -79.02 -31.04 44.53 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.305 -0.407 . . . . 74.319999999999993 111.2 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 43' ' ' GLY . 82.5 t -71.8 -38.06 64.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.289 -0.634 . . . . 63.439999999999998 109.289 176.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.5 mt -60.73 -46.6 95.69 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.852 0 CA-C-N 116.091 -0.504 . . . . 75.109999999999999 111.558 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -76.7 -15.93 59.65 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.6 -0.84 . . . . 74.409999999999997 112.114 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.4 -40.19 12.21 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.213 -0.449 . . . . 63.43 112.055 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 t -91.61 -20.61 21.46 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 112.463 0.542 . . . . 73.409999999999997 112.463 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -128.35 -179.97 5.31 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.6 0.714 . . . . 74.049999999999997 110.45 -174.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -105.54 106.52 17.06 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 104.155 -2.535 . . . . 71.319999999999993 104.155 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -118.2 135.63 54.13 Favored 'General case' 0 N--CA 1.404 -2.759 0 C-N-CA 119.533 -0.867 . . . . 64.439999999999998 113.114 -172.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.473 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 29.4 m -99.16 106.88 19.11 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 104.418 -2.438 . . . . 63.409999999999997 104.418 166.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 p -99.16 118.13 45.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.452 -0.944 . . . . 71.25 108.452 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -116.33 129.13 56.1 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.072 -0.967 . . . . 73.209999999999994 109.952 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -85.56 118.19 24.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.68 -0.691 . . . . 71.310000000000002 109.747 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mp -119.3 167.22 12.09 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 109.018 -0.734 . . . . 64.340000000000003 109.018 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -109.74 147.96 32.26 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 108.103 -1.073 . . . . 74.5 108.103 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.16 176.09 35.5 Favored Glycine 0 N--CA 1.407 -3.265 0 CA-C-N 115.512 -0.767 . . . . 73.150000000000006 112.725 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.453 ' N ' ' HB2' ' A' ' 65' ' ' ASP . 44.4 mt-10 -66.02 -173.33 0.18 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 124.893 1.277 . . . . 65.420000000000002 110.347 174.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -58.01 -44.7 87.42 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.462 0.648 . . . . 61.039999999999999 111.791 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 90.2 m -80.08 -23.45 41.3 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.6 -0.727 . . . . 34.409999999999997 111.757 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.453 ' HB2' ' N ' ' A' ' 62' ' ' GLU . 9.6 m-20 -90.87 123.23 34.23 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 119.342 -0.943 . . . . 73.430000000000007 111.013 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.7 t -84.43 -33.27 8.56 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 115.849 -0.614 . . . . 74.030000000000001 111.791 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.9 tp -151.58 139.9 20.39 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.441 -0.577 . . . . 73.030000000000001 109.441 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -130.8 121.41 25.31 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 107.622 -1.251 . . . . 62.329999999999998 107.622 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -118.72 123.66 45.42 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.665 -1.235 . . . . 70.5 107.665 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -103.63 109.96 21.85 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.268 -1.012 . . . . 72.209999999999994 108.268 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -96.43 119.17 34.44 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.01 -1.107 . . . . 62.229999999999997 108.01 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 16.9 m -98.95 115.93 30.02 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 106.527 -1.657 . . . . 55.539999999999999 106.527 174.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -108.59 151.04 26.66 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 113.537 0.94 . . . . 73.120000000000005 113.537 -170.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 36.6 tt0 -147.28 125.79 12.44 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 113.421 -1.718 . . . . 72.239999999999995 106.831 169.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -128.16 81.73 2.04 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 108.116 -1.068 . . . . 74.109999999999999 108.116 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 45.22 76.65 0.09 Allowed 'General case' 0 C--O 1.244 0.79 0 C-N-CA 126.239 1.816 . . . . 71.329999999999998 113.586 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.36 -23.18 28.78 Favored Glycine 0 C--N 1.309 -0.93 0 CA-C-N 115.777 -0.647 . . . . 52.210000000000001 112.933 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 14.2 mptt -96.01 129.42 43.28 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.551 -1.278 . . . . 65.329999999999998 107.551 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -145.97 138.49 25.53 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-O 121.132 0.492 . . . . 65.540000000000006 111.76 -173.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.3 179.76 42.28 Favored Glycine 0 CA--C 1.493 -1.285 0 N-CA-C 110.472 -1.051 . . . . 53.140000000000001 110.472 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 29.7 mt -120.1 145.96 25.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 109.404 -0.591 . . . . 70.239999999999995 109.404 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 83.8 t -126.45 112.64 30.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.716 -0.846 . . . . 72.510000000000005 108.716 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -98.87 107.54 20.0 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.309 -0.997 . . . . 75.239999999999995 108.309 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 44.0 t -102.58 110.47 29.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.696 -0.483 . . . . 74.099999999999994 109.696 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.444 ' HG3' ' HB ' ' A' ' 6' ' ' VAL . 8.1 ptpt -116.68 135.55 53.69 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 120.766 0.317 . . . . 72.0 110.677 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.1 mt -103.62 109.92 21.79 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 106.667 -1.605 . . . . 74.239999999999995 106.667 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.424 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 13.4 mtp180 -98.0 140.53 32.2 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 119.686 -0.806 . . . . 75.219999999999999 109.329 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -84.86 113.05 21.09 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 107.891 -1.151 . . . . 64.120000000000005 107.891 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 tt -87.26 111.64 22.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.79 -0.818 . . . . 71.540000000000006 108.79 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -128.18 174.59 9.13 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.505 -1.295 . . . . 72.129999999999995 107.505 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -78.2 0.16 26.12 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 120.282 -0.567 . . . . 75.030000000000001 112.322 -173.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -119.01 10.58 12.21 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.847 -0.615 . . . . 65.109999999999999 110.683 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.8 t -146.91 118.82 4.76 Favored Pre-proline 0 N--CA 1.446 -0.635 0 O-C-N 122.09 -0.381 . . . . 72.200000000000003 110.3 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.65 148.13 22.66 Favored 'Trans proline' 0 C--O 1.249 1.067 0 C-N-CA 123.209 2.606 . . . . 62.299999999999997 113.947 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.72 164.39 33.78 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 123.567 2.845 . . . . 64.439999999999998 110.217 175.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.5 t -100.51 156.48 4.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.742 -1.207 . . . . 72.200000000000003 107.742 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.89 116.34 24.96 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 122.024 0.916 . . . . 74.129999999999995 112.371 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.37 -160.5 8.34 Favored Glycine 0 N--CA 1.415 -2.748 0 N-CA-C 109.634 -1.387 . . . . 62.420000000000002 109.634 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -60.64 104.8 0.38 Allowed 'General case' 0 N--CA 1.398 -3.066 0 C-N-CA 124.792 1.237 . . . . 61.130000000000003 110.011 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -82.39 105.74 13.69 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 106.643 -1.614 . . . . 53.329999999999998 106.643 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.69 -179.23 5.21 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.421 -0.809 . . . . 72.5 109.207 -174.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.3 m -74.14 93.82 2.35 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.045 -0.724 . . . . 73.430000000000007 109.045 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.431 HG13 ' OD2' ' A' ' 109' ' ' ASP . 31.7 t -98.98 143.8 12.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.562 -0.903 . . . . 65.430000000000007 108.562 -177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.4 tp -161.57 -75.31 0.05 Allowed 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 122.133 0.968 . . . . 73.230000000000004 109.654 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -151.0 169.46 21.74 Favored 'General case' 0 C--N 1.259 -3.343 0 CA-C-N 112.945 -1.934 . . . . 72.230000000000004 108.193 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.426 ' O ' HG22 ' A' ' 110' ' ' ILE . 70.1 t80 -33.16 -63.47 0.23 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 115.559 1.689 . . . . 72.219999999999999 115.559 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.62 -42.62 93.1 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.914 0.709 . . . . 70.209999999999994 112.914 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.64 -36.18 62.88 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.256 -0.577 . . . . 54.520000000000003 109.714 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.552 ' O ' HG12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -64.88 -50.71 65.49 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 124.024 0.828 . . . . 63.43 110.134 177.854 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.509 HD13 ' HA ' ' A' ' 44' ' ' VAL . 7.6 tp -63.55 -36.25 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-O 120.914 0.388 . . . . 75.439999999999998 110.116 -176.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.37 -48.06 83.38 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.545 -0.752 . . . . 75.129999999999995 110.387 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 6.4 t -67.36 -36.31 81.13 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 116.065 -0.516 . . . . 62.299999999999997 109.782 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 109' ' ' ASP . 49.9 mm -64.89 -47.2 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.592 -0.731 . . . . 70.209999999999994 110.167 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 110' ' ' ILE . 77.0 t -63.39 -41.0 91.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-O 121.113 0.483 . . . . 64.349999999999994 110.174 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.33 -42.95 99.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.505 -0.77 . . . . 71.030000000000001 111.13 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.01 -38.06 79.03 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 123.191 0.307 . . . . 65.209999999999994 111.373 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.423 ' O ' HD13 ' A' ' 121' ' ' LEU . 77.8 mt -64.77 -45.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.543 -0.54 . . . . 65.530000000000001 109.543 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -71.75 -31.14 66.35 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 119.19 -1.004 . . . . 72.409999999999997 112.307 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.62 -43.75 88.6 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 109.156 -0.683 . . . . 74.109999999999999 109.156 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 52.1 t -58.66 -46.87 86.24 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.531 -0.758 . . . . 71.439999999999998 110.64 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.0 mp -73.26 -26.64 61.18 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.022 0.439 . . . . 73.230000000000004 111.811 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.68 -32.47 28.11 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 111.945 0.35 . . . . 72.349999999999994 111.945 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -87.73 9.93 19.96 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.486 0.55 . . . . 65.439999999999998 112.486 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -52.43 127.57 33.78 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.076 -0.511 . . . . 33.109999999999999 112.142 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.474 ' H ' ' HB2' ' A' ' 22' ' ' HIS 0.326 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 C-N-CA 125.742 1.617 . . . . 72.530000000000001 113.608 -178.086 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.412 ' HA ' ' HE3' ' A' ' 1' ' ' MET . 4.6 tpt . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.22 0.533 . . . . 74.010000000000005 110.282 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.49 157.71 16.98 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.164 -1.05 . . . . 44.450000000000003 108.164 175.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.609 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 73.4 m-85 -111.62 136.24 51.11 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.363 -0.977 . . . . 74.030000000000001 108.363 174.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 87' ' ' ARG . 30.4 t70 -113.15 114.29 26.58 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.967 -1.015 . . . . 63.229999999999997 108.491 -173.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -90.28 113.88 27.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 109.509 -0.552 . . . . 73.430000000000007 109.509 -174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.29 111.92 38.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 108.73 -0.841 . . . . 75.120000000000005 108.73 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.587 HG23 ' HB2' ' A' ' 27' ' ' MET . 4.5 tt -104.17 121.24 55.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 CA-C-N 115.754 -0.657 . . . . 75.329999999999998 110.26 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 19.8 mm -99.58 106.32 39.16 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 107.861 -1.163 . . . . 74.310000000000002 107.861 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 7' ' ' ILE . 18.4 Cg_endo -94.35 137.84 1.06 Allowed 'Trans proline' 0 N--CA 1.437 -1.836 0 C-N-CA 122.283 1.989 . . . . 73.329999999999998 111.432 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -146.89 154.98 41.94 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.155 -0.683 . . . . 64.310000000000002 109.155 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.522 ' OG ' ' HB3' ' A' ' 22' ' ' HIS . 90.0 p -79.85 156.1 27.52 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 107.296 -1.372 . . . . 73.230000000000004 107.296 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.481 ' HB3' ' CG ' ' A' ' 79' ' ' LYS . 53.7 t80 -81.63 76.89 8.53 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 109.16 -0.681 . . . . 75.239999999999995 109.16 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.412 ' CD2' ' HB3' ' A' ' 125' ' ' GLU . 71.5 m80 -150.82 101.96 2.95 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-N 114.761 -1.109 . . . . 75.450000000000003 110.439 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -88.1 155.77 19.62 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 106.863 -1.532 . . . . 74.120000000000005 106.863 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -55.82 99.84 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 115.527 1.677 . . . . 75.540000000000006 115.527 -173.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 17' ' ' LYS . 23.4 t70 -85.63 -152.23 0.16 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 113.088 -1.869 . . . . 52.219999999999999 106.799 172.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.438 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 9.3 tmtt? -69.82 -58.76 3.5 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.282 -1.007 . . . . 73.409999999999997 108.282 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -138.77 -51.78 0.56 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.514 -0.874 . . . . 72.519999999999996 112.451 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -90.12 55.2 3.02 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.581 1.326 . . . . 73.310000000000002 114.581 -166.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 61.1 mtt -162.85 90.74 0.71 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 125.682 1.593 . . . . 72.319999999999993 107.263 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -175.37 118.19 0.17 Allowed 'General case' 0 N--CA 1.424 -1.762 0 C-N-CA 124.741 1.217 . . . . 62.310000000000002 108.345 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.522 ' HB3' ' OG ' ' A' ' 11' ' ' SER . 10.8 t60 -169.78 110.92 0.44 Allowed 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.419 -0.81 . . . . 74.310000000000002 110.037 170.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.3 mm -112.19 139.69 35.54 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 105.04 -2.207 . . . . 70.319999999999993 105.04 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 50.9 m -108.17 145.85 32.32 Favored Pre-proline 0 C--N 1.274 -2.684 0 N-CA-C 109.008 -0.738 . . . . 75.519999999999996 109.008 -178.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.3 Cg_exo -60.88 150.43 83.48 Favored 'Trans proline' 0 C--O 1.248 0.99 0 C-N-CA 122.455 2.103 . . . . 63.5 112.072 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 22.9 Cg_exo -66.45 137.75 47.9 Favored 'Trans proline' 0 CA--C 1.503 -1.039 0 C-N-CA 122.998 2.465 . . . . 72.319999999999993 111.344 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.587 ' HB2' HG23 ' A' ' 7' ' ' ILE . 48.2 mtp -99.81 128.85 45.88 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 105.922 -1.881 . . . . 75.549999999999997 105.922 173.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.7 t -111.4 123.73 67.52 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 C-N-CA 119.786 -0.766 . . . . 53.539999999999999 109.373 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.2 mp -122.31 102.31 11.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.763 -1.569 . . . . 74.150000000000006 106.763 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.18 -169.01 14.21 Favored Glycine 0 C--N 1.276 -2.804 0 C-N-CA 119.225 -1.465 . . . . 75.299999999999997 114.178 -172.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.1 t70 57.37 43.26 23.58 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 123.043 1.402 . . . . 65.129999999999995 110.156 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -116.92 136.14 53.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 105.708 -1.96 . . . . 74.219999999999999 105.708 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 p -79.83 169.63 17.65 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 119.211 0.914 . . . . 75.030000000000001 108.645 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.609 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 68.0 t80 -57.48 -45.67 84.59 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 123.188 0.595 . . . . 74.430000000000007 111.573 -172.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -66.87 -42.15 86.09 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 114.735 -1.12 . . . . 74.409999999999997 110.725 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.7 mt -72.97 -36.86 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 115.325 -0.852 . . . . 72.299999999999997 109.865 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.434 ' HA ' HG22 ' A' ' 40' ' ' ILE . . . -64.06 -41.16 97.46 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.954 -0.566 . . . . 73.030000000000001 110.324 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.2 ttm -70.3 -37.95 74.89 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 120.139 -0.624 . . . . 62.0 110.819 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -73.12 -36.0 66.64 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.428 0.899 . . . . 72.420000000000002 113.428 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 37' ' ' ALA . 11.6 tt -68.31 -40.87 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 119.842 -0.743 . . . . 72.409999999999997 109.28 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.4 t -65.42 -43.82 94.56 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.864 0 N-CA-C 109.57 -0.53 . . . . 72.340000000000003 109.57 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -59.42 -39.24 82.86 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.595 0.358 . . . . 72.329999999999998 111.82 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.8 -44.0 95.37 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.714 -0.755 . . . . 74.109999999999999 111.369 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 40' ' ' ILE . 56.6 t -71.06 -39.09 74.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.378 -0.601 . . . . 61.420000000000002 109.378 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.441 ' OD2' HG21 ' A' ' 56' ' ' VAL . 14.1 t70 -56.68 -46.93 80.85 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.752 1.621 . . . . 64.450000000000003 109.966 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -64.73 -40.56 95.52 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.157 -0.929 . . . . 75.140000000000001 109.917 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.1 t -66.77 -39.29 83.32 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 CA-C-N 116.311 -0.404 . . . . 62.229999999999997 111.139 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 72.9 mt -69.44 -40.74 80.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 110.66 -0.126 . . . . 73.209999999999994 110.66 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -71.92 -30.79 65.72 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.337 -0.545 . . . . 74.25 110.607 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.2 -45.66 11.8 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 112.545 0.572 . . . . 73.349999999999994 112.545 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.5 m -85.44 -20.01 30.44 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.885 0.698 . . . . 73.209999999999994 112.885 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 48' ' ' ILE . 6.4 m-85 -123.15 157.08 33.74 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-O 121.145 0.498 . . . . 72.519999999999996 109.683 -175.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 45.1 t30 -85.86 87.35 7.4 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 104.367 -2.457 . . . . 60.030000000000001 104.367 172.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -133.5 136.25 44.95 Favored 'General case' 0 N--CA 1.397 -3.112 0 CA-C-N 115.434 -0.803 . . . . 72.310000000000002 111.975 -173.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.419 ' OG ' ' HB ' ' A' ' 72' ' ' THR . 41.0 p -95.8 122.77 38.94 Favored 'General case' 0 N--CA 1.404 -2.731 0 N-CA-C 106.727 -1.582 . . . . 62.0 106.727 171.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.441 HG21 ' OD2' ' A' ' 45' ' ' ASP . 3.2 p -99.68 119.34 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 N-CA-C 108.126 -1.065 . . . . 71.310000000000002 108.126 177.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -117.61 112.28 20.33 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 114.12 -1.4 . . . . 53.299999999999997 108.584 -174.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -94.21 122.36 36.66 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.406 0.622 . . . . 72.129999999999995 111.464 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mp -121.94 178.11 5.02 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 115.197 -0.91 . . . . 54.329999999999998 109.193 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -95.61 140.8 29.91 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.325 -0.852 . . . . 61.149999999999999 108.748 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.12 175.69 41.57 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 115.574 -0.739 . . . . 54.539999999999999 113.089 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -72.52 174.87 6.85 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 123.995 0.918 . . . . 70.420000000000002 108.595 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -49.73 -41.33 43.39 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 124.613 1.165 . . . . 72.109999999999999 113.034 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.01 -8.54 57.88 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.124 -0.944 . . . . 70.010000000000005 111.644 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -99.15 159.08 15.23 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 107.667 -1.234 . . . . 74.209999999999994 107.667 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.75 -37.64 3.67 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.638 0 CA-C-O 121.57 0.7 . . . . 74.030000000000001 110.212 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.7 tp -156.88 144.24 18.9 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.798 -1.186 . . . . 73.120000000000005 107.798 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -131.32 107.12 8.73 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.857 -0.794 . . . . 74.230000000000004 108.857 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -116.19 129.33 56.25 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.017 -1.073 . . . . 74.430000000000007 111.262 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -109.32 128.89 55.45 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.532 -0.758 . . . . 53.109999999999999 109.447 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -105.91 134.72 48.58 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 107.255 -1.387 . . . . 63.229999999999997 107.255 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.559 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 30.6 m -109.18 107.3 17.53 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 106.578 -1.638 . . . . 62.229999999999997 106.578 173.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.66 140.13 41.16 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 120.954 0.407 . . . . 52.149999999999999 111.865 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 44.3 tt0 -147.81 86.82 1.6 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.627 -0.715 . . . . 74.299999999999997 109.073 168.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -95.91 104.0 15.91 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.922 -0.581 . . . . 72.25 110.556 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 56.9 34.81 25.43 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.804 0.69 . . . . 74.150000000000006 112.46 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.94 -7.88 57.47 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 120.754 -0.736 . . . . 55.539999999999999 113.086 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 53.4 mtpt -92.37 102.11 14.59 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.108 -1.071 . . . . 73.200000000000003 108.108 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.642 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -102.09 138.19 39.37 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.576 -0.738 . . . . 75.420000000000002 111.21 -173.525 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.441 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . -164.03 164.48 36.55 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.438 -0.411 . . . . 54.43 112.751 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 34.0 mm -120.13 134.63 63.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 105.584 -2.006 . . . . 74.200000000000003 105.584 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.6 t -127.57 120.3 54.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.879 -0.513 . . . . 62.310000000000002 110.25 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 67.1 m-70 -105.62 104.14 13.8 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.328 -0.619 . . . . 65.099999999999994 109.328 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.3 t -100.11 110.59 27.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 109.669 -0.493 . . . . 74.140000000000001 109.669 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -112.55 140.54 47.22 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.042 0.449 . . . . 72.510000000000005 110.406 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.2 mt -97.78 125.7 42.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 105.831 -1.915 . . . . 70.540000000000006 105.831 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 4' ' ' ASP . 22.9 mmm180 -104.55 141.54 36.23 Favored 'General case' 0 C--N 1.273 -2.761 0 N-CA-C 108.017 -1.105 . . . . 73.510000000000005 108.017 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -90.0 98.04 11.54 Favored 'General case' 0 C--N 1.279 -2.48 0 C-N-CA 119.294 -0.962 . . . . 63.439999999999998 108.958 172.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.3 tt -74.13 112.31 10.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 121.261 -0.899 . . . . 61.25 110.39 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 93' ' ' CYS . 0.8 OUTLIER -142.34 177.14 8.46 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.084 -1.08 . . . . 62.149999999999999 108.084 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -77.99 -13.83 59.74 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 118.774 0.715 . . . . 61.140000000000001 111.119 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -109.02 9.82 26.31 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.124 -0.943 . . . . 62.310000000000002 110.156 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.408 ' HB3' ' OG1' ' A' ' 90' ' ' THR . 42.1 t -147.84 102.07 3.66 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 109.075 -0.713 . . . . 74.439999999999998 109.075 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.56 139.65 25.77 Favored 'Trans proline' 0 C--O 1.252 1.224 0 C-N-CA 122.429 2.086 . . . . 60.539999999999999 113.851 -174.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.62 161.07 28.08 Favored 'Trans proline' 0 N--CA 1.439 -1.71 0 C-N-CA 122.45 2.1 . . . . 70.319999999999993 108.78 173.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.3 t -91.68 157.92 2.92 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.559 0 N-CA-C 107.232 -1.396 . . . . 73.420000000000002 107.232 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -109.82 133.48 53.1 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.09 -1.078 . . . . 71.239999999999995 108.09 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -155.52 -144.88 4.03 Favored Glycine 0 N--CA 1.413 -2.867 0 C-N-CA 119.842 -1.171 . . . . 72.5 112.244 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -64.9 127.01 29.81 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 113.456 -1.372 . . . . 53.229999999999997 109.521 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -77.11 99.33 5.33 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.549 -1.278 . . . . 74.349999999999994 107.549 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 44.1 t -79.96 152.59 29.43 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 115.404 -0.816 . . . . 72.239999999999995 109.565 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.8 m -76.6 86.4 3.28 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.232 -1.025 . . . . 63.119999999999997 108.232 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.469 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 28.8 t -115.51 138.0 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 110.515 -174.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 103' ' ' VAL . 25.6 mt -170.55 -49.98 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 126.556 1.943 . . . . 54.140000000000001 110.948 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.6 142.37 17.8 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 113.996 -1.456 . . . . 75.530000000000001 107.537 -172.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -32.96 -44.43 0.11 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.145 2.178 . . . . 74.200000000000003 116.552 -170.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -54.84 -53.72 51.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.373 0.606 . . . . 73.25 112.567 -175.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -80.72 -30.14 36.31 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.989 -0.55 . . . . 71.049999999999997 110.041 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.94 -47.88 81.33 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.944 -1.026 . . . . 75.420000000000002 109.477 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.7 tt -65.53 -37.0 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.552 -0.295 . . . . 52.310000000000002 110.523 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.28 -48.32 82.25 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 109.655 -0.498 . . . . 73.109999999999999 109.655 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 21.5 t -62.81 -39.25 93.71 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.514 -0.767 . . . . 70.129999999999995 111.632 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 75.9 mt -70.18 -45.71 74.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 120.505 -0.478 . . . . 74.439999999999998 110.846 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.6 t -70.19 -38.86 75.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.264 -0.574 . . . . 64.209999999999994 110.72 -176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -74.53 -22.05 59.22 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 112.291 0.478 . . . . 75.200000000000003 112.291 -176.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.439 ' HB3' ' SD ' ' A' ' 27' ' ' MET . . . -83.04 -37.69 23.56 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 119.073 -1.051 . . . . 63.299999999999997 110.486 175.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 81.6 mt -62.48 -45.37 98.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 108.968 -0.752 . . . . 55.549999999999997 108.968 175.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -54.4 -43.64 71.63 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 123.575 0.75 . . . . 60.450000000000003 112.382 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 22.5 mm-40 -65.7 -44.11 87.13 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.818 0.699 . . . . 74.450000000000003 110.93 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 36.5 t -62.4 -40.94 98.15 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.198 0.523 . . . . 43.0 110.163 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 117' ' ' ILE . 70.6 mt -71.82 -29.14 64.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.977 -0.556 . . . . 74.019999999999996 110.656 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.08 -31.81 39.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 112.727 0.64 . . . . 74.540000000000006 112.727 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 119' ' ' GLU . 72.3 mmtt -65.56 -40.25 92.62 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 119.841 -0.743 . . . . 63.520000000000003 109.933 -177.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.62 -154.3 50.76 Favored Glycine 0 C--N 1.291 -1.966 0 CA-C-N 114.44 -1.254 . . . . 63.219999999999999 114.798 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.412 ' HB3' ' CD2' ' A' ' 13' ' ' HIS . 9.2 pt-20 . . . . . 0 C--N 1.294 -1.846 0 C-N-CA 124.703 1.201 . . . . 61.109999999999999 112.799 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptm . . . . . 0 CA--C 1.515 -0.388 0 N-CA-C 109.375 -0.602 . . . . 65.239999999999995 109.375 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HE3' ' HA ' ' A' ' 31' ' ' ASP . 87.5 tttt -122.3 136.96 54.99 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.072 0.463 . . . . 73.299999999999997 111.499 -173.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.586 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 19.2 m-85 -117.24 152.44 34.82 Favored 'General case' 0 C--O 1.251 1.169 0 C-N-CA 125.0 1.32 . . . . 73.010000000000005 109.338 173.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.631 ' OD1' ' HA3' ' A' ' 30' ' ' GLY . 24.6 t70 -123.67 108.77 12.93 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.581 -1.637 . . . . 55.450000000000003 106.581 -177.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.44 127.05 48.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.195 0.522 . . . . 62.119999999999997 111.927 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 85' ' ' LYS . 4.8 p -115.15 121.66 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.621 0 N-CA-C 108.156 -1.053 . . . . 75.340000000000003 108.156 176.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.486 HG23 ' CG ' ' A' ' 27' ' ' MET . 1.9 tt -122.2 123.48 68.95 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 CA-C-N 115.392 -0.822 . . . . 73.099999999999994 109.878 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.54 ' CG1' ' HB2' ' A' ' 83' ' ' HIS . 40.2 pt -108.06 118.59 52.27 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.864 -0.607 . . . . 53.049999999999997 110.463 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.498 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 11.5 Cg_endo -90.94 142.7 3.21 Favored 'Trans proline' 0 N--CA 1.431 -2.152 0 C-N-CA 122.153 1.902 . . . . 72.019999999999996 109.726 170.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -151.41 146.95 26.32 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 108.909 -0.774 . . . . 72.5 108.909 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.614 ' OG ' ' HB3' ' A' ' 22' ' ' HIS . 86.5 p -90.4 143.9 26.32 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.302 -1.37 . . . . 72.420000000000002 107.302 175.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.542 ' CE1' ' HB2' ' A' ' 79' ' ' LYS 0.351 1.6 p90 -80.61 87.5 5.76 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 118.098 -1.441 . . . . 74.230000000000004 113.189 178.379 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -130.14 99.53 5.09 Favored 'General case' 0 N--CA 1.414 -2.271 0 CA-C-N 113.729 -1.578 . . . . 63.210000000000001 110.833 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.92 118.05 9.86 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 122.305 1.05 . . . . 63.340000000000003 109.395 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.54 ' HA ' ' O ' ' A' ' 20' ' ' MET . 56.1 t80 -60.71 111.62 1.69 Allowed 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 112.208 -2.269 . . . . 74.019999999999996 111.074 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -85.69 -105.04 0.06 Allowed 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 113.433 -1.712 . . . . 73.25 110.218 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -112.35 -57.31 2.29 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.451 0.644 . . . . 72.540000000000006 110.627 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -124.92 -23.28 4.31 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.497 -0.774 . . . . 75.540000000000006 109.909 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -103.07 157.41 17.01 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.554 -0.748 . . . . 52.310000000000002 111.654 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.54 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 83.1 mtp 72.96 76.7 0.14 Allowed 'General case' 0 C--O 1.209 -1.038 0 O-C-N 124.829 1.331 . . . . 71.439999999999998 114.085 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -161.2 99.39 1.19 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.305 -0.998 . . . . 73.109999999999999 108.305 171.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.614 ' HB3' ' OG ' ' A' ' 11' ' ' SER . 47.0 t60 -136.63 93.04 2.82 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.651 -0.87 . . . . 72.219999999999999 108.651 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.2 mm -109.01 138.53 35.73 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 106.126 -1.805 . . . . 71.430000000000007 106.126 176.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 62.9 m -106.81 122.73 40.79 Favored Pre-proline 0 C--N 1.273 -2.736 0 C-N-CA 120.278 -0.569 . . . . 53.350000000000001 110.078 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -49.55 143.35 21.66 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.976 3.117 . . . . 50.43 113.733 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.85 133.05 55.75 Favored 'Trans proline' 0 CA--C 1.509 -0.727 0 C-N-CA 123.792 2.995 . . . . 73.129999999999995 113.051 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.486 ' CG ' HG23 ' A' ' 7' ' ' ILE . 22.1 ptp -106.07 141.55 37.25 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.652 -1.611 . . . . 74.409999999999997 106.652 172.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.443 HG22 HG23 ' A' ' 6' ' ' VAL . 39.8 t -133.86 127.75 52.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 120.229 -0.588 . . . . 51.210000000000001 110.91 -169.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.408 HD13 ' O ' ' A' ' 28' ' ' VAL . 45.3 mm -129.17 103.8 9.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.715 -1.217 . . . . 75.319999999999993 107.715 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.631 ' HA3' ' OD1' ' A' ' 4' ' ' ASP . . . -123.04 88.91 0.41 Allowed Glycine 0 N--CA 1.419 -2.461 0 C-N-CA 118.919 -1.61 . . . . 72.420000000000002 113.618 -175.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.461 ' HA ' ' HE3' ' A' ' 2' ' ' LYS . 5.9 p-10 -165.52 29.29 0.05 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.991 0.901 . . . . 74.349999999999994 109.118 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -118.32 136.98 53.39 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-N 115.572 -0.74 . . . . 74.340000000000003 109.21 -170.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.4 p -76.31 169.66 17.8 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 106.765 -1.568 . . . . 65.150000000000006 106.765 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.586 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 84.8 t80 -59.0 -39.21 81.15 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.465 0.65 . . . . 63.219999999999999 110.758 -177.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.15 -50.31 72.38 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.144 -1.389 . . . . 72.109999999999999 110.755 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.3 mt -69.99 -37.19 71.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.5 -0.555 . . . . 63.43 109.5 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -65.17 -42.1 94.01 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.612 -0.722 . . . . 70.329999999999998 110.8 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.6 tpp -69.76 -41.15 75.57 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 120.103 -0.639 . . . . 41.25 110.16 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.4 -38.03 80.92 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 112.489 0.552 . . . . 73.019999999999996 112.489 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 44' ' ' VAL . 14.4 tt -69.52 -39.39 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 119.516 -0.874 . . . . 72.25 110.114 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 37' ' ' ALA . 96.7 t -67.95 -40.41 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 120.544 -0.462 . . . . 55.539999999999999 109.964 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -69.55 -25.91 64.24 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.77 0.319 . . . . 72.209999999999994 111.559 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.59 -46.51 39.3 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 110.541 -1.024 . . . . 73.049999999999997 110.541 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 48' ' ' ILE . 86.3 t -61.1 -42.62 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 109.21 -0.663 . . . . 64.530000000000001 109.21 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -49.92 -52.36 33.87 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 125.912 1.685 . . . . 52.32 111.057 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -68.28 -35.19 77.48 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.773 -1.103 . . . . 73.310000000000002 110.387 -175.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 91.6 t -71.73 -36.56 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 116.075 -0.511 . . . . 62.43 111.253 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 44' ' ' VAL . 60.4 mt -68.35 -38.76 79.89 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.959 0 N-CA-C 109.541 -0.54 . . . . 74.450000000000003 109.541 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -66.62 -33.84 76.55 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.803 0.335 . . . . 74.209999999999994 111.682 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.99 -25.5 34.7 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.452 0.538 . . . . 60.049999999999997 112.452 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.9 m -99.48 -23.96 14.93 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.164 0.801 . . . . 75.120000000000005 113.164 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -133.24 -172.52 2.96 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.792 0.806 . . . . 73.439999999999998 111.6 -173.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -106.93 100.25 9.77 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 104.287 -2.486 . . . . 71.319999999999993 104.287 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -114.69 144.49 43.36 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 113.343 0.868 . . . . 72.319999999999993 113.343 -169.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -123.68 112.15 17.04 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.798 -1.556 . . . . 73.109999999999999 106.798 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -100.55 137.2 28.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.127 0.489 . . . . 74.310000000000002 109.993 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -136.32 117.96 14.96 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.223 -1.029 . . . . 73.340000000000003 108.223 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -97.65 129.25 44.75 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.55 -0.86 . . . . 71.120000000000005 111.366 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.2 mp -122.51 177.44 5.41 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.744 -1.116 . . . . 32.399999999999999 108.072 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -101.58 161.83 13.35 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.389 -1.337 . . . . 73.040000000000006 107.389 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.39 176.63 19.7 Favored Glycine 0 N--CA 1.413 -2.85 0 N-CA-C 111.052 -0.819 . . . . 53.530000000000001 111.052 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.48 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 11.9 pt-20 -65.23 -178.33 0.47 Allowed 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 123.403 0.681 . . . . 61.109999999999999 110.418 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -50.13 -38.45 39.15 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 114.442 1.275 . . . . 43.32 114.442 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 44.0 t -92.96 -0.93 57.11 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 121.687 0.756 . . . . 75.340000000000003 110.558 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.524 ' OD1' ' HG2' ' A' ' 87' ' ' ARG . 88.0 m-20 -100.75 152.82 20.03 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-N 115.974 -0.557 . . . . 74.349999999999994 110.077 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -113.45 -24.89 3.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-O 121.288 0.566 . . . . 50.140000000000001 111.893 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.433 ' HB3' HD12 ' A' ' 86' ' ' LEU . 57.2 tp -154.36 141.73 19.63 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 109.141 -0.688 . . . . 73.129999999999995 109.141 177.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -130.34 102.13 6.06 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 106.655 -1.609 . . . . 73.549999999999997 106.655 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -111.24 124.63 52.61 Favored 'General case' 0 C--N 1.281 -2.38 0 C-N-CA 119.436 -0.906 . . . . 64.140000000000001 109.642 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -105.74 143.27 34.13 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.284 -0.636 . . . . 73.109999999999999 109.284 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.489 ' HB3' HD11 ' A' ' 73' ' ' LEU . 87.6 m-85 -127.88 126.26 41.22 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.384 -0.969 . . . . 72.450000000000003 108.384 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.0 m -103.28 117.0 33.52 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.112 -1.81 . . . . 65.209999999999994 106.112 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 71' ' ' TYR . 0.7 OUTLIER -122.55 144.31 49.17 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.415 0.626 . . . . 75.5 112.393 -170.67 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -147.55 160.4 42.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.574 1.178 . . . . 63.420000000000002 111.134 171.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -154.29 157.44 38.68 Favored 'General case' 0 C--N 1.258 -3.409 0 N-CA-C 102.327 -3.212 . . . . 75.040000000000006 102.327 165.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -53.06 99.59 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.994 0.902 . . . . 52.520000000000003 112.726 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.72 0.51 56.46 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.401 -0.818 . . . . 71.219999999999999 112.648 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 95.6 mttt -134.33 108.55 8.26 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.047 -1.094 . . . . 40.409999999999997 108.047 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 16.5 ptpt -131.64 132.66 44.19 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.397 0.517 . . . . 71.340000000000003 112.397 -174.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -170.87 177.27 43.99 Favored Glycine 0 C--O 1.215 -1.036 0 C-N-CA 119.955 -1.117 . . . . 65.430000000000007 113.819 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.0 mt -129.22 148.81 33.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 106.884 -1.524 . . . . 62.539999999999999 106.884 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.25 123.86 51.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.634 -0.506 . . . . 55.210000000000001 109.634 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.54 ' HB2' ' CG1' ' A' ' 8' ' ' ILE . 11.9 m170 -110.7 112.44 24.32 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.641 -0.503 . . . . 73.329999999999998 109.641 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.47 114.51 42.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.514 -0.921 . . . . 74.120000000000005 108.514 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.495 ' HB3' HG13 ' A' ' 6' ' ' VAL . 59.9 tttp -115.72 118.28 32.63 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.958 -1.127 . . . . 74.420000000000002 107.958 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.433 HD12 ' HB3' ' A' ' 67' ' ' LEU . 90.5 mt -98.16 114.63 26.9 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 107.232 -1.395 . . . . 74.120000000000005 107.232 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.524 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 76.0 mtp85 -102.42 139.62 37.78 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.581 0.705 . . . . 71.519999999999996 110.073 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -90.71 98.27 11.68 Favored 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 115.089 -0.96 . . . . 73.439999999999998 108.49 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 tt -75.14 110.81 10.49 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-O 122.824 1.297 . . . . 70.209999999999994 109.173 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.1 p -123.31 -170.81 2.18 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 113.773 -1.558 . . . . 74.310000000000002 107.744 -174.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -82.63 -0.46 47.21 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.672 -0.862 . . . . 75.230000000000004 108.672 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -112.51 -5.05 14.07 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.974 -1.012 . . . . 72.140000000000001 110.18 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.2 m -137.97 113.97 9.15 Favored Pre-proline 0 C--N 1.311 -1.087 0 C-N-CA 123.202 0.601 . . . . 75.129999999999995 110.814 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.48 163.34 29.79 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 122.015 1.81 . . . . 64.049999999999997 110.552 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.96 163.2 29.32 Favored 'Trans proline' 0 C--O 1.247 0.952 0 C-N-CA 122.885 2.39 . . . . 63.030000000000001 112.048 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 t -93.41 156.54 3.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.582 -0.896 . . . . 71.430000000000007 108.582 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -106.41 141.54 37.55 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.272 -1.01 . . . . 72.510000000000005 108.272 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.42 -163.83 31.51 Favored Glycine 0 N--CA 1.419 -2.466 0 C-N-CA 120.149 -1.024 . . . . 55.109999999999999 111.714 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -69.58 139.23 53.68 Favored 'General case' 0 N--CA 1.417 -2.124 0 C-N-CA 125.205 1.402 . . . . 75.239999999999995 107.921 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -102.59 123.54 46.5 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 119.655 -0.818 . . . . 72.439999999999998 111.803 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.1 t -79.34 137.92 37.5 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.311 -1.366 . . . . 71.530000000000001 107.311 172.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.5 m -75.33 95.47 3.21 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.647 0.737 . . . . 63.25 110.191 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.431 HG13 ' CG ' ' A' ' 109' ' ' ASP . 57.7 t -97.89 147.55 6.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.778 -1.101 . . . . 45.219999999999999 109.369 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 47.1 tp -149.56 -74.1 0.17 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.289 -0.869 . . . . 70.420000000000002 109.56 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -143.56 151.41 40.18 Favored 'General case' 0 C--N 1.258 -3.385 0 N-CA-C 106.831 -1.544 . . . . 54.100000000000001 106.831 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.467 ' O ' HG22 ' A' ' 110' ' ' ILE . 79.9 t80 -35.78 -42.08 0.24 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.512 1.671 . . . . 72.349999999999994 115.512 -172.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -55.26 -47.75 74.99 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 122.804 0.442 . . . . 71.530000000000001 112.015 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.89 -34.22 30.11 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 107.672 -1.232 . . . . 60.219999999999999 107.672 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.431 ' CG ' HG13 ' A' ' 103' ' ' VAL . 26.2 m-20 -62.37 -46.8 87.0 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.476 -0.784 . . . . 74.349999999999994 110.218 -176.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 106' ' ' PHE . 8.5 tp -65.56 -41.36 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 115.571 -0.74 . . . . 73.310000000000002 110.612 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -26.37 60.32 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 120.285 -0.566 . . . . 72.340000000000003 111.572 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 12.0 t -68.26 -48.01 66.21 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 116.585 -0.28 . . . . 71.209999999999994 110.382 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.73 -42.93 93.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.216 -0.447 . . . . 72.319999999999993 110.087 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 70.9 t -64.65 -40.9 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 116.207 -0.451 . . . . 73.450000000000003 110.306 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -61.55 -44.09 97.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.351 -0.386 . . . . 74.430000000000007 111.355 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.49 -35.64 75.76 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.847 0.356 . . . . 33.409999999999997 111.573 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.46 ' O ' HD13 ' A' ' 121' ' ' LEU . 80.8 mt -69.33 -44.57 80.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 109.587 -0.523 . . . . 72.439999999999998 109.587 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -60.37 -45.22 94.3 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.886 -0.783 . . . . 63.219999999999999 108.886 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 44.5 mt-10 -68.57 -33.74 74.6 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 112.081 0.4 . . . . 64.219999999999999 112.081 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 9' ' ' PRO . 30.3 t -67.42 -31.3 71.41 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.417 0.627 . . . . 60.210000000000001 109.818 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.462 ' HG ' ' C ' ' A' ' 79' ' ' LYS . 9.0 mp -81.33 -37.84 27.69 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 121.151 0.501 . . . . 71.549999999999997 110.812 176.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.4 -16.71 41.76 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 115.579 1.696 . . . . 75.430000000000007 115.579 -175.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 62.9 mttm -75.81 -3.88 37.52 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 119.884 1.22 . . . . 75.340000000000003 113.603 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.07 -157.45 20.08 Favored Glycine 0 N--CA 1.422 -2.263 0 C-N-CA 119.943 -1.122 . . . . 74.329999999999998 113.429 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 20' ' ' MET . 10.0 pt-20 . . . . . 0 C--N 1.286 -2.189 0 CA-C-N 114.421 -0.889 . . . . 73.129999999999995 111.214 -174.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.428 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 2.0 mmt . . . . . 0 CA--C 1.506 -0.732 0 CA-C-O 121.367 0.603 . . . . 71.439999999999998 112.194 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -126.18 143.77 51.01 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.671 -1.233 . . . . 55.43 107.671 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 11.8 m-85 -114.7 145.34 42.16 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 122.002 0.906 . . . . 72.099999999999994 112.778 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.666 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 35.4 t70 -106.12 100.89 10.41 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 127.026 2.131 . . . . 64.239999999999995 105.541 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -92.42 124.6 44.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.638 -0.664 . . . . 54.140000000000001 109.334 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.9 t -113.51 119.05 59.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.288 -1.004 . . . . 73.239999999999995 108.288 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.536 HG23 ' HB2' ' A' ' 27' ' ' MET . 7.7 tt -114.29 116.55 52.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 121.504 0.669 . . . . 61.140000000000001 109.391 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 20.7 mt -106.61 106.72 58.58 Favored Pre-proline 0 C--N 1.3 -1.551 0 CA-C-N 115.56 -0.745 . . . . 72.219999999999999 110.056 -175.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.536 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 25.3 Cg_endo -95.42 137.22 0.74 Allowed 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.507 2.138 . . . . 73.420000000000002 111.185 173.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -158.55 137.45 11.29 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 121.845 -0.534 . . . . 71.409999999999997 111.065 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -84.5 106.92 16.45 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.21 -0.45 . . . . 50.409999999999997 109.853 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.629 ' CE1' ' HB2' ' A' ' 79' ' ' LYS . 2.0 p90 -63.26 106.98 0.97 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.103 1.149 . . . . 64.219999999999999 114.103 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 73.7 m80 -142.24 156.36 45.3 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.96 -1.018 . . . . 74.319999999999993 108.704 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -98.26 120.68 39.1 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 108.0 -1.111 . . . . 71.430000000000007 108.0 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -60.04 111.08 1.36 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 124.754 1.284 . . . . 75.349999999999994 110.603 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.07 -100.53 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.576 -1.193 . . . . 72.299999999999997 108.355 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -113.19 -60.31 1.9 Allowed 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 106.862 -1.533 . . . . 75.5 106.862 167.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.457 ' HA ' ' OE1' ' A' ' 21' ' ' GLU . 7.2 p-80 -138.5 34.56 2.26 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 113.797 -1.547 . . . . 74.25 110.005 175.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -135.29 152.61 51.66 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 106.619 -1.622 . . . . 61.310000000000002 106.619 -178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.461 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 0.0 OUTLIER 60.99 58.09 2.38 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.512 1.149 . . . . 62.520000000000003 110.009 -175.239 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 18' ' ' HIS . 7.4 pt-20 -141.06 88.22 2.16 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 113.47 -1.695 . . . . 64.5 110.684 -176.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -128.75 104.65 7.75 Favored 'General case' 0 C--N 1.285 -2.22 0 O-C-N 121.68 -0.638 . . . . 72.420000000000002 109.456 174.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.6 mm -116.51 136.68 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.733 0 N-CA-C 107.02 -1.474 . . . . 70.430000000000007 107.02 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 70.2 m -108.38 145.63 31.94 Favored Pre-proline 0 C--N 1.281 -2.397 0 N-CA-C 107.335 -1.357 . . . . 73.430000000000007 107.335 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.42 152.01 33.9 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 121.902 1.734 . . . . 63.119999999999997 112.451 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.02 125.2 17.49 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.631 2.221 . . . . 64.439999999999998 111.261 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.536 ' HB2' HG23 ' A' ' 7' ' ' ILE . 38.9 mtt -95.56 134.45 38.41 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.454 -1.684 . . . . 23.440000000000001 106.454 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -131.33 136.86 56.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.383 -0.527 . . . . 65.230000000000004 110.954 -168.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.4 mp -133.65 109.17 12.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.201 -1.037 . . . . 72.129999999999995 108.201 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.666 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -119.08 81.19 0.32 Allowed Glycine 0 C--N 1.3 -1.465 0 C-N-CA 119.209 -1.472 . . . . 42.329999999999998 115.137 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -176.06 31.03 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 124.555 1.142 . . . . 53.5 112.268 172.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.42 ' NH1' HG11 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -109.65 133.23 53.36 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 106.228 -1.767 . . . . 71.329999999999998 106.228 -179.185 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 p -75.13 161.48 29.36 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 119.471 1.032 . . . . 72.25 109.509 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.575 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 61.9 t80 -58.89 -43.63 90.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.499 0.666 . . . . 74.150000000000006 111.263 -173.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -70.08 -34.96 73.82 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.841 -1.072 . . . . 73.140000000000001 112.098 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.5 -35.79 17.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.404 -0.591 . . . . 42.229999999999997 109.404 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.8 -45.72 93.31 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-N 115.497 -0.774 . . . . 51.030000000000001 109.997 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 18.4 mmt -62.99 -38.11 89.87 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 116.504 -0.316 . . . . 70.109999999999999 111.249 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -65.54 -45.26 84.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.396 -0.365 . . . . 63.200000000000003 111.035 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.463 ' O ' HG23 ' A' ' 44' ' ' VAL . 10.4 tt -71.79 -39.73 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 119.146 -1.022 . . . . 65.299999999999997 110.541 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 83.5 t -67.8 -33.73 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 121.133 -0.227 . . . . 63.409999999999997 110.615 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -67.83 -40.94 83.7 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.86 -0.422 . . . . 75.219999999999999 109.86 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.34 -45.05 92.34 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-N 115.64 -0.709 . . . . 62.32 111.342 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 40' ' ' ILE . 69.7 t -61.7 -42.7 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.012 0.434 . . . . 74.519999999999996 109.875 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.56 -46.21 80.85 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 124.306 1.042 . . . . 72.239999999999995 111.225 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -71.54 -35.32 70.62 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.059 -0.973 . . . . 71.340000000000003 110.323 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 43' ' ' GLY . 97.7 t -67.73 -40.6 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 121.051 -0.259 . . . . 75.030000000000001 110.445 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 44' ' ' VAL . 74.8 mt -64.15 -39.6 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.958 0.409 . . . . 74.200000000000003 109.9 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -74.89 -19.28 60.21 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 115.973 -0.558 . . . . 75.319999999999993 111.321 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.72 -14.74 16.54 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 112.874 0.694 . . . . 73.319999999999993 112.874 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 m -108.23 -23.42 11.94 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 112.429 0.529 . . . . 70.409999999999997 112.429 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -133.97 177.93 7.35 Favored 'General case' 0 CA--C 1.484 -1.564 0 CA-C-O 121.461 0.648 . . . . 72.150000000000006 110.069 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.534 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 38.4 t30 -98.93 95.89 7.47 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 104.938 -2.245 . . . . 72.019999999999996 104.938 175.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -117.41 135.25 54.02 Favored 'General case' 0 N--CA 1.402 -2.859 0 CA-C-N 115.427 -0.806 . . . . 44.43 112.408 -173.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.4 m -109.72 121.26 44.82 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 106.812 -1.551 . . . . 64.219999999999999 106.812 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.35 128.82 51.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-O 121.294 0.568 . . . . 74.219999999999999 110.539 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -122.37 112.33 17.96 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.879 -1.526 . . . . 71.209999999999994 106.879 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.16 119.13 34.09 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.814 0.34 . . . . 53.399999999999999 110.818 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.48 174.4 6.57 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.291 0.567 . . . . 62.130000000000003 109.824 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -95.98 155.18 16.86 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.2 -1.408 . . . . 64.420000000000002 107.2 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.66 175.73 24.6 Favored Glycine 0 C--N 1.277 -2.749 0 C-N-CA 120.519 -0.848 . . . . 73.150000000000006 112.891 -176.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.51 ' HB3' ' OD2' ' A' ' 65' ' ' ASP . 11.6 tp10 -65.91 177.05 1.42 Allowed 'General case' 0 C--O 1.21 -1.025 0 C-N-CA 124.735 1.214 . . . . 72.140000000000001 108.813 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -45.25 -49.11 12.69 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 113.813 1.042 . . . . 74.420000000000002 113.813 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 76.8 m -82.03 -15.07 54.86 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.758 -0.655 . . . . 75.209999999999994 111.712 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 12.3 m-20 -98.87 118.09 34.85 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.1 -0.64 . . . . 73.219999999999999 110.618 -176.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.0 t -80.73 -36.21 15.47 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.508 0 CA-C-N 116.062 -0.517 . . . . 61.200000000000003 112.272 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.8 tp -146.48 140.68 26.4 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.896 -1.15 . . . . 75.439999999999998 107.896 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.79 102.01 6.13 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 107.374 -1.343 . . . . 65.519999999999996 107.374 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -109.43 114.53 28.25 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.83 0.824 . . . . 63.009999999999998 110.372 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -98.49 139.33 34.39 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.811 -1.086 . . . . 72.420000000000002 109.012 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.84 128.48 51.7 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 107.257 -1.386 . . . . 71.329999999999998 107.257 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.3 m -103.42 119.17 38.37 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 106.78 -1.563 . . . . 75.409999999999997 106.78 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.57 137.71 44.07 Favored 'General case' 0 CA--C 1.495 -1.156 0 CA-C-O 121.084 0.468 . . . . 61.240000000000002 112.182 -173.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -142.45 83.55 1.83 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.145 -1.428 . . . . 74.109999999999999 107.145 173.125 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -85.62 66.79 9.83 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.063 -0.517 . . . . 75.409999999999997 109.831 -177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 51.56 64.1 1.98 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.507 -1.224 . . . . 74.5 111.427 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.93 -11.8 62.39 Favored Glycine 0 C--N 1.314 -0.667 0 C-N-CA 120.666 -0.778 . . . . 74.109999999999999 112.856 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -108.64 107.7 18.28 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.38 -1.341 . . . . 64.109999999999999 107.38 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.629 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -121.63 142.65 49.92 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 113.14 0.793 . . . . 70.239999999999995 113.14 -165.348 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.98 171.29 43.77 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.967 -0.56 . . . . 41.409999999999997 111.877 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.4 mt -116.53 147.0 20.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.759 -1.2 . . . . 75.329999999999998 107.759 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.3 t -130.18 110.44 19.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.588 -0.893 . . . . 71.530000000000001 108.588 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.502 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 38.6 m-70 -98.89 106.32 18.57 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.294 -0.632 . . . . 63.299999999999997 109.294 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.6 t -104.66 109.87 28.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.603 -0.888 . . . . 64.340000000000003 108.603 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -119.76 139.44 52.3 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.61 -0.515 . . . . 71.099999999999994 109.61 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.7 mt -102.52 106.22 16.9 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 107.385 -1.339 . . . . 74.120000000000005 107.385 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 60.0 ttt-85 -98.05 141.55 30.86 Favored 'General case' 0 C--N 1.263 -3.17 0 N-CA-C 108.843 -0.799 . . . . 64.340000000000003 108.843 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -93.59 108.35 20.08 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 109.346 -0.613 . . . . 73.0 109.346 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 tt -83.15 116.12 26.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.29 0.567 . . . . 73.420000000000002 109.68 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.8 p -115.79 -172.04 2.09 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 107.957 -1.127 . . . . 72.409999999999997 107.957 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -87.76 -13.2 42.97 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.464 0.65 . . . . 73.109999999999999 109.977 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -95.49 -38.23 10.54 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.919 -1.037 . . . . 65.430000000000007 109.63 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 49.3 t -101.52 104.3 33.25 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 109.465 -0.568 . . . . 63.039999999999999 109.465 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.85 146.97 33.96 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.219 2.612 . . . . 70.129999999999995 113.017 -176.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.16 162.18 27.45 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 123.782 2.988 . . . . 73.239999999999995 113.447 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 t -92.22 159.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 107.339 -1.356 . . . . 61.340000000000003 107.339 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.48 141.34 48.66 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.316 -0.624 . . . . 53.420000000000002 109.316 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.09 -169.9 41.41 Favored Glycine 0 CA--C 1.467 -2.927 0 N-CA-C 108.762 -1.735 . . . . 64.510000000000005 108.762 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.511 ' HB3' ' HG2' ' A' ' 27' ' ' MET . 4.4 t-20 -56.31 111.0 0.86 Allowed 'General case' 0 N--CA 1.426 -1.634 0 O-C-N 124.234 0.608 . . . . 72.450000000000003 109.788 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -87.16 126.17 34.63 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 108.344 -0.984 . . . . 74.219999999999999 108.344 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.11 151.97 44.87 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.305 -0.861 . . . . 51.329999999999998 110.435 -175.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.9 m -78.93 81.92 5.17 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.523 0.677 . . . . 74.549999999999997 109.766 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.531 HG13 ' OD2' ' A' ' 109' ' ' ASP . 49.3 t -80.74 143.72 11.86 Favored 'Isoleucine or valine' 0 C--O 1.251 1.137 0 CA-C-N 114.705 -1.134 . . . . 54.310000000000002 109.64 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -154.67 -67.98 0.13 Allowed 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.44 -1.319 . . . . 70.430000000000007 107.44 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -158.6 163.06 37.32 Favored 'General case' 1 C--N 1.24 -4.189 0 CA-C-N 112.54 -2.118 . . . . 64.030000000000001 105.62 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -39.35 -43.12 1.14 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.336 1.606 . . . . 73.0 115.336 -172.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -60.36 -49.76 76.29 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.025 0.379 . . . . 71.120000000000005 112.025 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -74.71 -33.87 62.48 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.295 -0.562 . . . . 71.329999999999998 110.645 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.531 ' OD2' HG13 ' A' ' 103' ' ' VAL . 0.9 OUTLIER -62.29 -48.37 80.2 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.387 -0.824 . . . . 64.439999999999998 110.423 178.193 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 10.5 tp -66.68 -37.99 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 120.711 -0.396 . . . . 65.209999999999994 110.452 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -63.58 -42.21 98.31 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.685 -0.406 . . . . 74.140000000000001 110.44 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 2.7 t -63.59 -41.32 98.36 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.164 -0.471 . . . . 73.120000000000005 111.907 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.424 ' O ' HG13 ' A' ' 117' ' ' ILE . 47.6 mm -70.54 -45.19 75.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 121.085 -0.246 . . . . 44.310000000000002 110.644 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.496 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 70.7 t -64.69 -42.91 96.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.333 -0.394 . . . . 72.129999999999995 110.912 -177.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.57 -27.35 62.14 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.173 -0.611 . . . . 53.149999999999999 111.163 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.18 84.8 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.47 -0.567 . . . . 14.15 109.47 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 113' ' ' ILE . 72.4 mt -63.8 -45.8 96.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.398 -0.819 . . . . 72.140000000000001 109.184 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 114' ' ' VAL . 80.6 mt-10 -60.71 -40.35 91.97 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 116.276 -0.42 . . . . 72.510000000000005 111.283 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -70.43 -35.22 73.26 Favored 'General case' 0 C--O 1.202 -1.438 0 C-N-CA 120.632 -0.427 . . . . 74.439999999999998 111.149 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 8.1 t -73.54 -37.15 65.68 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.196 -0.602 . . . . 73.140000000000001 110.483 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.3 mp -77.58 -42.67 34.38 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.866 -0.734 . . . . 71.329999999999998 111.211 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.29 -19.88 29.22 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 116.29 1.959 . . . . 65.019999999999996 116.29 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.4 30.4 mttp -59.63 -47.76 84.33 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 116.73 2.122 . . . . 72.200000000000003 116.73 -172.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 155.34 149.84 5.41 Favored Glycine 0 C--N 1.264 -3.431 0 C-N-CA 119.405 -1.378 . . . . 63.439999999999998 113.017 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 . . . . . 0 C--N 1.297 -1.698 0 C-N-CA 124.424 1.09 . . . . 71.530000000000001 111.128 -176.261 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 N-CA-C 107.022 -1.473 . . . . 74.400000000000006 107.022 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 98.3 mttt -88.06 155.29 19.88 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.673 0.749 . . . . 63.25 112.195 -178.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.632 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 7.6 m-85 -122.95 151.86 41.4 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.957 -1.02 . . . . 74.239999999999995 111.856 178.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.61 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 32.3 t70 -103.32 101.55 11.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 105.753 -1.943 . . . . 70.129999999999995 105.753 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -90.41 120.91 40.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.643 0.735 . . . . 73.140000000000001 109.335 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.0 t -110.69 112.39 40.35 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 107.664 -1.236 . . . . 71.530000000000001 107.664 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.522 HG23 ' HB3' ' A' ' 27' ' ' MET . 4.7 tt -120.08 108.83 24.19 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 CA-C-O 121.938 0.875 . . . . 74.430000000000007 109.903 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.0 mt -110.27 117.25 51.82 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-N 114.799 -1.091 . . . . 73.549999999999997 108.553 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.604 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 44.6 Cg_endo -93.67 140.25 1.55 Allowed 'Trans proline' 0 N--CA 1.431 -2.171 0 C-N-CA 121.51 1.473 . . . . 73.530000000000001 110.728 171.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.55 124.49 8.61 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.187 0.518 . . . . 74.329999999999998 111.054 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.577 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 57.4 m -67.51 114.64 6.33 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 122.108 -0.37 . . . . 71.310000000000002 110.143 177.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 2.7 p90 -57.39 115.17 2.55 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 113.726 1.009 . . . . 64.129999999999995 113.726 -176.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 71.0 m80 -146.45 162.79 37.5 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 114.275 -1.329 . . . . 64.409999999999997 108.324 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -133.63 149.5 51.58 Favored 'General case' 0 N--CA 1.401 -2.896 0 N-CA-C 104.945 -2.243 . . . . 71.430000000000007 104.945 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -61.12 115.93 4.15 Favored 'General case' 0 N--CA 1.413 -2.316 0 O-C-N 124.214 0.946 . . . . 74.450000000000003 110.806 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -91.27 -159.31 0.62 Allowed 'General case' 0 C--N 1.266 -3.064 0 N-CA-C 105.504 -2.036 . . . . 72.409999999999997 105.504 172.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -70.64 -52.84 18.57 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 119.466 1.03 . . . . 64.430000000000007 110.599 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -136.16 5.47 3.02 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.546 0.689 . . . . 52.420000000000002 110.511 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -125.82 170.95 11.1 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.486 -0.561 . . . . 75.150000000000006 109.486 -175.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.401 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 57.9 mtt 66.2 85.19 0.14 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.86 1.264 . . . . 65.150000000000006 113.347 175.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -161.73 98.72 1.11 Allowed 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.854 -1.165 . . . . 70.530000000000001 107.854 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -149.62 134.21 17.61 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.919 -0.488 . . . . 73.519999999999996 111.391 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.2 mp -128.86 144.72 37.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 104.572 -2.381 . . . . 72.349999999999994 104.572 172.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.604 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 37.4 m -107.15 160.0 27.99 Favored Pre-proline 0 C--N 1.277 -2.547 0 N-CA-C 108.584 -0.895 . . . . 52.109999999999999 108.584 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.89 119.81 7.1 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.228 2.619 . . . . 71.129999999999995 114.182 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.59 125.14 10.35 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.64 2.227 . . . . 62.420000000000002 110.925 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.522 ' HB3' HG23 ' A' ' 7' ' ' ILE . 39.0 tpp -101.15 128.19 47.36 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.899 -1.149 . . . . 70.400000000000006 107.899 -175.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.7 t -129.31 129.34 67.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.449 -0.574 . . . . 72.109999999999999 109.449 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.409 HD11 ' H ' ' A' ' 101' ' ' CYS . 38.7 mm -134.39 106.59 8.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.062 0.458 . . . . 74.430000000000007 110.684 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -104.47 81.12 0.32 Allowed Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 119.875 -1.155 . . . . 61.219999999999999 112.091 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -170.04 31.12 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.895 0.855 . . . . 41.200000000000003 111.023 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 -124.61 133.94 53.09 Favored 'General case' 0 C--O 1.201 -1.457 0 N-CA-C 107.667 -1.235 . . . . 72.209999999999994 107.667 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 2.3 p -84.44 155.25 22.32 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 118.524 0.602 . . . . 73.319999999999993 110.553 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.632 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 90.3 t80 -48.9 -53.74 18.3 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 124.464 1.106 . . . . 72.120000000000005 113.315 -172.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 25.5 m-20 -70.18 -35.43 73.96 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.749 -1.114 . . . . 73.109999999999999 111.06 -174.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.8 mt -76.28 -38.23 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 109.619 -0.512 . . . . 71.109999999999999 109.619 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.01 -44.96 95.61 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.716 -0.675 . . . . 43.310000000000002 110.414 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.8 ttm -66.45 -38.38 87.24 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 119.968 -0.693 . . . . 65.519999999999996 110.674 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 35' ' ' ASP . 55.9 mm-40 -67.82 -40.14 83.85 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.494 -0.482 . . . . 65.129999999999995 111.752 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 44' ' ' VAL . 14.6 tt -73.38 -38.36 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 119.464 -0.894 . . . . 73.340000000000003 110.736 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.87 -39.23 84.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 110.193 -0.299 . . . . 64.400000000000006 110.193 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -71.31 -16.59 62.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.031 0.443 . . . . 65.109999999999999 111.822 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.79 -43.47 6.79 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 110.233 -1.147 . . . . 74.530000000000001 110.233 173.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 40' ' ' ILE . 77.4 t -59.8 -38.26 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.045 -1.095 . . . . 62.149999999999999 108.045 177.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -51.09 -50.08 59.44 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 126.051 1.74 . . . . 72.439999999999998 111.069 176.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -67.26 -38.19 84.74 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.753 -0.832 . . . . 73.319999999999993 108.753 -177.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -62.32 -45.4 98.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.07 -0.514 . . . . 72.230000000000004 110.696 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 44' ' ' VAL . 61.6 mt -69.42 -38.35 76.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.912 0.386 . . . . 73.219999999999999 110.397 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -79.58 -14.29 58.93 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.245 0.545 . . . . 74.439999999999998 112.263 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.65 -38.46 7.9 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.722 -0.611 . . . . 65.310000000000002 112.009 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -84.72 -14.08 49.42 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.663 0.744 . . . . 70.140000000000001 110.377 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -141.19 -175.58 4.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.58 -1.267 . . . . 65.120000000000005 107.58 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -106.78 100.1 9.63 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 105.609 -1.997 . . . . 63.409999999999997 105.609 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -129.46 136.04 49.4 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-O 121.194 0.521 . . . . 74.25 111.952 -175.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.427 ' OG ' ' HB ' ' A' ' 72' ' ' THR . 5.5 p -116.87 127.57 54.4 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.725 -1.213 . . . . 71.030000000000001 107.725 175.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 p -101.03 119.1 48.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 119.805 -0.758 . . . . 72.219999999999999 111.77 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -95.91 111.11 23.19 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.806 -1.924 . . . . 70.010000000000005 105.806 171.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -103.24 108.51 19.75 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 122.069 0.937 . . . . 73.519999999999996 112.315 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mp -111.85 177.56 4.61 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.888 -1.506 . . . . 74.120000000000005 109.422 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -94.42 161.82 14.07 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.427 -0.953 . . . . 63.450000000000003 108.427 177.695 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.1 176.52 24.66 Favored Glycine 0 C--N 1.285 -2.298 0 N-CA-C 110.345 -1.102 . . . . 54.149999999999999 110.345 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -65.19 -179.47 0.58 Allowed 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 116.973 0.386 . . . . 73.120000000000005 110.126 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -52.05 -31.9 32.1 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 113.273 0.842 . . . . 74.400000000000006 113.273 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 51.8 t -87.67 -15.6 36.71 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.765 -0.652 . . . . 74.230000000000004 111.463 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.501 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 11.5 m-20 -105.64 156.81 17.9 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-O 121.244 0.545 . . . . 73.329999999999998 110.141 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.6 t -112.22 -31.94 2.17 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 120.497 -0.481 . . . . 74.530000000000001 111.857 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 57.3 tp -151.15 138.64 19.55 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.071 -0.652 . . . . 53.009999999999998 109.764 -176.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.2 104.18 6.91 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.392 -0.596 . . . . 73.329999999999998 109.392 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -104.62 116.58 32.3 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.482 -0.932 . . . . 72.319999999999993 108.482 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -98.72 110.27 22.9 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.669 -1.234 . . . . 75.230000000000004 107.669 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -94.93 123.04 38.17 Favored 'General case' 0 C--N 1.264 -3.122 0 N-CA-C 109.713 -0.477 . . . . 64.5 109.713 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 29.9 m -94.26 122.38 36.74 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.452 -1.314 . . . . 65.200000000000003 107.452 176.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.47 136.78 50.15 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 114.391 1.256 . . . . 73.340000000000003 114.391 -172.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -133.62 135.68 44.35 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.91 -1.885 . . . . 74.519999999999996 105.91 170.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.546 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 80.1 tttt -139.82 172.62 12.52 Favored 'General case' 0 C--N 1.27 -2.886 0 N-CA-C 104.422 -2.436 . . . . 71.510000000000005 104.422 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.469 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 8.2 pt-20 -47.2 87.67 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.907 0.883 . . . . 74.140000000000001 112.942 176.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.32 19.16 78.63 Favored Glycine 0 N--CA 1.432 -1.623 0 CA-C-N 115.175 -0.921 . . . . 61.240000000000002 112.482 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 59.2 mmtt -127.86 156.43 42.58 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.725 -1.583 . . . . 74.310000000000002 106.725 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -156.85 140.77 16.21 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 123.262 0.351 . . . . 74.329999999999998 110.349 -178.164 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -170.5 177.46 43.66 Favored Glycine 0 C--O 1.205 -1.692 0 C-N-CA 120.113 -1.041 . . . . 71.120000000000005 113.432 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.403 HG13 ' HB3' ' A' ' 12' ' ' PHE . 60.8 mt -123.79 151.5 28.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 106.493 -1.669 . . . . 75.120000000000005 106.493 175.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.1 t -134.64 109.9 12.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.324 -0.991 . . . . 63.25 108.324 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -89.4 104.22 16.79 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.693 -0.484 . . . . 72.230000000000004 109.693 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.2 t -105.13 109.81 28.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.385 -0.969 . . . . 72.219999999999999 108.385 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 18.1 pttp -122.68 144.22 49.28 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 120.111 -0.635 . . . . 65.439999999999998 110.014 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.4 mt -105.81 109.47 21.44 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 107.226 -1.398 . . . . 52.240000000000002 107.226 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.524 ' HD3' ' OD2' ' A' ' 4' ' ' ASP . 36.6 ttt180 -98.51 141.34 31.48 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.4 -0.963 . . . . 61.409999999999997 108.4 -177.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -85.01 111.18 19.48 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 120.346 -0.542 . . . . 75.420000000000002 109.925 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.9 tt -74.47 112.13 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-O 122.168 0.985 . . . . 71.510000000000005 108.993 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -135.31 -177.95 4.89 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 106.235 -1.765 . . . . 73.239999999999995 106.235 -171.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -80.91 -13.75 58.63 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.472 1.13 . . . . 64.319999999999993 108.987 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -79.34 -33.39 43.09 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 113.849 -1.523 . . . . 71.25 108.474 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 95.9 m -129.76 94.22 32.44 Favored Pre-proline 0 N--CA 1.439 -1.002 0 CA-C-N 115.209 -0.905 . . . . 74.239999999999995 110.403 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.6 153.39 43.86 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 122.529 2.153 . . . . 51.520000000000003 112.269 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.34 138.48 60.85 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.171 2.581 . . . . 53.130000000000003 111.762 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.4 t -97.27 153.26 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.307 -0.997 . . . . 73.219999999999999 108.307 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -105.64 92.27 4.11 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 108.364 -0.976 . . . . 71.140000000000001 108.364 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -109.96 -149.67 12.68 Favored Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 109.741 -1.344 . . . . 61.149999999999999 109.741 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -72.9 118.27 15.64 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 107.426 -1.324 . . . . 25.350000000000001 107.426 172.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -94.78 121.6 36.54 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.519 0.676 . . . . 71.129999999999995 109.201 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.409 ' H ' HD11 ' A' ' 29' ' ' ILE . 20.8 t -69.37 151.48 46.11 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.673 -1.149 . . . . 74.209999999999994 110.261 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 m -77.34 88.74 3.74 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.75 -0.833 . . . . 51.039999999999999 108.75 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -106.0 148.29 10.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 114.924 -1.035 . . . . 65.219999999999999 110.976 -172.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.0 tp -157.83 -61.45 0.08 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.628 1.204 . . . . 74.150000000000006 107.887 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -146.43 167.2 24.22 Favored 'General case' 0 C--N 1.256 -3.475 0 CA-C-N 112.243 -2.253 . . . . 71.219999999999999 108.192 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.55 ' O ' HG22 ' A' ' 110' ' ' ILE . 63.8 t80 -46.59 -49.17 19.33 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 124.627 1.204 . . . . 71.140000000000001 113.611 -175.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -58.73 -28.93 66.32 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.061 0.458 . . . . 74.329999999999998 112.063 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -87.11 -40.44 14.65 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 116.323 -0.399 . . . . 72.239999999999995 111.366 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.455 ' O ' HG12 ' A' ' 113' ' ' ILE 0.367 4.5 p30 -78.26 -28.34 47.7 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 118.788 -1.165 . . . . 73.299999999999997 112.954 -176.113 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 106' ' ' PHE . 8.2 tp -67.59 -40.3 83.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 109.482 -0.562 . . . . 72.019999999999996 109.482 175.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -66.91 -41.01 87.85 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 108.95 -0.759 . . . . 75.219999999999999 108.95 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 8.5 t -64.19 -41.87 96.9 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.13 -0.941 . . . . 74.540000000000006 111.744 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 109' ' ' ASP . 35.8 mm -68.16 -42.0 84.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 120.494 0.188 . . . . 61.399999999999999 110.596 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 93.1 t -67.03 -41.23 87.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.396 -0.594 . . . . 73.420000000000002 109.396 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -60.6 -39.91 89.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.936 -0.574 . . . . 71.140000000000001 110.964 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.45 98.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.86 0.362 . . . . 73.109999999999999 110.711 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 77.3 mt -68.8 -43.52 82.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.326 -0.62 . . . . 73.0 109.326 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -58.25 -46.18 86.45 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 123.817 0.847 . . . . 61.229999999999997 111.618 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -69.86 -36.05 75.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.533 -0.758 . . . . 65.109999999999999 109.464 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 52.7 t -65.21 -47.2 77.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.699 -0.682 . . . . 53.219999999999999 110.193 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.3 mp -68.88 -30.41 68.91 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.157 -0.474 . . . . 73.200000000000003 111.596 -177.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.12 -35.32 56.35 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.66 -0.7 . . . . 72.140000000000001 111.128 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -87.05 -12.93 45.8 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.52 0.676 . . . . 75.319999999999993 110.781 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.35 60.51 4.51 Favored Glycine 0 C--N 1.304 -1.203 0 CA-C-N 115.306 -0.861 . . . . 70.120000000000005 113.265 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--N 1.268 -2.973 0 C-N-CA 124.733 1.213 . . . . 74.140000000000001 108.479 178.644 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.1 mmm . . . . . 0 CA--C 1.499 -1.002 0 CA-C-O 121.011 0.434 . . . . 64.140000000000001 110.291 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -99.56 143.47 29.76 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.976 -0.556 . . . . 74.219999999999999 109.962 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.608 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 21.0 m-85 -116.49 141.04 48.7 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.62 -0.718 . . . . 74.409999999999997 110.008 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.659 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 33.2 t70 -111.92 108.63 18.05 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 125.418 1.487 . . . . 43.520000000000003 109.988 -174.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 p -88.87 116.04 29.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 115.894 -0.594 . . . . 71.120000000000005 109.962 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.21 116.8 50.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.412 -1.329 . . . . 73.439999999999998 107.412 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.491 HG23 ' HB3' ' A' ' 27' ' ' MET . 4.9 tt -121.32 115.86 47.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-O 121.305 0.574 . . . . 43.030000000000001 110.551 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.8 tt -110.42 110.3 58.02 Favored Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 116.028 -0.533 . . . . 74.120000000000005 110.298 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.566 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 72.4 Cg_endo -91.62 147.4 3.35 Favored 'Trans proline' 0 N--CA 1.435 -1.952 0 C-N-CA 122.301 2.001 . . . . 64.299999999999997 110.112 173.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.61 177.66 9.83 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.933 -0.766 . . . . 64.140000000000001 108.933 177.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.47 ' HB2' ' HB3' ' A' ' 22' ' ' HIS . 52.1 m -122.6 104.29 9.25 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 109.019 -0.734 . . . . 53.350000000000001 109.019 173.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 24.0 p90 -49.56 95.61 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 115.131 1.53 . . . . 73.049999999999997 115.131 -176.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.498 ' CE1' ' HB3' ' A' ' 125' ' ' GLU . 76.6 m80 -145.85 168.89 19.71 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.42 -0.809 . . . . 74.310000000000002 109.299 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.75 147.23 46.57 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 104.322 -2.473 . . . . 73.049999999999997 104.322 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -70.43 93.36 0.87 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 123.77 0.669 . . . . 65.120000000000005 109.265 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.5 -84.28 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.212 -0.904 . . . . 71.150000000000006 110.529 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -107.61 -59.91 1.77 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.61 -0.515 . . . . 64.299999999999997 109.61 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -138.06 -52.43 0.62 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.066 -1.087 . . . . 73.239999999999995 108.066 173.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -74.97 174.92 8.65 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 113.114 -1.857 . . . . 60.219999999999999 111.083 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.464 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 4.5 mpp? 74.0 72.16 0.11 Allowed 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 124.881 1.363 . . . . 74.5 108.567 -175.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 5.1 pt-20 -148.84 93.29 2.09 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 113.804 -1.544 . . . . 65.439999999999998 109.249 -171.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 125' ' ' GLU . 19.0 t60 -160.96 107.47 1.45 Allowed 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.143 -1.423 . . . . 55.539999999999999 113.616 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -123.34 136.63 59.33 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 105.27 -2.122 . . . . 73.109999999999999 105.27 172.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 64.0 m -108.3 153.73 41.78 Favored Pre-proline 0 C--N 1.294 -1.83 0 O-C-N 123.109 0.256 . . . . 72.409999999999997 110.791 -176.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.2 Cg_exo -65.83 143.18 72.51 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 123.244 2.629 . . . . 64.099999999999994 113.849 -178.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 7.4 Cg_exo -74.97 130.45 13.31 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.905 2.403 . . . . 61.210000000000001 112.002 176.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.491 ' HB3' HG23 ' A' ' 7' ' ' ILE . 50.3 ttm -92.42 135.3 34.15 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.941 -1.133 . . . . 64.519999999999996 107.941 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 83.9 t -131.09 116.4 33.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 O-C-N 123.238 0.337 . . . . 71.420000000000002 110.786 -171.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.2 mm -129.2 106.06 13.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 120.638 0.256 . . . . 71.430000000000007 111.357 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -112.83 80.91 0.28 Allowed Glycine 0 CA--C 1.476 -2.396 0 C-N-CA 120.27 -0.966 . . . . 72.450000000000003 112.139 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -144.33 1.58 1.08 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.648 0.981 . . . . 51.100000000000001 113.648 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -107.33 134.57 50.2 Favored 'General case' 0 C--N 1.285 -2.204 0 O-C-N 121.025 -1.047 . . . . 71.150000000000006 108.304 -172.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 p -74.65 164.48 26.53 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 107.569 -1.271 . . . . 61.229999999999997 107.569 173.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.608 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 82.1 t80 -55.3 -45.48 76.24 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 120.789 0.328 . . . . 75.209999999999994 111.848 -173.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.85 -39.24 93.24 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.272 -0.876 . . . . 43.210000000000001 111.498 -176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.9 mm -74.31 -43.19 50.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.754 -0.832 . . . . 74.120000000000005 108.754 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 40' ' ' ILE . . . -61.92 -43.38 98.95 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 115.539 -0.755 . . . . 74.109999999999999 111.074 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.3 tpt -68.81 -38.0 79.6 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.972 -0.291 . . . . 61.340000000000003 110.871 -175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -84.36 -21.43 30.89 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 118.905 -1.118 . . . . 74.219999999999999 112.594 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.507 ' O ' HG23 ' A' ' 44' ' ' VAL . 17.6 tt -82.6 -40.25 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 C-N-CA 119.005 -1.078 . . . . 73.25 109.78 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.36 -36.28 71.3 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.876 0 C-N-CA 121.095 -0.242 . . . . 71.340000000000003 110.439 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -64.05 -31.98 73.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.147 0.499 . . . . 71.25 110.158 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -69.41 -44.78 63.27 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.714 -0.955 . . . . 52.219999999999999 110.714 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 40' ' ' ILE . 63.3 t -60.14 -44.93 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.282 -0.636 . . . . 73.409999999999997 109.282 177.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.8 -43.42 80.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.848 1.259 . . . . 70.430000000000007 110.862 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -68.96 -38.5 79.44 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.478 -0.783 . . . . 65.209999999999994 109.78 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 43' ' ' GLY . 92.9 t -66.41 -42.27 90.17 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.361 0 CA-C-N 116.513 -0.312 . . . . 73.409999999999997 110.674 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.458 ' CG2' HD11 ' A' ' 73' ' ' LEU . 72.7 mt -66.81 -41.81 88.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 121.287 0.565 . . . . 61.119999999999997 110.496 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -78.22 -11.38 59.92 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.499 -0.773 . . . . 71.319999999999993 110.583 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.9 -41.94 5.06 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 113.192 0.812 . . . . 72.430000000000007 113.192 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.5 m -91.03 -6.44 53.9 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.583 0.586 . . . . 64.439999999999998 112.583 -175.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -136.47 168.91 18.56 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 108.33 -0.989 . . . . 74.140000000000001 108.33 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 17.6 t-20 -96.15 100.17 11.84 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 105.588 -2.004 . . . . 73.439999999999998 105.588 176.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.19 136.23 55.01 Favored 'General case' 0 N--CA 1.408 -2.542 0 C-N-CA 120.079 -0.648 . . . . 75.040000000000006 112.626 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.485 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 11.6 m -99.45 106.46 18.51 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 103.737 -2.69 . . . . 60.439999999999998 103.737 167.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.439 ' CG2' ' HD2' ' A' ' 69' ' ' ARG . 5.1 p -99.86 121.76 50.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-O 121.661 0.743 . . . . 45.420000000000002 111.419 -171.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -116.25 135.93 53.46 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.293 -0.867 . . . . 75.019999999999996 109.505 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.483 ' HB3' ' NH1' ' A' ' 69' ' ' ARG . 8.5 pt-20 -98.78 136.36 38.93 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.382 -0.372 . . . . 74.120000000000005 110.025 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.6 mt -142.02 175.41 9.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.234 0.54 . . . . 64.409999999999997 111.021 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.37 161.78 13.44 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.466 -1.679 . . . . 72.329999999999998 106.466 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.569 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -114.69 175.22 15.93 Favored Glycine 0 C--N 1.284 -2.306 0 C-N-CA 119.714 -1.231 . . . . 61.409999999999997 113.061 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -93.53 134.05 36.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 123.07 0.548 . . . . 74.019999999999996 111.19 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 52.17 -88.67 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.629 1.714 . . . . 70.200000000000003 115.629 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 73.9 m -89.26 -12.96 39.21 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.546 -0.752 . . . . 53.340000000000003 112.069 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.569 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 14.0 m-20 -69.24 125.87 28.02 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.799 -1.186 . . . . 70.129999999999995 107.799 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.4 t -92.53 -31.8 4.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 121.279 0.561 . . . . 72.129999999999995 110.491 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.2 tp -151.76 145.22 24.84 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.124 -1.065 . . . . 71.25 108.124 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -130.12 122.21 27.83 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 107.938 -1.134 . . . . 74.420000000000002 107.938 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.483 ' NH1' ' HB3' ' A' ' 58' ' ' GLU . 22.0 tpp180 -120.1 119.07 32.24 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.406 -1.331 . . . . 74.439999999999998 107.406 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -108.83 136.26 48.68 Favored 'General case' 0 C--N 1.282 -2.327 0 C-N-CA 123.624 0.77 . . . . 73.510000000000005 109.215 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -126.31 131.87 51.76 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.329 -0.619 . . . . 74.409999999999997 109.329 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 18.6 m -103.02 109.51 21.08 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.663 -1.606 . . . . 72.150000000000006 106.663 172.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.458 HD11 ' CG2' ' A' ' 48' ' ' ILE . 3.3 mm? -98.67 140.51 32.78 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 113.027 0.751 . . . . 52.520000000000003 113.027 -172.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 44.0 mt-10 -135.71 95.9 3.33 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.279 -1.328 . . . . 65.430000000000007 108.493 171.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -92.08 76.36 5.41 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.082 -1.822 . . . . 72.0 106.082 179.066 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.333 0.7 OUTLIER 30.45 76.92 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.917 1.687 . . . . 75.409999999999997 115.417 -175.876 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.76 -23.51 35.44 Favored Glycine 0 C--O 1.236 0.273 0 C-N-CA 121.333 -0.46 . . . . 52.530000000000001 112.415 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 61.5 mttp -98.47 144.39 27.87 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 105.301 -2.111 . . . . 74.430000000000007 105.301 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 5.3 ptpp? -145.59 150.52 36.52 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 120.216 -0.594 . . . . 73.450000000000003 109.929 -168.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . 171.82 156.2 11.82 Favored Glycine 0 C--N 1.309 -0.951 0 C-N-CA 120.53 -0.843 . . . . 72.450000000000003 112.79 175.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 27.4 mt -103.57 139.22 25.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.504 -0.924 . . . . 63.409999999999997 108.504 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.3 t -118.53 116.45 51.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.342 -0.984 . . . . 74.420000000000002 108.342 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -104.34 109.5 21.37 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.568 -0.901 . . . . 74.120000000000005 108.568 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.08 119.53 55.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.028 -0.73 . . . . 74.239999999999995 109.028 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -121.47 140.24 52.43 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.23 -0.655 . . . . 63.409999999999997 109.23 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.0 mt -106.48 109.75 21.75 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.148 -1.427 . . . . 75.519999999999996 107.148 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -97.05 148.28 23.16 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-O 121.788 0.804 . . . . 73.239999999999995 111.014 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 88' ' ' LYS . 36.9 ttpt -92.18 105.5 17.7 Favored 'General case' 0 C--N 1.259 -3.352 0 CA-C-N 114.83 -1.077 . . . . 73.319999999999993 108.613 175.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 tt -91.34 112.34 25.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.412 0.625 . . . . 53.310000000000002 109.384 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.3 p -131.94 -171.01 2.52 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.815 -0.63 . . . . 74.430000000000007 109.993 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.47 -14.34 46.37 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.755 0.788 . . . . 62.32 108.905 176.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -90.41 -39.87 12.39 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.968 -1.015 . . . . 65.140000000000001 109.708 176.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 42.5 t -85.5 132.61 44.23 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 109.538 -0.541 . . . . 65.040000000000006 109.538 176.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 93' ' ' CYS . 5.4 Cg_exo -77.33 117.1 4.27 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.877 2.384 . . . . 72.239999999999995 111.88 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.34 122.31 11.12 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.836 2.357 . . . . 75.230000000000004 111.717 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.7 t -88.9 157.68 3.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 107.636 -1.246 . . . . 74.25 107.636 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -122.76 161.5 23.82 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.59 -0.893 . . . . 72.239999999999995 108.59 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -173.68 -166.24 31.63 Favored Glycine 0 CA--C 1.458 -3.486 0 N-CA-C 106.718 -2.553 . . . . 61.140000000000001 106.718 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 27' ' ' MET . 65.5 t30 -56.01 102.98 0.09 Allowed 'General case' 0 N--CA 1.409 -2.49 0 O-C-N 124.411 0.712 . . . . 71.200000000000003 109.584 176.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -85.66 114.15 22.42 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.943 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 41.7 t -78.53 141.26 38.29 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.422 -1.325 . . . . 53.25 107.422 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.5 m -64.79 117.32 7.34 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.399 -0.963 . . . . 30.210000000000001 108.399 177.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.7 t -76.01 141.26 16.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.445 0.64 . . . . 74.310000000000002 110.539 -172.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.539 ' HG ' ' H ' ' A' ' 105' ' ' GLU . 15.2 tp -161.7 -159.46 0.62 Allowed 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.053 -2.203 . . . . 72.310000000000002 105.053 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.539 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 36.3 mt-10 -89.14 173.05 8.65 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 119.134 0.879 . . . . 61.509999999999998 112.038 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.489 ' O ' HG22 ' A' ' 110' ' ' ILE . 71.6 t80 -32.82 -58.05 0.36 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.517 1.927 . . . . 74.420000000000002 116.201 -171.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -68.64 -21.54 64.46 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 113.052 0.76 . . . . 72.420000000000002 113.052 -170.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -87.73 -42.39 12.65 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 119.671 -0.812 . . . . 75.310000000000002 111.001 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 113' ' ' ILE 0.262 17.1 p-10 -77.94 -30.08 50.29 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 118.684 -1.206 . . . . 60.039999999999999 111.783 -175.854 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 106' ' ' PHE . 16.5 tt -69.65 -38.78 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 119.225 -0.99 . . . . 72.319999999999993 109.829 175.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.25 -36.51 83.2 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 109.154 -0.684 . . . . 64.319999999999993 109.154 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 43.5 t -60.17 -45.49 92.9 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.798 -0.637 . . . . 61.240000000000002 109.703 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 109' ' ' ASP . 46.4 mm -61.28 -46.27 96.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 122.954 0.501 . . . . 74.150000000000006 109.891 175.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 110' ' ' ILE . 80.9 t -61.38 -42.77 95.01 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 CA-C-N 115.608 -0.723 . . . . 64.329999999999998 109.996 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 115' ' ' LYS . 37.3 mmtm -67.64 -32.19 72.71 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 112.139 0.422 . . . . 53.340000000000003 112.139 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.99 -39.37 83.28 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.284 -0.566 . . . . 71.109999999999999 110.044 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.5 mt -69.92 -47.12 71.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.856 -0.611 . . . . 72.200000000000003 110.11 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -64.7 -40.53 95.53 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 116.253 -0.431 . . . . 71.409999999999997 110.987 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.67 -17.72 58.97 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 120.298 -0.561 . . . . 65.340000000000003 112.154 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 27.4 t -78.24 -48.14 16.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.144 -1.058 . . . . 72.439999999999998 108.144 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 11.2 mp -69.37 -36.74 77.13 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.502 -0.772 . . . . 53.310000000000002 111.918 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.93 -13.57 53.13 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 114.002 1.112 . . . . 74.310000000000002 114.002 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -74.93 -12.39 60.34 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.255 -0.978 . . . . 74.519999999999996 110.893 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.92 169.01 42.29 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 115.113 -0.949 . . . . 55.340000000000003 111.12 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.498 ' HB3' ' CE1' ' A' ' 13' ' ' HIS . 0.7 OUTLIER . . . . . 0 C--N 1.293 -1.859 0 O-C-N 122.152 -0.616 . . . . 52.329999999999998 112.04 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 mtm . . . . . 0 CA--C 1.494 -1.185 0 N-CA-C 108.808 -0.812 . . . . 65.530000000000001 108.808 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -92.87 145.42 24.4 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.659 -0.497 . . . . 62.219999999999999 109.659 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.615 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 21.9 m-85 -112.48 142.68 44.73 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 121.564 0.697 . . . . 73.549999999999997 111.466 177.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.676 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 31.9 t70 -111.26 102.66 11.05 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 105.793 -1.929 . . . . 73.099999999999994 105.793 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.65 119.3 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 CA-C-O 122.087 0.946 . . . . 62.520000000000003 110.865 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.419 HG13 HG22 ' A' ' 28' ' ' VAL . 45.9 t -105.99 116.58 50.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-N 114.083 -1.417 . . . . 73.230000000000004 107.848 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.528 HG23 ' HB3' ' A' ' 27' ' ' MET . 6.2 tt -115.3 114.85 47.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 CA-C-O 121.348 0.594 . . . . 75.450000000000003 109.614 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mp -104.0 106.61 53.88 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 108.936 -0.764 . . . . 70.030000000000001 108.936 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.631 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 2.0 Cg_endo -84.87 139.16 7.29 Favored 'Trans proline' 0 N--CA 1.44 -1.646 0 C-N-CA 121.964 1.776 . . . . 65.540000000000006 109.199 172.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -157.78 133.65 9.26 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.056 0.455 . . . . 74.329999999999998 110.524 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.479 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 48.7 m -84.26 118.56 24.26 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.588 -0.523 . . . . 51.32 109.588 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 3.7 p90 -61.77 109.84 1.35 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.257 1.206 . . . . 63.350000000000001 114.257 -174.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -139.29 128.65 24.18 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.494 -0.776 . . . . 74.019999999999996 111.416 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -81.37 104.09 11.58 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 105.68 -1.97 . . . . 73.510000000000005 105.68 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 20' ' ' MET . 49.3 t80 -45.99 103.0 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 O-C-N 125.84 1.963 . . . . 74.200000000000003 109.662 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.25 -103.96 0.1 Allowed 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.134 -1.393 . . . . 73.310000000000002 113.688 -173.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -111.96 -58.99 2.05 Favored 'General case' 0 N--CA 1.434 -1.256 0 O-C-N 122.041 -0.412 . . . . 63.530000000000001 110.61 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -136.62 -36.76 0.7 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.405 -0.591 . . . . 74.400000000000006 109.405 176.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -102.04 163.25 12.35 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.766 -1.198 . . . . 74.340000000000003 107.766 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 1.8 mpt? 72.73 80.17 0.14 Allowed 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 124.28 1.032 . . . . 74.200000000000003 110.389 -173.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 178.03 132.4 0.07 Allowed 'General case' 0 N--CA 1.407 -2.605 0 N-CA-C 104.042 -2.577 . . . . 72.519999999999996 104.042 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 67.2 t60 179.41 92.37 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.804 0 O-C-N 124.336 1.023 . . . . 73.299999999999997 112.275 174.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mm -100.88 139.82 21.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 N-CA-C 105.692 -1.966 . . . . 55.310000000000002 105.692 171.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.631 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 42.0 m -106.58 153.92 40.31 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 109.708 -0.479 . . . . 71.409999999999997 109.708 -174.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 42.6 Cg_endo -68.75 151.1 74.61 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 122.812 2.341 . . . . 73.120000000000005 112.718 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 13.4 Cg_exo -72.63 151.55 52.51 Favored 'Trans proline' 0 C--O 1.255 1.356 0 C-N-CA 123.178 2.586 . . . . 70.109999999999999 114.107 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.557 ' SD ' ' HB3' ' A' ' 99' ' ' ASN . 2.4 tpt -114.56 134.99 54.62 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 104.606 -2.368 . . . . 74.409999999999997 104.606 176.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.419 HG22 HG13 ' A' ' 6' ' ' VAL . 92.0 t -130.73 130.43 64.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 119.088 0.858 . . . . 73.239999999999995 110.731 -176.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.8 mm -124.1 102.51 11.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 106.961 -1.496 . . . . 73.239999999999995 106.961 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -126.31 81.13 0.36 Allowed Glycine 0 CA--C 1.476 -2.344 0 C-N-CA 117.586 -2.245 . . . . 63.509999999999998 114.198 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -161.15 18.45 0.12 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.438 -0.881 . . . . 62.43 111.372 176.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -115.25 134.14 55.4 Favored 'General case' 0 C--O 1.2 -1.514 0 N-CA-C 108.209 -1.034 . . . . 71.329999999999998 108.209 -171.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -72.88 163.38 28.22 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.13 -1.063 . . . . 72.519999999999996 108.13 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.615 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 83.0 t80 -52.09 -47.97 64.95 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.936 0.494 . . . . 62.030000000000001 112.092 -172.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.68 -40.66 92.98 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.176 -0.92 . . . . 73.439999999999998 111.302 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.4 mt -76.25 -37.88 32.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.343 -0.614 . . . . 63.240000000000002 109.343 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.6 99.74 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.483 -0.78 . . . . 53.420000000000002 110.008 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -67.26 -36.35 81.41 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.251 -0.431 . . . . 64.439999999999998 110.066 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -68.64 -42.51 77.92 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.23 -0.441 . . . . 73.319999999999993 110.888 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 44' ' ' VAL . 8.1 tp -71.1 -37.52 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.277 -0.569 . . . . 64.120000000000005 110.337 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.9 t -67.09 -37.19 78.79 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 N-CA-C 109.808 -0.441 . . . . 52.399999999999999 109.808 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -65.12 -33.54 76.27 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 109.643 -0.503 . . . . 74.319999999999993 109.643 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.22 -43.71 78.79 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 111.42 -0.672 . . . . 64.140000000000001 111.42 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 40' ' ' ILE . 99.4 t -62.03 -46.1 97.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.747 -0.835 . . . . 73.329999999999998 108.747 177.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -53.85 -46.27 71.19 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 125.498 1.519 . . . . 74.530000000000001 110.927 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -66.86 -41.08 87.93 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 114.391 -1.277 . . . . 71.409999999999997 110.316 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 88.8 t -71.25 -35.0 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 116.036 -0.529 . . . . 62.439999999999998 110.005 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 64.8 mt -65.12 -45.84 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 110.091 -0.337 . . . . 55.32 110.091 175.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -62.78 -35.4 79.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.21 0.448 . . . . 61.420000000000002 112.21 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.32 -33.74 22.01 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 113.445 0.905 . . . . 73.340000000000003 113.445 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -97.03 -16.32 20.62 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 113.564 0.95 . . . . 61.539999999999999 113.564 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -128.16 -177.02 3.98 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.204 -0.665 . . . . 72.109999999999999 109.204 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -107.76 100.25 9.65 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 103.719 -2.697 . . . . 65.209999999999994 103.719 171.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.05 144.95 30.62 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 114.759 1.392 . . . . 50.219999999999999 114.759 -168.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.426 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 1.9 m -123.34 103.47 8.52 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 103.983 -2.599 . . . . 60.399999999999999 103.983 169.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 p -100.66 119.26 48.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-O 121.649 0.738 . . . . 71.140000000000001 111.351 -174.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -120.0 122.45 41.18 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.383 -0.826 . . . . 74.209999999999994 111.469 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -89.25 140.97 28.94 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.802 -0.444 . . . . 73.219999999999999 109.802 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 mp -136.49 172.42 13.04 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.106 -1.442 . . . . 74.239999999999995 107.106 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.49 147.81 24.47 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.255 -0.578 . . . . 73.420000000000002 109.716 176.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.44 148.79 41.09 Favored Glycine 0 C--N 1.293 -1.835 0 CA-C-N 115.29 -0.868 . . . . 32.539999999999999 111.137 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.92 132.74 34.33 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-O 121.158 0.504 . . . . 63.119999999999997 110.789 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.0 t70 52.31 -84.14 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 126.137 1.775 . . . . 74.439999999999998 113.681 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.5 t -110.54 -0.55 17.31 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.171 0.51 . . . . 51.310000000000002 111.786 -176.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 23.1 m-20 -74.24 138.21 43.52 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 106.664 -1.606 . . . . 74.329999999999998 106.664 172.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.8 t -93.81 -29.93 4.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 112.698 0.629 . . . . 53.210000000000001 112.698 -173.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.3 tp -150.29 140.24 21.94 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 108.669 -0.863 . . . . 73.230000000000004 108.669 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -130.68 133.7 46.31 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 107.054 -1.461 . . . . 74.200000000000003 107.054 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -137.05 120.34 16.84 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.492 -1.299 . . . . 73.150000000000006 107.492 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -111.94 118.09 34.53 Favored 'General case' 0 N--CA 1.413 -2.294 0 C-N-CA 118.828 -1.149 . . . . 74.030000000000001 108.612 175.068 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.43 ' HB3' HD11 ' A' ' 73' ' ' LEU . 13.0 m-85 -94.11 125.68 38.89 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 114.658 -1.155 . . . . 73.209999999999994 108.624 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 19.5 m -100.06 113.99 27.0 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.78 -1.563 . . . . 74.109999999999999 106.78 175.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.43 HD11 ' HB3' ' A' ' 71' ' ' TYR . 0.8 OUTLIER -120.41 152.4 37.97 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 113.538 0.94 . . . . 55.240000000000002 113.538 -170.574 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -135.32 140.81 45.4 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.222 -1.808 . . . . 72.430000000000007 106.807 170.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.549 ' HG2' ' OE1' ' A' ' 76' ' ' GLU . 51.6 tttm -139.47 -178.64 5.48 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 104.988 -2.227 . . . . 75.099999999999994 104.988 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.549 ' OE1' ' HG2' ' A' ' 75' ' ' LYS 0.26 0.0 OUTLIER -59.87 86.25 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 115.233 1.568 . . . . 70.120000000000005 115.233 -177.568 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.15 19.33 67.28 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 114.798 -1.092 . . . . 64.129999999999995 111.263 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 44.7 mtpt -132.74 135.9 46.03 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.306 -0.998 . . . . 73.409999999999997 108.306 -176.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -137.94 138.65 39.19 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.982 -0.747 . . . . 74.439999999999998 108.982 -175.488 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -174.04 172.12 45.06 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 119.414 -1.374 . . . . 63.420000000000002 113.612 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.5 mt -124.43 143.68 37.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 106.996 -1.483 . . . . 71.230000000000004 106.996 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 97.4 t -124.03 110.1 24.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.085 -0.709 . . . . 62.439999999999998 109.085 177.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -94.15 104.18 16.21 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.002 -0.545 . . . . 74.409999999999997 109.648 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.3 t -105.62 115.07 46.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 109.245 -0.65 . . . . 75.329999999999998 109.245 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -125.34 134.94 52.02 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.019 -0.673 . . . . 71.439999999999998 110.185 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.8 mp -112.1 108.1 17.26 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 109.115 -0.698 . . . . 64.349999999999994 109.115 -173.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.529 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 12.3 ptp180 -102.14 151.42 22.2 Favored 'General case' 0 CA--C 1.468 -2.196 0 C-N-CA 119.333 -0.947 . . . . 74.519999999999996 112.28 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -84.29 98.45 10.0 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.885 -1.052 . . . . 62.43 109.557 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.458 HD12 ' HB3' ' A' ' 95' ' ' PRO . 6.3 tt -74.11 114.95 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-O 122.16 0.981 . . . . 72.340000000000003 109.959 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.5 p -133.04 -171.84 2.78 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 107.695 -1.224 . . . . 62.200000000000003 107.695 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -83.03 -5.83 59.25 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.235 0.54 . . . . 54.399999999999999 110.093 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -98.91 -39.93 8.33 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.989 -0.745 . . . . 73.120000000000005 108.989 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 62.7 m -104.35 120.69 49.88 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 116.494 -0.321 . . . . 74.319999999999993 111.615 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.37 142.79 19.07 Favored 'Trans proline' 0 CA--C 1.555 1.569 0 C-N-CA 123.069 2.512 . . . . 70.420000000000002 113.859 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.458 ' HB3' HD12 ' A' ' 89' ' ' ILE . 66.9 Cg_endo -73.69 164.72 34.1 Favored 'Trans proline' 0 C--O 1.248 1.025 0 C-N-CA 124.016 3.144 . . . . 75.310000000000002 111.883 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.5 t -101.11 159.67 3.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 107.989 -1.115 . . . . 75.540000000000006 107.989 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -112.66 111.5 22.35 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.185 0.517 . . . . 73.349999999999994 110.7 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -128.49 -163.5 11.31 Favored Glycine 0 CA--C 1.487 -1.712 0 N-CA-C 110.462 -1.055 . . . . 74.510000000000005 110.462 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.557 ' HB3' ' SD ' ' A' ' 27' ' ' MET . 2.6 t-20 -75.19 140.91 43.6 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 122.446 0.298 . . . . 64.540000000000006 110.37 177.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -83.92 97.69 9.38 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 122.083 0.944 . . . . 64.409999999999997 110.581 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.19 151.99 44.77 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 113.422 -1.717 . . . . 63.43 108.978 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -76.83 93.27 3.7 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.839 0.828 . . . . 75.099999999999994 110.69 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.25 146.16 6.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 114.923 -1.035 . . . . 73.310000000000002 109.866 -175.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.7 mt -156.9 -90.8 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 126.116 1.766 . . . . 75.319999999999993 107.934 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.44 173.72 11.23 Favored 'General case' 0 C--N 1.255 -3.515 0 N-CA-C 105.944 -1.873 . . . . 75.209999999999994 105.944 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.464 ' O ' HG22 ' A' ' 110' ' ' ILE . 90.6 t80 -33.01 -46.39 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.682 1.734 . . . . 64.140000000000001 115.682 -172.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -56.1 -55.39 33.62 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 123.087 0.555 . . . . 74.150000000000006 112.204 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -78.83 -30.86 45.51 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.818 -0.628 . . . . 74.510000000000005 109.49 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.431 ' O ' HG12 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -65.76 -49.16 69.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.259 -0.882 . . . . 62.229999999999997 110.425 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 106' ' ' PHE . 9.9 tp -68.3 -35.76 72.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 121.365 0.603 . . . . 74.120000000000005 109.498 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -65.11 -44.68 87.97 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 115.205 -0.907 . . . . 75.409999999999997 110.12 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 27.0 t -67.55 -39.32 84.97 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 123.448 0.468 . . . . 63.5 110.974 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.569 ' O ' HG12 ' A' ' 117' ' ' ILE . 44.4 mm -66.01 -45.09 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 116.494 -0.321 . . . . 74.219999999999999 110.593 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.77 -35.5 74.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 N-CA-C 109.88 -0.415 . . . . 74.430000000000007 109.88 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 119' ' ' GLU . 60.1 tttp -60.1 -47.11 87.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.652 -0.703 . . . . 73.150000000000006 110.28 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.42 95.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.167 -0.47 . . . . 72.439999999999998 110.958 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 113' ' ' ILE . 43.0 mm -66.84 -44.03 89.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.742 -0.466 . . . . 61.340000000000003 109.742 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.78 -36.59 83.98 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.973 -0.558 . . . . 74.140000000000001 112.288 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 54.5 mm-40 -68.45 -45.54 72.21 Favored 'General case' 0 C--O 1.221 -0.441 0 O-C-N 123.727 0.642 . . . . 65.400000000000006 110.034 176.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 44.6 t -56.63 -46.27 81.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.938 -0.574 . . . . 72.299999999999997 111.233 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.7 mp -78.6 -19.86 51.77 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.26 -0.576 . . . . 74.129999999999995 111.777 -177.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.63 -29.8 41.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.053 0.454 . . . . 70.400000000000006 109.928 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -83.13 -1.97 54.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.884 -0.598 . . . . 73.430000000000007 111.032 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -53.86 131.1 43.99 Favored Glycine 0 C--O 1.245 0.808 0 N-CA-C 110.814 -0.915 . . . . 71.329999999999998 110.814 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 N--CA 1.468 0.427 0 C-N-CA 124.63 1.172 . . . . 74.120000000000005 109.937 -171.611 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 CA--C 1.489 -1.392 0 N-CA-C 108.305 -0.998 . . . . 75.230000000000004 108.305 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.67 153.47 51.08 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.043 -1.095 . . . . 74.510000000000005 108.043 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.495 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 14.4 m-85 -112.95 145.67 40.38 Favored 'General case' 0 C--N 1.283 -2.313 0 C-N-CA 123.387 0.675 . . . . 75.209999999999994 109.508 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.644 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 15.7 t70 -103.08 110.67 22.69 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.532 -1.285 . . . . 73.140000000000001 107.532 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -93.11 111.46 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 CA-C-O 121.897 0.856 . . . . 74.230000000000004 108.721 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 27' ' ' MET . 4.8 p -109.29 110.97 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.76 0 CA-C-N 114.778 -1.101 . . . . 73.209999999999994 109.284 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.678 HG23 ' HB2' ' A' ' 27' ' ' MET . 4.3 tt -103.93 125.36 58.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.868 -1.06 . . . . 52.329999999999998 110.372 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.2 mt -118.93 103.31 48.27 Favored Pre-proline 0 N--CA 1.425 -1.723 0 CA-C-N 115.52 -0.764 . . . . 60.310000000000002 109.275 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.555 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 3.1 Cg_exo -82.39 140.58 10.89 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.175 1.917 . . . . 75.439999999999998 109.582 173.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -156.97 114.27 3.12 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.949 0.881 . . . . 71.329999999999998 110.677 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 m -80.42 128.39 33.52 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.811 -0.632 . . . . 62.539999999999999 109.619 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.482 ' HD2' ' CD1' ' A' ' 81' ' ' ILE . 2.2 p90 -59.18 105.18 0.31 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 114.632 1.345 . . . . 71.530000000000001 114.632 -175.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -141.14 106.73 5.08 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.395 -1.275 . . . . 73.540000000000006 109.538 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -69.08 159.14 33.44 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 106.86 -1.533 . . . . 72.430000000000007 106.86 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -82.91 92.16 7.26 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.012 -1.075 . . . . 72.349999999999994 110.462 176.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.547 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 16.9 t70 -66.76 -102.0 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.76 -1.109 . . . . 74.329999999999998 109.43 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -113.32 -60.36 1.89 Allowed 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 108.269 -1.011 . . . . 63.340000000000003 108.269 171.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -139.5 -53.08 0.54 Allowed 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.677 0.751 . . . . 74.109999999999999 112.205 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -86.1 74.47 10.07 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.376 -0.829 . . . . 73.120000000000005 111.109 -174.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.547 ' SD ' ' HB2' ' A' ' 16' ' ' ASP . 53.0 ttm 173.87 93.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.719 2.007 . . . . 74.349999999999994 105.614 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 10.0 pt-20 -176.16 115.99 0.13 Allowed 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.082 -1.451 . . . . 63.43 107.082 -175.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -157.44 98.23 1.67 Allowed 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 119.326 -0.95 . . . . 73.310000000000002 111.429 172.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.4 mm -120.05 131.04 73.49 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 105.832 -1.914 . . . . 55.399999999999999 105.832 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 73.5 m -107.47 129.03 24.82 Favored Pre-proline 0 C--N 1.293 -1.885 0 C-N-CA 119.764 -0.775 . . . . 64.239999999999995 110.745 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 53.8 Cg_exo -56.17 146.15 72.58 Favored 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 123.217 2.612 . . . . 63.530000000000001 112.537 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 49.6 Cg_exo -57.8 145.11 91.88 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 123.684 2.922 . . . . 50.340000000000003 114.265 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.678 ' HB2' HG23 ' A' ' 7' ' ' ILE . 62.9 mtp -103.41 131.13 50.75 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 104.994 -2.224 . . . . 64.219999999999999 104.994 173.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.6 t -120.66 123.23 69.9 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 O-C-N 123.133 0.27 . . . . 74.150000000000006 110.355 -173.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.68 107.5 15.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 107.389 -1.338 . . . . 72.209999999999994 107.389 176.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -127.13 81.77 0.35 Allowed Glycine 0 CA--C 1.475 -2.429 0 C-N-CA 118.019 -2.039 . . . . 75.540000000000006 115.416 -173.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -174.38 37.92 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.979 0.895 . . . . 74.049999999999997 111.126 173.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -113.7 133.34 55.39 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 106.423 -1.695 . . . . 33.219999999999999 106.423 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 p -76.71 163.49 26.78 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 119.139 0.881 . . . . 72.340000000000003 109.089 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.495 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 63.2 t80 -52.55 -43.32 65.11 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 123.758 0.823 . . . . 74.239999999999995 111.689 -174.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -68.14 -40.23 82.47 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.008 -0.996 . . . . 72.400000000000006 111.331 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.2 mm -73.65 -39.35 53.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.131 -0.692 . . . . 65.439999999999998 109.131 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.78 95.14 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.936 -1.029 . . . . 74.329999999999998 110.331 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.1 mmt -65.67 -36.04 82.5 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.495 -0.482 . . . . 74.129999999999995 111.287 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -68.42 -43.58 76.88 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 120.634 -0.426 . . . . 74.409999999999997 111.285 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 44' ' ' VAL . 13.7 tt -70.32 -39.33 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 C-N-CA 119.826 -0.75 . . . . 44.130000000000003 110.464 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.3 -45.09 99.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-N 116.737 -0.21 . . . . 74.209999999999994 110.868 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -68.44 -32.59 72.71 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 119.977 -0.689 . . . . 53.450000000000003 111.4 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -69.78 -46.05 55.29 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 110.983 -0.847 . . . . 74.010000000000005 110.983 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 40' ' ' ILE . 69.0 t -62.35 -41.11 90.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.729 -0.471 . . . . 63.409999999999997 109.729 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.448 ' CG ' HH21 ' A' ' 69' ' ' ARG . 16.4 t70 -58.48 -46.67 86.19 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.919 -1.037 . . . . 61.530000000000001 110.346 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -40.77 96.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.633 -0.712 . . . . 64.409999999999997 110.817 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 43' ' ' GLY . 98.3 t -63.75 -43.22 97.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.531 -0.304 . . . . 74.25 111.067 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.8 mt -69.9 -39.59 77.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.561 0.219 . . . . 73.319999999999993 110.922 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -74.92 -24.72 58.55 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 120.903 0.382 . . . . 74.340000000000003 110.912 -175.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.39 -42.15 9.94 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 112.502 0.556 . . . . 25.219999999999999 112.502 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.1 m -83.9 -17.93 39.12 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.199 0.523 . . . . 74.329999999999998 111.737 -174.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -134.58 179.34 6.35 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 121.533 0.682 . . . . 60.450000000000003 109.995 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.547 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 26.7 t-20 -98.8 102.66 14.47 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.007 -1.849 . . . . 75.25 106.007 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -133.98 135.94 43.8 Favored 'General case' 0 N--CA 1.412 -2.357 0 C-N-CA 119.595 -0.842 . . . . 72.420000000000002 112.446 -175.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.9 m -102.1 111.89 24.34 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 105.24 -2.133 . . . . 74.150000000000006 105.24 171.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.415 HG21 ' OD1' ' A' ' 45' ' ' ASP . 7.4 p -100.64 142.74 15.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 120.699 0.285 . . . . 62.539999999999999 110.778 -174.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -139.88 151.74 45.89 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.634 -0.876 . . . . 73.239999999999995 108.634 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -125.63 106.46 9.75 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.983 0.897 . . . . 61.32 110.068 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -99.08 172.49 7.36 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.854 -1.067 . . . . 72.219999999999999 109.148 -175.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -109.03 137.84 46.3 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.059 -0.518 . . . . 72.230000000000004 109.687 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.494 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -98.29 176.83 30.65 Favored Glycine 0 C--N 1.294 -1.784 0 CA-C-N 115.196 -0.911 . . . . 60.200000000000003 112.671 -174.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.72 166.74 8.36 Favored 'General case' 0 C--O 1.19 -2.047 0 N-CA-C 107.388 -1.338 . . . . 65.109999999999999 107.388 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -42.6 -39.77 2.46 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 115.311 1.597 . . . . 72.430000000000007 115.311 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 51.5 t -73.71 -29.64 62.38 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.082 0.468 . . . . 63.200000000000003 111.518 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.494 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 8.0 m-20 -98.26 115.17 27.82 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.545 -0.909 . . . . 63.240000000000002 108.545 -176.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.0 t -83.67 -32.57 8.96 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 N-CA-C 113.29 0.848 . . . . 74.340000000000003 113.29 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.1 tp -148.79 140.8 23.85 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.238 -1.023 . . . . 73.439999999999998 108.238 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -129.72 126.11 37.49 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.962 -1.495 . . . . 75.530000000000001 106.962 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.448 HH21 ' CG ' ' A' ' 45' ' ' ASP . 10.8 tpt180 -113.73 138.8 49.74 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 107.529 -1.286 . . . . 65.540000000000006 107.529 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -123.96 130.64 52.92 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.981 -1.118 . . . . 52.219999999999999 107.981 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -125.56 115.82 20.78 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.234 -0.654 . . . . 70.0 109.234 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 39.5 m -88.26 110.3 20.63 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.974 -1.121 . . . . 74.329999999999998 107.974 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.0 142.23 28.47 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.13 0.572 . . . . 74.239999999999995 112.317 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 36.7 tt0 -144.32 93.9 2.5 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.917 -1.038 . . . . 63.140000000000001 109.041 171.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.539 ' HG2' ' H ' ' A' ' 76' ' ' GLU . 49.8 tttt -99.53 -176.04 3.17 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 105.968 -1.864 . . . . 64.0 105.968 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.539 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 8.6 pt-20 -48.83 91.26 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.092 1.357 . . . . 70.140000000000001 113.271 177.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.24 17.27 68.0 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.188 -0.914 . . . . 62.32 113.414 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 53.7 mtmt -138.78 122.41 17.44 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.48 -0.933 . . . . 73.140000000000001 108.48 -177.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -145.24 145.58 31.35 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 120.698 0.285 . . . . 72.540000000000006 111.298 -173.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.92 171.9 41.81 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 110.47 -1.052 . . . . 71.530000000000001 110.47 -176.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.482 ' CD1' ' HD2' ' A' ' 12' ' ' PHE . 3.7 mp -105.03 143.87 15.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 117.888 0.844 . . . . 72.099999999999994 109.669 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.4 t -119.6 110.27 28.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.967 -0.753 . . . . 73.319999999999993 108.967 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -93.89 131.3 39.45 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 124.006 0.922 . . . . 74.439999999999998 110.017 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.14 109.92 18.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.235 -1.024 . . . . 63.32 108.235 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -118.45 146.27 44.61 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.936 -1.106 . . . . 54.439999999999998 111.338 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.5 mt -105.52 107.89 19.12 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.502 -1.296 . . . . 73.549999999999997 107.502 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 37.3 ptt180 -103.84 135.89 44.54 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.403 -0.962 . . . . 74.129999999999995 108.403 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -76.73 108.34 9.68 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.447 0.641 . . . . 73.549999999999997 110.81 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 tt -82.82 111.42 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.276 1.036 . . . . 74.420000000000002 108.564 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 91' ' ' GLU . 3.6 m -144.53 -171.95 3.71 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 104.27 -2.493 . . . . 73.319999999999993 104.27 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.512 ' H ' HG22 ' A' ' 90' ' ' THR . 3.8 mp0 -60.82 -24.34 65.78 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 119.112 0.869 . . . . 74.5 111.765 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -76.45 -39.92 52.0 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.544 -0.753 . . . . 73.540000000000006 110.665 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 73.9 m -119.21 89.87 40.61 Favored Pre-proline 0 N--CA 1.431 -1.4 0 CA-C-N 116.459 -0.337 . . . . 73.109999999999999 110.627 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.24 152.75 56.17 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 121.809 1.673 . . . . 65.329999999999998 110.575 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.96 141.98 91.24 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.213 2.608 . . . . 44.140000000000001 113.317 -175.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.25 155.62 16.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 106.619 -1.622 . . . . 54.009999999999998 106.619 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.92 144.97 27.36 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 120.958 0.409 . . . . 74.439999999999998 110.183 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -157.24 -159.74 9.7 Favored Glycine 0 CA--C 1.464 -3.14 0 N-CA-C 107.992 -2.043 . . . . 45.039999999999999 107.992 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.474 ' HB3' ' HA ' ' A' ' 27' ' ' MET . 9.1 t-20 -69.45 108.99 3.99 Favored 'General case' 0 N--CA 1.395 -3.206 0 N-CA-C 107.652 -1.24 . . . . 70.420000000000002 107.652 171.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -83.29 109.62 17.41 Favored 'General case' 0 N--CA 1.416 -2.164 0 N-CA-C 107.894 -1.15 . . . . 74.409999999999997 107.894 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 36.7 t -69.32 156.74 38.3 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.856 -1.066 . . . . 65.109999999999999 109.723 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -79.43 94.58 5.58 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.982 -1.118 . . . . 61.049999999999997 107.982 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.7 t -96.31 129.96 45.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.339 -0.846 . . . . 63.43 110.297 -172.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 mp -139.64 -90.42 0.19 Allowed 'General case' 0 C--N 1.269 -2.905 0 CA-C-N 114.746 -1.116 . . . . 71.010000000000005 108.569 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -139.41 163.14 33.29 Favored 'General case' 0 C--N 1.251 -3.684 0 CA-C-N 113.587 -1.642 . . . . 70.409999999999997 106.873 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -34.35 -49.99 0.4 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.284 1.433 . . . . 52.240000000000002 114.843 -172.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 111' ' ' GLU . 27.9 tt0 -61.08 -46.5 90.41 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.095 0.406 . . . . 63.25 112.095 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -78.08 -31.16 50.02 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.494 -0.321 . . . . 61.329999999999998 110.555 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.417 ' O ' HG12 ' A' ' 113' ' ' ILE . 2.3 m-20 -66.43 -45.99 77.99 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.324 -0.853 . . . . 71.010000000000005 110.127 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.2 tp -63.35 -38.08 81.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 116.558 -0.292 . . . . 74.230000000000004 110.729 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 107' ' ' GLU . 44.9 mt-10 -60.14 -46.13 90.7 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.835 -0.431 . . . . 63.420000000000002 109.835 177.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 18.6 t -61.5 -41.1 96.78 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.497 -0.774 . . . . 71.099999999999994 111.137 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 117' ' ' ILE . 46.3 mm -65.42 -46.33 90.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.312 -0.404 . . . . 75.010000000000005 110.377 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 80.1 t -64.88 -39.97 87.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.158 -0.474 . . . . 73.010000000000005 110.554 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -67.46 -32.28 73.02 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 116.366 -0.379 . . . . 71.219999999999999 111.252 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.53 -34.67 53.87 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 120.641 0.258 . . . . 61.229999999999997 111.338 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 113' ' ' ILE . 82.4 mt -64.17 -48.12 87.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.791 -1.189 . . . . 71.430000000000007 107.791 174.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -62.77 -29.73 70.91 Favored 'General case' 0 C--O 1.192 -1.933 0 CA-C-N 115.447 -0.797 . . . . 72.450000000000003 111.633 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -67.59 -35.55 79.19 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.234 0.54 . . . . 54.219999999999999 109.795 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 4.5 t -84.47 -31.15 24.7 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.143 0.973 . . . . 75.349999999999994 109.537 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.6 mp -78.54 -39.34 38.16 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.859 -0.609 . . . . 72.219999999999999 111.98 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.67 -15.55 44.95 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 114.826 1.417 . . . . 42.520000000000003 114.826 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HD3' ' HA ' ' A' ' 123' ' ' LYS 0.346 34.0 mmtp -84.14 -3.93 58.45 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 116.271 1.952 . . . . 62.130000000000003 116.271 -175.274 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.33 -163.45 53.92 Favored Glycine 0 C--O 1.215 -1.075 0 C-N-CA 120.442 -0.885 . . . . 62.210000000000001 113.44 173.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.287 -2.135 0 CA-C-O 121.86 0.838 . . . . 63.049999999999997 112.823 -177.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 tmm? . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 107.816 -1.179 . . . . 61.409999999999997 107.816 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -110.93 165.72 11.63 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.821 0.819 . . . . 71.340000000000003 113.193 -169.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 7.5 m-85 -121.65 145.81 47.62 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.684 -1.144 . . . . 71.430000000000007 110.28 177.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.442 ' OD1' ' HA3' ' A' ' 30' ' ' GLY . 32.4 t70 -115.13 120.75 40.84 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.762 -1.57 . . . . 73.450000000000003 106.762 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -99.91 116.78 43.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 109.63 -0.507 . . . . 63.130000000000003 109.63 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.42 ' HB ' ' CG ' ' A' ' 85' ' ' LYS . 46.6 t -108.48 117.46 54.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 107.862 -1.162 . . . . 60.409999999999997 107.862 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.503 HG23 ' HB2' ' A' ' 27' ' ' MET . 7.7 tt -117.95 123.09 71.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 121.376 0.608 . . . . 62.420000000000002 110.306 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.2 mp -114.27 98.24 48.04 Favored Pre-proline 0 N--CA 1.422 -1.849 0 CA-C-N 115.648 -0.705 . . . . 44.509999999999998 109.138 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.696 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 5.8 Cg_exo -81.49 130.36 6.95 Favored 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 122.009 1.806 . . . . 74.230000000000004 107.427 171.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.37 131.08 12.36 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.285 0.564 . . . . 72.099999999999994 110.697 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -73.53 122.17 21.77 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 107.672 -1.233 . . . . 54.409999999999997 107.672 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.495 ' HD1' ' O ' ' A' ' 12' ' ' PHE 0.255 0.1 OUTLIER -68.02 105.68 2.11 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.981 0.896 . . . . 63.020000000000003 113.08 -175.256 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -126.75 126.29 43.19 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 113.942 1.09 . . . . 74.120000000000005 113.942 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -76.64 129.18 36.02 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 103.171 -2.9 . . . . 73.5 103.171 165.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.65 111.46 9.86 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-O 121.602 0.715 . . . . 73.319999999999993 110.026 -169.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.57 -164.17 0.61 Allowed 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 114.36 -1.291 . . . . 32.539999999999999 107.967 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -100.88 -29.9 11.97 Favored 'General case' 0 N--CA 1.411 -2.381 0 O-C-N 121.499 -0.751 . . . . 72.209999999999994 110.745 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.1 t60 -135.05 -51.08 0.77 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 118.776 -1.169 . . . . 65.430000000000007 113.357 -175.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -122.22 139.08 54.19 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 109.358 -0.608 . . . . 72.140000000000001 109.358 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.303 59.3 mtm 96.64 73.35 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 126.338 1.855 . . . . 65.019999999999996 111.295 -175.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -156.41 94.07 1.46 Allowed 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 112.696 -2.047 . . . . 42.539999999999999 107.44 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -142.17 120.55 12.37 Favored 'General case' 0 CA--C 1.47 -2.116 0 O-C-N 121.577 -0.702 . . . . 71.540000000000006 109.462 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mm -133.05 143.67 38.72 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.799 0 N-CA-C 104.225 -2.509 . . . . 74.349999999999994 104.225 175.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.696 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 60.5 m -107.77 150.1 39.82 Favored Pre-proline 0 C--N 1.274 -2.7 0 N-CA-C 109.989 -0.374 . . . . 73.420000000000002 109.989 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 27.0 Cg_exo -65.29 142.5 73.26 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.239 2.626 . . . . 63.32 114.255 -176.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 31.8 Cg_exo -63.06 126.49 18.05 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 123.104 2.536 . . . . 41.119999999999997 110.994 175.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.503 ' HB2' HG23 ' A' ' 7' ' ' ILE . 84.3 mtp -101.23 145.29 29.03 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.333 -0.988 . . . . 60.140000000000001 108.333 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 62.2 t -130.76 121.21 49.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.417 -0.586 . . . . 65.25 109.417 -178.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.6 mp -131.14 102.18 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.772 0 N-CA-C 106.205 -1.776 . . . . 72.049999999999997 106.205 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.442 ' HA3' ' OD1' ' A' ' 4' ' ' ASP . . . -117.53 -172.75 16.09 Favored Glycine 0 C--N 1.269 -3.146 0 C-N-CA 119.902 -1.142 . . . . 55.030000000000001 112.773 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.45 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 9.0 t70 71.7 67.6 0.15 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 125.636 1.574 . . . . 71.140000000000001 110.515 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.515 HH22 ' CG1' ' A' ' 103' ' ' VAL . 3.8 mpt_? -140.25 143.92 36.21 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 104.818 -2.29 . . . . 74.25 104.818 172.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 t -78.53 -179.71 6.56 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.78 -1.168 . . . . 62.149999999999999 108.07 174.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.455 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 88.3 t80 -55.98 -52.91 62.5 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 123.094 0.558 . . . . 70.349999999999994 112.394 -174.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 46.2 m-20 -68.04 -39.9 82.96 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.008 -0.997 . . . . 64.310000000000002 110.136 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.0 mt -65.03 -38.32 82.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.305 -0.861 . . . . 75.25 109.925 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.16 -42.47 88.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.791 -0.448 . . . . 72.129999999999995 109.791 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 24.0 mmt -64.77 -41.32 95.95 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.037 -0.529 . . . . 74.099999999999994 110.825 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 35' ' ' ASP . 40.1 mt-10 -66.27 -40.29 90.02 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 112.337 0.495 . . . . 73.349999999999994 112.337 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 44' ' ' VAL . 15.0 tt -72.58 -41.49 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 119.198 -1.001 . . . . 74.450000000000003 110.609 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.433 HG21 HD21 ' A' ' 86' ' ' LEU . 92.6 t -72.15 -37.15 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 120.468 -0.493 . . . . 62.219999999999999 111.309 -177.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -74.31 -23.89 59.14 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.611 -0.436 . . . . 74.219999999999999 111.057 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.87 -45.93 40.24 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.196 -1.161 . . . . 32.140000000000001 110.196 175.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 40' ' ' ILE . 61.5 t -63.3 -41.97 94.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 N-CA-C 108.981 -0.748 . . . . 75.319999999999993 108.981 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.68 -52.34 31.76 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 125.372 1.469 . . . . 65.25 110.793 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -63.93 -40.25 96.02 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.789 -1.096 . . . . 71.310000000000002 110.732 -177.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.93 -36.62 74.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.215 -0.448 . . . . 72.420000000000002 110.592 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.4 mt -67.62 -43.74 86.69 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.171 0 N-CA-C 109.901 -0.407 . . . . 73.420000000000002 109.901 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -74.26 -15.75 60.97 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.628 0.603 . . . . 75.109999999999999 112.628 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.76 -33.99 13.38 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 112.177 0.436 . . . . 45.130000000000003 112.177 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -96.52 -19.21 19.27 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.258 0.551 . . . . 72.040000000000006 112.359 -176.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.416 ' CD2' ' HD2' ' A' ' 75' ' ' LYS . 22.4 m-85 -137.23 -176.36 4.36 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.686 -1.227 . . . . 71.310000000000002 107.686 -176.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.403 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 36.6 t30 -107.49 117.78 34.99 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.985 -1.487 . . . . 73.109999999999999 106.985 174.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -138.24 134.98 35.09 Favored 'General case' 0 N--CA 1.405 -2.71 0 C-N-CA 119.892 -0.723 . . . . 72.230000000000004 110.934 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.6 m -108.18 120.04 41.21 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 105.754 -1.943 . . . . 73.030000000000001 105.754 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.32 127.36 53.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.185 0.517 . . . . 64.129999999999995 110.767 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -121.72 116.6 24.82 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.748 -1.205 . . . . 64.140000000000001 107.748 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' A' ' 69' ' ' ARG . 42.1 mt-10 -100.49 118.18 36.17 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 120.872 0.368 . . . . 72.319999999999993 111.634 -177.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mp -121.32 178.13 4.9 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.69 -0.855 . . . . 62.219999999999999 108.69 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -87.59 149.61 24.21 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.746 -0.835 . . . . 75.549999999999997 108.746 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -92.35 175.17 37.47 Favored Glycine 0 C--N 1.292 -1.908 0 N-CA-C 110.316 -1.114 . . . . 71.109999999999999 110.316 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -92.5 133.81 35.57 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 118.079 0.939 . . . . 74.209999999999994 112.749 -175.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.3 t70 59.26 -76.59 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.918 1.687 . . . . 62.109999999999999 114.53 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.9 t -119.38 5.53 11.16 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.425 0.631 . . . . 72.430000000000007 110.748 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.508 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 65.3 m-20 -81.43 124.17 29.2 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.943 -1.873 . . . . 73.150000000000006 105.943 173.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.8 t -83.75 -37.15 13.0 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 112.457 0.54 . . . . 74.5 112.457 -173.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 59.2 tp -142.18 137.85 31.13 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 109.169 -0.678 . . . . 64.409999999999997 109.169 -175.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.06 103.59 6.85 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.097 -1.446 . . . . 70.230000000000004 107.097 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.461 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 8.2 ptp180 -107.67 119.81 40.46 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 122.047 0.927 . . . . 74.420000000000002 111.226 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -98.71 108.69 21.44 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 113.704 -1.589 . . . . 74.340000000000003 108.036 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.413 ' CE1' ' HD3' ' A' ' 69' ' ' ARG . 89.0 m-85 -97.21 131.38 44.0 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.882 -0.784 . . . . 74.319999999999993 108.882 176.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 15.4 m -96.13 118.58 32.99 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.662 -1.607 . . . . 53.100000000000001 106.662 173.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.24 134.74 47.84 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 112.976 0.732 . . . . 73.510000000000005 112.976 -173.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 53' ' ' ASN . 51.6 mm-40 -136.45 137.04 40.01 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.155 -1.384 . . . . 75.519999999999996 108.105 174.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.577 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -141.79 85.88 1.96 Allowed 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.141 -1.429 . . . . 62.210000000000001 107.141 175.417 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.278 15.5 pt-20 32.95 69.62 0.12 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.919 1.687 . . . . 75.230000000000004 114.572 -174.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.19 -23.33 35.18 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.035 -0.984 . . . . 52.219999999999999 112.565 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.539 ' N ' ' HE3' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -85.88 124.25 32.14 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.064 -1.828 . . . . 74.209999999999994 106.064 178.801 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -132.2 146.51 52.07 Favored 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 120.057 -0.657 . . . . 71.420000000000002 111.745 -172.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.24 176.56 38.61 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.196 -0.911 . . . . 73.049999999999997 111.174 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 72' ' ' THR . 9.4 tp -129.47 138.0 55.44 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 106.668 -1.604 . . . . 73.420000000000002 106.668 178.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 62.1 t -125.44 110.32 24.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.467 -0.771 . . . . 63.240000000000002 110.083 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -96.92 106.36 18.67 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 123.838 0.855 . . . . 73.140000000000001 110.411 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.461 ' HB ' ' HG3' ' A' ' 69' ' ' ARG . 24.2 t -107.09 115.46 48.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.048 -0.723 . . . . 72.150000000000006 109.048 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.42 ' CG ' ' HB ' ' A' ' 6' ' ' VAL . 18.3 ptpt -110.45 140.42 44.71 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.819 -0.437 . . . . 70.140000000000001 109.819 177.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.433 HD21 HG21 ' A' ' 41' ' ' VAL . 44.4 mt -107.8 108.02 19.04 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 105.399 -2.074 . . . . 72.430000000000007 105.399 178.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 43.9 ttt85 -97.81 133.13 42.74 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 109.057 -0.72 . . . . 72.439999999999998 109.057 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -79.34 112.82 16.95 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.42 -0.955 . . . . 72.299999999999997 108.42 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.5 tt -91.08 111.44 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-O 122.373 1.082 . . . . 74.310000000000002 109.023 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.6 m -133.53 172.6 12.51 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 105.206 -2.146 . . . . 53.539999999999999 105.206 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -64.55 -20.89 66.5 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 118.872 0.76 . . . . 70.140000000000001 110.485 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -94.48 -5.83 45.27 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.039 -0.982 . . . . 74.340000000000003 111.59 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 70.3 m -133.32 109.52 12.51 Favored Pre-proline 0 C--N 1.314 -0.94 0 O-C-N 122.124 -0.36 . . . . 73.019999999999996 111.046 -175.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.56 138.86 24.79 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.143 1.895 . . . . 53.420000000000002 112.387 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.95 164.66 33.9 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 123.414 2.742 . . . . 51.340000000000003 111.13 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.7 t -94.11 155.7 3.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.988 -0.745 . . . . 72.549999999999997 108.988 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -106.19 122.08 45.48 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.512 -0.767 . . . . 70.209999999999994 109.086 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -158.13 -159.65 9.74 Favored Glycine 0 CA--C 1.468 -2.85 0 N-CA-C 110.229 -1.148 . . . . 54.0 110.229 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -76.29 93.0 3.36 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-O 121.828 0.823 . . . . 54.25 111.375 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 62.9 ttt180 -73.89 122.01 21.84 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.252 -1.34 . . . . 72.109999999999999 108.037 177.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 38.7 t -88.97 163.79 15.4 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.896 -0.722 . . . . 73.329999999999998 109.846 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.7 m -75.31 107.75 7.63 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 122.934 0.494 . . . . 75.340000000000003 109.902 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.515 ' CG1' HH22 ' A' ' 32' ' ' ARG . 36.5 t -85.01 135.91 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-O 122.132 0.967 . . . . 70.450000000000003 110.277 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.0 mt -153.18 -163.84 1.78 Allowed 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 104.805 -2.294 . . . . 73.099999999999994 104.805 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -54.05 145.93 15.76 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 118.405 0.548 . . . . 75.219999999999999 111.406 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.428 ' O ' HG22 ' A' ' 110' ' ' ILE . 13.9 t80 -32.91 -48.57 0.21 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.425 2.29 . . . . 75.230000000000004 113.707 -173.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.564 ' O ' ' HG3' ' A' ' 111' ' ' GLU . 43.3 tt0 -57.4 -43.87 84.05 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 112.349 0.5 . . . . 62.299999999999997 112.349 -176.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 -72.09 -31.4 66.04 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.145 -0.622 . . . . 61.409999999999997 111.501 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -71.38 -44.7 64.46 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.879 -1.055 . . . . 74.200000000000003 108.412 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 106' ' ' PHE . 12.7 tt -68.37 -36.79 76.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 C-N-CA 120.479 -0.489 . . . . 74.099999999999994 110.681 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 107' ' ' GLU . 52.6 mt-10 -61.56 -35.94 79.22 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.874 0.368 . . . . 74.140000000000001 110.064 176.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 44.5 t -64.98 -43.44 92.62 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.005 -0.543 . . . . 75.439999999999998 109.953 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.6 mm -64.58 -46.66 91.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.513 -0.767 . . . . 73.430000000000007 110.301 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 110' ' ' ILE . 92.3 t -63.29 -39.2 84.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.456 -0.338 . . . . 73.319999999999993 110.53 -177.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -62.64 -38.7 91.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.052 0.453 . . . . 74.120000000000005 110.4 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.89 -42.32 90.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.132 -0.486 . . . . 71.030000000000001 110.326 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.78 -42.75 93.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.008 -0.542 . . . . 75.209999999999994 110.569 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 114' ' ' VAL . 52.8 mt-10 -61.12 -44.81 96.77 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 121.319 -0.152 . . . . 75.129999999999995 110.618 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -65.07 -46.59 80.55 Favored 'General case' 0 C--O 1.181 -2.502 0 C-N-CA 119.685 -0.806 . . . . 72.439999999999998 110.336 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 2.7 t -68.84 -22.71 64.21 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.324 0.583 . . . . 61.310000000000002 111.616 -172.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 8.2 mp -81.96 -47.1 13.12 Favored 'General case' 0 N--CA 1.428 -1.553 0 O-C-N 121.999 -0.438 . . . . 55.310000000000002 111.473 174.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.16 -25.59 31.71 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.855 0.687 . . . . 51.100000000000001 112.855 -172.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -102.65 9.92 38.98 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.431 -1.322 . . . . 44.439999999999998 107.431 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.11 57.35 2.75 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 114.445 -1.252 . . . . 61.210000000000001 115.329 -174.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--N 1.272 -2.765 0 C-N-CA 125.233 1.413 . . . . 72.25 107.228 172.68 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 mtp . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 121.363 0.601 . . . . 73.319999999999993 112.179 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -141.32 174.12 10.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.561 -1.274 . . . . 71.219999999999999 107.561 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 24.9 m-85 -120.35 134.96 55.17 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-O 121.325 0.583 . . . . 71.439999999999998 109.697 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.672 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 62.3 t0 -115.26 119.37 36.09 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.245 -1.343 . . . . 74.420000000000002 108.404 -175.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.6 125.7 50.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 115.673 -0.694 . . . . 75.439999999999998 111.393 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.498 ' HB ' HH21 ' A' ' 87' ' ' ARG . 7.7 p -112.39 115.84 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 N-CA-C 108.603 -0.888 . . . . 71.129999999999995 108.603 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.454 HG23 ' HB2' ' A' ' 27' ' ' MET . 8.3 tt -104.02 124.45 58.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.482 -0.781 . . . . 70.319999999999993 108.952 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.1 mt -114.92 95.81 42.78 Favored Pre-proline 0 C--N 1.302 -1.457 0 CA-C-N 115.808 -0.633 . . . . 51.439999999999998 109.346 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.635 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 9.7 Cg_endo -89.45 126.6 1.58 Allowed 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.762 2.308 . . . . 71.129999999999995 110.173 176.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -150.67 127.67 11.12 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.615 0.722 . . . . 63.409999999999997 110.781 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.2 m -74.42 111.44 9.6 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.791 -1.189 . . . . 72.310000000000002 107.791 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.44 120.64 14.85 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.647 0.737 . . . . 73.140000000000001 112.948 -173.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -129.65 114.72 16.37 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 115.176 -0.92 . . . . 74.319999999999993 110.305 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -78.86 118.65 21.1 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 104.927 -2.249 . . . . 74.239999999999995 104.927 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -48.11 104.31 0.06 Allowed 'General case' 0 N--CA 1.424 -1.765 0 O-C-N 125.378 1.673 . . . . 73.409999999999997 110.578 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.451 ' H ' ' HB2' ' A' ' 20' ' ' MET . 12.9 t70 -84.8 -145.89 0.09 Allowed 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 112.685 -2.052 . . . . 40.32 108.292 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -63.05 -58.37 7.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 118.3 0.5 . . . . 61.210000000000001 111.369 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -137.3 -52.55 0.67 Allowed 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 118.866 -1.134 . . . . 74.319999999999993 113.833 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' O ' ' HG2' ' A' ' 20' ' ' MET . 10.5 t30 -108.27 80.95 1.41 Allowed 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 113.104 0.779 . . . . 74.349999999999994 113.104 -170.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 70.5 mmm -163.24 70.94 0.25 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.08 1.352 . . . . 75.129999999999995 109.287 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -146.21 89.89 1.91 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.319 -1.734 . . . . 62.299999999999997 106.319 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -113.25 118.03 33.5 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.201 -1.0 . . . . 74.230000000000004 111.08 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.408 HD11 ' N ' ' A' ' 132' ' ' GLY . 21.5 mm -133.18 127.48 54.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.489 -0.778 . . . . 63.399999999999999 110.735 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 76.9 m -111.54 129.23 24.32 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 108.458 -0.941 . . . . 60.229999999999997 108.458 172.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.4 ' HB2' ' ND2' ' A' ' 99' ' ' ASN . 27.0 Cg_exo -63.49 146.95 93.43 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.685 2.257 . . . . 74.219999999999999 112.725 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.86 147.93 92.02 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 123.68 2.92 . . . . 62.119999999999997 113.422 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.502 ' HG2' ' HB2' ' A' ' 99' ' ' ASN . 64.2 mtt -111.07 132.94 53.84 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.194 -1.039 . . . . 74.010000000000005 108.194 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.9 t -126.37 125.6 67.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 O-C-N 123.497 0.498 . . . . 71.510000000000005 110.457 -171.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.8 mm -138.21 116.17 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.748 0.819 . . . . 45.009999999999998 109.504 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.672 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -127.94 81.98 0.34 Allowed Glycine 0 CA--C 1.48 -2.139 0 C-N-CA 118.726 -1.702 . . . . 74.319999999999993 114.801 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.92 7.91 1.65 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.205 -0.598 . . . . 63.43 112.432 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.459 HH21 ' CG1' ' A' ' 103' ' ' VAL . 14.8 mmt85 -103.99 134.41 47.31 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.148 -0.621 . . . . 43.240000000000002 109.553 -169.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 p -78.19 163.76 25.52 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 107.678 -1.23 . . . . 71.120000000000005 107.678 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.513 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 63.3 t80 -51.42 -43.24 61.94 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 124.27 1.028 . . . . 75.219999999999999 111.22 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.99 -41.78 95.11 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.151 -0.931 . . . . 63.240000000000002 111.719 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.8 mt -79.29 -30.47 14.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.529 -0.545 . . . . 64.310000000000002 109.529 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.31 -45.8 89.68 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.353 -0.839 . . . . 75.030000000000001 110.098 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.08 -31.38 70.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 119.924 -0.711 . . . . 72.120000000000005 112.276 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.23 -45.07 67.28 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 119.495 -0.882 . . . . 74.329999999999998 110.508 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.4 tp -66.72 -40.9 87.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 C-N-CA 120.107 -0.637 . . . . 72.439999999999998 110.176 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.3 t -65.57 -42.67 93.5 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.008 0 CA-C-N 116.737 -0.21 . . . . 72.200000000000003 110.57 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -63.85 -40.73 97.26 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 120.761 0.315 . . . . 74.439999999999998 111.349 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -66.85 -44.9 87.98 Favored Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 111.062 -0.815 . . . . 52.149999999999999 111.062 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.17 -39.85 86.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.649 -0.5 . . . . 73.239999999999995 109.649 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.447 ' OD2' ' HE2' ' A' ' 49' ' ' LYS . 23.2 t70 -57.75 -46.42 84.54 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 124.387 1.075 . . . . 61.409999999999997 110.653 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 46' ' ' ARG . 29.7 mmt180 -67.42 -37.64 83.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.14 -0.482 . . . . 73.409999999999997 111.597 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 43' ' ' GLY . 62.3 t -68.36 -41.89 83.83 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 120.772 -0.371 . . . . 60.130000000000003 110.302 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.49 HG23 HD11 ' A' ' 73' ' ' LEU . 66.3 mt -66.01 -38.33 81.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 O-C-N 122.035 -0.416 . . . . 73.510000000000005 111.091 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 142' ' ' LEU . 54.0 mtmt -76.57 -17.79 59.02 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.912 0.708 . . . . 74.409999999999997 112.912 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.02 -33.91 7.34 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 113.625 0.972 . . . . 65.450000000000003 113.625 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 t -87.4 -9.99 53.22 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.423 0.63 . . . . 61.25 110.053 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.615 ' CE2' ' HD2' ' A' ' 75' ' ' LYS . 12.3 m-85 -137.33 175.81 9.27 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 107.503 -1.295 . . . . 71.239999999999995 107.503 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 142' ' ' LEU . 64.0 t30 -104.42 77.35 1.38 Allowed 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 105.462 -2.051 . . . . 72.129999999999995 105.462 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.499 ' HB2' HD13 ' A' ' 73' ' ' LEU . . . -114.46 136.44 53.01 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-N 115.158 -0.928 . . . . 73.430000000000007 112.532 -172.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 m -109.37 123.54 49.49 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.282 -1.377 . . . . 75.340000000000003 107.282 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 p -100.63 152.42 4.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 116.11 -0.495 . . . . 31.23 110.293 -173.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -142.13 140.08 32.36 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.691 -1.225 . . . . 73.040000000000006 107.691 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.96 136.32 49.42 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.34 0.59 . . . . 73.299999999999997 110.883 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mp -135.91 167.53 21.01 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.913 -1.143 . . . . 63.020000000000003 107.913 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -100.54 142.76 31.56 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.038 -1.468 . . . . 73.010000000000005 107.038 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.52 174.89 48.93 Favored Glycine 0 C--N 1.296 -1.681 0 C-N-CA 120.708 -0.758 . . . . 72.450000000000003 112.121 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.77 130.47 35.13 Favored 'General case' 0 C--O 1.179 -2.628 0 N-CA-C 108.188 -1.042 . . . . 51.039999999999999 108.188 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 13.64 -73.76 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 C-N-CA 128.241 2.616 . . . . 75.340000000000003 116.829 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 53.3 t -57.12 -37.75 72.43 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 124.151 0.98 . . . . 75.329999999999998 110.046 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 8.7 m-20 -86.18 124.4 32.54 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.601 -1.259 . . . . 62.5 107.601 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.4 t -93.83 -28.78 4.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-O 121.304 0.573 . . . . 72.439999999999998 111.717 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.6 tp -145.34 141.3 28.38 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.124 -0.695 . . . . 63.229999999999997 109.124 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.28 108.96 10.4 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.199 -1.408 . . . . 74.420000000000002 107.199 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -104.79 114.77 29.19 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.279 -1.378 . . . . 75.439999999999998 107.279 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 36.1 ttmt -101.12 132.64 46.49 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.341 0.657 . . . . 74.150000000000006 109.295 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -126.4 125.24 41.86 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.716 -0.475 . . . . 74.310000000000002 109.716 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 m -98.38 113.49 25.49 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.999 -1.482 . . . . 74.319999999999993 106.999 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.499 HD13 ' HB2' ' A' ' 54' ' ' ALA . 4.2 mm? -98.38 139.99 33.32 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.573 0.583 . . . . 75.409999999999997 112.573 -172.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HB2' ' HE2' ' A' ' 79' ' ' LYS . 42.9 tt0 -140.13 127.95 21.92 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 105.715 -1.957 . . . . 73.239999999999995 105.715 170.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.615 ' HD2' ' CE2' ' A' ' 52' ' ' PHE . 49.2 tttm -134.79 -176.91 4.39 Favored 'General case' 0 C--N 1.273 -2.744 0 N-CA-C 104.933 -2.247 . . . . 61.509999999999998 104.933 177.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.428 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -55.97 92.25 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 114.568 1.322 . . . . 73.510000000000005 114.568 -175.691 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.7 17.6 74.99 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 114.903 -1.044 . . . . 62.130000000000003 113.146 175.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 44.4 mtmt -140.09 143.99 36.57 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.419 -0.586 . . . . 72.120000000000005 109.419 -175.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 73' ' ' LEU . 33.6 ttmt -146.79 139.31 24.98 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 110.033 -0.358 . . . . 73.420000000000002 110.033 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.62 174.4 35.71 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 110.902 -0.879 . . . . 61.119999999999997 110.902 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.9 tp -119.56 134.46 63.05 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 108.106 -1.072 . . . . 74.430000000000007 108.106 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.2 t -123.61 115.59 45.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.432 0.634 . . . . 75.319999999999993 109.673 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.409 ' CD2' ' HG3' ' A' ' 70' ' ' LYS . 36.4 m170 -107.15 116.67 32.33 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.257 -0.883 . . . . 63.32 110.512 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.58 110.0 30.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.737 -0.838 . . . . 75.430000000000007 108.737 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -118.27 137.4 53.07 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.891 -0.506 . . . . 72.540000000000006 111.336 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.7 mt -106.37 118.76 37.48 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.112 -0.495 . . . . 73.230000000000004 109.944 -171.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.498 HH21 ' HB ' ' A' ' 6' ' ' VAL . 28.5 mtm105 -97.15 141.14 30.65 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.025 0.441 . . . . 73.510000000000005 110.096 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 64' ' ' CYS . 49.7 pttt -80.23 98.11 7.23 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 109.301 -0.629 . . . . 71.209999999999994 109.301 173.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.0 tt -69.22 112.01 3.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-O 122.513 1.149 . . . . 74.439999999999998 109.636 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.6 p -140.68 -171.4 3.22 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 113.35 -1.75 . . . . 51.020000000000003 107.723 -170.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.47 -5.0 53.83 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.593 0.711 . . . . 62.020000000000003 110.658 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -99.74 -29.25 12.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.547 -0.751 . . . . 54.25 109.169 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 84.9 m -121.27 92.87 48.76 Favored Pre-proline 0 N--CA 1.431 -1.377 0 CA-C-N 115.429 -0.805 . . . . 54.109999999999999 109.719 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -76.48 167.79 24.97 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.189 1.926 . . . . 73.040000000000006 110.976 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.24 123.34 12.31 Favored 'Trans proline' 0 C--O 1.251 1.157 0 C-N-CA 122.032 1.821 . . . . 62.420000000000002 110.194 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 t -86.68 157.57 3.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.462 -0.57 . . . . 73.430000000000007 109.462 -176.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.47 137.49 32.31 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.96 -0.564 . . . . 74.200000000000003 110.299 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -177.1 -170.43 39.52 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 108.76 -1.736 . . . . 74.439999999999998 108.76 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.502 ' HB2' ' HG2' ' A' ' 27' ' ' MET . 94.1 m-20 -71.63 140.01 49.54 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.187 -0.671 . . . . 62.140000000000001 109.187 178.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -98.63 119.7 37.81 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.019 0.438 . . . . 71.439999999999998 111.133 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 41.1 t -73.2 139.04 46.0 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.553 -0.906 . . . . 72.219999999999999 108.553 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 m -74.03 91.15 2.03 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.494 0.664 . . . . 73.519999999999996 110.374 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.459 ' CG1' HH21 ' A' ' 32' ' ' ARG . 66.7 t -89.57 136.59 23.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 114.748 -1.115 . . . . 65.150000000000006 109.897 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 93.4 mt -148.48 -88.74 0.08 Allowed 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.099 -0.955 . . . . 61.549999999999997 109.606 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -120.58 166.9 13.0 Favored 'General case' 0 C--N 1.262 -3.239 0 N-CA-C 107.006 -1.479 . . . . 64.219999999999999 107.006 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -44.71 -46.74 10.54 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 124.172 0.92 . . . . 74.329999999999998 112.761 -178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.04 -31.54 72.14 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.477 -0.783 . . . . 72.010000000000005 112.271 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -81.47 -36.9 28.77 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.112 -0.699 . . . . 75.230000000000004 109.112 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.415 ' O ' HG12 ' A' ' 113' ' ' ILE . 44.2 m-20 -63.61 -45.39 90.51 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.11 -0.95 . . . . 71.540000000000006 109.198 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 114' ' ' VAL . 7.0 tp -67.69 -36.91 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 120.335 -0.546 . . . . 60.439999999999998 110.951 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.26 -33.18 75.17 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.266 -0.642 . . . . 70.319999999999993 109.266 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 41.6 t -65.09 -38.93 92.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.677 -0.692 . . . . 60.229999999999997 110.248 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 109' ' ' ASP . 51.5 mm -67.69 -43.57 86.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.906 -0.405 . . . . 75.319999999999993 109.906 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 110' ' ' ILE . 83.7 t -60.43 -43.65 94.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.024 -0.535 . . . . 73.329999999999998 111.037 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -66.92 -31.35 71.88 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 120.767 -0.373 . . . . 41.43 110.38 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.64 -45.58 71.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.017 0.437 . . . . 75.140000000000001 110.809 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.4 mt -68.1 -44.13 84.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.545 -0.752 . . . . 72.439999999999998 109.461 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.1 -31.48 71.99 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 112.398 0.518 . . . . 62.43 112.398 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.35 -43.0 61.57 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 119.416 -0.914 . . . . 74.150000000000006 110.012 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 2.6 t -70.36 -41.26 73.35 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.6 0.714 . . . . 62.329999999999998 109.556 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 10.4 mp -74.61 -35.68 62.95 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.75 -0.659 . . . . 74.400000000000006 111.994 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.15 -14.77 52.85 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 119.544 -0.863 . . . . 44.200000000000003 113.033 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.53 -34.59 58.54 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 118.232 -1.387 . . . . 71.519999999999996 111.733 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.48 -153.93 39.16 Favored Glycine 0 C--N 1.295 -1.701 0 CA-C-N 114.726 -1.124 . . . . 71.140000000000001 115.752 172.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -51.39 103.77 0.07 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 125.088 1.355 . . . . 75.329999999999998 112.494 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.89 -178.74 5.96 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 106.883 -1.525 . . . . 75.219999999999999 106.883 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -110.13 139.17 45.56 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.453 -0.943 . . . . 54.210000000000001 108.453 172.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.8 t -155.5 -164.66 1.8 Allowed 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.874 -1.158 . . . . 73.120000000000005 107.874 -174.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -56.1 144.37 29.52 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.204 1.002 . . . . 62.119999999999997 109.913 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -80.34 88.9 5.53 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.436 0.636 . . . . 72.040000000000006 109.949 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -151.82 -164.87 2.08 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 105.352 -2.092 . . . . 73.120000000000005 105.352 173.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.522 ' O ' ' HD3' ' A' ' 134' ' ' PRO . . . 121.46 106.19 1.97 Allowed Glycine 0 CA--C 1.474 -2.479 0 N-CA-C 109.778 -1.329 . . . . 63.219999999999999 109.778 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -102.57 100.93 17.5 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-O 121.535 0.683 . . . . 60.25 111.772 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 132' ' ' GLY . 1.6 Cg_endo -81.88 85.72 1.66 Allowed 'Trans proline' 0 N--CA 1.43 -2.26 0 C-N-CA 122.162 1.908 . . . . 73.519999999999996 109.649 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 46.0 mm -87.85 110.31 34.06 Favored Pre-proline 0 N--CA 1.417 -2.102 0 N-CA-C 108.716 -0.846 . . . . 73.329999999999998 108.716 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.35 134.64 39.66 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 122.99 2.46 . . . . 70.420000000000002 111.959 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -127.48 112.39 21.07 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 107.532 -1.284 . . . . 75.239999999999995 107.532 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -68.12 -11.37 31.82 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.963 2.442 . . . . 74.450000000000003 113.658 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.47 123.25 40.07 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.869 -0.419 . . . . 74.219999999999999 109.869 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mp -125.52 89.66 3.08 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.028 -0.73 . . . . 62.549999999999997 109.028 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.93 151.31 12.1 Favored Glycine 0 C--N 1.304 -1.24 0 C-N-CA 120.545 -0.836 . . . . 62.229999999999997 111.549 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 2.5 pt? -96.43 -178.62 4.35 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.698 -0.482 . . . . 72.319999999999993 109.698 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 49' ' ' LYS . 22.8 t0 -130.29 112.13 13.04 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.18 -0.674 . . . . 63.32 109.18 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 24.2 m -64.04 117.47 7.11 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.297 -0.865 . . . . 41.130000000000003 112.75 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.1 m -162.28 93.57 0.87 Allowed 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.448 -1.316 . . . . 65.120000000000005 107.448 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -85.23 149.32 25.57 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.913 -1.143 . . . . 74.040000000000006 107.913 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.9 m -77.7 130.05 36.3 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.409 -0.96 . . . . 70.310000000000002 108.409 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.472 0 N-CA-C 109.895 -1.282 . . . . 41.32 109.895 -177.69 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 tpt . . . . . 0 CA--C 1.511 -0.524 0 N-CA-C 109.402 -0.592 . . . . 52.329999999999998 109.402 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -128.84 170.77 12.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.362 -0.607 . . . . 70.319999999999993 109.362 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.484 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 16.6 m-85 -124.18 146.93 48.37 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.832 -0.622 . . . . 74.319999999999993 110.694 177.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.645 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 0.4 OUTLIER -99.03 102.44 14.16 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 125.27 1.428 . . . . 71.219999999999999 108.246 178.173 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.1 t -85.0 113.13 23.03 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 107.526 -1.287 . . . . 71.340000000000003 107.526 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.442 HG13 HG22 ' A' ' 28' ' ' VAL . 60.0 t -107.26 107.78 23.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.882 -1.155 . . . . 74.239999999999995 107.882 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.9 tt -110.91 110.06 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-O 122.064 0.935 . . . . 73.540000000000006 109.466 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.406 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 45.6 mt -106.77 104.71 52.57 Favored Pre-proline 0 C--N 1.293 -1.879 0 CA-C-N 114.245 -1.343 . . . . 75.519999999999996 110.143 -174.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.693 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 5.9 Cg_exo -81.04 137.51 10.9 Favored 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 121.701 1.601 . . . . 73.109999999999999 108.463 170.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -139.27 156.59 46.95 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.001 -1.481 . . . . 73.219999999999999 107.001 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.458 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 35.7 m -104.58 126.47 51.69 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.397 -0.964 . . . . 73.120000000000005 108.397 175.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.523 ' CE1' ' HB3' ' A' ' 79' ' ' LYS 0.275 8.2 p90 -73.79 75.31 1.59 Allowed 'General case' 0 C--N 1.349 0.573 0 CA-C-O 122.723 1.249 . . . . 72.329999999999998 114.098 -176.504 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.635 ' NE2' ' HD2' ' A' ' 79' ' ' LYS . 50.3 m80 -128.46 111.41 13.26 Favored 'General case' 0 N--CA 1.414 -2.265 0 O-C-N 121.59 -0.694 . . . . 70.120000000000005 111.696 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -72.47 144.22 48.15 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.388 -1.278 . . . . 74.409999999999997 108.91 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -52.69 120.33 5.58 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 116.983 2.216 . . . . 73.319999999999993 116.983 -173.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.595 ' HB3' ' O ' ' A' ' 19' ' ' ASN . 9.5 t70 -100.45 168.22 9.88 Favored 'General case' 0 C--N 1.262 -3.203 0 CA-C-N 111.974 -2.376 . . . . 70.239999999999995 105.114 165.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -62.63 -32.84 73.94 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 122.63 0.372 . . . . 55.43 111.885 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -135.55 -35.68 0.8 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.901 0.704 . . . . 73.430000000000007 112.901 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.595 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 5.1 m-20 -95.84 -178.62 4.43 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.097 -0.501 . . . . 73.439999999999998 109.662 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 62.8 mtt 56.58 71.32 0.57 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 114.12 1.156 . . . . 71.510000000000005 114.12 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.423 ' OE2' ' HA ' ' A' ' 128' ' ' SER . 12.2 tt0 -165.72 116.45 1.05 Allowed 'General case' 0 N--CA 1.406 -2.658 0 N-CA-C 103.412 -2.811 . . . . 64.549999999999997 103.412 172.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.632 ' ND1' ' HB3' ' A' ' 127' ' ' ASN . 3.6 t60 -153.73 104.75 2.73 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-O 122.034 0.921 . . . . 62.43 110.77 171.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.5 mm -96.58 128.85 47.4 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.707 0 N-CA-C 104.076 -2.564 . . . . 75.150000000000006 104.076 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.693 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 59.3 m -107.81 159.06 31.82 Favored Pre-proline 0 C--N 1.288 -2.104 0 C-N-CA 119.812 -0.755 . . . . 72.120000000000005 110.426 -168.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.33 116.85 3.48 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.571 2.18 . . . . 73.150000000000006 112.741 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.52 128.87 5.55 Favored 'Trans proline' 0 C--O 1.256 1.39 0 C-N-CA 122.111 1.874 . . . . 74.349999999999994 111.501 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -91.44 126.26 36.47 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.723 -0.671 . . . . 74.219999999999999 110.594 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.449 HG11 ' HB ' ' A' ' 96' ' ' VAL . 94.6 t -123.14 115.24 45.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.555 -0.748 . . . . 53.43 108.994 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.475 HD11 ' H ' ' A' ' 101' ' ' CYS . 45.3 mm -125.14 102.47 10.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 109.664 -0.495 . . . . 52.399999999999999 109.664 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.645 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -110.1 80.39 0.27 Allowed Glycine 0 CA--C 1.474 -2.505 0 C-N-CA 119.84 -1.172 . . . . 64.310000000000002 112.92 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -165.3 20.69 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.06 -1.07 . . . . 74.109999999999999 110.304 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -103.08 133.39 48.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.99 -1.855 . . . . 73.140000000000001 105.99 -173.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.0 p -77.93 165.92 23.5 Favored 'General case' 0 N--CA 1.408 -2.526 0 N-CA-C 107.929 -1.137 . . . . 61.32 107.929 174.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.484 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 59.7 t80 -52.76 -43.92 66.13 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 123.333 0.653 . . . . 71.140000000000001 111.029 -174.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.01 -31.33 68.95 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.019 -0.991 . . . . 60.109999999999999 112.889 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -81.63 -34.36 12.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.216 0.531 . . . . 75.430000000000007 109.601 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.04 -45.43 88.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.672 -0.695 . . . . 61.229999999999997 110.012 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.3 mmt -69.85 -29.72 67.03 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.891 0.376 . . . . 74.450000000000003 110.313 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -67.68 -44.71 77.14 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 115.789 -0.641 . . . . 74.219999999999999 110.31 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 44' ' ' VAL . 7.9 tp -69.93 -39.91 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 119.709 -0.797 . . . . 73.120000000000005 109.738 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.31 -42.09 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 116.602 -0.272 . . . . 53.439999999999998 110.931 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.554 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 46.3 t-20 -64.44 -42.42 96.01 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.494 -0.558 . . . . 34.329999999999998 109.494 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.474 ' HA3' ' CE1' ' A' ' 106' ' ' PHE . . . -67.53 -40.46 90.93 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.588 -0.815 . . . . 42.109999999999999 112.058 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 40' ' ' ILE . 72.1 t -65.22 -41.36 91.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.53 -0.545 . . . . 62.340000000000003 109.53 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -53.71 -47.22 70.74 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.481 1.112 . . . . 65.099999999999994 110.92 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 42' ' ' ASN . 88.0 mtt180 -69.5 -37.21 77.11 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.333 -0.848 . . . . 73.209999999999994 110.645 -177.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.2 t -71.12 -36.01 61.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.217 -0.447 . . . . 51.119999999999997 110.649 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.56 -45.63 97.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 122.6 0.36 . . . . 64.019999999999996 110.921 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -70.94 -25.32 62.69 Favored 'General case' 0 C--O 1.209 -1.064 0 CA-C-O 121.02 0.438 . . . . 74.420000000000002 110.82 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.418 ' HB1' ' H ' ' A' ' 148' ' ' GLY . . . -83.6 -40.84 18.52 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.893 0.701 . . . . 63.130000000000003 112.893 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -92.23 -14.11 29.46 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 112.729 0.64 . . . . 74.150000000000006 112.729 -173.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -135.44 -175.71 4.03 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.505 0.669 . . . . 72.439999999999998 110.543 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.495 ' HA ' ' OD1' ' A' ' 143' ' ' ASP . 58.8 t30 -113.53 100.62 8.64 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 103.487 -2.783 . . . . 73.099999999999994 103.487 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.72 153.74 28.49 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 114.07 1.137 . . . . 62.32 114.07 -167.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.6 m -126.73 118.25 24.33 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 105.56 -2.015 . . . . 52.439999999999998 105.56 168.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.9 p -99.96 118.74 47.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.482 0.658 . . . . 75.439999999999998 109.953 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HB2' ' HG3' ' A' ' 70' ' ' LYS . 39.2 mt-10 -114.83 122.23 45.72 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.569 -0.741 . . . . 61.32 109.075 -177.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.13 141.33 28.71 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.972 -0.381 . . . . 64.0 109.972 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.57 168.57 19.4 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.563 0.697 . . . . 53.009999999999998 109.481 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -106.24 127.0 52.92 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.179 -1.415 . . . . 74.310000000000002 107.179 174.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' A' ' 65' ' ' ASP . . . -72.83 176.51 43.04 Favored Glycine 0 N--CA 1.422 -2.273 0 CA-C-N 115.742 -0.663 . . . . 53.149999999999999 112.672 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' A' ' 65' ' ' ASP . 9.4 pt-20 -64.23 174.64 1.54 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.271 1.028 . . . . 73.420000000000002 110.146 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -49.49 -40.65 38.24 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.081 0.952 . . . . 63.229999999999997 111.736 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.18 -20.25 48.9 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.566 -1.197 . . . . 53.520000000000003 111.999 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.47 ' OD2' ' HB2' ' A' ' 85' ' ' LYS . 2.1 t70 -89.0 171.29 9.97 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.836 -0.54 . . . . 73.209999999999994 109.877 -174.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.7 t -114.19 -37.94 2.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 C-N-CA 123.857 0.863 . . . . 54.310000000000002 109.532 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.3 tp -167.3 131.57 1.89 Allowed 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.891 -0.595 . . . . 52.409999999999997 110.503 -171.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.28 133.68 52.56 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 107.41 -1.33 . . . . 72.120000000000005 107.41 -176.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -139.3 142.32 37.71 Favored 'General case' 0 C--N 1.28 -2.433 0 O-C-N 121.618 -0.676 . . . . 61.32 110.713 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HG3' ' HB2' ' A' ' 57' ' ' GLU . 14.4 ptmm? -121.64 122.69 40.17 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.376 0.608 . . . . 62.520000000000003 109.522 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -97.57 119.85 36.89 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 107.177 -1.416 . . . . 74.319999999999993 107.177 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.7 m -94.35 116.17 28.5 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.305 -1.369 . . . . 52.020000000000003 107.305 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.94 142.2 47.61 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-O 121.04 0.448 . . . . 64.120000000000005 110.913 -173.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 26.6 tt0 -150.41 100.49 2.88 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 107.936 -1.135 . . . . 73.129999999999995 107.936 168.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -102.75 90.4 3.8 Favored 'General case' 0 N--CA 1.417 -2.078 0 C-N-CA 118.959 -1.096 . . . . 54.210000000000001 108.39 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 55.51 67.58 0.99 Allowed 'General case' 0 CA--C 1.545 0.771 0 O-C-N 124.707 1.254 . . . . 70.099999999999994 111.385 171.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.62 -23.5 19.22 Favored Glycine 0 C--N 1.308 -1.021 0 CA-C-N 115.483 -0.781 . . . . 73.409999999999997 113.341 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 53.2 mtmt -84.44 101.12 11.78 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.261 -1.015 . . . . 74.129999999999995 108.261 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.635 ' HD2' ' NE2' ' A' ' 13' ' ' HIS . 42.0 mttp -103.73 134.11 47.6 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 123.843 0.715 . . . . 72.549999999999997 110.187 -172.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -171.8 169.46 42.53 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.074 -1.06 . . . . 52.539999999999999 112.825 177.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.1 mt -131.62 138.22 53.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.147 -1.427 . . . . 71.109999999999999 107.147 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.8 t -115.18 110.34 31.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 109.084 -0.71 . . . . 74.409999999999997 109.084 176.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 88.4 m-70 -97.27 105.83 18.05 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.664 -0.698 . . . . 74.230000000000004 109.827 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.2 t -101.29 115.44 43.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 107.927 -1.138 . . . . 72.540000000000006 107.927 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.47 ' HB2' ' OD2' ' A' ' 65' ' ' ASP . 21.7 ptmt -124.16 133.78 53.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.29 -0.633 . . . . 74.200000000000003 109.29 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.6 mt -107.33 112.91 25.97 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.863 -0.791 . . . . 70.519999999999996 108.863 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.472 ' HB2' ' HB2' ' A' ' 4' ' ' ASP . 45.5 mmm-85 -97.13 139.01 33.76 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.316 -0.994 . . . . 74.400000000000006 108.316 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 93' ' ' CYS . 21.8 pttm -92.06 98.98 11.89 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 120.208 -0.597 . . . . 74.450000000000003 111.464 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.2 tt -66.59 111.7 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 122.326 1.06 . . . . 73.129999999999995 109.494 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.3 p -145.67 -170.46 3.46 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.25 -1.341 . . . . 64.310000000000002 108.924 -169.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -72.73 -19.49 61.38 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.87 -1.159 . . . . 75.310000000000002 107.87 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.1 -36.84 17.88 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.253 -1.34 . . . . 73.239999999999995 109.556 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 86.3 m -122.36 125.43 26.53 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 113.463 0.912 . . . . 54.32 113.463 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.21 161.98 15.32 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.522 2.148 . . . . 75.450000000000003 110.905 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.12 142.99 89.34 Favored 'Trans proline' 0 C--O 1.262 1.71 0 C-N-CA 121.943 1.762 . . . . 71.439999999999998 109.667 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.449 ' HB ' HG11 ' A' ' 28' ' ' VAL . 13.7 t -87.98 159.42 3.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 109.576 -0.527 . . . . 71.200000000000003 109.576 -176.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -109.51 131.15 55.33 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.782 -0.821 . . . . 72.329999999999998 108.782 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -174.6 -160.76 23.26 Favored Glycine 0 CA--C 1.479 -2.17 0 N-CA-C 110.731 -0.948 . . . . 71.530000000000001 110.731 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -79.73 125.75 30.06 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.207 -0.664 . . . . 72.340000000000003 109.207 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -87.72 105.87 17.66 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.891 0.853 . . . . 75.209999999999994 110.761 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.475 ' H ' HD11 ' A' ' 29' ' ' ILE . 53.1 t -69.73 152.54 44.53 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.846 -1.525 . . . . 31.210000000000001 109.468 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.0 m -74.33 104.56 5.13 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.518 -0.919 . . . . 60.420000000000002 108.518 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.6 t -113.21 140.51 32.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 121.753 0.787 . . . . 74.439999999999998 110.518 -175.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.6 tp -149.76 -64.94 0.22 Allowed 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 114.452 -1.249 . . . . 75.150000000000006 108.164 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -158.42 162.04 37.55 Favored 'General case' 0 C--N 1.249 -3.787 0 CA-C-N 112.743 -2.026 . . . . 71.450000000000003 106.828 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.474 ' CE1' ' HA3' ' A' ' 43' ' ' GLY . 57.5 t80 -32.52 -55.03 0.34 Allowed 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 116.004 1.853 . . . . 53.200000000000003 116.004 -173.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.26 -28.13 69.52 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 113.669 0.988 . . . . 73.310000000000002 113.669 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -39.75 15.21 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.367 -1.346 . . . . 74.0 107.367 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 113' ' ' ILE . 11.9 m-20 -65.91 -46.51 78.02 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.603 -1.18 . . . . 74.019999999999996 108.629 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.428 HG13 HG22 ' A' ' 44' ' ' VAL . 16.2 tt -69.6 -25.86 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.536 -0.756 . . . . 73.209999999999994 110.504 -176.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -65.34 -49.92 67.56 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 107.025 -1.472 . . . . 60.340000000000003 107.025 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 3.4 t -63.29 -39.82 95.63 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.688 -1.142 . . . . 55.530000000000001 111.27 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 109' ' ' ASP . 41.4 mm -64.89 -46.91 90.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.048 -0.524 . . . . 74.019999999999996 111.368 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 92.6 t -69.99 -33.64 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 C-N-CA 120.184 -0.607 . . . . 73.310000000000002 110.173 -176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -66.4 -37.75 85.94 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.827 -0.624 . . . . 75.329999999999998 110.79 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.55 -41.03 80.36 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.064 0.459 . . . . 65.25 110.403 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.39 -45.7 95.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.671 -0.695 . . . . 71.409999999999997 109.186 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.6 -38.15 89.04 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 115.928 -0.578 . . . . 73.340000000000003 112.1 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -68.7 -40.21 80.13 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.602 -0.439 . . . . 72.310000000000002 110.632 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 42.8 t -59.22 -49.84 76.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.359 0.6 . . . . 62.219999999999999 109.433 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 10.5 mp -74.68 -14.84 60.79 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.603 -0.726 . . . . 74.129999999999995 112.427 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.26 -33.68 25.97 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 110.243 -0.28 . . . . 62.539999999999999 110.243 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.54 -34.84 46.89 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.311 0.577 . . . . 70.209999999999994 109.815 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.22 -136.35 51.03 Favored Glycine 0 CA--C 1.474 -2.521 0 CA-C-N 114.094 -1.412 . . . . 55.539999999999999 114.594 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.479 ' HB3' ' CD2' ' A' ' 13' ' ' HIS . 1.3 pm0 -73.66 38.72 0.1 Allowed 'General case' 0 C--N 1.262 -3.225 0 N-CA-C 114.934 1.457 . . . . 71.5 114.934 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 127' ' ' ASN . 48.5 mt -159.35 86.53 0.81 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 114.369 1.248 . . . . 71.400000000000006 114.369 -178.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.632 ' HB3' ' ND1' ' A' ' 22' ' ' HIS . 16.5 t-20 174.28 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.687 0.795 . . . . 74.420000000000002 110.78 166.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.423 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 45.0 t -78.12 125.52 29.48 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.596 -1.183 . . . . 75.319999999999993 110.497 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -173.83 89.15 0.07 Allowed 'General case' 0 C--O 1.247 0.964 0 N-CA-C 113.648 0.981 . . . . 72.349999999999994 113.648 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.0 tp 65.58 87.61 0.12 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.597 1.159 . . . . 63.299999999999997 113.93 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -104.01 115.76 31.02 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.178 -1.045 . . . . 75.040000000000006 108.178 175.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -151.38 46.56 0.6 Allowed Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 109.156 -1.578 . . . . 62.149999999999999 109.156 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -159.84 95.43 1.61 Allowed Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-N 115.511 -0.345 . . . . 72.400000000000006 110.138 -174.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -79.83 117.26 3.58 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.655 2.237 . . . . 72.430000000000007 110.62 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 48.0 mm -124.55 103.11 32.11 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-O 120.715 0.293 . . . . 43.140000000000001 111.521 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -77.43 162.93 30.35 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.479 2.119 . . . . 62.140000000000001 110.756 172.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -122.38 95.51 46.93 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-O 120.837 0.351 . . . . 62.240000000000002 110.494 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -73.7 -22.54 17.79 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.892 2.395 . . . . 74.019999999999996 112.492 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 53.5 tp -111.79 122.44 47.81 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.66 0.743 . . . . 62.409999999999997 112.469 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.5 mp -117.3 79.61 1.37 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.586 -1.635 . . . . 75.530000000000001 106.586 169.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.56 -146.3 11.34 Favored Glycine 0 N--CA 1.42 -2.374 0 C-N-CA 120.303 -0.951 . . . . 71.430000000000007 110.894 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -163.79 167.18 21.21 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.761 -0.829 . . . . 71.040000000000006 108.761 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.495 ' OD1' ' HA ' ' A' ' 53' ' ' ASN . 6.7 p-10 -97.8 175.25 6.23 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.134 -1.062 . . . . 73.409999999999997 108.134 177.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.3 m -144.33 61.06 1.35 Allowed 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 107.332 -1.358 . . . . 75.239999999999995 107.332 171.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 89.7 m -130.93 131.03 44.21 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.47 -1.241 . . . . 63.140000000000001 110.002 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.76 161.97 27.29 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.29 -1.004 . . . . 72.430000000000007 108.29 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.8 m -71.73 92.51 1.2 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.221 0.534 . . . . 63.32 110.404 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.418 ' H ' ' HB1' ' A' ' 50' ' ' ALA . . . . . . . . 0 N--CA 1.426 -1.982 0 N-CA-C 109.246 -1.542 . . . . 75.129999999999995 109.246 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.436 ' SD ' ' HE1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.504 -0.793 0 CA-C-O 120.807 0.337 . . . . 70.129999999999995 111.189 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -110.27 164.28 12.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.669 0.747 . . . . 51.549999999999997 111.986 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 11.3 m-85 -120.04 140.28 51.23 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.527 -1.215 . . . . 74.319999999999993 111.152 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.649 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 28.7 t70 -101.08 102.58 13.57 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 104.855 -2.276 . . . . 63.049999999999997 104.855 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.78 117.76 32.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.325 -0.852 . . . . 73.239999999999995 109.442 -172.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.19 116.72 52.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.028 -1.101 . . . . 74.519999999999996 108.028 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.409 HD13 HD12 ' A' ' 113' ' ' ILE . 10.3 tt -118.69 120.75 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 121.396 0.617 . . . . 74.25 109.732 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.493 HG12 ' HB3' ' A' ' 26' ' ' PRO . 5.5 mt -112.49 100.8 51.14 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 115.543 -0.753 . . . . 65.439999999999998 108.98 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.603 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 1.4 Cg_endo -85.53 120.53 2.11 Favored 'Trans proline' 0 N--CA 1.436 -1.87 0 N-CA-C 107.769 -1.666 . . . . 75.409999999999997 107.769 171.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -144.61 129.7 18.56 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 120.922 0.391 . . . . 70.340000000000003 110.431 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.653 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 37.5 m -73.08 120.39 18.63 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.65 -0.5 . . . . 62.100000000000001 109.65 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.601 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 2.7 p90 -61.52 110.89 1.6 Allowed 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 113.967 1.099 . . . . 72.109999999999999 113.967 -174.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -143.84 106.26 4.41 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 114.854 -1.066 . . . . 65.049999999999997 110.114 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -68.84 122.24 18.2 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.878 -1.897 . . . . 74.310000000000002 105.878 173.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.48 103.69 0.55 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 124.585 1.178 . . . . 73.349999999999994 109.77 -172.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 17' ' ' LYS . 14.0 t70 -89.1 -158.15 0.49 Allowed 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 114.02 -1.445 . . . . 55.420000000000002 110.492 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 23.3 tptm -72.46 -45.34 59.99 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.741 0.816 . . . . 74.150000000000006 111.694 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -132.62 -51.46 0.92 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.584 0.707 . . . . 51.100000000000001 110.249 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -96.36 -177.83 4.09 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 114.489 -1.232 . . . . 63.43 110.612 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 86.9 mtp 70.75 80.13 0.17 Allowed 'General case' 0 C--N 1.313 -0.99 0 O-C-N 124.572 1.17 . . . . 32.149999999999999 109.977 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.424 ' OE1' ' HA ' ' A' ' 127' ' ' ASN . 2.2 tm-20 -168.05 121.24 0.89 Allowed 'General case' 0 N--CA 1.403 -2.792 0 N-CA-C 105.083 -2.192 . . . . 70.530000000000001 105.083 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.45 ' NE2' ' HB3' ' A' ' 123' ' ' LYS . 18.5 t60 -168.42 84.28 0.17 Allowed 'General case' 0 C--N 1.282 -2.34 0 O-C-N 124.57 1.169 . . . . 75.230000000000004 110.334 165.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 131' ' ' GLU . 46.5 mm -103.17 136.05 37.72 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 N-CA-C 107.165 -1.42 . . . . 74.450000000000003 107.165 175.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 79.0 m -107.25 145.49 31.29 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 110.126 -0.324 . . . . 74.439999999999998 110.126 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 24' ' ' CYS . 52.5 Cg_exo -55.49 136.27 73.12 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 123.424 2.749 . . . . 71.340000000000003 112.873 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.493 ' HB3' HG12 ' A' ' 8' ' ' ILE . 74.5 Cg_endo -73.05 140.66 31.64 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.887 2.391 . . . . 63.340000000000003 112.394 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 99' ' ' ASN . 53.8 mtt -98.12 139.56 33.74 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-N 116.233 -0.44 . . . . 74.319999999999993 109.84 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.6 t -130.12 116.7 37.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 116.524 -0.307 . . . . 71.099999999999994 110.448 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.25 102.39 9.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 107.188 -1.412 . . . . 63.420000000000002 107.188 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.649 ' CA ' ' HA ' ' A' ' 4' ' ' ASP . . . -121.85 81.7 0.34 Allowed Glycine 0 N--CA 1.42 -2.372 0 C-N-CA 119.056 -1.545 . . . . 53.329999999999998 115.262 -175.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -153.64 15.82 0.51 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.24 -0.98 . . . . 71.329999999999998 110.803 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -102.07 136.43 41.91 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.745 -0.835 . . . . 72.430000000000007 108.745 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 p -74.05 168.31 19.78 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 106.595 -1.632 . . . . 73.129999999999995 106.595 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.562 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 73.9 t80 -61.62 -38.69 88.57 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 118.425 0.557 . . . . 41.130000000000003 110.735 -174.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -59.65 -49.26 78.44 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.486 -0.779 . . . . 71.129999999999995 111.209 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.1 mt -70.83 -38.74 73.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.647 -0.706 . . . . 72.5 109.308 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.401 ' HA ' HG22 ' A' ' 40' ' ' ILE . . . -65.94 -41.64 91.06 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.635 -0.711 . . . . 74.430000000000007 110.703 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 11.7 tpt -68.94 -40.83 78.73 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.839 -0.43 . . . . 52.329999999999998 109.839 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -74.21 -32.71 63.14 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 112.744 0.646 . . . . 70.109999999999999 112.744 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.557 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -74.68 -42.66 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.601 -0.889 . . . . 55.229999999999997 108.601 178.369 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.404 HG21 HD21 ' A' ' 86' ' ' LEU . 73.4 t -69.75 -38.78 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 120.956 -0.298 . . . . 71.109999999999999 110.7 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.549 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 4.0 m-20 -73.96 -26.75 60.64 Favored 'General case' 0 C--O 1.201 -1.479 0 C-N-CA 119.8 -0.76 . . . . 73.409999999999997 110.474 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.407 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -66.2 -46.33 80.39 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.133 -1.187 . . . . 54.25 110.133 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 40' ' ' ILE . 96.2 t -58.24 -45.07 89.11 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 N-CA-C 108.523 -0.917 . . . . 71.319999999999993 108.523 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 8.3 t70 -50.07 -49.27 51.89 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.646 1.578 . . . . 74.209999999999994 111.457 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 42' ' ' ASN . 45.4 mtt180 -67.36 -36.64 81.79 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.906 -1.043 . . . . 75.239999999999995 109.717 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 43' ' ' GLY . 60.9 t -71.72 -38.85 67.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 123.358 0.411 . . . . 61.310000000000002 110.695 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.455 HG23 HD11 ' A' ' 73' ' ' LEU . 70.3 mt -63.99 -46.1 94.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 C-N-CA 122.471 0.308 . . . . 52.310000000000002 110.614 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -78.68 -14.35 59.34 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.83 -0.748 . . . . 65.420000000000002 110.819 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.5 -49.27 10.1 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.948 -0.569 . . . . 61.119999999999997 111.126 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -91.8 -16.17 27.18 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 113.222 0.823 . . . . 74.219999999999999 113.222 -171.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.416 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 9.6 m-85 -129.09 -177.26 4.15 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.583 0.706 . . . . 74.25 110.281 -175.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 26.2 t-20 -109.81 108.23 18.48 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 104.352 -2.462 . . . . 73.120000000000005 104.352 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.66 157.97 45.27 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 115.963 -0.562 . . . . 71.239999999999995 112.202 -172.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 t -129.01 120.02 25.29 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.6 -1.63 . . . . 75.129999999999995 106.6 171.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.9 p -100.62 124.04 53.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.233 0.54 . . . . 73.340000000000003 110.612 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -122.73 146.92 47.07 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.791 -0.818 . . . . 75.239999999999995 108.791 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -119.68 127.67 53.1 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.955 0.883 . . . . 73.409999999999997 111.791 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.29 176.78 5.3 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.14 -1.43 . . . . 72.400000000000006 107.14 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -111.99 136.84 50.81 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.681 -0.859 . . . . 71.219999999999999 108.681 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.565 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -84.17 176.69 51.77 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 115.828 -0.624 . . . . 54.549999999999997 112.874 -175.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -74.68 133.04 42.13 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 123.328 0.651 . . . . 74.530000000000001 111.84 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t70 46.31 -84.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 126.298 1.839 . . . . 72.329999999999998 114.973 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.5 p -97.49 -1.6 43.78 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 113.556 0.947 . . . . 75.530000000000001 113.556 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.565 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 13.4 m-20 -76.96 117.78 18.89 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.659 -1.608 . . . . 75.310000000000002 106.659 172.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.0 t -85.31 -31.3 6.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-O 121.264 0.554 . . . . 52.329999999999998 112.235 -173.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 63.2 tp -148.67 133.91 18.38 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 109.409 -0.589 . . . . 60.130000000000003 109.409 -176.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.462 ' CE2' ' HD3' ' A' ' 85' ' ' LYS . 1.1 t80 -129.91 105.44 7.99 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.261 -1.385 . . . . 75.329999999999998 107.261 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -107.69 125.38 51.3 Favored 'General case' 0 C--N 1.281 -2.396 0 C-N-CA 120.191 -0.604 . . . . 74.340000000000003 111.732 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -103.0 115.14 30.03 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 125.201 1.4 . . . . 64.019999999999996 108.476 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 75.3 m-85 -102.56 118.04 36.0 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.606 -0.516 . . . . 74.099999999999994 109.606 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.0 m -87.87 123.15 32.33 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.804 -1.184 . . . . 71.25 107.804 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.455 HD11 HG23 ' A' ' 48' ' ' ILE . 4.3 mm? -111.14 138.46 47.55 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.972 0.909 . . . . 64.310000000000002 111.985 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 2.0 tm-20 -151.16 83.0 1.32 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.887 -1.051 . . . . 74.519999999999996 108.899 170.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -87.9 70.55 9.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.848 -0.797 . . . . 44.039999999999999 108.848 178.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 45.55 71.53 0.27 Allowed 'General case' 0 C--O 1.244 0.783 0 C-N-CA 125.255 1.422 . . . . 72.319999999999993 111.542 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.15 -24.1 33.08 Favored Glycine 0 C--N 1.304 -1.226 0 CA-C-N 115.466 -0.788 . . . . 45.32 112.207 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 99.0 mttt -88.53 103.13 15.6 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.417 -0.957 . . . . 71.420000000000002 108.417 175.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -106.78 146.96 30.24 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 120.307 -0.557 . . . . 72.420000000000002 110.515 -175.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . 177.72 177.42 46.52 Favored Glycine 0 CA--C 1.48 -2.148 0 C-N-CA 120.202 -0.999 . . . . 60.530000000000001 112.528 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 32.2 mt -132.22 145.19 35.09 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 106.796 -1.557 . . . . 73.019999999999996 106.796 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 100.0 t -122.5 109.22 23.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 108.208 -1.034 . . . . 53.530000000000001 108.208 172.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -95.05 106.54 18.55 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 123.868 0.867 . . . . 74.200000000000003 110.381 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.3 t -107.96 112.48 40.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.028 -0.73 . . . . 71.109999999999999 109.028 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.462 ' HD3' ' CE2' ' A' ' 68' ' ' TYR . 58.0 pttt -116.66 135.08 54.08 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 120.906 0.384 . . . . 63.030000000000001 110.867 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.404 HD21 HG21 ' A' ' 41' ' ' VAL . 56.3 mt -106.27 105.69 15.84 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.255 -1.387 . . . . 70.319999999999993 107.255 -175.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 33.8 ttt85 -98.02 118.29 34.28 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.366 -0.605 . . . . 72.340000000000003 109.366 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -70.54 104.01 2.66 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.232 -0.655 . . . . 74.530000000000001 109.232 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.2 tt -78.44 111.26 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 CA-C-O 122.415 1.102 . . . . 52.240000000000002 108.989 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.4 t -138.77 -177.87 5.06 Favored 'General case' 0 N--CA 1.401 -2.903 0 N-CA-C 105.989 -1.856 . . . . 73.049999999999997 105.989 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -75.12 -21.74 58.67 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 118.799 0.727 . . . . 73.340000000000003 110.691 -173.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -96.74 11.37 35.8 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.592 -1.185 . . . . 73.109999999999999 109.686 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 41.3 t -139.92 116.46 8.16 Favored Pre-proline 0 C--N 1.319 -0.739 0 O-C-N 121.177 -0.952 . . . . 63.549999999999997 112.096 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -79.61 131.23 9.23 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.756 2.304 . . . . 71.030000000000001 110.876 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.14 164.15 36.18 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 123.108 2.538 . . . . 75.430000000000007 111.648 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.89 156.82 3.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.726 -0.842 . . . . 71.439999999999998 108.726 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -107.93 140.68 40.7 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.449 -0.945 . . . . 71.400000000000006 108.449 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.58 -171.29 40.12 Favored Glycine 0 CA--C 1.471 -2.67 0 N-CA-C 109.064 -1.614 . . . . 75.310000000000002 109.064 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 27' ' ' MET . 6.9 t-20 -63.63 103.78 0.58 Allowed 'General case' 0 N--CA 1.409 -2.486 0 C-N-CA 123.814 0.846 . . . . 65.010000000000005 110.018 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -89.32 103.08 15.74 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.141 -1.059 . . . . 72.230000000000004 108.141 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 42.6 t -71.19 175.2 5.49 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.054 -0.975 . . . . 72.219999999999999 111.136 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.9 p -60.72 110.3 1.27 Allowed 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.245 1.018 . . . . 61.109999999999999 110.949 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.22 139.12 17.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.884 -0.784 . . . . 64.310000000000002 108.884 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.586 ' HG ' ' H ' ' A' ' 105' ' ' GLU . 15.8 tp -178.72 -159.47 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 104.53 -2.396 . . . . 61.539999999999999 104.53 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.586 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 43.0 mt-10 -81.39 171.61 14.55 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 118.614 0.643 . . . . 75.120000000000005 111.259 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' O ' HG22 ' A' ' 110' ' ' ILE . 1.2 t80 -36.13 -48.5 0.62 Allowed 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 127.59 2.356 . . . . 64.299999999999997 113.351 -173.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.69 -28.5 68.67 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 123.85 0.86 . . . . 74.439999999999998 112.449 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.451 ' HA ' ' NE ' ' A' ' 108' ' ' ARG . 0.8 OUTLIER -87.38 -40.83 14.07 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.348 -0.541 . . . . 73.329999999999998 110.279 -178.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.592 ' O ' HG12 ' A' ' 113' ' ' ILE 0.328 18.5 p-10 -80.52 -26.01 38.37 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 119.377 -0.929 . . . . 61.140000000000001 112.211 -174.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 106' ' ' PHE . 8.6 tp -64.55 -38.97 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 109.457 -0.572 . . . . 74.430000000000007 109.457 173.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.41 -43.32 86.09 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.311 -0.626 . . . . 54.100000000000001 109.311 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 42.9 t -58.5 -44.32 89.4 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.816 -1.084 . . . . 74.120000000000005 111.612 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 109' ' ' ASP . 43.4 mm -65.25 -41.39 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 120.923 -0.311 . . . . 74.239999999999995 110.591 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 110' ' ' ILE . 86.0 t -63.87 -42.87 97.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.544 -0.539 . . . . 64.340000000000003 109.544 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -61.47 -41.77 97.75 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.875 -0.602 . . . . 55.200000000000003 111.534 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.63 97.35 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 123.422 0.451 . . . . 54.210000000000001 111.444 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.3 mt -67.89 -44.79 85.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.165 -0.68 . . . . 72.329999999999998 109.165 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.92 -33.97 77.3 Favored 'General case' 0 C--O 1.211 -0.928 0 CA-C-N 115.702 -0.681 . . . . 70.450000000000003 111.64 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -69.97 -43.36 71.65 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.331 0.586 . . . . 72.310000000000002 110.64 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 5.3 t -70.22 -41.54 73.48 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.402 0.62 . . . . 62.539999999999999 109.594 -176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.422 HD23 ' HB3' ' A' ' 78' ' ' LYS . 9.5 mp -78.13 -15.7 58.62 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.503 -0.771 . . . . 74.200000000000003 111.77 -177.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.41 -38.25 22.17 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 121.034 -0.266 . . . . 51.100000000000001 111.031 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB3' ' NE2' ' A' ' 22' ' ' HIS . 23.1 tptm -62.79 -47.52 83.14 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.264 0.554 . . . . 64.340000000000003 110.103 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.64 -164.21 53.05 Favored Glycine 0 C--N 1.286 -2.229 0 CA-C-N 114.326 -1.306 . . . . 73.140000000000001 114.341 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -63.92 104.78 0.74 Allowed 'General case' 0 C--O 1.246 0.907 0 C-N-CA 124.057 0.943 . . . . 72.420000000000002 110.258 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -175.05 107.62 0.1 Allowed 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 106.434 -1.691 . . . . 64.230000000000004 106.434 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.424 ' HA ' ' OE1' ' A' ' 21' ' ' GLU . 3.0 t-20 -54.41 112.07 0.92 Allowed 'General case' 0 N--CA 1.469 0.521 0 O-C-N 124.154 0.908 . . . . 64.450000000000003 109.235 177.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 22.8 t -142.13 16.4 2.08 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.868 0.842 . . . . 41.310000000000002 110.846 -173.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -170.61 174.75 4.91 Favored 'General case' 0 C--N 1.271 -2.838 0 N-CA-C 107.383 -1.34 . . . . 72.140000000000001 107.383 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.2 tp -129.19 84.76 2.25 Favored 'General case' 0 N--CA 1.413 -2.288 0 O-C-N 121.677 -0.639 . . . . 74.140000000000001 109.942 176.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.539 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 18.4 mm-40 -116.0 85.86 2.37 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.173 -0.921 . . . . 72.549999999999997 110.415 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.54 62.43 3.08 Favored Glycine 0 N--CA 1.426 -1.981 0 CA-C-N 115.377 -0.828 . . . . 60.240000000000002 112.323 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -104.28 121.05 48.8 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 108.915 -0.772 . . . . 73.219999999999999 108.915 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.53 131.19 22.47 Favored 'Trans proline' 0 C--O 1.244 0.802 0 C-N-CA 122.493 2.129 . . . . 73.439999999999998 112.336 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.6 mm -126.14 102.32 27.63 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 108.582 -0.895 . . . . 73.519999999999996 108.582 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.58 132.09 18.37 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.356 2.038 . . . . 62.329999999999998 111.098 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 60.66 85.57 0.18 Allowed Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 124.094 0.957 . . . . 74.010000000000005 112.34 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -72.59 -27.06 15.86 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.251 1.967 . . . . 73.219999999999999 110.775 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.6 pp -131.63 132.53 44.11 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 107.604 -1.258 . . . . 73.349999999999994 107.604 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 24.6 tp -151.23 133.66 15.46 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.324 -0.991 . . . . 53.420000000000002 108.324 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 61.64 -160.34 29.17 Favored Glycine 0 C--O 1.254 1.398 0 O-C-N 123.985 0.803 . . . . 73.420000000000002 113.26 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 47.5 tp -161.23 79.98 0.6 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.433 -0.58 . . . . 52.25 109.433 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -97.59 91.1 5.26 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.627 -0.879 . . . . 74.420000000000002 108.627 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.1 m -107.89 74.49 0.95 Allowed 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 108.895 -0.78 . . . . 75.200000000000003 108.895 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 18.2 p -94.69 133.84 37.92 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.723 -1.126 . . . . 71.340000000000003 108.213 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 145' ' ' THR . 25.2 mmm180 78.36 158.8 0.18 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.944 0.897 . . . . 72.510000000000005 111.962 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.2 t -162.42 157.79 22.98 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 105.507 -2.034 . . . . 75.109999999999999 105.507 174.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.115 0 N-CA-C 110.026 -1.23 . . . . 51.219999999999999 110.026 -179.69 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.434 ' HE2' ' HB3' ' A' ' 1' ' ' MET . 62.0 mmm . . . . . 0 CA--C 1.494 -1.211 0 N-CA-C 111.965 0.357 . . . . 75.200000000000003 111.965 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -101.71 141.38 34.66 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.26 -1.015 . . . . 71.219999999999999 108.26 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 56.0 m-85 -118.06 142.79 47.03 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.64 -0.504 . . . . 63.219999999999999 109.64 174.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.627 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 32.0 t70 -104.31 115.58 30.64 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 124.475 1.11 . . . . 73.239999999999995 109.627 -172.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.82 117.32 48.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.917 -0.489 . . . . 45.530000000000001 109.861 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.506 HG23 HG22 ' A' ' 28' ' ' VAL . 7.3 p -111.52 124.27 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-O 121.357 0.599 . . . . 74.109999999999999 109.409 176.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 27' ' ' MET . 7.1 tt -123.41 118.27 53.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-O 121.556 0.693 . . . . 74.120000000000005 111.062 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.484 HG12 ' HB3' ' A' ' 26' ' ' PRO . 61.9 mt -106.61 111.77 63.86 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 115.267 -0.878 . . . . 71.030000000000001 109.838 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.509 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 3.3 Cg_endo -87.34 123.79 1.94 Allowed 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.029 1.819 . . . . 72.219999999999999 109.205 171.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -142.74 119.35 11.07 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.484 0.659 . . . . 72.200000000000003 111.076 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 22' ' ' HIS . 49.4 m -77.36 116.65 18.14 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.233 -0.44 . . . . 70.209999999999994 110.298 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.689 ' CE1' ' HB2' ' A' ' 79' ' ' LYS . 1.8 p90 -65.46 123.99 21.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.65 0.738 . . . . 75.219999999999999 112.035 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 39.4 m80 -139.71 146.39 39.54 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.951 -1.022 . . . . 73.439999999999998 110.299 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -82.13 104.89 12.79 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-O 122.443 1.116 . . . . 72.409999999999997 109.927 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -67.47 100.7 0.88 Allowed 'General case' 0 N--CA 1.398 -3.036 0 CA-C-N 113.201 -1.818 . . . . 61.329999999999998 109.165 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -87.31 -94.48 0.09 Allowed 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.474 -0.785 . . . . 72.129999999999995 111.885 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 1.8 tmtp? -112.77 -57.8 2.24 Favored 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 119.32 -0.952 . . . . 73.349999999999994 112.729 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -121.98 -26.53 4.76 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 118.975 -1.09 . . . . 62.340000000000003 112.901 -169.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -137.34 169.9 17.0 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.333 -0.617 . . . . 74.5 109.333 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.435 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 64.2 mtm 82.19 70.85 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 126.159 1.783 . . . . 44.439999999999998 111.226 -176.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -161.76 96.33 1.02 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 105.046 -2.205 . . . . 74.25 105.046 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 11' ' ' SER . 39.1 t60 -114.15 89.91 3.21 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 119.24 -0.984 . . . . 73.299999999999997 112.041 -171.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mm -100.99 131.12 49.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 106.529 -1.656 . . . . 71.129999999999995 106.529 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 71.4 m -107.68 130.34 22.95 Favored Pre-proline 0 C--N 1.292 -1.918 0 C-N-CA 119.927 -0.709 . . . . 72.129999999999995 109.099 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -42.62 134.43 5.04 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 124.037 3.158 . . . . 43.509999999999998 113.915 -177.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HB3' HG12 ' A' ' 8' ' ' ILE . 15.7 Cg_endo -59.29 136.77 74.46 Favored 'Trans proline' 0 C--O 1.256 1.393 0 C-N-CA 123.477 2.785 . . . . 75.409999999999997 114.073 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.534 ' HB2' HG23 ' A' ' 7' ' ' ILE . 24.8 mmt -96.52 131.45 43.11 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 105.401 -2.074 . . . . 73.420000000000002 105.401 172.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 6' ' ' VAL . 29.6 t -126.17 129.58 72.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 120.228 -0.589 . . . . 65.239999999999995 110.256 -175.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.3 mm -136.04 101.19 2.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 106.985 -1.487 . . . . 54.409999999999997 106.985 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.627 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -120.01 82.42 0.34 Allowed Glycine 0 CA--C 1.488 -1.604 0 C-N-CA 120.078 -1.058 . . . . 63.119999999999997 112.783 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -158.74 26.21 0.22 Allowed 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.982 -0.609 . . . . 75.209999999999994 111.46 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.56 HH22 HG12 ' A' ' 103' ' ' VAL . 21.3 mmt85 -118.04 141.97 47.9 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 107.828 -1.175 . . . . 74.230000000000004 107.828 -174.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.8 p -75.86 172.6 12.42 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 118.842 0.746 . . . . 73.120000000000005 109.481 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.532 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 60.1 t80 -55.19 -47.53 75.12 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.35 0.595 . . . . 65.049999999999997 112.139 -174.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.02 -40.01 78.9 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.343 -0.844 . . . . 63.329999999999998 111.197 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.72 -33.33 43.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.248 -0.433 . . . . 65.329999999999998 110.218 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.417 ' O ' HG22 ' A' ' 40' ' ' ILE . . . -65.28 -44.8 86.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.408 -0.36 . . . . 73.120000000000005 110.59 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.6 mtm -73.08 -33.34 65.57 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 118.912 -1.115 . . . . 74.209999999999994 111.06 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.11 -44.0 85.57 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.069 -0.514 . . . . 60.030000000000001 110.415 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 37' ' ' ALA . 8.5 tp -65.46 -38.92 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 109.807 -0.442 . . . . 71.219999999999999 109.807 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.448 HG21 HD21 ' A' ' 86' ' ' LEU . 96.8 t -69.29 -39.94 79.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 CA-C-N 116.213 -0.449 . . . . 65.209999999999994 110.196 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -67.84 -28.25 67.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.127 0.489 . . . . 72.019999999999996 110.183 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.43 -47.36 63.42 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.296 -1.121 . . . . 71.409999999999997 110.296 175.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 40' ' ' ILE . 92.9 t -62.7 -41.96 94.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.452 -0.573 . . . . 74.430000000000007 109.452 177.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -53.38 -53.05 56.71 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 125.265 1.426 . . . . 72.310000000000002 110.565 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.42 ' HA ' ' CD ' ' A' ' 49' ' ' LYS . 61.9 mtm180 -71.1 -23.77 62.17 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.511 -0.768 . . . . 75.219999999999999 112.523 -175.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 43' ' ' GLY . 94.3 t -78.2 -44.87 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 C-N-CA 120.522 -0.471 . . . . 70.239999999999995 110.47 175.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.429 HG22 ' HB2' ' A' ' 54' ' ' ALA . 54.9 mt -73.17 -33.77 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 120.537 -0.465 . . . . 72.439999999999998 111.456 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 13.3 ptmt -74.4 -16.22 60.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.391 0.615 . . . . 61.149999999999999 110.455 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 144' ' ' SER . . . -95.7 -49.79 5.21 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 115.318 -0.856 . . . . 64.209999999999994 111.081 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 t -77.07 -22.53 52.7 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 123.528 0.731 . . . . 64.319999999999993 112.649 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -127.7 -172.75 2.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.608 0.718 . . . . 64.140000000000001 110.8 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 18.6 t-20 -105.21 89.68 3.2 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 104.326 -2.472 . . . . 74.430000000000007 104.326 172.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' A' ' 49' ' ' LYS . . . -108.13 135.89 48.72 Favored 'General case' 0 N--CA 1.407 -2.599 0 CA-C-N 115.169 -0.923 . . . . 72.349999999999994 112.029 -172.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.5 m -115.6 110.73 19.62 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 106.171 -1.789 . . . . 54.149999999999999 106.171 172.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.85 118.72 46.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.54 -0.541 . . . . 72.019999999999996 109.54 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.56 ' HG3' ' HB2' ' A' ' 70' ' ' LYS . 9.2 pt-20 -120.88 122.32 40.0 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.123 -0.695 . . . . 73.430000000000007 109.123 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.449 ' HG2' ' HG2' ' A' ' 69' ' ' ARG . 42.7 mt-10 -95.28 130.44 42.04 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.814 -0.63 . . . . 75.140000000000001 111.37 -175.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.2 mp -125.52 176.5 6.8 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.437 -0.801 . . . . 72.209999999999994 109.324 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -105.27 139.14 40.36 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-O 121.198 0.523 . . . . 72.120000000000005 109.846 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.26 176.44 41.96 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 110.514 -1.034 . . . . 52.229999999999997 110.514 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.518 ' N ' ' HB2' ' A' ' 65' ' ' ASP . 26.7 mm-40 -65.51 -176.17 0.32 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 122.102 0.953 . . . . 65.010000000000005 111.67 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.69 -34.93 78.94 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.688 -1.142 . . . . 63.350000000000001 110.084 172.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.9 t -77.1 -22.06 53.31 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.591 -1.186 . . . . 62.539999999999999 108.997 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.518 ' HB2' ' N ' ' A' ' 62' ' ' GLU . 67.3 m-20 -93.53 172.46 8.25 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 109.024 -0.732 . . . . 74.319999999999993 109.024 177.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.1 t -117.7 -43.27 2.97 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 CA-C-O 121.513 0.673 . . . . 74.430000000000007 110.382 174.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.1 tp -157.34 149.1 22.28 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.73 -0.668 . . . . 65.230000000000004 109.724 -172.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.26 135.36 47.27 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.595 -0.891 . . . . 75.200000000000003 108.595 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.449 ' HG2' ' HG2' ' A' ' 58' ' ' GLU . 88.6 mtt180 -132.27 129.42 39.57 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.227 -0.296 . . . . 75.129999999999995 110.76 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.56 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . 6.4 mtpm? -105.55 116.56 32.15 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 105.615 -1.995 . . . . 73.430000000000007 105.615 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.425 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 71.6 m-85 -101.54 106.08 17.13 Favored 'General case' 0 C--N 1.263 -3.184 0 N-CA-C 107.678 -1.23 . . . . 74.120000000000005 107.678 174.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.3 m -91.93 112.44 24.37 Favored 'General case' 0 C--N 1.276 -2.628 0 N-CA-C 107.672 -1.233 . . . . 65.219999999999999 107.672 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.83 149.39 37.13 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.286 0.565 . . . . 65.340000000000003 111.023 -173.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 42.7 tt0 -150.25 98.26 2.65 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.991 -1.004 . . . . 74.439999999999998 109.8 168.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -105.91 88.66 2.86 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 115.872 -0.604 . . . . 65.239999999999995 109.674 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.295 5.7 pt-20 36.74 74.29 0.08 Allowed 'General case' 0 C--O 1.243 0.749 0 C-N-CA 125.825 1.65 . . . . 70.239999999999995 114.974 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.37 -23.91 34.37 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 113.604 -1.635 . . . . 71.219999999999999 112.47 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 57.9 mtmt -95.12 94.74 8.11 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 122.368 -0.489 . . . . 75.329999999999998 109.701 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.689 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 2.3 ptpp? -113.54 124.0 51.34 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.242 -0.89 . . . . 73.129999999999995 111.211 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.416 ' HA2' ' H ' ' A' ' 12' ' ' PHE . . . -173.04 172.49 45.16 Favored Glycine 0 CA--C 1.491 -1.411 0 C-N-CA 120.967 -0.635 . . . . 61.130000000000003 112.0 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.9 mt -121.65 145.99 27.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.552 -0.907 . . . . 61.350000000000001 108.552 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 95.6 t -119.94 110.34 28.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 108.512 -0.921 . . . . 63.420000000000002 108.512 174.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.518 ' CD2' ' HG2' ' A' ' 70' ' ' LYS . 33.0 m170 -94.94 107.85 19.89 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.816 -0.629 . . . . 73.230000000000004 110.196 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.14 118.49 53.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 115.792 -0.64 . . . . 74.0 109.565 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -111.82 142.39 44.25 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.203 -0.666 . . . . 65.430000000000007 109.203 173.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.448 HD21 HG21 ' A' ' 41' ' ' VAL . 92.5 mt -107.37 123.94 49.1 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 103.549 -2.759 . . . . 51.210000000000001 103.549 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 41.6 mtp-105 -112.84 155.92 23.81 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 109.267 -0.642 . . . . 74.25 109.267 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -98.06 105.49 17.64 Favored 'General case' 0 C--N 1.282 -2.346 0 C-N-CA 120.327 -0.549 . . . . 64.329999999999998 110.485 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 tt -82.81 110.17 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 107.749 -1.204 . . . . 71.109999999999999 107.749 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 m -145.85 -175.39 4.72 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 105.045 -2.206 . . . . 62.530000000000001 105.045 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -15.9 63.04 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 120.087 1.312 . . . . 71.329999999999998 110.458 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -81.07 -23.95 38.12 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.949 -1.023 . . . . 71.109999999999999 111.803 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 40.8 m -145.35 117.61 5.23 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 112.472 0.545 . . . . 64.439999999999998 112.472 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 93' ' ' CYS . 2.7 Cg_exo -73.59 158.49 47.4 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 122.622 2.215 . . . . 64.310000000000002 110.499 175.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.3 160.37 49.03 Favored 'Trans proline' 0 C--O 1.255 1.337 0 C-N-CA 122.789 2.326 . . . . 64.140000000000001 110.65 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 t -82.93 149.46 4.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 107.24 -1.393 . . . . 53.509999999999998 107.24 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -112.38 112.81 24.65 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 106.75 -1.574 . . . . 70.209999999999994 106.75 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -151.51 -157.62 7.97 Favored Glycine 0 CA--C 1.461 -3.309 0 C-N-CA 120.165 -1.017 . . . . 62.439999999999998 112.018 -174.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' A' ' 27' ' ' MET . 35.5 m-80 -76.58 104.23 6.98 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.798 -0.816 . . . . 65.25 108.798 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -83.11 112.32 19.7 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-O 121.651 0.739 . . . . 75.349999999999994 109.387 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.488 ' HB3' HG23 ' A' ' 103' ' ' VAL . 4.8 t -70.29 153.02 43.53 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.914 -1.513 . . . . 74.540000000000006 106.914 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.424 ' N ' ' SG ' ' A' ' 112' ' ' CYS . 15.5 m -69.84 77.63 0.46 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.426 1.107 . . . . 73.129999999999995 109.906 178.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.56 HG12 HH22 ' A' ' 32' ' ' ARG . 76.9 t -124.57 149.45 28.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 C-N-CA 125.429 1.491 . . . . 75.040000000000006 108.635 -173.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.2 mt -161.15 -82.61 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 125.625 1.57 . . . . 74.519999999999996 109.296 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -98.4 150.37 21.68 Favored 'General case' 0 C--N 1.262 -3.197 0 CA-C-N 114.109 -1.405 . . . . 75.340000000000003 108.948 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.518 ' HA ' ' HB3' ' A' ' 109' ' ' ASP . 74.6 t80 -46.34 -44.05 16.52 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.365 1.246 . . . . 70.219999999999999 114.365 -172.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -62.55 -35.61 79.99 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 112.587 0.588 . . . . 72.319999999999993 112.587 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -90.82 -30.7 16.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.441 0.639 . . . . 72.010000000000005 109.571 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.518 ' HB3' ' HA ' ' A' ' 106' ' ' PHE . 7.9 t0 -55.74 -55.15 35.7 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 125.731 1.613 . . . . 65.540000000000006 109.642 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.6 tp -59.78 -38.04 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 O-C-N 123.966 0.792 . . . . 63.049999999999997 110.865 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 40.3 mt-10 -69.5 -38.46 77.62 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 120.479 -0.488 . . . . 71.310000000000002 111.492 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 102' ' ' SER . 10.0 t -65.91 -40.77 91.78 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.0 -0.68 . . . . 44.229999999999997 109.36 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 117' ' ' ILE . 49.4 mm -64.41 -46.54 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 115.521 -0.763 . . . . 72.239999999999995 110.223 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 72.7 t -63.91 -41.88 93.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.52 -0.309 . . . . 64.030000000000001 110.732 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 111' ' ' GLU . 29.4 mtpp -67.19 -30.33 70.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 111.7 0.259 . . . . 75.230000000000004 111.7 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.37 -40.8 67.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.018 0.437 . . . . 53.329999999999998 110.298 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.57 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 83.0 mt -66.05 -45.78 89.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.137 -0.69 . . . . 73.409999999999997 109.137 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -57.57 -42.32 82.84 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.842 -0.617 . . . . 74.549999999999997 111.576 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -65.9 -41.9 90.91 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.539 -0.755 . . . . 74.400000000000006 110.288 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 15.1 t -70.17 -39.68 75.13 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.826 -0.435 . . . . 55.210000000000001 109.826 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 117' ' ' ILE . 61.4 mt -72.76 -37.39 67.68 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 116.423 -0.353 . . . . 73.420000000000002 111.359 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.89 -14.22 51.62 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 112.565 0.58 . . . . 61.340000000000003 112.565 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -66.63 -21.62 66.12 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.288 0.566 . . . . 74.439999999999998 112.432 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.88 -161.54 47.81 Favored Glycine 0 C--N 1.296 -1.681 0 CA-C-N 115.617 -0.72 . . . . 53.200000000000003 114.894 173.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.77 83.43 3.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.79 1.281 . . . . 65.099999999999994 112.498 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -128.17 123.26 33.9 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.544 -2.021 . . . . 73.25 105.544 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -76.13 126.04 30.25 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.429 -0.908 . . . . 73.140000000000001 111.753 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.3 t -135.82 97.39 3.63 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 105.714 -1.958 . . . . 72.200000000000003 105.714 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -90.7 103.78 16.44 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 114.628 -1.169 . . . . 75.019999999999996 110.783 -171.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.3 tp -149.08 172.9 14.02 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 107.713 -1.218 . . . . 65.030000000000001 107.713 -176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -70.71 109.65 5.06 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.186 0.517 . . . . 74.239999999999995 112.219 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -144.09 -161.9 9.17 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 107.076 -2.41 . . . . 63.420000000000002 107.076 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -163.81 75.62 1.73 Allowed Pre-proline 0 C--N 1.306 -1.315 0 CA-C-N 118.108 0.954 . . . . 75.219999999999999 109.927 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.95 92.94 0.33 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.841 2.361 . . . . 62.420000000000002 113.352 -176.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.516 ' HB ' ' HE3' ' A' ' 70' ' ' LYS . 47.5 mm -115.99 102.9 53.84 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 107.542 -1.281 . . . . 73.540000000000006 107.542 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.82 170.79 9.55 Favored 'Trans proline' 0 C--O 1.252 1.212 0 C-N-CA 123.744 2.963 . . . . 55.530000000000001 114.11 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.452 ' O ' HD22 ' A' ' 139' ' ' LEU . 21.8 t-20 -137.11 150.26 68.76 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 105.181 -2.155 . . . . 64.040000000000006 105.181 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.5 -0.06 6.96 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 122.253 1.969 . . . . 72.109999999999999 113.24 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.452 HD22 ' O ' ' A' ' 137' ' ' ASN . 3.4 mm? 71.82 113.09 0.06 Allowed 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.221 1.409 . . . . 72.329999999999998 112.602 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -138.01 98.32 3.61 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.27 -1.382 . . . . 75.019999999999996 107.27 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -170.47 175.79 44.24 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 109.722 -1.351 . . . . 75.420000000000002 109.722 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.4 tp -161.06 136.79 8.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 117.517 0.659 . . . . 54.039999999999999 109.348 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.44 110.58 0.8 Allowed 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 123.932 0.77 . . . . 74.340000000000003 110.479 176.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.459 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 7.6 m -115.42 84.67 2.13 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 106.846 -1.538 . . . . 54.310000000000002 106.846 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.5 m -67.11 -18.17 65.19 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.337 -0.847 . . . . 70.340000000000003 112.372 -172.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 67.47 -171.65 0.19 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.893 0.877 . . . . 73.120000000000005 108.847 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.1 t -81.77 97.7 8.09 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.956 0.884 . . . . 73.519999999999996 109.779 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.257 0 N-CA-C 108.854 -1.698 . . . . 71.430000000000007 108.854 -178.594 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.474 0 N-CA-C 106.803 -1.554 . . . . 73.239999999999995 106.803 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -138.63 163.24 32.6 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.433 0.635 . . . . 74.430000000000007 112.173 -172.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 46.2 m-85 -119.7 145.29 46.65 Favored 'General case' 0 C--O 1.251 1.144 0 C-N-CA 124.266 1.026 . . . . 74.409999999999997 110.616 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.604 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 30.6 t70 -115.44 111.23 20.47 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 125.542 1.537 . . . . 63.32 107.204 -175.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 p -96.65 127.87 48.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 122.119 -0.363 . . . . 65.340000000000003 110.916 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.577 HG23 HG22 ' A' ' 28' ' ' VAL . 4.8 p -117.9 127.48 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 115.923 -0.58 . . . . 60.310000000000002 111.177 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.429 HG23 ' HB2' ' A' ' 27' ' ' MET . 3.2 tt -115.62 112.86 41.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.473 -0.785 . . . . 72.409999999999997 109.698 176.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.436 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 3.3 mp -98.92 109.2 52.93 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 108.247 -1.02 . . . . 41.340000000000003 108.247 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 17.7 Cg_endo -93.9 138.6 1.27 Allowed 'Trans proline' 0 N--CA 1.436 -1.895 0 C-N-CA 122.193 1.928 . . . . 64.439999999999998 110.684 173.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -159.13 130.61 6.29 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 110.189 -0.3 . . . . 50.130000000000003 110.189 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.526 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.3 m -69.82 121.37 17.14 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.001 -0.74 . . . . 72.150000000000006 109.001 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.561 ' CE1' ' HD3' ' A' ' 79' ' ' LYS . 21.3 p90 -70.01 101.58 1.83 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 112.529 0.566 . . . . 64.239999999999995 112.529 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.482 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 81.9 m-70 -146.65 151.34 37.08 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.991 -0.549 . . . . 74.099999999999994 111.77 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -80.41 119.44 23.11 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 106.905 -1.517 . . . . 73.230000000000004 106.905 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -62.04 104.41 0.46 Allowed 'General case' 0 N--CA 1.406 -2.654 0 O-C-N 124.527 1.142 . . . . 72.420000000000002 109.383 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -87.22 -155.02 0.26 Allowed 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 113.957 -1.474 . . . . 54.340000000000003 108.668 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -81.56 -56.88 3.74 Favored 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 121.45 -0.781 . . . . 74.400000000000006 112.412 -175.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -136.12 15.01 3.28 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.824 0.821 . . . . 63.119999999999997 110.207 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -148.57 157.34 43.4 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.919 -1.141 . . . . 65.120000000000005 107.919 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.482 ' CG ' ' HB3' ' A' ' 13' ' ' HIS . 41.4 ttp 63.53 62.31 0.95 Allowed 'General case' 0 C--N 1.348 0.519 0 CA-C-O 122.848 1.308 . . . . 62.009999999999998 109.658 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -148.3 96.05 2.55 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.688 -1.596 . . . . 62.149999999999999 107.562 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.502 ' CE1' ' HB2' ' A' ' 128' ' ' SER . 41.6 t60 -141.84 113.67 7.93 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.994 -1.083 . . . . 62.409999999999997 110.925 175.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.1 mm -126.93 126.91 69.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 106.394 -1.706 . . . . 73.450000000000003 106.394 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 46.6 m -107.68 149.85 39.46 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 112.264 0.468 . . . . 64.049999999999997 112.264 -171.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 33.3 Cg_endo -65.3 129.74 23.55 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.27 2.647 . . . . 75.25 112.367 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 20.1 Cg_exo -68.26 133.35 28.24 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.35 2.033 . . . . 75.120000000000005 112.199 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.429 ' HB2' HG23 ' A' ' 7' ' ' ILE . 25.0 mmt -86.96 131.32 34.13 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.67 -1.604 . . . . 74.219999999999999 106.67 174.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.577 HG22 HG23 ' A' ' 6' ' ' VAL . 19.0 t -127.64 127.91 69.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 109.503 -0.554 . . . . 62.539999999999999 109.503 -177.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.8 mm -126.65 114.4 37.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.561 -0.903 . . . . 74.439999999999998 108.561 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -127.87 82.14 0.34 Allowed Glycine 0 CA--C 1.48 -2.144 0 C-N-CA 119.06 -1.543 . . . . 50.210000000000001 114.531 -175.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -156.92 21.94 0.32 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.327 -0.936 . . . . 72.420000000000002 109.545 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.437 HH11 HD12 ' A' ' 40' ' ' ILE . 1.1 mmp_? -95.51 146.43 24.44 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.132 -1.433 . . . . 64.230000000000004 107.132 -172.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 p -85.07 175.6 8.92 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 105.947 -1.871 . . . . 72.299999999999997 105.947 168.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.491 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 76.8 t80 -60.41 -41.94 94.96 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 118.699 0.681 . . . . 72.120000000000005 110.695 -176.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -67.85 -41.58 82.72 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.48 -1.236 . . . . 63.340000000000003 111.197 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mm -74.01 -29.85 26.43 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 N-CA-C 109.613 -0.514 . . . . 71.150000000000006 109.613 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.407 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -63.42 -45.2 92.06 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.87 -0.605 . . . . 44.039999999999999 109.991 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.1 mmt -67.79 -39.46 84.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.225 -0.443 . . . . 73.420000000000002 110.713 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -69.43 -34.65 74.75 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.957 1.095 . . . . 65.109999999999999 113.957 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.52 ' O ' HG23 ' A' ' 44' ' ' VAL . 13.9 tt -70.46 -41.75 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 119.125 -1.03 . . . . 73.349999999999994 109.665 176.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 82.5 t -62.37 -44.1 98.85 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.369 0 N-CA-C 109.41 -0.589 . . . . 73.430000000000007 109.41 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -58.32 -41.84 85.42 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 123.119 0.568 . . . . 73.239999999999995 110.993 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.22 -43.55 92.79 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.62 -0.8 . . . . 74.25 111.401 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 40' ' ' ILE . 97.4 t -65.84 -41.32 89.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.31 -0.626 . . . . 71.010000000000005 109.31 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.93 -46.34 85.18 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 125.298 1.439 . . . . 63.310000000000002 110.717 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -64.8 -44.16 90.84 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.549 -1.205 . . . . 72.400000000000006 110.644 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.9 t -66.87 -38.95 82.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 116.266 -0.425 . . . . 65.340000000000003 110.759 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.487 HG23 HD11 ' A' ' 73' ' ' LEU . 66.1 mt -68.79 -41.87 82.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 121.029 -0.268 . . . . 74.319999999999993 111.675 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -80.39 -17.8 50.81 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 118.749 -1.18 . . . . 65.450000000000003 110.993 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.63 -43.02 8.48 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 112.371 0.508 . . . . 65.430000000000007 112.371 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.3 m -83.27 -16.13 47.52 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 112.801 0.667 . . . . 43.020000000000003 112.801 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -138.13 -174.49 3.81 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.097 0.475 . . . . 71.129999999999995 110.351 -174.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -103.78 105.86 16.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.014 -1.847 . . . . 74.450000000000003 106.014 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.67 136.4 40.9 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 112.948 0.722 . . . . 72.239999999999995 112.948 -174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -100.49 115.52 30.27 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.329 -1.73 . . . . 74.230000000000004 106.329 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 p -100.98 123.07 53.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.26 0.552 . . . . 64.329999999999998 111.437 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -130.67 119.75 22.88 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.107 -0.497 . . . . 72.439999999999998 110.772 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -82.51 137.41 34.63 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.014 -0.539 . . . . 61.340000000000003 110.173 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.4 mt -134.25 171.83 13.71 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.661 -0.866 . . . . 74.209999999999994 108.661 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -99.35 162.04 13.27 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.499 -0.556 . . . . 74.319999999999993 109.499 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.75 177.48 16.43 Favored Glycine 0 C--N 1.278 -2.681 0 N-CA-C 109.292 -1.523 . . . . 52.009999999999998 109.292 178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.509 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 12.8 pt-20 -65.84 179.48 0.87 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.437 -0.579 . . . . 72.140000000000001 109.437 175.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.04 -27.56 69.19 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 122.09 0.948 . . . . 73.530000000000001 111.474 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.8 t -77.42 -16.66 58.7 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.703 -1.135 . . . . 70.430000000000007 109.869 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.509 ' OD2' ' HG2' ' A' ' 62' ' ' GLU . 78.2 m-20 -101.24 157.72 16.57 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 108.436 -0.949 . . . . 74.209999999999994 108.436 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.471 HG21 ' CE2' ' A' ' 3' ' ' TYR . 36.9 t -104.56 -44.2 8.57 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-O 121.579 0.704 . . . . 73.409999999999997 110.314 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.1 tp -163.0 153.08 15.99 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.826 -1.176 . . . . 53.299999999999997 107.826 -174.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -130.08 128.34 41.69 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 106.873 -1.529 . . . . 75.450000000000003 106.873 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -123.43 108.51 12.77 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 107.351 -1.352 . . . . 73.530000000000001 107.351 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.439 ' HE3' ' HB3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -109.99 117.7 34.47 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.105 0.478 . . . . 71.140000000000001 110.218 -175.212 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -107.44 132.98 52.61 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.248 -0.649 . . . . 74.299999999999997 109.248 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.7 m -97.75 113.39 25.16 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 107.087 -1.449 . . . . 65.329999999999998 107.087 171.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.487 HD11 HG23 ' A' ' 48' ' ' ILE . 4.1 mm? -98.18 139.19 34.34 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 124.306 1.042 . . . . 73.329999999999998 113.51 -173.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -140.41 139.41 35.26 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-N 113.87 -1.514 . . . . 73.150000000000006 107.057 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -132.68 176.52 8.38 Favored 'General case' 0 C--N 1.263 -3.185 0 N-CA-C 102.686 -3.079 . . . . 75.25 102.686 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.3 0.0 OUTLIER -62.86 90.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 115.112 1.523 . . . . 73.329999999999998 115.112 -177.24 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.26 2.19 77.55 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 114.709 -1.132 . . . . 72.510000000000005 112.8 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 55.3 mttp -130.22 143.38 50.75 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.753 -0.832 . . . . 72.030000000000001 108.753 -174.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.561 ' HD3' ' CE1' ' A' ' 12' ' ' PHE . 14.8 ptpt -151.69 156.2 39.86 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 112.737 0.643 . . . . 62.439999999999998 112.737 -169.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -177.65 170.68 43.17 Favored Glycine 0 C--O 1.2 -2.004 0 CA-C-N 115.372 -0.831 . . . . 73.109999999999999 111.383 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.9 mt -115.75 138.14 47.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 107.684 -1.228 . . . . 74.329999999999998 107.684 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.6 t -115.99 110.37 31.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 109.003 -0.74 . . . . 70.200000000000003 109.003 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 31.2 m-70 -100.73 103.97 15.23 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.484 -0.78 . . . . 75.120000000000005 109.044 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.6 t -109.6 109.75 29.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.268 -0.641 . . . . 71.310000000000002 109.268 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -122.72 149.69 43.74 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 119.488 -0.885 . . . . 75.120000000000005 110.418 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.407 HD22 ' HB1' ' A' ' 37' ' ' ALA . 92.7 mt -99.16 126.54 44.95 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 107.736 -1.209 . . . . 75.049999999999997 107.736 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.5 ttt85 -115.95 134.52 54.89 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 108.273 -1.01 . . . . 75.219999999999999 108.273 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.501 ' HG2' HG23 ' A' ' 90' ' ' THR . 38.4 ttmt -81.06 98.3 7.92 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 116.295 -0.412 . . . . 73.109999999999999 111.482 -176.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.6 tt -75.04 111.4 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 122.235 1.017 . . . . 62.119999999999997 108.825 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.501 HG23 ' HG2' ' A' ' 88' ' ' LYS . 4.5 p -145.15 -171.21 3.61 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-N 114.943 -1.026 . . . . 64.219999999999999 108.941 -172.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -78.79 -4.55 49.97 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.967 0.889 . . . . 72.340000000000003 109.279 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -98.8 -23.34 15.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.312 -0.858 . . . . 70.099999999999994 109.607 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 96.9 m -138.46 118.05 9.71 Favored Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 112.145 0.424 . . . . 52.130000000000003 112.145 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.58 157.48 36.15 Favored 'Trans proline' 0 C--O 1.25 1.119 0 C-N-CA 122.037 1.825 . . . . 75.109999999999999 109.651 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.97 160.7 32.55 Favored 'Trans proline' 0 C--O 1.255 1.329 0 C-N-CA 123.074 2.516 . . . . 73.340000000000003 112.502 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 t -81.2 144.71 10.02 Favored 'Isoleucine or valine' 0 C--O 1.252 1.201 0 N-CA-C 108.493 -0.928 . . . . 74.150000000000006 108.493 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -97.24 85.89 3.79 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 121.953 0.882 . . . . 74.329999999999998 110.809 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -129.37 -158.61 9.59 Favored Glycine 0 N--CA 1.412 -2.959 0 N-CA-C 109.362 -1.495 . . . . 70.219999999999999 109.362 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -80.91 98.43 7.88 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 108.274 -1.01 . . . . 52.140000000000001 108.274 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 64.2 mtp85 -86.63 93.63 9.26 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 108.064 -1.087 . . . . 75.519999999999996 108.064 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 19.3 t -72.51 168.38 18.67 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 113.854 -1.521 . . . . 44.409999999999997 113.144 -170.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.4 m -73.53 105.9 5.08 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 124.726 1.21 . . . . 73.030000000000001 111.028 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.9 t -84.89 155.03 3.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.799 -1.092 . . . . 65.230000000000004 108.866 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.5 tp -150.35 -68.59 0.19 Allowed 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.686 1.231 . . . . 70.439999999999998 109.177 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.32 165.61 35.34 Favored 'General case' 1 C--N 1.237 -4.297 0 N-CA-C 103.224 -2.88 . . . . 55.43 103.224 178.244 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' O ' HG22 ' A' ' 110' ' ' ILE . 91.6 t80 -45.98 -36.39 5.52 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.781 1.03 . . . . 74.109999999999999 113.781 -173.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -58.12 -40.45 81.25 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 113.341 0.867 . . . . 73.420000000000002 113.341 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -88.2 -30.41 19.76 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 119.929 -0.708 . . . . 71.109999999999999 109.337 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.44 -47.02 83.6 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.932 -1.031 . . . . 70.25 109.379 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 106' ' ' PHE . 10.3 tp -69.0 -31.71 51.55 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 CA-C-N 116.14 -0.482 . . . . 74.329999999999998 109.826 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -63.81 -41.86 97.79 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.699 -0.482 . . . . 75.420000000000002 109.699 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 53.6 t -70.2 -40.22 74.72 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.001 -0.545 . . . . 45.43 110.178 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.07 -45.18 99.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.81 -0.632 . . . . 62.420000000000002 111.379 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.27 -41.76 92.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.618 0.247 . . . . 61.350000000000001 110.37 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -69.73 -23.79 63.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.464 0.542 . . . . 72.329999999999998 112.464 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.62 -43.94 58.32 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.972 -0.381 . . . . 74.209999999999994 109.972 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.15 -45.45 98.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.359 -0.608 . . . . 75.329999999999998 109.359 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -61.74 -38.23 87.19 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 116.059 -0.519 . . . . 74.329999999999998 111.541 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -64.11 -46.43 84.2 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 108.989 -0.745 . . . . 73.120000000000005 108.989 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 5.6 t -70.69 -29.88 66.3 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.387 -0.824 . . . . 55.420000000000002 111.25 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.29 -37.27 28.71 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.58 -0.7 . . . . 65.450000000000003 111.421 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . . . -76.78 -36.01 57.29 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 111.956 0.354 . . . . 52.210000000000001 111.956 -177.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -99.53 9.94 42.29 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 110.014 -0.365 . . . . 65.129999999999995 110.014 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.485 ' HA2' ' CD2' ' A' ' 22' ' ' HIS . . . -71.7 33.37 0.59 Allowed Glycine 0 C--N 1.334 0.469 0 N-CA-C 117.304 1.682 . . . . 60.109999999999999 117.304 -171.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.94 54.54 0.08 Allowed 'General case' 0 C--N 1.268 -2.96 0 N-CA-C 106.365 -1.717 . . . . 72.519999999999996 106.365 177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -155.62 134.58 12.08 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 104.258 -2.497 . . . . 34.399999999999999 104.258 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -69.25 93.62 0.64 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.244 1.021 . . . . 73.340000000000003 113.233 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.502 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 49.6 m -134.46 123.88 24.72 Favored 'General case' 0 N--CA 1.395 -3.18 0 N-CA-C 103.318 -2.845 . . . . 61.149999999999999 103.318 171.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -153.09 109.0 3.32 Favored 'General case' 0 N--CA 1.412 -2.357 0 C-N-CA 119.243 -0.983 . . . . 74.420000000000002 111.845 -171.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.5 tp -94.36 93.55 7.76 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.546 -2.02 . . . . 62.450000000000003 105.546 168.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -66.48 115.99 6.98 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.166 -0.924 . . . . 75.299999999999997 111.105 -172.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.47 170.59 26.77 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 114.069 -1.423 . . . . 75.010000000000005 114.135 -175.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -123.24 152.11 63.38 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.009 -0.737 . . . . 71.150000000000006 109.009 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.78 95.28 0.88 Allowed 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 121.843 1.695 . . . . 75.109999999999999 110.68 176.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.4 mm -83.67 121.75 76.37 Favored Pre-proline 0 N--CA 1.41 -2.429 0 N-CA-C 106.267 -1.753 . . . . 63.009999999999998 106.267 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -60.09 157.25 35.35 Favored 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 123.248 2.632 . . . . 64.120000000000005 111.692 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -122.28 85.48 47.18 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 109.344 -0.613 . . . . 60.119999999999997 109.344 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.47 ' HD2' ' OE1' ' A' ' 62' ' ' GLU . 12.1 Cg_exo -74.06 100.54 1.3 Allowed 'Trans proline' 0 N--CA 1.433 -2.08 0 C-N-CA 121.811 1.674 . . . . 65.120000000000005 110.905 175.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.02 136.6 35.22 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.069 -1.456 . . . . 72.219999999999999 107.069 171.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 66.28 104.35 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.156 0.983 . . . . 75.409999999999997 111.392 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -137.6 -65.12 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 110.437 -1.065 . . . . 74.230000000000004 110.437 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.8 tp -148.71 102.17 3.27 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.843 0.354 . . . . 43.43 110.835 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -114.57 -5.2 12.78 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.998 0.428 . . . . 73.099999999999994 109.928 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.5 m -59.97 108.38 0.76 Allowed 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 123.787 0.835 . . . . 53.009999999999998 113.187 -175.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.9 t -144.31 27.5 1.4 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.195 -1.409 . . . . 74.239999999999995 107.195 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.3 97.02 7.35 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 106.23 -1.767 . . . . 73.209999999999994 106.23 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 32.8 m 73.36 105.7 0.07 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.695 1.198 . . . . 70.109999999999999 111.372 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.144 0 N-CA-C 110.634 -0.986 . . . . 24.399999999999999 110.634 179.21 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.635 0 N-CA-C 105.66 -1.978 . . . . 74.25 105.66 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.01 139.07 32.05 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.327 0.584 . . . . 71.209999999999994 112.055 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.654 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 62.9 m-85 -125.93 137.07 53.68 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.001 -1.0 . . . . 74.25 109.333 176.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.481 ' OD1' ' HB ' ' A' ' 89' ' ' ILE . 4.9 m-20 -101.83 122.1 43.34 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.477 -0.783 . . . . 73.510000000000005 108.898 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 p -95.53 109.14 22.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 108.339 -0.986 . . . . 64.120000000000005 108.339 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 28' ' ' VAL . 61.0 t -102.96 106.28 19.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.921 -1.14 . . . . 70.129999999999995 107.921 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -105.67 118.48 53.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 CA-C-N 115.577 -0.738 . . . . 71.140000000000001 109.858 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.401 HG13 ' HB3' ' A' ' 26' ' ' PRO . 3.5 mp -106.18 108.18 61.22 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 107.927 -1.138 . . . . 74.120000000000005 107.927 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.648 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 28.5 Cg_endo -99.84 120.33 0.11 Allowed 'Trans proline' 0 N--CA 1.429 -2.314 0 C-N-CA 121.772 1.648 . . . . 74.299999999999997 110.908 171.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.713 ' HA ' ' SG ' ' A' ' 120' ' ' CYS . 0.7 OUTLIER -138.69 145.79 40.78 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.154 0.502 . . . . 64.400000000000006 109.901 174.06 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.598 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.6 p -81.76 129.99 34.91 Favored 'General case' 0 N--CA 1.398 -3.062 0 N-CA-C 107.468 -1.308 . . . . 60.439999999999998 107.468 175.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.505 ' CE1' ' HB3' ' A' ' 79' ' ' LYS 0.284 0.0 OUTLIER -73.95 80.63 1.67 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 115.003 1.483 . . . . 75.329999999999998 115.003 -169.143 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -91.12 151.61 20.92 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.444 -1.253 . . . . 75.109999999999999 112.445 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -104.43 -158.25 0.65 Allowed 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 106.152 -1.795 . . . . 75.140000000000001 106.152 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -128.66 110.72 12.47 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 110.042 -0.355 . . . . 70.5 110.042 172.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -91.79 -104.99 0.11 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.136 -0.69 . . . . 72.340000000000003 109.136 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -113.35 -54.37 2.62 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.474 -0.935 . . . . 74.340000000000003 108.474 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -134.75 -29.55 1.15 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.322 -1.308 . . . . 60.299999999999997 108.443 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -63.04 133.56 54.73 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.217 -1.031 . . . . 72.310000000000002 108.217 171.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.2 mtt 74.32 99.12 0.07 Allowed 'General case' 0 C--N 1.313 -0.983 0 O-C-N 124.126 0.891 . . . . 70.109999999999999 112.139 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -174.1 82.18 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 125.662 1.585 . . . . 73.310000000000002 107.867 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.471 ' ND1' ' HB2' ' A' ' 128' ' ' SER . 41.6 t60 -148.71 116.18 6.21 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-N 115.946 -0.57 . . . . 52.329999999999998 111.075 -175.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.9 mm -132.93 139.1 50.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.15 -1.426 . . . . 74.129999999999995 107.15 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 60.5 m -107.53 149.3 38.68 Favored Pre-proline 0 C--N 1.288 -2.087 0 N-CA-C 108.856 -0.794 . . . . 74.430000000000007 108.856 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 55.1 Cg_endo -69.29 147.76 66.59 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.655 2.237 . . . . 73.409999999999997 113.551 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 33.5 Cg_exo -64.45 136.69 51.83 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.117 2.544 . . . . 71.239999999999995 111.856 178.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.522 ' SD ' ' HB2' ' A' ' 101' ' ' CYS . 47.9 ttm -103.11 129.11 49.86 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.479 -0.934 . . . . 71.420000000000002 108.479 175.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 6' ' ' VAL . 58.9 t -120.76 132.39 70.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 116.338 -0.392 . . . . 74.540000000000006 110.265 -174.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.33 102.41 9.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 106.121 -1.807 . . . . 64.310000000000002 106.121 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -124.39 82.2 0.35 Allowed Glycine 0 C--N 1.285 -2.29 0 C-N-CA 120.025 -1.083 . . . . 60.340000000000003 114.587 -173.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -170.38 27.47 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.717 0.77 . . . . 73.400000000000006 109.276 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -105.04 154.0 20.71 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.765 -1.568 . . . . 74.329999999999998 106.765 -173.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.3 p -89.64 173.94 8.02 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 106.525 -1.657 . . . . 72.409999999999997 106.525 171.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.654 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 63.8 t80 -60.79 -46.15 91.64 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 118.603 0.638 . . . . 74.450000000000003 110.156 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.69 -42.3 95.42 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.569 -1.196 . . . . 62.140000000000001 111.567 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mm -69.66 -39.25 77.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 116.257 -0.429 . . . . 71.209999999999994 110.146 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.54 -44.7 81.68 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.857 -0.611 . . . . 61.109999999999999 110.077 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.6 mmt -65.88 -35.93 82.0 Favored 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 120.768 -0.373 . . . . 64.420000000000002 111.847 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.6 -41.61 92.6 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 120.555 -0.458 . . . . 63.0 111.509 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 44' ' ' VAL . 8.9 tt -71.96 -41.79 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 118.605 -1.238 . . . . 72.420000000000002 110.527 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.448 HG12 ' NH2' ' A' ' 69' ' ' ARG . 91.3 t -66.77 -38.37 81.38 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 CA-C-N 116.726 -0.216 . . . . 64.299999999999997 110.953 -177.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -67.47 -37.95 83.69 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.067 0.46 . . . . 73.430000000000007 110.277 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.464 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.72 -48.04 70.85 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.355 -0.926 . . . . 61.340000000000003 111.12 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 40' ' ' ILE . 92.0 t -64.81 -39.67 86.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.206 0.527 . . . . 73.510000000000005 109.78 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.07 -42.91 91.5 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.788 0.835 . . . . 74.109999999999999 112.117 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -79.63 -26.13 41.23 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 120.162 -0.615 . . . . 72.219999999999999 111.178 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 43' ' ' GLY . 79.5 t -70.03 -44.84 78.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 110.126 -0.324 . . . . 73.230000000000004 110.126 174.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 72.1 mt -65.1 -40.48 89.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 111.972 0.36 . . . . 75.319999999999993 111.972 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.415 ' HB2' ' OG ' ' A' ' 144' ' ' SER . 35.1 mtmm -80.27 -10.75 59.76 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.067 -1.053 . . . . 75.439999999999998 112.175 -176.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -98.81 -47.87 5.14 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.29 -0.414 . . . . 74.349999999999994 111.164 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.7 m -81.09 -18.12 47.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.629 0.603 . . . . 50.350000000000001 112.629 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.657 ' CE2' ' HD2' ' A' ' 75' ' ' LYS . 1.8 m-85 -127.68 175.2 8.48 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.333 -0.988 . . . . 73.319999999999993 108.333 -176.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.575 ' HA ' HD21 ' A' ' 142' ' ' LEU . 6.4 t-20 -105.03 91.7 3.91 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 105.716 -1.957 . . . . 52.310000000000002 105.716 174.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.558 ' HB2' HD13 ' A' ' 73' ' ' LEU . . . -132.25 136.39 46.94 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 112.998 0.74 . . . . 41.210000000000001 112.998 -172.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.556 ' OG ' ' HA ' ' A' ' 140' ' ' LEU . 23.3 t -94.46 159.77 14.95 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.856 -1.535 . . . . 53.049999999999997 106.856 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.0 130.9 55.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 120.909 0.385 . . . . 75.319999999999993 109.988 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -135.61 112.22 10.02 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.59 -0.522 . . . . 64.230000000000004 109.59 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -87.88 136.13 33.1 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.635 -0.426 . . . . 75.230000000000004 110.411 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.0 mt -133.59 171.65 13.81 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.436 -0.802 . . . . 74.310000000000002 108.898 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -85.37 143.78 28.43 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.329 -0.989 . . . . 44.240000000000002 108.329 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -96.67 175.43 31.46 Favored Glycine 0 N--CA 1.414 -2.777 0 N-CA-C 110.394 -1.082 . . . . 63.119999999999997 110.394 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.428 ' HG2' ' CG ' ' A' ' 65' ' ' ASP . 11.2 pt-20 -70.39 179.84 2.32 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 122.767 0.427 . . . . 73.439999999999998 110.03 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.4 -38.16 76.78 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.724 0.773 . . . . 72.319999999999993 112.795 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 76.9 m -83.78 -5.19 59.14 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.504 -0.771 . . . . 72.340000000000003 111.908 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 85' ' ' LYS . 13.4 m-20 -95.8 171.6 8.55 Favored 'General case' 0 CA--C 1.49 -1.365 0 CA-C-N 115.396 -0.82 . . . . 72.230000000000004 110.091 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.15 -42.65 3.58 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.447 0 CA-C-N 114.651 -1.159 . . . . 73.400000000000006 109.089 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.1 tp -163.21 151.77 14.12 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 106.901 -1.518 . . . . 74.329999999999998 106.901 -176.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.58 118.36 21.88 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.483 -1.673 . . . . 73.099999999999994 106.483 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.448 ' NH2' HG12 ' A' ' 41' ' ' VAL . 36.3 ttp180 -122.72 124.2 42.84 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.23 -0.988 . . . . 73.140000000000001 110.43 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -98.42 145.11 27.06 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 124.367 1.067 . . . . 72.439999999999998 108.986 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 95.4 m-85 -131.76 137.74 48.32 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.878 -1.156 . . . . 74.150000000000006 107.878 175.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 32.0 m -113.86 111.85 22.4 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.698 -0.853 . . . . 72.439999999999998 108.698 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 54' ' ' ALA . 4.2 mm? -96.9 139.96 32.16 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 113.273 0.842 . . . . 60.109999999999999 113.273 -171.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -143.85 89.75 2.08 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 105.038 -2.208 . . . . 54.399999999999999 105.038 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.657 ' HD2' ' CE2' ' A' ' 52' ' ' PHE . 63.9 tttm -105.34 96.34 6.45 Favored 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.766 -0.584 . . . . 71.349999999999994 109.632 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 13.6 pt-20 53.5 35.51 20.92 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.618 1.167 . . . . 72.5 113.092 173.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.54 -8.64 56.8 Favored Glycine 0 CA--C 1.506 -0.505 0 C-N-CA 121.165 -0.54 . . . . 74.439999999999998 112.764 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HE3' ' HA ' ' A' ' 122' ' ' ALA . 50.4 mtpt -98.86 102.72 14.55 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.392 -1.707 . . . . 62.119999999999997 106.392 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.505 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . 58.9 mttp -101.53 153.96 19.26 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.792 -0.64 . . . . 72.030000000000001 112.176 -174.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -173.04 176.58 45.78 Favored Glycine 0 N--CA 1.417 -2.596 0 N-CA-C 110.599 -1.0 . . . . 60.039999999999999 110.599 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.3 tt -133.78 149.36 30.68 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.039 0 N-CA-C 106.948 -1.501 . . . . 54.219999999999999 106.948 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 91.0 t -132.34 127.52 57.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.252 -0.648 . . . . 75.329999999999998 109.252 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -113.86 113.72 25.28 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.322 -0.621 . . . . 74.129999999999995 109.322 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.54 110.59 30.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.879 -0.786 . . . . 61.210000000000001 108.879 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.511 ' HB2' ' OD2' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -110.67 126.53 54.61 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.03 -1.1 . . . . 64.129999999999995 108.03 178.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.0 mt -100.22 125.94 46.45 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.995 -1.854 . . . . 60.039999999999999 105.995 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.456 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 70.1 mtp85 -112.36 141.8 45.64 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-O 121.091 0.472 . . . . 72.040000000000006 110.927 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -94.29 98.71 11.11 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 115.309 -0.86 . . . . 71.129999999999995 109.373 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.481 ' HB ' ' OD1' ' A' ' 4' ' ' ASP . 10.9 tt -65.38 111.72 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 122.44 1.114 . . . . 70.109999999999999 109.141 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.7 p -137.8 176.75 8.43 Favored 'General case' 0 N--CA 1.39 -3.44 0 CA-C-N 114.685 -1.143 . . . . 55.399999999999999 109.807 -174.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -71.38 -17.78 62.39 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.895 -1.048 . . . . 72.030000000000001 109.32 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -98.06 -32.12 11.79 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.665 -1.152 . . . . 73.530000000000001 110.817 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 42.3 m -133.69 108.46 11.96 Favored Pre-proline 0 N--CA 1.432 -1.349 0 N-CA-C 113.695 0.998 . . . . 74.299999999999997 113.695 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -90.4 144.92 4.03 Favored 'Trans proline' 0 N--CA 1.438 -1.785 0 C-N-CA 122.465 2.11 . . . . 32.420000000000002 111.236 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -82.87 158.93 15.97 Favored 'Trans proline' 0 C--O 1.255 1.37 0 C-N-CA 122.378 2.052 . . . . 74.239999999999995 111.518 172.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 t -98.73 150.13 5.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 105.252 -2.129 . . . . 75.409999999999997 105.252 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -107.13 146.31 31.43 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.788 0.804 . . . . 73.219999999999999 112.162 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -138.59 -147.58 5.17 Favored Glycine 0 CA--C 1.476 -2.344 0 CA-C-N 114.071 -1.422 . . . . 72.109999999999999 110.079 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -60.84 125.84 25.18 Favored 'General case' 0 C--N 1.288 -2.093 0 O-C-N 124.286 0.639 . . . . 74.340000000000003 110.007 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -97.7 131.43 44.25 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.213 0.53 . . . . 60.450000000000003 110.395 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.522 ' HB2' ' SD ' ' A' ' 27' ' ' MET . 44.3 t -73.35 154.91 39.89 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.558 -1.201 . . . . 64.400000000000006 109.919 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.3 t -80.96 74.97 7.94 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.519 -1.289 . . . . 64.319999999999993 107.519 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.94 140.05 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 114.866 -1.061 . . . . 75.420000000000002 109.803 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.9 tp -153.7 -121.87 0.03 OUTLIER 'General case' 0 C--N 1.257 -3.453 0 N-CA-C 103.866 -2.642 . . . . 74.239999999999995 103.866 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.62 168.59 10.07 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 107.817 -1.179 . . . . 63.240000000000002 107.817 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.457 ' O ' HG22 ' A' ' 110' ' ' ILE . 74.5 t80 -43.25 -36.64 1.87 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.57 1.148 . . . . 73.319999999999993 114.071 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -56.84 -37.63 71.53 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.707 0.803 . . . . 63.420000000000002 112.249 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -90.62 -34.69 15.37 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.687 -0.486 . . . . 75.319999999999993 109.687 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 26.0 m-20 -62.55 -46.87 86.37 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.15 -0.932 . . . . 74.519999999999996 110.613 -176.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 106' ' ' PHE . 9.1 tp -64.59 -39.75 86.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 N-CA-C 109.963 -0.384 . . . . 72.209999999999994 109.963 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.96 -41.5 82.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.774 -0.648 . . . . 75.219999999999999 110.671 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 7.8 t -63.0 -44.25 96.54 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.693 -0.685 . . . . 74.310000000000002 111.259 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 47.0 mm -68.25 -41.46 83.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.994 -0.372 . . . . 54.439999999999998 109.994 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 51.6 t -64.22 -43.06 97.23 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 CA-C-N 116.029 -0.532 . . . . 61.219999999999999 110.366 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -61.9 -40.47 95.56 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 122.826 0.45 . . . . 75.25 111.19 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.59 84.33 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.183 0.516 . . . . 70.329999999999998 111.412 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.415 ' O ' HD13 ' A' ' 121' ' ' LEU . 79.0 mt -71.3 -43.28 74.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.364 -0.606 . . . . 72.329999999999998 109.364 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 114' ' ' VAL . 1.7 tm-20 -62.63 -40.49 97.18 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.484 -0.78 . . . . 63.539999999999999 110.448 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.74 -36.78 76.12 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 120.069 -0.652 . . . . 74.319999999999993 110.669 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.713 ' SG ' ' HA ' ' A' ' 10' ' ' GLU . 10.8 t -67.96 -34.05 75.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.657 0.741 . . . . 75.099999999999994 109.665 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.3 mp -75.79 -35.34 60.12 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.474 -0.784 . . . . 73.319999999999993 111.247 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.477 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . . . -69.67 -33.77 73.02 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.991 0.424 . . . . 74.230000000000004 111.144 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -80.55 10.32 4.9 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.7 -0.682 . . . . 70.319999999999993 111.556 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -53.71 124.15 28.57 Favored Glycine 0 C--O 1.249 1.044 0 CA-C-N 116.111 -0.495 . . . . 50.25 112.817 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 68.04 57.98 0.48 Allowed 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 125.706 1.602 . . . . 74.310000000000002 112.259 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.2 mt -142.77 135.87 28.31 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.497 -1.229 . . . . 70.439999999999998 108.827 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -58.63 100.31 0.06 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.388 1.075 . . . . 71.239999999999995 112.0 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.471 ' HB2' ' ND1' ' A' ' 22' ' ' HIS . 58.2 m -155.55 105.83 2.47 Favored 'General case' 0 N--CA 1.422 -1.86 0 C-N-CA 124.416 1.086 . . . . 71.319999999999993 110.058 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm 68.5 103.06 0.05 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.855 1.262 . . . . 44.340000000000003 112.634 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . 0.289 0.6 OUTLIER -76.45 73.02 3.19 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 123.058 1.408 . . . . 51.43 112.83 176.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -134.28 151.49 51.3 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.308 -1.367 . . . . 71.340000000000003 107.308 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -119.76 142.18 16.09 Favored Glycine 0 N--CA 1.428 -1.866 0 C-N-CA 120.051 -1.071 . . . . 72.030000000000001 111.717 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.511 ' HE3' ' OE2' ' A' ' 10' ' ' GLU . 19.7 tptp -118.97 87.17 33.18 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 106.45 -1.685 . . . . 73.099999999999994 106.45 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -84.01 72.51 5.24 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.693 2.262 . . . . 61.119999999999997 112.699 -173.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.1 mt -128.5 100.6 22.17 Favored Pre-proline 0 N--CA 1.42 -1.972 0 CA-C-N 115.297 -0.865 . . . . 64.420000000000002 108.989 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -87.36 129.89 2.79 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.086 1.857 . . . . 64.519999999999996 110.234 172.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -120.66 102.77 44.44 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 109.149 -0.685 . . . . 63.149999999999999 109.149 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -86.66 -5.22 8.13 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.242 1.961 . . . . 73.109999999999999 112.651 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 tt -95.92 102.37 14.16 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 107.947 -1.131 . . . . 74.310000000000002 107.947 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.556 ' HA ' ' OG ' ' A' ' 55' ' ' SER 0.284 1.6 pp -125.16 115.32 20.26 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 113.081 0.771 . . . . 71.109999999999999 113.081 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -153.52 152.91 24.46 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.554 -1.018 . . . . 42.530000000000001 110.554 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.575 HD21 ' HA ' ' A' ' 53' ' ' ASN . 5.5 mp -126.99 143.65 51.23 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 117.072 0.436 . . . . 53.43 111.149 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -144.26 92.16 2.28 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.788 -0.642 . . . . 74.239999999999995 109.581 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' ' 49' ' ' LYS . 74.8 m -165.45 100.21 0.71 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.441 1.096 . . . . 73.019999999999996 109.074 178.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.8 t -82.4 67.55 8.47 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.774 0.797 . . . . 72.510000000000005 110.542 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.457 ' HG2' ' H ' ' A' ' 147' ' ' THR . 42.7 ttt180 62.23 -175.63 0.14 Allowed 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.239 -1.346 . . . . 65.299999999999997 110.71 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.457 ' H ' ' HG2' ' A' ' 146' ' ' ARG . 19.4 m -66.7 125.16 24.95 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.488 -0.56 . . . . 63.25 109.488 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.285 0 N-CA-C 109.028 -1.629 . . . . 62.049999999999997 109.028 -177.84 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.252 0 N-CA-C 106.764 -1.569 . . . . 72.140000000000001 106.764 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -120.45 128.89 53.59 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.905 0.383 . . . . 41.43 110.405 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.623 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 28.8 m-85 -117.69 148.95 41.51 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.395 0.617 . . . . 74.549999999999997 111.377 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.477 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 29.4 t70 -121.36 107.47 12.54 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.222 -2.14 . . . . 60.229999999999997 105.222 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -93.23 114.91 30.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 116.186 -0.461 . . . . 64.5 110.23 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.444 ' HB ' ' HG3' ' A' ' 85' ' ' LYS . 46.9 t -104.87 112.89 40.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 108.432 -0.951 . . . . 63.200000000000003 108.432 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.506 HG23 ' HB2' ' A' ' 27' ' ' MET . 3.7 tt -114.34 108.34 25.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.835 0.826 . . . . 75.25 108.847 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.9 mt -104.06 106.4 53.08 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 114.991 -1.004 . . . . 75.519999999999996 111.799 -171.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.584 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 7.1 Cg_endo -92.9 140.05 1.8 Allowed 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 122.419 2.079 . . . . 63.219999999999999 110.572 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -164.08 155.87 16.53 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 122.468 0.307 . . . . 71.140000000000001 110.76 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.9 m -91.57 135.19 34.04 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.707 -0.479 . . . . 52.009999999999998 109.707 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.15 68.65 10.0 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 113.551 0.945 . . . . 75.200000000000003 113.551 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -122.82 138.21 54.71 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.126 -1.064 . . . . 74.519999999999996 108.126 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.415 ' N ' ' HD2' ' A' ' 14' ' ' ARG . 9.0 mpt_? -82.39 134.98 35.25 Favored 'General case' 0 CA--C 1.475 -1.938 0 N-CA-C 108.998 -0.742 . . . . 73.200000000000003 108.998 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.432 ' HB3' HD22 ' A' ' 130' ' ' LEU . 7.1 t80 -62.67 110.44 1.72 Allowed 'General case' 0 N--CA 1.405 -2.702 0 O-C-N 124.688 1.242 . . . . 73.519999999999996 111.131 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.72 -99.31 0.06 Allowed 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 114.603 -1.18 . . . . 71.530000000000001 109.623 173.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -113.79 -58.45 2.15 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.033 0.444 . . . . 62.119999999999997 109.956 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -138.12 -51.91 0.6 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.085 0.945 . . . . 62.310000000000002 109.813 173.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -84.99 67.41 10.2 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.851 -1.068 . . . . 64.450000000000003 112.74 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 48.1 ttp 159.42 88.75 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.384 0 C-N-CA 128.169 2.588 . . . . 73.510000000000005 105.359 171.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 168.98 121.8 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.323 -2.103 . . . . 73.230000000000004 105.323 -173.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.474 ' HB2' ' H ' ' A' ' 125' ' ' GLU . 77.1 t60 -156.81 113.46 3.05 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.804 -0.758 . . . . 74.439999999999998 112.592 172.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.3 mm -113.64 132.5 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 N-CA-C 107.272 -1.381 . . . . 73.319999999999993 107.272 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 9.1 m -109.6 138.63 20.66 Favored Pre-proline 0 C--N 1.273 -2.723 0 N-CA-C 107.353 -1.351 . . . . 72.030000000000001 107.353 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -53.88 128.96 31.81 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 122.797 2.331 . . . . 70.409999999999997 112.427 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.88 130.43 26.0 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.489 2.126 . . . . 72.109999999999999 110.343 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.506 ' HB2' HG23 ' A' ' 7' ' ' ILE . 73.0 mtm -88.82 138.97 30.94 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 109.849 -0.426 . . . . 43.520000000000003 109.849 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.3 119.99 53.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.3 0.571 . . . . 74.430000000000007 110.04 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 30.6 mm -113.13 100.87 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 105.783 -1.932 . . . . 64.230000000000004 105.783 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -107.2 165.04 13.1 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 119.6 -1.286 . . . . 65.0 112.132 -176.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.6 t70 65.72 70.05 0.45 Allowed 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 125.339 1.456 . . . . 62.049999999999997 110.634 -175.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -138.34 136.05 35.99 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 105.364 -2.088 . . . . 75.349999999999994 105.364 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.6 p -77.95 163.73 25.73 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 106.558 -1.645 . . . . 63.020000000000003 106.558 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.623 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 74.7 t80 -59.13 -37.26 76.81 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.609 0.718 . . . . 71.430000000000007 110.393 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -63.56 -47.17 82.62 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.309 -1.314 . . . . 54.420000000000002 110.857 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.1 mt -73.13 -38.52 55.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.935 -0.765 . . . . 71.120000000000005 108.935 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.82 98.9 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.866 -1.061 . . . . 43.329999999999998 110.893 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.4 tpp -67.69 -39.9 84.39 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.624 -0.831 . . . . 75.319999999999993 110.545 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -70.52 -34.48 72.35 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 119.838 -0.745 . . . . 71.400000000000006 112.745 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 44' ' ' VAL . 7.0 tp -73.79 -43.01 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 119.484 -0.886 . . . . 42.520000000000003 110.57 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t -68.57 -39.65 80.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 121.249 -0.18 . . . . 63.219999999999999 111.159 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -70.51 -29.38 65.87 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.272 -0.64 . . . . 65.219999999999999 109.272 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.29 -47.54 78.89 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 110.42 -1.072 . . . . 71.549999999999997 110.42 174.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 40' ' ' ILE . 90.5 t -57.59 -46.06 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 109.146 -0.687 . . . . 73.239999999999995 109.146 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -55.86 -39.4 71.43 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 125.231 1.412 . . . . 75.010000000000005 113.108 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 46' ' ' ARG . 25.8 mtp180 -79.02 -31.04 44.53 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.305 -0.407 . . . . 74.319999999999993 111.2 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 43' ' ' GLY . 82.5 t -71.8 -38.06 64.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.289 -0.634 . . . . 63.439999999999998 109.289 176.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.5 mt -60.73 -46.6 95.69 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.852 0 CA-C-N 116.091 -0.504 . . . . 75.109999999999999 111.558 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.444 ' HD2' HD21 ' A' ' 142' ' ' LEU . 38.2 mtmm -76.7 -15.93 59.65 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.6 -0.84 . . . . 74.409999999999997 112.114 -178.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.4 -40.19 12.21 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.213 -0.449 . . . . 63.43 112.055 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 t -91.61 -20.61 21.46 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 112.463 0.542 . . . . 73.409999999999997 112.463 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -128.35 -179.97 5.31 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.6 0.714 . . . . 74.049999999999997 110.45 -174.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -105.54 106.52 17.06 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 104.155 -2.535 . . . . 71.319999999999993 104.155 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -118.2 135.63 54.13 Favored 'General case' 0 N--CA 1.404 -2.759 0 C-N-CA 119.533 -0.867 . . . . 64.439999999999998 113.114 -172.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.473 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 29.4 m -99.16 106.88 19.11 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 104.418 -2.438 . . . . 63.409999999999997 104.418 166.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 p -99.16 118.13 45.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.452 -0.944 . . . . 71.25 108.452 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -116.33 129.13 56.1 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.072 -0.967 . . . . 73.209999999999994 109.952 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -85.56 118.19 24.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.68 -0.691 . . . . 71.310000000000002 109.747 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mp -119.3 167.22 12.09 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 109.018 -0.734 . . . . 64.340000000000003 109.018 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -109.74 147.96 32.26 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 108.103 -1.073 . . . . 74.5 108.103 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.16 176.09 35.5 Favored Glycine 0 N--CA 1.407 -3.265 0 CA-C-N 115.512 -0.767 . . . . 73.150000000000006 112.725 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.453 ' N ' ' HB2' ' A' ' 65' ' ' ASP . 44.4 mt-10 -66.02 -173.33 0.18 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 124.893 1.277 . . . . 65.420000000000002 110.347 174.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -58.01 -44.7 87.42 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.462 0.648 . . . . 61.039999999999999 111.791 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 90.2 m -80.08 -23.45 41.3 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.6 -0.727 . . . . 34.409999999999997 111.757 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.453 ' HB2' ' N ' ' A' ' 62' ' ' GLU . 9.6 m-20 -90.87 123.23 34.23 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 119.342 -0.943 . . . . 73.430000000000007 111.013 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.7 t -84.43 -33.27 8.56 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 115.849 -0.614 . . . . 74.030000000000001 111.791 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.9 tp -151.58 139.9 20.39 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.441 -0.577 . . . . 73.030000000000001 109.441 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -130.8 121.41 25.31 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 107.622 -1.251 . . . . 62.329999999999998 107.622 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -118.72 123.66 45.42 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.665 -1.235 . . . . 70.5 107.665 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -103.63 109.96 21.85 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.268 -1.012 . . . . 72.209999999999994 108.268 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -96.43 119.17 34.44 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.01 -1.107 . . . . 62.229999999999997 108.01 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 16.9 m -98.95 115.93 30.02 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 106.527 -1.657 . . . . 55.539999999999999 106.527 174.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -108.59 151.04 26.66 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 113.537 0.94 . . . . 73.120000000000005 113.537 -170.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 36.6 tt0 -147.28 125.79 12.44 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 113.421 -1.718 . . . . 72.239999999999995 106.831 169.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -128.16 81.73 2.04 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 108.116 -1.068 . . . . 74.109999999999999 108.116 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 45.22 76.65 0.09 Allowed 'General case' 0 C--O 1.244 0.79 0 C-N-CA 126.239 1.816 . . . . 71.329999999999998 113.586 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.36 -23.18 28.78 Favored Glycine 0 C--N 1.309 -0.93 0 CA-C-N 115.777 -0.647 . . . . 52.210000000000001 112.933 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 14.2 mptt -96.01 129.42 43.28 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.551 -1.278 . . . . 65.329999999999998 107.551 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -145.97 138.49 25.53 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-O 121.132 0.492 . . . . 65.540000000000006 111.76 -173.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.3 179.76 42.28 Favored Glycine 0 CA--C 1.493 -1.285 0 N-CA-C 110.472 -1.051 . . . . 53.140000000000001 110.472 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 29.7 mt -120.1 145.96 25.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 109.404 -0.591 . . . . 70.239999999999995 109.404 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 83.8 t -126.45 112.64 30.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.716 -0.846 . . . . 72.510000000000005 108.716 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -98.87 107.54 20.0 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.309 -0.997 . . . . 75.239999999999995 108.309 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 44.0 t -102.58 110.47 29.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.696 -0.483 . . . . 74.099999999999994 109.696 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.444 ' HG3' ' HB ' ' A' ' 6' ' ' VAL . 8.1 ptpt -116.68 135.55 53.69 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 120.766 0.317 . . . . 72.0 110.677 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.1 mt -103.62 109.92 21.79 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 106.667 -1.605 . . . . 74.239999999999995 106.667 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.424 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 13.4 mtp180 -98.0 140.53 32.2 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 119.686 -0.806 . . . . 75.219999999999999 109.329 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -84.86 113.05 21.09 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 107.891 -1.151 . . . . 64.120000000000005 107.891 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 tt -87.26 111.64 22.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.79 -0.818 . . . . 71.540000000000006 108.79 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -128.18 174.59 9.13 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.505 -1.295 . . . . 72.129999999999995 107.505 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -78.2 0.16 26.12 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 120.282 -0.567 . . . . 75.030000000000001 112.322 -173.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -119.01 10.58 12.21 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.847 -0.615 . . . . 65.109999999999999 110.683 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.8 t -146.91 118.82 4.76 Favored Pre-proline 0 N--CA 1.446 -0.635 0 O-C-N 122.09 -0.381 . . . . 72.200000000000003 110.3 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.65 148.13 22.66 Favored 'Trans proline' 0 C--O 1.249 1.067 0 C-N-CA 123.209 2.606 . . . . 62.299999999999997 113.947 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.72 164.39 33.78 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 123.567 2.845 . . . . 64.439999999999998 110.217 175.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.5 t -100.51 156.48 4.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.742 -1.207 . . . . 72.200000000000003 107.742 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.89 116.34 24.96 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 122.024 0.916 . . . . 74.129999999999995 112.371 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.37 -160.5 8.34 Favored Glycine 0 N--CA 1.415 -2.748 0 N-CA-C 109.634 -1.387 . . . . 62.420000000000002 109.634 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -60.64 104.8 0.38 Allowed 'General case' 0 N--CA 1.398 -3.066 0 C-N-CA 124.792 1.237 . . . . 61.130000000000003 110.011 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -82.39 105.74 13.69 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 106.643 -1.614 . . . . 53.329999999999998 106.643 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.69 -179.23 5.21 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.421 -0.809 . . . . 72.5 109.207 -174.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.3 m -74.14 93.82 2.35 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.045 -0.724 . . . . 73.430000000000007 109.045 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.431 HG13 ' OD2' ' A' ' 109' ' ' ASP . 31.7 t -98.98 143.8 12.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.562 -0.903 . . . . 65.430000000000007 108.562 -177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.4 tp -161.57 -75.31 0.05 Allowed 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 122.133 0.968 . . . . 73.230000000000004 109.654 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -151.0 169.46 21.74 Favored 'General case' 0 C--N 1.259 -3.343 0 CA-C-N 112.945 -1.934 . . . . 72.230000000000004 108.193 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.426 ' O ' HG22 ' A' ' 110' ' ' ILE . 70.1 t80 -33.16 -63.47 0.23 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 115.559 1.689 . . . . 72.219999999999999 115.559 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.62 -42.62 93.1 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.914 0.709 . . . . 70.209999999999994 112.914 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.64 -36.18 62.88 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.256 -0.577 . . . . 54.520000000000003 109.714 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.552 ' O ' HG12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -64.88 -50.71 65.49 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 124.024 0.828 . . . . 63.43 110.134 177.854 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.509 HD13 ' HA ' ' A' ' 44' ' ' VAL . 7.6 tp -63.55 -36.25 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-O 120.914 0.388 . . . . 75.439999999999998 110.116 -176.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.37 -48.06 83.38 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.545 -0.752 . . . . 75.129999999999995 110.387 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 6.4 t -67.36 -36.31 81.13 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 116.065 -0.516 . . . . 62.299999999999997 109.782 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 109' ' ' ASP . 49.9 mm -64.89 -47.2 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.592 -0.731 . . . . 70.209999999999994 110.167 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 110' ' ' ILE . 77.0 t -63.39 -41.0 91.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-O 121.113 0.483 . . . . 64.349999999999994 110.174 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.33 -42.95 99.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.505 -0.77 . . . . 71.030000000000001 111.13 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.01 -38.06 79.03 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 123.191 0.307 . . . . 65.209999999999994 111.373 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.423 ' O ' HD13 ' A' ' 121' ' ' LEU . 77.8 mt -64.77 -45.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.543 -0.54 . . . . 65.530000000000001 109.543 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -71.75 -31.14 66.35 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 119.19 -1.004 . . . . 72.409999999999997 112.307 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.62 -43.75 88.6 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 109.156 -0.683 . . . . 74.109999999999999 109.156 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 52.1 t -58.66 -46.87 86.24 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.531 -0.758 . . . . 71.439999999999998 110.64 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.0 mp -73.26 -26.64 61.18 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.022 0.439 . . . . 73.230000000000004 111.811 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.68 -32.47 28.11 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 111.945 0.35 . . . . 72.349999999999994 111.945 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -87.73 9.93 19.96 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.486 0.55 . . . . 65.439999999999998 112.486 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -52.43 127.57 33.78 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.076 -0.511 . . . . 33.109999999999999 112.142 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.474 ' H ' ' HB2' ' A' ' 22' ' ' HIS 0.326 0.7 OUTLIER 86.2 22.32 0.07 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.742 1.617 . . . . 72.530000000000001 113.608 -178.086 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.2 mt -135.42 86.27 2.23 Favored 'General case' 0 C--N 1.264 -3.135 0 CA-C-N 112.861 -1.972 . . . . 61.149999999999999 106.603 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 22' ' ' HIS . 8.2 t30 -153.26 155.6 36.88 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.38 -0.528 . . . . 62.210000000000001 110.424 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 25.0 m -127.35 101.9 6.67 Favored 'General case' 0 N--CA 1.393 -3.317 0 N-CA-C 109.068 -0.716 . . . . 73.409999999999997 109.068 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 83.1 112.87 0.06 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.928 1.291 . . . . 74.430000000000007 113.433 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.432 HD22 ' HB3' ' A' ' 15' ' ' PHE . 31.3 tp -66.03 156.34 34.03 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 115.075 -0.966 . . . . 70.239999999999995 110.563 177.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -145.32 119.4 9.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.652 -1.24 . . . . 70.219999999999999 107.652 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.76 -167.81 46.71 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 120.61 -0.805 . . . . 71.409999999999997 111.607 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -138.68 137.92 20.93 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.771 -0.826 . . . . 74.239999999999995 108.771 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -49.3 124.19 11.41 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.728 2.952 . . . . 75.120000000000005 113.529 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 50.2 mm -87.84 128.83 52.73 Favored Pre-proline 0 N--CA 1.421 -1.902 0 N-CA-C 108.854 -0.795 . . . . 64.019999999999996 108.854 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.19 170.93 7.03 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 124.374 3.382 . . . . 72.209999999999994 114.081 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -151.51 157.05 34.95 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 108.24 -1.022 . . . . 72.420000000000002 108.24 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.93 -6.57 10.45 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 121.978 1.785 . . . . 74.120000000000005 111.129 175.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 55.5 tp 64.96 101.01 0.04 OUTLIER 'General case' 0 C--N 1.346 0.434 0 C-N-CA 124.789 1.236 . . . . 73.040000000000006 109.756 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.482 ' HG ' HD12 ' A' ' 142' ' ' LEU . 44.5 tp -118.92 117.29 28.43 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.948 -0.569 . . . . 52.240000000000002 110.338 -173.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -106.82 98.2 1.3 Allowed Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 109.913 -1.275 . . . . 74.219999999999999 109.913 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.482 HD12 ' HG ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -109.48 157.32 19.08 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.454 0.645 . . . . 63.32 111.59 -178.678 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -103.12 91.97 4.33 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.21 -0.663 . . . . 74.129999999999995 109.21 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 20.4 m -140.16 35.47 1.91 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 123.252 1.501 . . . . 72.519999999999996 108.037 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.5 m -97.24 84.88 3.56 Favored 'General case' 0 C--N 1.265 -3.075 0 CA-C-N 112.021 -2.354 . . . . 74.409999999999997 106.713 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -135.62 149.47 49.36 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.986 -1.006 . . . . 70.420000000000002 109.393 -173.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 55.5 m -146.18 150.13 35.26 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.357 -1.349 . . . . 73.310000000000002 107.357 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.528 0 C-N-CA 120.422 -0.894 . . . . 44.210000000000001 110.897 179.057 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HA ' ' HE3' ' A' ' 1' ' ' MET . 4.6 tpt . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.22 0.533 . . . . 74.010000000000005 110.282 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.49 157.71 16.98 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.164 -1.05 . . . . 44.450000000000003 108.164 175.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.609 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 73.4 m-85 -111.62 136.24 51.11 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.363 -0.977 . . . . 74.030000000000001 108.363 174.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 87' ' ' ARG . 30.4 t70 -113.15 114.29 26.58 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.967 -1.015 . . . . 63.229999999999997 108.491 -173.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -90.28 113.88 27.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 109.509 -0.552 . . . . 73.430000000000007 109.509 -174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.29 111.92 38.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 108.73 -0.841 . . . . 75.120000000000005 108.73 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.587 HG23 ' HB2' ' A' ' 27' ' ' MET . 4.5 tt -104.17 121.24 55.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 CA-C-N 115.754 -0.657 . . . . 75.329999999999998 110.26 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 19.8 mm -99.58 106.32 39.16 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 107.861 -1.163 . . . . 74.310000000000002 107.861 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 7' ' ' ILE . 18.4 Cg_endo -94.35 137.84 1.06 Allowed 'Trans proline' 0 N--CA 1.437 -1.836 0 C-N-CA 122.283 1.989 . . . . 73.329999999999998 111.432 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -146.89 154.98 41.94 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.155 -0.683 . . . . 64.310000000000002 109.155 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.522 ' OG ' ' HB3' ' A' ' 22' ' ' HIS . 90.0 p -79.85 156.1 27.52 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 107.296 -1.372 . . . . 73.230000000000004 107.296 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.481 ' HB3' ' CG ' ' A' ' 79' ' ' LYS . 53.7 t80 -81.63 76.89 8.53 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 109.16 -0.681 . . . . 75.239999999999995 109.16 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.412 ' CD2' ' HB3' ' A' ' 125' ' ' GLU . 71.5 m80 -150.82 101.96 2.95 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-N 114.761 -1.109 . . . . 75.450000000000003 110.439 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -88.1 155.77 19.62 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 106.863 -1.532 . . . . 74.120000000000005 106.863 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -55.82 99.84 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 115.527 1.677 . . . . 75.540000000000006 115.527 -173.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 17' ' ' LYS . 23.4 t70 -85.63 -152.23 0.16 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 113.088 -1.869 . . . . 52.219999999999999 106.799 172.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.438 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 9.3 tmtt? -69.82 -58.76 3.5 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.282 -1.007 . . . . 73.409999999999997 108.282 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -138.77 -51.78 0.56 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.514 -0.874 . . . . 72.519999999999996 112.451 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -90.12 55.2 3.02 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.581 1.326 . . . . 73.310000000000002 114.581 -166.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 61.1 mtt -162.85 90.74 0.71 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 125.682 1.593 . . . . 72.319999999999993 107.263 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -175.37 118.19 0.17 Allowed 'General case' 0 N--CA 1.424 -1.762 0 C-N-CA 124.741 1.217 . . . . 62.310000000000002 108.345 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.522 ' HB3' ' OG ' ' A' ' 11' ' ' SER . 10.8 t60 -169.78 110.92 0.44 Allowed 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.419 -0.81 . . . . 74.310000000000002 110.037 170.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.429 HG21 ' CA ' ' A' ' 132' ' ' GLY . 45.3 mm -112.19 139.69 35.54 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 105.04 -2.207 . . . . 70.319999999999993 105.04 175.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 50.9 m -108.17 145.85 32.32 Favored Pre-proline 0 C--N 1.274 -2.684 0 N-CA-C 109.008 -0.738 . . . . 75.519999999999996 109.008 -178.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.3 Cg_exo -60.88 150.43 83.48 Favored 'Trans proline' 0 C--O 1.248 0.99 0 C-N-CA 122.455 2.103 . . . . 63.5 112.072 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.516 ' HD3' ' OE1' ' A' ' 131' ' ' GLU . 22.9 Cg_exo -66.45 137.75 47.9 Favored 'Trans proline' 0 CA--C 1.503 -1.039 0 C-N-CA 122.998 2.465 . . . . 72.319999999999993 111.344 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.587 ' HB2' HG23 ' A' ' 7' ' ' ILE . 48.2 mtp -99.81 128.85 45.88 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 105.922 -1.881 . . . . 75.549999999999997 105.922 173.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.7 t -111.4 123.73 67.52 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 C-N-CA 119.786 -0.766 . . . . 53.539999999999999 109.373 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.2 mp -122.31 102.31 11.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.763 -1.569 . . . . 74.150000000000006 106.763 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.18 -169.01 14.21 Favored Glycine 0 C--N 1.276 -2.804 0 C-N-CA 119.225 -1.465 . . . . 75.299999999999997 114.178 -172.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.1 t70 57.37 43.26 23.58 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 123.043 1.402 . . . . 65.129999999999995 110.156 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -116.92 136.14 53.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 105.708 -1.96 . . . . 74.219999999999999 105.708 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 p -79.83 169.63 17.65 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 119.211 0.914 . . . . 75.030000000000001 108.645 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.609 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 68.0 t80 -57.48 -45.67 84.59 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 123.188 0.595 . . . . 74.430000000000007 111.573 -172.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -66.87 -42.15 86.09 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 114.735 -1.12 . . . . 74.409999999999997 110.725 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.7 mt -72.97 -36.86 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 115.325 -0.852 . . . . 72.299999999999997 109.865 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.434 ' HA ' HG22 ' A' ' 40' ' ' ILE . . . -64.06 -41.16 97.46 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.954 -0.566 . . . . 73.030000000000001 110.324 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.2 ttm -70.3 -37.95 74.89 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 120.139 -0.624 . . . . 62.0 110.819 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -73.12 -36.0 66.64 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.428 0.899 . . . . 72.420000000000002 113.428 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 37' ' ' ALA . 11.6 tt -68.31 -40.87 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 119.842 -0.743 . . . . 72.409999999999997 109.28 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.4 t -65.42 -43.82 94.56 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.864 0 N-CA-C 109.57 -0.53 . . . . 72.340000000000003 109.57 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -59.42 -39.24 82.86 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.595 0.358 . . . . 72.329999999999998 111.82 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.8 -44.0 95.37 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.714 -0.755 . . . . 74.109999999999999 111.369 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 40' ' ' ILE . 56.6 t -71.06 -39.09 74.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.378 -0.601 . . . . 61.420000000000002 109.378 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.441 ' OD2' HG21 ' A' ' 56' ' ' VAL . 14.1 t70 -56.68 -46.93 80.85 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.752 1.621 . . . . 64.450000000000003 109.966 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -64.73 -40.56 95.52 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.157 -0.929 . . . . 75.140000000000001 109.917 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.1 t -66.77 -39.29 83.32 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 CA-C-N 116.311 -0.404 . . . . 62.229999999999997 111.139 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 72.9 mt -69.44 -40.74 80.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 110.66 -0.126 . . . . 73.209999999999994 110.66 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -71.92 -30.79 65.72 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.337 -0.545 . . . . 74.25 110.607 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.2 -45.66 11.8 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 112.545 0.572 . . . . 73.349999999999994 112.545 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.5 m -85.44 -20.01 30.44 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.885 0.698 . . . . 73.209999999999994 112.885 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 48' ' ' ILE . 6.4 m-85 -123.15 157.08 33.74 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-O 121.145 0.498 . . . . 72.519999999999996 109.683 -175.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 45.1 t30 -85.86 87.35 7.4 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 104.367 -2.457 . . . . 60.030000000000001 104.367 172.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -133.5 136.25 44.95 Favored 'General case' 0 N--CA 1.397 -3.112 0 CA-C-N 115.434 -0.803 . . . . 72.310000000000002 111.975 -173.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.419 ' OG ' ' HB ' ' A' ' 72' ' ' THR . 41.0 p -95.8 122.77 38.94 Favored 'General case' 0 N--CA 1.404 -2.731 0 N-CA-C 106.727 -1.582 . . . . 62.0 106.727 171.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.441 HG21 ' OD2' ' A' ' 45' ' ' ASP . 3.2 p -99.68 119.34 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 N-CA-C 108.126 -1.065 . . . . 71.310000000000002 108.126 177.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.471 ' HG2' HD22 ' A' ' 139' ' ' LEU . 28.3 mt-10 -117.61 112.28 20.33 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 114.12 -1.4 . . . . 53.299999999999997 108.584 -174.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -94.21 122.36 36.66 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.406 0.622 . . . . 72.129999999999995 111.464 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mp -121.94 178.11 5.02 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 115.197 -0.91 . . . . 54.329999999999998 109.193 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -95.61 140.8 29.91 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.325 -0.852 . . . . 61.149999999999999 108.748 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.12 175.69 41.57 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 115.574 -0.739 . . . . 54.539999999999999 113.089 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -72.52 174.87 6.85 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 123.995 0.918 . . . . 70.420000000000002 108.595 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -49.73 -41.33 43.39 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 124.613 1.165 . . . . 72.109999999999999 113.034 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.01 -8.54 57.88 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.124 -0.944 . . . . 70.010000000000005 111.644 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -99.15 159.08 15.23 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 107.667 -1.234 . . . . 74.209999999999994 107.667 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.75 -37.64 3.67 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.638 0 CA-C-O 121.57 0.7 . . . . 74.030000000000001 110.212 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.7 tp -156.88 144.24 18.9 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.798 -1.186 . . . . 73.120000000000005 107.798 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -131.32 107.12 8.73 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.857 -0.794 . . . . 74.230000000000004 108.857 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -116.19 129.33 56.25 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.017 -1.073 . . . . 74.430000000000007 111.262 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -109.32 128.89 55.45 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.532 -0.758 . . . . 53.109999999999999 109.447 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -105.91 134.72 48.58 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 107.255 -1.387 . . . . 63.229999999999997 107.255 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.559 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 30.6 m -109.18 107.3 17.53 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 106.578 -1.638 . . . . 62.229999999999997 106.578 173.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.66 140.13 41.16 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 120.954 0.407 . . . . 52.149999999999999 111.865 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 44.3 tt0 -147.81 86.82 1.6 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.627 -0.715 . . . . 74.299999999999997 109.073 168.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -95.91 104.0 15.91 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.922 -0.581 . . . . 72.25 110.556 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 56.9 34.81 25.43 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.804 0.69 . . . . 74.150000000000006 112.46 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.94 -7.88 57.47 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 120.754 -0.736 . . . . 55.539999999999999 113.086 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 53.4 mtpt -92.37 102.11 14.59 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.108 -1.071 . . . . 73.200000000000003 108.108 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.642 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -102.09 138.19 39.37 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.576 -0.738 . . . . 75.420000000000002 111.21 -173.525 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.441 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . -164.03 164.48 36.55 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.438 -0.411 . . . . 54.43 112.751 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 34.0 mm -120.13 134.63 63.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 105.584 -2.006 . . . . 74.200000000000003 105.584 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.6 t -127.57 120.3 54.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.879 -0.513 . . . . 62.310000000000002 110.25 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 67.1 m-70 -105.62 104.14 13.8 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.328 -0.619 . . . . 65.099999999999994 109.328 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.3 t -100.11 110.59 27.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 109.669 -0.493 . . . . 74.140000000000001 109.669 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -112.55 140.54 47.22 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.042 0.449 . . . . 72.510000000000005 110.406 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.2 mt -97.78 125.7 42.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 105.831 -1.915 . . . . 70.540000000000006 105.831 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 4' ' ' ASP . 22.9 mmm180 -104.55 141.54 36.23 Favored 'General case' 0 C--N 1.273 -2.761 0 N-CA-C 108.017 -1.105 . . . . 73.510000000000005 108.017 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -90.0 98.04 11.54 Favored 'General case' 0 C--N 1.279 -2.48 0 C-N-CA 119.294 -0.962 . . . . 63.439999999999998 108.958 172.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.3 tt -74.13 112.31 10.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 121.261 -0.899 . . . . 61.25 110.39 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 93' ' ' CYS . 0.8 OUTLIER -142.34 177.14 8.46 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.084 -1.08 . . . . 62.149999999999999 108.084 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -77.99 -13.83 59.74 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 118.774 0.715 . . . . 61.140000000000001 111.119 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -109.02 9.82 26.31 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.124 -0.943 . . . . 62.310000000000002 110.156 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.408 ' HB3' ' OG1' ' A' ' 90' ' ' THR . 42.1 t -147.84 102.07 3.66 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 109.075 -0.713 . . . . 74.439999999999998 109.075 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.56 139.65 25.77 Favored 'Trans proline' 0 C--O 1.252 1.224 0 C-N-CA 122.429 2.086 . . . . 60.539999999999999 113.851 -174.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.62 161.07 28.08 Favored 'Trans proline' 0 N--CA 1.439 -1.71 0 C-N-CA 122.45 2.1 . . . . 70.319999999999993 108.78 173.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.3 t -91.68 157.92 2.92 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.559 0 N-CA-C 107.232 -1.396 . . . . 73.420000000000002 107.232 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -109.82 133.48 53.1 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.09 -1.078 . . . . 71.239999999999995 108.09 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -155.52 -144.88 4.03 Favored Glycine 0 N--CA 1.413 -2.867 0 C-N-CA 119.842 -1.171 . . . . 72.5 112.244 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -64.9 127.01 29.81 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 113.456 -1.372 . . . . 53.229999999999997 109.521 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -77.11 99.33 5.33 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.549 -1.278 . . . . 74.349999999999994 107.549 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 44.1 t -79.96 152.59 29.43 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 115.404 -0.816 . . . . 72.239999999999995 109.565 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.8 m -76.6 86.4 3.28 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.232 -1.025 . . . . 63.119999999999997 108.232 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.469 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 28.8 t -115.51 138.0 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 110.515 -174.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 103' ' ' VAL . 25.6 mt -170.55 -49.98 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 126.556 1.943 . . . . 54.140000000000001 110.948 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.6 142.37 17.8 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 113.996 -1.456 . . . . 75.530000000000001 107.537 -172.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -32.96 -44.43 0.11 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.145 2.178 . . . . 74.200000000000003 116.552 -170.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -54.84 -53.72 51.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.373 0.606 . . . . 73.25 112.567 -175.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -80.72 -30.14 36.31 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.989 -0.55 . . . . 71.049999999999997 110.041 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.94 -47.88 81.33 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.944 -1.026 . . . . 75.420000000000002 109.477 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.7 tt -65.53 -37.0 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.552 -0.295 . . . . 52.310000000000002 110.523 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.28 -48.32 82.25 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 109.655 -0.498 . . . . 73.109999999999999 109.655 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 21.5 t -62.81 -39.25 93.71 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.514 -0.767 . . . . 70.129999999999995 111.632 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 75.9 mt -70.18 -45.71 74.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 120.505 -0.478 . . . . 74.439999999999998 110.846 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.6 t -70.19 -38.86 75.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.264 -0.574 . . . . 64.209999999999994 110.72 -176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -74.53 -22.05 59.22 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 112.291 0.478 . . . . 75.200000000000003 112.291 -176.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.439 ' HB3' ' SD ' ' A' ' 27' ' ' MET . . . -83.04 -37.69 23.56 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 119.073 -1.051 . . . . 63.299999999999997 110.486 175.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 81.6 mt -62.48 -45.37 98.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 108.968 -0.752 . . . . 55.549999999999997 108.968 175.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -54.4 -43.64 71.63 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 123.575 0.75 . . . . 60.450000000000003 112.382 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 22.5 mm-40 -65.7 -44.11 87.13 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.818 0.699 . . . . 74.450000000000003 110.93 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 36.5 t -62.4 -40.94 98.15 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.198 0.523 . . . . 43.0 110.163 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 117' ' ' ILE . 70.6 mt -71.82 -29.14 64.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.977 -0.556 . . . . 74.019999999999996 110.656 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.08 -31.81 39.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 112.727 0.64 . . . . 74.540000000000006 112.727 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 119' ' ' GLU . 72.3 mmtt -65.56 -40.25 92.62 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 119.841 -0.743 . . . . 63.520000000000003 109.933 -177.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.62 -154.3 50.76 Favored Glycine 0 C--N 1.291 -1.966 0 CA-C-N 114.44 -1.254 . . . . 63.219999999999999 114.798 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.412 ' HB3' ' CD2' ' A' ' 13' ' ' HIS . 9.2 pt-20 -63.8 133.12 52.86 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 124.703 1.201 . . . . 61.109999999999999 112.799 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp 74.03 80.23 0.12 Allowed 'General case' 0 C--O 1.244 0.795 0 C-N-CA 124.983 1.313 . . . . 50.130000000000003 111.783 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -161.38 165.96 28.13 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.106 -1.072 . . . . 71.319999999999993 108.106 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.5 m -41.97 128.16 3.47 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.075 1.75 . . . . 64.030000000000001 114.753 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 129' ' ' LYS . 1.2 pptp? -145.8 142.37 28.81 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.348 -0.982 . . . . 52.149999999999999 108.348 173.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 46.0 tp -158.0 25.96 0.26 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.326 1.06 . . . . 75.25 108.457 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.516 ' OE1' ' HD3' ' A' ' 26' ' ' PRO . 14.3 pt-20 -177.37 -171.81 0.35 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.326 -1.307 . . . . 73.099999999999994 107.749 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.429 ' CA ' HG21 ' A' ' 23' ' ' ILE . . . 131.28 151.15 6.9 Favored Glycine 0 N--CA 1.431 -1.64 0 O-C-N 123.868 0.73 . . . . 50.219999999999999 112.551 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -143.35 70.24 17.83 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 107.167 -1.42 . . . . 64.5 107.167 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.73 104.85 1.87 Allowed 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 122.466 2.111 . . . . 52.109999999999999 111.468 -173.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 7.4 tp -127.31 102.07 24.2 Favored Pre-proline 0 N--CA 1.42 -1.971 0 CA-C-O 121.823 0.82 . . . . 62.310000000000002 110.919 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.95 160.66 27.14 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.707 2.271 . . . . 73.319999999999993 111.537 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -162.87 125.69 1.73 Allowed Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 108.523 -0.917 . . . . 74.340000000000003 108.523 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -69.05 -15.82 40.05 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.746 2.298 . . . . 75.239999999999995 112.657 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.471 HD22 ' HG2' ' A' ' 57' ' ' GLU . 25.2 tp 71.51 153.33 0.12 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.132 1.373 . . . . 53.009999999999998 111.46 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.3 tp -68.41 122.04 17.58 Favored 'General case' 0 C--O 1.249 1.046 0 N-CA-C 108.464 -0.939 . . . . 64.430000000000007 108.464 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.71 77.98 1.55 Allowed Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 115.716 -0.674 . . . . 34.039999999999999 112.656 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 tt -116.18 101.59 8.85 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 104.963 -2.236 . . . . 64.439999999999998 104.963 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -88.94 158.32 18.09 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.191 0.519 . . . . 65.329999999999998 110.616 -175.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.4 m -114.25 98.97 7.26 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 115.508 -0.769 . . . . 64.319999999999993 109.105 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 87.3 m -98.56 88.65 4.15 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.694 -1.224 . . . . 72.430000000000007 107.694 173.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -108.88 137.4 46.87 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.043 -1.435 . . . . 74.409999999999997 109.488 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.2 m -84.42 81.98 8.59 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 108.365 -0.976 . . . . 53.340000000000003 108.365 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.349 0 N-CA-C 109.806 -1.318 . . . . 42.43 109.806 -178.781 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptm . . . . . 0 CA--C 1.515 -0.388 0 N-CA-C 109.375 -0.602 . . . . 65.239999999999995 109.375 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HE3' ' HA ' ' A' ' 31' ' ' ASP . 87.5 tttt -122.3 136.96 54.99 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.072 0.463 . . . . 73.299999999999997 111.499 -173.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.586 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 19.2 m-85 -117.24 152.44 34.82 Favored 'General case' 0 C--O 1.251 1.169 0 C-N-CA 125.0 1.32 . . . . 73.010000000000005 109.338 173.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.631 ' OD1' ' HA3' ' A' ' 30' ' ' GLY . 24.6 t70 -123.67 108.77 12.93 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.581 -1.637 . . . . 55.450000000000003 106.581 -177.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.44 127.05 48.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.195 0.522 . . . . 62.119999999999997 111.927 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 85' ' ' LYS . 4.8 p -115.15 121.66 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.621 0 N-CA-C 108.156 -1.053 . . . . 75.340000000000003 108.156 176.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.486 HG23 ' CG ' ' A' ' 27' ' ' MET . 1.9 tt -122.2 123.48 68.95 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 CA-C-N 115.392 -0.822 . . . . 73.099999999999994 109.878 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.54 ' CG1' ' HB2' ' A' ' 83' ' ' HIS . 40.2 pt -108.06 118.59 52.27 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.864 -0.607 . . . . 53.049999999999997 110.463 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.498 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 11.5 Cg_endo -90.94 142.7 3.21 Favored 'Trans proline' 0 N--CA 1.431 -2.152 0 C-N-CA 122.153 1.902 . . . . 72.019999999999996 109.726 170.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -151.41 146.95 26.32 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 108.909 -0.774 . . . . 72.5 108.909 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.614 ' OG ' ' HB3' ' A' ' 22' ' ' HIS . 86.5 p -90.4 143.9 26.32 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.302 -1.37 . . . . 72.420000000000002 107.302 175.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.542 ' CE1' ' HB2' ' A' ' 79' ' ' LYS 0.351 1.6 p90 -80.61 87.5 5.76 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 118.098 -1.441 . . . . 74.230000000000004 113.189 178.379 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -130.14 99.53 5.09 Favored 'General case' 0 N--CA 1.414 -2.271 0 CA-C-N 113.729 -1.578 . . . . 63.210000000000001 110.833 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.92 118.05 9.86 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 122.305 1.05 . . . . 63.340000000000003 109.395 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.54 ' HA ' ' O ' ' A' ' 20' ' ' MET . 56.1 t80 -60.71 111.62 1.69 Allowed 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 112.208 -2.269 . . . . 74.019999999999996 111.074 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -85.69 -105.04 0.06 Allowed 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 113.433 -1.712 . . . . 73.25 110.218 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -112.35 -57.31 2.29 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.451 0.644 . . . . 72.540000000000006 110.627 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -124.92 -23.28 4.31 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.497 -0.774 . . . . 75.540000000000006 109.909 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -103.07 157.41 17.01 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.554 -0.748 . . . . 52.310000000000002 111.654 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.54 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 83.1 mtp 72.96 76.7 0.14 Allowed 'General case' 0 C--O 1.209 -1.038 0 O-C-N 124.829 1.331 . . . . 71.439999999999998 114.085 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -161.2 99.39 1.19 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.305 -0.998 . . . . 73.109999999999999 108.305 171.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.614 ' HB3' ' OG ' ' A' ' 11' ' ' SER . 47.0 t60 -136.63 93.04 2.82 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.651 -0.87 . . . . 72.219999999999999 108.651 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.421 HG13 ' HA ' ' A' ' 130' ' ' LEU . 52.2 mm -109.01 138.53 35.73 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 106.126 -1.805 . . . . 71.430000000000007 106.126 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 62.9 m -106.81 122.73 40.79 Favored Pre-proline 0 C--N 1.273 -2.736 0 C-N-CA 120.278 -0.569 . . . . 53.350000000000001 110.078 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -49.55 143.35 21.66 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.976 3.117 . . . . 50.43 113.733 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.85 133.05 55.75 Favored 'Trans proline' 0 CA--C 1.509 -0.727 0 C-N-CA 123.792 2.995 . . . . 73.129999999999995 113.051 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.486 ' CG ' HG23 ' A' ' 7' ' ' ILE . 22.1 ptp -106.07 141.55 37.25 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.652 -1.611 . . . . 74.409999999999997 106.652 172.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.443 HG22 HG23 ' A' ' 6' ' ' VAL . 39.8 t -133.86 127.75 52.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 120.229 -0.588 . . . . 51.210000000000001 110.91 -169.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.408 HD13 ' O ' ' A' ' 28' ' ' VAL . 45.3 mm -129.17 103.8 9.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.715 -1.217 . . . . 75.319999999999993 107.715 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.631 ' HA3' ' OD1' ' A' ' 4' ' ' ASP . . . -123.04 88.91 0.41 Allowed Glycine 0 N--CA 1.419 -2.461 0 C-N-CA 118.919 -1.61 . . . . 72.420000000000002 113.618 -175.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.461 ' HA ' ' HE3' ' A' ' 2' ' ' LYS . 5.9 p-10 -165.52 29.29 0.05 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.991 0.901 . . . . 74.349999999999994 109.118 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -118.32 136.98 53.39 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-N 115.572 -0.74 . . . . 74.340000000000003 109.21 -170.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.4 p -76.31 169.66 17.8 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 106.765 -1.568 . . . . 65.150000000000006 106.765 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.586 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 84.8 t80 -59.0 -39.21 81.15 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.465 0.65 . . . . 63.219999999999999 110.758 -177.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.15 -50.31 72.38 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.144 -1.389 . . . . 72.109999999999999 110.755 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.3 mt -69.99 -37.19 71.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.5 -0.555 . . . . 63.43 109.5 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -65.17 -42.1 94.01 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.612 -0.722 . . . . 70.329999999999998 110.8 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.6 tpp -69.76 -41.15 75.57 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 120.103 -0.639 . . . . 41.25 110.16 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.4 -38.03 80.92 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 112.489 0.552 . . . . 73.019999999999996 112.489 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 44' ' ' VAL . 14.4 tt -69.52 -39.39 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 119.516 -0.874 . . . . 72.25 110.114 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 37' ' ' ALA . 96.7 t -67.95 -40.41 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 120.544 -0.462 . . . . 55.539999999999999 109.964 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -69.55 -25.91 64.24 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.77 0.319 . . . . 72.209999999999994 111.559 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.59 -46.51 39.3 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 110.541 -1.024 . . . . 73.049999999999997 110.541 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 48' ' ' ILE . 86.3 t -61.1 -42.62 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 109.21 -0.663 . . . . 64.530000000000001 109.21 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -49.92 -52.36 33.87 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 125.912 1.685 . . . . 52.32 111.057 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -68.28 -35.19 77.48 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.773 -1.103 . . . . 73.310000000000002 110.387 -175.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 91.6 t -71.73 -36.56 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 116.075 -0.511 . . . . 62.43 111.253 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 44' ' ' VAL . 60.4 mt -68.35 -38.76 79.89 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.959 0 N-CA-C 109.541 -0.54 . . . . 74.450000000000003 109.541 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -66.62 -33.84 76.55 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.803 0.335 . . . . 74.209999999999994 111.682 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.99 -25.5 34.7 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.452 0.538 . . . . 60.049999999999997 112.452 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.9 m -99.48 -23.96 14.93 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.164 0.801 . . . . 75.120000000000005 113.164 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -133.24 -172.52 2.96 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.792 0.806 . . . . 73.439999999999998 111.6 -173.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -106.93 100.25 9.77 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 104.287 -2.486 . . . . 71.319999999999993 104.287 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -114.69 144.49 43.36 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 113.343 0.868 . . . . 72.319999999999993 113.343 -169.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -123.68 112.15 17.04 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.798 -1.556 . . . . 73.109999999999999 106.798 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -100.55 137.2 28.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.127 0.489 . . . . 74.310000000000002 109.993 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -136.32 117.96 14.96 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.223 -1.029 . . . . 73.340000000000003 108.223 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -97.65 129.25 44.75 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.55 -0.86 . . . . 71.120000000000005 111.366 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.2 mp -122.51 177.44 5.41 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.744 -1.116 . . . . 32.399999999999999 108.072 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -101.58 161.83 13.35 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.389 -1.337 . . . . 73.040000000000006 107.389 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.39 176.63 19.7 Favored Glycine 0 N--CA 1.413 -2.85 0 N-CA-C 111.052 -0.819 . . . . 53.530000000000001 111.052 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.48 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 11.9 pt-20 -65.23 -178.33 0.47 Allowed 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 123.403 0.681 . . . . 61.109999999999999 110.418 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -50.13 -38.45 39.15 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 114.442 1.275 . . . . 43.32 114.442 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 44.0 t -92.96 -0.93 57.11 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 121.687 0.756 . . . . 75.340000000000003 110.558 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.524 ' OD1' ' HG2' ' A' ' 87' ' ' ARG . 88.0 m-20 -100.75 152.82 20.03 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-N 115.974 -0.557 . . . . 74.349999999999994 110.077 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -113.45 -24.89 3.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-O 121.288 0.566 . . . . 50.140000000000001 111.893 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.433 ' HB3' HD12 ' A' ' 86' ' ' LEU . 57.2 tp -154.36 141.73 19.63 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 109.141 -0.688 . . . . 73.129999999999995 109.141 177.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -130.34 102.13 6.06 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 106.655 -1.609 . . . . 73.549999999999997 106.655 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -111.24 124.63 52.61 Favored 'General case' 0 C--N 1.281 -2.38 0 C-N-CA 119.436 -0.906 . . . . 64.140000000000001 109.642 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -105.74 143.27 34.13 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.284 -0.636 . . . . 73.109999999999999 109.284 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.489 ' HB3' HD11 ' A' ' 73' ' ' LEU . 87.6 m-85 -127.88 126.26 41.22 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.384 -0.969 . . . . 72.450000000000003 108.384 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.0 m -103.28 117.0 33.52 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.112 -1.81 . . . . 65.209999999999994 106.112 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 71' ' ' TYR . 0.7 OUTLIER -122.55 144.31 49.17 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.415 0.626 . . . . 75.5 112.393 -170.67 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.5 ' OE2' ' HG ' ' A' ' 140' ' ' LEU . 22.2 mt-10 -147.55 160.4 42.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.574 1.178 . . . . 63.420000000000002 111.134 171.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -154.29 157.44 38.68 Favored 'General case' 0 C--N 1.258 -3.409 0 N-CA-C 102.327 -3.212 . . . . 75.040000000000006 102.327 165.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -53.06 99.59 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.994 0.902 . . . . 52.520000000000003 112.726 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.72 0.51 56.46 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.401 -0.818 . . . . 71.219999999999999 112.648 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 95.6 mttt -134.33 108.55 8.26 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.047 -1.094 . . . . 40.409999999999997 108.047 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 16.5 ptpt -131.64 132.66 44.19 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.397 0.517 . . . . 71.340000000000003 112.397 -174.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -170.87 177.27 43.99 Favored Glycine 0 C--O 1.215 -1.036 0 C-N-CA 119.955 -1.117 . . . . 65.430000000000007 113.819 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.0 mt -129.22 148.81 33.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 106.884 -1.524 . . . . 62.539999999999999 106.884 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.25 123.86 51.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.634 -0.506 . . . . 55.210000000000001 109.634 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.54 ' HB2' ' CG1' ' A' ' 8' ' ' ILE . 11.9 m170 -110.7 112.44 24.32 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.641 -0.503 . . . . 73.329999999999998 109.641 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.47 114.51 42.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.514 -0.921 . . . . 74.120000000000005 108.514 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.495 ' HB3' HG13 ' A' ' 6' ' ' VAL . 59.9 tttp -115.72 118.28 32.63 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.958 -1.127 . . . . 74.420000000000002 107.958 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.433 HD12 ' HB3' ' A' ' 67' ' ' LEU . 90.5 mt -98.16 114.63 26.9 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 107.232 -1.395 . . . . 74.120000000000005 107.232 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.524 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 76.0 mtp85 -102.42 139.62 37.78 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.581 0.705 . . . . 71.519999999999996 110.073 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -90.71 98.27 11.68 Favored 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 115.089 -0.96 . . . . 73.439999999999998 108.49 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 tt -75.14 110.81 10.49 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-O 122.824 1.297 . . . . 70.209999999999994 109.173 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.1 p -123.31 -170.81 2.18 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 113.773 -1.558 . . . . 74.310000000000002 107.744 -174.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -82.63 -0.46 47.21 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.672 -0.862 . . . . 75.230000000000004 108.672 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -112.51 -5.05 14.07 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.974 -1.012 . . . . 72.140000000000001 110.18 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.2 m -137.97 113.97 9.15 Favored Pre-proline 0 C--N 1.311 -1.087 0 C-N-CA 123.202 0.601 . . . . 75.129999999999995 110.814 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.48 163.34 29.79 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 122.015 1.81 . . . . 64.049999999999997 110.552 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.96 163.2 29.32 Favored 'Trans proline' 0 C--O 1.247 0.952 0 C-N-CA 122.885 2.39 . . . . 63.030000000000001 112.048 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 t -93.41 156.54 3.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.582 -0.896 . . . . 71.430000000000007 108.582 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -106.41 141.54 37.55 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.272 -1.01 . . . . 72.510000000000005 108.272 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.42 -163.83 31.51 Favored Glycine 0 N--CA 1.419 -2.466 0 C-N-CA 120.149 -1.024 . . . . 55.109999999999999 111.714 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -69.58 139.23 53.68 Favored 'General case' 0 N--CA 1.417 -2.124 0 C-N-CA 125.205 1.402 . . . . 75.239999999999995 107.921 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -102.59 123.54 46.5 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 119.655 -0.818 . . . . 72.439999999999998 111.803 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.1 t -79.34 137.92 37.5 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.311 -1.366 . . . . 71.530000000000001 107.311 172.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.5 m -75.33 95.47 3.21 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.647 0.737 . . . . 63.25 110.191 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.431 HG13 ' CG ' ' A' ' 109' ' ' ASP . 57.7 t -97.89 147.55 6.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.778 -1.101 . . . . 45.219999999999999 109.369 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 47.1 tp -149.56 -74.1 0.17 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.289 -0.869 . . . . 70.420000000000002 109.56 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -143.56 151.41 40.18 Favored 'General case' 0 C--N 1.258 -3.385 0 N-CA-C 106.831 -1.544 . . . . 54.100000000000001 106.831 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.467 ' O ' HG22 ' A' ' 110' ' ' ILE . 79.9 t80 -35.78 -42.08 0.24 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.512 1.671 . . . . 72.349999999999994 115.512 -172.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -55.26 -47.75 74.99 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 122.804 0.442 . . . . 71.530000000000001 112.015 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.89 -34.22 30.11 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 107.672 -1.232 . . . . 60.219999999999999 107.672 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.431 ' CG ' HG13 ' A' ' 103' ' ' VAL . 26.2 m-20 -62.37 -46.8 87.0 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.476 -0.784 . . . . 74.349999999999994 110.218 -176.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 106' ' ' PHE . 8.5 tp -65.56 -41.36 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 115.571 -0.74 . . . . 73.310000000000002 110.612 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -26.37 60.32 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 120.285 -0.566 . . . . 72.340000000000003 111.572 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 12.0 t -68.26 -48.01 66.21 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 116.585 -0.28 . . . . 71.209999999999994 110.382 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.73 -42.93 93.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.216 -0.447 . . . . 72.319999999999993 110.087 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 70.9 t -64.65 -40.9 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 116.207 -0.451 . . . . 73.450000000000003 110.306 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -61.55 -44.09 97.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.351 -0.386 . . . . 74.430000000000007 111.355 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.49 -35.64 75.76 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.847 0.356 . . . . 33.409999999999997 111.573 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.46 ' O ' HD13 ' A' ' 121' ' ' LEU . 80.8 mt -69.33 -44.57 80.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 109.587 -0.523 . . . . 72.439999999999998 109.587 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -60.37 -45.22 94.3 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.886 -0.783 . . . . 63.219999999999999 108.886 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 44.5 mt-10 -68.57 -33.74 74.6 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 112.081 0.4 . . . . 64.219999999999999 112.081 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 9' ' ' PRO . 30.3 t -67.42 -31.3 71.41 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.417 0.627 . . . . 60.210000000000001 109.818 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.462 ' HG ' ' C ' ' A' ' 79' ' ' LYS . 9.0 mp -81.33 -37.84 27.69 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 121.151 0.501 . . . . 71.549999999999997 110.812 176.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.4 -16.71 41.76 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 115.579 1.696 . . . . 75.430000000000007 115.579 -175.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 62.9 mttm -75.81 -3.88 37.52 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 119.884 1.22 . . . . 75.340000000000003 113.603 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.07 -157.45 20.08 Favored Glycine 0 N--CA 1.422 -2.263 0 C-N-CA 119.943 -1.122 . . . . 74.329999999999998 113.429 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 20' ' ' MET . 10.0 pt-20 -102.93 30.77 4.57 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.421 -0.889 . . . . 73.129999999999995 111.214 -174.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.9 mt -138.56 104.02 5.02 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 114.674 -1.148 . . . . 71.010000000000005 113.723 -171.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 t30 179.46 96.54 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.791 1.636 . . . . 71.209999999999994 106.682 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.6 m -59.26 172.22 0.65 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 125.278 1.431 . . . . 61.109999999999999 114.603 -171.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 57.2 tptt 83.77 93.6 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.683 1.993 . . . . 72.540000000000006 111.742 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.421 ' HA ' HG13 ' A' ' 23' ' ' ILE . 94.2 mt -76.04 81.48 2.89 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.218 -0.901 . . . . 73.120000000000005 111.163 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -105.76 11.89 31.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 123.765 1.745 . . . . 74.420000000000002 107.974 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -137.76 145.82 17.52 Favored Glycine 0 N--CA 1.413 -2.849 0 N-CA-C 105.044 -3.223 . . . . 72.109999999999999 105.044 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -121.15 93.8 48.83 Favored Pre-proline 0 C--N 1.286 -2.18 0 CA-C-N 117.982 0.891 . . . . 64.439999999999998 109.084 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.69 120.33 7.7 Favored 'Trans proline' 0 C--O 1.244 0.776 0 C-N-CA 122.868 2.379 . . . . 65.430000000000007 113.634 -171.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.9 tp -127.55 104.23 21.74 Favored Pre-proline 0 N--CA 1.428 -1.533 0 CA-C-N 115.302 -0.863 . . . . 73.5 110.634 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -67.6 132.62 27.53 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 121.789 1.659 . . . . 61.219999999999999 110.672 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -96.09 163.01 21.91 Favored Pre-proline 0 C--N 1.306 -1.306 0 CA-C-N 116.368 -0.378 . . . . 63.039999999999999 110.39 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.09 -25.09 77.12 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.741 2.294 . . . . 70.120000000000005 111.335 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 80.4 mt -85.8 104.04 15.12 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 105.747 -1.946 . . . . 55.450000000000003 105.747 173.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.5 ' HG ' ' OE2' ' A' ' 74' ' ' GLU . 13.8 tp -132.74 150.24 52.18 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.081 -1.081 . . . . 75.200000000000003 108.081 -171.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.459 ' HA3' ' HB2' ' A' ' 74' ' ' GLU . . . -81.89 84.09 1.5 Allowed Glycine 0 CA--C 1.503 -0.68 0 C-N-CA 121.167 -0.54 . . . . 71.109999999999999 112.35 -173.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.413 HD23 ' H ' ' A' ' 142' ' ' LEU . 1.9 pt? -84.5 32.11 0.51 Allowed 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 123.074 0.549 . . . . 72.150000000000006 112.018 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -104.78 162.37 13.37 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.846 0.832 . . . . 73.319999999999993 111.444 -176.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.7 t -151.62 46.94 0.8 Allowed 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 104.364 -2.458 . . . . 75.310000000000002 104.364 172.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.2 m -75.83 94.82 3.38 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 112.699 -2.046 . . . . 73.329999999999998 108.626 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -94.3 90.36 6.26 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.364 -0.835 . . . . 75.329999999999998 109.387 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.1 p -80.73 126.88 31.85 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-O 121.814 0.816 . . . . 73.230000000000004 112.434 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.663 0 N-CA-C 107.645 -2.182 . . . . 73.129999999999995 107.645 177.571 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.428 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 2.0 mmt . . . . . 0 CA--C 1.506 -0.732 0 CA-C-O 121.367 0.603 . . . . 71.439999999999998 112.194 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -126.18 143.77 51.01 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.671 -1.233 . . . . 55.43 107.671 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 11.8 m-85 -114.7 145.34 42.16 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 122.002 0.906 . . . . 72.099999999999994 112.778 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.666 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 35.4 t70 -106.12 100.89 10.41 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 127.026 2.131 . . . . 64.239999999999995 105.541 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -92.42 124.6 44.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.638 -0.664 . . . . 54.140000000000001 109.334 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.9 t -113.51 119.05 59.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.288 -1.004 . . . . 73.239999999999995 108.288 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.536 HG23 ' HB2' ' A' ' 27' ' ' MET . 7.7 tt -114.29 116.55 52.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 121.504 0.669 . . . . 61.140000000000001 109.391 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 20.7 mt -106.61 106.72 58.58 Favored Pre-proline 0 C--N 1.3 -1.551 0 CA-C-N 115.56 -0.745 . . . . 72.219999999999999 110.056 -175.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.536 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 25.3 Cg_endo -95.42 137.22 0.74 Allowed 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.507 2.138 . . . . 73.420000000000002 111.185 173.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -158.55 137.45 11.29 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 121.845 -0.534 . . . . 71.409999999999997 111.065 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -84.5 106.92 16.45 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.21 -0.45 . . . . 50.409999999999997 109.853 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.629 ' CE1' ' HB2' ' A' ' 79' ' ' LYS . 2.0 p90 -63.26 106.98 0.97 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.103 1.149 . . . . 64.219999999999999 114.103 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 73.7 m80 -142.24 156.36 45.3 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.96 -1.018 . . . . 74.319999999999993 108.704 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -98.26 120.68 39.1 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 108.0 -1.111 . . . . 71.430000000000007 108.0 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -60.04 111.08 1.36 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 124.754 1.284 . . . . 75.349999999999994 110.603 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.07 -100.53 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.576 -1.193 . . . . 72.299999999999997 108.355 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -113.19 -60.31 1.9 Allowed 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 106.862 -1.533 . . . . 75.5 106.862 167.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.457 ' HA ' ' OE1' ' A' ' 21' ' ' GLU . 7.2 p-80 -138.5 34.56 2.26 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 113.797 -1.547 . . . . 74.25 110.005 175.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -135.29 152.61 51.66 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 106.619 -1.622 . . . . 61.310000000000002 106.619 -178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.461 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 0.0 OUTLIER 60.99 58.09 2.38 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.512 1.149 . . . . 62.520000000000003 110.009 -175.239 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 18' ' ' HIS . 7.4 pt-20 -141.06 88.22 2.16 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 113.47 -1.695 . . . . 64.5 110.684 -176.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -128.75 104.65 7.75 Favored 'General case' 0 C--N 1.285 -2.22 0 O-C-N 121.68 -0.638 . . . . 72.420000000000002 109.456 174.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.6 mm -116.51 136.68 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.733 0 N-CA-C 107.02 -1.474 . . . . 70.430000000000007 107.02 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 70.2 m -108.38 145.63 31.94 Favored Pre-proline 0 C--N 1.281 -2.397 0 N-CA-C 107.335 -1.357 . . . . 73.430000000000007 107.335 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.42 152.01 33.9 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 121.902 1.734 . . . . 63.119999999999997 112.451 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.02 125.2 17.49 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.631 2.221 . . . . 64.439999999999998 111.261 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.536 ' HB2' HG23 ' A' ' 7' ' ' ILE . 38.9 mtt -95.56 134.45 38.41 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.454 -1.684 . . . . 23.440000000000001 106.454 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -131.33 136.86 56.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.383 -0.527 . . . . 65.230000000000004 110.954 -168.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.4 mp -133.65 109.17 12.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.201 -1.037 . . . . 72.129999999999995 108.201 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.666 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -119.08 81.19 0.32 Allowed Glycine 0 C--N 1.3 -1.465 0 C-N-CA 119.209 -1.472 . . . . 42.329999999999998 115.137 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -176.06 31.03 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 124.555 1.142 . . . . 53.5 112.268 172.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.42 ' NH1' HG11 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -109.65 133.23 53.36 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 106.228 -1.767 . . . . 71.329999999999998 106.228 -179.185 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 p -75.13 161.48 29.36 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 119.471 1.032 . . . . 72.25 109.509 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.575 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 61.9 t80 -58.89 -43.63 90.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.499 0.666 . . . . 74.150000000000006 111.263 -173.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -70.08 -34.96 73.82 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.841 -1.072 . . . . 73.140000000000001 112.098 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.5 -35.79 17.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.404 -0.591 . . . . 42.229999999999997 109.404 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.8 -45.72 93.31 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-N 115.497 -0.774 . . . . 51.030000000000001 109.997 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 18.4 mmt -62.99 -38.11 89.87 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 116.504 -0.316 . . . . 70.109999999999999 111.249 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -65.54 -45.26 84.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.396 -0.365 . . . . 63.200000000000003 111.035 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.463 ' O ' HG23 ' A' ' 44' ' ' VAL . 10.4 tt -71.79 -39.73 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 119.146 -1.022 . . . . 65.299999999999997 110.541 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 83.5 t -67.8 -33.73 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 121.133 -0.227 . . . . 63.409999999999997 110.615 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -67.83 -40.94 83.7 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.86 -0.422 . . . . 75.219999999999999 109.86 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.34 -45.05 92.34 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-N 115.64 -0.709 . . . . 62.32 111.342 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 40' ' ' ILE . 69.7 t -61.7 -42.7 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.012 0.434 . . . . 74.519999999999996 109.875 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.56 -46.21 80.85 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 124.306 1.042 . . . . 72.239999999999995 111.225 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -71.54 -35.32 70.62 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.059 -0.973 . . . . 71.340000000000003 110.323 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 43' ' ' GLY . 97.7 t -67.73 -40.6 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 121.051 -0.259 . . . . 75.030000000000001 110.445 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 44' ' ' VAL . 74.8 mt -64.15 -39.6 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.958 0.409 . . . . 74.200000000000003 109.9 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -74.89 -19.28 60.21 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 115.973 -0.558 . . . . 75.319999999999993 111.321 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.72 -14.74 16.54 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 112.874 0.694 . . . . 73.319999999999993 112.874 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 m -108.23 -23.42 11.94 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 112.429 0.529 . . . . 70.409999999999997 112.429 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -133.97 177.93 7.35 Favored 'General case' 0 CA--C 1.484 -1.564 0 CA-C-O 121.461 0.648 . . . . 72.150000000000006 110.069 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.534 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 38.4 t30 -98.93 95.89 7.47 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 104.938 -2.245 . . . . 72.019999999999996 104.938 175.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -117.41 135.25 54.02 Favored 'General case' 0 N--CA 1.402 -2.859 0 CA-C-N 115.427 -0.806 . . . . 44.43 112.408 -173.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.4 m -109.72 121.26 44.82 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 106.812 -1.551 . . . . 64.219999999999999 106.812 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.35 128.82 51.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-O 121.294 0.568 . . . . 74.219999999999999 110.539 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -122.37 112.33 17.96 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.879 -1.526 . . . . 71.209999999999994 106.879 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.16 119.13 34.09 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.814 0.34 . . . . 53.399999999999999 110.818 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.48 174.4 6.57 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.291 0.567 . . . . 62.130000000000003 109.824 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -95.98 155.18 16.86 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.2 -1.408 . . . . 64.420000000000002 107.2 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.66 175.73 24.6 Favored Glycine 0 C--N 1.277 -2.749 0 C-N-CA 120.519 -0.848 . . . . 73.150000000000006 112.891 -176.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.51 ' HB3' ' OD2' ' A' ' 65' ' ' ASP . 11.6 tp10 -65.91 177.05 1.42 Allowed 'General case' 0 C--O 1.21 -1.025 0 C-N-CA 124.735 1.214 . . . . 72.140000000000001 108.813 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -45.25 -49.11 12.69 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 113.813 1.042 . . . . 74.420000000000002 113.813 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 76.8 m -82.03 -15.07 54.86 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.758 -0.655 . . . . 75.209999999999994 111.712 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 12.3 m-20 -98.87 118.09 34.85 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.1 -0.64 . . . . 73.219999999999999 110.618 -176.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.0 t -80.73 -36.21 15.47 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.508 0 CA-C-N 116.062 -0.517 . . . . 61.200000000000003 112.272 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.8 tp -146.48 140.68 26.4 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.896 -1.15 . . . . 75.439999999999998 107.896 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.79 102.01 6.13 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 107.374 -1.343 . . . . 65.519999999999996 107.374 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -109.43 114.53 28.25 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.83 0.824 . . . . 63.009999999999998 110.372 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -98.49 139.33 34.39 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.811 -1.086 . . . . 72.420000000000002 109.012 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.84 128.48 51.7 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 107.257 -1.386 . . . . 71.329999999999998 107.257 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.3 m -103.42 119.17 38.37 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 106.78 -1.563 . . . . 75.409999999999997 106.78 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.57 137.71 44.07 Favored 'General case' 0 CA--C 1.495 -1.156 0 CA-C-O 121.084 0.468 . . . . 61.240000000000002 112.182 -173.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -142.45 83.55 1.83 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.145 -1.428 . . . . 74.109999999999999 107.145 173.125 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -85.62 66.79 9.83 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.063 -0.517 . . . . 75.409999999999997 109.831 -177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 51.56 64.1 1.98 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.507 -1.224 . . . . 74.5 111.427 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.93 -11.8 62.39 Favored Glycine 0 C--N 1.314 -0.667 0 C-N-CA 120.666 -0.778 . . . . 74.109999999999999 112.856 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -108.64 107.7 18.28 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.38 -1.341 . . . . 64.109999999999999 107.38 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.629 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -121.63 142.65 49.92 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 113.14 0.793 . . . . 70.239999999999995 113.14 -165.348 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.98 171.29 43.77 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.967 -0.56 . . . . 41.409999999999997 111.877 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.4 mt -116.53 147.0 20.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.759 -1.2 . . . . 75.329999999999998 107.759 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.3 t -130.18 110.44 19.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.588 -0.893 . . . . 71.530000000000001 108.588 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.502 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 38.6 m-70 -98.89 106.32 18.57 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.294 -0.632 . . . . 63.299999999999997 109.294 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.6 t -104.66 109.87 28.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.603 -0.888 . . . . 64.340000000000003 108.603 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -119.76 139.44 52.3 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.61 -0.515 . . . . 71.099999999999994 109.61 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.7 mt -102.52 106.22 16.9 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 107.385 -1.339 . . . . 74.120000000000005 107.385 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 60.0 ttt-85 -98.05 141.55 30.86 Favored 'General case' 0 C--N 1.263 -3.17 0 N-CA-C 108.843 -0.799 . . . . 64.340000000000003 108.843 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -93.59 108.35 20.08 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 109.346 -0.613 . . . . 73.0 109.346 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 tt -83.15 116.12 26.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.29 0.567 . . . . 73.420000000000002 109.68 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.8 p -115.79 -172.04 2.09 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 107.957 -1.127 . . . . 72.409999999999997 107.957 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -87.76 -13.2 42.97 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.464 0.65 . . . . 73.109999999999999 109.977 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -95.49 -38.23 10.54 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.919 -1.037 . . . . 65.430000000000007 109.63 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 49.3 t -101.52 104.3 33.25 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 109.465 -0.568 . . . . 63.039999999999999 109.465 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.85 146.97 33.96 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.219 2.612 . . . . 70.129999999999995 113.017 -176.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.16 162.18 27.45 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 123.782 2.988 . . . . 73.239999999999995 113.447 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 t -92.22 159.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 107.339 -1.356 . . . . 61.340000000000003 107.339 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.48 141.34 48.66 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.316 -0.624 . . . . 53.420000000000002 109.316 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.09 -169.9 41.41 Favored Glycine 0 CA--C 1.467 -2.927 0 N-CA-C 108.762 -1.735 . . . . 64.510000000000005 108.762 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.511 ' HB3' ' HG2' ' A' ' 27' ' ' MET . 4.4 t-20 -56.31 111.0 0.86 Allowed 'General case' 0 N--CA 1.426 -1.634 0 O-C-N 124.234 0.608 . . . . 72.450000000000003 109.788 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -87.16 126.17 34.63 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 108.344 -0.984 . . . . 74.219999999999999 108.344 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.11 151.97 44.87 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.305 -0.861 . . . . 51.329999999999998 110.435 -175.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.9 m -78.93 81.92 5.17 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.523 0.677 . . . . 74.549999999999997 109.766 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.531 HG13 ' OD2' ' A' ' 109' ' ' ASP . 49.3 t -80.74 143.72 11.86 Favored 'Isoleucine or valine' 0 C--O 1.251 1.137 0 CA-C-N 114.705 -1.134 . . . . 54.310000000000002 109.64 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -154.67 -67.98 0.13 Allowed 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.44 -1.319 . . . . 70.430000000000007 107.44 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -158.6 163.06 37.32 Favored 'General case' 1 C--N 1.24 -4.189 0 CA-C-N 112.54 -2.118 . . . . 64.030000000000001 105.62 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -39.35 -43.12 1.14 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.336 1.606 . . . . 73.0 115.336 -172.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -60.36 -49.76 76.29 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.025 0.379 . . . . 71.120000000000005 112.025 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -74.71 -33.87 62.48 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.295 -0.562 . . . . 71.329999999999998 110.645 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.531 ' OD2' HG13 ' A' ' 103' ' ' VAL . 0.9 OUTLIER -62.29 -48.37 80.2 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.387 -0.824 . . . . 64.439999999999998 110.423 178.193 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 10.5 tp -66.68 -37.99 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 120.711 -0.396 . . . . 65.209999999999994 110.452 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -63.58 -42.21 98.31 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.685 -0.406 . . . . 74.140000000000001 110.44 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 2.7 t -63.59 -41.32 98.36 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.164 -0.471 . . . . 73.120000000000005 111.907 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.424 ' O ' HG13 ' A' ' 117' ' ' ILE . 47.6 mm -70.54 -45.19 75.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 121.085 -0.246 . . . . 44.310000000000002 110.644 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.496 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 70.7 t -64.69 -42.91 96.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.333 -0.394 . . . . 72.129999999999995 110.912 -177.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.57 -27.35 62.14 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.173 -0.611 . . . . 53.149999999999999 111.163 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.18 84.8 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.47 -0.567 . . . . 14.15 109.47 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 113' ' ' ILE . 72.4 mt -63.8 -45.8 96.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.398 -0.819 . . . . 72.140000000000001 109.184 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 114' ' ' VAL . 80.6 mt-10 -60.71 -40.35 91.97 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 116.276 -0.42 . . . . 72.510000000000005 111.283 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -70.43 -35.22 73.26 Favored 'General case' 0 C--O 1.202 -1.438 0 C-N-CA 120.632 -0.427 . . . . 74.439999999999998 111.149 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 8.1 t -73.54 -37.15 65.68 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.196 -0.602 . . . . 73.140000000000001 110.483 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.3 mp -77.58 -42.67 34.38 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.866 -0.734 . . . . 71.329999999999998 111.211 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.29 -19.88 29.22 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 116.29 1.959 . . . . 65.019999999999996 116.29 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.4 30.4 mttp -59.63 -47.76 84.33 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 116.73 2.122 . . . . 72.200000000000003 116.73 -172.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 155.34 149.84 5.41 Favored Glycine 0 C--N 1.264 -3.431 0 C-N-CA 119.405 -1.378 . . . . 63.439999999999998 113.017 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -83.17 48.78 1.43 Allowed 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 124.424 1.09 . . . . 71.530000000000001 111.128 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.5 tp 176.95 101.85 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 125.2 1.4 . . . . 71.230000000000004 109.67 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 34.6 t30 177.41 113.34 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.668 1.187 . . . . 71.420000000000002 109.665 174.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.9 m 55.58 94.84 0.02 OUTLIER 'General case' 0 N--CA 1.421 -1.917 0 C-N-CA 125.824 1.65 . . . . 50.210000000000001 114.539 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -82.03 114.5 20.64 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 115.044 -0.98 . . . . 72.420000000000002 110.424 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 98.8 mt -128.68 -174.9 3.37 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.989 -1.856 . . . . 74.230000000000004 105.989 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.61 120.38 16.14 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.648 -0.501 . . . . 74.409999999999997 109.648 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -133.08 160.47 23.91 Favored Glycine 0 CA--C 1.482 -1.982 0 N-CA-C 109.533 -1.427 . . . . 62.109999999999999 109.533 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.404 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 3.0 mppt? -110.49 109.28 58.25 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 117.366 0.583 . . . . 74.329999999999998 110.254 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.83 112.07 3.3 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 121.849 1.699 . . . . 75.209999999999994 109.139 174.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.422 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 49.6 mm -106.9 110.15 63.47 Favored Pre-proline 0 N--CA 1.421 -1.89 0 CA-C-N 116.32 -0.4 . . . . 74.010000000000005 110.354 -176.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 135' ' ' ILE . 55.8 Cg_endo -74.01 150.04 42.71 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.294 1.996 . . . . 61.030000000000001 109.304 170.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.1 m120 66.03 87.44 0.12 Allowed Pre-proline 0 C--N 1.32 -0.703 0 C-N-CA 124.073 0.949 . . . . 74.329999999999998 111.672 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -81.85 -10.96 11.5 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.558 2.172 . . . . 71.439999999999998 111.658 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 66.03 100.32 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 124.851 1.26 . . . . 74.420000000000002 111.167 -176.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.7 mp -86.34 69.6 10.44 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 121.444 0.64 . . . . 62.32 109.427 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.63 -36.55 58.41 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 115.185 -0.916 . . . . 55.310000000000002 111.078 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.8 tt 66.64 94.14 0.07 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.922 1.289 . . . . 72.129999999999995 109.075 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -130.62 109.68 10.83 Favored 'General case' 0 CA--C 1.469 -2.155 0 CA-C-N 114.491 -1.231 . . . . 73.310000000000002 109.558 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 66.6 m -161.88 71.84 0.37 Allowed 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.213 -1.403 . . . . 54.229999999999997 107.213 174.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.4 m -78.65 86.71 4.61 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.566 -0.743 . . . . 61.409999999999997 109.249 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -169.83 132.88 1.18 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.378 -1.712 . . . . 72.030000000000001 106.378 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.6 m -88.22 98.4 11.55 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.943 -0.762 . . . . 73.209999999999994 108.943 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.459 0 N-CA-C 109.672 -1.371 . . . . 62.329999999999998 109.672 -178.665 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 N-CA-C 107.022 -1.473 . . . . 74.400000000000006 107.022 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 98.3 mttt -88.06 155.29 19.88 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.673 0.749 . . . . 63.25 112.195 -178.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.632 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 7.6 m-85 -122.95 151.86 41.4 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.957 -1.02 . . . . 74.239999999999995 111.856 178.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.61 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 32.3 t70 -103.32 101.55 11.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 105.753 -1.943 . . . . 70.129999999999995 105.753 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -90.41 120.91 40.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.643 0.735 . . . . 73.140000000000001 109.335 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.0 t -110.69 112.39 40.35 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 107.664 -1.236 . . . . 71.530000000000001 107.664 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.522 HG23 ' HB3' ' A' ' 27' ' ' MET . 4.7 tt -120.08 108.83 24.19 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 CA-C-O 121.938 0.875 . . . . 74.430000000000007 109.903 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.0 mt -110.27 117.25 51.82 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-N 114.799 -1.091 . . . . 73.549999999999997 108.553 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.604 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 44.6 Cg_endo -93.67 140.25 1.55 Allowed 'Trans proline' 0 N--CA 1.431 -2.171 0 C-N-CA 121.51 1.473 . . . . 73.530000000000001 110.728 171.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.55 124.49 8.61 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.187 0.518 . . . . 74.329999999999998 111.054 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.577 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 57.4 m -67.51 114.64 6.33 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 122.108 -0.37 . . . . 71.310000000000002 110.143 177.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 2.7 p90 -57.39 115.17 2.55 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 113.726 1.009 . . . . 64.129999999999995 113.726 -176.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 71.0 m80 -146.45 162.79 37.5 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 114.275 -1.329 . . . . 64.409999999999997 108.324 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -133.63 149.5 51.58 Favored 'General case' 0 N--CA 1.401 -2.896 0 N-CA-C 104.945 -2.243 . . . . 71.430000000000007 104.945 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -61.12 115.93 4.15 Favored 'General case' 0 N--CA 1.413 -2.316 0 O-C-N 124.214 0.946 . . . . 74.450000000000003 110.806 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -91.27 -159.31 0.62 Allowed 'General case' 0 C--N 1.266 -3.064 0 N-CA-C 105.504 -2.036 . . . . 72.409999999999997 105.504 172.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -70.64 -52.84 18.57 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 119.466 1.03 . . . . 64.430000000000007 110.599 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -136.16 5.47 3.02 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.546 0.689 . . . . 52.420000000000002 110.511 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -125.82 170.95 11.1 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.486 -0.561 . . . . 75.150000000000006 109.486 -175.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.401 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 57.9 mtt 66.2 85.19 0.14 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.86 1.264 . . . . 65.150000000000006 113.347 175.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -161.73 98.72 1.11 Allowed 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.854 -1.165 . . . . 70.530000000000001 107.854 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -149.62 134.21 17.61 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.919 -0.488 . . . . 73.519999999999996 111.391 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.2 mp -128.86 144.72 37.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 104.572 -2.381 . . . . 72.349999999999994 104.572 172.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.604 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 37.4 m -107.15 160.0 27.99 Favored Pre-proline 0 C--N 1.277 -2.547 0 N-CA-C 108.584 -0.895 . . . . 52.109999999999999 108.584 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.89 119.81 7.1 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.228 2.619 . . . . 71.129999999999995 114.182 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.59 125.14 10.35 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.64 2.227 . . . . 62.420000000000002 110.925 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.522 ' HB3' HG23 ' A' ' 7' ' ' ILE . 39.0 tpp -101.15 128.19 47.36 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.899 -1.149 . . . . 70.400000000000006 107.899 -175.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.7 t -129.31 129.34 67.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.449 -0.574 . . . . 72.109999999999999 109.449 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.409 HD11 ' H ' ' A' ' 101' ' ' CYS . 38.7 mm -134.39 106.59 8.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.062 0.458 . . . . 74.430000000000007 110.684 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -104.47 81.12 0.32 Allowed Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 119.875 -1.155 . . . . 61.219999999999999 112.091 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -170.04 31.12 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.895 0.855 . . . . 41.200000000000003 111.023 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 -124.61 133.94 53.09 Favored 'General case' 0 C--O 1.201 -1.457 0 N-CA-C 107.667 -1.235 . . . . 72.209999999999994 107.667 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 2.3 p -84.44 155.25 22.32 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 118.524 0.602 . . . . 73.319999999999993 110.553 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.632 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 90.3 t80 -48.9 -53.74 18.3 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 124.464 1.106 . . . . 72.120000000000005 113.315 -172.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 25.5 m-20 -70.18 -35.43 73.96 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.749 -1.114 . . . . 73.109999999999999 111.06 -174.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.8 mt -76.28 -38.23 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 109.619 -0.512 . . . . 71.109999999999999 109.619 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.01 -44.96 95.61 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.716 -0.675 . . . . 43.310000000000002 110.414 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.8 ttm -66.45 -38.38 87.24 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 119.968 -0.693 . . . . 65.519999999999996 110.674 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 35' ' ' ASP . 55.9 mm-40 -67.82 -40.14 83.85 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.494 -0.482 . . . . 65.129999999999995 111.752 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 44' ' ' VAL . 14.6 tt -73.38 -38.36 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 119.464 -0.894 . . . . 73.340000000000003 110.736 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.87 -39.23 84.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 110.193 -0.299 . . . . 64.400000000000006 110.193 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -71.31 -16.59 62.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.031 0.443 . . . . 65.109999999999999 111.822 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.79 -43.47 6.79 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 110.233 -1.147 . . . . 74.530000000000001 110.233 173.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 40' ' ' ILE . 77.4 t -59.8 -38.26 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.045 -1.095 . . . . 62.149999999999999 108.045 177.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -51.09 -50.08 59.44 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 126.051 1.74 . . . . 72.439999999999998 111.069 176.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -67.26 -38.19 84.74 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.753 -0.832 . . . . 73.319999999999993 108.753 -177.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -62.32 -45.4 98.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.07 -0.514 . . . . 72.230000000000004 110.696 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 44' ' ' VAL . 61.6 mt -69.42 -38.35 76.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.912 0.386 . . . . 73.219999999999999 110.397 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -79.58 -14.29 58.93 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.245 0.545 . . . . 74.439999999999998 112.263 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.65 -38.46 7.9 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.722 -0.611 . . . . 65.310000000000002 112.009 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -84.72 -14.08 49.42 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.663 0.744 . . . . 70.140000000000001 110.377 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -141.19 -175.58 4.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.58 -1.267 . . . . 65.120000000000005 107.58 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -106.78 100.1 9.63 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 105.609 -1.997 . . . . 63.409999999999997 105.609 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -129.46 136.04 49.4 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-O 121.194 0.521 . . . . 74.25 111.952 -175.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.507 ' OG ' ' HA2' ' A' ' 141' ' ' GLY . 5.5 p -116.87 127.57 54.4 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.725 -1.213 . . . . 71.030000000000001 107.725 175.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 p -101.03 119.1 48.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 119.805 -0.758 . . . . 72.219999999999999 111.77 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -95.91 111.11 23.19 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.806 -1.924 . . . . 70.010000000000005 105.806 171.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -103.24 108.51 19.75 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 122.069 0.937 . . . . 73.519999999999996 112.315 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mp -111.85 177.56 4.61 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.888 -1.506 . . . . 74.120000000000005 109.422 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -94.42 161.82 14.07 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.427 -0.953 . . . . 63.450000000000003 108.427 177.695 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.1 176.52 24.66 Favored Glycine 0 C--N 1.285 -2.298 0 N-CA-C 110.345 -1.102 . . . . 54.149999999999999 110.345 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -65.19 -179.47 0.58 Allowed 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 116.973 0.386 . . . . 73.120000000000005 110.126 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -52.05 -31.9 32.1 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 113.273 0.842 . . . . 74.400000000000006 113.273 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 51.8 t -87.67 -15.6 36.71 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.765 -0.652 . . . . 74.230000000000004 111.463 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.501 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 11.5 m-20 -105.64 156.81 17.9 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-O 121.244 0.545 . . . . 73.329999999999998 110.141 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.6 t -112.22 -31.94 2.17 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 120.497 -0.481 . . . . 74.530000000000001 111.857 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 57.3 tp -151.15 138.64 19.55 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.071 -0.652 . . . . 53.009999999999998 109.764 -176.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.2 104.18 6.91 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.392 -0.596 . . . . 73.329999999999998 109.392 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -104.62 116.58 32.3 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.482 -0.932 . . . . 72.319999999999993 108.482 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -98.72 110.27 22.9 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.669 -1.234 . . . . 75.230000000000004 107.669 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -94.93 123.04 38.17 Favored 'General case' 0 C--N 1.264 -3.122 0 N-CA-C 109.713 -0.477 . . . . 64.5 109.713 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 29.9 m -94.26 122.38 36.74 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.452 -1.314 . . . . 65.200000000000003 107.452 176.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.47 136.78 50.15 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 114.391 1.256 . . . . 73.340000000000003 114.391 -172.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -133.62 135.68 44.35 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.91 -1.885 . . . . 74.519999999999996 105.91 170.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.546 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 80.1 tttt -139.82 172.62 12.52 Favored 'General case' 0 C--N 1.27 -2.886 0 N-CA-C 104.422 -2.436 . . . . 71.510000000000005 104.422 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.469 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 8.2 pt-20 -47.2 87.67 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.907 0.883 . . . . 74.140000000000001 112.942 176.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.32 19.16 78.63 Favored Glycine 0 N--CA 1.432 -1.623 0 CA-C-N 115.175 -0.921 . . . . 61.240000000000002 112.482 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 59.2 mmtt -127.86 156.43 42.58 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.725 -1.583 . . . . 74.310000000000002 106.725 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -156.85 140.77 16.21 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 123.262 0.351 . . . . 74.329999999999998 110.349 -178.164 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -170.5 177.46 43.66 Favored Glycine 0 C--O 1.205 -1.692 0 C-N-CA 120.113 -1.041 . . . . 71.120000000000005 113.432 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.403 HG13 ' HB3' ' A' ' 12' ' ' PHE . 60.8 mt -123.79 151.5 28.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 106.493 -1.669 . . . . 75.120000000000005 106.493 175.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.1 t -134.64 109.9 12.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.324 -0.991 . . . . 63.25 108.324 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -89.4 104.22 16.79 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.693 -0.484 . . . . 72.230000000000004 109.693 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.2 t -105.13 109.81 28.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.385 -0.969 . . . . 72.219999999999999 108.385 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 18.1 pttp -122.68 144.22 49.28 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 120.111 -0.635 . . . . 65.439999999999998 110.014 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.4 mt -105.81 109.47 21.44 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 107.226 -1.398 . . . . 52.240000000000002 107.226 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.524 ' HD3' ' OD2' ' A' ' 4' ' ' ASP . 36.6 ttt180 -98.51 141.34 31.48 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.4 -0.963 . . . . 61.409999999999997 108.4 -177.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -85.01 111.18 19.48 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 120.346 -0.542 . . . . 75.420000000000002 109.925 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.9 tt -74.47 112.13 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-O 122.168 0.985 . . . . 71.510000000000005 108.993 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -135.31 -177.95 4.89 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 106.235 -1.765 . . . . 73.239999999999995 106.235 -171.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -80.91 -13.75 58.63 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.472 1.13 . . . . 64.319999999999993 108.987 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -79.34 -33.39 43.09 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 113.849 -1.523 . . . . 71.25 108.474 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 95.9 m -129.76 94.22 32.44 Favored Pre-proline 0 N--CA 1.439 -1.002 0 CA-C-N 115.209 -0.905 . . . . 74.239999999999995 110.403 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.6 153.39 43.86 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 122.529 2.153 . . . . 51.520000000000003 112.269 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.34 138.48 60.85 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.171 2.581 . . . . 53.130000000000003 111.762 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.4 t -97.27 153.26 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.307 -0.997 . . . . 73.219999999999999 108.307 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -105.64 92.27 4.11 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 108.364 -0.976 . . . . 71.140000000000001 108.364 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -109.96 -149.67 12.68 Favored Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 109.741 -1.344 . . . . 61.149999999999999 109.741 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -72.9 118.27 15.64 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 107.426 -1.324 . . . . 25.350000000000001 107.426 172.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -94.78 121.6 36.54 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.519 0.676 . . . . 71.129999999999995 109.201 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.409 ' H ' HD11 ' A' ' 29' ' ' ILE . 20.8 t -69.37 151.48 46.11 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.673 -1.149 . . . . 74.209999999999994 110.261 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 m -77.34 88.74 3.74 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.75 -0.833 . . . . 51.039999999999999 108.75 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -106.0 148.29 10.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 114.924 -1.035 . . . . 65.219999999999999 110.976 -172.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.0 tp -157.83 -61.45 0.08 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.628 1.204 . . . . 74.150000000000006 107.887 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -146.43 167.2 24.22 Favored 'General case' 0 C--N 1.256 -3.475 0 CA-C-N 112.243 -2.253 . . . . 71.219999999999999 108.192 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.55 ' O ' HG22 ' A' ' 110' ' ' ILE . 63.8 t80 -46.59 -49.17 19.33 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 124.627 1.204 . . . . 71.140000000000001 113.611 -175.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -58.73 -28.93 66.32 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.061 0.458 . . . . 74.329999999999998 112.063 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -87.11 -40.44 14.65 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 116.323 -0.399 . . . . 72.239999999999995 111.366 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.455 ' O ' HG12 ' A' ' 113' ' ' ILE 0.367 4.5 p30 -78.26 -28.34 47.7 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 118.788 -1.165 . . . . 73.299999999999997 112.954 -176.113 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 106' ' ' PHE . 8.2 tp -67.59 -40.3 83.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 109.482 -0.562 . . . . 72.019999999999996 109.482 175.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -66.91 -41.01 87.85 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 108.95 -0.759 . . . . 75.219999999999999 108.95 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 8.5 t -64.19 -41.87 96.9 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.13 -0.941 . . . . 74.540000000000006 111.744 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 109' ' ' ASP . 35.8 mm -68.16 -42.0 84.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 120.494 0.188 . . . . 61.399999999999999 110.596 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 93.1 t -67.03 -41.23 87.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.396 -0.594 . . . . 73.420000000000002 109.396 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -60.6 -39.91 89.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.936 -0.574 . . . . 71.140000000000001 110.964 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.45 98.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.86 0.362 . . . . 73.109999999999999 110.711 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 77.3 mt -68.8 -43.52 82.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.326 -0.62 . . . . 73.0 109.326 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -58.25 -46.18 86.45 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 123.817 0.847 . . . . 61.229999999999997 111.618 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -69.86 -36.05 75.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.533 -0.758 . . . . 65.109999999999999 109.464 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 52.7 t -65.21 -47.2 77.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.699 -0.682 . . . . 53.219999999999999 110.193 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.3 mp -68.88 -30.41 68.91 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.157 -0.474 . . . . 73.200000000000003 111.596 -177.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.12 -35.32 56.35 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.66 -0.7 . . . . 72.140000000000001 111.128 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -87.05 -12.93 45.8 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.52 0.676 . . . . 75.319999999999993 110.781 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.35 60.51 4.51 Favored Glycine 0 C--N 1.304 -1.203 0 CA-C-N 115.306 -0.861 . . . . 70.120000000000005 113.265 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -130.54 108.35 9.88 Favored 'General case' 0 C--N 1.268 -2.973 0 C-N-CA 124.733 1.213 . . . . 74.140000000000001 108.479 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.7 mp 66.51 -178.65 0.2 Allowed 'General case' 0 C--O 1.242 0.702 0 O-C-N 124.265 0.978 . . . . 71.319999999999993 110.917 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -62.89 127.79 32.88 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.512 -1.292 . . . . 74.319999999999993 107.512 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.7 m -127.1 161.18 29.06 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 109.04 -0.726 . . . . 72.319999999999993 109.04 -176.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.464 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 22.3 ttmm -80.38 77.63 7.13 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 122.499 1.142 . . . . 51.310000000000002 112.332 -178.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 129' ' ' LYS . 20.6 mt -171.21 54.15 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 129.893 3.277 . . . . 62.530000000000001 103.511 174.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -75.29 175.88 7.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.353 -2.203 . . . . 51.020000000000003 111.37 -173.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 138.95 -137.53 8.72 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 108.787 -1.725 . . . . 62.020000000000003 108.787 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -116.99 110.64 41.44 Favored Pre-proline 0 C--N 1.305 -1.357 0 CA-C-N 117.088 0.444 . . . . 71.019999999999996 110.087 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.61 173.71 13.87 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.563 2.175 . . . . 75.310000000000002 110.79 176.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 46.5 mm -111.22 102.76 53.77 Favored Pre-proline 0 N--CA 1.432 -1.359 0 CA-C-O 121.164 0.507 . . . . 75.299999999999997 110.075 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -88.18 138.84 4.19 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 123.017 2.478 . . . . 60.329999999999998 112.073 172.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.465 ' HB3' ' HD2' ' A' ' 138' ' ' PRO . 44.9 m-80 -136.78 173.73 5.22 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 107.521 -1.288 . . . . 64.209999999999994 107.521 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 137' ' ' ASN . 23.5 Cg_endo -66.58 -18.01 53.58 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 121.535 1.49 . . . . 74.439999999999998 112.333 174.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.9 mp 73.65 102.14 0.07 Allowed 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.539 1.136 . . . . 74.430000000000007 112.51 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.1 mt -112.64 101.54 9.67 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.173 -1.417 . . . . 73.310000000000002 107.173 173.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.507 ' HA2' ' OG ' ' A' ' 55' ' ' SER . . . -127.68 4.73 7.05 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.478 -0.868 . . . . 74.010000000000005 113.21 -175.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.1 mp -89.17 76.06 7.75 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.275 1.036 . . . . 65.340000000000003 112.313 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -143.07 31.87 1.38 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 104.319 -2.475 . . . . 73.120000000000005 104.319 175.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.3 m -41.42 111.08 0.19 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 111.621 -2.536 . . . . 73.409999999999997 114.752 -172.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.3 p -128.98 147.69 50.88 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.045 -1.094 . . . . 75.109999999999999 108.045 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -146.32 141.86 27.69 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.216 0.532 . . . . 75.019999999999996 111.553 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 49.2 m -145.07 101.55 3.64 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.281 -1.007 . . . . 64.109999999999999 108.281 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.04 0 N-CA-C 109.503 -1.439 . . . . 31.219999999999999 109.503 -179.789 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.1 mmm . . . . . 0 CA--C 1.499 -1.002 0 CA-C-O 121.011 0.434 . . . . 64.140000000000001 110.291 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -99.56 143.47 29.76 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.976 -0.556 . . . . 74.219999999999999 109.962 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.608 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 21.0 m-85 -116.49 141.04 48.7 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.62 -0.718 . . . . 74.409999999999997 110.008 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.659 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 33.2 t70 -111.92 108.63 18.05 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 125.418 1.487 . . . . 43.520000000000003 109.988 -174.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 p -88.87 116.04 29.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 115.894 -0.594 . . . . 71.120000000000005 109.962 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.21 116.8 50.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.412 -1.329 . . . . 73.439999999999998 107.412 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.491 HG23 ' HB3' ' A' ' 27' ' ' MET . 4.9 tt -121.32 115.86 47.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-O 121.305 0.574 . . . . 43.030000000000001 110.551 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.8 tt -110.42 110.3 58.02 Favored Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 116.028 -0.533 . . . . 74.120000000000005 110.298 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.566 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 72.4 Cg_endo -91.62 147.4 3.35 Favored 'Trans proline' 0 N--CA 1.435 -1.952 0 C-N-CA 122.301 2.001 . . . . 64.299999999999997 110.112 173.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.61 177.66 9.83 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.933 -0.766 . . . . 64.140000000000001 108.933 177.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.47 ' HB2' ' HB3' ' A' ' 22' ' ' HIS . 52.1 m -122.6 104.29 9.25 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 109.019 -0.734 . . . . 53.350000000000001 109.019 173.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 24.0 p90 -49.56 95.61 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 115.131 1.53 . . . . 73.049999999999997 115.131 -176.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.498 ' CE1' ' HB3' ' A' ' 125' ' ' GLU . 76.6 m80 -145.85 168.89 19.71 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.42 -0.809 . . . . 74.310000000000002 109.299 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.75 147.23 46.57 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 104.322 -2.473 . . . . 73.049999999999997 104.322 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -70.43 93.36 0.87 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 123.77 0.669 . . . . 65.120000000000005 109.265 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.5 -84.28 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.212 -0.904 . . . . 71.150000000000006 110.529 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -107.61 -59.91 1.77 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.61 -0.515 . . . . 64.299999999999997 109.61 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -138.06 -52.43 0.62 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.066 -1.087 . . . . 73.239999999999995 108.066 173.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -74.97 174.92 8.65 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 113.114 -1.857 . . . . 60.219999999999999 111.083 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.464 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 4.5 mpp? 74.0 72.16 0.11 Allowed 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 124.881 1.363 . . . . 74.5 108.567 -175.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 5.1 pt-20 -148.84 93.29 2.09 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 113.804 -1.544 . . . . 65.439999999999998 109.249 -171.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 125' ' ' GLU . 19.0 t60 -160.96 107.47 1.45 Allowed 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.143 -1.423 . . . . 55.539999999999999 113.616 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -123.34 136.63 59.33 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 105.27 -2.122 . . . . 73.109999999999999 105.27 172.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 64.0 m -108.3 153.73 41.78 Favored Pre-proline 0 C--N 1.294 -1.83 0 O-C-N 123.109 0.256 . . . . 72.409999999999997 110.791 -176.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.2 Cg_exo -65.83 143.18 72.51 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 123.244 2.629 . . . . 64.099999999999994 113.849 -178.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 7.4 Cg_exo -74.97 130.45 13.31 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.905 2.403 . . . . 61.210000000000001 112.002 176.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.491 ' HB3' HG23 ' A' ' 7' ' ' ILE . 50.3 ttm -92.42 135.3 34.15 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.941 -1.133 . . . . 64.519999999999996 107.941 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 83.9 t -131.09 116.4 33.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 O-C-N 123.238 0.337 . . . . 71.420000000000002 110.786 -171.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.2 mm -129.2 106.06 13.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 120.638 0.256 . . . . 71.430000000000007 111.357 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -112.83 80.91 0.28 Allowed Glycine 0 CA--C 1.476 -2.396 0 C-N-CA 120.27 -0.966 . . . . 72.450000000000003 112.139 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -144.33 1.58 1.08 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.648 0.981 . . . . 51.100000000000001 113.648 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -107.33 134.57 50.2 Favored 'General case' 0 C--N 1.285 -2.204 0 O-C-N 121.025 -1.047 . . . . 71.150000000000006 108.304 -172.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 p -74.65 164.48 26.53 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 107.569 -1.271 . . . . 61.229999999999997 107.569 173.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.608 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 82.1 t80 -55.3 -45.48 76.24 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 120.789 0.328 . . . . 75.209999999999994 111.848 -173.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.85 -39.24 93.24 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.272 -0.876 . . . . 43.210000000000001 111.498 -176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.9 mm -74.31 -43.19 50.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.754 -0.832 . . . . 74.120000000000005 108.754 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 40' ' ' ILE . . . -61.92 -43.38 98.95 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 115.539 -0.755 . . . . 74.109999999999999 111.074 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.3 tpt -68.81 -38.0 79.6 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.972 -0.291 . . . . 61.340000000000003 110.871 -175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -84.36 -21.43 30.89 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 118.905 -1.118 . . . . 74.219999999999999 112.594 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.507 ' O ' HG23 ' A' ' 44' ' ' VAL . 17.6 tt -82.6 -40.25 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 C-N-CA 119.005 -1.078 . . . . 73.25 109.78 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.36 -36.28 71.3 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.876 0 C-N-CA 121.095 -0.242 . . . . 71.340000000000003 110.439 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -64.05 -31.98 73.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.147 0.499 . . . . 71.25 110.158 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -69.41 -44.78 63.27 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.714 -0.955 . . . . 52.219999999999999 110.714 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 40' ' ' ILE . 63.3 t -60.14 -44.93 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.282 -0.636 . . . . 73.409999999999997 109.282 177.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.8 -43.42 80.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.848 1.259 . . . . 70.430000000000007 110.862 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -68.96 -38.5 79.44 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.478 -0.783 . . . . 65.209999999999994 109.78 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 43' ' ' GLY . 92.9 t -66.41 -42.27 90.17 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.361 0 CA-C-N 116.513 -0.312 . . . . 73.409999999999997 110.674 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.458 ' CG2' HD11 ' A' ' 73' ' ' LEU . 72.7 mt -66.81 -41.81 88.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 121.287 0.565 . . . . 61.119999999999997 110.496 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -78.22 -11.38 59.92 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.499 -0.773 . . . . 71.319999999999993 110.583 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.9 -41.94 5.06 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 113.192 0.812 . . . . 72.430000000000007 113.192 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.5 m -91.03 -6.44 53.9 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.583 0.586 . . . . 64.439999999999998 112.583 -175.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -136.47 168.91 18.56 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 108.33 -0.989 . . . . 74.140000000000001 108.33 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 17.6 t-20 -96.15 100.17 11.84 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 105.588 -2.004 . . . . 73.439999999999998 105.588 176.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.19 136.23 55.01 Favored 'General case' 0 N--CA 1.408 -2.542 0 C-N-CA 120.079 -0.648 . . . . 75.040000000000006 112.626 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.485 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 11.6 m -99.45 106.46 18.51 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 103.737 -2.69 . . . . 60.439999999999998 103.737 167.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.439 ' CG2' ' HD2' ' A' ' 69' ' ' ARG . 5.1 p -99.86 121.76 50.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-O 121.661 0.743 . . . . 45.420000000000002 111.419 -171.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -116.25 135.93 53.46 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.293 -0.867 . . . . 75.019999999999996 109.505 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.483 ' HB3' ' NH1' ' A' ' 69' ' ' ARG . 8.5 pt-20 -98.78 136.36 38.93 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.382 -0.372 . . . . 74.120000000000005 110.025 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.6 mt -142.02 175.41 9.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.234 0.54 . . . . 64.409999999999997 111.021 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.37 161.78 13.44 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.466 -1.679 . . . . 72.329999999999998 106.466 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.569 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -114.69 175.22 15.93 Favored Glycine 0 C--N 1.284 -2.306 0 C-N-CA 119.714 -1.231 . . . . 61.409999999999997 113.061 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -93.53 134.05 36.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 123.07 0.548 . . . . 74.019999999999996 111.19 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 52.17 -88.67 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.629 1.714 . . . . 70.200000000000003 115.629 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 73.9 m -89.26 -12.96 39.21 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.546 -0.752 . . . . 53.340000000000003 112.069 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.569 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 14.0 m-20 -69.24 125.87 28.02 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.799 -1.186 . . . . 70.129999999999995 107.799 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.4 t -92.53 -31.8 4.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 121.279 0.561 . . . . 72.129999999999995 110.491 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.2 tp -151.76 145.22 24.84 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.124 -1.065 . . . . 71.25 108.124 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -130.12 122.21 27.83 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 107.938 -1.134 . . . . 74.420000000000002 107.938 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.483 ' NH1' ' HB3' ' A' ' 58' ' ' GLU . 22.0 tpp180 -120.1 119.07 32.24 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.406 -1.331 . . . . 74.439999999999998 107.406 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -108.83 136.26 48.68 Favored 'General case' 0 C--N 1.282 -2.327 0 C-N-CA 123.624 0.77 . . . . 73.510000000000005 109.215 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -126.31 131.87 51.76 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.329 -0.619 . . . . 74.409999999999997 109.329 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 18.6 m -103.02 109.51 21.08 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.663 -1.606 . . . . 72.150000000000006 106.663 172.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.458 HD11 ' CG2' ' A' ' 48' ' ' ILE . 3.3 mm? -98.67 140.51 32.78 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 113.027 0.751 . . . . 52.520000000000003 113.027 -172.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 44.0 mt-10 -135.71 95.9 3.33 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.279 -1.328 . . . . 65.430000000000007 108.493 171.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -92.08 76.36 5.41 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.082 -1.822 . . . . 72.0 106.082 179.066 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.333 0.7 OUTLIER 30.45 76.92 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.917 1.687 . . . . 75.409999999999997 115.417 -175.876 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.76 -23.51 35.44 Favored Glycine 0 C--O 1.236 0.273 0 C-N-CA 121.333 -0.46 . . . . 52.530000000000001 112.415 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 61.5 mttp -98.47 144.39 27.87 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 105.301 -2.111 . . . . 74.430000000000007 105.301 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 5.3 ptpp? -145.59 150.52 36.52 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 120.216 -0.594 . . . . 73.450000000000003 109.929 -168.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . 171.82 156.2 11.82 Favored Glycine 0 C--N 1.309 -0.951 0 C-N-CA 120.53 -0.843 . . . . 72.450000000000003 112.79 175.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 27.4 mt -103.57 139.22 25.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.504 -0.924 . . . . 63.409999999999997 108.504 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.3 t -118.53 116.45 51.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.342 -0.984 . . . . 74.420000000000002 108.342 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -104.34 109.5 21.37 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.568 -0.901 . . . . 74.120000000000005 108.568 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.08 119.53 55.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.028 -0.73 . . . . 74.239999999999995 109.028 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -121.47 140.24 52.43 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.23 -0.655 . . . . 63.409999999999997 109.23 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.0 mt -106.48 109.75 21.75 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.148 -1.427 . . . . 75.519999999999996 107.148 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -97.05 148.28 23.16 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-O 121.788 0.804 . . . . 73.239999999999995 111.014 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 88' ' ' LYS . 36.9 ttpt -92.18 105.5 17.7 Favored 'General case' 0 C--N 1.259 -3.352 0 CA-C-N 114.83 -1.077 . . . . 73.319999999999993 108.613 175.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 tt -91.34 112.34 25.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.412 0.625 . . . . 53.310000000000002 109.384 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.3 p -131.94 -171.01 2.52 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.815 -0.63 . . . . 74.430000000000007 109.993 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.47 -14.34 46.37 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.755 0.788 . . . . 62.32 108.905 176.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -90.41 -39.87 12.39 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.968 -1.015 . . . . 65.140000000000001 109.708 176.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 42.5 t -85.5 132.61 44.23 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 109.538 -0.541 . . . . 65.040000000000006 109.538 176.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 93' ' ' CYS . 5.4 Cg_exo -77.33 117.1 4.27 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.877 2.384 . . . . 72.239999999999995 111.88 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.34 122.31 11.12 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.836 2.357 . . . . 75.230000000000004 111.717 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.7 t -88.9 157.68 3.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 107.636 -1.246 . . . . 74.25 107.636 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -122.76 161.5 23.82 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.59 -0.893 . . . . 72.239999999999995 108.59 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -173.68 -166.24 31.63 Favored Glycine 0 CA--C 1.458 -3.486 0 N-CA-C 106.718 -2.553 . . . . 61.140000000000001 106.718 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 27' ' ' MET . 65.5 t30 -56.01 102.98 0.09 Allowed 'General case' 0 N--CA 1.409 -2.49 0 O-C-N 124.411 0.712 . . . . 71.200000000000003 109.584 176.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -85.66 114.15 22.42 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.943 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 41.7 t -78.53 141.26 38.29 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.422 -1.325 . . . . 53.25 107.422 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.5 m -64.79 117.32 7.34 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.399 -0.963 . . . . 30.210000000000001 108.399 177.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.7 t -76.01 141.26 16.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.445 0.64 . . . . 74.310000000000002 110.539 -172.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.539 ' HG ' ' H ' ' A' ' 105' ' ' GLU . 15.2 tp -161.7 -159.46 0.62 Allowed 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.053 -2.203 . . . . 72.310000000000002 105.053 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.539 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 36.3 mt-10 -89.14 173.05 8.65 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 119.134 0.879 . . . . 61.509999999999998 112.038 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.489 ' O ' HG22 ' A' ' 110' ' ' ILE . 71.6 t80 -32.82 -58.05 0.36 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.517 1.927 . . . . 74.420000000000002 116.201 -171.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -68.64 -21.54 64.46 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 113.052 0.76 . . . . 72.420000000000002 113.052 -170.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -87.73 -42.39 12.65 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 119.671 -0.812 . . . . 75.310000000000002 111.001 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 113' ' ' ILE 0.262 17.1 p-10 -77.94 -30.08 50.29 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 118.684 -1.206 . . . . 60.039999999999999 111.783 -175.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 106' ' ' PHE . 16.5 tt -69.65 -38.78 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 119.225 -0.99 . . . . 72.319999999999993 109.829 175.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.25 -36.51 83.2 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 109.154 -0.684 . . . . 64.319999999999993 109.154 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 43.5 t -60.17 -45.49 92.9 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.798 -0.637 . . . . 61.240000000000002 109.703 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 109' ' ' ASP . 46.4 mm -61.28 -46.27 96.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 122.954 0.501 . . . . 74.150000000000006 109.891 175.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 110' ' ' ILE . 80.9 t -61.38 -42.77 95.01 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 CA-C-N 115.608 -0.723 . . . . 64.329999999999998 109.996 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 115' ' ' LYS . 37.3 mmtm -67.64 -32.19 72.71 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 112.139 0.422 . . . . 53.340000000000003 112.139 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.99 -39.37 83.28 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.284 -0.566 . . . . 71.109999999999999 110.044 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.5 mt -69.92 -47.12 71.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.856 -0.611 . . . . 72.200000000000003 110.11 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -64.7 -40.53 95.53 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 116.253 -0.431 . . . . 71.409999999999997 110.987 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.67 -17.72 58.97 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 120.298 -0.561 . . . . 65.340000000000003 112.154 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 27.4 t -78.24 -48.14 16.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.144 -1.058 . . . . 72.439999999999998 108.144 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 11.2 mp -69.37 -36.74 77.13 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.502 -0.772 . . . . 53.310000000000002 111.918 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.93 -13.57 53.13 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 114.002 1.112 . . . . 74.310000000000002 114.002 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -74.93 -12.39 60.34 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.255 -0.978 . . . . 74.519999999999996 110.893 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.92 169.01 42.29 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 115.113 -0.949 . . . . 55.340000000000003 111.12 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.498 ' HB3' ' CE1' ' A' ' 13' ' ' HIS . 0.7 OUTLIER -83.98 51.87 2.16 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 122.152 -0.616 . . . . 52.329999999999998 112.04 -178.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -137.19 80.41 1.81 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.918 -1.037 . . . . 74.340000000000003 112.338 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.6 t30 177.93 100.62 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.097 1.359 . . . . 73.200000000000003 109.751 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 63.9 m -67.07 119.38 11.91 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.692 0.758 . . . . 62.310000000000002 112.337 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -158.13 136.82 11.23 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 102.235 -3.246 . . . . 63.219999999999999 102.235 173.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -150.0 108.63 3.83 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 119.148 0.885 . . . . 63.5 113.243 -175.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.18 92.99 0.51 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 104.4 -2.445 . . . . 50.439999999999998 104.4 173.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 147.86 176.82 21.75 Favored Glycine 0 C--N 1.289 -2.071 0 N-CA-C 107.831 -2.108 . . . . 72.349999999999994 107.831 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -148.08 108.85 3.7 Favored Pre-proline 0 C--N 1.302 -1.497 0 CA-C-N 118.087 0.943 . . . . 73.420000000000002 110.025 -177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.98 110.7 1.78 Allowed 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 122.498 2.132 . . . . 65.120000000000005 112.033 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 48.1 mm -116.17 100.68 53.69 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 108.322 -0.992 . . . . 72.040000000000006 108.322 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.34 130.28 8.01 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 122.867 2.378 . . . . 44.109999999999999 112.366 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -126.97 120.59 22.67 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 107.029 -1.471 . . . . 74.209999999999994 107.029 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.93 61.82 5.68 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 122.777 2.318 . . . . 75.200000000000003 113.669 -175.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.5 tp -95.44 53.77 1.52 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.495 -1.668 . . . . 72.319999999999993 106.495 174.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.47 HD23 ' H ' ' A' ' 140' ' ' LEU . 2.5 pt? -85.45 151.1 24.23 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 113.285 -1.78 . . . . 73.540000000000006 111.052 -173.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 104.99 -20.46 38.37 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.703 -0.76 . . . . 52.32 111.967 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 30.7 tp -76.19 85.35 3.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 122.152 0.977 . . . . 72.129999999999995 109.668 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -120.94 147.55 45.3 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.426 -1.716 . . . . 72.109999999999999 108.929 -173.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 67.9 p -124.53 93.68 3.98 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.414 -0.958 . . . . 64.129999999999995 108.414 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 40.7 m -63.18 106.32 0.85 Allowed 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.631 0.729 . . . . 74.439999999999998 111.656 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -137.78 115.62 11.48 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.05 -1.093 . . . . 72.430000000000007 108.05 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.3 t -131.51 128.85 40.21 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.389 0.614 . . . . 74.129999999999995 109.99 175.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.509 0 N-CA-C 108.333 -1.907 . . . . 53.210000000000001 108.333 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 mtm . . . . . 0 CA--C 1.494 -1.185 0 N-CA-C 108.808 -0.812 . . . . 65.530000000000001 108.808 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -92.87 145.42 24.4 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.659 -0.497 . . . . 62.219999999999999 109.659 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.615 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 21.9 m-85 -112.48 142.68 44.73 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 121.564 0.697 . . . . 73.549999999999997 111.466 177.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.676 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 31.9 t70 -111.26 102.66 11.05 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 105.793 -1.929 . . . . 73.099999999999994 105.793 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.65 119.3 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 CA-C-O 122.087 0.946 . . . . 62.520000000000003 110.865 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.419 HG13 HG22 ' A' ' 28' ' ' VAL . 45.9 t -105.99 116.58 50.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-N 114.083 -1.417 . . . . 73.230000000000004 107.848 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.528 HG23 ' HB3' ' A' ' 27' ' ' MET . 6.2 tt -115.3 114.85 47.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 CA-C-O 121.348 0.594 . . . . 75.450000000000003 109.614 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mp -104.0 106.61 53.88 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 108.936 -0.764 . . . . 70.030000000000001 108.936 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.631 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 2.0 Cg_endo -84.87 139.16 7.29 Favored 'Trans proline' 0 N--CA 1.44 -1.646 0 C-N-CA 121.964 1.776 . . . . 65.540000000000006 109.199 172.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -157.78 133.65 9.26 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.056 0.455 . . . . 74.329999999999998 110.524 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.479 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 48.7 m -84.26 118.56 24.26 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.588 -0.523 . . . . 51.32 109.588 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 3.7 p90 -61.77 109.84 1.35 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.257 1.206 . . . . 63.350000000000001 114.257 -174.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -139.29 128.65 24.18 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.494 -0.776 . . . . 74.019999999999996 111.416 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -81.37 104.09 11.58 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 105.68 -1.97 . . . . 73.510000000000005 105.68 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 20' ' ' MET . 49.3 t80 -45.99 103.0 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 O-C-N 125.84 1.963 . . . . 74.200000000000003 109.662 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.25 -103.96 0.1 Allowed 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.134 -1.393 . . . . 73.310000000000002 113.688 -173.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -111.96 -58.99 2.05 Favored 'General case' 0 N--CA 1.434 -1.256 0 O-C-N 122.041 -0.412 . . . . 63.530000000000001 110.61 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -136.62 -36.76 0.7 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.405 -0.591 . . . . 74.400000000000006 109.405 176.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -102.04 163.25 12.35 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.766 -1.198 . . . . 74.340000000000003 107.766 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 1.8 mpt? 72.73 80.17 0.14 Allowed 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 124.28 1.032 . . . . 74.200000000000003 110.389 -173.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 178.03 132.4 0.07 Allowed 'General case' 0 N--CA 1.407 -2.605 0 N-CA-C 104.042 -2.577 . . . . 72.519999999999996 104.042 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 67.2 t60 179.41 92.37 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.804 0 O-C-N 124.336 1.023 . . . . 73.299999999999997 112.275 174.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.439 ' HB ' HD11 ' A' ' 130' ' ' LEU . 49.1 mm -100.88 139.82 21.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 N-CA-C 105.692 -1.966 . . . . 55.310000000000002 105.692 171.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.631 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 42.0 m -106.58 153.92 40.31 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 109.708 -0.479 . . . . 71.409999999999997 109.708 -174.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 42.6 Cg_endo -68.75 151.1 74.61 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 122.812 2.341 . . . . 73.120000000000005 112.718 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 13.4 Cg_exo -72.63 151.55 52.51 Favored 'Trans proline' 0 C--O 1.255 1.356 0 C-N-CA 123.178 2.586 . . . . 70.109999999999999 114.107 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.557 ' SD ' ' HB3' ' A' ' 99' ' ' ASN . 2.4 tpt -114.56 134.99 54.62 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 104.606 -2.368 . . . . 74.409999999999997 104.606 176.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.419 HG22 HG13 ' A' ' 6' ' ' VAL . 92.0 t -130.73 130.43 64.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 119.088 0.858 . . . . 73.239999999999995 110.731 -176.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.8 mm -124.1 102.51 11.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 106.961 -1.496 . . . . 73.239999999999995 106.961 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -126.31 81.13 0.36 Allowed Glycine 0 CA--C 1.476 -2.344 0 C-N-CA 117.586 -2.245 . . . . 63.509999999999998 114.198 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -161.15 18.45 0.12 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.438 -0.881 . . . . 62.43 111.372 176.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -115.25 134.14 55.4 Favored 'General case' 0 C--O 1.2 -1.514 0 N-CA-C 108.209 -1.034 . . . . 71.329999999999998 108.209 -171.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -72.88 163.38 28.22 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.13 -1.063 . . . . 72.519999999999996 108.13 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.615 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 83.0 t80 -52.09 -47.97 64.95 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.936 0.494 . . . . 62.030000000000001 112.092 -172.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.68 -40.66 92.98 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.176 -0.92 . . . . 73.439999999999998 111.302 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.4 mt -76.25 -37.88 32.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.343 -0.614 . . . . 63.240000000000002 109.343 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.6 99.74 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.483 -0.78 . . . . 53.420000000000002 110.008 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -67.26 -36.35 81.41 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.251 -0.431 . . . . 64.439999999999998 110.066 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -68.64 -42.51 77.92 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.23 -0.441 . . . . 73.319999999999993 110.888 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 44' ' ' VAL . 8.1 tp -71.1 -37.52 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.277 -0.569 . . . . 64.120000000000005 110.337 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.9 t -67.09 -37.19 78.79 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 N-CA-C 109.808 -0.441 . . . . 52.399999999999999 109.808 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -65.12 -33.54 76.27 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 109.643 -0.503 . . . . 74.319999999999993 109.643 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.22 -43.71 78.79 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 111.42 -0.672 . . . . 64.140000000000001 111.42 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 40' ' ' ILE . 99.4 t -62.03 -46.1 97.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.747 -0.835 . . . . 73.329999999999998 108.747 177.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -53.85 -46.27 71.19 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 125.498 1.519 . . . . 74.530000000000001 110.927 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -66.86 -41.08 87.93 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 114.391 -1.277 . . . . 71.409999999999997 110.316 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 88.8 t -71.25 -35.0 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 116.036 -0.529 . . . . 62.439999999999998 110.005 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 64.8 mt -65.12 -45.84 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 110.091 -0.337 . . . . 55.32 110.091 175.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -62.78 -35.4 79.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.21 0.448 . . . . 61.420000000000002 112.21 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.32 -33.74 22.01 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 113.445 0.905 . . . . 73.340000000000003 113.445 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -97.03 -16.32 20.62 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 113.564 0.95 . . . . 61.539999999999999 113.564 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -128.16 -177.02 3.98 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.204 -0.665 . . . . 72.109999999999999 109.204 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -107.76 100.25 9.65 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 103.719 -2.697 . . . . 65.209999999999994 103.719 171.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.05 144.95 30.62 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 114.759 1.392 . . . . 50.219999999999999 114.759 -168.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.426 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 1.9 m -123.34 103.47 8.52 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 103.983 -2.599 . . . . 60.399999999999999 103.983 169.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 p -100.66 119.26 48.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-O 121.649 0.738 . . . . 71.140000000000001 111.351 -174.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -120.0 122.45 41.18 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.383 -0.826 . . . . 74.209999999999994 111.469 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -89.25 140.97 28.94 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.802 -0.444 . . . . 73.219999999999999 109.802 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 mp -136.49 172.42 13.04 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.106 -1.442 . . . . 74.239999999999995 107.106 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.49 147.81 24.47 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.255 -0.578 . . . . 73.420000000000002 109.716 176.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.44 148.79 41.09 Favored Glycine 0 C--N 1.293 -1.835 0 CA-C-N 115.29 -0.868 . . . . 32.539999999999999 111.137 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.92 132.74 34.33 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-O 121.158 0.504 . . . . 63.119999999999997 110.789 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.0 t70 52.31 -84.14 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 126.137 1.775 . . . . 74.439999999999998 113.681 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.5 t -110.54 -0.55 17.31 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.171 0.51 . . . . 51.310000000000002 111.786 -176.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 23.1 m-20 -74.24 138.21 43.52 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 106.664 -1.606 . . . . 74.329999999999998 106.664 172.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.8 t -93.81 -29.93 4.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 112.698 0.629 . . . . 53.210000000000001 112.698 -173.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.3 tp -150.29 140.24 21.94 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 108.669 -0.863 . . . . 73.230000000000004 108.669 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -130.68 133.7 46.31 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 107.054 -1.461 . . . . 74.200000000000003 107.054 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -137.05 120.34 16.84 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.492 -1.299 . . . . 73.150000000000006 107.492 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -111.94 118.09 34.53 Favored 'General case' 0 N--CA 1.413 -2.294 0 C-N-CA 118.828 -1.149 . . . . 74.030000000000001 108.612 175.068 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.43 ' HB3' HD11 ' A' ' 73' ' ' LEU . 13.0 m-85 -94.11 125.68 38.89 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 114.658 -1.155 . . . . 73.209999999999994 108.624 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 19.5 m -100.06 113.99 27.0 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.78 -1.563 . . . . 74.109999999999999 106.78 175.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.43 HD11 ' HB3' ' A' ' 71' ' ' TYR . 0.8 OUTLIER -120.41 152.4 37.97 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 113.538 0.94 . . . . 55.240000000000002 113.538 -170.574 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -135.32 140.81 45.4 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.222 -1.808 . . . . 72.430000000000007 106.807 170.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.549 ' HG2' ' OE1' ' A' ' 76' ' ' GLU . 51.6 tttm -139.47 -178.64 5.48 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 104.988 -2.227 . . . . 75.099999999999994 104.988 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.549 ' OE1' ' HG2' ' A' ' 75' ' ' LYS 0.26 0.0 OUTLIER -59.87 86.25 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 115.233 1.568 . . . . 70.120000000000005 115.233 -177.568 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.15 19.33 67.28 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 114.798 -1.092 . . . . 64.129999999999995 111.263 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 44.7 mtpt -132.74 135.9 46.03 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.306 -0.998 . . . . 73.409999999999997 108.306 -176.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -137.94 138.65 39.19 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.982 -0.747 . . . . 74.439999999999998 108.982 -175.488 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -174.04 172.12 45.06 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 119.414 -1.374 . . . . 63.420000000000002 113.612 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.5 mt -124.43 143.68 37.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 106.996 -1.483 . . . . 71.230000000000004 106.996 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 97.4 t -124.03 110.1 24.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.085 -0.709 . . . . 62.439999999999998 109.085 177.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -94.15 104.18 16.21 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.002 -0.545 . . . . 74.409999999999997 109.648 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.3 t -105.62 115.07 46.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 109.245 -0.65 . . . . 75.329999999999998 109.245 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -125.34 134.94 52.02 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.019 -0.673 . . . . 71.439999999999998 110.185 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.8 mp -112.1 108.1 17.26 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 109.115 -0.698 . . . . 64.349999999999994 109.115 -173.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.529 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 12.3 ptp180 -102.14 151.42 22.2 Favored 'General case' 0 CA--C 1.468 -2.196 0 C-N-CA 119.333 -0.947 . . . . 74.519999999999996 112.28 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -84.29 98.45 10.0 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.885 -1.052 . . . . 62.43 109.557 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.458 HD12 ' HB3' ' A' ' 95' ' ' PRO . 6.3 tt -74.11 114.95 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-O 122.16 0.981 . . . . 72.340000000000003 109.959 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.5 p -133.04 -171.84 2.78 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 107.695 -1.224 . . . . 62.200000000000003 107.695 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -83.03 -5.83 59.25 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.235 0.54 . . . . 54.399999999999999 110.093 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -98.91 -39.93 8.33 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.989 -0.745 . . . . 73.120000000000005 108.989 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 62.7 m -104.35 120.69 49.88 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 116.494 -0.321 . . . . 74.319999999999993 111.615 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.37 142.79 19.07 Favored 'Trans proline' 0 CA--C 1.555 1.569 0 C-N-CA 123.069 2.512 . . . . 70.420000000000002 113.859 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.458 ' HB3' HD12 ' A' ' 89' ' ' ILE . 66.9 Cg_endo -73.69 164.72 34.1 Favored 'Trans proline' 0 C--O 1.248 1.025 0 C-N-CA 124.016 3.144 . . . . 75.310000000000002 111.883 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.5 t -101.11 159.67 3.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 107.989 -1.115 . . . . 75.540000000000006 107.989 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -112.66 111.5 22.35 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.185 0.517 . . . . 73.349999999999994 110.7 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -128.49 -163.5 11.31 Favored Glycine 0 CA--C 1.487 -1.712 0 N-CA-C 110.462 -1.055 . . . . 74.510000000000005 110.462 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.557 ' HB3' ' SD ' ' A' ' 27' ' ' MET . 2.6 t-20 -75.19 140.91 43.6 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 122.446 0.298 . . . . 64.540000000000006 110.37 177.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -83.92 97.69 9.38 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 122.083 0.944 . . . . 64.409999999999997 110.581 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.19 151.99 44.77 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 113.422 -1.717 . . . . 63.43 108.978 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -76.83 93.27 3.7 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.839 0.828 . . . . 75.099999999999994 110.69 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.25 146.16 6.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 114.923 -1.035 . . . . 73.310000000000002 109.866 -175.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.7 mt -156.9 -90.8 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 126.116 1.766 . . . . 75.319999999999993 107.934 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.44 173.72 11.23 Favored 'General case' 0 C--N 1.255 -3.515 0 N-CA-C 105.944 -1.873 . . . . 75.209999999999994 105.944 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.464 ' O ' HG22 ' A' ' 110' ' ' ILE . 90.6 t80 -33.01 -46.39 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.682 1.734 . . . . 64.140000000000001 115.682 -172.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -56.1 -55.39 33.62 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 123.087 0.555 . . . . 74.150000000000006 112.204 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -78.83 -30.86 45.51 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.818 -0.628 . . . . 74.510000000000005 109.49 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.431 ' O ' HG12 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -65.76 -49.16 69.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.259 -0.882 . . . . 62.229999999999997 110.425 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 106' ' ' PHE . 9.9 tp -68.3 -35.76 72.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 121.365 0.603 . . . . 74.120000000000005 109.498 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -65.11 -44.68 87.97 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 115.205 -0.907 . . . . 75.409999999999997 110.12 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 27.0 t -67.55 -39.32 84.97 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 123.448 0.468 . . . . 63.5 110.974 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.569 ' O ' HG12 ' A' ' 117' ' ' ILE . 44.4 mm -66.01 -45.09 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 116.494 -0.321 . . . . 74.219999999999999 110.593 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.77 -35.5 74.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 N-CA-C 109.88 -0.415 . . . . 74.430000000000007 109.88 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 119' ' ' GLU . 60.1 tttp -60.1 -47.11 87.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.652 -0.703 . . . . 73.150000000000006 110.28 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.42 95.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.167 -0.47 . . . . 72.439999999999998 110.958 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 113' ' ' ILE . 43.0 mm -66.84 -44.03 89.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.742 -0.466 . . . . 61.340000000000003 109.742 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.78 -36.59 83.98 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.973 -0.558 . . . . 74.140000000000001 112.288 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 54.5 mm-40 -68.45 -45.54 72.21 Favored 'General case' 0 C--O 1.221 -0.441 0 O-C-N 123.727 0.642 . . . . 65.400000000000006 110.034 176.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 44.6 t -56.63 -46.27 81.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.938 -0.574 . . . . 72.299999999999997 111.233 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.7 mp -78.6 -19.86 51.77 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.26 -0.576 . . . . 74.129999999999995 111.777 -177.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.63 -29.8 41.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.053 0.454 . . . . 70.400000000000006 109.928 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -83.13 -1.97 54.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.884 -0.598 . . . . 73.430000000000007 111.032 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -53.86 131.1 43.99 Favored Glycine 0 C--O 1.245 0.808 0 N-CA-C 110.814 -0.915 . . . . 71.329999999999998 110.814 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 73.9 74.66 0.12 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.63 1.172 . . . . 74.120000000000005 109.937 -171.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.1 tp -131.88 149.22 52.51 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 106.141 -1.8 . . . . 74.329999999999998 106.141 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -81.31 104.49 11.8 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 119.026 -1.069 . . . . 52.450000000000003 110.839 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.5 t -151.19 171.88 16.69 Favored 'General case' 0 N--CA 1.409 -2.52 0 N-CA-C 103.996 -2.594 . . . . 72.120000000000005 103.996 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.68 123.57 8.68 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.19 -0.604 . . . . 62.229999999999997 112.421 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.439 HD11 ' HB ' ' A' ' 23' ' ' ILE . 2.1 pt? -161.24 -157.64 0.52 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.636 -1.616 . . . . 74.400000000000006 106.636 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -98.89 93.41 6.02 Favored 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 120.052 -0.659 . . . . 73.340000000000003 111.724 176.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.21 159.11 37.5 Favored Glycine 0 C--O 1.249 1.05 0 CA-C-N 115.146 -0.933 . . . . 52.310000000000002 111.904 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -98.94 131.19 25.96 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 112.475 0.546 . . . . 44.439999999999998 112.475 -176.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.78 156.48 63.2 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.275 1.983 . . . . 74.409999999999997 108.403 168.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.59 101.41 54.21 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.712 -0.477 . . . . 73.420000000000002 109.712 -175.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -79.1 131.7 10.02 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 N-CA-C 107.849 -1.635 . . . . 74.420000000000002 107.849 168.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -81.65 117.0 66.54 Favored Pre-proline 0 C--N 1.296 -1.724 0 C-N-CA 119.847 -0.741 . . . . 62.25 111.282 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.53 -24.77 25.78 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.344 2.03 . . . . 42.25 111.589 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 82.4 mt 58.72 67.23 0.95 Allowed 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 123.024 1.392 . . . . 62.210000000000001 109.862 -175.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 68.2 tp -148.56 115.32 6.0 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 112.76 -2.018 . . . . 72.129999999999995 106.311 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -177.2 -129.69 1.28 Allowed Glycine 0 N--CA 1.419 -2.499 0 C-N-CA 119.38 -1.39 . . . . 61.539999999999999 111.918 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.7 mp 63.88 28.88 14.66 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.702 0.763 . . . . 75.510000000000005 109.301 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -85.84 98.81 10.97 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.428 -1.323 . . . . 71.340000000000003 107.428 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.8 m -93.21 147.92 22.48 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-N 115.165 -0.925 . . . . 74.219999999999999 111.421 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -148.48 170.06 18.87 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 106.978 -1.49 . . . . 72.310000000000002 106.978 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -139.16 98.53 3.54 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.401 -0.963 . . . . 63.130000000000003 108.401 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 62.9 m -150.34 142.76 24.36 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.643 -0.873 . . . . 72.340000000000003 108.643 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.212 0 N-CA-C 109.073 -1.611 . . . . 61.210000000000001 109.073 -179.676 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 CA--C 1.489 -1.392 0 N-CA-C 108.305 -0.998 . . . . 75.230000000000004 108.305 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.67 153.47 51.08 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.043 -1.095 . . . . 74.510000000000005 108.043 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.495 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 14.4 m-85 -112.95 145.67 40.38 Favored 'General case' 0 C--N 1.283 -2.313 0 C-N-CA 123.387 0.675 . . . . 75.209999999999994 109.508 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.644 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 15.7 t70 -103.08 110.67 22.69 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.532 -1.285 . . . . 73.140000000000001 107.532 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -93.11 111.46 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 CA-C-O 121.897 0.856 . . . . 74.230000000000004 108.721 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 27' ' ' MET . 4.8 p -109.29 110.97 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.76 0 CA-C-N 114.778 -1.101 . . . . 73.209999999999994 109.284 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.678 HG23 ' HB2' ' A' ' 27' ' ' MET . 4.3 tt -103.93 125.36 58.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.868 -1.06 . . . . 52.329999999999998 110.372 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.2 mt -118.93 103.31 48.27 Favored Pre-proline 0 N--CA 1.425 -1.723 0 CA-C-N 115.52 -0.764 . . . . 60.310000000000002 109.275 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.555 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 3.1 Cg_exo -82.39 140.58 10.89 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.175 1.917 . . . . 75.439999999999998 109.582 173.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -156.97 114.27 3.12 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.949 0.881 . . . . 71.329999999999998 110.677 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 m -80.42 128.39 33.52 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.811 -0.632 . . . . 62.539999999999999 109.619 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.482 ' HD2' ' CD1' ' A' ' 81' ' ' ILE . 2.2 p90 -59.18 105.18 0.31 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 114.632 1.345 . . . . 71.530000000000001 114.632 -175.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -141.14 106.73 5.08 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.395 -1.275 . . . . 73.540000000000006 109.538 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -69.08 159.14 33.44 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 106.86 -1.533 . . . . 72.430000000000007 106.86 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -82.91 92.16 7.26 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.012 -1.075 . . . . 72.349999999999994 110.462 176.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.547 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 16.9 t70 -66.76 -102.0 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.76 -1.109 . . . . 74.329999999999998 109.43 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -113.32 -60.36 1.89 Allowed 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 108.269 -1.011 . . . . 63.340000000000003 108.269 171.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -139.5 -53.08 0.54 Allowed 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.677 0.751 . . . . 74.109999999999999 112.205 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -86.1 74.47 10.07 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.376 -0.829 . . . . 73.120000000000005 111.109 -174.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.547 ' SD ' ' HB2' ' A' ' 16' ' ' ASP . 53.0 ttm 173.87 93.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.719 2.007 . . . . 74.349999999999994 105.614 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 10.0 pt-20 -176.16 115.99 0.13 Allowed 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.082 -1.451 . . . . 63.43 107.082 -175.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -157.44 98.23 1.67 Allowed 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 119.326 -0.95 . . . . 73.310000000000002 111.429 172.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.4 mm -120.05 131.04 73.49 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 105.832 -1.914 . . . . 55.399999999999999 105.832 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 73.5 m -107.47 129.03 24.82 Favored Pre-proline 0 C--N 1.293 -1.885 0 C-N-CA 119.764 -0.775 . . . . 64.239999999999995 110.745 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 53.8 Cg_exo -56.17 146.15 72.58 Favored 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 123.217 2.612 . . . . 63.530000000000001 112.537 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 49.6 Cg_exo -57.8 145.11 91.88 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 123.684 2.922 . . . . 50.340000000000003 114.265 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.678 ' HB2' HG23 ' A' ' 7' ' ' ILE . 62.9 mtp -103.41 131.13 50.75 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 104.994 -2.224 . . . . 64.219999999999999 104.994 173.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.6 t -120.66 123.23 69.9 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 O-C-N 123.133 0.27 . . . . 74.150000000000006 110.355 -173.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.68 107.5 15.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 107.389 -1.338 . . . . 72.209999999999994 107.389 176.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -127.13 81.77 0.35 Allowed Glycine 0 CA--C 1.475 -2.429 0 C-N-CA 118.019 -2.039 . . . . 75.540000000000006 115.416 -173.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -174.38 37.92 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.979 0.895 . . . . 74.049999999999997 111.126 173.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -113.7 133.34 55.39 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 106.423 -1.695 . . . . 33.219999999999999 106.423 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 p -76.71 163.49 26.78 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 119.139 0.881 . . . . 72.340000000000003 109.089 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.495 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 63.2 t80 -52.55 -43.32 65.11 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 123.758 0.823 . . . . 74.239999999999995 111.689 -174.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -68.14 -40.23 82.47 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.008 -0.996 . . . . 72.400000000000006 111.331 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.2 mm -73.65 -39.35 53.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.131 -0.692 . . . . 65.439999999999998 109.131 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.78 95.14 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.936 -1.029 . . . . 74.329999999999998 110.331 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.1 mmt -65.67 -36.04 82.5 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.495 -0.482 . . . . 74.129999999999995 111.287 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -68.42 -43.58 76.88 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 120.634 -0.426 . . . . 74.409999999999997 111.285 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 44' ' ' VAL . 13.7 tt -70.32 -39.33 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 C-N-CA 119.826 -0.75 . . . . 44.130000000000003 110.464 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.3 -45.09 99.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-N 116.737 -0.21 . . . . 74.209999999999994 110.868 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -68.44 -32.59 72.71 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 119.977 -0.689 . . . . 53.450000000000003 111.4 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -69.78 -46.05 55.29 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 110.983 -0.847 . . . . 74.010000000000005 110.983 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 40' ' ' ILE . 69.0 t -62.35 -41.11 90.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.729 -0.471 . . . . 63.409999999999997 109.729 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.448 ' CG ' HH21 ' A' ' 69' ' ' ARG . 16.4 t70 -58.48 -46.67 86.19 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.919 -1.037 . . . . 61.530000000000001 110.346 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -40.77 96.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.633 -0.712 . . . . 64.409999999999997 110.817 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 43' ' ' GLY . 98.3 t -63.75 -43.22 97.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.531 -0.304 . . . . 74.25 111.067 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.8 mt -69.9 -39.59 77.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.561 0.219 . . . . 73.319999999999993 110.922 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -74.92 -24.72 58.55 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 120.903 0.382 . . . . 74.340000000000003 110.912 -175.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.39 -42.15 9.94 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 112.502 0.556 . . . . 25.219999999999999 112.502 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.1 m -83.9 -17.93 39.12 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.199 0.523 . . . . 74.329999999999998 111.737 -174.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -134.58 179.34 6.35 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 121.533 0.682 . . . . 60.450000000000003 109.995 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.547 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 26.7 t-20 -98.8 102.66 14.47 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.007 -1.849 . . . . 75.25 106.007 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -133.98 135.94 43.8 Favored 'General case' 0 N--CA 1.412 -2.357 0 C-N-CA 119.595 -0.842 . . . . 72.420000000000002 112.446 -175.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.9 m -102.1 111.89 24.34 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 105.24 -2.133 . . . . 74.150000000000006 105.24 171.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.415 HG21 ' OD1' ' A' ' 45' ' ' ASP . 7.4 p -100.64 142.74 15.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 120.699 0.285 . . . . 62.539999999999999 110.778 -174.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.46 ' HB2' ' ND2' ' A' ' 137' ' ' ASN . 10.0 tp10 -139.88 151.74 45.89 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.634 -0.876 . . . . 73.239999999999995 108.634 175.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -125.63 106.46 9.75 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.983 0.897 . . . . 61.32 110.068 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -99.08 172.49 7.36 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.854 -1.067 . . . . 72.219999999999999 109.148 -175.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -109.03 137.84 46.3 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.059 -0.518 . . . . 72.230000000000004 109.687 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.494 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -98.29 176.83 30.65 Favored Glycine 0 C--N 1.294 -1.784 0 CA-C-N 115.196 -0.911 . . . . 60.200000000000003 112.671 -174.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.72 166.74 8.36 Favored 'General case' 0 C--O 1.19 -2.047 0 N-CA-C 107.388 -1.338 . . . . 65.109999999999999 107.388 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -42.6 -39.77 2.46 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 115.311 1.597 . . . . 72.430000000000007 115.311 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 51.5 t -73.71 -29.64 62.38 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.082 0.468 . . . . 63.200000000000003 111.518 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.494 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 8.0 m-20 -98.26 115.17 27.82 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.545 -0.909 . . . . 63.240000000000002 108.545 -176.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.0 t -83.67 -32.57 8.96 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 N-CA-C 113.29 0.848 . . . . 74.340000000000003 113.29 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.1 tp -148.79 140.8 23.85 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.238 -1.023 . . . . 73.439999999999998 108.238 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -129.72 126.11 37.49 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.962 -1.495 . . . . 75.530000000000001 106.962 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.448 HH21 ' CG ' ' A' ' 45' ' ' ASP . 10.8 tpt180 -113.73 138.8 49.74 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 107.529 -1.286 . . . . 65.540000000000006 107.529 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -123.96 130.64 52.92 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.981 -1.118 . . . . 52.219999999999999 107.981 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -125.56 115.82 20.78 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.234 -0.654 . . . . 70.0 109.234 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 39.5 m -88.26 110.3 20.63 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.974 -1.121 . . . . 74.329999999999998 107.974 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.0 142.23 28.47 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.13 0.572 . . . . 74.239999999999995 112.317 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 36.7 tt0 -144.32 93.9 2.5 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.917 -1.038 . . . . 63.140000000000001 109.041 171.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.539 ' HG2' ' H ' ' A' ' 76' ' ' GLU . 49.8 tttt -99.53 -176.04 3.17 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 105.968 -1.864 . . . . 64.0 105.968 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.539 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 8.6 pt-20 -48.83 91.26 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.092 1.357 . . . . 70.140000000000001 113.271 177.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.24 17.27 68.0 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.188 -0.914 . . . . 62.32 113.414 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 53.7 mtmt -138.78 122.41 17.44 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.48 -0.933 . . . . 73.140000000000001 108.48 -177.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -145.24 145.58 31.35 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 120.698 0.285 . . . . 72.540000000000006 111.298 -173.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.92 171.9 41.81 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 110.47 -1.052 . . . . 71.530000000000001 110.47 -176.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.482 ' CD1' ' HD2' ' A' ' 12' ' ' PHE . 3.7 mp -105.03 143.87 15.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 117.888 0.844 . . . . 72.099999999999994 109.669 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.4 t -119.6 110.27 28.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.967 -0.753 . . . . 73.319999999999993 108.967 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -93.89 131.3 39.45 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 124.006 0.922 . . . . 74.439999999999998 110.017 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.14 109.92 18.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.235 -1.024 . . . . 63.32 108.235 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -118.45 146.27 44.61 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.936 -1.106 . . . . 54.439999999999998 111.338 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.5 mt -105.52 107.89 19.12 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.502 -1.296 . . . . 73.549999999999997 107.502 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 37.3 ptt180 -103.84 135.89 44.54 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.403 -0.962 . . . . 74.129999999999995 108.403 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -76.73 108.34 9.68 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.447 0.641 . . . . 73.549999999999997 110.81 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 tt -82.82 111.42 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.276 1.036 . . . . 74.420000000000002 108.564 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 91' ' ' GLU . 3.6 m -144.53 -171.95 3.71 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 104.27 -2.493 . . . . 73.319999999999993 104.27 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.512 ' H ' HG22 ' A' ' 90' ' ' THR . 3.8 mp0 -60.82 -24.34 65.78 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 119.112 0.869 . . . . 74.5 111.765 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -76.45 -39.92 52.0 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.544 -0.753 . . . . 73.540000000000006 110.665 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 73.9 m -119.21 89.87 40.61 Favored Pre-proline 0 N--CA 1.431 -1.4 0 CA-C-N 116.459 -0.337 . . . . 73.109999999999999 110.627 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.24 152.75 56.17 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 121.809 1.673 . . . . 65.329999999999998 110.575 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.96 141.98 91.24 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.213 2.608 . . . . 44.140000000000001 113.317 -175.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.25 155.62 16.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 106.619 -1.622 . . . . 54.009999999999998 106.619 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.92 144.97 27.36 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 120.958 0.409 . . . . 74.439999999999998 110.183 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -157.24 -159.74 9.7 Favored Glycine 0 CA--C 1.464 -3.14 0 N-CA-C 107.992 -2.043 . . . . 45.039999999999999 107.992 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.474 ' HB3' ' HA ' ' A' ' 27' ' ' MET . 9.1 t-20 -69.45 108.99 3.99 Favored 'General case' 0 N--CA 1.395 -3.206 0 N-CA-C 107.652 -1.24 . . . . 70.420000000000002 107.652 171.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -83.29 109.62 17.41 Favored 'General case' 0 N--CA 1.416 -2.164 0 N-CA-C 107.894 -1.15 . . . . 74.409999999999997 107.894 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 36.7 t -69.32 156.74 38.3 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.856 -1.066 . . . . 65.109999999999999 109.723 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -79.43 94.58 5.58 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.982 -1.118 . . . . 61.049999999999997 107.982 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.7 t -96.31 129.96 45.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.339 -0.846 . . . . 63.43 110.297 -172.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 mp -139.64 -90.42 0.19 Allowed 'General case' 0 C--N 1.269 -2.905 0 CA-C-N 114.746 -1.116 . . . . 71.010000000000005 108.569 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -139.41 163.14 33.29 Favored 'General case' 0 C--N 1.251 -3.684 0 CA-C-N 113.587 -1.642 . . . . 70.409999999999997 106.873 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -34.35 -49.99 0.4 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.284 1.433 . . . . 52.240000000000002 114.843 -172.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 111' ' ' GLU . 27.9 tt0 -61.08 -46.5 90.41 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.095 0.406 . . . . 63.25 112.095 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -78.08 -31.16 50.02 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.494 -0.321 . . . . 61.329999999999998 110.555 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.417 ' O ' HG12 ' A' ' 113' ' ' ILE . 2.3 m-20 -66.43 -45.99 77.99 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.324 -0.853 . . . . 71.010000000000005 110.127 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.2 tp -63.35 -38.08 81.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 116.558 -0.292 . . . . 74.230000000000004 110.729 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 107' ' ' GLU . 44.9 mt-10 -60.14 -46.13 90.7 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.835 -0.431 . . . . 63.420000000000002 109.835 177.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 18.6 t -61.5 -41.1 96.78 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.497 -0.774 . . . . 71.099999999999994 111.137 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 117' ' ' ILE . 46.3 mm -65.42 -46.33 90.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.312 -0.404 . . . . 75.010000000000005 110.377 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 80.1 t -64.88 -39.97 87.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.158 -0.474 . . . . 73.010000000000005 110.554 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -67.46 -32.28 73.02 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 116.366 -0.379 . . . . 71.219999999999999 111.252 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.53 -34.67 53.87 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 120.641 0.258 . . . . 61.229999999999997 111.338 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 113' ' ' ILE . 82.4 mt -64.17 -48.12 87.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.791 -1.189 . . . . 71.430000000000007 107.791 174.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -62.77 -29.73 70.91 Favored 'General case' 0 C--O 1.192 -1.933 0 CA-C-N 115.447 -0.797 . . . . 72.450000000000003 111.633 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -67.59 -35.55 79.19 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.234 0.54 . . . . 54.219999999999999 109.795 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 4.5 t -84.47 -31.15 24.7 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.143 0.973 . . . . 75.349999999999994 109.537 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.6 mp -78.54 -39.34 38.16 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.859 -0.609 . . . . 72.219999999999999 111.98 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.67 -15.55 44.95 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 114.826 1.417 . . . . 42.520000000000003 114.826 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HD3' ' HA ' ' A' ' 123' ' ' LYS 0.346 34.0 mmtp -84.14 -3.93 58.45 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 116.271 1.952 . . . . 62.130000000000003 116.271 -175.274 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.33 -163.45 53.92 Favored Glycine 0 C--O 1.215 -1.075 0 C-N-CA 120.442 -0.885 . . . . 62.210000000000001 113.44 173.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 0.1 OUTLIER -92.1 88.63 6.6 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-O 121.86 0.838 . . . . 63.049999999999997 112.823 -177.601 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 127' ' ' ASN . 6.2 tt -161.84 140.65 9.52 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 105.996 -1.853 . . . . 70.420000000000002 105.996 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.443 ' N ' HD23 ' A' ' 126' ' ' LEU . 6.3 t30 78.16 113.27 0.07 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.251 1.204 . . . . 73.099999999999994 114.251 177.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.2 p -144.0 104.52 4.15 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 114.76 -1.109 . . . . 72.340000000000003 108.267 173.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -107.42 32.56 4.57 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.993 0.901 . . . . 72.129999999999995 110.464 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.0 tp -171.72 135.15 0.85 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 113.717 -1.583 . . . . 65.400000000000006 107.14 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.09 105.91 18.14 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.236 -1.764 . . . . 73.340000000000003 106.236 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -145.59 154.39 25.9 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 110.546 -1.022 . . . . 70.310000000000002 110.546 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -114.68 105.3 53.61 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 109.905 -0.406 . . . . 73.129999999999995 109.905 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.22 121.3 8.28 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.502 2.135 . . . . 51.350000000000001 110.68 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.4 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 49.3 mm -104.89 102.94 38.38 Favored Pre-proline 0 N--CA 1.436 -1.128 0 N-CA-C 109.074 -0.713 . . . . 74.129999999999995 109.074 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 135' ' ' ILE . 37.5 Cg_endo -67.26 143.32 63.92 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.449 2.099 . . . . 71.129999999999995 110.352 175.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.46 ' ND2' ' HB2' ' A' ' 57' ' ' GLU . 27.2 p-10 -101.78 135.4 19.75 Favored Pre-proline 0 C--N 1.298 -1.641 0 C-N-CA 120.019 -0.672 . . . . 61.539999999999999 110.131 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.72 -52.37 2.4 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.347 2.031 . . . . 71.239999999999995 110.654 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 55.4 tp 66.18 123.1 0.02 OUTLIER 'General case' 0 C--O 1.242 0.677 0 C-N-CA 125.532 1.533 . . . . 72.540000000000006 112.517 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.0 tp -84.66 78.31 9.88 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.22 -1.4 . . . . 71.140000000000001 107.22 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -121.07 122.77 5.32 Favored Glycine 0 N--CA 1.412 -2.935 0 CA-C-N 114.903 -1.044 . . . . 62.43 111.63 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 142' ' ' LEU . 1.9 pt? -123.91 27.33 7.27 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.662 -1.607 . . . . 50.539999999999999 106.662 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -95.6 93.15 6.98 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.77 -1.559 . . . . 75.420000000000002 111.019 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.8 m -125.92 93.35 3.8 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.067 -1.457 . . . . 73.129999999999995 107.067 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.7 t -153.99 138.71 17.01 Favored 'General case' 0 N--CA 1.411 -2.382 0 N-CA-C 108.152 -1.055 . . . . 70.430000000000007 108.152 -176.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.52 100.93 4.64 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 106.366 -1.716 . . . . 71.310000000000002 106.366 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.5 t -138.29 135.68 35.7 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.543 -0.91 . . . . 72.450000000000003 108.543 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.489 0 N-CA-C 107.453 -2.259 . . . . 74.109999999999999 107.453 -175.267 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 tmm? . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 107.816 -1.179 . . . . 61.409999999999997 107.816 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -110.93 165.72 11.63 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.821 0.819 . . . . 71.340000000000003 113.193 -169.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 7.5 m-85 -121.65 145.81 47.62 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.684 -1.144 . . . . 71.430000000000007 110.28 177.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.442 ' OD1' ' HA3' ' A' ' 30' ' ' GLY . 32.4 t70 -115.13 120.75 40.84 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.762 -1.57 . . . . 73.450000000000003 106.762 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -99.91 116.78 43.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 109.63 -0.507 . . . . 63.130000000000003 109.63 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.42 ' HB ' ' CG ' ' A' ' 85' ' ' LYS . 46.6 t -108.48 117.46 54.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 107.862 -1.162 . . . . 60.409999999999997 107.862 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.503 HG23 ' HB2' ' A' ' 27' ' ' MET . 7.7 tt -117.95 123.09 71.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 121.376 0.608 . . . . 62.420000000000002 110.306 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.2 mp -114.27 98.24 48.04 Favored Pre-proline 0 N--CA 1.422 -1.849 0 CA-C-N 115.648 -0.705 . . . . 44.509999999999998 109.138 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.696 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 5.8 Cg_exo -81.49 130.36 6.95 Favored 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 122.009 1.806 . . . . 74.230000000000004 107.427 171.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.37 131.08 12.36 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.285 0.564 . . . . 72.099999999999994 110.697 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -73.53 122.17 21.77 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 107.672 -1.233 . . . . 54.409999999999997 107.672 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.495 ' HD1' ' O ' ' A' ' 12' ' ' PHE 0.255 0.1 OUTLIER -68.02 105.68 2.11 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.981 0.896 . . . . 63.020000000000003 113.08 -175.256 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -126.75 126.29 43.19 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 113.942 1.09 . . . . 74.120000000000005 113.942 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -76.64 129.18 36.02 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 103.171 -2.9 . . . . 73.5 103.171 165.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.65 111.46 9.86 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-O 121.602 0.715 . . . . 73.319999999999993 110.026 -169.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.57 -164.17 0.61 Allowed 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 114.36 -1.291 . . . . 32.539999999999999 107.967 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -100.88 -29.9 11.97 Favored 'General case' 0 N--CA 1.411 -2.381 0 O-C-N 121.499 -0.751 . . . . 72.209999999999994 110.745 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.1 t60 -135.05 -51.08 0.77 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 118.776 -1.169 . . . . 65.430000000000007 113.357 -175.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -122.22 139.08 54.19 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 109.358 -0.608 . . . . 72.140000000000001 109.358 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.303 59.3 mtm 96.64 73.35 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 126.338 1.855 . . . . 65.019999999999996 111.295 -175.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -156.41 94.07 1.46 Allowed 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 112.696 -2.047 . . . . 42.539999999999999 107.44 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.535 ' CD2' ' HB2' ' A' ' 126' ' ' LEU . 27.9 t-80 -142.17 120.55 12.37 Favored 'General case' 0 CA--C 1.47 -2.116 0 O-C-N 121.577 -0.702 . . . . 71.540000000000006 109.462 178.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.419 HG13 ' H ' ' A' ' 132' ' ' GLY . 41.6 mm -133.05 143.67 38.72 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.799 0 N-CA-C 104.225 -2.509 . . . . 74.349999999999994 104.225 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.696 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 60.5 m -107.77 150.1 39.82 Favored Pre-proline 0 C--N 1.274 -2.7 0 N-CA-C 109.989 -0.374 . . . . 73.420000000000002 109.989 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 27.0 Cg_exo -65.29 142.5 73.26 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.239 2.626 . . . . 63.32 114.255 -176.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 31.8 Cg_exo -63.06 126.49 18.05 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 123.104 2.536 . . . . 41.119999999999997 110.994 175.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.503 ' HB2' HG23 ' A' ' 7' ' ' ILE . 84.3 mtp -101.23 145.29 29.03 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.333 -0.988 . . . . 60.140000000000001 108.333 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 62.2 t -130.76 121.21 49.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.417 -0.586 . . . . 65.25 109.417 -178.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.6 mp -131.14 102.18 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.772 0 N-CA-C 106.205 -1.776 . . . . 72.049999999999997 106.205 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.442 ' HA3' ' OD1' ' A' ' 4' ' ' ASP . . . -117.53 -172.75 16.09 Favored Glycine 0 C--N 1.269 -3.146 0 C-N-CA 119.902 -1.142 . . . . 55.030000000000001 112.773 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.45 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 9.0 t70 71.7 67.6 0.15 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 125.636 1.574 . . . . 71.140000000000001 110.515 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.515 HH22 ' CG1' ' A' ' 103' ' ' VAL . 3.8 mpt_? -140.25 143.92 36.21 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 104.818 -2.29 . . . . 74.25 104.818 172.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 t -78.53 -179.71 6.56 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.78 -1.168 . . . . 62.149999999999999 108.07 174.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.455 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 88.3 t80 -55.98 -52.91 62.5 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 123.094 0.558 . . . . 70.349999999999994 112.394 -174.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 46.2 m-20 -68.04 -39.9 82.96 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.008 -0.997 . . . . 64.310000000000002 110.136 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.0 mt -65.03 -38.32 82.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.305 -0.861 . . . . 75.25 109.925 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.16 -42.47 88.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.791 -0.448 . . . . 72.129999999999995 109.791 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 24.0 mmt -64.77 -41.32 95.95 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.037 -0.529 . . . . 74.099999999999994 110.825 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 35' ' ' ASP . 40.1 mt-10 -66.27 -40.29 90.02 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 112.337 0.495 . . . . 73.349999999999994 112.337 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 44' ' ' VAL . 15.0 tt -72.58 -41.49 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 119.198 -1.001 . . . . 74.450000000000003 110.609 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.433 HG21 HD21 ' A' ' 86' ' ' LEU . 92.6 t -72.15 -37.15 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 120.468 -0.493 . . . . 62.219999999999999 111.309 -177.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -74.31 -23.89 59.14 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.611 -0.436 . . . . 74.219999999999999 111.057 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.87 -45.93 40.24 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.196 -1.161 . . . . 32.140000000000001 110.196 175.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 40' ' ' ILE . 61.5 t -63.3 -41.97 94.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 N-CA-C 108.981 -0.748 . . . . 75.319999999999993 108.981 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.68 -52.34 31.76 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 125.372 1.469 . . . . 65.25 110.793 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -63.93 -40.25 96.02 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.789 -1.096 . . . . 71.310000000000002 110.732 -177.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.93 -36.62 74.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.215 -0.448 . . . . 72.420000000000002 110.592 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.4 mt -67.62 -43.74 86.69 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.171 0 N-CA-C 109.901 -0.407 . . . . 73.420000000000002 109.901 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -74.26 -15.75 60.97 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.628 0.603 . . . . 75.109999999999999 112.628 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.76 -33.99 13.38 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 112.177 0.436 . . . . 45.130000000000003 112.177 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -96.52 -19.21 19.27 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.258 0.551 . . . . 72.040000000000006 112.359 -176.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.416 ' CD2' ' HD2' ' A' ' 75' ' ' LYS . 22.4 m-85 -137.23 -176.36 4.36 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.686 -1.227 . . . . 71.310000000000002 107.686 -176.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.403 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 2.2 t-20 -107.49 117.78 34.99 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.985 -1.487 . . . . 73.109999999999999 106.985 174.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -138.24 134.98 35.09 Favored 'General case' 0 N--CA 1.405 -2.71 0 C-N-CA 119.892 -0.723 . . . . 72.230000000000004 110.934 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.6 m -108.18 120.04 41.21 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 105.754 -1.943 . . . . 73.030000000000001 105.754 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.32 127.36 53.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.185 0.517 . . . . 64.129999999999995 110.767 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -121.72 116.6 24.82 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.748 -1.205 . . . . 64.140000000000001 107.748 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' A' ' 69' ' ' ARG . 42.1 mt-10 -100.49 118.18 36.17 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 120.872 0.368 . . . . 72.319999999999993 111.634 -177.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mp -121.32 178.13 4.9 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.69 -0.855 . . . . 62.219999999999999 108.69 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -87.59 149.61 24.21 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.746 -0.835 . . . . 75.549999999999997 108.746 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -92.35 175.17 37.47 Favored Glycine 0 C--N 1.292 -1.908 0 N-CA-C 110.316 -1.114 . . . . 71.109999999999999 110.316 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -92.5 133.81 35.57 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 118.079 0.939 . . . . 74.209999999999994 112.749 -175.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.3 t70 59.26 -76.59 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.918 1.687 . . . . 62.109999999999999 114.53 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.9 t -119.38 5.53 11.16 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.425 0.631 . . . . 72.430000000000007 110.748 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.508 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 65.3 m-20 -81.43 124.17 29.2 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.943 -1.873 . . . . 73.150000000000006 105.943 173.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.8 t -83.75 -37.15 13.0 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 112.457 0.54 . . . . 74.5 112.457 -173.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 59.2 tp -142.18 137.85 31.13 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 109.169 -0.678 . . . . 64.409999999999997 109.169 -175.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.06 103.59 6.85 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.097 -1.446 . . . . 70.230000000000004 107.097 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.461 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 8.2 ptp180 -107.67 119.81 40.46 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 122.047 0.927 . . . . 74.420000000000002 111.226 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -98.71 108.69 21.44 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 113.704 -1.589 . . . . 74.340000000000003 108.036 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.413 ' CE1' ' HD3' ' A' ' 69' ' ' ARG . 89.0 m-85 -97.21 131.38 44.0 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.882 -0.784 . . . . 74.319999999999993 108.882 176.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 15.4 m -96.13 118.58 32.99 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.662 -1.607 . . . . 53.100000000000001 106.662 173.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.24 134.74 47.84 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 112.976 0.732 . . . . 73.510000000000005 112.976 -173.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 53' ' ' ASN . 51.6 mm-40 -136.45 137.04 40.01 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.155 -1.384 . . . . 75.519999999999996 108.105 174.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.577 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -141.79 85.88 1.96 Allowed 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.141 -1.429 . . . . 62.210000000000001 107.141 175.417 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.278 15.5 pt-20 32.95 69.62 0.12 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.919 1.687 . . . . 75.230000000000004 114.572 -174.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.19 -23.33 35.18 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.035 -0.984 . . . . 52.219999999999999 112.565 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.539 ' N ' ' HE3' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -85.88 124.25 32.14 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.064 -1.828 . . . . 74.209999999999994 106.064 178.801 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -132.2 146.51 52.07 Favored 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 120.057 -0.657 . . . . 71.420000000000002 111.745 -172.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.24 176.56 38.61 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.196 -0.911 . . . . 73.049999999999997 111.174 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 72' ' ' THR . 9.4 tp -129.47 138.0 55.44 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 106.668 -1.604 . . . . 73.420000000000002 106.668 178.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 62.1 t -125.44 110.32 24.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.467 -0.771 . . . . 63.240000000000002 110.083 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -96.92 106.36 18.67 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 123.838 0.855 . . . . 73.140000000000001 110.411 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.461 ' HB ' ' HG3' ' A' ' 69' ' ' ARG . 24.2 t -107.09 115.46 48.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.048 -0.723 . . . . 72.150000000000006 109.048 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.42 ' CG ' ' HB ' ' A' ' 6' ' ' VAL . 18.3 ptpt -110.45 140.42 44.71 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.819 -0.437 . . . . 70.140000000000001 109.819 177.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.433 HD21 HG21 ' A' ' 41' ' ' VAL . 44.4 mt -107.8 108.02 19.04 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 105.399 -2.074 . . . . 72.430000000000007 105.399 178.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 43.9 ttt85 -97.81 133.13 42.74 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 109.057 -0.72 . . . . 72.439999999999998 109.057 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -79.34 112.82 16.95 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.42 -0.955 . . . . 72.299999999999997 108.42 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.5 tt -91.08 111.44 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-O 122.373 1.082 . . . . 74.310000000000002 109.023 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.6 m -133.53 172.6 12.51 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 105.206 -2.146 . . . . 53.539999999999999 105.206 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -64.55 -20.89 66.5 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 118.872 0.76 . . . . 70.140000000000001 110.485 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -94.48 -5.83 45.27 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.039 -0.982 . . . . 74.340000000000003 111.59 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 70.3 m -133.32 109.52 12.51 Favored Pre-proline 0 C--N 1.314 -0.94 0 O-C-N 122.124 -0.36 . . . . 73.019999999999996 111.046 -175.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.56 138.86 24.79 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.143 1.895 . . . . 53.420000000000002 112.387 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.95 164.66 33.9 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 123.414 2.742 . . . . 51.340000000000003 111.13 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.7 t -94.11 155.7 3.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.988 -0.745 . . . . 72.549999999999997 108.988 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -106.19 122.08 45.48 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.512 -0.767 . . . . 70.209999999999994 109.086 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -158.13 -159.65 9.74 Favored Glycine 0 CA--C 1.468 -2.85 0 N-CA-C 110.229 -1.148 . . . . 54.0 110.229 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -76.29 93.0 3.36 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-O 121.828 0.823 . . . . 54.25 111.375 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 62.9 ttt180 -73.89 122.01 21.84 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.252 -1.34 . . . . 72.109999999999999 108.037 177.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 38.7 t -88.97 163.79 15.4 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.896 -0.722 . . . . 73.329999999999998 109.846 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.7 m -75.31 107.75 7.63 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 122.934 0.494 . . . . 75.340000000000003 109.902 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.515 ' CG1' HH22 ' A' ' 32' ' ' ARG . 36.5 t -85.01 135.91 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-O 122.132 0.967 . . . . 70.450000000000003 110.277 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.0 mt -153.18 -163.84 1.78 Allowed 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 104.805 -2.294 . . . . 73.099999999999994 104.805 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -54.05 145.93 15.76 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 118.405 0.548 . . . . 75.219999999999999 111.406 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.428 ' O ' HG22 ' A' ' 110' ' ' ILE . 13.9 t80 -32.91 -48.57 0.21 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.425 2.29 . . . . 75.230000000000004 113.707 -173.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.564 ' O ' ' HG3' ' A' ' 111' ' ' GLU . 43.3 tt0 -57.4 -43.87 84.05 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 112.349 0.5 . . . . 62.299999999999997 112.349 -176.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 -72.09 -31.4 66.04 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.145 -0.622 . . . . 61.409999999999997 111.501 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -71.38 -44.7 64.46 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.879 -1.055 . . . . 74.200000000000003 108.412 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 106' ' ' PHE . 12.7 tt -68.37 -36.79 76.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 C-N-CA 120.479 -0.489 . . . . 74.099999999999994 110.681 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 107' ' ' GLU . 52.6 mt-10 -61.56 -35.94 79.22 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.874 0.368 . . . . 74.140000000000001 110.064 176.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 44.5 t -64.98 -43.44 92.62 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.005 -0.543 . . . . 75.439999999999998 109.953 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.6 mm -64.58 -46.66 91.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.513 -0.767 . . . . 73.430000000000007 110.301 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 110' ' ' ILE . 92.3 t -63.29 -39.2 84.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.456 -0.338 . . . . 73.319999999999993 110.53 -177.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -62.64 -38.7 91.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.052 0.453 . . . . 74.120000000000005 110.4 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.89 -42.32 90.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.132 -0.486 . . . . 71.030000000000001 110.326 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.78 -42.75 93.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.008 -0.542 . . . . 75.209999999999994 110.569 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 114' ' ' VAL . 52.8 mt-10 -61.12 -44.81 96.77 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 121.319 -0.152 . . . . 75.129999999999995 110.618 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -65.07 -46.59 80.55 Favored 'General case' 0 C--O 1.181 -2.502 0 C-N-CA 119.685 -0.806 . . . . 72.439999999999998 110.336 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 2.7 t -68.84 -22.71 64.21 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.324 0.583 . . . . 61.310000000000002 111.616 -172.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 8.2 mp -81.96 -47.1 13.12 Favored 'General case' 0 N--CA 1.428 -1.553 0 O-C-N 121.999 -0.438 . . . . 55.310000000000002 111.473 174.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.16 -25.59 31.71 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.855 0.687 . . . . 51.100000000000001 112.855 -172.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -102.65 9.92 38.98 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.431 -1.322 . . . . 44.439999999999998 107.431 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.11 57.35 2.75 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 114.445 -1.252 . . . . 61.210000000000001 115.329 -174.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -173.26 98.5 0.12 Allowed 'General case' 0 C--N 1.272 -2.765 0 C-N-CA 125.233 1.413 . . . . 72.25 107.228 172.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.535 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 0.4 OUTLIER -131.81 -178.38 4.85 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 115.598 -0.728 . . . . 71.129999999999995 110.022 -178.061 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -134.1 159.46 40.78 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 126.02 1.728 . . . . 71.120000000000005 106.467 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.8 t 63.56 34.66 12.37 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 122.033 0.921 . . . . 72.400000000000006 110.996 177.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.453 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 1.9 mmpt? -122.69 107.54 12.06 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.594 -1.185 . . . . 70.519999999999996 111.004 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.6 tp -65.42 144.79 56.84 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.349 -0.841 . . . . 63.229999999999997 109.308 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.4 165.66 13.83 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.167 -0.924 . . . . 74.010000000000005 112.232 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.419 ' H ' HG13 ' A' ' 23' ' ' ILE . . . -120.56 -74.3 0.38 Allowed Glycine 0 N--CA 1.42 -2.368 0 N-CA-C 105.232 -3.147 . . . . 73.239999999999995 105.232 170.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -117.97 119.49 33.59 Favored Pre-proline 0 N--CA 1.427 -1.605 0 N-CA-C 106.82 -1.548 . . . . 62.030000000000001 106.82 170.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.7 106.43 1.98 Allowed 'Trans proline' 0 N--CA 1.446 -1.285 0 N-CA-C 107.598 -1.732 . . . . 73.340000000000003 107.598 172.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 49.3 mm -112.27 102.12 53.43 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 120.825 -0.35 . . . . 71.319999999999993 111.184 -174.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.57 132.72 7.97 Favored 'Trans proline' 0 N--CA 1.436 -1.878 0 C-N-CA 122.001 1.801 . . . . 75.040000000000006 107.695 167.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -136.79 98.73 10.58 Favored Pre-proline 0 C--N 1.289 -2.037 0 C-N-CA 119.287 -0.965 . . . . 63.039999999999999 108.99 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.76 75.93 4.54 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 122.314 2.009 . . . . 74.219999999999999 112.867 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.495 HD21 HG21 ' A' ' 72' ' ' THR . 2.2 pp -143.53 162.03 36.92 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.399 -0.819 . . . . 60.509999999999998 111.016 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.77 97.95 6.89 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.016 -0.735 . . . . 62.140000000000001 109.016 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.12 129.79 41.13 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 111.329 -0.708 . . . . 62.119999999999997 111.329 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.6 tt -123.98 98.3 5.73 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.685 -0.858 . . . . 73.030000000000001 108.685 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -141.08 139.82 34.09 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.463 -0.79 . . . . 61.549999999999997 110.495 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 t -147.46 47.27 1.12 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.378 1.085 . . . . 73.340000000000003 108.611 175.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 20.9 p -88.89 116.57 27.27 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 107.781 -1.192 . . . . 71.129999999999995 107.781 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 50.2 ttp85 -53.06 112.11 0.8 Allowed 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.765 0.826 . . . . 62.0 111.952 -172.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.2 m -80.95 120.48 24.81 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.479 -0.782 . . . . 74.450000000000003 109.967 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.422 0 N-CA-C 109.829 -1.309 . . . . 73.549999999999997 109.829 178.282 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 mtp . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 121.363 0.601 . . . . 73.319999999999993 112.179 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -141.32 174.12 10.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.561 -1.274 . . . . 71.219999999999999 107.561 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 24.9 m-85 -120.35 134.96 55.17 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-O 121.325 0.583 . . . . 71.439999999999998 109.697 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.672 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 62.3 t0 -115.26 119.37 36.09 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.245 -1.343 . . . . 74.420000000000002 108.404 -175.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.6 125.7 50.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 115.673 -0.694 . . . . 75.439999999999998 111.393 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.498 ' HB ' HH21 ' A' ' 87' ' ' ARG . 7.7 p -112.39 115.84 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 N-CA-C 108.603 -0.888 . . . . 71.129999999999995 108.603 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.454 HG23 ' HB2' ' A' ' 27' ' ' MET . 8.3 tt -104.02 124.45 58.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.482 -0.781 . . . . 70.319999999999993 108.952 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.1 mt -114.92 95.81 42.78 Favored Pre-proline 0 C--N 1.302 -1.457 0 CA-C-N 115.808 -0.633 . . . . 51.439999999999998 109.346 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.635 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 9.7 Cg_endo -89.45 126.6 1.58 Allowed 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.762 2.308 . . . . 71.129999999999995 110.173 176.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -150.67 127.67 11.12 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.615 0.722 . . . . 63.409999999999997 110.781 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.2 m -74.42 111.44 9.6 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.791 -1.189 . . . . 72.310000000000002 107.791 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.44 120.64 14.85 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.647 0.737 . . . . 73.140000000000001 112.948 -173.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -129.65 114.72 16.37 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 115.176 -0.92 . . . . 74.319999999999993 110.305 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -78.86 118.65 21.1 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 104.927 -2.249 . . . . 74.239999999999995 104.927 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -48.11 104.31 0.06 Allowed 'General case' 0 N--CA 1.424 -1.765 0 O-C-N 125.378 1.673 . . . . 73.409999999999997 110.578 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.451 ' H ' ' HB2' ' A' ' 20' ' ' MET . 12.9 t70 -84.8 -145.89 0.09 Allowed 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 112.685 -2.052 . . . . 40.32 108.292 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -63.05 -58.37 7.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 118.3 0.5 . . . . 61.210000000000001 111.369 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -137.3 -52.55 0.67 Allowed 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 118.866 -1.134 . . . . 74.319999999999993 113.833 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.52 ' O ' ' HG2' ' A' ' 20' ' ' MET . 10.5 t30 -108.27 80.95 1.41 Allowed 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 113.104 0.779 . . . . 74.349999999999994 113.104 -170.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 70.5 mmm -163.24 70.94 0.25 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.08 1.352 . . . . 75.129999999999995 109.287 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -146.21 89.89 1.91 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.319 -1.734 . . . . 62.299999999999997 106.319 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -113.25 118.03 33.5 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.201 -1.0 . . . . 74.230000000000004 111.08 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.5 mm -133.18 127.48 54.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.489 -0.778 . . . . 63.399999999999999 110.735 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 76.9 m -111.54 129.23 24.32 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 108.458 -0.941 . . . . 60.229999999999997 108.458 172.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.4 ' HB2' ' ND2' ' A' ' 99' ' ' ASN . 27.0 Cg_exo -63.49 146.95 93.43 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.685 2.257 . . . . 74.219999999999999 112.725 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.86 147.93 92.02 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 123.68 2.92 . . . . 62.119999999999997 113.422 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.502 ' HG2' ' HB2' ' A' ' 99' ' ' ASN . 64.2 mtt -111.07 132.94 53.84 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.194 -1.039 . . . . 74.010000000000005 108.194 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.9 t -126.37 125.6 67.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 O-C-N 123.497 0.498 . . . . 71.510000000000005 110.457 -171.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.8 mm -138.21 116.17 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.748 0.819 . . . . 45.009999999999998 109.504 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.672 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -127.94 81.98 0.34 Allowed Glycine 0 CA--C 1.48 -2.139 0 C-N-CA 118.726 -1.702 . . . . 74.319999999999993 114.801 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.92 7.91 1.65 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.205 -0.598 . . . . 63.43 112.432 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.459 HH21 ' CG1' ' A' ' 103' ' ' VAL . 14.8 mmt85 -103.99 134.41 47.31 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.148 -0.621 . . . . 43.240000000000002 109.553 -169.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 p -78.19 163.76 25.52 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 107.678 -1.23 . . . . 71.120000000000005 107.678 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.513 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 63.3 t80 -51.42 -43.24 61.94 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 124.27 1.028 . . . . 75.219999999999999 111.22 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.99 -41.78 95.11 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.151 -0.931 . . . . 63.240000000000002 111.719 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.8 mt -79.29 -30.47 14.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.529 -0.545 . . . . 64.310000000000002 109.529 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.31 -45.8 89.68 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.353 -0.839 . . . . 75.030000000000001 110.098 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.08 -31.38 70.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 119.924 -0.711 . . . . 72.120000000000005 112.276 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.23 -45.07 67.28 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 119.495 -0.882 . . . . 74.329999999999998 110.508 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.4 tp -66.72 -40.9 87.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 C-N-CA 120.107 -0.637 . . . . 72.439999999999998 110.176 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.3 t -65.57 -42.67 93.5 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.008 0 CA-C-N 116.737 -0.21 . . . . 72.200000000000003 110.57 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -63.85 -40.73 97.26 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 120.761 0.315 . . . . 74.439999999999998 111.349 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -66.85 -44.9 87.98 Favored Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 111.062 -0.815 . . . . 52.149999999999999 111.062 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.17 -39.85 86.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.649 -0.5 . . . . 73.239999999999995 109.649 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.447 ' OD2' ' HE2' ' A' ' 49' ' ' LYS . 23.2 t70 -57.75 -46.42 84.54 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 124.387 1.075 . . . . 61.409999999999997 110.653 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 46' ' ' ARG . 29.7 mmt180 -67.42 -37.64 83.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.14 -0.482 . . . . 73.409999999999997 111.597 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 43' ' ' GLY . 62.3 t -68.36 -41.89 83.83 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 120.772 -0.371 . . . . 60.130000000000003 110.302 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.49 HG23 HD11 ' A' ' 73' ' ' LEU . 66.3 mt -66.01 -38.33 81.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 O-C-N 122.035 -0.416 . . . . 73.510000000000005 111.091 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.447 ' HE2' ' OD2' ' A' ' 45' ' ' ASP . 54.0 mtmt -76.57 -17.79 59.02 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.912 0.708 . . . . 74.409999999999997 112.912 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.02 -33.91 7.34 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 113.625 0.972 . . . . 65.450000000000003 113.625 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 t -87.4 -9.99 53.22 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.423 0.63 . . . . 61.25 110.053 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.615 ' CE2' ' HD2' ' A' ' 75' ' ' LYS . 12.3 m-85 -137.33 175.81 9.27 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 107.503 -1.295 . . . . 71.239999999999995 107.503 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -104.42 77.35 1.38 Allowed 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 105.462 -2.051 . . . . 72.129999999999995 105.462 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.499 ' HB2' HD13 ' A' ' 73' ' ' LEU . . . -114.46 136.44 53.01 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-N 115.158 -0.928 . . . . 73.430000000000007 112.532 -172.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 m -109.37 123.54 49.49 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.282 -1.377 . . . . 75.340000000000003 107.282 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 p -100.63 152.42 4.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 116.11 -0.495 . . . . 31.23 110.293 -173.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -142.13 140.08 32.36 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.691 -1.225 . . . . 73.040000000000006 107.691 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.96 136.32 49.42 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.34 0.59 . . . . 73.299999999999997 110.883 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mp -135.91 167.53 21.01 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.913 -1.143 . . . . 63.020000000000003 107.913 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -100.54 142.76 31.56 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.038 -1.468 . . . . 73.010000000000005 107.038 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.52 174.89 48.93 Favored Glycine 0 C--N 1.296 -1.681 0 C-N-CA 120.708 -0.758 . . . . 72.450000000000003 112.121 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.77 130.47 35.13 Favored 'General case' 0 C--O 1.179 -2.628 0 N-CA-C 108.188 -1.042 . . . . 51.039999999999999 108.188 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 13.64 -73.76 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 C-N-CA 128.241 2.616 . . . . 75.340000000000003 116.829 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 53.3 t -57.12 -37.75 72.43 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 124.151 0.98 . . . . 75.329999999999998 110.046 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 8.7 m-20 -86.18 124.4 32.54 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.601 -1.259 . . . . 62.5 107.601 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.4 t -93.83 -28.78 4.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-O 121.304 0.573 . . . . 72.439999999999998 111.717 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.6 tp -145.34 141.3 28.38 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.124 -0.695 . . . . 63.229999999999997 109.124 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.28 108.96 10.4 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.199 -1.408 . . . . 74.420000000000002 107.199 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -104.79 114.77 29.19 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.279 -1.378 . . . . 75.439999999999998 107.279 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 36.1 ttmt -101.12 132.64 46.49 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.341 0.657 . . . . 74.150000000000006 109.295 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -126.4 125.24 41.86 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.716 -0.475 . . . . 74.310000000000002 109.716 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 m -98.38 113.49 25.49 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.999 -1.482 . . . . 74.319999999999993 106.999 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.499 HD13 ' HB2' ' A' ' 54' ' ' ALA . 4.2 mm? -98.38 139.99 33.32 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.573 0.583 . . . . 75.409999999999997 112.573 -172.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HB2' ' HE2' ' A' ' 79' ' ' LYS . 42.9 tt0 -140.13 127.95 21.92 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 105.715 -1.957 . . . . 73.239999999999995 105.715 170.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.615 ' HD2' ' CE2' ' A' ' 52' ' ' PHE . 49.2 tttm -134.79 -176.91 4.39 Favored 'General case' 0 C--N 1.273 -2.744 0 N-CA-C 104.933 -2.247 . . . . 61.509999999999998 104.933 177.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.428 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -55.97 92.25 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 114.568 1.322 . . . . 73.510000000000005 114.568 -175.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.7 17.6 74.99 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 114.903 -1.044 . . . . 62.130000000000003 113.146 175.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 44.4 mtmt -140.09 143.99 36.57 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.419 -0.586 . . . . 72.120000000000005 109.419 -175.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 73' ' ' LEU . 33.6 ttmt -146.79 139.31 24.98 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 110.033 -0.358 . . . . 73.420000000000002 110.033 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.62 174.4 35.71 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 110.902 -0.879 . . . . 61.119999999999997 110.902 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.9 tp -119.56 134.46 63.05 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 108.106 -1.072 . . . . 74.430000000000007 108.106 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.2 t -123.61 115.59 45.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.432 0.634 . . . . 75.319999999999993 109.673 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.409 ' CD2' ' HG3' ' A' ' 70' ' ' LYS . 36.4 m170 -107.15 116.67 32.33 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.257 -0.883 . . . . 63.32 110.512 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.58 110.0 30.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.737 -0.838 . . . . 75.430000000000007 108.737 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -118.27 137.4 53.07 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.891 -0.506 . . . . 72.540000000000006 111.336 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.7 mt -106.37 118.76 37.48 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.112 -0.495 . . . . 73.230000000000004 109.944 -171.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.498 HH21 ' HB ' ' A' ' 6' ' ' VAL . 28.5 mtm105 -97.15 141.14 30.65 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.025 0.441 . . . . 73.510000000000005 110.096 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 64' ' ' CYS . 49.7 pttt -80.23 98.11 7.23 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 109.301 -0.629 . . . . 71.209999999999994 109.301 173.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.0 tt -69.22 112.01 3.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-O 122.513 1.149 . . . . 74.439999999999998 109.636 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.6 p -140.68 -171.4 3.22 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 113.35 -1.75 . . . . 51.020000000000003 107.723 -170.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.47 -5.0 53.83 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.593 0.711 . . . . 62.020000000000003 110.658 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -99.74 -29.25 12.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.547 -0.751 . . . . 54.25 109.169 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 84.9 m -121.27 92.87 48.76 Favored Pre-proline 0 N--CA 1.431 -1.377 0 CA-C-N 115.429 -0.805 . . . . 54.109999999999999 109.719 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -76.48 167.79 24.97 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.189 1.926 . . . . 73.040000000000006 110.976 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.24 123.34 12.31 Favored 'Trans proline' 0 C--O 1.251 1.157 0 C-N-CA 122.032 1.821 . . . . 62.420000000000002 110.194 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 t -86.68 157.57 3.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.462 -0.57 . . . . 73.430000000000007 109.462 -176.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.47 137.49 32.31 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.96 -0.564 . . . . 74.200000000000003 110.299 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -177.1 -170.43 39.52 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 108.76 -1.736 . . . . 74.439999999999998 108.76 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.502 ' HB2' ' HG2' ' A' ' 27' ' ' MET . 94.1 m-20 -71.63 140.01 49.54 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.187 -0.671 . . . . 62.140000000000001 109.187 178.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -98.63 119.7 37.81 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.019 0.438 . . . . 71.439999999999998 111.133 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 41.1 t -73.2 139.04 46.0 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.553 -0.906 . . . . 72.219999999999999 108.553 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 m -74.03 91.15 2.03 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.494 0.664 . . . . 73.519999999999996 110.374 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.459 ' CG1' HH21 ' A' ' 32' ' ' ARG . 66.7 t -89.57 136.59 23.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 114.748 -1.115 . . . . 65.150000000000006 109.897 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 93.4 mt -148.48 -88.74 0.08 Allowed 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.099 -0.955 . . . . 61.549999999999997 109.606 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -120.58 166.9 13.0 Favored 'General case' 0 C--N 1.262 -3.239 0 N-CA-C 107.006 -1.479 . . . . 64.219999999999999 107.006 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -44.71 -46.74 10.54 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 124.172 0.92 . . . . 74.329999999999998 112.761 -178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.04 -31.54 72.14 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.477 -0.783 . . . . 72.010000000000005 112.271 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -81.47 -36.9 28.77 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.112 -0.699 . . . . 75.230000000000004 109.112 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.415 ' O ' HG12 ' A' ' 113' ' ' ILE . 44.2 m-20 -63.61 -45.39 90.51 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.11 -0.95 . . . . 71.540000000000006 109.198 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 114' ' ' VAL . 7.0 tp -67.69 -36.91 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 120.335 -0.546 . . . . 60.439999999999998 110.951 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.26 -33.18 75.17 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.266 -0.642 . . . . 70.319999999999993 109.266 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 41.6 t -65.09 -38.93 92.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.677 -0.692 . . . . 60.229999999999997 110.248 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 109' ' ' ASP . 51.5 mm -67.69 -43.57 86.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.906 -0.405 . . . . 75.319999999999993 109.906 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 110' ' ' ILE . 83.7 t -60.43 -43.65 94.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.024 -0.535 . . . . 73.329999999999998 111.037 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -66.92 -31.35 71.88 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 120.767 -0.373 . . . . 41.43 110.38 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.64 -45.58 71.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.017 0.437 . . . . 75.140000000000001 110.809 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.4 mt -68.1 -44.13 84.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.545 -0.752 . . . . 72.439999999999998 109.461 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.1 -31.48 71.99 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 112.398 0.518 . . . . 62.43 112.398 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.35 -43.0 61.57 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 119.416 -0.914 . . . . 74.150000000000006 110.012 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 2.6 t -70.36 -41.26 73.35 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.6 0.714 . . . . 62.329999999999998 109.556 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 10.4 mp -74.61 -35.68 62.95 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.75 -0.659 . . . . 74.400000000000006 111.994 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.15 -14.77 52.85 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 119.544 -0.863 . . . . 44.200000000000003 113.033 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.53 -34.59 58.54 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 118.232 -1.387 . . . . 71.519999999999996 111.733 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.48 -153.93 39.16 Favored Glycine 0 C--N 1.295 -1.701 0 CA-C-N 114.726 -1.124 . . . . 71.140000000000001 115.752 172.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--N 1.312 -1.057 0 C-N-CA 125.088 1.355 . . . . 75.329999999999998 112.494 -177.046 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 tpt . . . . . 0 CA--C 1.511 -0.524 0 N-CA-C 109.402 -0.592 . . . . 52.329999999999998 109.402 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -128.84 170.77 12.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.362 -0.607 . . . . 70.319999999999993 109.362 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.484 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 16.6 m-85 -124.18 146.93 48.37 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.832 -0.622 . . . . 74.319999999999993 110.694 177.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.645 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 0.4 OUTLIER -99.03 102.44 14.16 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 125.27 1.428 . . . . 71.219999999999999 108.246 178.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.1 t -85.0 113.13 23.03 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 107.526 -1.287 . . . . 71.340000000000003 107.526 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.442 HG13 HG22 ' A' ' 28' ' ' VAL . 60.0 t -107.26 107.78 23.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.882 -1.155 . . . . 74.239999999999995 107.882 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.9 tt -110.91 110.06 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-O 122.064 0.935 . . . . 73.540000000000006 109.466 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.406 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 45.6 mt -106.77 104.71 52.57 Favored Pre-proline 0 C--N 1.293 -1.879 0 CA-C-N 114.245 -1.343 . . . . 75.519999999999996 110.143 -174.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.693 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 5.9 Cg_exo -81.04 137.51 10.9 Favored 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 121.701 1.601 . . . . 73.109999999999999 108.463 170.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -139.27 156.59 46.95 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.001 -1.481 . . . . 73.219999999999999 107.001 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.458 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 35.7 m -104.58 126.47 51.69 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.397 -0.964 . . . . 73.120000000000005 108.397 175.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.523 ' CE1' ' HB3' ' A' ' 79' ' ' LYS 0.275 8.2 p90 -73.79 75.31 1.59 Allowed 'General case' 0 C--N 1.349 0.573 0 CA-C-O 122.723 1.249 . . . . 72.329999999999998 114.098 -176.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.635 ' NE2' ' HD2' ' A' ' 79' ' ' LYS . 50.3 m80 -128.46 111.41 13.26 Favored 'General case' 0 N--CA 1.414 -2.265 0 O-C-N 121.59 -0.694 . . . . 70.120000000000005 111.696 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -72.47 144.22 48.15 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.388 -1.278 . . . . 74.409999999999997 108.91 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -52.69 120.33 5.58 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 116.983 2.216 . . . . 73.319999999999993 116.983 -173.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.595 ' HB3' ' O ' ' A' ' 19' ' ' ASN . 9.5 t70 -100.45 168.22 9.88 Favored 'General case' 0 C--N 1.262 -3.203 0 CA-C-N 111.974 -2.376 . . . . 70.239999999999995 105.114 165.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -62.63 -32.84 73.94 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 122.63 0.372 . . . . 55.43 111.885 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -135.55 -35.68 0.8 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.901 0.704 . . . . 73.430000000000007 112.901 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.595 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 5.1 m-20 -95.84 -178.62 4.43 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.097 -0.501 . . . . 73.439999999999998 109.662 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 62.8 mtt 56.58 71.32 0.57 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 114.12 1.156 . . . . 71.510000000000005 114.12 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -165.72 116.45 1.05 Allowed 'General case' 0 N--CA 1.406 -2.658 0 N-CA-C 103.412 -2.811 . . . . 64.549999999999997 103.412 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -153.73 104.75 2.73 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-O 122.034 0.921 . . . . 62.43 110.77 171.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.5 mm -96.58 128.85 47.4 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.707 0 N-CA-C 104.076 -2.564 . . . . 75.150000000000006 104.076 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.693 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 59.3 m -107.81 159.06 31.82 Favored Pre-proline 0 C--N 1.288 -2.104 0 C-N-CA 119.812 -0.755 . . . . 72.120000000000005 110.426 -168.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.33 116.85 3.48 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.571 2.18 . . . . 73.150000000000006 112.741 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.52 128.87 5.55 Favored 'Trans proline' 0 C--O 1.256 1.39 0 C-N-CA 122.111 1.874 . . . . 74.349999999999994 111.501 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -91.44 126.26 36.47 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.723 -0.671 . . . . 74.219999999999999 110.594 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.449 HG11 ' HB ' ' A' ' 96' ' ' VAL . 94.6 t -123.14 115.24 45.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.555 -0.748 . . . . 53.43 108.994 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.475 HD11 ' H ' ' A' ' 101' ' ' CYS . 45.3 mm -125.14 102.47 10.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 109.664 -0.495 . . . . 52.399999999999999 109.664 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.645 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -110.1 80.39 0.27 Allowed Glycine 0 CA--C 1.474 -2.505 0 C-N-CA 119.84 -1.172 . . . . 64.310000000000002 112.92 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -165.3 20.69 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.06 -1.07 . . . . 74.109999999999999 110.304 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -103.08 133.39 48.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.99 -1.855 . . . . 73.140000000000001 105.99 -173.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.0 p -77.93 165.92 23.5 Favored 'General case' 0 N--CA 1.408 -2.526 0 N-CA-C 107.929 -1.137 . . . . 61.32 107.929 174.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.484 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 59.7 t80 -52.76 -43.92 66.13 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 123.333 0.653 . . . . 71.140000000000001 111.029 -174.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.01 -31.33 68.95 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.019 -0.991 . . . . 60.109999999999999 112.889 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -81.63 -34.36 12.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.216 0.531 . . . . 75.430000000000007 109.601 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.04 -45.43 88.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.672 -0.695 . . . . 61.229999999999997 110.012 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.3 mmt -69.85 -29.72 67.03 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.891 0.376 . . . . 74.450000000000003 110.313 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -67.68 -44.71 77.14 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 115.789 -0.641 . . . . 74.219999999999999 110.31 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 44' ' ' VAL . 7.9 tp -69.93 -39.91 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 119.709 -0.797 . . . . 73.120000000000005 109.738 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.31 -42.09 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 116.602 -0.272 . . . . 53.439999999999998 110.931 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.554 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 46.3 t-20 -64.44 -42.42 96.01 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.494 -0.558 . . . . 34.329999999999998 109.494 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.474 ' HA3' ' CE1' ' A' ' 106' ' ' PHE . . . -67.53 -40.46 90.93 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.588 -0.815 . . . . 42.109999999999999 112.058 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 40' ' ' ILE . 72.1 t -65.22 -41.36 91.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.53 -0.545 . . . . 62.340000000000003 109.53 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -53.71 -47.22 70.74 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.481 1.112 . . . . 65.099999999999994 110.92 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 42' ' ' ASN . 88.0 mtt180 -69.5 -37.21 77.11 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.333 -0.848 . . . . 73.209999999999994 110.645 -177.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.2 t -71.12 -36.01 61.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.217 -0.447 . . . . 51.119999999999997 110.649 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.56 -45.63 97.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 122.6 0.36 . . . . 64.019999999999996 110.921 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -70.94 -25.32 62.69 Favored 'General case' 0 C--O 1.209 -1.064 0 CA-C-O 121.02 0.438 . . . . 74.420000000000002 110.82 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.6 -40.84 18.52 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.893 0.701 . . . . 63.130000000000003 112.893 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -92.23 -14.11 29.46 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 112.729 0.64 . . . . 74.150000000000006 112.729 -173.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -135.44 -175.71 4.03 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.505 0.669 . . . . 72.439999999999998 110.543 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -113.53 100.62 8.64 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 103.487 -2.783 . . . . 73.099999999999994 103.487 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.72 153.74 28.49 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 114.07 1.137 . . . . 62.32 114.07 -167.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.6 m -126.73 118.25 24.33 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 105.56 -2.015 . . . . 52.439999999999998 105.56 168.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.9 p -99.96 118.74 47.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.482 0.658 . . . . 75.439999999999998 109.953 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HB2' ' HG3' ' A' ' 70' ' ' LYS . 39.2 mt-10 -114.83 122.23 45.72 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.569 -0.741 . . . . 61.32 109.075 -177.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.13 141.33 28.71 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.972 -0.381 . . . . 64.0 109.972 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.57 168.57 19.4 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.563 0.697 . . . . 53.009999999999998 109.481 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -106.24 127.0 52.92 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.179 -1.415 . . . . 74.310000000000002 107.179 174.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' A' ' 65' ' ' ASP . . . -72.83 176.51 43.04 Favored Glycine 0 N--CA 1.422 -2.273 0 CA-C-N 115.742 -0.663 . . . . 53.149999999999999 112.672 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' A' ' 65' ' ' ASP . 9.4 pt-20 -64.23 174.64 1.54 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.271 1.028 . . . . 73.420000000000002 110.146 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -49.49 -40.65 38.24 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.081 0.952 . . . . 63.229999999999997 111.736 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.18 -20.25 48.9 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.566 -1.197 . . . . 53.520000000000003 111.999 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.47 ' OD2' ' HB2' ' A' ' 85' ' ' LYS . 2.1 t70 -89.0 171.29 9.97 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.836 -0.54 . . . . 73.209999999999994 109.877 -174.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.7 t -114.19 -37.94 2.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 C-N-CA 123.857 0.863 . . . . 54.310000000000002 109.532 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.3 tp -167.3 131.57 1.89 Allowed 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.891 -0.595 . . . . 52.409999999999997 110.503 -171.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.28 133.68 52.56 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 107.41 -1.33 . . . . 72.120000000000005 107.41 -176.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -139.3 142.32 37.71 Favored 'General case' 0 C--N 1.28 -2.433 0 O-C-N 121.618 -0.676 . . . . 61.32 110.713 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HG3' ' HB2' ' A' ' 57' ' ' GLU . 14.4 ptmm? -121.64 122.69 40.17 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.376 0.608 . . . . 62.520000000000003 109.522 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -97.57 119.85 36.89 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 107.177 -1.416 . . . . 74.319999999999993 107.177 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.7 m -94.35 116.17 28.5 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.305 -1.369 . . . . 52.020000000000003 107.305 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.94 142.2 47.61 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-O 121.04 0.448 . . . . 64.120000000000005 110.913 -173.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 26.6 tt0 -150.41 100.49 2.88 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 107.936 -1.135 . . . . 73.129999999999995 107.936 168.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -102.75 90.4 3.8 Favored 'General case' 0 N--CA 1.417 -2.078 0 C-N-CA 118.959 -1.096 . . . . 54.210000000000001 108.39 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 55.51 67.58 0.99 Allowed 'General case' 0 CA--C 1.545 0.771 0 O-C-N 124.707 1.254 . . . . 70.099999999999994 111.385 171.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.62 -23.5 19.22 Favored Glycine 0 C--N 1.308 -1.021 0 CA-C-N 115.483 -0.781 . . . . 73.409999999999997 113.341 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 53.2 mtmt -84.44 101.12 11.78 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.261 -1.015 . . . . 74.129999999999995 108.261 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.635 ' HD2' ' NE2' ' A' ' 13' ' ' HIS . 42.0 mttp -103.73 134.11 47.6 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 123.843 0.715 . . . . 72.549999999999997 110.187 -172.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -171.8 169.46 42.53 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.074 -1.06 . . . . 52.539999999999999 112.825 177.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.1 mt -131.62 138.22 53.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.147 -1.427 . . . . 71.109999999999999 107.147 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.8 t -115.18 110.34 31.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 109.084 -0.71 . . . . 74.409999999999997 109.084 176.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 88.4 m-70 -97.27 105.83 18.05 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.664 -0.698 . . . . 74.230000000000004 109.827 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.2 t -101.29 115.44 43.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 107.927 -1.138 . . . . 72.540000000000006 107.927 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.47 ' HB2' ' OD2' ' A' ' 65' ' ' ASP . 21.7 ptmt -124.16 133.78 53.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.29 -0.633 . . . . 74.200000000000003 109.29 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.6 mt -107.33 112.91 25.97 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.863 -0.791 . . . . 70.519999999999996 108.863 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.472 ' HB2' ' HB2' ' A' ' 4' ' ' ASP . 45.5 mmm-85 -97.13 139.01 33.76 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.316 -0.994 . . . . 74.400000000000006 108.316 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 93' ' ' CYS . 21.8 pttm -92.06 98.98 11.89 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 120.208 -0.597 . . . . 74.450000000000003 111.464 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.2 tt -66.59 111.7 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 122.326 1.06 . . . . 73.129999999999995 109.494 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.3 p -145.67 -170.46 3.46 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.25 -1.341 . . . . 64.310000000000002 108.924 -169.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -72.73 -19.49 61.38 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.87 -1.159 . . . . 75.310000000000002 107.87 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.1 -36.84 17.88 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.253 -1.34 . . . . 73.239999999999995 109.556 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 86.3 m -122.36 125.43 26.53 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 113.463 0.912 . . . . 54.32 113.463 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.21 161.98 15.32 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.522 2.148 . . . . 75.450000000000003 110.905 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.12 142.99 89.34 Favored 'Trans proline' 0 C--O 1.262 1.71 0 C-N-CA 121.943 1.762 . . . . 71.439999999999998 109.667 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.449 ' HB ' HG11 ' A' ' 28' ' ' VAL . 13.7 t -87.98 159.42 3.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 109.576 -0.527 . . . . 71.200000000000003 109.576 -176.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -109.51 131.15 55.33 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.782 -0.821 . . . . 72.329999999999998 108.782 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -174.6 -160.76 23.26 Favored Glycine 0 CA--C 1.479 -2.17 0 N-CA-C 110.731 -0.948 . . . . 71.530000000000001 110.731 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -79.73 125.75 30.06 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.207 -0.664 . . . . 72.340000000000003 109.207 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -87.72 105.87 17.66 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.891 0.853 . . . . 75.209999999999994 110.761 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.475 ' H ' HD11 ' A' ' 29' ' ' ILE . 53.1 t -69.73 152.54 44.53 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.846 -1.525 . . . . 31.210000000000001 109.468 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.0 m -74.33 104.56 5.13 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.518 -0.919 . . . . 60.420000000000002 108.518 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.6 t -113.21 140.51 32.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 121.753 0.787 . . . . 74.439999999999998 110.518 -175.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.6 tp -149.76 -64.94 0.22 Allowed 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 114.452 -1.249 . . . . 75.150000000000006 108.164 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -158.42 162.04 37.55 Favored 'General case' 0 C--N 1.249 -3.787 0 CA-C-N 112.743 -2.026 . . . . 71.450000000000003 106.828 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.474 ' CE1' ' HA3' ' A' ' 43' ' ' GLY . 57.5 t80 -32.52 -55.03 0.34 Allowed 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 116.004 1.853 . . . . 53.200000000000003 116.004 -173.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.26 -28.13 69.52 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 113.669 0.988 . . . . 73.310000000000002 113.669 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -39.75 15.21 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.367 -1.346 . . . . 74.0 107.367 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 113' ' ' ILE . 11.9 m-20 -65.91 -46.51 78.02 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.603 -1.18 . . . . 74.019999999999996 108.629 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.428 HG13 HG22 ' A' ' 44' ' ' VAL . 16.2 tt -69.6 -25.86 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.536 -0.756 . . . . 73.209999999999994 110.504 -176.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -65.34 -49.92 67.56 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 107.025 -1.472 . . . . 60.340000000000003 107.025 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 3.4 t -63.29 -39.82 95.63 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.688 -1.142 . . . . 55.530000000000001 111.27 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 109' ' ' ASP . 41.4 mm -64.89 -46.91 90.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.048 -0.524 . . . . 74.019999999999996 111.368 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 92.6 t -69.99 -33.64 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 C-N-CA 120.184 -0.607 . . . . 73.310000000000002 110.173 -176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -66.4 -37.75 85.94 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.827 -0.624 . . . . 75.329999999999998 110.79 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.55 -41.03 80.36 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.064 0.459 . . . . 65.25 110.403 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.39 -45.7 95.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.671 -0.695 . . . . 71.409999999999997 109.186 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.6 -38.15 89.04 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 115.928 -0.578 . . . . 73.340000000000003 112.1 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -68.7 -40.21 80.13 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.602 -0.439 . . . . 72.310000000000002 110.632 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 42.8 t -59.22 -49.84 76.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.359 0.6 . . . . 62.219999999999999 109.433 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 10.5 mp -74.68 -14.84 60.79 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.603 -0.726 . . . . 74.129999999999995 112.427 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.26 -33.68 25.97 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 110.243 -0.28 . . . . 62.539999999999999 110.243 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.54 -34.84 46.89 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.311 0.577 . . . . 70.209999999999994 109.815 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.22 -136.35 51.03 Favored Glycine 0 CA--C 1.474 -2.521 0 CA-C-N 114.094 -1.412 . . . . 55.539999999999999 114.594 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.479 ' HB3' ' CD2' ' A' ' 13' ' ' HIS . 1.3 pm0 . . . . . 0 C--N 1.262 -3.225 0 N-CA-C 114.934 1.457 . . . . 71.5 114.934 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.436 ' SD ' ' HE1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.504 -0.793 0 CA-C-O 120.807 0.337 . . . . 70.129999999999995 111.189 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -110.27 164.28 12.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.669 0.747 . . . . 51.549999999999997 111.986 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 11.3 m-85 -120.04 140.28 51.23 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.527 -1.215 . . . . 74.319999999999993 111.152 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.649 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 28.7 t70 -101.08 102.58 13.57 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 104.855 -2.276 . . . . 63.049999999999997 104.855 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.78 117.76 32.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.325 -0.852 . . . . 73.239999999999995 109.442 -172.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.19 116.72 52.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.028 -1.101 . . . . 74.519999999999996 108.028 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.409 HD13 HD12 ' A' ' 113' ' ' ILE . 10.3 tt -118.69 120.75 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 121.396 0.617 . . . . 74.25 109.732 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.493 HG12 ' HB3' ' A' ' 26' ' ' PRO . 5.5 mt -112.49 100.8 51.14 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 115.543 -0.753 . . . . 65.439999999999998 108.98 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.603 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 1.4 Cg_endo -85.53 120.53 2.11 Favored 'Trans proline' 0 N--CA 1.436 -1.87 0 N-CA-C 107.769 -1.666 . . . . 75.409999999999997 107.769 171.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -144.61 129.7 18.56 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 120.922 0.391 . . . . 70.340000000000003 110.431 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.653 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 37.5 m -73.08 120.39 18.63 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.65 -0.5 . . . . 62.100000000000001 109.65 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.601 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 2.7 p90 -61.52 110.89 1.6 Allowed 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 113.967 1.099 . . . . 72.109999999999999 113.967 -174.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -143.84 106.26 4.41 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 114.854 -1.066 . . . . 65.049999999999997 110.114 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -68.84 122.24 18.2 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.878 -1.897 . . . . 74.310000000000002 105.878 173.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.48 103.69 0.55 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 124.585 1.178 . . . . 73.349999999999994 109.77 -172.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 17' ' ' LYS . 14.0 t70 -89.1 -158.15 0.49 Allowed 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 114.02 -1.445 . . . . 55.420000000000002 110.492 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.447 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 23.3 tptm -72.46 -45.34 59.99 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.741 0.816 . . . . 74.150000000000006 111.694 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -132.62 -51.46 0.92 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.584 0.707 . . . . 51.100000000000001 110.249 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -96.36 -177.83 4.09 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 114.489 -1.232 . . . . 63.43 110.612 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 86.9 mtp 70.75 80.13 0.17 Allowed 'General case' 0 C--N 1.313 -0.99 0 O-C-N 124.572 1.17 . . . . 32.149999999999999 109.977 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -168.05 121.24 0.89 Allowed 'General case' 0 N--CA 1.403 -2.792 0 N-CA-C 105.083 -2.192 . . . . 70.530000000000001 105.083 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.45 ' NE2' ' HB3' ' A' ' 123' ' ' LYS . 18.5 t60 -168.42 84.28 0.17 Allowed 'General case' 0 C--N 1.282 -2.34 0 O-C-N 124.57 1.169 . . . . 75.230000000000004 110.334 165.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.5 mm -103.17 136.05 37.72 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 N-CA-C 107.165 -1.42 . . . . 74.450000000000003 107.165 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 79.0 m -107.25 145.49 31.29 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 110.126 -0.324 . . . . 74.439999999999998 110.126 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 24' ' ' CYS . 52.5 Cg_exo -55.49 136.27 73.12 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 123.424 2.749 . . . . 71.340000000000003 112.873 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.493 ' HB3' HG12 ' A' ' 8' ' ' ILE . 74.5 Cg_endo -73.05 140.66 31.64 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.887 2.391 . . . . 63.340000000000003 112.394 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 99' ' ' ASN . 53.8 mtt -98.12 139.56 33.74 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-N 116.233 -0.44 . . . . 74.319999999999993 109.84 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.6 t -130.12 116.7 37.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 116.524 -0.307 . . . . 71.099999999999994 110.448 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.25 102.39 9.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 107.188 -1.412 . . . . 63.420000000000002 107.188 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.649 ' CA ' ' HA ' ' A' ' 4' ' ' ASP . . . -121.85 81.7 0.34 Allowed Glycine 0 N--CA 1.42 -2.372 0 C-N-CA 119.056 -1.545 . . . . 53.329999999999998 115.262 -175.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -153.64 15.82 0.51 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.24 -0.98 . . . . 71.329999999999998 110.803 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -102.07 136.43 41.91 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.745 -0.835 . . . . 72.430000000000007 108.745 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 p -74.05 168.31 19.78 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 106.595 -1.632 . . . . 73.129999999999995 106.595 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.562 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 73.9 t80 -61.62 -38.69 88.57 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 118.425 0.557 . . . . 41.130000000000003 110.735 -174.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -59.65 -49.26 78.44 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.486 -0.779 . . . . 71.129999999999995 111.209 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.1 mt -70.83 -38.74 73.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.647 -0.706 . . . . 72.5 109.308 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.401 ' HA ' HG22 ' A' ' 40' ' ' ILE . . . -65.94 -41.64 91.06 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.635 -0.711 . . . . 74.430000000000007 110.703 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 11.7 tpt -68.94 -40.83 78.73 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.839 -0.43 . . . . 52.329999999999998 109.839 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -74.21 -32.71 63.14 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 112.744 0.646 . . . . 70.109999999999999 112.744 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.557 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -74.68 -42.66 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.601 -0.889 . . . . 55.229999999999997 108.601 178.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.404 HG21 HD21 ' A' ' 86' ' ' LEU . 73.4 t -69.75 -38.78 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 120.956 -0.298 . . . . 71.109999999999999 110.7 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.549 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -73.96 -26.75 60.64 Favored 'General case' 0 C--O 1.201 -1.479 0 C-N-CA 119.8 -0.76 . . . . 73.409999999999997 110.474 177.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.407 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -66.2 -46.33 80.39 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.133 -1.187 . . . . 54.25 110.133 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 40' ' ' ILE . 96.2 t -58.24 -45.07 89.11 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 N-CA-C 108.523 -0.917 . . . . 71.319999999999993 108.523 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 8.3 t70 -50.07 -49.27 51.89 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.646 1.578 . . . . 74.209999999999994 111.457 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 42' ' ' ASN . 45.4 mtt180 -67.36 -36.64 81.79 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.906 -1.043 . . . . 75.239999999999995 109.717 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 43' ' ' GLY . 60.9 t -71.72 -38.85 67.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 123.358 0.411 . . . . 61.310000000000002 110.695 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.455 HG23 HD11 ' A' ' 73' ' ' LEU . 70.3 mt -63.99 -46.1 94.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 C-N-CA 122.471 0.308 . . . . 52.310000000000002 110.614 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -78.68 -14.35 59.34 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.83 -0.748 . . . . 65.420000000000002 110.819 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.5 -49.27 10.1 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.948 -0.569 . . . . 61.119999999999997 111.126 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -91.8 -16.17 27.18 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 113.222 0.823 . . . . 74.219999999999999 113.222 -171.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.416 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 9.6 m-85 -129.09 -177.26 4.15 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.583 0.706 . . . . 74.25 110.281 -175.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 26.2 t-20 -109.81 108.23 18.48 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 104.352 -2.462 . . . . 73.120000000000005 104.352 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.66 157.97 45.27 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 115.963 -0.562 . . . . 71.239999999999995 112.202 -172.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 t -129.01 120.02 25.29 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.6 -1.63 . . . . 75.129999999999995 106.6 171.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.9 p -100.62 124.04 53.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.233 0.54 . . . . 73.340000000000003 110.612 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -122.73 146.92 47.07 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.791 -0.818 . . . . 75.239999999999995 108.791 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -119.68 127.67 53.1 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.955 0.883 . . . . 73.409999999999997 111.791 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.29 176.78 5.3 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.14 -1.43 . . . . 72.400000000000006 107.14 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -111.99 136.84 50.81 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.681 -0.859 . . . . 71.219999999999999 108.681 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.565 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -84.17 176.69 51.77 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 115.828 -0.624 . . . . 54.549999999999997 112.874 -175.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -74.68 133.04 42.13 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 123.328 0.651 . . . . 74.530000000000001 111.84 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t70 46.31 -84.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 126.298 1.839 . . . . 72.329999999999998 114.973 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.5 p -97.49 -1.6 43.78 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 113.556 0.947 . . . . 75.530000000000001 113.556 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.565 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 13.4 m-20 -76.96 117.78 18.89 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.659 -1.608 . . . . 75.310000000000002 106.659 172.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.0 t -85.31 -31.3 6.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-O 121.264 0.554 . . . . 52.329999999999998 112.235 -173.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 63.2 tp -148.67 133.91 18.38 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 109.409 -0.589 . . . . 60.130000000000003 109.409 -176.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.462 ' CE2' ' HD3' ' A' ' 85' ' ' LYS . 1.1 t80 -129.91 105.44 7.99 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.261 -1.385 . . . . 75.329999999999998 107.261 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -107.69 125.38 51.3 Favored 'General case' 0 C--N 1.281 -2.396 0 C-N-CA 120.191 -0.604 . . . . 74.340000000000003 111.732 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -103.0 115.14 30.03 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 125.201 1.4 . . . . 64.019999999999996 108.476 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 75.3 m-85 -102.56 118.04 36.0 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.606 -0.516 . . . . 74.099999999999994 109.606 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.0 m -87.87 123.15 32.33 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.804 -1.184 . . . . 71.25 107.804 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.455 HD11 HG23 ' A' ' 48' ' ' ILE . 4.3 mm? -111.14 138.46 47.55 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.972 0.909 . . . . 64.310000000000002 111.985 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 2.0 tm-20 -151.16 83.0 1.32 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.887 -1.051 . . . . 74.519999999999996 108.899 170.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -87.9 70.55 9.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.848 -0.797 . . . . 44.039999999999999 108.848 178.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 45.55 71.53 0.27 Allowed 'General case' 0 C--O 1.244 0.783 0 C-N-CA 125.255 1.422 . . . . 72.319999999999993 111.542 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.15 -24.1 33.08 Favored Glycine 0 C--N 1.304 -1.226 0 CA-C-N 115.466 -0.788 . . . . 45.32 112.207 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 99.0 mttt -88.53 103.13 15.6 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.417 -0.957 . . . . 71.420000000000002 108.417 175.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -106.78 146.96 30.24 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 120.307 -0.557 . . . . 72.420000000000002 110.515 -175.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . 177.72 177.42 46.52 Favored Glycine 0 CA--C 1.48 -2.148 0 C-N-CA 120.202 -0.999 . . . . 60.530000000000001 112.528 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 32.2 mt -132.22 145.19 35.09 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 106.796 -1.557 . . . . 73.019999999999996 106.796 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 100.0 t -122.5 109.22 23.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 108.208 -1.034 . . . . 53.530000000000001 108.208 172.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -95.05 106.54 18.55 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 123.868 0.867 . . . . 74.200000000000003 110.381 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.3 t -107.96 112.48 40.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.028 -0.73 . . . . 71.109999999999999 109.028 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.462 ' HD3' ' CE2' ' A' ' 68' ' ' TYR . 58.0 pttt -116.66 135.08 54.08 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 120.906 0.384 . . . . 63.030000000000001 110.867 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.404 HD21 HG21 ' A' ' 41' ' ' VAL . 56.3 mt -106.27 105.69 15.84 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.255 -1.387 . . . . 70.319999999999993 107.255 -175.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 33.8 ttt85 -98.02 118.29 34.28 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.366 -0.605 . . . . 72.340000000000003 109.366 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -70.54 104.01 2.66 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.232 -0.655 . . . . 74.530000000000001 109.232 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.2 tt -78.44 111.26 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 CA-C-O 122.415 1.102 . . . . 52.240000000000002 108.989 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.4 t -138.77 -177.87 5.06 Favored 'General case' 0 N--CA 1.401 -2.903 0 N-CA-C 105.989 -1.856 . . . . 73.049999999999997 105.989 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -75.12 -21.74 58.67 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 118.799 0.727 . . . . 73.340000000000003 110.691 -173.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -96.74 11.37 35.8 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.592 -1.185 . . . . 73.109999999999999 109.686 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 41.3 t -139.92 116.46 8.16 Favored Pre-proline 0 C--N 1.319 -0.739 0 O-C-N 121.177 -0.952 . . . . 63.549999999999997 112.096 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -79.61 131.23 9.23 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.756 2.304 . . . . 71.030000000000001 110.876 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.14 164.15 36.18 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 123.108 2.538 . . . . 75.430000000000007 111.648 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.89 156.82 3.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.726 -0.842 . . . . 71.439999999999998 108.726 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -107.93 140.68 40.7 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.449 -0.945 . . . . 71.400000000000006 108.449 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.58 -171.29 40.12 Favored Glycine 0 CA--C 1.471 -2.67 0 N-CA-C 109.064 -1.614 . . . . 75.310000000000002 109.064 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 27' ' ' MET . 6.9 t-20 -63.63 103.78 0.58 Allowed 'General case' 0 N--CA 1.409 -2.486 0 C-N-CA 123.814 0.846 . . . . 65.010000000000005 110.018 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -89.32 103.08 15.74 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.141 -1.059 . . . . 72.230000000000004 108.141 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 42.6 t -71.19 175.2 5.49 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.054 -0.975 . . . . 72.219999999999999 111.136 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.9 p -60.72 110.3 1.27 Allowed 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.245 1.018 . . . . 61.109999999999999 110.949 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.22 139.12 17.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.884 -0.784 . . . . 64.310000000000002 108.884 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.586 ' HG ' ' H ' ' A' ' 105' ' ' GLU . 15.8 tp -178.72 -159.47 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 104.53 -2.396 . . . . 61.539999999999999 104.53 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.586 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 43.0 mt-10 -81.39 171.61 14.55 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 118.614 0.643 . . . . 75.120000000000005 111.259 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' O ' HG22 ' A' ' 110' ' ' ILE . 1.2 t80 -36.13 -48.5 0.62 Allowed 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 127.59 2.356 . . . . 64.299999999999997 113.351 -173.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.69 -28.5 68.67 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 123.85 0.86 . . . . 74.439999999999998 112.449 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.451 ' HA ' ' NE ' ' A' ' 108' ' ' ARG . 0.8 OUTLIER -87.38 -40.83 14.07 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.348 -0.541 . . . . 73.329999999999998 110.279 -178.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.592 ' O ' HG12 ' A' ' 113' ' ' ILE 0.328 18.5 p-10 -80.52 -26.01 38.37 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 119.377 -0.929 . . . . 61.140000000000001 112.211 -174.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 106' ' ' PHE . 8.6 tp -64.55 -38.97 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 109.457 -0.572 . . . . 74.430000000000007 109.457 173.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.41 -43.32 86.09 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.311 -0.626 . . . . 54.100000000000001 109.311 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 42.9 t -58.5 -44.32 89.4 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.816 -1.084 . . . . 74.120000000000005 111.612 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 109' ' ' ASP . 43.4 mm -65.25 -41.39 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 120.923 -0.311 . . . . 74.239999999999995 110.591 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 110' ' ' ILE . 86.0 t -63.87 -42.87 97.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.544 -0.539 . . . . 64.340000000000003 109.544 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -61.47 -41.77 97.75 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.875 -0.602 . . . . 55.200000000000003 111.534 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.63 97.35 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 123.422 0.451 . . . . 54.210000000000001 111.444 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.3 mt -67.89 -44.79 85.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.165 -0.68 . . . . 72.329999999999998 109.165 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.92 -33.97 77.3 Favored 'General case' 0 C--O 1.211 -0.928 0 CA-C-N 115.702 -0.681 . . . . 70.450000000000003 111.64 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -69.97 -43.36 71.65 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.331 0.586 . . . . 72.310000000000002 110.64 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 5.3 t -70.22 -41.54 73.48 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.402 0.62 . . . . 62.539999999999999 109.594 -176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.422 HD23 ' HB3' ' A' ' 78' ' ' LYS . 9.5 mp -78.13 -15.7 58.62 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.503 -0.771 . . . . 74.200000000000003 111.77 -177.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.41 -38.25 22.17 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 121.034 -0.266 . . . . 51.100000000000001 111.031 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB3' ' NE2' ' A' ' 22' ' ' HIS . 23.1 tptm -62.79 -47.52 83.14 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.264 0.554 . . . . 64.340000000000003 110.103 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.64 -164.21 53.05 Favored Glycine 0 C--N 1.286 -2.229 0 CA-C-N 114.326 -1.306 . . . . 73.140000000000001 114.341 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.246 0.907 0 C-N-CA 124.057 0.943 . . . . 72.420000000000002 110.258 -179.455 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.434 ' HE2' ' HB3' ' A' ' 1' ' ' MET . 62.0 mmm . . . . . 0 CA--C 1.494 -1.211 0 N-CA-C 111.965 0.357 . . . . 75.200000000000003 111.965 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -101.71 141.38 34.66 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.26 -1.015 . . . . 71.219999999999999 108.26 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 56.0 m-85 -118.06 142.79 47.03 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.64 -0.504 . . . . 63.219999999999999 109.64 174.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.627 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 32.0 t70 -104.31 115.58 30.64 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 124.475 1.11 . . . . 73.239999999999995 109.627 -172.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.82 117.32 48.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.917 -0.489 . . . . 45.530000000000001 109.861 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.506 HG23 HG22 ' A' ' 28' ' ' VAL . 7.3 p -111.52 124.27 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-O 121.357 0.599 . . . . 74.109999999999999 109.409 176.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 27' ' ' MET . 7.1 tt -123.41 118.27 53.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-O 121.556 0.693 . . . . 74.120000000000005 111.062 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.484 HG12 ' HB3' ' A' ' 26' ' ' PRO . 61.9 mt -106.61 111.77 63.86 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 115.267 -0.878 . . . . 71.030000000000001 109.838 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.509 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 3.3 Cg_endo -87.34 123.79 1.94 Allowed 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.029 1.819 . . . . 72.219999999999999 109.205 171.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -142.74 119.35 11.07 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.484 0.659 . . . . 72.200000000000003 111.076 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 22' ' ' HIS . 49.4 m -77.36 116.65 18.14 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.233 -0.44 . . . . 70.209999999999994 110.298 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.689 ' CE1' ' HB2' ' A' ' 79' ' ' LYS . 1.8 p90 -65.46 123.99 21.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.65 0.738 . . . . 75.219999999999999 112.035 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 39.4 m80 -139.71 146.39 39.54 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.951 -1.022 . . . . 73.439999999999998 110.299 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -82.13 104.89 12.79 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-O 122.443 1.116 . . . . 72.409999999999997 109.927 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -67.47 100.7 0.88 Allowed 'General case' 0 N--CA 1.398 -3.036 0 CA-C-N 113.201 -1.818 . . . . 61.329999999999998 109.165 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -87.31 -94.48 0.09 Allowed 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.474 -0.785 . . . . 72.129999999999995 111.885 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 1.8 tmtp? -112.77 -57.8 2.24 Favored 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 119.32 -0.952 . . . . 73.349999999999994 112.729 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -121.98 -26.53 4.76 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 118.975 -1.09 . . . . 62.340000000000003 112.901 -169.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -137.34 169.9 17.0 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.333 -0.617 . . . . 74.5 109.333 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.435 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 64.2 mtm 82.19 70.85 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 126.159 1.783 . . . . 44.439999999999998 111.226 -176.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -161.76 96.33 1.02 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 105.046 -2.205 . . . . 74.25 105.046 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 11' ' ' SER . 39.1 t60 -114.15 89.91 3.21 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 119.24 -0.984 . . . . 73.299999999999997 112.041 -171.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mm -100.99 131.12 49.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 106.529 -1.656 . . . . 71.129999999999995 106.529 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 71.4 m -107.68 130.34 22.95 Favored Pre-proline 0 C--N 1.292 -1.918 0 C-N-CA 119.927 -0.709 . . . . 72.129999999999995 109.099 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -42.62 134.43 5.04 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 124.037 3.158 . . . . 43.509999999999998 113.915 -177.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HB3' HG12 ' A' ' 8' ' ' ILE . 15.7 Cg_endo -59.29 136.77 74.46 Favored 'Trans proline' 0 C--O 1.256 1.393 0 C-N-CA 123.477 2.785 . . . . 75.409999999999997 114.073 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.534 ' HB2' HG23 ' A' ' 7' ' ' ILE . 24.8 mmt -96.52 131.45 43.11 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 105.401 -2.074 . . . . 73.420000000000002 105.401 172.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 6' ' ' VAL . 29.6 t -126.17 129.58 72.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 120.228 -0.589 . . . . 65.239999999999995 110.256 -175.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.3 mm -136.04 101.19 2.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 106.985 -1.487 . . . . 54.409999999999997 106.985 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.627 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -120.01 82.42 0.34 Allowed Glycine 0 CA--C 1.488 -1.604 0 C-N-CA 120.078 -1.058 . . . . 63.119999999999997 112.783 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -158.74 26.21 0.22 Allowed 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.982 -0.609 . . . . 75.209999999999994 111.46 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.56 HH22 HG12 ' A' ' 103' ' ' VAL . 21.3 mmt85 -118.04 141.97 47.9 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 107.828 -1.175 . . . . 74.230000000000004 107.828 -174.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.8 p -75.86 172.6 12.42 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 118.842 0.746 . . . . 73.120000000000005 109.481 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.532 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 60.1 t80 -55.19 -47.53 75.12 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.35 0.595 . . . . 65.049999999999997 112.139 -174.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.02 -40.01 78.9 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.343 -0.844 . . . . 63.329999999999998 111.197 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.72 -33.33 43.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.248 -0.433 . . . . 65.329999999999998 110.218 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.417 ' O ' HG22 ' A' ' 40' ' ' ILE . . . -65.28 -44.8 86.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.408 -0.36 . . . . 73.120000000000005 110.59 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.6 mtm -73.08 -33.34 65.57 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 118.912 -1.115 . . . . 74.209999999999994 111.06 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.11 -44.0 85.57 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.069 -0.514 . . . . 60.030000000000001 110.415 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 37' ' ' ALA . 8.5 tp -65.46 -38.92 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 109.807 -0.442 . . . . 71.219999999999999 109.807 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.448 HG21 HD21 ' A' ' 86' ' ' LEU . 96.8 t -69.29 -39.94 79.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 CA-C-N 116.213 -0.449 . . . . 65.209999999999994 110.196 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -67.84 -28.25 67.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.127 0.489 . . . . 72.019999999999996 110.183 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.43 -47.36 63.42 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.296 -1.121 . . . . 71.409999999999997 110.296 175.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 40' ' ' ILE . 92.9 t -62.7 -41.96 94.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.452 -0.573 . . . . 74.430000000000007 109.452 177.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -53.38 -53.05 56.71 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 125.265 1.426 . . . . 72.310000000000002 110.565 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.42 ' HA ' ' CD ' ' A' ' 49' ' ' LYS . 61.9 mtm180 -71.1 -23.77 62.17 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.511 -0.768 . . . . 75.219999999999999 112.523 -175.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 43' ' ' GLY . 94.3 t -78.2 -44.87 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 C-N-CA 120.522 -0.471 . . . . 70.239999999999995 110.47 175.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.429 HG22 ' HB2' ' A' ' 54' ' ' ALA . 54.9 mt -73.17 -33.77 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 120.537 -0.465 . . . . 72.439999999999998 111.456 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 13.3 ptmt -74.4 -16.22 60.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.391 0.615 . . . . 61.149999999999999 110.455 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.7 -49.79 5.21 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 115.318 -0.856 . . . . 64.209999999999994 111.081 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 t -77.07 -22.53 52.7 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 123.528 0.731 . . . . 64.319999999999993 112.649 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -127.7 -172.75 2.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.608 0.718 . . . . 64.140000000000001 110.8 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 18.6 t-20 -105.21 89.68 3.2 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 104.326 -2.472 . . . . 74.430000000000007 104.326 172.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' A' ' 49' ' ' LYS . . . -108.13 135.89 48.72 Favored 'General case' 0 N--CA 1.407 -2.599 0 CA-C-N 115.169 -0.923 . . . . 72.349999999999994 112.029 -172.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.5 m -115.6 110.73 19.62 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 106.171 -1.789 . . . . 54.149999999999999 106.171 172.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.85 118.72 46.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.54 -0.541 . . . . 72.019999999999996 109.54 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.56 ' HG3' ' HB2' ' A' ' 70' ' ' LYS . 9.2 pt-20 -120.88 122.32 40.0 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.123 -0.695 . . . . 73.430000000000007 109.123 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.449 ' HG2' ' HG2' ' A' ' 69' ' ' ARG . 42.7 mt-10 -95.28 130.44 42.04 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.814 -0.63 . . . . 75.140000000000001 111.37 -175.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.2 mp -125.52 176.5 6.8 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.437 -0.801 . . . . 72.209999999999994 109.324 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -105.27 139.14 40.36 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-O 121.198 0.523 . . . . 72.120000000000005 109.846 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.26 176.44 41.96 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 110.514 -1.034 . . . . 52.229999999999997 110.514 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.518 ' N ' ' HB2' ' A' ' 65' ' ' ASP . 26.7 mm-40 -65.51 -176.17 0.32 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 122.102 0.953 . . . . 65.010000000000005 111.67 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.69 -34.93 78.94 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.688 -1.142 . . . . 63.350000000000001 110.084 172.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.9 t -77.1 -22.06 53.31 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.591 -1.186 . . . . 62.539999999999999 108.997 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.518 ' HB2' ' N ' ' A' ' 62' ' ' GLU . 67.3 m-20 -93.53 172.46 8.25 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 109.024 -0.732 . . . . 74.319999999999993 109.024 177.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.1 t -117.7 -43.27 2.97 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 CA-C-O 121.513 0.673 . . . . 74.430000000000007 110.382 174.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.1 tp -157.34 149.1 22.28 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.73 -0.668 . . . . 65.230000000000004 109.724 -172.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.26 135.36 47.27 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.595 -0.891 . . . . 75.200000000000003 108.595 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.449 ' HG2' ' HG2' ' A' ' 58' ' ' GLU . 88.6 mtt180 -132.27 129.42 39.57 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.227 -0.296 . . . . 75.129999999999995 110.76 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.56 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . 6.4 mtpm? -105.55 116.56 32.15 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 105.615 -1.995 . . . . 73.430000000000007 105.615 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.425 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 71.6 m-85 -101.54 106.08 17.13 Favored 'General case' 0 C--N 1.263 -3.184 0 N-CA-C 107.678 -1.23 . . . . 74.120000000000005 107.678 174.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.3 m -91.93 112.44 24.37 Favored 'General case' 0 C--N 1.276 -2.628 0 N-CA-C 107.672 -1.233 . . . . 65.219999999999999 107.672 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.83 149.39 37.13 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.286 0.565 . . . . 65.340000000000003 111.023 -173.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 42.7 tt0 -150.25 98.26 2.65 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.991 -1.004 . . . . 74.439999999999998 109.8 168.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -105.91 88.66 2.86 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 115.872 -0.604 . . . . 65.239999999999995 109.674 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.295 5.7 pt-20 36.74 74.29 0.08 Allowed 'General case' 0 C--O 1.243 0.749 0 C-N-CA 125.825 1.65 . . . . 70.239999999999995 114.974 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.37 -23.91 34.37 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 113.604 -1.635 . . . . 71.219999999999999 112.47 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 57.9 mtmt -95.12 94.74 8.11 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 122.368 -0.489 . . . . 75.329999999999998 109.701 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.689 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 2.3 ptpp? -113.54 124.0 51.34 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.242 -0.89 . . . . 73.129999999999995 111.211 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.416 ' HA2' ' H ' ' A' ' 12' ' ' PHE . . . -173.04 172.49 45.16 Favored Glycine 0 CA--C 1.491 -1.411 0 C-N-CA 120.967 -0.635 . . . . 61.130000000000003 112.0 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.9 mt -121.65 145.99 27.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.552 -0.907 . . . . 61.350000000000001 108.552 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 95.6 t -119.94 110.34 28.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 108.512 -0.921 . . . . 63.420000000000002 108.512 174.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.518 ' CD2' ' HG2' ' A' ' 70' ' ' LYS . 33.0 m170 -94.94 107.85 19.89 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.816 -0.629 . . . . 73.230000000000004 110.196 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.14 118.49 53.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 115.792 -0.64 . . . . 74.0 109.565 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -111.82 142.39 44.25 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.203 -0.666 . . . . 65.430000000000007 109.203 173.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.448 HD21 HG21 ' A' ' 41' ' ' VAL . 92.5 mt -107.37 123.94 49.1 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 103.549 -2.759 . . . . 51.210000000000001 103.549 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 41.6 mtp-105 -112.84 155.92 23.81 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 109.267 -0.642 . . . . 74.25 109.267 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -98.06 105.49 17.64 Favored 'General case' 0 C--N 1.282 -2.346 0 C-N-CA 120.327 -0.549 . . . . 64.329999999999998 110.485 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 tt -82.81 110.17 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 107.749 -1.204 . . . . 71.109999999999999 107.749 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 m -145.85 -175.39 4.72 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 105.045 -2.206 . . . . 62.530000000000001 105.045 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -15.9 63.04 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 120.087 1.312 . . . . 71.329999999999998 110.458 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.07 -23.95 38.12 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.949 -1.023 . . . . 71.109999999999999 111.803 175.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 40.8 m -145.35 117.61 5.23 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 112.472 0.545 . . . . 64.439999999999998 112.472 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 93' ' ' CYS . 2.7 Cg_exo -73.59 158.49 47.4 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 122.622 2.215 . . . . 64.310000000000002 110.499 175.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.3 160.37 49.03 Favored 'Trans proline' 0 C--O 1.255 1.337 0 C-N-CA 122.789 2.326 . . . . 64.140000000000001 110.65 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 t -82.93 149.46 4.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 107.24 -1.393 . . . . 53.509999999999998 107.24 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -112.38 112.81 24.65 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 106.75 -1.574 . . . . 70.209999999999994 106.75 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -151.51 -157.62 7.97 Favored Glycine 0 CA--C 1.461 -3.309 0 C-N-CA 120.165 -1.017 . . . . 62.439999999999998 112.018 -174.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' A' ' 27' ' ' MET . 35.5 m-80 -76.58 104.23 6.98 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.798 -0.816 . . . . 65.25 108.798 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -83.11 112.32 19.7 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-O 121.651 0.739 . . . . 75.349999999999994 109.387 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.488 ' HB3' HG23 ' A' ' 103' ' ' VAL . 4.8 t -70.29 153.02 43.53 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.914 -1.513 . . . . 74.540000000000006 106.914 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.424 ' N ' ' SG ' ' A' ' 112' ' ' CYS . 15.5 m -69.84 77.63 0.46 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.426 1.107 . . . . 73.129999999999995 109.906 178.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.56 HG12 HH22 ' A' ' 32' ' ' ARG . 76.9 t -124.57 149.45 28.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 C-N-CA 125.429 1.491 . . . . 75.040000000000006 108.635 -173.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.2 mt -161.15 -82.61 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 125.625 1.57 . . . . 74.519999999999996 109.296 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -98.4 150.37 21.68 Favored 'General case' 0 C--N 1.262 -3.197 0 CA-C-N 114.109 -1.405 . . . . 75.340000000000003 108.948 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.518 ' HA ' ' HB3' ' A' ' 109' ' ' ASP . 74.6 t80 -46.34 -44.05 16.52 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.365 1.246 . . . . 70.219999999999999 114.365 -172.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -62.55 -35.61 79.99 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 112.587 0.588 . . . . 72.319999999999993 112.587 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -90.82 -30.7 16.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.441 0.639 . . . . 72.010000000000005 109.571 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.518 ' HB3' ' HA ' ' A' ' 106' ' ' PHE . 7.9 t0 -55.74 -55.15 35.7 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 125.731 1.613 . . . . 65.540000000000006 109.642 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.6 tp -59.78 -38.04 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 O-C-N 123.966 0.792 . . . . 63.049999999999997 110.865 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 40.3 mt-10 -69.5 -38.46 77.62 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 120.479 -0.488 . . . . 71.310000000000002 111.492 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 102' ' ' SER . 10.0 t -65.91 -40.77 91.78 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.0 -0.68 . . . . 44.229999999999997 109.36 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 117' ' ' ILE . 49.4 mm -64.41 -46.54 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 115.521 -0.763 . . . . 72.239999999999995 110.223 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 72.7 t -63.91 -41.88 93.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.52 -0.309 . . . . 64.030000000000001 110.732 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 111' ' ' GLU . 29.4 mtpp -67.19 -30.33 70.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 111.7 0.259 . . . . 75.230000000000004 111.7 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.37 -40.8 67.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.018 0.437 . . . . 53.329999999999998 110.298 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.57 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 83.0 mt -66.05 -45.78 89.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.137 -0.69 . . . . 73.409999999999997 109.137 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -57.57 -42.32 82.84 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.842 -0.617 . . . . 74.549999999999997 111.576 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -65.9 -41.9 90.91 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.539 -0.755 . . . . 74.400000000000006 110.288 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 15.1 t -70.17 -39.68 75.13 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.826 -0.435 . . . . 55.210000000000001 109.826 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 117' ' ' ILE . 61.4 mt -72.76 -37.39 67.68 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 116.423 -0.353 . . . . 73.420000000000002 111.359 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.89 -14.22 51.62 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 112.565 0.58 . . . . 61.340000000000003 112.565 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -66.63 -21.62 66.12 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.288 0.566 . . . . 74.439999999999998 112.432 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.88 -161.54 47.81 Favored Glycine 0 C--N 1.296 -1.681 0 CA-C-N 115.617 -0.72 . . . . 53.200000000000003 114.894 173.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 C--N 1.318 -0.799 0 CA-C-O 122.79 1.281 . . . . 65.099999999999994 112.498 -178.403 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.474 0 N-CA-C 106.803 -1.554 . . . . 73.239999999999995 106.803 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -138.63 163.24 32.6 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.433 0.635 . . . . 74.430000000000007 112.173 -172.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 46.2 m-85 -119.7 145.29 46.65 Favored 'General case' 0 C--O 1.251 1.144 0 C-N-CA 124.266 1.026 . . . . 74.409999999999997 110.616 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.604 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 30.6 t70 -115.44 111.23 20.47 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 125.542 1.537 . . . . 63.32 107.204 -175.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 p -96.65 127.87 48.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 122.119 -0.363 . . . . 65.340000000000003 110.916 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.577 HG23 HG22 ' A' ' 28' ' ' VAL . 4.8 p -117.9 127.48 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 115.923 -0.58 . . . . 60.310000000000002 111.177 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.429 HG23 ' HB2' ' A' ' 27' ' ' MET . 3.2 tt -115.62 112.86 41.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.473 -0.785 . . . . 72.409999999999997 109.698 176.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.436 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 3.3 mp -98.92 109.2 52.93 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 108.247 -1.02 . . . . 41.340000000000003 108.247 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 17.7 Cg_endo -93.9 138.6 1.27 Allowed 'Trans proline' 0 N--CA 1.436 -1.895 0 C-N-CA 122.193 1.928 . . . . 64.439999999999998 110.684 173.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -159.13 130.61 6.29 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 110.189 -0.3 . . . . 50.130000000000003 110.189 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.526 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.3 m -69.82 121.37 17.14 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.001 -0.74 . . . . 72.150000000000006 109.001 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.561 ' CE1' ' HD3' ' A' ' 79' ' ' LYS . 21.3 p90 -70.01 101.58 1.83 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 112.529 0.566 . . . . 64.239999999999995 112.529 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.482 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 54.4 m80 -146.65 151.34 37.08 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.991 -0.549 . . . . 74.099999999999994 111.77 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -80.41 119.44 23.11 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 106.905 -1.517 . . . . 73.230000000000004 106.905 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -62.04 104.41 0.46 Allowed 'General case' 0 N--CA 1.406 -2.654 0 O-C-N 124.527 1.142 . . . . 72.420000000000002 109.383 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -87.22 -155.02 0.26 Allowed 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 113.957 -1.474 . . . . 54.340000000000003 108.668 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -81.56 -56.88 3.74 Favored 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 121.45 -0.781 . . . . 74.400000000000006 112.412 -175.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -136.12 15.01 3.28 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.824 0.821 . . . . 63.119999999999997 110.207 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -148.57 157.34 43.4 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.919 -1.141 . . . . 65.120000000000005 107.919 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.482 ' CG ' ' HB3' ' A' ' 13' ' ' HIS . 41.4 ttp 63.53 62.31 0.95 Allowed 'General case' 0 C--N 1.348 0.519 0 CA-C-O 122.848 1.308 . . . . 62.009999999999998 109.658 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -148.3 96.05 2.55 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.688 -1.596 . . . . 62.149999999999999 107.562 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.485 ' CD2' ' HA2' ' A' ' 124' ' ' GLY . 41.6 t60 -141.84 113.67 7.93 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.994 -1.083 . . . . 62.409999999999997 110.925 175.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.1 mm -126.93 126.91 69.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 106.394 -1.706 . . . . 73.450000000000003 106.394 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 46.6 m -107.68 149.85 39.46 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 112.264 0.468 . . . . 64.049999999999997 112.264 -171.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 33.3 Cg_endo -65.3 129.74 23.55 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.27 2.647 . . . . 75.25 112.367 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 20.1 Cg_exo -68.26 133.35 28.24 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.35 2.033 . . . . 75.120000000000005 112.199 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.429 ' HB2' HG23 ' A' ' 7' ' ' ILE . 25.0 mmt -86.96 131.32 34.13 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.67 -1.604 . . . . 74.219999999999999 106.67 174.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.577 HG22 HG23 ' A' ' 6' ' ' VAL . 19.0 t -127.64 127.91 69.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 109.503 -0.554 . . . . 62.539999999999999 109.503 -177.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.8 mm -126.65 114.4 37.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.561 -0.903 . . . . 74.439999999999998 108.561 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -127.87 82.14 0.34 Allowed Glycine 0 CA--C 1.48 -2.144 0 C-N-CA 119.06 -1.543 . . . . 50.210000000000001 114.531 -175.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -156.92 21.94 0.32 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.327 -0.936 . . . . 72.420000000000002 109.545 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.437 HH11 HD12 ' A' ' 40' ' ' ILE . 1.1 mmp_? -95.51 146.43 24.44 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.132 -1.433 . . . . 64.230000000000004 107.132 -172.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 p -85.07 175.6 8.92 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 105.947 -1.871 . . . . 72.299999999999997 105.947 168.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.491 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 76.8 t80 -60.41 -41.94 94.96 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 118.699 0.681 . . . . 72.120000000000005 110.695 -176.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -67.85 -41.58 82.72 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.48 -1.236 . . . . 63.340000000000003 111.197 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mm -74.01 -29.85 26.43 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 N-CA-C 109.613 -0.514 . . . . 71.150000000000006 109.613 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.407 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -63.42 -45.2 92.06 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.87 -0.605 . . . . 44.039999999999999 109.991 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.1 mmt -67.79 -39.46 84.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.225 -0.443 . . . . 73.420000000000002 110.713 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -69.43 -34.65 74.75 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.957 1.095 . . . . 65.109999999999999 113.957 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.52 ' O ' HG23 ' A' ' 44' ' ' VAL . 13.9 tt -70.46 -41.75 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 119.125 -1.03 . . . . 73.349999999999994 109.665 176.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 82.5 t -62.37 -44.1 98.85 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.369 0 N-CA-C 109.41 -0.589 . . . . 73.430000000000007 109.41 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -58.32 -41.84 85.42 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 123.119 0.568 . . . . 73.239999999999995 110.993 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.22 -43.55 92.79 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.62 -0.8 . . . . 74.25 111.401 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 40' ' ' ILE . 97.4 t -65.84 -41.32 89.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.31 -0.626 . . . . 71.010000000000005 109.31 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.93 -46.34 85.18 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 125.298 1.439 . . . . 63.310000000000002 110.717 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -64.8 -44.16 90.84 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.549 -1.205 . . . . 72.400000000000006 110.644 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.9 t -66.87 -38.95 82.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 116.266 -0.425 . . . . 65.340000000000003 110.759 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.487 HG23 HD11 ' A' ' 73' ' ' LEU . 66.1 mt -68.79 -41.87 82.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 121.029 -0.268 . . . . 74.319999999999993 111.675 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -80.39 -17.8 50.81 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 118.749 -1.18 . . . . 65.450000000000003 110.993 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.63 -43.02 8.48 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 112.371 0.508 . . . . 65.430000000000007 112.371 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.3 m -83.27 -16.13 47.52 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 112.801 0.667 . . . . 43.020000000000003 112.801 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -138.13 -174.49 3.81 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.097 0.475 . . . . 71.129999999999995 110.351 -174.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -103.78 105.86 16.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.014 -1.847 . . . . 74.450000000000003 106.014 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.67 136.4 40.9 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 112.948 0.722 . . . . 72.239999999999995 112.948 -174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -100.49 115.52 30.27 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.329 -1.73 . . . . 74.230000000000004 106.329 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 p -100.98 123.07 53.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.26 0.552 . . . . 64.329999999999998 111.437 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -130.67 119.75 22.88 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.107 -0.497 . . . . 72.439999999999998 110.772 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -82.51 137.41 34.63 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.014 -0.539 . . . . 61.340000000000003 110.173 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.4 mt -134.25 171.83 13.71 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.661 -0.866 . . . . 74.209999999999994 108.661 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -99.35 162.04 13.27 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.499 -0.556 . . . . 74.319999999999993 109.499 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.75 177.48 16.43 Favored Glycine 0 C--N 1.278 -2.681 0 N-CA-C 109.292 -1.523 . . . . 52.009999999999998 109.292 178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.509 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 12.8 pt-20 -65.84 179.48 0.87 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.437 -0.579 . . . . 72.140000000000001 109.437 175.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.04 -27.56 69.19 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 122.09 0.948 . . . . 73.530000000000001 111.474 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.8 t -77.42 -16.66 58.7 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.703 -1.135 . . . . 70.430000000000007 109.869 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.509 ' OD2' ' HG2' ' A' ' 62' ' ' GLU . 78.2 m-20 -101.24 157.72 16.57 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 108.436 -0.949 . . . . 74.209999999999994 108.436 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.471 HG21 ' CE2' ' A' ' 3' ' ' TYR . 36.9 t -104.56 -44.2 8.57 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-O 121.579 0.704 . . . . 73.409999999999997 110.314 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.1 tp -163.0 153.08 15.99 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.826 -1.176 . . . . 53.299999999999997 107.826 -174.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -130.08 128.34 41.69 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 106.873 -1.529 . . . . 75.450000000000003 106.873 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -123.43 108.51 12.77 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 107.351 -1.352 . . . . 73.530000000000001 107.351 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.439 ' HE3' ' HB3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -109.99 117.7 34.47 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.105 0.478 . . . . 71.140000000000001 110.218 -175.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -107.44 132.98 52.61 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.248 -0.649 . . . . 74.299999999999997 109.248 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.7 m -97.75 113.39 25.16 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 107.087 -1.449 . . . . 65.329999999999998 107.087 171.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.487 HD11 HG23 ' A' ' 48' ' ' ILE . 4.1 mm? -98.18 139.19 34.34 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 124.306 1.042 . . . . 73.329999999999998 113.51 -173.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -140.41 139.41 35.26 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-N 113.87 -1.514 . . . . 73.150000000000006 107.057 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -132.68 176.52 8.38 Favored 'General case' 0 C--N 1.263 -3.185 0 N-CA-C 102.686 -3.079 . . . . 75.25 102.686 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.3 0.0 OUTLIER -62.86 90.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 115.112 1.523 . . . . 73.329999999999998 115.112 -177.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.26 2.19 77.55 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 114.709 -1.132 . . . . 72.510000000000005 112.8 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 55.3 mttp -130.22 143.38 50.75 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.753 -0.832 . . . . 72.030000000000001 108.753 -174.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.561 ' HD3' ' CE1' ' A' ' 12' ' ' PHE . 14.8 ptpt -151.69 156.2 39.86 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 112.737 0.643 . . . . 62.439999999999998 112.737 -169.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -177.65 170.68 43.17 Favored Glycine 0 C--O 1.2 -2.004 0 CA-C-N 115.372 -0.831 . . . . 73.109999999999999 111.383 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.9 mt -115.75 138.14 47.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 107.684 -1.228 . . . . 74.329999999999998 107.684 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.6 t -115.99 110.37 31.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 109.003 -0.74 . . . . 70.200000000000003 109.003 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 31.2 m-70 -100.73 103.97 15.23 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.484 -0.78 . . . . 75.120000000000005 109.044 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.6 t -109.6 109.75 29.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.268 -0.641 . . . . 71.310000000000002 109.268 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -122.72 149.69 43.74 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 119.488 -0.885 . . . . 75.120000000000005 110.418 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.407 HD22 ' HB1' ' A' ' 37' ' ' ALA . 92.7 mt -99.16 126.54 44.95 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 107.736 -1.209 . . . . 75.049999999999997 107.736 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.5 ttt85 -115.95 134.52 54.89 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 108.273 -1.01 . . . . 75.219999999999999 108.273 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.501 ' HG2' HG23 ' A' ' 90' ' ' THR . 38.4 ttmt -81.06 98.3 7.92 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 116.295 -0.412 . . . . 73.109999999999999 111.482 -176.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.6 tt -75.04 111.4 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 122.235 1.017 . . . . 62.119999999999997 108.825 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.501 HG23 ' HG2' ' A' ' 88' ' ' LYS . 4.5 p -145.15 -171.21 3.61 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-N 114.943 -1.026 . . . . 64.219999999999999 108.941 -172.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -78.79 -4.55 49.97 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.967 0.889 . . . . 72.340000000000003 109.279 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -98.8 -23.34 15.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.312 -0.858 . . . . 70.099999999999994 109.607 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 96.9 m -138.46 118.05 9.71 Favored Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 112.145 0.424 . . . . 52.130000000000003 112.145 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.58 157.48 36.15 Favored 'Trans proline' 0 C--O 1.25 1.119 0 C-N-CA 122.037 1.825 . . . . 75.109999999999999 109.651 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.97 160.7 32.55 Favored 'Trans proline' 0 C--O 1.255 1.329 0 C-N-CA 123.074 2.516 . . . . 73.340000000000003 112.502 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 t -81.2 144.71 10.02 Favored 'Isoleucine or valine' 0 C--O 1.252 1.201 0 N-CA-C 108.493 -0.928 . . . . 74.150000000000006 108.493 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -97.24 85.89 3.79 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 121.953 0.882 . . . . 74.329999999999998 110.809 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -129.37 -158.61 9.59 Favored Glycine 0 N--CA 1.412 -2.959 0 N-CA-C 109.362 -1.495 . . . . 70.219999999999999 109.362 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.91 98.43 7.88 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 108.274 -1.01 . . . . 52.140000000000001 108.274 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 64.2 mtp85 -86.63 93.63 9.26 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 108.064 -1.087 . . . . 75.519999999999996 108.064 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 19.3 t -72.51 168.38 18.67 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 113.854 -1.521 . . . . 44.409999999999997 113.144 -170.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.4 m -73.53 105.9 5.08 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 124.726 1.21 . . . . 73.030000000000001 111.028 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.9 t -84.89 155.03 3.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.799 -1.092 . . . . 65.230000000000004 108.866 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.5 tp -150.35 -68.59 0.19 Allowed 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.686 1.231 . . . . 70.439999999999998 109.177 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.32 165.61 35.34 Favored 'General case' 1 C--N 1.237 -4.297 0 N-CA-C 103.224 -2.88 . . . . 55.43 103.224 178.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' O ' HG22 ' A' ' 110' ' ' ILE . 91.6 t80 -45.98 -36.39 5.52 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.781 1.03 . . . . 74.109999999999999 113.781 -173.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -58.12 -40.45 81.25 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 113.341 0.867 . . . . 73.420000000000002 113.341 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -88.2 -30.41 19.76 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 119.929 -0.708 . . . . 71.109999999999999 109.337 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.44 -47.02 83.6 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.932 -1.031 . . . . 70.25 109.379 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 106' ' ' PHE . 10.3 tp -69.0 -31.71 51.55 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 CA-C-N 116.14 -0.482 . . . . 74.329999999999998 109.826 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -63.81 -41.86 97.79 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.699 -0.482 . . . . 75.420000000000002 109.699 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 53.6 t -70.2 -40.22 74.72 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.001 -0.545 . . . . 45.43 110.178 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.07 -45.18 99.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.81 -0.632 . . . . 62.420000000000002 111.379 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.27 -41.76 92.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.618 0.247 . . . . 61.350000000000001 110.37 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -69.73 -23.79 63.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.464 0.542 . . . . 72.329999999999998 112.464 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.62 -43.94 58.32 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.972 -0.381 . . . . 74.209999999999994 109.972 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.15 -45.45 98.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.359 -0.608 . . . . 75.329999999999998 109.359 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -61.74 -38.23 87.19 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 116.059 -0.519 . . . . 74.329999999999998 111.541 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -64.11 -46.43 84.2 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 108.989 -0.745 . . . . 73.120000000000005 108.989 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 5.6 t -70.69 -29.88 66.3 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.387 -0.824 . . . . 55.420000000000002 111.25 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.29 -37.27 28.71 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.58 -0.7 . . . . 65.450000000000003 111.421 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . . . -76.78 -36.01 57.29 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 111.956 0.354 . . . . 52.210000000000001 111.956 -177.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -99.53 9.94 42.29 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 110.014 -0.365 . . . . 65.129999999999995 110.014 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.485 ' HA2' ' CD2' ' A' ' 22' ' ' HIS . . . -71.7 33.37 0.59 Allowed Glycine 0 C--N 1.334 0.469 0 N-CA-C 117.304 1.682 . . . . 60.109999999999999 117.304 -171.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.268 -2.96 0 N-CA-C 106.365 -1.717 . . . . 72.519999999999996 106.365 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.635 0 N-CA-C 105.66 -1.978 . . . . 74.25 105.66 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.01 139.07 32.05 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.327 0.584 . . . . 71.209999999999994 112.055 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.654 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 62.9 m-85 -125.93 137.07 53.68 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.001 -1.0 . . . . 74.25 109.333 176.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.481 ' OD1' ' HB ' ' A' ' 89' ' ' ILE . 4.9 m-20 -101.83 122.1 43.34 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.477 -0.783 . . . . 73.510000000000005 108.898 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 p -95.53 109.14 22.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 108.339 -0.986 . . . . 64.120000000000005 108.339 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 28' ' ' VAL . 61.0 t -102.96 106.28 19.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.921 -1.14 . . . . 70.129999999999995 107.921 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -105.67 118.48 53.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 CA-C-N 115.577 -0.738 . . . . 71.140000000000001 109.858 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.401 HG13 ' HB3' ' A' ' 26' ' ' PRO . 3.5 mp -106.18 108.18 61.22 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 107.927 -1.138 . . . . 74.120000000000005 107.927 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.648 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 28.5 Cg_endo -99.84 120.33 0.11 Allowed 'Trans proline' 0 N--CA 1.429 -2.314 0 C-N-CA 121.772 1.648 . . . . 74.299999999999997 110.908 171.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.713 ' HA ' ' SG ' ' A' ' 120' ' ' CYS . 0.7 OUTLIER -138.69 145.79 40.78 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.154 0.502 . . . . 64.400000000000006 109.901 174.06 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.598 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.6 p -81.76 129.99 34.91 Favored 'General case' 0 N--CA 1.398 -3.062 0 N-CA-C 107.468 -1.308 . . . . 60.439999999999998 107.468 175.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.505 ' CE1' ' HB3' ' A' ' 79' ' ' LYS 0.284 0.0 OUTLIER -73.95 80.63 1.67 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 115.003 1.483 . . . . 75.329999999999998 115.003 -169.143 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -91.12 151.61 20.92 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.444 -1.253 . . . . 75.109999999999999 112.445 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -104.43 -158.25 0.65 Allowed 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 106.152 -1.795 . . . . 75.140000000000001 106.152 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -128.66 110.72 12.47 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 110.042 -0.355 . . . . 70.5 110.042 172.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -91.79 -104.99 0.11 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.136 -0.69 . . . . 72.340000000000003 109.136 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -113.35 -54.37 2.62 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.474 -0.935 . . . . 74.340000000000003 108.474 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -134.75 -29.55 1.15 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.322 -1.308 . . . . 60.299999999999997 108.443 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -63.04 133.56 54.73 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.217 -1.031 . . . . 72.310000000000002 108.217 171.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.2 mtt 74.32 99.12 0.07 Allowed 'General case' 0 C--N 1.313 -0.983 0 O-C-N 124.126 0.891 . . . . 70.109999999999999 112.139 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -174.1 82.18 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 125.662 1.585 . . . . 73.310000000000002 107.867 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -148.71 116.18 6.21 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-N 115.946 -0.57 . . . . 52.329999999999998 111.075 -175.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.9 mm -132.93 139.1 50.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.15 -1.426 . . . . 74.129999999999995 107.15 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 60.5 m -107.53 149.3 38.68 Favored Pre-proline 0 C--N 1.288 -2.087 0 N-CA-C 108.856 -0.794 . . . . 74.430000000000007 108.856 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 55.1 Cg_endo -69.29 147.76 66.59 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.655 2.237 . . . . 73.409999999999997 113.551 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 33.5 Cg_exo -64.45 136.69 51.83 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.117 2.544 . . . . 71.239999999999995 111.856 178.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.522 ' SD ' ' HB2' ' A' ' 101' ' ' CYS . 47.9 ttm -103.11 129.11 49.86 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.479 -0.934 . . . . 71.420000000000002 108.479 175.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 6' ' ' VAL . 58.9 t -120.76 132.39 70.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 116.338 -0.392 . . . . 74.540000000000006 110.265 -174.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.33 102.41 9.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 106.121 -1.807 . . . . 64.310000000000002 106.121 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -124.39 82.2 0.35 Allowed Glycine 0 C--N 1.285 -2.29 0 C-N-CA 120.025 -1.083 . . . . 60.340000000000003 114.587 -173.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -170.38 27.47 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.717 0.77 . . . . 73.400000000000006 109.276 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -105.04 154.0 20.71 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.765 -1.568 . . . . 74.329999999999998 106.765 -173.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.3 p -89.64 173.94 8.02 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 106.525 -1.657 . . . . 72.409999999999997 106.525 171.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.654 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 63.8 t80 -60.79 -46.15 91.64 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 118.603 0.638 . . . . 74.450000000000003 110.156 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.69 -42.3 95.42 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.569 -1.196 . . . . 62.140000000000001 111.567 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mm -69.66 -39.25 77.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 116.257 -0.429 . . . . 71.209999999999994 110.146 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.54 -44.7 81.68 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.857 -0.611 . . . . 61.109999999999999 110.077 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.6 mmt -65.88 -35.93 82.0 Favored 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 120.768 -0.373 . . . . 64.420000000000002 111.847 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.6 -41.61 92.6 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 120.555 -0.458 . . . . 63.0 111.509 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 44' ' ' VAL . 8.9 tt -71.96 -41.79 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 118.605 -1.238 . . . . 72.420000000000002 110.527 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.448 HG12 ' NH2' ' A' ' 69' ' ' ARG . 91.3 t -66.77 -38.37 81.38 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 CA-C-N 116.726 -0.216 . . . . 64.299999999999997 110.953 -177.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -67.47 -37.95 83.69 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.067 0.46 . . . . 73.430000000000007 110.277 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.464 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.72 -48.04 70.85 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.355 -0.926 . . . . 61.340000000000003 111.12 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 40' ' ' ILE . 92.0 t -64.81 -39.67 86.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.206 0.527 . . . . 73.510000000000005 109.78 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.07 -42.91 91.5 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.788 0.835 . . . . 74.109999999999999 112.117 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -79.63 -26.13 41.23 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 120.162 -0.615 . . . . 72.219999999999999 111.178 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 43' ' ' GLY . 79.5 t -70.03 -44.84 78.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 110.126 -0.324 . . . . 73.230000000000004 110.126 174.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 72.1 mt -65.1 -40.48 89.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 111.972 0.36 . . . . 75.319999999999993 111.972 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -80.27 -10.75 59.76 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.067 -1.053 . . . . 75.439999999999998 112.175 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -98.81 -47.87 5.14 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.29 -0.414 . . . . 74.349999999999994 111.164 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.7 m -81.09 -18.12 47.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.629 0.603 . . . . 50.350000000000001 112.629 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.657 ' CE2' ' HD2' ' A' ' 75' ' ' LYS . 1.8 m-85 -127.68 175.2 8.48 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.333 -0.988 . . . . 73.319999999999993 108.333 -176.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -105.03 91.7 3.91 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 105.716 -1.957 . . . . 52.310000000000002 105.716 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.558 ' HB2' HD13 ' A' ' 73' ' ' LEU . . . -132.25 136.39 46.94 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 112.998 0.74 . . . . 41.210000000000001 112.998 -172.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 71' ' ' TYR . 23.3 t -94.46 159.77 14.95 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.856 -1.535 . . . . 53.049999999999997 106.856 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.0 130.9 55.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 120.909 0.385 . . . . 75.319999999999993 109.988 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -135.61 112.22 10.02 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.59 -0.522 . . . . 64.230000000000004 109.59 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -87.88 136.13 33.1 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.635 -0.426 . . . . 75.230000000000004 110.411 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.0 mt -133.59 171.65 13.81 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.436 -0.802 . . . . 74.310000000000002 108.898 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -85.37 143.78 28.43 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.329 -0.989 . . . . 44.240000000000002 108.329 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -96.67 175.43 31.46 Favored Glycine 0 N--CA 1.414 -2.777 0 N-CA-C 110.394 -1.082 . . . . 63.119999999999997 110.394 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.428 ' HG2' ' CG ' ' A' ' 65' ' ' ASP . 11.2 pt-20 -70.39 179.84 2.32 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 122.767 0.427 . . . . 73.439999999999998 110.03 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.4 -38.16 76.78 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.724 0.773 . . . . 72.319999999999993 112.795 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 76.9 m -83.78 -5.19 59.14 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.504 -0.771 . . . . 72.340000000000003 111.908 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 85' ' ' LYS . 13.4 m-20 -95.8 171.6 8.55 Favored 'General case' 0 CA--C 1.49 -1.365 0 CA-C-N 115.396 -0.82 . . . . 72.230000000000004 110.091 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.15 -42.65 3.58 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.447 0 CA-C-N 114.651 -1.159 . . . . 73.400000000000006 109.089 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.1 tp -163.21 151.77 14.12 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 106.901 -1.518 . . . . 74.329999999999998 106.901 -176.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.58 118.36 21.88 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.483 -1.673 . . . . 73.099999999999994 106.483 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.448 ' NH2' HG12 ' A' ' 41' ' ' VAL . 36.3 ttp180 -122.72 124.2 42.84 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.23 -0.988 . . . . 73.140000000000001 110.43 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -98.42 145.11 27.06 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 124.367 1.067 . . . . 72.439999999999998 108.986 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 95.4 m-85 -131.76 137.74 48.32 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.878 -1.156 . . . . 74.150000000000006 107.878 175.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 32.0 m -113.86 111.85 22.4 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.698 -0.853 . . . . 72.439999999999998 108.698 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 54' ' ' ALA . 4.2 mm? -96.9 139.96 32.16 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 113.273 0.842 . . . . 60.109999999999999 113.273 -171.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -143.85 89.75 2.08 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 105.038 -2.208 . . . . 54.399999999999999 105.038 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.657 ' HD2' ' CE2' ' A' ' 52' ' ' PHE . 63.9 tttm -105.34 96.34 6.45 Favored 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.766 -0.584 . . . . 71.349999999999994 109.632 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 13.6 pt-20 53.5 35.51 20.92 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.618 1.167 . . . . 72.5 113.092 173.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.54 -8.64 56.8 Favored Glycine 0 CA--C 1.506 -0.505 0 C-N-CA 121.165 -0.54 . . . . 74.439999999999998 112.764 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HE3' ' HA ' ' A' ' 122' ' ' ALA . 50.4 mtpt -98.86 102.72 14.55 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.392 -1.707 . . . . 62.119999999999997 106.392 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.505 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . 58.9 mttp -101.53 153.96 19.26 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.792 -0.64 . . . . 72.030000000000001 112.176 -174.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -173.04 176.58 45.78 Favored Glycine 0 N--CA 1.417 -2.596 0 N-CA-C 110.599 -1.0 . . . . 60.039999999999999 110.599 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.3 tt -133.78 149.36 30.68 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.039 0 N-CA-C 106.948 -1.501 . . . . 54.219999999999999 106.948 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 91.0 t -132.34 127.52 57.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.252 -0.648 . . . . 75.329999999999998 109.252 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -113.86 113.72 25.28 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.322 -0.621 . . . . 74.129999999999995 109.322 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.54 110.59 30.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.879 -0.786 . . . . 61.210000000000001 108.879 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.511 ' HB2' ' OD2' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -110.67 126.53 54.61 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.03 -1.1 . . . . 64.129999999999995 108.03 178.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.0 mt -100.22 125.94 46.45 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.995 -1.854 . . . . 60.039999999999999 105.995 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.456 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 70.1 mtp85 -112.36 141.8 45.64 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-O 121.091 0.472 . . . . 72.040000000000006 110.927 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -94.29 98.71 11.11 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 115.309 -0.86 . . . . 71.129999999999995 109.373 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.481 ' HB ' ' OD1' ' A' ' 4' ' ' ASP . 10.9 tt -65.38 111.72 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 122.44 1.114 . . . . 70.109999999999999 109.141 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.7 p -137.8 176.75 8.43 Favored 'General case' 0 N--CA 1.39 -3.44 0 CA-C-N 114.685 -1.143 . . . . 55.399999999999999 109.807 -174.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -71.38 -17.78 62.39 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.895 -1.048 . . . . 72.030000000000001 109.32 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -98.06 -32.12 11.79 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.665 -1.152 . . . . 73.530000000000001 110.817 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 42.3 m -133.69 108.46 11.96 Favored Pre-proline 0 N--CA 1.432 -1.349 0 N-CA-C 113.695 0.998 . . . . 74.299999999999997 113.695 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -90.4 144.92 4.03 Favored 'Trans proline' 0 N--CA 1.438 -1.785 0 C-N-CA 122.465 2.11 . . . . 32.420000000000002 111.236 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -82.87 158.93 15.97 Favored 'Trans proline' 0 C--O 1.255 1.37 0 C-N-CA 122.378 2.052 . . . . 74.239999999999995 111.518 172.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 t -98.73 150.13 5.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 105.252 -2.129 . . . . 75.409999999999997 105.252 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -107.13 146.31 31.43 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.788 0.804 . . . . 73.219999999999999 112.162 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -138.59 -147.58 5.17 Favored Glycine 0 CA--C 1.476 -2.344 0 CA-C-N 114.071 -1.422 . . . . 72.109999999999999 110.079 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -60.84 125.84 25.18 Favored 'General case' 0 C--N 1.288 -2.093 0 O-C-N 124.286 0.639 . . . . 74.340000000000003 110.007 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -97.7 131.43 44.25 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.213 0.53 . . . . 60.450000000000003 110.395 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.522 ' HB2' ' SD ' ' A' ' 27' ' ' MET . 44.3 t -73.35 154.91 39.89 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.558 -1.201 . . . . 64.400000000000006 109.919 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.3 t -80.96 74.97 7.94 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.519 -1.289 . . . . 64.319999999999993 107.519 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.94 140.05 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 114.866 -1.061 . . . . 75.420000000000002 109.803 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.9 tp -153.7 -121.87 0.03 OUTLIER 'General case' 0 C--N 1.257 -3.453 0 N-CA-C 103.866 -2.642 . . . . 74.239999999999995 103.866 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.62 168.59 10.07 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 107.817 -1.179 . . . . 63.240000000000002 107.817 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.457 ' O ' HG22 ' A' ' 110' ' ' ILE . 74.5 t80 -43.25 -36.64 1.87 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.57 1.148 . . . . 73.319999999999993 114.071 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -56.84 -37.63 71.53 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.707 0.803 . . . . 63.420000000000002 112.249 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -90.62 -34.69 15.37 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.687 -0.486 . . . . 75.319999999999993 109.687 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 26.0 m-20 -62.55 -46.87 86.37 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.15 -0.932 . . . . 74.519999999999996 110.613 -176.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 106' ' ' PHE . 9.1 tp -64.59 -39.75 86.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 N-CA-C 109.963 -0.384 . . . . 72.209999999999994 109.963 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.96 -41.5 82.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.774 -0.648 . . . . 75.219999999999999 110.671 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 7.8 t -63.0 -44.25 96.54 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.693 -0.685 . . . . 74.310000000000002 111.259 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 47.0 mm -68.25 -41.46 83.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.994 -0.372 . . . . 54.439999999999998 109.994 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 51.6 t -64.22 -43.06 97.23 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 CA-C-N 116.029 -0.532 . . . . 61.219999999999999 110.366 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -61.9 -40.47 95.56 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 122.826 0.45 . . . . 75.25 111.19 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.59 84.33 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.183 0.516 . . . . 70.329999999999998 111.412 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.415 ' O ' HD13 ' A' ' 121' ' ' LEU . 79.0 mt -71.3 -43.28 74.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.364 -0.606 . . . . 72.329999999999998 109.364 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 114' ' ' VAL . 1.7 tm-20 -62.63 -40.49 97.18 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.484 -0.78 . . . . 63.539999999999999 110.448 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.74 -36.78 76.12 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 120.069 -0.652 . . . . 74.319999999999993 110.669 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.713 ' SG ' ' HA ' ' A' ' 10' ' ' GLU . 10.8 t -67.96 -34.05 75.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.657 0.741 . . . . 75.099999999999994 109.665 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.3 mp -75.79 -35.34 60.12 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.474 -0.784 . . . . 73.319999999999993 111.247 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.477 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . . . -69.67 -33.77 73.02 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.991 0.424 . . . . 74.230000000000004 111.144 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -80.55 10.32 4.9 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.7 -0.682 . . . . 70.319999999999993 111.556 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -53.71 124.15 28.57 Favored Glycine 0 C--O 1.249 1.044 0 CA-C-N 116.111 -0.495 . . . . 50.25 112.817 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 . . . . . 0 C--N 1.318 -0.784 0 C-N-CA 125.706 1.602 . . . . 74.310000000000002 112.259 -177.555 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.252 0 N-CA-C 106.764 -1.569 . . . . 72.140000000000001 106.764 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -120.45 128.89 53.59 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.905 0.383 . . . . 41.43 110.405 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.623 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 28.8 m-85 -117.69 148.95 41.51 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.395 0.617 . . . . 74.549999999999997 111.377 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.477 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 29.4 t70 -121.36 107.47 12.54 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.222 -2.14 . . . . 60.229999999999997 105.222 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -93.23 114.91 30.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 116.186 -0.461 . . . . 64.5 110.23 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.444 ' HB ' ' HG3' ' A' ' 85' ' ' LYS . 46.9 t -104.87 112.89 40.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 108.432 -0.951 . . . . 63.200000000000003 108.432 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.506 HG23 ' HB2' ' A' ' 27' ' ' MET . 3.7 tt -114.34 108.34 25.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.835 0.826 . . . . 75.25 108.847 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.9 mt -104.06 106.4 53.08 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 114.991 -1.004 . . . . 75.519999999999996 111.799 -171.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.584 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 7.1 Cg_endo -92.9 140.05 1.8 Allowed 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 122.419 2.079 . . . . 63.219999999999999 110.572 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -164.08 155.87 16.53 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 122.468 0.307 . . . . 71.140000000000001 110.76 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.9 m -91.57 135.19 34.04 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.707 -0.479 . . . . 52.009999999999998 109.707 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.15 68.65 10.0 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 113.551 0.945 . . . . 75.200000000000003 113.551 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -122.82 138.21 54.71 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.126 -1.064 . . . . 74.519999999999996 108.126 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.415 ' N ' ' HD2' ' A' ' 14' ' ' ARG . 9.0 mpt_? -82.39 134.98 35.25 Favored 'General case' 0 CA--C 1.475 -1.938 0 N-CA-C 108.998 -0.742 . . . . 73.200000000000003 108.998 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 20' ' ' MET . 7.1 t80 -62.67 110.44 1.72 Allowed 'General case' 0 N--CA 1.405 -2.702 0 O-C-N 124.688 1.242 . . . . 73.519999999999996 111.131 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.72 -99.31 0.06 Allowed 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 114.603 -1.18 . . . . 71.530000000000001 109.623 173.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -113.79 -58.45 2.15 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.033 0.444 . . . . 62.119999999999997 109.956 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -138.12 -51.91 0.6 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.085 0.945 . . . . 62.310000000000002 109.813 173.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -84.99 67.41 10.2 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.851 -1.068 . . . . 64.450000000000003 112.74 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 48.1 ttp 159.42 88.75 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.384 0 C-N-CA 128.169 2.588 . . . . 73.510000000000005 105.359 171.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 168.98 121.8 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.323 -2.103 . . . . 73.230000000000004 105.323 -173.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.474 ' HB2' ' H ' ' A' ' 125' ' ' GLU . 77.1 t60 -156.81 113.46 3.05 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.804 -0.758 . . . . 74.439999999999998 112.592 172.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.3 mm -113.64 132.5 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 N-CA-C 107.272 -1.381 . . . . 73.319999999999993 107.272 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 9.1 m -109.6 138.63 20.66 Favored Pre-proline 0 C--N 1.273 -2.723 0 N-CA-C 107.353 -1.351 . . . . 72.030000000000001 107.353 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -53.88 128.96 31.81 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 122.797 2.331 . . . . 70.409999999999997 112.427 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.88 130.43 26.0 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.489 2.126 . . . . 72.109999999999999 110.343 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.506 ' HB2' HG23 ' A' ' 7' ' ' ILE . 73.0 mtm -88.82 138.97 30.94 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 109.849 -0.426 . . . . 43.520000000000003 109.849 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.3 119.99 53.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.3 0.571 . . . . 74.430000000000007 110.04 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 30.6 mm -113.13 100.87 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 105.783 -1.932 . . . . 64.230000000000004 105.783 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -107.2 165.04 13.1 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 119.6 -1.286 . . . . 65.0 112.132 -176.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.6 t70 65.72 70.05 0.45 Allowed 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 125.339 1.456 . . . . 62.049999999999997 110.634 -175.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -138.34 136.05 35.99 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 105.364 -2.088 . . . . 75.349999999999994 105.364 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.6 p -77.95 163.73 25.73 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 106.558 -1.645 . . . . 63.020000000000003 106.558 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.623 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 74.7 t80 -59.13 -37.26 76.81 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.609 0.718 . . . . 71.430000000000007 110.393 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -63.56 -47.17 82.62 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.309 -1.314 . . . . 54.420000000000002 110.857 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.1 mt -73.13 -38.52 55.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.935 -0.765 . . . . 71.120000000000005 108.935 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.82 98.9 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.866 -1.061 . . . . 43.329999999999998 110.893 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.4 tpp -67.69 -39.9 84.39 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.624 -0.831 . . . . 75.319999999999993 110.545 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -70.52 -34.48 72.35 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 119.838 -0.745 . . . . 71.400000000000006 112.745 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 44' ' ' VAL . 7.0 tp -73.79 -43.01 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 119.484 -0.886 . . . . 42.520000000000003 110.57 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t -68.57 -39.65 80.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 121.249 -0.18 . . . . 63.219999999999999 111.159 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -70.51 -29.38 65.87 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.272 -0.64 . . . . 65.219999999999999 109.272 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.29 -47.54 78.89 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 110.42 -1.072 . . . . 71.549999999999997 110.42 174.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 40' ' ' ILE . 90.5 t -57.59 -46.06 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 109.146 -0.687 . . . . 73.239999999999995 109.146 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -55.86 -39.4 71.43 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 125.231 1.412 . . . . 75.010000000000005 113.108 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 46' ' ' ARG . 25.8 mtp180 -79.02 -31.04 44.53 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.305 -0.407 . . . . 74.319999999999993 111.2 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 43' ' ' GLY . 82.5 t -71.8 -38.06 64.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.289 -0.634 . . . . 63.439999999999998 109.289 176.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.5 mt -60.73 -46.6 95.69 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.852 0 CA-C-N 116.091 -0.504 . . . . 75.109999999999999 111.558 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -76.7 -15.93 59.65 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.6 -0.84 . . . . 74.409999999999997 112.114 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.4 -40.19 12.21 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.213 -0.449 . . . . 63.43 112.055 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 t -91.61 -20.61 21.46 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 112.463 0.542 . . . . 73.409999999999997 112.463 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -128.35 -179.97 5.31 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.6 0.714 . . . . 74.049999999999997 110.45 -174.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -105.54 106.52 17.06 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 104.155 -2.535 . . . . 71.319999999999993 104.155 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -118.2 135.63 54.13 Favored 'General case' 0 N--CA 1.404 -2.759 0 C-N-CA 119.533 -0.867 . . . . 64.439999999999998 113.114 -172.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.473 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 29.4 m -99.16 106.88 19.11 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 104.418 -2.438 . . . . 63.409999999999997 104.418 166.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 p -99.16 118.13 45.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.452 -0.944 . . . . 71.25 108.452 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -116.33 129.13 56.1 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.072 -0.967 . . . . 73.209999999999994 109.952 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -85.56 118.19 24.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.68 -0.691 . . . . 71.310000000000002 109.747 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mp -119.3 167.22 12.09 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 109.018 -0.734 . . . . 64.340000000000003 109.018 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -109.74 147.96 32.26 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 108.103 -1.073 . . . . 74.5 108.103 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.16 176.09 35.5 Favored Glycine 0 N--CA 1.407 -3.265 0 CA-C-N 115.512 -0.767 . . . . 73.150000000000006 112.725 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.453 ' N ' ' HB2' ' A' ' 65' ' ' ASP . 44.4 mt-10 -66.02 -173.33 0.18 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 124.893 1.277 . . . . 65.420000000000002 110.347 174.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -58.01 -44.7 87.42 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.462 0.648 . . . . 61.039999999999999 111.791 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 90.2 m -80.08 -23.45 41.3 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.6 -0.727 . . . . 34.409999999999997 111.757 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.453 ' HB2' ' N ' ' A' ' 62' ' ' GLU . 9.6 m-20 -90.87 123.23 34.23 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 119.342 -0.943 . . . . 73.430000000000007 111.013 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.7 t -84.43 -33.27 8.56 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 115.849 -0.614 . . . . 74.030000000000001 111.791 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.9 tp -151.58 139.9 20.39 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.441 -0.577 . . . . 73.030000000000001 109.441 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -130.8 121.41 25.31 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 107.622 -1.251 . . . . 62.329999999999998 107.622 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -118.72 123.66 45.42 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.665 -1.235 . . . . 70.5 107.665 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -103.63 109.96 21.85 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.268 -1.012 . . . . 72.209999999999994 108.268 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -96.43 119.17 34.44 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.01 -1.107 . . . . 62.229999999999997 108.01 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 16.9 m -98.95 115.93 30.02 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 106.527 -1.657 . . . . 55.539999999999999 106.527 174.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -108.59 151.04 26.66 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 113.537 0.94 . . . . 73.120000000000005 113.537 -170.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 36.6 tt0 -147.28 125.79 12.44 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 113.421 -1.718 . . . . 72.239999999999995 106.831 169.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -128.16 81.73 2.04 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 108.116 -1.068 . . . . 74.109999999999999 108.116 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 45.22 76.65 0.09 Allowed 'General case' 0 C--O 1.244 0.79 0 C-N-CA 126.239 1.816 . . . . 71.329999999999998 113.586 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.36 -23.18 28.78 Favored Glycine 0 C--N 1.309 -0.93 0 CA-C-N 115.777 -0.647 . . . . 52.210000000000001 112.933 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 14.2 mptt -96.01 129.42 43.28 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.551 -1.278 . . . . 65.329999999999998 107.551 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -145.97 138.49 25.53 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-O 121.132 0.492 . . . . 65.540000000000006 111.76 -173.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.3 179.76 42.28 Favored Glycine 0 CA--C 1.493 -1.285 0 N-CA-C 110.472 -1.051 . . . . 53.140000000000001 110.472 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 29.7 mt -120.1 145.96 25.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 109.404 -0.591 . . . . 70.239999999999995 109.404 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 83.8 t -126.45 112.64 30.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.716 -0.846 . . . . 72.510000000000005 108.716 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -98.87 107.54 20.0 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.309 -0.997 . . . . 75.239999999999995 108.309 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 44.0 t -102.58 110.47 29.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.696 -0.483 . . . . 74.099999999999994 109.696 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.444 ' HG3' ' HB ' ' A' ' 6' ' ' VAL . 8.1 ptpt -116.68 135.55 53.69 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 120.766 0.317 . . . . 72.0 110.677 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.1 mt -103.62 109.92 21.79 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 106.667 -1.605 . . . . 74.239999999999995 106.667 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.424 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 13.4 mtp180 -98.0 140.53 32.2 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 119.686 -0.806 . . . . 75.219999999999999 109.329 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -84.86 113.05 21.09 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 107.891 -1.151 . . . . 64.120000000000005 107.891 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 tt -87.26 111.64 22.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.79 -0.818 . . . . 71.540000000000006 108.79 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -128.18 174.59 9.13 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.505 -1.295 . . . . 72.129999999999995 107.505 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -78.2 0.16 26.12 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 120.282 -0.567 . . . . 75.030000000000001 112.322 -173.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -119.01 10.58 12.21 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.847 -0.615 . . . . 65.109999999999999 110.683 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.8 t -146.91 118.82 4.76 Favored Pre-proline 0 N--CA 1.446 -0.635 0 O-C-N 122.09 -0.381 . . . . 72.200000000000003 110.3 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.65 148.13 22.66 Favored 'Trans proline' 0 C--O 1.249 1.067 0 C-N-CA 123.209 2.606 . . . . 62.299999999999997 113.947 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.72 164.39 33.78 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 123.567 2.845 . . . . 64.439999999999998 110.217 175.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.5 t -100.51 156.48 4.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.742 -1.207 . . . . 72.200000000000003 107.742 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.89 116.34 24.96 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 122.024 0.916 . . . . 74.129999999999995 112.371 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.37 -160.5 8.34 Favored Glycine 0 N--CA 1.415 -2.748 0 N-CA-C 109.634 -1.387 . . . . 62.420000000000002 109.634 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -60.64 104.8 0.38 Allowed 'General case' 0 N--CA 1.398 -3.066 0 C-N-CA 124.792 1.237 . . . . 61.130000000000003 110.011 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -82.39 105.74 13.69 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 106.643 -1.614 . . . . 53.329999999999998 106.643 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.69 -179.23 5.21 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.421 -0.809 . . . . 72.5 109.207 -174.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.3 m -74.14 93.82 2.35 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.045 -0.724 . . . . 73.430000000000007 109.045 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.431 HG13 ' OD2' ' A' ' 109' ' ' ASP . 31.7 t -98.98 143.8 12.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.562 -0.903 . . . . 65.430000000000007 108.562 -177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.4 tp -161.57 -75.31 0.05 Allowed 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 122.133 0.968 . . . . 73.230000000000004 109.654 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -151.0 169.46 21.74 Favored 'General case' 0 C--N 1.259 -3.343 0 CA-C-N 112.945 -1.934 . . . . 72.230000000000004 108.193 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.426 ' O ' HG22 ' A' ' 110' ' ' ILE . 70.1 t80 -33.16 -63.47 0.23 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 115.559 1.689 . . . . 72.219999999999999 115.559 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.62 -42.62 93.1 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.914 0.709 . . . . 70.209999999999994 112.914 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.64 -36.18 62.88 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.256 -0.577 . . . . 54.520000000000003 109.714 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.552 ' O ' HG12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -64.88 -50.71 65.49 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 124.024 0.828 . . . . 63.43 110.134 177.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.509 HD13 ' HA ' ' A' ' 44' ' ' VAL . 7.6 tp -63.55 -36.25 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-O 120.914 0.388 . . . . 75.439999999999998 110.116 -176.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.37 -48.06 83.38 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.545 -0.752 . . . . 75.129999999999995 110.387 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 6.4 t -67.36 -36.31 81.13 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 116.065 -0.516 . . . . 62.299999999999997 109.782 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 109' ' ' ASP . 49.9 mm -64.89 -47.2 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.592 -0.731 . . . . 70.209999999999994 110.167 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 110' ' ' ILE . 77.0 t -63.39 -41.0 91.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-O 121.113 0.483 . . . . 64.349999999999994 110.174 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.33 -42.95 99.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.505 -0.77 . . . . 71.030000000000001 111.13 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.01 -38.06 79.03 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 123.191 0.307 . . . . 65.209999999999994 111.373 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.423 ' O ' HD13 ' A' ' 121' ' ' LEU . 77.8 mt -64.77 -45.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.543 -0.54 . . . . 65.530000000000001 109.543 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -71.75 -31.14 66.35 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 119.19 -1.004 . . . . 72.409999999999997 112.307 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.62 -43.75 88.6 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 109.156 -0.683 . . . . 74.109999999999999 109.156 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 52.1 t -58.66 -46.87 86.24 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.531 -0.758 . . . . 71.439999999999998 110.64 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.0 mp -73.26 -26.64 61.18 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.022 0.439 . . . . 73.230000000000004 111.811 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.68 -32.47 28.11 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 111.945 0.35 . . . . 72.349999999999994 111.945 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -87.73 9.93 19.96 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.486 0.55 . . . . 65.439999999999998 112.486 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -52.43 127.57 33.78 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.076 -0.511 . . . . 33.109999999999999 112.142 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.474 ' H ' ' HB2' ' A' ' 22' ' ' HIS 0.326 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 C-N-CA 125.742 1.617 . . . . 72.530000000000001 113.608 -178.086 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.412 ' HA ' ' HE3' ' A' ' 1' ' ' MET . 4.6 tpt . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.22 0.533 . . . . 74.010000000000005 110.282 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.49 157.71 16.98 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.164 -1.05 . . . . 44.450000000000003 108.164 175.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.609 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 73.4 m-85 -111.62 136.24 51.11 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.363 -0.977 . . . . 74.030000000000001 108.363 174.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 87' ' ' ARG . 30.4 t70 -113.15 114.29 26.58 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.967 -1.015 . . . . 63.229999999999997 108.491 -173.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -90.28 113.88 27.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 109.509 -0.552 . . . . 73.430000000000007 109.509 -174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.29 111.92 38.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 108.73 -0.841 . . . . 75.120000000000005 108.73 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.587 HG23 ' HB2' ' A' ' 27' ' ' MET . 4.5 tt -104.17 121.24 55.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 CA-C-N 115.754 -0.657 . . . . 75.329999999999998 110.26 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 19.8 mm -99.58 106.32 39.16 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 107.861 -1.163 . . . . 74.310000000000002 107.861 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 7' ' ' ILE . 18.4 Cg_endo -94.35 137.84 1.06 Allowed 'Trans proline' 0 N--CA 1.437 -1.836 0 C-N-CA 122.283 1.989 . . . . 73.329999999999998 111.432 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -146.89 154.98 41.94 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.155 -0.683 . . . . 64.310000000000002 109.155 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.522 ' OG ' ' HB3' ' A' ' 22' ' ' HIS . 90.0 p -79.85 156.1 27.52 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 107.296 -1.372 . . . . 73.230000000000004 107.296 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.481 ' HB3' ' CG ' ' A' ' 79' ' ' LYS . 53.7 t80 -81.63 76.89 8.53 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 109.16 -0.681 . . . . 75.239999999999995 109.16 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.412 ' CD2' ' HB3' ' A' ' 125' ' ' GLU . 71.5 m80 -150.82 101.96 2.95 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-N 114.761 -1.109 . . . . 75.450000000000003 110.439 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -88.1 155.77 19.62 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 106.863 -1.532 . . . . 74.120000000000005 106.863 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -55.82 99.84 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 115.527 1.677 . . . . 75.540000000000006 115.527 -173.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 17' ' ' LYS . 23.4 t70 -85.63 -152.23 0.16 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 113.088 -1.869 . . . . 52.219999999999999 106.799 172.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.438 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 9.3 tmtt? -69.82 -58.76 3.5 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.282 -1.007 . . . . 73.409999999999997 108.282 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -138.77 -51.78 0.56 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.514 -0.874 . . . . 72.519999999999996 112.451 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -90.12 55.2 3.02 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.581 1.326 . . . . 73.310000000000002 114.581 -166.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 61.1 mtt -162.85 90.74 0.71 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 125.682 1.593 . . . . 72.319999999999993 107.263 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -175.37 118.19 0.17 Allowed 'General case' 0 N--CA 1.424 -1.762 0 C-N-CA 124.741 1.217 . . . . 62.310000000000002 108.345 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.522 ' HB3' ' OG ' ' A' ' 11' ' ' SER . 10.8 t60 -169.78 110.92 0.44 Allowed 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.419 -0.81 . . . . 74.310000000000002 110.037 170.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.3 mm -112.19 139.69 35.54 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 105.04 -2.207 . . . . 70.319999999999993 105.04 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 50.9 m -108.17 145.85 32.32 Favored Pre-proline 0 C--N 1.274 -2.684 0 N-CA-C 109.008 -0.738 . . . . 75.519999999999996 109.008 -178.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.3 Cg_exo -60.88 150.43 83.48 Favored 'Trans proline' 0 C--O 1.248 0.99 0 C-N-CA 122.455 2.103 . . . . 63.5 112.072 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 22.9 Cg_exo -66.45 137.75 47.9 Favored 'Trans proline' 0 CA--C 1.503 -1.039 0 C-N-CA 122.998 2.465 . . . . 72.319999999999993 111.344 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.587 ' HB2' HG23 ' A' ' 7' ' ' ILE . 48.2 mtp -99.81 128.85 45.88 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 105.922 -1.881 . . . . 75.549999999999997 105.922 173.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.7 t -111.4 123.73 67.52 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 C-N-CA 119.786 -0.766 . . . . 53.539999999999999 109.373 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.2 mp -122.31 102.31 11.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.763 -1.569 . . . . 74.150000000000006 106.763 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.18 -169.01 14.21 Favored Glycine 0 C--N 1.276 -2.804 0 C-N-CA 119.225 -1.465 . . . . 75.299999999999997 114.178 -172.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.1 t70 57.37 43.26 23.58 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 123.043 1.402 . . . . 65.129999999999995 110.156 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -116.92 136.14 53.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 105.708 -1.96 . . . . 74.219999999999999 105.708 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 p -79.83 169.63 17.65 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 119.211 0.914 . . . . 75.030000000000001 108.645 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.609 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 68.0 t80 -57.48 -45.67 84.59 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 123.188 0.595 . . . . 74.430000000000007 111.573 -172.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -66.87 -42.15 86.09 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 114.735 -1.12 . . . . 74.409999999999997 110.725 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.7 mt -72.97 -36.86 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 115.325 -0.852 . . . . 72.299999999999997 109.865 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.434 ' HA ' HG22 ' A' ' 40' ' ' ILE . . . -64.06 -41.16 97.46 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.954 -0.566 . . . . 73.030000000000001 110.324 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.2 ttm -70.3 -37.95 74.89 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 120.139 -0.624 . . . . 62.0 110.819 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -73.12 -36.0 66.64 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.428 0.899 . . . . 72.420000000000002 113.428 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 37' ' ' ALA . 11.6 tt -68.31 -40.87 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 119.842 -0.743 . . . . 72.409999999999997 109.28 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.4 t -65.42 -43.82 94.56 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.864 0 N-CA-C 109.57 -0.53 . . . . 72.340000000000003 109.57 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -59.42 -39.24 82.86 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.595 0.358 . . . . 72.329999999999998 111.82 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.8 -44.0 95.37 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.714 -0.755 . . . . 74.109999999999999 111.369 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 40' ' ' ILE . 56.6 t -71.06 -39.09 74.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.378 -0.601 . . . . 61.420000000000002 109.378 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.441 ' OD2' HG21 ' A' ' 56' ' ' VAL . 14.1 t70 -56.68 -46.93 80.85 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.752 1.621 . . . . 64.450000000000003 109.966 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -64.73 -40.56 95.52 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.157 -0.929 . . . . 75.140000000000001 109.917 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.1 t -66.77 -39.29 83.32 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 CA-C-N 116.311 -0.404 . . . . 62.229999999999997 111.139 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 72.9 mt -69.44 -40.74 80.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 110.66 -0.126 . . . . 73.209999999999994 110.66 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -71.92 -30.79 65.72 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.337 -0.545 . . . . 74.25 110.607 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.2 -45.66 11.8 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 112.545 0.572 . . . . 73.349999999999994 112.545 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.5 m -85.44 -20.01 30.44 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.885 0.698 . . . . 73.209999999999994 112.885 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 48' ' ' ILE . 6.4 m-85 -123.15 157.08 33.74 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-O 121.145 0.498 . . . . 72.519999999999996 109.683 -175.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 45.1 t30 -85.86 87.35 7.4 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 104.367 -2.457 . . . . 60.030000000000001 104.367 172.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -133.5 136.25 44.95 Favored 'General case' 0 N--CA 1.397 -3.112 0 CA-C-N 115.434 -0.803 . . . . 72.310000000000002 111.975 -173.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.419 ' OG ' ' HB ' ' A' ' 72' ' ' THR . 41.0 p -95.8 122.77 38.94 Favored 'General case' 0 N--CA 1.404 -2.731 0 N-CA-C 106.727 -1.582 . . . . 62.0 106.727 171.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.441 HG21 ' OD2' ' A' ' 45' ' ' ASP . 3.2 p -99.68 119.34 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 N-CA-C 108.126 -1.065 . . . . 71.310000000000002 108.126 177.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -117.61 112.28 20.33 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 114.12 -1.4 . . . . 53.299999999999997 108.584 -174.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -94.21 122.36 36.66 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.406 0.622 . . . . 72.129999999999995 111.464 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mp -121.94 178.11 5.02 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 115.197 -0.91 . . . . 54.329999999999998 109.193 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -95.61 140.8 29.91 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.325 -0.852 . . . . 61.149999999999999 108.748 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.12 175.69 41.57 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 115.574 -0.739 . . . . 54.539999999999999 113.089 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -72.52 174.87 6.85 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 123.995 0.918 . . . . 70.420000000000002 108.595 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -49.73 -41.33 43.39 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 124.613 1.165 . . . . 72.109999999999999 113.034 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.01 -8.54 57.88 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.124 -0.944 . . . . 70.010000000000005 111.644 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -99.15 159.08 15.23 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 107.667 -1.234 . . . . 74.209999999999994 107.667 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.75 -37.64 3.67 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.638 0 CA-C-O 121.57 0.7 . . . . 74.030000000000001 110.212 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.7 tp -156.88 144.24 18.9 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.798 -1.186 . . . . 73.120000000000005 107.798 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -131.32 107.12 8.73 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.857 -0.794 . . . . 74.230000000000004 108.857 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -116.19 129.33 56.25 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.017 -1.073 . . . . 74.430000000000007 111.262 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -109.32 128.89 55.45 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.532 -0.758 . . . . 53.109999999999999 109.447 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -105.91 134.72 48.58 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 107.255 -1.387 . . . . 63.229999999999997 107.255 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.559 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 30.6 m -109.18 107.3 17.53 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 106.578 -1.638 . . . . 62.229999999999997 106.578 173.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.66 140.13 41.16 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 120.954 0.407 . . . . 52.149999999999999 111.865 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 44.3 tt0 -147.81 86.82 1.6 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.627 -0.715 . . . . 74.299999999999997 109.073 168.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -95.91 104.0 15.91 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.922 -0.581 . . . . 72.25 110.556 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 56.9 34.81 25.43 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.804 0.69 . . . . 74.150000000000006 112.46 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.94 -7.88 57.47 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 120.754 -0.736 . . . . 55.539999999999999 113.086 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 53.4 mtpt -92.37 102.11 14.59 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.108 -1.071 . . . . 73.200000000000003 108.108 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.642 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -102.09 138.19 39.37 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.576 -0.738 . . . . 75.420000000000002 111.21 -173.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.441 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . -164.03 164.48 36.55 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.438 -0.411 . . . . 54.43 112.751 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 34.0 mm -120.13 134.63 63.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 105.584 -2.006 . . . . 74.200000000000003 105.584 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.6 t -127.57 120.3 54.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.879 -0.513 . . . . 62.310000000000002 110.25 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 67.1 m-70 -105.62 104.14 13.8 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.328 -0.619 . . . . 65.099999999999994 109.328 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.3 t -100.11 110.59 27.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 109.669 -0.493 . . . . 74.140000000000001 109.669 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -112.55 140.54 47.22 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.042 0.449 . . . . 72.510000000000005 110.406 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.2 mt -97.78 125.7 42.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 105.831 -1.915 . . . . 70.540000000000006 105.831 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 4' ' ' ASP . 22.9 mmm180 -104.55 141.54 36.23 Favored 'General case' 0 C--N 1.273 -2.761 0 N-CA-C 108.017 -1.105 . . . . 73.510000000000005 108.017 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -90.0 98.04 11.54 Favored 'General case' 0 C--N 1.279 -2.48 0 C-N-CA 119.294 -0.962 . . . . 63.439999999999998 108.958 172.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.3 tt -74.13 112.31 10.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 121.261 -0.899 . . . . 61.25 110.39 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 93' ' ' CYS . 0.8 OUTLIER -142.34 177.14 8.46 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.084 -1.08 . . . . 62.149999999999999 108.084 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -77.99 -13.83 59.74 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 118.774 0.715 . . . . 61.140000000000001 111.119 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -109.02 9.82 26.31 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.124 -0.943 . . . . 62.310000000000002 110.156 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.408 ' HB3' ' OG1' ' A' ' 90' ' ' THR . 42.1 t -147.84 102.07 3.66 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 109.075 -0.713 . . . . 74.439999999999998 109.075 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.56 139.65 25.77 Favored 'Trans proline' 0 C--O 1.252 1.224 0 C-N-CA 122.429 2.086 . . . . 60.539999999999999 113.851 -174.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.62 161.07 28.08 Favored 'Trans proline' 0 N--CA 1.439 -1.71 0 C-N-CA 122.45 2.1 . . . . 70.319999999999993 108.78 173.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.3 t -91.68 157.92 2.92 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.559 0 N-CA-C 107.232 -1.396 . . . . 73.420000000000002 107.232 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -109.82 133.48 53.1 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.09 -1.078 . . . . 71.239999999999995 108.09 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -155.52 -144.88 4.03 Favored Glycine 0 N--CA 1.413 -2.867 0 C-N-CA 119.842 -1.171 . . . . 72.5 112.244 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -64.9 127.01 29.81 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 113.456 -1.372 . . . . 53.229999999999997 109.521 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -77.11 99.33 5.33 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.549 -1.278 . . . . 74.349999999999994 107.549 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 44.1 t -79.96 152.59 29.43 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 115.404 -0.816 . . . . 72.239999999999995 109.565 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.8 m -76.6 86.4 3.28 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.232 -1.025 . . . . 63.119999999999997 108.232 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.469 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 28.8 t -115.51 138.0 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 110.515 -174.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 103' ' ' VAL . 25.6 mt -170.55 -49.98 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 126.556 1.943 . . . . 54.140000000000001 110.948 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.6 142.37 17.8 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 113.996 -1.456 . . . . 75.530000000000001 107.537 -172.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -32.96 -44.43 0.11 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.145 2.178 . . . . 74.200000000000003 116.552 -170.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -54.84 -53.72 51.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.373 0.606 . . . . 73.25 112.567 -175.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -80.72 -30.14 36.31 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.989 -0.55 . . . . 71.049999999999997 110.041 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.94 -47.88 81.33 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.944 -1.026 . . . . 75.420000000000002 109.477 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.7 tt -65.53 -37.0 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.552 -0.295 . . . . 52.310000000000002 110.523 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.28 -48.32 82.25 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 109.655 -0.498 . . . . 73.109999999999999 109.655 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 21.5 t -62.81 -39.25 93.71 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.514 -0.767 . . . . 70.129999999999995 111.632 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 75.9 mt -70.18 -45.71 74.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 120.505 -0.478 . . . . 74.439999999999998 110.846 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.6 t -70.19 -38.86 75.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.264 -0.574 . . . . 64.209999999999994 110.72 -176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -74.53 -22.05 59.22 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 112.291 0.478 . . . . 75.200000000000003 112.291 -176.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.439 ' HB3' ' SD ' ' A' ' 27' ' ' MET . . . -83.04 -37.69 23.56 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 119.073 -1.051 . . . . 63.299999999999997 110.486 175.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 81.6 mt -62.48 -45.37 98.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 108.968 -0.752 . . . . 55.549999999999997 108.968 175.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -54.4 -43.64 71.63 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 123.575 0.75 . . . . 60.450000000000003 112.382 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 22.5 mm-40 -65.7 -44.11 87.13 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.818 0.699 . . . . 74.450000000000003 110.93 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 36.5 t -62.4 -40.94 98.15 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.198 0.523 . . . . 43.0 110.163 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 117' ' ' ILE . 70.6 mt -71.82 -29.14 64.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.977 -0.556 . . . . 74.019999999999996 110.656 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.08 -31.81 39.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 112.727 0.64 . . . . 74.540000000000006 112.727 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 119' ' ' GLU . 72.3 mmtt -65.56 -40.25 92.62 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 119.841 -0.743 . . . . 63.520000000000003 109.933 -177.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.62 -154.3 50.76 Favored Glycine 0 C--N 1.291 -1.966 0 CA-C-N 114.44 -1.254 . . . . 63.219999999999999 114.798 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.412 ' HB3' ' CD2' ' A' ' 13' ' ' HIS . 9.2 pt-20 . . . . . 0 C--N 1.294 -1.846 0 C-N-CA 124.703 1.201 . . . . 61.109999999999999 112.799 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptm . . . . . 0 CA--C 1.515 -0.388 0 N-CA-C 109.375 -0.602 . . . . 65.239999999999995 109.375 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HE3' ' HA ' ' A' ' 31' ' ' ASP . 87.5 tttt -122.3 136.96 54.99 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.072 0.463 . . . . 73.299999999999997 111.499 -173.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.586 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 19.2 m-85 -117.24 152.44 34.82 Favored 'General case' 0 C--O 1.251 1.169 0 C-N-CA 125.0 1.32 . . . . 73.010000000000005 109.338 173.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.631 ' OD1' ' HA3' ' A' ' 30' ' ' GLY . 24.6 t70 -123.67 108.77 12.93 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.581 -1.637 . . . . 55.450000000000003 106.581 -177.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.44 127.05 48.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.195 0.522 . . . . 62.119999999999997 111.927 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 85' ' ' LYS . 4.8 p -115.15 121.66 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.621 0 N-CA-C 108.156 -1.053 . . . . 75.340000000000003 108.156 176.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.486 HG23 ' CG ' ' A' ' 27' ' ' MET . 1.9 tt -122.2 123.48 68.95 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 CA-C-N 115.392 -0.822 . . . . 73.099999999999994 109.878 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.54 ' CG1' ' HB2' ' A' ' 83' ' ' HIS . 40.2 pt -108.06 118.59 52.27 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.864 -0.607 . . . . 53.049999999999997 110.463 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.498 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 11.5 Cg_endo -90.94 142.7 3.21 Favored 'Trans proline' 0 N--CA 1.431 -2.152 0 C-N-CA 122.153 1.902 . . . . 72.019999999999996 109.726 170.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -151.41 146.95 26.32 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 108.909 -0.774 . . . . 72.5 108.909 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.614 ' OG ' ' HB3' ' A' ' 22' ' ' HIS . 86.5 p -90.4 143.9 26.32 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.302 -1.37 . . . . 72.420000000000002 107.302 175.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.542 ' CE1' ' HB2' ' A' ' 79' ' ' LYS 0.351 1.6 p90 -80.61 87.5 5.76 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 118.098 -1.441 . . . . 74.230000000000004 113.189 178.379 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -130.14 99.53 5.09 Favored 'General case' 0 N--CA 1.414 -2.271 0 CA-C-N 113.729 -1.578 . . . . 63.210000000000001 110.833 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.92 118.05 9.86 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 122.305 1.05 . . . . 63.340000000000003 109.395 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.54 ' HA ' ' O ' ' A' ' 20' ' ' MET . 56.1 t80 -60.71 111.62 1.69 Allowed 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 112.208 -2.269 . . . . 74.019999999999996 111.074 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -85.69 -105.04 0.06 Allowed 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 113.433 -1.712 . . . . 73.25 110.218 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -112.35 -57.31 2.29 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.451 0.644 . . . . 72.540000000000006 110.627 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -124.92 -23.28 4.31 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.497 -0.774 . . . . 75.540000000000006 109.909 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -103.07 157.41 17.01 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.554 -0.748 . . . . 52.310000000000002 111.654 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.54 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 83.1 mtp 72.96 76.7 0.14 Allowed 'General case' 0 C--O 1.209 -1.038 0 O-C-N 124.829 1.331 . . . . 71.439999999999998 114.085 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -161.2 99.39 1.19 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.305 -0.998 . . . . 73.109999999999999 108.305 171.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.614 ' HB3' ' OG ' ' A' ' 11' ' ' SER . 47.0 t60 -136.63 93.04 2.82 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.651 -0.87 . . . . 72.219999999999999 108.651 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.2 mm -109.01 138.53 35.73 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 106.126 -1.805 . . . . 71.430000000000007 106.126 176.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 62.9 m -106.81 122.73 40.79 Favored Pre-proline 0 C--N 1.273 -2.736 0 C-N-CA 120.278 -0.569 . . . . 53.350000000000001 110.078 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -49.55 143.35 21.66 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.976 3.117 . . . . 50.43 113.733 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.85 133.05 55.75 Favored 'Trans proline' 0 CA--C 1.509 -0.727 0 C-N-CA 123.792 2.995 . . . . 73.129999999999995 113.051 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.486 ' CG ' HG23 ' A' ' 7' ' ' ILE . 22.1 ptp -106.07 141.55 37.25 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.652 -1.611 . . . . 74.409999999999997 106.652 172.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.443 HG22 HG23 ' A' ' 6' ' ' VAL . 39.8 t -133.86 127.75 52.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 120.229 -0.588 . . . . 51.210000000000001 110.91 -169.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.408 HD13 ' O ' ' A' ' 28' ' ' VAL . 45.3 mm -129.17 103.8 9.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.715 -1.217 . . . . 75.319999999999993 107.715 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.631 ' HA3' ' OD1' ' A' ' 4' ' ' ASP . . . -123.04 88.91 0.41 Allowed Glycine 0 N--CA 1.419 -2.461 0 C-N-CA 118.919 -1.61 . . . . 72.420000000000002 113.618 -175.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.461 ' HA ' ' HE3' ' A' ' 2' ' ' LYS . 5.9 p-10 -165.52 29.29 0.05 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.991 0.901 . . . . 74.349999999999994 109.118 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -118.32 136.98 53.39 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-N 115.572 -0.74 . . . . 74.340000000000003 109.21 -170.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.4 p -76.31 169.66 17.8 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 106.765 -1.568 . . . . 65.150000000000006 106.765 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.586 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 84.8 t80 -59.0 -39.21 81.15 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.465 0.65 . . . . 63.219999999999999 110.758 -177.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.15 -50.31 72.38 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.144 -1.389 . . . . 72.109999999999999 110.755 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.3 mt -69.99 -37.19 71.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.5 -0.555 . . . . 63.43 109.5 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -65.17 -42.1 94.01 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.612 -0.722 . . . . 70.329999999999998 110.8 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.6 tpp -69.76 -41.15 75.57 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 120.103 -0.639 . . . . 41.25 110.16 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.4 -38.03 80.92 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 112.489 0.552 . . . . 73.019999999999996 112.489 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 44' ' ' VAL . 14.4 tt -69.52 -39.39 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 119.516 -0.874 . . . . 72.25 110.114 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 37' ' ' ALA . 96.7 t -67.95 -40.41 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 120.544 -0.462 . . . . 55.539999999999999 109.964 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -69.55 -25.91 64.24 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.77 0.319 . . . . 72.209999999999994 111.559 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.59 -46.51 39.3 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 110.541 -1.024 . . . . 73.049999999999997 110.541 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 48' ' ' ILE . 86.3 t -61.1 -42.62 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 109.21 -0.663 . . . . 64.530000000000001 109.21 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -49.92 -52.36 33.87 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 125.912 1.685 . . . . 52.32 111.057 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -68.28 -35.19 77.48 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.773 -1.103 . . . . 73.310000000000002 110.387 -175.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 91.6 t -71.73 -36.56 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 116.075 -0.511 . . . . 62.43 111.253 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 44' ' ' VAL . 60.4 mt -68.35 -38.76 79.89 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.959 0 N-CA-C 109.541 -0.54 . . . . 74.450000000000003 109.541 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -66.62 -33.84 76.55 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.803 0.335 . . . . 74.209999999999994 111.682 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.99 -25.5 34.7 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.452 0.538 . . . . 60.049999999999997 112.452 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.9 m -99.48 -23.96 14.93 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.164 0.801 . . . . 75.120000000000005 113.164 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -133.24 -172.52 2.96 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.792 0.806 . . . . 73.439999999999998 111.6 -173.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -106.93 100.25 9.77 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 104.287 -2.486 . . . . 71.319999999999993 104.287 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -114.69 144.49 43.36 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 113.343 0.868 . . . . 72.319999999999993 113.343 -169.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -123.68 112.15 17.04 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.798 -1.556 . . . . 73.109999999999999 106.798 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -100.55 137.2 28.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.127 0.489 . . . . 74.310000000000002 109.993 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -136.32 117.96 14.96 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.223 -1.029 . . . . 73.340000000000003 108.223 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -97.65 129.25 44.75 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.55 -0.86 . . . . 71.120000000000005 111.366 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.2 mp -122.51 177.44 5.41 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.744 -1.116 . . . . 32.399999999999999 108.072 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -101.58 161.83 13.35 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.389 -1.337 . . . . 73.040000000000006 107.389 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.39 176.63 19.7 Favored Glycine 0 N--CA 1.413 -2.85 0 N-CA-C 111.052 -0.819 . . . . 53.530000000000001 111.052 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.48 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 11.9 pt-20 -65.23 -178.33 0.47 Allowed 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 123.403 0.681 . . . . 61.109999999999999 110.418 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -50.13 -38.45 39.15 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 114.442 1.275 . . . . 43.32 114.442 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 44.0 t -92.96 -0.93 57.11 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 121.687 0.756 . . . . 75.340000000000003 110.558 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.524 ' OD1' ' HG2' ' A' ' 87' ' ' ARG . 88.0 m-20 -100.75 152.82 20.03 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-N 115.974 -0.557 . . . . 74.349999999999994 110.077 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -113.45 -24.89 3.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-O 121.288 0.566 . . . . 50.140000000000001 111.893 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.433 ' HB3' HD12 ' A' ' 86' ' ' LEU . 57.2 tp -154.36 141.73 19.63 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 109.141 -0.688 . . . . 73.129999999999995 109.141 177.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -130.34 102.13 6.06 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 106.655 -1.609 . . . . 73.549999999999997 106.655 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -111.24 124.63 52.61 Favored 'General case' 0 C--N 1.281 -2.38 0 C-N-CA 119.436 -0.906 . . . . 64.140000000000001 109.642 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -105.74 143.27 34.13 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.284 -0.636 . . . . 73.109999999999999 109.284 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.489 ' HB3' HD11 ' A' ' 73' ' ' LEU . 87.6 m-85 -127.88 126.26 41.22 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.384 -0.969 . . . . 72.450000000000003 108.384 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.0 m -103.28 117.0 33.52 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.112 -1.81 . . . . 65.209999999999994 106.112 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 71' ' ' TYR . 0.7 OUTLIER -122.55 144.31 49.17 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.415 0.626 . . . . 75.5 112.393 -170.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -147.55 160.4 42.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.574 1.178 . . . . 63.420000000000002 111.134 171.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -154.29 157.44 38.68 Favored 'General case' 0 C--N 1.258 -3.409 0 N-CA-C 102.327 -3.212 . . . . 75.040000000000006 102.327 165.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -53.06 99.59 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.994 0.902 . . . . 52.520000000000003 112.726 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.72 0.51 56.46 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.401 -0.818 . . . . 71.219999999999999 112.648 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 95.6 mttt -134.33 108.55 8.26 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.047 -1.094 . . . . 40.409999999999997 108.047 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 16.5 ptpt -131.64 132.66 44.19 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.397 0.517 . . . . 71.340000000000003 112.397 -174.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -170.87 177.27 43.99 Favored Glycine 0 C--O 1.215 -1.036 0 C-N-CA 119.955 -1.117 . . . . 65.430000000000007 113.819 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.0 mt -129.22 148.81 33.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 106.884 -1.524 . . . . 62.539999999999999 106.884 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.25 123.86 51.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.634 -0.506 . . . . 55.210000000000001 109.634 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.54 ' HB2' ' CG1' ' A' ' 8' ' ' ILE . 11.9 m170 -110.7 112.44 24.32 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.641 -0.503 . . . . 73.329999999999998 109.641 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.47 114.51 42.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.514 -0.921 . . . . 74.120000000000005 108.514 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.495 ' HB3' HG13 ' A' ' 6' ' ' VAL . 59.9 tttp -115.72 118.28 32.63 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.958 -1.127 . . . . 74.420000000000002 107.958 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.433 HD12 ' HB3' ' A' ' 67' ' ' LEU . 90.5 mt -98.16 114.63 26.9 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 107.232 -1.395 . . . . 74.120000000000005 107.232 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.524 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 76.0 mtp85 -102.42 139.62 37.78 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.581 0.705 . . . . 71.519999999999996 110.073 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -90.71 98.27 11.68 Favored 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 115.089 -0.96 . . . . 73.439999999999998 108.49 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 tt -75.14 110.81 10.49 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-O 122.824 1.297 . . . . 70.209999999999994 109.173 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.1 p -123.31 -170.81 2.18 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 113.773 -1.558 . . . . 74.310000000000002 107.744 -174.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -82.63 -0.46 47.21 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.672 -0.862 . . . . 75.230000000000004 108.672 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -112.51 -5.05 14.07 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.974 -1.012 . . . . 72.140000000000001 110.18 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.2 m -137.97 113.97 9.15 Favored Pre-proline 0 C--N 1.311 -1.087 0 C-N-CA 123.202 0.601 . . . . 75.129999999999995 110.814 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.48 163.34 29.79 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 122.015 1.81 . . . . 64.049999999999997 110.552 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.96 163.2 29.32 Favored 'Trans proline' 0 C--O 1.247 0.952 0 C-N-CA 122.885 2.39 . . . . 63.030000000000001 112.048 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 t -93.41 156.54 3.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.582 -0.896 . . . . 71.430000000000007 108.582 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -106.41 141.54 37.55 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.272 -1.01 . . . . 72.510000000000005 108.272 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.42 -163.83 31.51 Favored Glycine 0 N--CA 1.419 -2.466 0 C-N-CA 120.149 -1.024 . . . . 55.109999999999999 111.714 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -69.58 139.23 53.68 Favored 'General case' 0 N--CA 1.417 -2.124 0 C-N-CA 125.205 1.402 . . . . 75.239999999999995 107.921 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -102.59 123.54 46.5 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 119.655 -0.818 . . . . 72.439999999999998 111.803 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.1 t -79.34 137.92 37.5 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.311 -1.366 . . . . 71.530000000000001 107.311 172.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.5 m -75.33 95.47 3.21 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.647 0.737 . . . . 63.25 110.191 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.431 HG13 ' CG ' ' A' ' 109' ' ' ASP . 57.7 t -97.89 147.55 6.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.778 -1.101 . . . . 45.219999999999999 109.369 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 47.1 tp -149.56 -74.1 0.17 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.289 -0.869 . . . . 70.420000000000002 109.56 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -143.56 151.41 40.18 Favored 'General case' 0 C--N 1.258 -3.385 0 N-CA-C 106.831 -1.544 . . . . 54.100000000000001 106.831 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.467 ' O ' HG22 ' A' ' 110' ' ' ILE . 79.9 t80 -35.78 -42.08 0.24 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.512 1.671 . . . . 72.349999999999994 115.512 -172.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -55.26 -47.75 74.99 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 122.804 0.442 . . . . 71.530000000000001 112.015 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.89 -34.22 30.11 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 107.672 -1.232 . . . . 60.219999999999999 107.672 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.431 ' CG ' HG13 ' A' ' 103' ' ' VAL . 26.2 m-20 -62.37 -46.8 87.0 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.476 -0.784 . . . . 74.349999999999994 110.218 -176.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 106' ' ' PHE . 8.5 tp -65.56 -41.36 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 115.571 -0.74 . . . . 73.310000000000002 110.612 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -26.37 60.32 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 120.285 -0.566 . . . . 72.340000000000003 111.572 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 12.0 t -68.26 -48.01 66.21 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 116.585 -0.28 . . . . 71.209999999999994 110.382 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.73 -42.93 93.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.216 -0.447 . . . . 72.319999999999993 110.087 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 70.9 t -64.65 -40.9 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 116.207 -0.451 . . . . 73.450000000000003 110.306 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -61.55 -44.09 97.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.351 -0.386 . . . . 74.430000000000007 111.355 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.49 -35.64 75.76 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.847 0.356 . . . . 33.409999999999997 111.573 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.46 ' O ' HD13 ' A' ' 121' ' ' LEU . 80.8 mt -69.33 -44.57 80.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 109.587 -0.523 . . . . 72.439999999999998 109.587 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -60.37 -45.22 94.3 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.886 -0.783 . . . . 63.219999999999999 108.886 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 44.5 mt-10 -68.57 -33.74 74.6 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 112.081 0.4 . . . . 64.219999999999999 112.081 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 9' ' ' PRO . 30.3 t -67.42 -31.3 71.41 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.417 0.627 . . . . 60.210000000000001 109.818 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.462 ' HG ' ' C ' ' A' ' 79' ' ' LYS . 9.0 mp -81.33 -37.84 27.69 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 121.151 0.501 . . . . 71.549999999999997 110.812 176.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.4 -16.71 41.76 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 115.579 1.696 . . . . 75.430000000000007 115.579 -175.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 62.9 mttm -75.81 -3.88 37.52 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 119.884 1.22 . . . . 75.340000000000003 113.603 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.07 -157.45 20.08 Favored Glycine 0 N--CA 1.422 -2.263 0 C-N-CA 119.943 -1.122 . . . . 74.329999999999998 113.429 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 20' ' ' MET . 10.0 pt-20 . . . . . 0 C--N 1.286 -2.189 0 CA-C-N 114.421 -0.889 . . . . 73.129999999999995 111.214 -174.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.428 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 2.0 mmt . . . . . 0 CA--C 1.506 -0.732 0 CA-C-O 121.367 0.603 . . . . 71.439999999999998 112.194 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -126.18 143.77 51.01 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.671 -1.233 . . . . 55.43 107.671 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 11.8 m-85 -114.7 145.34 42.16 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 122.002 0.906 . . . . 72.099999999999994 112.778 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.666 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 35.4 t70 -106.12 100.89 10.41 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 127.026 2.131 . . . . 64.239999999999995 105.541 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -92.42 124.6 44.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.638 -0.664 . . . . 54.140000000000001 109.334 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.9 t -113.51 119.05 59.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.288 -1.004 . . . . 73.239999999999995 108.288 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.536 HG23 ' HB2' ' A' ' 27' ' ' MET . 7.7 tt -114.29 116.55 52.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 121.504 0.669 . . . . 61.140000000000001 109.391 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 20.7 mt -106.61 106.72 58.58 Favored Pre-proline 0 C--N 1.3 -1.551 0 CA-C-N 115.56 -0.745 . . . . 72.219999999999999 110.056 -175.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.536 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 25.3 Cg_endo -95.42 137.22 0.74 Allowed 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.507 2.138 . . . . 73.420000000000002 111.185 173.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -158.55 137.45 11.29 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 121.845 -0.534 . . . . 71.409999999999997 111.065 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -84.5 106.92 16.45 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.21 -0.45 . . . . 50.409999999999997 109.853 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.629 ' CE1' ' HB2' ' A' ' 79' ' ' LYS . 2.0 p90 -63.26 106.98 0.97 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.103 1.149 . . . . 64.219999999999999 114.103 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 73.7 m80 -142.24 156.36 45.3 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.96 -1.018 . . . . 74.319999999999993 108.704 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -98.26 120.68 39.1 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 108.0 -1.111 . . . . 71.430000000000007 108.0 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -60.04 111.08 1.36 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 124.754 1.284 . . . . 75.349999999999994 110.603 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.07 -100.53 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.576 -1.193 . . . . 72.299999999999997 108.355 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -113.19 -60.31 1.9 Allowed 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 106.862 -1.533 . . . . 75.5 106.862 167.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.457 ' HA ' ' OE1' ' A' ' 21' ' ' GLU . 7.2 p-80 -138.5 34.56 2.26 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 113.797 -1.547 . . . . 74.25 110.005 175.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -135.29 152.61 51.66 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 106.619 -1.622 . . . . 61.310000000000002 106.619 -178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.461 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 0.0 OUTLIER 60.99 58.09 2.38 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.512 1.149 . . . . 62.520000000000003 110.009 -175.239 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 18' ' ' HIS . 7.4 pt-20 -141.06 88.22 2.16 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 113.47 -1.695 . . . . 64.5 110.684 -176.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -128.75 104.65 7.75 Favored 'General case' 0 C--N 1.285 -2.22 0 O-C-N 121.68 -0.638 . . . . 72.420000000000002 109.456 174.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.6 mm -116.51 136.68 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.733 0 N-CA-C 107.02 -1.474 . . . . 70.430000000000007 107.02 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 70.2 m -108.38 145.63 31.94 Favored Pre-proline 0 C--N 1.281 -2.397 0 N-CA-C 107.335 -1.357 . . . . 73.430000000000007 107.335 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.42 152.01 33.9 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 121.902 1.734 . . . . 63.119999999999997 112.451 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.02 125.2 17.49 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.631 2.221 . . . . 64.439999999999998 111.261 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.536 ' HB2' HG23 ' A' ' 7' ' ' ILE . 38.9 mtt -95.56 134.45 38.41 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.454 -1.684 . . . . 23.440000000000001 106.454 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -131.33 136.86 56.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.383 -0.527 . . . . 65.230000000000004 110.954 -168.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.4 mp -133.65 109.17 12.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.201 -1.037 . . . . 72.129999999999995 108.201 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.666 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -119.08 81.19 0.32 Allowed Glycine 0 C--N 1.3 -1.465 0 C-N-CA 119.209 -1.472 . . . . 42.329999999999998 115.137 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -176.06 31.03 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 124.555 1.142 . . . . 53.5 112.268 172.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.42 ' NH1' HG11 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -109.65 133.23 53.36 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 106.228 -1.767 . . . . 71.329999999999998 106.228 -179.185 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 p -75.13 161.48 29.36 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 119.471 1.032 . . . . 72.25 109.509 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.575 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 61.9 t80 -58.89 -43.63 90.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.499 0.666 . . . . 74.150000000000006 111.263 -173.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -70.08 -34.96 73.82 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.841 -1.072 . . . . 73.140000000000001 112.098 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.5 -35.79 17.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.404 -0.591 . . . . 42.229999999999997 109.404 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.8 -45.72 93.31 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-N 115.497 -0.774 . . . . 51.030000000000001 109.997 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 18.4 mmt -62.99 -38.11 89.87 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 116.504 -0.316 . . . . 70.109999999999999 111.249 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -65.54 -45.26 84.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.396 -0.365 . . . . 63.200000000000003 111.035 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.463 ' O ' HG23 ' A' ' 44' ' ' VAL . 10.4 tt -71.79 -39.73 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 119.146 -1.022 . . . . 65.299999999999997 110.541 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 83.5 t -67.8 -33.73 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 121.133 -0.227 . . . . 63.409999999999997 110.615 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -67.83 -40.94 83.7 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.86 -0.422 . . . . 75.219999999999999 109.86 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.34 -45.05 92.34 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-N 115.64 -0.709 . . . . 62.32 111.342 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 40' ' ' ILE . 69.7 t -61.7 -42.7 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.012 0.434 . . . . 74.519999999999996 109.875 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.56 -46.21 80.85 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 124.306 1.042 . . . . 72.239999999999995 111.225 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -71.54 -35.32 70.62 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.059 -0.973 . . . . 71.340000000000003 110.323 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 43' ' ' GLY . 97.7 t -67.73 -40.6 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 121.051 -0.259 . . . . 75.030000000000001 110.445 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 44' ' ' VAL . 74.8 mt -64.15 -39.6 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.958 0.409 . . . . 74.200000000000003 109.9 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -74.89 -19.28 60.21 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 115.973 -0.558 . . . . 75.319999999999993 111.321 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.72 -14.74 16.54 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 112.874 0.694 . . . . 73.319999999999993 112.874 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 m -108.23 -23.42 11.94 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 112.429 0.529 . . . . 70.409999999999997 112.429 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -133.97 177.93 7.35 Favored 'General case' 0 CA--C 1.484 -1.564 0 CA-C-O 121.461 0.648 . . . . 72.150000000000006 110.069 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.534 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 38.4 t30 -98.93 95.89 7.47 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 104.938 -2.245 . . . . 72.019999999999996 104.938 175.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -117.41 135.25 54.02 Favored 'General case' 0 N--CA 1.402 -2.859 0 CA-C-N 115.427 -0.806 . . . . 44.43 112.408 -173.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.4 m -109.72 121.26 44.82 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 106.812 -1.551 . . . . 64.219999999999999 106.812 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.35 128.82 51.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-O 121.294 0.568 . . . . 74.219999999999999 110.539 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -122.37 112.33 17.96 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.879 -1.526 . . . . 71.209999999999994 106.879 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.16 119.13 34.09 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.814 0.34 . . . . 53.399999999999999 110.818 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.48 174.4 6.57 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.291 0.567 . . . . 62.130000000000003 109.824 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -95.98 155.18 16.86 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.2 -1.408 . . . . 64.420000000000002 107.2 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.66 175.73 24.6 Favored Glycine 0 C--N 1.277 -2.749 0 C-N-CA 120.519 -0.848 . . . . 73.150000000000006 112.891 -176.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.51 ' HB3' ' OD2' ' A' ' 65' ' ' ASP . 11.6 tp10 -65.91 177.05 1.42 Allowed 'General case' 0 C--O 1.21 -1.025 0 C-N-CA 124.735 1.214 . . . . 72.140000000000001 108.813 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -45.25 -49.11 12.69 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 113.813 1.042 . . . . 74.420000000000002 113.813 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 76.8 m -82.03 -15.07 54.86 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.758 -0.655 . . . . 75.209999999999994 111.712 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 12.3 m-20 -98.87 118.09 34.85 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.1 -0.64 . . . . 73.219999999999999 110.618 -176.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.0 t -80.73 -36.21 15.47 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.508 0 CA-C-N 116.062 -0.517 . . . . 61.200000000000003 112.272 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.8 tp -146.48 140.68 26.4 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.896 -1.15 . . . . 75.439999999999998 107.896 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.79 102.01 6.13 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 107.374 -1.343 . . . . 65.519999999999996 107.374 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -109.43 114.53 28.25 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.83 0.824 . . . . 63.009999999999998 110.372 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -98.49 139.33 34.39 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.811 -1.086 . . . . 72.420000000000002 109.012 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.84 128.48 51.7 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 107.257 -1.386 . . . . 71.329999999999998 107.257 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.3 m -103.42 119.17 38.37 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 106.78 -1.563 . . . . 75.409999999999997 106.78 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.57 137.71 44.07 Favored 'General case' 0 CA--C 1.495 -1.156 0 CA-C-O 121.084 0.468 . . . . 61.240000000000002 112.182 -173.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -142.45 83.55 1.83 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.145 -1.428 . . . . 74.109999999999999 107.145 173.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -85.62 66.79 9.83 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.063 -0.517 . . . . 75.409999999999997 109.831 -177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 51.56 64.1 1.98 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.507 -1.224 . . . . 74.5 111.427 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.93 -11.8 62.39 Favored Glycine 0 C--N 1.314 -0.667 0 C-N-CA 120.666 -0.778 . . . . 74.109999999999999 112.856 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -108.64 107.7 18.28 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.38 -1.341 . . . . 64.109999999999999 107.38 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.629 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -121.63 142.65 49.92 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 113.14 0.793 . . . . 70.239999999999995 113.14 -165.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.98 171.29 43.77 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.967 -0.56 . . . . 41.409999999999997 111.877 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.4 mt -116.53 147.0 20.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.759 -1.2 . . . . 75.329999999999998 107.759 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.3 t -130.18 110.44 19.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.588 -0.893 . . . . 71.530000000000001 108.588 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.502 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 38.6 m-70 -98.89 106.32 18.57 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.294 -0.632 . . . . 63.299999999999997 109.294 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.6 t -104.66 109.87 28.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.603 -0.888 . . . . 64.340000000000003 108.603 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -119.76 139.44 52.3 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.61 -0.515 . . . . 71.099999999999994 109.61 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.7 mt -102.52 106.22 16.9 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 107.385 -1.339 . . . . 74.120000000000005 107.385 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 60.0 ttt-85 -98.05 141.55 30.86 Favored 'General case' 0 C--N 1.263 -3.17 0 N-CA-C 108.843 -0.799 . . . . 64.340000000000003 108.843 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -93.59 108.35 20.08 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 109.346 -0.613 . . . . 73.0 109.346 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 tt -83.15 116.12 26.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.29 0.567 . . . . 73.420000000000002 109.68 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.8 p -115.79 -172.04 2.09 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 107.957 -1.127 . . . . 72.409999999999997 107.957 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -87.76 -13.2 42.97 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.464 0.65 . . . . 73.109999999999999 109.977 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -95.49 -38.23 10.54 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.919 -1.037 . . . . 65.430000000000007 109.63 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 49.3 t -101.52 104.3 33.25 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 109.465 -0.568 . . . . 63.039999999999999 109.465 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.85 146.97 33.96 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.219 2.612 . . . . 70.129999999999995 113.017 -176.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.16 162.18 27.45 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 123.782 2.988 . . . . 73.239999999999995 113.447 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 t -92.22 159.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 107.339 -1.356 . . . . 61.340000000000003 107.339 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.48 141.34 48.66 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.316 -0.624 . . . . 53.420000000000002 109.316 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.09 -169.9 41.41 Favored Glycine 0 CA--C 1.467 -2.927 0 N-CA-C 108.762 -1.735 . . . . 64.510000000000005 108.762 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.511 ' HB3' ' HG2' ' A' ' 27' ' ' MET . 4.4 t-20 -56.31 111.0 0.86 Allowed 'General case' 0 N--CA 1.426 -1.634 0 O-C-N 124.234 0.608 . . . . 72.450000000000003 109.788 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -87.16 126.17 34.63 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 108.344 -0.984 . . . . 74.219999999999999 108.344 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.11 151.97 44.87 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.305 -0.861 . . . . 51.329999999999998 110.435 -175.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.9 m -78.93 81.92 5.17 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.523 0.677 . . . . 74.549999999999997 109.766 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.531 HG13 ' OD2' ' A' ' 109' ' ' ASP . 49.3 t -80.74 143.72 11.86 Favored 'Isoleucine or valine' 0 C--O 1.251 1.137 0 CA-C-N 114.705 -1.134 . . . . 54.310000000000002 109.64 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -154.67 -67.98 0.13 Allowed 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.44 -1.319 . . . . 70.430000000000007 107.44 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -158.6 163.06 37.32 Favored 'General case' 1 C--N 1.24 -4.189 0 CA-C-N 112.54 -2.118 . . . . 64.030000000000001 105.62 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -39.35 -43.12 1.14 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.336 1.606 . . . . 73.0 115.336 -172.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -60.36 -49.76 76.29 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.025 0.379 . . . . 71.120000000000005 112.025 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -74.71 -33.87 62.48 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.295 -0.562 . . . . 71.329999999999998 110.645 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.531 ' OD2' HG13 ' A' ' 103' ' ' VAL . 0.9 OUTLIER -62.29 -48.37 80.2 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.387 -0.824 . . . . 64.439999999999998 110.423 178.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 10.5 tp -66.68 -37.99 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 120.711 -0.396 . . . . 65.209999999999994 110.452 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -63.58 -42.21 98.31 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.685 -0.406 . . . . 74.140000000000001 110.44 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 2.7 t -63.59 -41.32 98.36 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.164 -0.471 . . . . 73.120000000000005 111.907 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.424 ' O ' HG13 ' A' ' 117' ' ' ILE . 47.6 mm -70.54 -45.19 75.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 121.085 -0.246 . . . . 44.310000000000002 110.644 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.496 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 70.7 t -64.69 -42.91 96.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.333 -0.394 . . . . 72.129999999999995 110.912 -177.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.57 -27.35 62.14 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.173 -0.611 . . . . 53.149999999999999 111.163 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.18 84.8 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.47 -0.567 . . . . 14.15 109.47 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 113' ' ' ILE . 72.4 mt -63.8 -45.8 96.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.398 -0.819 . . . . 72.140000000000001 109.184 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 114' ' ' VAL . 80.6 mt-10 -60.71 -40.35 91.97 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 116.276 -0.42 . . . . 72.510000000000005 111.283 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -70.43 -35.22 73.26 Favored 'General case' 0 C--O 1.202 -1.438 0 C-N-CA 120.632 -0.427 . . . . 74.439999999999998 111.149 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 8.1 t -73.54 -37.15 65.68 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.196 -0.602 . . . . 73.140000000000001 110.483 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.3 mp -77.58 -42.67 34.38 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.866 -0.734 . . . . 71.329999999999998 111.211 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.29 -19.88 29.22 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 116.29 1.959 . . . . 65.019999999999996 116.29 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.4 30.4 mttp -59.63 -47.76 84.33 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 116.73 2.122 . . . . 72.200000000000003 116.73 -172.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 155.34 149.84 5.41 Favored Glycine 0 C--N 1.264 -3.431 0 C-N-CA 119.405 -1.378 . . . . 63.439999999999998 113.017 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 . . . . . 0 C--N 1.297 -1.698 0 C-N-CA 124.424 1.09 . . . . 71.530000000000001 111.128 -176.261 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 N-CA-C 107.022 -1.473 . . . . 74.400000000000006 107.022 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 98.3 mttt -88.06 155.29 19.88 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.673 0.749 . . . . 63.25 112.195 -178.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.632 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 7.6 m-85 -122.95 151.86 41.4 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.957 -1.02 . . . . 74.239999999999995 111.856 178.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.61 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 32.3 t70 -103.32 101.55 11.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 105.753 -1.943 . . . . 70.129999999999995 105.753 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -90.41 120.91 40.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.643 0.735 . . . . 73.140000000000001 109.335 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.0 t -110.69 112.39 40.35 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 107.664 -1.236 . . . . 71.530000000000001 107.664 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.522 HG23 ' HB3' ' A' ' 27' ' ' MET . 4.7 tt -120.08 108.83 24.19 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 CA-C-O 121.938 0.875 . . . . 74.430000000000007 109.903 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.0 mt -110.27 117.25 51.82 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-N 114.799 -1.091 . . . . 73.549999999999997 108.553 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.604 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 44.6 Cg_endo -93.67 140.25 1.55 Allowed 'Trans proline' 0 N--CA 1.431 -2.171 0 C-N-CA 121.51 1.473 . . . . 73.530000000000001 110.728 171.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.55 124.49 8.61 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.187 0.518 . . . . 74.329999999999998 111.054 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.577 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 57.4 m -67.51 114.64 6.33 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 122.108 -0.37 . . . . 71.310000000000002 110.143 177.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 2.7 p90 -57.39 115.17 2.55 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 113.726 1.009 . . . . 64.129999999999995 113.726 -176.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 71.0 m80 -146.45 162.79 37.5 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 114.275 -1.329 . . . . 64.409999999999997 108.324 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -133.63 149.5 51.58 Favored 'General case' 0 N--CA 1.401 -2.896 0 N-CA-C 104.945 -2.243 . . . . 71.430000000000007 104.945 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -61.12 115.93 4.15 Favored 'General case' 0 N--CA 1.413 -2.316 0 O-C-N 124.214 0.946 . . . . 74.450000000000003 110.806 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -91.27 -159.31 0.62 Allowed 'General case' 0 C--N 1.266 -3.064 0 N-CA-C 105.504 -2.036 . . . . 72.409999999999997 105.504 172.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -70.64 -52.84 18.57 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 119.466 1.03 . . . . 64.430000000000007 110.599 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -136.16 5.47 3.02 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.546 0.689 . . . . 52.420000000000002 110.511 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -125.82 170.95 11.1 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.486 -0.561 . . . . 75.150000000000006 109.486 -175.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.401 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 57.9 mtt 66.2 85.19 0.14 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.86 1.264 . . . . 65.150000000000006 113.347 175.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -161.73 98.72 1.11 Allowed 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.854 -1.165 . . . . 70.530000000000001 107.854 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -149.62 134.21 17.61 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.919 -0.488 . . . . 73.519999999999996 111.391 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.2 mp -128.86 144.72 37.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 104.572 -2.381 . . . . 72.349999999999994 104.572 172.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.604 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 37.4 m -107.15 160.0 27.99 Favored Pre-proline 0 C--N 1.277 -2.547 0 N-CA-C 108.584 -0.895 . . . . 52.109999999999999 108.584 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.89 119.81 7.1 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.228 2.619 . . . . 71.129999999999995 114.182 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.59 125.14 10.35 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.64 2.227 . . . . 62.420000000000002 110.925 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.522 ' HB3' HG23 ' A' ' 7' ' ' ILE . 39.0 tpp -101.15 128.19 47.36 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.899 -1.149 . . . . 70.400000000000006 107.899 -175.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.7 t -129.31 129.34 67.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.449 -0.574 . . . . 72.109999999999999 109.449 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.409 HD11 ' H ' ' A' ' 101' ' ' CYS . 38.7 mm -134.39 106.59 8.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.062 0.458 . . . . 74.430000000000007 110.684 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -104.47 81.12 0.32 Allowed Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 119.875 -1.155 . . . . 61.219999999999999 112.091 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -170.04 31.12 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.895 0.855 . . . . 41.200000000000003 111.023 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 -124.61 133.94 53.09 Favored 'General case' 0 C--O 1.201 -1.457 0 N-CA-C 107.667 -1.235 . . . . 72.209999999999994 107.667 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 2.3 p -84.44 155.25 22.32 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 118.524 0.602 . . . . 73.319999999999993 110.553 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.632 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 90.3 t80 -48.9 -53.74 18.3 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 124.464 1.106 . . . . 72.120000000000005 113.315 -172.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 25.5 m-20 -70.18 -35.43 73.96 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.749 -1.114 . . . . 73.109999999999999 111.06 -174.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.8 mt -76.28 -38.23 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 109.619 -0.512 . . . . 71.109999999999999 109.619 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.01 -44.96 95.61 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.716 -0.675 . . . . 43.310000000000002 110.414 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.8 ttm -66.45 -38.38 87.24 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 119.968 -0.693 . . . . 65.519999999999996 110.674 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 35' ' ' ASP . 55.9 mm-40 -67.82 -40.14 83.85 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.494 -0.482 . . . . 65.129999999999995 111.752 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 44' ' ' VAL . 14.6 tt -73.38 -38.36 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 119.464 -0.894 . . . . 73.340000000000003 110.736 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.87 -39.23 84.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 110.193 -0.299 . . . . 64.400000000000006 110.193 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -71.31 -16.59 62.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.031 0.443 . . . . 65.109999999999999 111.822 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.79 -43.47 6.79 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 110.233 -1.147 . . . . 74.530000000000001 110.233 173.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 40' ' ' ILE . 77.4 t -59.8 -38.26 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.045 -1.095 . . . . 62.149999999999999 108.045 177.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -51.09 -50.08 59.44 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 126.051 1.74 . . . . 72.439999999999998 111.069 176.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -67.26 -38.19 84.74 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.753 -0.832 . . . . 73.319999999999993 108.753 -177.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -62.32 -45.4 98.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.07 -0.514 . . . . 72.230000000000004 110.696 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 44' ' ' VAL . 61.6 mt -69.42 -38.35 76.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.912 0.386 . . . . 73.219999999999999 110.397 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -79.58 -14.29 58.93 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.245 0.545 . . . . 74.439999999999998 112.263 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.65 -38.46 7.9 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.722 -0.611 . . . . 65.310000000000002 112.009 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -84.72 -14.08 49.42 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.663 0.744 . . . . 70.140000000000001 110.377 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -141.19 -175.58 4.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.58 -1.267 . . . . 65.120000000000005 107.58 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -106.78 100.1 9.63 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 105.609 -1.997 . . . . 63.409999999999997 105.609 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -129.46 136.04 49.4 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-O 121.194 0.521 . . . . 74.25 111.952 -175.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.427 ' OG ' ' HB ' ' A' ' 72' ' ' THR . 5.5 p -116.87 127.57 54.4 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.725 -1.213 . . . . 71.030000000000001 107.725 175.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 p -101.03 119.1 48.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 119.805 -0.758 . . . . 72.219999999999999 111.77 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -95.91 111.11 23.19 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.806 -1.924 . . . . 70.010000000000005 105.806 171.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -103.24 108.51 19.75 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 122.069 0.937 . . . . 73.519999999999996 112.315 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mp -111.85 177.56 4.61 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.888 -1.506 . . . . 74.120000000000005 109.422 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -94.42 161.82 14.07 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.427 -0.953 . . . . 63.450000000000003 108.427 177.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.1 176.52 24.66 Favored Glycine 0 C--N 1.285 -2.298 0 N-CA-C 110.345 -1.102 . . . . 54.149999999999999 110.345 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -65.19 -179.47 0.58 Allowed 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 116.973 0.386 . . . . 73.120000000000005 110.126 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -52.05 -31.9 32.1 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 113.273 0.842 . . . . 74.400000000000006 113.273 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 51.8 t -87.67 -15.6 36.71 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.765 -0.652 . . . . 74.230000000000004 111.463 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.501 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 11.5 m-20 -105.64 156.81 17.9 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-O 121.244 0.545 . . . . 73.329999999999998 110.141 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.6 t -112.22 -31.94 2.17 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 120.497 -0.481 . . . . 74.530000000000001 111.857 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 57.3 tp -151.15 138.64 19.55 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.071 -0.652 . . . . 53.009999999999998 109.764 -176.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.2 104.18 6.91 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.392 -0.596 . . . . 73.329999999999998 109.392 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -104.62 116.58 32.3 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.482 -0.932 . . . . 72.319999999999993 108.482 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -98.72 110.27 22.9 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.669 -1.234 . . . . 75.230000000000004 107.669 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -94.93 123.04 38.17 Favored 'General case' 0 C--N 1.264 -3.122 0 N-CA-C 109.713 -0.477 . . . . 64.5 109.713 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 29.9 m -94.26 122.38 36.74 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.452 -1.314 . . . . 65.200000000000003 107.452 176.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.47 136.78 50.15 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 114.391 1.256 . . . . 73.340000000000003 114.391 -172.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -133.62 135.68 44.35 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.91 -1.885 . . . . 74.519999999999996 105.91 170.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.546 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 80.1 tttt -139.82 172.62 12.52 Favored 'General case' 0 C--N 1.27 -2.886 0 N-CA-C 104.422 -2.436 . . . . 71.510000000000005 104.422 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.469 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 8.2 pt-20 -47.2 87.67 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.907 0.883 . . . . 74.140000000000001 112.942 176.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.32 19.16 78.63 Favored Glycine 0 N--CA 1.432 -1.623 0 CA-C-N 115.175 -0.921 . . . . 61.240000000000002 112.482 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 59.2 mmtt -127.86 156.43 42.58 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.725 -1.583 . . . . 74.310000000000002 106.725 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -156.85 140.77 16.21 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 123.262 0.351 . . . . 74.329999999999998 110.349 -178.164 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -170.5 177.46 43.66 Favored Glycine 0 C--O 1.205 -1.692 0 C-N-CA 120.113 -1.041 . . . . 71.120000000000005 113.432 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.403 HG13 ' HB3' ' A' ' 12' ' ' PHE . 60.8 mt -123.79 151.5 28.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 106.493 -1.669 . . . . 75.120000000000005 106.493 175.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.1 t -134.64 109.9 12.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.324 -0.991 . . . . 63.25 108.324 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -89.4 104.22 16.79 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.693 -0.484 . . . . 72.230000000000004 109.693 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.2 t -105.13 109.81 28.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.385 -0.969 . . . . 72.219999999999999 108.385 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 18.1 pttp -122.68 144.22 49.28 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 120.111 -0.635 . . . . 65.439999999999998 110.014 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.4 mt -105.81 109.47 21.44 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 107.226 -1.398 . . . . 52.240000000000002 107.226 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.524 ' HD3' ' OD2' ' A' ' 4' ' ' ASP . 36.6 ttt180 -98.51 141.34 31.48 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.4 -0.963 . . . . 61.409999999999997 108.4 -177.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -85.01 111.18 19.48 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 120.346 -0.542 . . . . 75.420000000000002 109.925 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.9 tt -74.47 112.13 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-O 122.168 0.985 . . . . 71.510000000000005 108.993 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -135.31 -177.95 4.89 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 106.235 -1.765 . . . . 73.239999999999995 106.235 -171.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -80.91 -13.75 58.63 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.472 1.13 . . . . 64.319999999999993 108.987 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -79.34 -33.39 43.09 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 113.849 -1.523 . . . . 71.25 108.474 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 95.9 m -129.76 94.22 32.44 Favored Pre-proline 0 N--CA 1.439 -1.002 0 CA-C-N 115.209 -0.905 . . . . 74.239999999999995 110.403 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.6 153.39 43.86 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 122.529 2.153 . . . . 51.520000000000003 112.269 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.34 138.48 60.85 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.171 2.581 . . . . 53.130000000000003 111.762 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.4 t -97.27 153.26 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.307 -0.997 . . . . 73.219999999999999 108.307 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -105.64 92.27 4.11 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 108.364 -0.976 . . . . 71.140000000000001 108.364 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -109.96 -149.67 12.68 Favored Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 109.741 -1.344 . . . . 61.149999999999999 109.741 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -72.9 118.27 15.64 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 107.426 -1.324 . . . . 25.350000000000001 107.426 172.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -94.78 121.6 36.54 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.519 0.676 . . . . 71.129999999999995 109.201 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.409 ' H ' HD11 ' A' ' 29' ' ' ILE . 20.8 t -69.37 151.48 46.11 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.673 -1.149 . . . . 74.209999999999994 110.261 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 m -77.34 88.74 3.74 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.75 -0.833 . . . . 51.039999999999999 108.75 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -106.0 148.29 10.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 114.924 -1.035 . . . . 65.219999999999999 110.976 -172.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.0 tp -157.83 -61.45 0.08 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.628 1.204 . . . . 74.150000000000006 107.887 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -146.43 167.2 24.22 Favored 'General case' 0 C--N 1.256 -3.475 0 CA-C-N 112.243 -2.253 . . . . 71.219999999999999 108.192 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.55 ' O ' HG22 ' A' ' 110' ' ' ILE . 63.8 t80 -46.59 -49.17 19.33 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 124.627 1.204 . . . . 71.140000000000001 113.611 -175.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -58.73 -28.93 66.32 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.061 0.458 . . . . 74.329999999999998 112.063 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -87.11 -40.44 14.65 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 116.323 -0.399 . . . . 72.239999999999995 111.366 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.455 ' O ' HG12 ' A' ' 113' ' ' ILE 0.367 4.5 p30 -78.26 -28.34 47.7 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 118.788 -1.165 . . . . 73.299999999999997 112.954 -176.113 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 106' ' ' PHE . 8.2 tp -67.59 -40.3 83.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 109.482 -0.562 . . . . 72.019999999999996 109.482 175.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -66.91 -41.01 87.85 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 108.95 -0.759 . . . . 75.219999999999999 108.95 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 8.5 t -64.19 -41.87 96.9 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.13 -0.941 . . . . 74.540000000000006 111.744 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 109' ' ' ASP . 35.8 mm -68.16 -42.0 84.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 120.494 0.188 . . . . 61.399999999999999 110.596 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 93.1 t -67.03 -41.23 87.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.396 -0.594 . . . . 73.420000000000002 109.396 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -60.6 -39.91 89.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.936 -0.574 . . . . 71.140000000000001 110.964 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.45 98.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.86 0.362 . . . . 73.109999999999999 110.711 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 77.3 mt -68.8 -43.52 82.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.326 -0.62 . . . . 73.0 109.326 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -58.25 -46.18 86.45 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 123.817 0.847 . . . . 61.229999999999997 111.618 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -69.86 -36.05 75.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.533 -0.758 . . . . 65.109999999999999 109.464 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 52.7 t -65.21 -47.2 77.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.699 -0.682 . . . . 53.219999999999999 110.193 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.3 mp -68.88 -30.41 68.91 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.157 -0.474 . . . . 73.200000000000003 111.596 -177.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.12 -35.32 56.35 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.66 -0.7 . . . . 72.140000000000001 111.128 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -87.05 -12.93 45.8 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.52 0.676 . . . . 75.319999999999993 110.781 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.35 60.51 4.51 Favored Glycine 0 C--N 1.304 -1.203 0 CA-C-N 115.306 -0.861 . . . . 70.120000000000005 113.265 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--N 1.268 -2.973 0 C-N-CA 124.733 1.213 . . . . 74.140000000000001 108.479 178.644 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.1 mmm . . . . . 0 CA--C 1.499 -1.002 0 CA-C-O 121.011 0.434 . . . . 64.140000000000001 110.291 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -99.56 143.47 29.76 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.976 -0.556 . . . . 74.219999999999999 109.962 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.608 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 21.0 m-85 -116.49 141.04 48.7 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.62 -0.718 . . . . 74.409999999999997 110.008 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.659 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 33.2 t70 -111.92 108.63 18.05 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 125.418 1.487 . . . . 43.520000000000003 109.988 -174.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 p -88.87 116.04 29.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 115.894 -0.594 . . . . 71.120000000000005 109.962 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.21 116.8 50.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.412 -1.329 . . . . 73.439999999999998 107.412 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.491 HG23 ' HB3' ' A' ' 27' ' ' MET . 4.9 tt -121.32 115.86 47.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-O 121.305 0.574 . . . . 43.030000000000001 110.551 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.8 tt -110.42 110.3 58.02 Favored Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 116.028 -0.533 . . . . 74.120000000000005 110.298 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.566 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 72.4 Cg_endo -91.62 147.4 3.35 Favored 'Trans proline' 0 N--CA 1.435 -1.952 0 C-N-CA 122.301 2.001 . . . . 64.299999999999997 110.112 173.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.61 177.66 9.83 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.933 -0.766 . . . . 64.140000000000001 108.933 177.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.47 ' HB2' ' HB3' ' A' ' 22' ' ' HIS . 52.1 m -122.6 104.29 9.25 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 109.019 -0.734 . . . . 53.350000000000001 109.019 173.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 24.0 p90 -49.56 95.61 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 115.131 1.53 . . . . 73.049999999999997 115.131 -176.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.498 ' CE1' ' HB3' ' A' ' 125' ' ' GLU . 76.6 m80 -145.85 168.89 19.71 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.42 -0.809 . . . . 74.310000000000002 109.299 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.75 147.23 46.57 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 104.322 -2.473 . . . . 73.049999999999997 104.322 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -70.43 93.36 0.87 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 123.77 0.669 . . . . 65.120000000000005 109.265 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.5 -84.28 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.212 -0.904 . . . . 71.150000000000006 110.529 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -107.61 -59.91 1.77 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.61 -0.515 . . . . 64.299999999999997 109.61 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -138.06 -52.43 0.62 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.066 -1.087 . . . . 73.239999999999995 108.066 173.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -74.97 174.92 8.65 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 113.114 -1.857 . . . . 60.219999999999999 111.083 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.464 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 4.5 mpp? 74.0 72.16 0.11 Allowed 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 124.881 1.363 . . . . 74.5 108.567 -175.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 5.1 pt-20 -148.84 93.29 2.09 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 113.804 -1.544 . . . . 65.439999999999998 109.249 -171.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 125' ' ' GLU . 19.0 t60 -160.96 107.47 1.45 Allowed 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.143 -1.423 . . . . 55.539999999999999 113.616 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -123.34 136.63 59.33 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 105.27 -2.122 . . . . 73.109999999999999 105.27 172.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 64.0 m -108.3 153.73 41.78 Favored Pre-proline 0 C--N 1.294 -1.83 0 O-C-N 123.109 0.256 . . . . 72.409999999999997 110.791 -176.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.2 Cg_exo -65.83 143.18 72.51 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 123.244 2.629 . . . . 64.099999999999994 113.849 -178.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 7.4 Cg_exo -74.97 130.45 13.31 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.905 2.403 . . . . 61.210000000000001 112.002 176.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.491 ' HB3' HG23 ' A' ' 7' ' ' ILE . 50.3 ttm -92.42 135.3 34.15 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.941 -1.133 . . . . 64.519999999999996 107.941 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 83.9 t -131.09 116.4 33.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 O-C-N 123.238 0.337 . . . . 71.420000000000002 110.786 -171.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.2 mm -129.2 106.06 13.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 120.638 0.256 . . . . 71.430000000000007 111.357 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -112.83 80.91 0.28 Allowed Glycine 0 CA--C 1.476 -2.396 0 C-N-CA 120.27 -0.966 . . . . 72.450000000000003 112.139 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -144.33 1.58 1.08 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.648 0.981 . . . . 51.100000000000001 113.648 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -107.33 134.57 50.2 Favored 'General case' 0 C--N 1.285 -2.204 0 O-C-N 121.025 -1.047 . . . . 71.150000000000006 108.304 -172.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 p -74.65 164.48 26.53 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 107.569 -1.271 . . . . 61.229999999999997 107.569 173.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.608 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 82.1 t80 -55.3 -45.48 76.24 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 120.789 0.328 . . . . 75.209999999999994 111.848 -173.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.85 -39.24 93.24 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.272 -0.876 . . . . 43.210000000000001 111.498 -176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.9 mm -74.31 -43.19 50.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.754 -0.832 . . . . 74.120000000000005 108.754 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 40' ' ' ILE . . . -61.92 -43.38 98.95 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 115.539 -0.755 . . . . 74.109999999999999 111.074 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.3 tpt -68.81 -38.0 79.6 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.972 -0.291 . . . . 61.340000000000003 110.871 -175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -84.36 -21.43 30.89 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 118.905 -1.118 . . . . 74.219999999999999 112.594 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.507 ' O ' HG23 ' A' ' 44' ' ' VAL . 17.6 tt -82.6 -40.25 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 C-N-CA 119.005 -1.078 . . . . 73.25 109.78 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.36 -36.28 71.3 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.876 0 C-N-CA 121.095 -0.242 . . . . 71.340000000000003 110.439 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -64.05 -31.98 73.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.147 0.499 . . . . 71.25 110.158 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -69.41 -44.78 63.27 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.714 -0.955 . . . . 52.219999999999999 110.714 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 40' ' ' ILE . 63.3 t -60.14 -44.93 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.282 -0.636 . . . . 73.409999999999997 109.282 177.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.8 -43.42 80.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.848 1.259 . . . . 70.430000000000007 110.862 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -68.96 -38.5 79.44 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.478 -0.783 . . . . 65.209999999999994 109.78 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 43' ' ' GLY . 92.9 t -66.41 -42.27 90.17 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.361 0 CA-C-N 116.513 -0.312 . . . . 73.409999999999997 110.674 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.458 ' CG2' HD11 ' A' ' 73' ' ' LEU . 72.7 mt -66.81 -41.81 88.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 121.287 0.565 . . . . 61.119999999999997 110.496 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -78.22 -11.38 59.92 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.499 -0.773 . . . . 71.319999999999993 110.583 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.9 -41.94 5.06 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 113.192 0.812 . . . . 72.430000000000007 113.192 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.5 m -91.03 -6.44 53.9 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.583 0.586 . . . . 64.439999999999998 112.583 -175.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -136.47 168.91 18.56 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 108.33 -0.989 . . . . 74.140000000000001 108.33 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 17.6 t-20 -96.15 100.17 11.84 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 105.588 -2.004 . . . . 73.439999999999998 105.588 176.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.19 136.23 55.01 Favored 'General case' 0 N--CA 1.408 -2.542 0 C-N-CA 120.079 -0.648 . . . . 75.040000000000006 112.626 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.485 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 11.6 m -99.45 106.46 18.51 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 103.737 -2.69 . . . . 60.439999999999998 103.737 167.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.439 ' CG2' ' HD2' ' A' ' 69' ' ' ARG . 5.1 p -99.86 121.76 50.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-O 121.661 0.743 . . . . 45.420000000000002 111.419 -171.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -116.25 135.93 53.46 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.293 -0.867 . . . . 75.019999999999996 109.505 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.483 ' HB3' ' NH1' ' A' ' 69' ' ' ARG . 8.5 pt-20 -98.78 136.36 38.93 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.382 -0.372 . . . . 74.120000000000005 110.025 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.6 mt -142.02 175.41 9.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.234 0.54 . . . . 64.409999999999997 111.021 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.37 161.78 13.44 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.466 -1.679 . . . . 72.329999999999998 106.466 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.569 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -114.69 175.22 15.93 Favored Glycine 0 C--N 1.284 -2.306 0 C-N-CA 119.714 -1.231 . . . . 61.409999999999997 113.061 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -93.53 134.05 36.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 123.07 0.548 . . . . 74.019999999999996 111.19 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 52.17 -88.67 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.629 1.714 . . . . 70.200000000000003 115.629 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 73.9 m -89.26 -12.96 39.21 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.546 -0.752 . . . . 53.340000000000003 112.069 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.569 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 14.0 m-20 -69.24 125.87 28.02 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.799 -1.186 . . . . 70.129999999999995 107.799 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.4 t -92.53 -31.8 4.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 121.279 0.561 . . . . 72.129999999999995 110.491 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.2 tp -151.76 145.22 24.84 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.124 -1.065 . . . . 71.25 108.124 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -130.12 122.21 27.83 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 107.938 -1.134 . . . . 74.420000000000002 107.938 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.483 ' NH1' ' HB3' ' A' ' 58' ' ' GLU . 22.0 tpp180 -120.1 119.07 32.24 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.406 -1.331 . . . . 74.439999999999998 107.406 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -108.83 136.26 48.68 Favored 'General case' 0 C--N 1.282 -2.327 0 C-N-CA 123.624 0.77 . . . . 73.510000000000005 109.215 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -126.31 131.87 51.76 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.329 -0.619 . . . . 74.409999999999997 109.329 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 18.6 m -103.02 109.51 21.08 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.663 -1.606 . . . . 72.150000000000006 106.663 172.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.458 HD11 ' CG2' ' A' ' 48' ' ' ILE . 3.3 mm? -98.67 140.51 32.78 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 113.027 0.751 . . . . 52.520000000000003 113.027 -172.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 44.0 mt-10 -135.71 95.9 3.33 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.279 -1.328 . . . . 65.430000000000007 108.493 171.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -92.08 76.36 5.41 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.082 -1.822 . . . . 72.0 106.082 179.066 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.333 0.7 OUTLIER 30.45 76.92 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.917 1.687 . . . . 75.409999999999997 115.417 -175.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.76 -23.51 35.44 Favored Glycine 0 C--O 1.236 0.273 0 C-N-CA 121.333 -0.46 . . . . 52.530000000000001 112.415 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 61.5 mttp -98.47 144.39 27.87 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 105.301 -2.111 . . . . 74.430000000000007 105.301 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 5.3 ptpp? -145.59 150.52 36.52 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 120.216 -0.594 . . . . 73.450000000000003 109.929 -168.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . 171.82 156.2 11.82 Favored Glycine 0 C--N 1.309 -0.951 0 C-N-CA 120.53 -0.843 . . . . 72.450000000000003 112.79 175.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 27.4 mt -103.57 139.22 25.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.504 -0.924 . . . . 63.409999999999997 108.504 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.3 t -118.53 116.45 51.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.342 -0.984 . . . . 74.420000000000002 108.342 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -104.34 109.5 21.37 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.568 -0.901 . . . . 74.120000000000005 108.568 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.08 119.53 55.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.028 -0.73 . . . . 74.239999999999995 109.028 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -121.47 140.24 52.43 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.23 -0.655 . . . . 63.409999999999997 109.23 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.0 mt -106.48 109.75 21.75 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.148 -1.427 . . . . 75.519999999999996 107.148 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -97.05 148.28 23.16 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-O 121.788 0.804 . . . . 73.239999999999995 111.014 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 88' ' ' LYS . 36.9 ttpt -92.18 105.5 17.7 Favored 'General case' 0 C--N 1.259 -3.352 0 CA-C-N 114.83 -1.077 . . . . 73.319999999999993 108.613 175.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 tt -91.34 112.34 25.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.412 0.625 . . . . 53.310000000000002 109.384 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.3 p -131.94 -171.01 2.52 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.815 -0.63 . . . . 74.430000000000007 109.993 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.47 -14.34 46.37 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.755 0.788 . . . . 62.32 108.905 176.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -90.41 -39.87 12.39 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.968 -1.015 . . . . 65.140000000000001 109.708 176.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 42.5 t -85.5 132.61 44.23 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 109.538 -0.541 . . . . 65.040000000000006 109.538 176.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 93' ' ' CYS . 5.4 Cg_exo -77.33 117.1 4.27 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.877 2.384 . . . . 72.239999999999995 111.88 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.34 122.31 11.12 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.836 2.357 . . . . 75.230000000000004 111.717 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.7 t -88.9 157.68 3.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 107.636 -1.246 . . . . 74.25 107.636 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -122.76 161.5 23.82 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.59 -0.893 . . . . 72.239999999999995 108.59 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -173.68 -166.24 31.63 Favored Glycine 0 CA--C 1.458 -3.486 0 N-CA-C 106.718 -2.553 . . . . 61.140000000000001 106.718 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 27' ' ' MET . 3.2 t-20 -56.01 102.98 0.09 Allowed 'General case' 0 N--CA 1.409 -2.49 0 O-C-N 124.411 0.712 . . . . 71.200000000000003 109.584 176.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -85.66 114.15 22.42 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.943 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 41.7 t -78.53 141.26 38.29 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.422 -1.325 . . . . 53.25 107.422 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.5 m -64.79 117.32 7.34 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.399 -0.963 . . . . 30.210000000000001 108.399 177.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.7 t -76.01 141.26 16.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.445 0.64 . . . . 74.310000000000002 110.539 -172.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.539 ' HG ' ' H ' ' A' ' 105' ' ' GLU . 15.2 tp -161.7 -159.46 0.62 Allowed 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.053 -2.203 . . . . 72.310000000000002 105.053 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.539 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 36.3 mt-10 -89.14 173.05 8.65 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 119.134 0.879 . . . . 61.509999999999998 112.038 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.489 ' O ' HG22 ' A' ' 110' ' ' ILE . 71.6 t80 -32.82 -58.05 0.36 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.517 1.927 . . . . 74.420000000000002 116.201 -171.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -68.64 -21.54 64.46 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 113.052 0.76 . . . . 72.420000000000002 113.052 -170.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -87.73 -42.39 12.65 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 119.671 -0.812 . . . . 75.310000000000002 111.001 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 113' ' ' ILE 0.262 17.1 p-10 -77.94 -30.08 50.29 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 118.684 -1.206 . . . . 60.039999999999999 111.783 -175.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 106' ' ' PHE . 16.5 tt -69.65 -38.78 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 119.225 -0.99 . . . . 72.319999999999993 109.829 175.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.25 -36.51 83.2 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 109.154 -0.684 . . . . 64.319999999999993 109.154 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 43.5 t -60.17 -45.49 92.9 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.798 -0.637 . . . . 61.240000000000002 109.703 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 109' ' ' ASP . 46.4 mm -61.28 -46.27 96.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 122.954 0.501 . . . . 74.150000000000006 109.891 175.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 110' ' ' ILE . 80.9 t -61.38 -42.77 95.01 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 CA-C-N 115.608 -0.723 . . . . 64.329999999999998 109.996 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 115' ' ' LYS . 37.3 mmtm -67.64 -32.19 72.71 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 112.139 0.422 . . . . 53.340000000000003 112.139 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.99 -39.37 83.28 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.284 -0.566 . . . . 71.109999999999999 110.044 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.5 mt -69.92 -47.12 71.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.856 -0.611 . . . . 72.200000000000003 110.11 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -64.7 -40.53 95.53 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 116.253 -0.431 . . . . 71.409999999999997 110.987 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.67 -17.72 58.97 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 120.298 -0.561 . . . . 65.340000000000003 112.154 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 27.4 t -78.24 -48.14 16.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.144 -1.058 . . . . 72.439999999999998 108.144 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 11.2 mp -69.37 -36.74 77.13 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.502 -0.772 . . . . 53.310000000000002 111.918 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.93 -13.57 53.13 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 114.002 1.112 . . . . 74.310000000000002 114.002 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -74.93 -12.39 60.34 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.255 -0.978 . . . . 74.519999999999996 110.893 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.92 169.01 42.29 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 115.113 -0.949 . . . . 55.340000000000003 111.12 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.498 ' HB3' ' CE1' ' A' ' 13' ' ' HIS . 0.7 OUTLIER . . . . . 0 C--N 1.293 -1.859 0 O-C-N 122.152 -0.616 . . . . 52.329999999999998 112.04 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 mtm . . . . . 0 CA--C 1.494 -1.185 0 N-CA-C 108.808 -0.812 . . . . 65.530000000000001 108.808 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -92.87 145.42 24.4 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.659 -0.497 . . . . 62.219999999999999 109.659 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.615 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 21.9 m-85 -112.48 142.68 44.73 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 121.564 0.697 . . . . 73.549999999999997 111.466 177.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.676 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 31.9 t70 -111.26 102.66 11.05 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 105.793 -1.929 . . . . 73.099999999999994 105.793 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.65 119.3 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 CA-C-O 122.087 0.946 . . . . 62.520000000000003 110.865 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.419 HG13 HG22 ' A' ' 28' ' ' VAL . 45.9 t -105.99 116.58 50.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-N 114.083 -1.417 . . . . 73.230000000000004 107.848 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.528 HG23 ' HB3' ' A' ' 27' ' ' MET . 6.2 tt -115.3 114.85 47.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 CA-C-O 121.348 0.594 . . . . 75.450000000000003 109.614 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mp -104.0 106.61 53.88 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 108.936 -0.764 . . . . 70.030000000000001 108.936 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.631 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 2.0 Cg_endo -84.87 139.16 7.29 Favored 'Trans proline' 0 N--CA 1.44 -1.646 0 C-N-CA 121.964 1.776 . . . . 65.540000000000006 109.199 172.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -157.78 133.65 9.26 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.056 0.455 . . . . 74.329999999999998 110.524 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.479 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 48.7 m -84.26 118.56 24.26 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.588 -0.523 . . . . 51.32 109.588 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 3.7 p90 -61.77 109.84 1.35 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.257 1.206 . . . . 63.350000000000001 114.257 -174.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -139.29 128.65 24.18 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.494 -0.776 . . . . 74.019999999999996 111.416 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -81.37 104.09 11.58 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 105.68 -1.97 . . . . 73.510000000000005 105.68 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 20' ' ' MET . 49.3 t80 -45.99 103.0 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 O-C-N 125.84 1.963 . . . . 74.200000000000003 109.662 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.25 -103.96 0.1 Allowed 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.134 -1.393 . . . . 73.310000000000002 113.688 -173.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -111.96 -58.99 2.05 Favored 'General case' 0 N--CA 1.434 -1.256 0 O-C-N 122.041 -0.412 . . . . 63.530000000000001 110.61 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -136.62 -36.76 0.7 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.405 -0.591 . . . . 74.400000000000006 109.405 176.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -102.04 163.25 12.35 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.766 -1.198 . . . . 74.340000000000003 107.766 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 1.8 mpt? 72.73 80.17 0.14 Allowed 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 124.28 1.032 . . . . 74.200000000000003 110.389 -173.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 178.03 132.4 0.07 Allowed 'General case' 0 N--CA 1.407 -2.605 0 N-CA-C 104.042 -2.577 . . . . 72.519999999999996 104.042 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 67.2 t60 179.41 92.37 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.804 0 O-C-N 124.336 1.023 . . . . 73.299999999999997 112.275 174.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mm -100.88 139.82 21.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 N-CA-C 105.692 -1.966 . . . . 55.310000000000002 105.692 171.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.631 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 42.0 m -106.58 153.92 40.31 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 109.708 -0.479 . . . . 71.409999999999997 109.708 -174.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 42.6 Cg_endo -68.75 151.1 74.61 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 122.812 2.341 . . . . 73.120000000000005 112.718 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 13.4 Cg_exo -72.63 151.55 52.51 Favored 'Trans proline' 0 C--O 1.255 1.356 0 C-N-CA 123.178 2.586 . . . . 70.109999999999999 114.107 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.557 ' SD ' ' HB3' ' A' ' 99' ' ' ASN . 2.4 tpt -114.56 134.99 54.62 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 104.606 -2.368 . . . . 74.409999999999997 104.606 176.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.419 HG22 HG13 ' A' ' 6' ' ' VAL . 92.0 t -130.73 130.43 64.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 119.088 0.858 . . . . 73.239999999999995 110.731 -176.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.8 mm -124.1 102.51 11.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 106.961 -1.496 . . . . 73.239999999999995 106.961 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -126.31 81.13 0.36 Allowed Glycine 0 CA--C 1.476 -2.344 0 C-N-CA 117.586 -2.245 . . . . 63.509999999999998 114.198 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -161.15 18.45 0.12 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.438 -0.881 . . . . 62.43 111.372 176.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -115.25 134.14 55.4 Favored 'General case' 0 C--O 1.2 -1.514 0 N-CA-C 108.209 -1.034 . . . . 71.329999999999998 108.209 -171.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -72.88 163.38 28.22 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.13 -1.063 . . . . 72.519999999999996 108.13 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.615 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 83.0 t80 -52.09 -47.97 64.95 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.936 0.494 . . . . 62.030000000000001 112.092 -172.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.68 -40.66 92.98 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.176 -0.92 . . . . 73.439999999999998 111.302 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.4 mt -76.25 -37.88 32.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.343 -0.614 . . . . 63.240000000000002 109.343 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.6 99.74 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.483 -0.78 . . . . 53.420000000000002 110.008 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -67.26 -36.35 81.41 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.251 -0.431 . . . . 64.439999999999998 110.066 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -68.64 -42.51 77.92 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.23 -0.441 . . . . 73.319999999999993 110.888 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 44' ' ' VAL . 8.1 tp -71.1 -37.52 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.277 -0.569 . . . . 64.120000000000005 110.337 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.9 t -67.09 -37.19 78.79 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 N-CA-C 109.808 -0.441 . . . . 52.399999999999999 109.808 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.12 -33.54 76.27 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 109.643 -0.503 . . . . 74.319999999999993 109.643 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.22 -43.71 78.79 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 111.42 -0.672 . . . . 64.140000000000001 111.42 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 40' ' ' ILE . 99.4 t -62.03 -46.1 97.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.747 -0.835 . . . . 73.329999999999998 108.747 177.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -53.85 -46.27 71.19 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 125.498 1.519 . . . . 74.530000000000001 110.927 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -66.86 -41.08 87.93 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 114.391 -1.277 . . . . 71.409999999999997 110.316 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 88.8 t -71.25 -35.0 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 116.036 -0.529 . . . . 62.439999999999998 110.005 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 64.8 mt -65.12 -45.84 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 110.091 -0.337 . . . . 55.32 110.091 175.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -62.78 -35.4 79.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.21 0.448 . . . . 61.420000000000002 112.21 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.32 -33.74 22.01 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 113.445 0.905 . . . . 73.340000000000003 113.445 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -97.03 -16.32 20.62 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 113.564 0.95 . . . . 61.539999999999999 113.564 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -128.16 -177.02 3.98 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.204 -0.665 . . . . 72.109999999999999 109.204 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -107.76 100.25 9.65 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 103.719 -2.697 . . . . 65.209999999999994 103.719 171.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.05 144.95 30.62 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 114.759 1.392 . . . . 50.219999999999999 114.759 -168.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.426 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 1.9 m -123.34 103.47 8.52 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 103.983 -2.599 . . . . 60.399999999999999 103.983 169.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 p -100.66 119.26 48.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-O 121.649 0.738 . . . . 71.140000000000001 111.351 -174.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -120.0 122.45 41.18 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.383 -0.826 . . . . 74.209999999999994 111.469 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -89.25 140.97 28.94 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.802 -0.444 . . . . 73.219999999999999 109.802 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 mp -136.49 172.42 13.04 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.106 -1.442 . . . . 74.239999999999995 107.106 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.49 147.81 24.47 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.255 -0.578 . . . . 73.420000000000002 109.716 176.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.44 148.79 41.09 Favored Glycine 0 C--N 1.293 -1.835 0 CA-C-N 115.29 -0.868 . . . . 32.539999999999999 111.137 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.92 132.74 34.33 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-O 121.158 0.504 . . . . 63.119999999999997 110.789 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.0 t70 52.31 -84.14 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 126.137 1.775 . . . . 74.439999999999998 113.681 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.5 t -110.54 -0.55 17.31 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.171 0.51 . . . . 51.310000000000002 111.786 -176.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 23.1 m-20 -74.24 138.21 43.52 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 106.664 -1.606 . . . . 74.329999999999998 106.664 172.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.8 t -93.81 -29.93 4.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 112.698 0.629 . . . . 53.210000000000001 112.698 -173.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.3 tp -150.29 140.24 21.94 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 108.669 -0.863 . . . . 73.230000000000004 108.669 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -130.68 133.7 46.31 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 107.054 -1.461 . . . . 74.200000000000003 107.054 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -137.05 120.34 16.84 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.492 -1.299 . . . . 73.150000000000006 107.492 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -111.94 118.09 34.53 Favored 'General case' 0 N--CA 1.413 -2.294 0 C-N-CA 118.828 -1.149 . . . . 74.030000000000001 108.612 175.068 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.43 ' HB3' HD11 ' A' ' 73' ' ' LEU . 13.0 m-85 -94.11 125.68 38.89 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 114.658 -1.155 . . . . 73.209999999999994 108.624 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 19.5 m -100.06 113.99 27.0 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.78 -1.563 . . . . 74.109999999999999 106.78 175.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.43 HD11 ' HB3' ' A' ' 71' ' ' TYR . 0.8 OUTLIER -120.41 152.4 37.97 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 113.538 0.94 . . . . 55.240000000000002 113.538 -170.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -135.32 140.81 45.4 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.222 -1.808 . . . . 72.430000000000007 106.807 170.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.549 ' HG2' ' OE1' ' A' ' 76' ' ' GLU . 51.6 tttm -139.47 -178.64 5.48 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 104.988 -2.227 . . . . 75.099999999999994 104.988 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.549 ' OE1' ' HG2' ' A' ' 75' ' ' LYS 0.26 0.0 OUTLIER -59.87 86.25 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 115.233 1.568 . . . . 70.120000000000005 115.233 -177.568 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.15 19.33 67.28 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 114.798 -1.092 . . . . 64.129999999999995 111.263 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 44.7 mtpt -132.74 135.9 46.03 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.306 -0.998 . . . . 73.409999999999997 108.306 -176.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -137.94 138.65 39.19 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.982 -0.747 . . . . 74.439999999999998 108.982 -175.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -174.04 172.12 45.06 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 119.414 -1.374 . . . . 63.420000000000002 113.612 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.5 mt -124.43 143.68 37.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 106.996 -1.483 . . . . 71.230000000000004 106.996 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 97.4 t -124.03 110.1 24.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.085 -0.709 . . . . 62.439999999999998 109.085 177.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -94.15 104.18 16.21 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.002 -0.545 . . . . 74.409999999999997 109.648 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.3 t -105.62 115.07 46.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 109.245 -0.65 . . . . 75.329999999999998 109.245 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -125.34 134.94 52.02 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.019 -0.673 . . . . 71.439999999999998 110.185 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.8 mp -112.1 108.1 17.26 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 109.115 -0.698 . . . . 64.349999999999994 109.115 -173.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.529 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 12.3 ptp180 -102.14 151.42 22.2 Favored 'General case' 0 CA--C 1.468 -2.196 0 C-N-CA 119.333 -0.947 . . . . 74.519999999999996 112.28 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -84.29 98.45 10.0 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.885 -1.052 . . . . 62.43 109.557 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.458 HD12 ' HB3' ' A' ' 95' ' ' PRO . 6.3 tt -74.11 114.95 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-O 122.16 0.981 . . . . 72.340000000000003 109.959 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.5 p -133.04 -171.84 2.78 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 107.695 -1.224 . . . . 62.200000000000003 107.695 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -83.03 -5.83 59.25 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.235 0.54 . . . . 54.399999999999999 110.093 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -98.91 -39.93 8.33 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.989 -0.745 . . . . 73.120000000000005 108.989 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 62.7 m -104.35 120.69 49.88 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 116.494 -0.321 . . . . 74.319999999999993 111.615 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.37 142.79 19.07 Favored 'Trans proline' 0 CA--C 1.555 1.569 0 C-N-CA 123.069 2.512 . . . . 70.420000000000002 113.859 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.458 ' HB3' HD12 ' A' ' 89' ' ' ILE . 66.9 Cg_endo -73.69 164.72 34.1 Favored 'Trans proline' 0 C--O 1.248 1.025 0 C-N-CA 124.016 3.144 . . . . 75.310000000000002 111.883 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.5 t -101.11 159.67 3.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 107.989 -1.115 . . . . 75.540000000000006 107.989 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -112.66 111.5 22.35 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.185 0.517 . . . . 73.349999999999994 110.7 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -128.49 -163.5 11.31 Favored Glycine 0 CA--C 1.487 -1.712 0 N-CA-C 110.462 -1.055 . . . . 74.510000000000005 110.462 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.557 ' HB3' ' SD ' ' A' ' 27' ' ' MET . 2.6 t-20 -75.19 140.91 43.6 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 122.446 0.298 . . . . 64.540000000000006 110.37 177.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -83.92 97.69 9.38 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 122.083 0.944 . . . . 64.409999999999997 110.581 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.19 151.99 44.77 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 113.422 -1.717 . . . . 63.43 108.978 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -76.83 93.27 3.7 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.839 0.828 . . . . 75.099999999999994 110.69 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.25 146.16 6.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 114.923 -1.035 . . . . 73.310000000000002 109.866 -175.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.7 mt -156.9 -90.8 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 126.116 1.766 . . . . 75.319999999999993 107.934 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.44 173.72 11.23 Favored 'General case' 0 C--N 1.255 -3.515 0 N-CA-C 105.944 -1.873 . . . . 75.209999999999994 105.944 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.464 ' O ' HG22 ' A' ' 110' ' ' ILE . 90.6 t80 -33.01 -46.39 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.682 1.734 . . . . 64.140000000000001 115.682 -172.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -56.1 -55.39 33.62 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 123.087 0.555 . . . . 74.150000000000006 112.204 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -78.83 -30.86 45.51 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.818 -0.628 . . . . 74.510000000000005 109.49 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.431 ' O ' HG12 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -65.76 -49.16 69.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.259 -0.882 . . . . 62.229999999999997 110.425 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 106' ' ' PHE . 9.9 tp -68.3 -35.76 72.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 121.365 0.603 . . . . 74.120000000000005 109.498 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -65.11 -44.68 87.97 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 115.205 -0.907 . . . . 75.409999999999997 110.12 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 27.0 t -67.55 -39.32 84.97 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 123.448 0.468 . . . . 63.5 110.974 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.569 ' O ' HG12 ' A' ' 117' ' ' ILE . 44.4 mm -66.01 -45.09 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 116.494 -0.321 . . . . 74.219999999999999 110.593 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.77 -35.5 74.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 N-CA-C 109.88 -0.415 . . . . 74.430000000000007 109.88 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 119' ' ' GLU . 60.1 tttp -60.1 -47.11 87.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.652 -0.703 . . . . 73.150000000000006 110.28 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.42 95.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.167 -0.47 . . . . 72.439999999999998 110.958 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 113' ' ' ILE . 43.0 mm -66.84 -44.03 89.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.742 -0.466 . . . . 61.340000000000003 109.742 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.78 -36.59 83.98 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.973 -0.558 . . . . 74.140000000000001 112.288 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 54.5 mm-40 -68.45 -45.54 72.21 Favored 'General case' 0 C--O 1.221 -0.441 0 O-C-N 123.727 0.642 . . . . 65.400000000000006 110.034 176.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 44.6 t -56.63 -46.27 81.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.938 -0.574 . . . . 72.299999999999997 111.233 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.7 mp -78.6 -19.86 51.77 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.26 -0.576 . . . . 74.129999999999995 111.777 -177.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.63 -29.8 41.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.053 0.454 . . . . 70.400000000000006 109.928 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -83.13 -1.97 54.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.884 -0.598 . . . . 73.430000000000007 111.032 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -53.86 131.1 43.99 Favored Glycine 0 C--O 1.245 0.808 0 N-CA-C 110.814 -0.915 . . . . 71.329999999999998 110.814 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 N--CA 1.468 0.427 0 C-N-CA 124.63 1.172 . . . . 74.120000000000005 109.937 -171.611 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 CA--C 1.489 -1.392 0 N-CA-C 108.305 -0.998 . . . . 75.230000000000004 108.305 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.67 153.47 51.08 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.043 -1.095 . . . . 74.510000000000005 108.043 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.495 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 14.4 m-85 -112.95 145.67 40.38 Favored 'General case' 0 C--N 1.283 -2.313 0 C-N-CA 123.387 0.675 . . . . 75.209999999999994 109.508 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.644 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 15.7 t70 -103.08 110.67 22.69 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.532 -1.285 . . . . 73.140000000000001 107.532 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -93.11 111.46 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 CA-C-O 121.897 0.856 . . . . 74.230000000000004 108.721 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 27' ' ' MET . 4.8 p -109.29 110.97 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.76 0 CA-C-N 114.778 -1.101 . . . . 73.209999999999994 109.284 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.678 HG23 ' HB2' ' A' ' 27' ' ' MET . 4.3 tt -103.93 125.36 58.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.868 -1.06 . . . . 52.329999999999998 110.372 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.2 mt -118.93 103.31 48.27 Favored Pre-proline 0 N--CA 1.425 -1.723 0 CA-C-N 115.52 -0.764 . . . . 60.310000000000002 109.275 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.555 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 3.1 Cg_exo -82.39 140.58 10.89 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.175 1.917 . . . . 75.439999999999998 109.582 173.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -156.97 114.27 3.12 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.949 0.881 . . . . 71.329999999999998 110.677 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 m -80.42 128.39 33.52 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.811 -0.632 . . . . 62.539999999999999 109.619 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.482 ' HD2' ' CD1' ' A' ' 81' ' ' ILE . 2.2 p90 -59.18 105.18 0.31 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 114.632 1.345 . . . . 71.530000000000001 114.632 -175.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -141.14 106.73 5.08 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.395 -1.275 . . . . 73.540000000000006 109.538 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -69.08 159.14 33.44 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 106.86 -1.533 . . . . 72.430000000000007 106.86 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -82.91 92.16 7.26 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.012 -1.075 . . . . 72.349999999999994 110.462 176.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.547 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 16.9 t70 -66.76 -102.0 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.76 -1.109 . . . . 74.329999999999998 109.43 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -113.32 -60.36 1.89 Allowed 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 108.269 -1.011 . . . . 63.340000000000003 108.269 171.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -139.5 -53.08 0.54 Allowed 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.677 0.751 . . . . 74.109999999999999 112.205 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -86.1 74.47 10.07 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.376 -0.829 . . . . 73.120000000000005 111.109 -174.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.547 ' SD ' ' HB2' ' A' ' 16' ' ' ASP . 53.0 ttm 173.87 93.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.719 2.007 . . . . 74.349999999999994 105.614 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 10.0 pt-20 -176.16 115.99 0.13 Allowed 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.082 -1.451 . . . . 63.43 107.082 -175.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -157.44 98.23 1.67 Allowed 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 119.326 -0.95 . . . . 73.310000000000002 111.429 172.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.4 mm -120.05 131.04 73.49 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 105.832 -1.914 . . . . 55.399999999999999 105.832 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 73.5 m -107.47 129.03 24.82 Favored Pre-proline 0 C--N 1.293 -1.885 0 C-N-CA 119.764 -0.775 . . . . 64.239999999999995 110.745 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 53.8 Cg_exo -56.17 146.15 72.58 Favored 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 123.217 2.612 . . . . 63.530000000000001 112.537 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 49.6 Cg_exo -57.8 145.11 91.88 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 123.684 2.922 . . . . 50.340000000000003 114.265 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.678 ' HB2' HG23 ' A' ' 7' ' ' ILE . 62.9 mtp -103.41 131.13 50.75 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 104.994 -2.224 . . . . 64.219999999999999 104.994 173.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.6 t -120.66 123.23 69.9 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 O-C-N 123.133 0.27 . . . . 74.150000000000006 110.355 -173.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.68 107.5 15.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 107.389 -1.338 . . . . 72.209999999999994 107.389 176.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -127.13 81.77 0.35 Allowed Glycine 0 CA--C 1.475 -2.429 0 C-N-CA 118.019 -2.039 . . . . 75.540000000000006 115.416 -173.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -174.38 37.92 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.979 0.895 . . . . 74.049999999999997 111.126 173.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -113.7 133.34 55.39 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 106.423 -1.695 . . . . 33.219999999999999 106.423 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 p -76.71 163.49 26.78 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 119.139 0.881 . . . . 72.340000000000003 109.089 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.495 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 63.2 t80 -52.55 -43.32 65.11 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 123.758 0.823 . . . . 74.239999999999995 111.689 -174.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -68.14 -40.23 82.47 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.008 -0.996 . . . . 72.400000000000006 111.331 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.2 mm -73.65 -39.35 53.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.131 -0.692 . . . . 65.439999999999998 109.131 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.78 95.14 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.936 -1.029 . . . . 74.329999999999998 110.331 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.1 mmt -65.67 -36.04 82.5 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.495 -0.482 . . . . 74.129999999999995 111.287 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -68.42 -43.58 76.88 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 120.634 -0.426 . . . . 74.409999999999997 111.285 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 44' ' ' VAL . 13.7 tt -70.32 -39.33 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 C-N-CA 119.826 -0.75 . . . . 44.130000000000003 110.464 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.3 -45.09 99.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-N 116.737 -0.21 . . . . 74.209999999999994 110.868 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -68.44 -32.59 72.71 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 119.977 -0.689 . . . . 53.450000000000003 111.4 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -69.78 -46.05 55.29 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 110.983 -0.847 . . . . 74.010000000000005 110.983 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 40' ' ' ILE . 69.0 t -62.35 -41.11 90.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.729 -0.471 . . . . 63.409999999999997 109.729 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.448 ' CG ' HH21 ' A' ' 69' ' ' ARG . 16.4 t70 -58.48 -46.67 86.19 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.919 -1.037 . . . . 61.530000000000001 110.346 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -40.77 96.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.633 -0.712 . . . . 64.409999999999997 110.817 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 43' ' ' GLY . 98.3 t -63.75 -43.22 97.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.531 -0.304 . . . . 74.25 111.067 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.8 mt -69.9 -39.59 77.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.561 0.219 . . . . 73.319999999999993 110.922 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -74.92 -24.72 58.55 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 120.903 0.382 . . . . 74.340000000000003 110.912 -175.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.39 -42.15 9.94 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 112.502 0.556 . . . . 25.219999999999999 112.502 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.1 m -83.9 -17.93 39.12 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.199 0.523 . . . . 74.329999999999998 111.737 -174.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -134.58 179.34 6.35 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 121.533 0.682 . . . . 60.450000000000003 109.995 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.547 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 26.7 t-20 -98.8 102.66 14.47 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.007 -1.849 . . . . 75.25 106.007 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -133.98 135.94 43.8 Favored 'General case' 0 N--CA 1.412 -2.357 0 C-N-CA 119.595 -0.842 . . . . 72.420000000000002 112.446 -175.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.9 m -102.1 111.89 24.34 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 105.24 -2.133 . . . . 74.150000000000006 105.24 171.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.415 HG21 ' OD1' ' A' ' 45' ' ' ASP . 7.4 p -100.64 142.74 15.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 120.699 0.285 . . . . 62.539999999999999 110.778 -174.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -139.88 151.74 45.89 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.634 -0.876 . . . . 73.239999999999995 108.634 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -125.63 106.46 9.75 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.983 0.897 . . . . 61.32 110.068 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -99.08 172.49 7.36 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.854 -1.067 . . . . 72.219999999999999 109.148 -175.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -109.03 137.84 46.3 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.059 -0.518 . . . . 72.230000000000004 109.687 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.494 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -98.29 176.83 30.65 Favored Glycine 0 C--N 1.294 -1.784 0 CA-C-N 115.196 -0.911 . . . . 60.200000000000003 112.671 -174.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.72 166.74 8.36 Favored 'General case' 0 C--O 1.19 -2.047 0 N-CA-C 107.388 -1.338 . . . . 65.109999999999999 107.388 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -42.6 -39.77 2.46 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 115.311 1.597 . . . . 72.430000000000007 115.311 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 51.5 t -73.71 -29.64 62.38 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.082 0.468 . . . . 63.200000000000003 111.518 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.494 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 8.0 m-20 -98.26 115.17 27.82 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.545 -0.909 . . . . 63.240000000000002 108.545 -176.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.0 t -83.67 -32.57 8.96 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 N-CA-C 113.29 0.848 . . . . 74.340000000000003 113.29 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.1 tp -148.79 140.8 23.85 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.238 -1.023 . . . . 73.439999999999998 108.238 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -129.72 126.11 37.49 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.962 -1.495 . . . . 75.530000000000001 106.962 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.448 HH21 ' CG ' ' A' ' 45' ' ' ASP . 10.8 tpt180 -113.73 138.8 49.74 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 107.529 -1.286 . . . . 65.540000000000006 107.529 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -123.96 130.64 52.92 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.981 -1.118 . . . . 52.219999999999999 107.981 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -125.56 115.82 20.78 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.234 -0.654 . . . . 70.0 109.234 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 39.5 m -88.26 110.3 20.63 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.974 -1.121 . . . . 74.329999999999998 107.974 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.0 142.23 28.47 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.13 0.572 . . . . 74.239999999999995 112.317 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 36.7 tt0 -144.32 93.9 2.5 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.917 -1.038 . . . . 63.140000000000001 109.041 171.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.539 ' HG2' ' H ' ' A' ' 76' ' ' GLU . 49.8 tttt -99.53 -176.04 3.17 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 105.968 -1.864 . . . . 64.0 105.968 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.539 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 8.6 pt-20 -48.83 91.26 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.092 1.357 . . . . 70.140000000000001 113.271 177.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.24 17.27 68.0 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.188 -0.914 . . . . 62.32 113.414 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 53.7 mtmt -138.78 122.41 17.44 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.48 -0.933 . . . . 73.140000000000001 108.48 -177.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -145.24 145.58 31.35 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 120.698 0.285 . . . . 72.540000000000006 111.298 -173.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.92 171.9 41.81 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 110.47 -1.052 . . . . 71.530000000000001 110.47 -176.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.482 ' CD1' ' HD2' ' A' ' 12' ' ' PHE . 3.7 mp -105.03 143.87 15.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 117.888 0.844 . . . . 72.099999999999994 109.669 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.4 t -119.6 110.27 28.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.967 -0.753 . . . . 73.319999999999993 108.967 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -93.89 131.3 39.45 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 124.006 0.922 . . . . 74.439999999999998 110.017 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.14 109.92 18.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.235 -1.024 . . . . 63.32 108.235 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -118.45 146.27 44.61 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.936 -1.106 . . . . 54.439999999999998 111.338 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.5 mt -105.52 107.89 19.12 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.502 -1.296 . . . . 73.549999999999997 107.502 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 37.3 ptt180 -103.84 135.89 44.54 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.403 -0.962 . . . . 74.129999999999995 108.403 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -76.73 108.34 9.68 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.447 0.641 . . . . 73.549999999999997 110.81 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 tt -82.82 111.42 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.276 1.036 . . . . 74.420000000000002 108.564 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 91' ' ' GLU . 3.6 m -144.53 -171.95 3.71 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 104.27 -2.493 . . . . 73.319999999999993 104.27 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.512 ' H ' HG22 ' A' ' 90' ' ' THR . 3.8 mp0 -60.82 -24.34 65.78 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 119.112 0.869 . . . . 74.5 111.765 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -76.45 -39.92 52.0 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.544 -0.753 . . . . 73.540000000000006 110.665 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 73.9 m -119.21 89.87 40.61 Favored Pre-proline 0 N--CA 1.431 -1.4 0 CA-C-N 116.459 -0.337 . . . . 73.109999999999999 110.627 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.24 152.75 56.17 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 121.809 1.673 . . . . 65.329999999999998 110.575 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.96 141.98 91.24 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.213 2.608 . . . . 44.140000000000001 113.317 -175.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.25 155.62 16.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 106.619 -1.622 . . . . 54.009999999999998 106.619 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.92 144.97 27.36 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 120.958 0.409 . . . . 74.439999999999998 110.183 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -157.24 -159.74 9.7 Favored Glycine 0 CA--C 1.464 -3.14 0 N-CA-C 107.992 -2.043 . . . . 45.039999999999999 107.992 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.474 ' HB3' ' HA ' ' A' ' 27' ' ' MET . 9.1 t-20 -69.45 108.99 3.99 Favored 'General case' 0 N--CA 1.395 -3.206 0 N-CA-C 107.652 -1.24 . . . . 70.420000000000002 107.652 171.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -83.29 109.62 17.41 Favored 'General case' 0 N--CA 1.416 -2.164 0 N-CA-C 107.894 -1.15 . . . . 74.409999999999997 107.894 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 36.7 t -69.32 156.74 38.3 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.856 -1.066 . . . . 65.109999999999999 109.723 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -79.43 94.58 5.58 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.982 -1.118 . . . . 61.049999999999997 107.982 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.7 t -96.31 129.96 45.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.339 -0.846 . . . . 63.43 110.297 -172.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 mp -139.64 -90.42 0.19 Allowed 'General case' 0 C--N 1.269 -2.905 0 CA-C-N 114.746 -1.116 . . . . 71.010000000000005 108.569 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -139.41 163.14 33.29 Favored 'General case' 0 C--N 1.251 -3.684 0 CA-C-N 113.587 -1.642 . . . . 70.409999999999997 106.873 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -34.35 -49.99 0.4 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.284 1.433 . . . . 52.240000000000002 114.843 -172.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 111' ' ' GLU . 27.9 tt0 -61.08 -46.5 90.41 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.095 0.406 . . . . 63.25 112.095 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -78.08 -31.16 50.02 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.494 -0.321 . . . . 61.329999999999998 110.555 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.417 ' O ' HG12 ' A' ' 113' ' ' ILE . 2.3 m-20 -66.43 -45.99 77.99 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.324 -0.853 . . . . 71.010000000000005 110.127 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.2 tp -63.35 -38.08 81.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 116.558 -0.292 . . . . 74.230000000000004 110.729 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 107' ' ' GLU . 44.9 mt-10 -60.14 -46.13 90.7 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.835 -0.431 . . . . 63.420000000000002 109.835 177.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 18.6 t -61.5 -41.1 96.78 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.497 -0.774 . . . . 71.099999999999994 111.137 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 117' ' ' ILE . 46.3 mm -65.42 -46.33 90.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.312 -0.404 . . . . 75.010000000000005 110.377 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 80.1 t -64.88 -39.97 87.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.158 -0.474 . . . . 73.010000000000005 110.554 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -67.46 -32.28 73.02 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 116.366 -0.379 . . . . 71.219999999999999 111.252 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.53 -34.67 53.87 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 120.641 0.258 . . . . 61.229999999999997 111.338 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 113' ' ' ILE . 82.4 mt -64.17 -48.12 87.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.791 -1.189 . . . . 71.430000000000007 107.791 174.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -62.77 -29.73 70.91 Favored 'General case' 0 C--O 1.192 -1.933 0 CA-C-N 115.447 -0.797 . . . . 72.450000000000003 111.633 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -67.59 -35.55 79.19 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.234 0.54 . . . . 54.219999999999999 109.795 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 4.5 t -84.47 -31.15 24.7 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.143 0.973 . . . . 75.349999999999994 109.537 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.6 mp -78.54 -39.34 38.16 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.859 -0.609 . . . . 72.219999999999999 111.98 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.67 -15.55 44.95 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 114.826 1.417 . . . . 42.520000000000003 114.826 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HD3' ' HA ' ' A' ' 123' ' ' LYS 0.346 34.0 mmtp -84.14 -3.93 58.45 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 116.271 1.952 . . . . 62.130000000000003 116.271 -175.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.33 -163.45 53.92 Favored Glycine 0 C--O 1.215 -1.075 0 C-N-CA 120.442 -0.885 . . . . 62.210000000000001 113.44 173.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.287 -2.135 0 CA-C-O 121.86 0.838 . . . . 63.049999999999997 112.823 -177.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 tmm? . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 107.816 -1.179 . . . . 61.409999999999997 107.816 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -110.93 165.72 11.63 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.821 0.819 . . . . 71.340000000000003 113.193 -169.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 7.5 m-85 -121.65 145.81 47.62 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.684 -1.144 . . . . 71.430000000000007 110.28 177.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.442 ' OD1' ' HA3' ' A' ' 30' ' ' GLY . 32.4 t70 -115.13 120.75 40.84 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.762 -1.57 . . . . 73.450000000000003 106.762 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -99.91 116.78 43.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 109.63 -0.507 . . . . 63.130000000000003 109.63 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.42 ' HB ' ' CG ' ' A' ' 85' ' ' LYS . 46.6 t -108.48 117.46 54.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 107.862 -1.162 . . . . 60.409999999999997 107.862 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.503 HG23 ' HB2' ' A' ' 27' ' ' MET . 7.7 tt -117.95 123.09 71.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 121.376 0.608 . . . . 62.420000000000002 110.306 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.2 mp -114.27 98.24 48.04 Favored Pre-proline 0 N--CA 1.422 -1.849 0 CA-C-N 115.648 -0.705 . . . . 44.509999999999998 109.138 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.696 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 5.8 Cg_exo -81.49 130.36 6.95 Favored 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 122.009 1.806 . . . . 74.230000000000004 107.427 171.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.37 131.08 12.36 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.285 0.564 . . . . 72.099999999999994 110.697 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -73.53 122.17 21.77 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 107.672 -1.233 . . . . 54.409999999999997 107.672 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.495 ' HD1' ' O ' ' A' ' 12' ' ' PHE 0.255 0.1 OUTLIER -68.02 105.68 2.11 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.981 0.896 . . . . 63.020000000000003 113.08 -175.256 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -126.75 126.29 43.19 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 113.942 1.09 . . . . 74.120000000000005 113.942 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -76.64 129.18 36.02 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 103.171 -2.9 . . . . 73.5 103.171 165.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.65 111.46 9.86 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-O 121.602 0.715 . . . . 73.319999999999993 110.026 -169.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.57 -164.17 0.61 Allowed 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 114.36 -1.291 . . . . 32.539999999999999 107.967 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -100.88 -29.9 11.97 Favored 'General case' 0 N--CA 1.411 -2.381 0 O-C-N 121.499 -0.751 . . . . 72.209999999999994 110.745 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.1 t60 -135.05 -51.08 0.77 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 118.776 -1.169 . . . . 65.430000000000007 113.357 -175.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -122.22 139.08 54.19 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 109.358 -0.608 . . . . 72.140000000000001 109.358 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.303 59.3 mtm 96.64 73.35 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 126.338 1.855 . . . . 65.019999999999996 111.295 -175.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -156.41 94.07 1.46 Allowed 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 112.696 -2.047 . . . . 42.539999999999999 107.44 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -142.17 120.55 12.37 Favored 'General case' 0 CA--C 1.47 -2.116 0 O-C-N 121.577 -0.702 . . . . 71.540000000000006 109.462 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mm -133.05 143.67 38.72 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.799 0 N-CA-C 104.225 -2.509 . . . . 74.349999999999994 104.225 175.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.696 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 60.5 m -107.77 150.1 39.82 Favored Pre-proline 0 C--N 1.274 -2.7 0 N-CA-C 109.989 -0.374 . . . . 73.420000000000002 109.989 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 27.0 Cg_exo -65.29 142.5 73.26 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.239 2.626 . . . . 63.32 114.255 -176.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 31.8 Cg_exo -63.06 126.49 18.05 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 123.104 2.536 . . . . 41.119999999999997 110.994 175.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.503 ' HB2' HG23 ' A' ' 7' ' ' ILE . 84.3 mtp -101.23 145.29 29.03 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.333 -0.988 . . . . 60.140000000000001 108.333 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 62.2 t -130.76 121.21 49.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.417 -0.586 . . . . 65.25 109.417 -178.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.6 mp -131.14 102.18 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.772 0 N-CA-C 106.205 -1.776 . . . . 72.049999999999997 106.205 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.442 ' HA3' ' OD1' ' A' ' 4' ' ' ASP . . . -117.53 -172.75 16.09 Favored Glycine 0 C--N 1.269 -3.146 0 C-N-CA 119.902 -1.142 . . . . 55.030000000000001 112.773 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.45 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 9.0 t70 71.7 67.6 0.15 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 125.636 1.574 . . . . 71.140000000000001 110.515 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.515 HH22 ' CG1' ' A' ' 103' ' ' VAL . 3.8 mpt_? -140.25 143.92 36.21 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 104.818 -2.29 . . . . 74.25 104.818 172.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 t -78.53 -179.71 6.56 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.78 -1.168 . . . . 62.149999999999999 108.07 174.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.455 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 88.3 t80 -55.98 -52.91 62.5 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 123.094 0.558 . . . . 70.349999999999994 112.394 -174.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 46.2 m-20 -68.04 -39.9 82.96 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.008 -0.997 . . . . 64.310000000000002 110.136 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.0 mt -65.03 -38.32 82.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.305 -0.861 . . . . 75.25 109.925 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.16 -42.47 88.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.791 -0.448 . . . . 72.129999999999995 109.791 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 24.0 mmt -64.77 -41.32 95.95 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.037 -0.529 . . . . 74.099999999999994 110.825 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 35' ' ' ASP . 40.1 mt-10 -66.27 -40.29 90.02 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 112.337 0.495 . . . . 73.349999999999994 112.337 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 44' ' ' VAL . 15.0 tt -72.58 -41.49 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 119.198 -1.001 . . . . 74.450000000000003 110.609 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.433 HG21 HD21 ' A' ' 86' ' ' LEU . 92.6 t -72.15 -37.15 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 120.468 -0.493 . . . . 62.219999999999999 111.309 -177.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -74.31 -23.89 59.14 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.611 -0.436 . . . . 74.219999999999999 111.057 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.87 -45.93 40.24 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.196 -1.161 . . . . 32.140000000000001 110.196 175.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 40' ' ' ILE . 61.5 t -63.3 -41.97 94.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 N-CA-C 108.981 -0.748 . . . . 75.319999999999993 108.981 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.68 -52.34 31.76 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 125.372 1.469 . . . . 65.25 110.793 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -63.93 -40.25 96.02 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.789 -1.096 . . . . 71.310000000000002 110.732 -177.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.93 -36.62 74.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.215 -0.448 . . . . 72.420000000000002 110.592 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.4 mt -67.62 -43.74 86.69 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.171 0 N-CA-C 109.901 -0.407 . . . . 73.420000000000002 109.901 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -74.26 -15.75 60.97 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.628 0.603 . . . . 75.109999999999999 112.628 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.76 -33.99 13.38 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 112.177 0.436 . . . . 45.130000000000003 112.177 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -96.52 -19.21 19.27 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.258 0.551 . . . . 72.040000000000006 112.359 -176.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.416 ' CD2' ' HD2' ' A' ' 75' ' ' LYS . 22.4 m-85 -137.23 -176.36 4.36 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.686 -1.227 . . . . 71.310000000000002 107.686 -176.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.403 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 36.6 t30 -107.49 117.78 34.99 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.985 -1.487 . . . . 73.109999999999999 106.985 174.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -138.24 134.98 35.09 Favored 'General case' 0 N--CA 1.405 -2.71 0 C-N-CA 119.892 -0.723 . . . . 72.230000000000004 110.934 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.6 m -108.18 120.04 41.21 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 105.754 -1.943 . . . . 73.030000000000001 105.754 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.32 127.36 53.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.185 0.517 . . . . 64.129999999999995 110.767 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -121.72 116.6 24.82 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.748 -1.205 . . . . 64.140000000000001 107.748 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' A' ' 69' ' ' ARG . 42.1 mt-10 -100.49 118.18 36.17 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 120.872 0.368 . . . . 72.319999999999993 111.634 -177.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mp -121.32 178.13 4.9 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.69 -0.855 . . . . 62.219999999999999 108.69 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -87.59 149.61 24.21 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.746 -0.835 . . . . 75.549999999999997 108.746 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -92.35 175.17 37.47 Favored Glycine 0 C--N 1.292 -1.908 0 N-CA-C 110.316 -1.114 . . . . 71.109999999999999 110.316 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -92.5 133.81 35.57 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 118.079 0.939 . . . . 74.209999999999994 112.749 -175.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.3 t70 59.26 -76.59 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.918 1.687 . . . . 62.109999999999999 114.53 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.9 t -119.38 5.53 11.16 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.425 0.631 . . . . 72.430000000000007 110.748 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.508 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 65.3 m-20 -81.43 124.17 29.2 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.943 -1.873 . . . . 73.150000000000006 105.943 173.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.8 t -83.75 -37.15 13.0 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 112.457 0.54 . . . . 74.5 112.457 -173.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 59.2 tp -142.18 137.85 31.13 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 109.169 -0.678 . . . . 64.409999999999997 109.169 -175.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.06 103.59 6.85 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.097 -1.446 . . . . 70.230000000000004 107.097 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.461 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 8.2 ptp180 -107.67 119.81 40.46 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 122.047 0.927 . . . . 74.420000000000002 111.226 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -98.71 108.69 21.44 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 113.704 -1.589 . . . . 74.340000000000003 108.036 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.413 ' CE1' ' HD3' ' A' ' 69' ' ' ARG . 89.0 m-85 -97.21 131.38 44.0 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.882 -0.784 . . . . 74.319999999999993 108.882 176.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 15.4 m -96.13 118.58 32.99 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.662 -1.607 . . . . 53.100000000000001 106.662 173.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.24 134.74 47.84 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 112.976 0.732 . . . . 73.510000000000005 112.976 -173.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 53' ' ' ASN . 51.6 mm-40 -136.45 137.04 40.01 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.155 -1.384 . . . . 75.519999999999996 108.105 174.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.577 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -141.79 85.88 1.96 Allowed 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.141 -1.429 . . . . 62.210000000000001 107.141 175.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.278 15.5 pt-20 32.95 69.62 0.12 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.919 1.687 . . . . 75.230000000000004 114.572 -174.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.19 -23.33 35.18 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.035 -0.984 . . . . 52.219999999999999 112.565 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.539 ' N ' ' HE3' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -85.88 124.25 32.14 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.064 -1.828 . . . . 74.209999999999994 106.064 178.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -132.2 146.51 52.07 Favored 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 120.057 -0.657 . . . . 71.420000000000002 111.745 -172.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.24 176.56 38.61 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.196 -0.911 . . . . 73.049999999999997 111.174 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 72' ' ' THR . 9.4 tp -129.47 138.0 55.44 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 106.668 -1.604 . . . . 73.420000000000002 106.668 178.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 62.1 t -125.44 110.32 24.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.467 -0.771 . . . . 63.240000000000002 110.083 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -96.92 106.36 18.67 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 123.838 0.855 . . . . 73.140000000000001 110.411 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.461 ' HB ' ' HG3' ' A' ' 69' ' ' ARG . 24.2 t -107.09 115.46 48.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.048 -0.723 . . . . 72.150000000000006 109.048 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.42 ' CG ' ' HB ' ' A' ' 6' ' ' VAL . 18.3 ptpt -110.45 140.42 44.71 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.819 -0.437 . . . . 70.140000000000001 109.819 177.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.433 HD21 HG21 ' A' ' 41' ' ' VAL . 44.4 mt -107.8 108.02 19.04 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 105.399 -2.074 . . . . 72.430000000000007 105.399 178.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 43.9 ttt85 -97.81 133.13 42.74 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 109.057 -0.72 . . . . 72.439999999999998 109.057 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -79.34 112.82 16.95 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.42 -0.955 . . . . 72.299999999999997 108.42 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.5 tt -91.08 111.44 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-O 122.373 1.082 . . . . 74.310000000000002 109.023 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.6 m -133.53 172.6 12.51 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 105.206 -2.146 . . . . 53.539999999999999 105.206 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -64.55 -20.89 66.5 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 118.872 0.76 . . . . 70.140000000000001 110.485 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -94.48 -5.83 45.27 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.039 -0.982 . . . . 74.340000000000003 111.59 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 70.3 m -133.32 109.52 12.51 Favored Pre-proline 0 C--N 1.314 -0.94 0 O-C-N 122.124 -0.36 . . . . 73.019999999999996 111.046 -175.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.56 138.86 24.79 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.143 1.895 . . . . 53.420000000000002 112.387 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.95 164.66 33.9 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 123.414 2.742 . . . . 51.340000000000003 111.13 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.7 t -94.11 155.7 3.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.988 -0.745 . . . . 72.549999999999997 108.988 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -106.19 122.08 45.48 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.512 -0.767 . . . . 70.209999999999994 109.086 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -158.13 -159.65 9.74 Favored Glycine 0 CA--C 1.468 -2.85 0 N-CA-C 110.229 -1.148 . . . . 54.0 110.229 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -76.29 93.0 3.36 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-O 121.828 0.823 . . . . 54.25 111.375 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 62.9 ttt180 -73.89 122.01 21.84 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.252 -1.34 . . . . 72.109999999999999 108.037 177.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 38.7 t -88.97 163.79 15.4 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.896 -0.722 . . . . 73.329999999999998 109.846 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.7 m -75.31 107.75 7.63 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 122.934 0.494 . . . . 75.340000000000003 109.902 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.515 ' CG1' HH22 ' A' ' 32' ' ' ARG . 36.5 t -85.01 135.91 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-O 122.132 0.967 . . . . 70.450000000000003 110.277 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.0 mt -153.18 -163.84 1.78 Allowed 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 104.805 -2.294 . . . . 73.099999999999994 104.805 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -54.05 145.93 15.76 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 118.405 0.548 . . . . 75.219999999999999 111.406 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.428 ' O ' HG22 ' A' ' 110' ' ' ILE . 13.9 t80 -32.91 -48.57 0.21 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.425 2.29 . . . . 75.230000000000004 113.707 -173.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.564 ' O ' ' HG3' ' A' ' 111' ' ' GLU . 43.3 tt0 -57.4 -43.87 84.05 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 112.349 0.5 . . . . 62.299999999999997 112.349 -176.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 -72.09 -31.4 66.04 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.145 -0.622 . . . . 61.409999999999997 111.501 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -71.38 -44.7 64.46 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.879 -1.055 . . . . 74.200000000000003 108.412 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 106' ' ' PHE . 12.7 tt -68.37 -36.79 76.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 C-N-CA 120.479 -0.489 . . . . 74.099999999999994 110.681 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 107' ' ' GLU . 52.6 mt-10 -61.56 -35.94 79.22 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.874 0.368 . . . . 74.140000000000001 110.064 176.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 44.5 t -64.98 -43.44 92.62 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.005 -0.543 . . . . 75.439999999999998 109.953 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.6 mm -64.58 -46.66 91.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.513 -0.767 . . . . 73.430000000000007 110.301 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 110' ' ' ILE . 92.3 t -63.29 -39.2 84.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.456 -0.338 . . . . 73.319999999999993 110.53 -177.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -62.64 -38.7 91.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.052 0.453 . . . . 74.120000000000005 110.4 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.89 -42.32 90.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.132 -0.486 . . . . 71.030000000000001 110.326 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.78 -42.75 93.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.008 -0.542 . . . . 75.209999999999994 110.569 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 114' ' ' VAL . 52.8 mt-10 -61.12 -44.81 96.77 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 121.319 -0.152 . . . . 75.129999999999995 110.618 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -65.07 -46.59 80.55 Favored 'General case' 0 C--O 1.181 -2.502 0 C-N-CA 119.685 -0.806 . . . . 72.439999999999998 110.336 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 2.7 t -68.84 -22.71 64.21 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.324 0.583 . . . . 61.310000000000002 111.616 -172.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 8.2 mp -81.96 -47.1 13.12 Favored 'General case' 0 N--CA 1.428 -1.553 0 O-C-N 121.999 -0.438 . . . . 55.310000000000002 111.473 174.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.16 -25.59 31.71 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.855 0.687 . . . . 51.100000000000001 112.855 -172.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -102.65 9.92 38.98 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.431 -1.322 . . . . 44.439999999999998 107.431 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.11 57.35 2.75 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 114.445 -1.252 . . . . 61.210000000000001 115.329 -174.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--N 1.272 -2.765 0 C-N-CA 125.233 1.413 . . . . 72.25 107.228 172.68 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 mtp . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 121.363 0.601 . . . . 73.319999999999993 112.179 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -141.32 174.12 10.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.561 -1.274 . . . . 71.219999999999999 107.561 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 24.9 m-85 -120.35 134.96 55.17 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-O 121.325 0.583 . . . . 71.439999999999998 109.697 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.672 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 62.3 t0 -115.26 119.37 36.09 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.245 -1.343 . . . . 74.420000000000002 108.404 -175.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.6 125.7 50.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 115.673 -0.694 . . . . 75.439999999999998 111.393 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.498 ' HB ' HH21 ' A' ' 87' ' ' ARG . 7.7 p -112.39 115.84 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 N-CA-C 108.603 -0.888 . . . . 71.129999999999995 108.603 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.454 HG23 ' HB2' ' A' ' 27' ' ' MET . 8.3 tt -104.02 124.45 58.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.482 -0.781 . . . . 70.319999999999993 108.952 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.1 mt -114.92 95.81 42.78 Favored Pre-proline 0 C--N 1.302 -1.457 0 CA-C-N 115.808 -0.633 . . . . 51.439999999999998 109.346 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.635 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 9.7 Cg_endo -89.45 126.6 1.58 Allowed 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.762 2.308 . . . . 71.129999999999995 110.173 176.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -150.67 127.67 11.12 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.615 0.722 . . . . 63.409999999999997 110.781 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.2 m -74.42 111.44 9.6 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.791 -1.189 . . . . 72.310000000000002 107.791 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.44 120.64 14.85 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.647 0.737 . . . . 73.140000000000001 112.948 -173.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -129.65 114.72 16.37 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 115.176 -0.92 . . . . 74.319999999999993 110.305 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -78.86 118.65 21.1 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 104.927 -2.249 . . . . 74.239999999999995 104.927 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -48.11 104.31 0.06 Allowed 'General case' 0 N--CA 1.424 -1.765 0 O-C-N 125.378 1.673 . . . . 73.409999999999997 110.578 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.451 ' H ' ' HB2' ' A' ' 20' ' ' MET . 12.9 t70 -84.8 -145.89 0.09 Allowed 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 112.685 -2.052 . . . . 40.32 108.292 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -63.05 -58.37 7.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 118.3 0.5 . . . . 61.210000000000001 111.369 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -137.3 -52.55 0.67 Allowed 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 118.866 -1.134 . . . . 74.319999999999993 113.833 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' O ' ' HG2' ' A' ' 20' ' ' MET . 10.5 t30 -108.27 80.95 1.41 Allowed 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 113.104 0.779 . . . . 74.349999999999994 113.104 -170.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 70.5 mmm -163.24 70.94 0.25 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.08 1.352 . . . . 75.129999999999995 109.287 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -146.21 89.89 1.91 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.319 -1.734 . . . . 62.299999999999997 106.319 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -113.25 118.03 33.5 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.201 -1.0 . . . . 74.230000000000004 111.08 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.408 HD11 ' N ' ' A' ' 132' ' ' GLY . 21.5 mm -133.18 127.48 54.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.489 -0.778 . . . . 63.399999999999999 110.735 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 76.9 m -111.54 129.23 24.32 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 108.458 -0.941 . . . . 60.229999999999997 108.458 172.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.4 ' HB2' ' ND2' ' A' ' 99' ' ' ASN . 27.0 Cg_exo -63.49 146.95 93.43 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.685 2.257 . . . . 74.219999999999999 112.725 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -63.86 147.93 92.02 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 123.68 2.92 . . . . 62.119999999999997 113.422 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.502 ' HG2' ' HB2' ' A' ' 99' ' ' ASN . 64.2 mtt -111.07 132.94 53.84 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.194 -1.039 . . . . 74.010000000000005 108.194 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.9 t -126.37 125.6 67.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 O-C-N 123.497 0.498 . . . . 71.510000000000005 110.457 -171.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.8 mm -138.21 116.17 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.748 0.819 . . . . 45.009999999999998 109.504 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.672 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -127.94 81.98 0.34 Allowed Glycine 0 CA--C 1.48 -2.139 0 C-N-CA 118.726 -1.702 . . . . 74.319999999999993 114.801 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.92 7.91 1.65 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.205 -0.598 . . . . 63.43 112.432 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.459 HH21 ' CG1' ' A' ' 103' ' ' VAL . 14.8 mmt85 -103.99 134.41 47.31 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.148 -0.621 . . . . 43.240000000000002 109.553 -169.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 p -78.19 163.76 25.52 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 107.678 -1.23 . . . . 71.120000000000005 107.678 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.513 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 63.3 t80 -51.42 -43.24 61.94 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 124.27 1.028 . . . . 75.219999999999999 111.22 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.99 -41.78 95.11 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.151 -0.931 . . . . 63.240000000000002 111.719 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.8 mt -79.29 -30.47 14.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.529 -0.545 . . . . 64.310000000000002 109.529 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.31 -45.8 89.68 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.353 -0.839 . . . . 75.030000000000001 110.098 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.08 -31.38 70.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 119.924 -0.711 . . . . 72.120000000000005 112.276 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.23 -45.07 67.28 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 119.495 -0.882 . . . . 74.329999999999998 110.508 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.4 tp -66.72 -40.9 87.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 C-N-CA 120.107 -0.637 . . . . 72.439999999999998 110.176 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.3 t -65.57 -42.67 93.5 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.008 0 CA-C-N 116.737 -0.21 . . . . 72.200000000000003 110.57 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -63.85 -40.73 97.26 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 120.761 0.315 . . . . 74.439999999999998 111.349 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -66.85 -44.9 87.98 Favored Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 111.062 -0.815 . . . . 52.149999999999999 111.062 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.17 -39.85 86.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.649 -0.5 . . . . 73.239999999999995 109.649 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.447 ' OD2' ' HE2' ' A' ' 49' ' ' LYS . 23.2 t70 -57.75 -46.42 84.54 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 124.387 1.075 . . . . 61.409999999999997 110.653 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 46' ' ' ARG . 29.7 mmt180 -67.42 -37.64 83.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.14 -0.482 . . . . 73.409999999999997 111.597 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 43' ' ' GLY . 62.3 t -68.36 -41.89 83.83 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 120.772 -0.371 . . . . 60.130000000000003 110.302 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.49 HG23 HD11 ' A' ' 73' ' ' LEU . 66.3 mt -66.01 -38.33 81.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 O-C-N 122.035 -0.416 . . . . 73.510000000000005 111.091 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 142' ' ' LEU . 54.0 mtmt -76.57 -17.79 59.02 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.912 0.708 . . . . 74.409999999999997 112.912 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.02 -33.91 7.34 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 113.625 0.972 . . . . 65.450000000000003 113.625 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 t -87.4 -9.99 53.22 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.423 0.63 . . . . 61.25 110.053 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.615 ' CE2' ' HD2' ' A' ' 75' ' ' LYS . 12.3 m-85 -137.33 175.81 9.27 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 107.503 -1.295 . . . . 71.239999999999995 107.503 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 142' ' ' LEU . 64.0 t30 -104.42 77.35 1.38 Allowed 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 105.462 -2.051 . . . . 72.129999999999995 105.462 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.499 ' HB2' HD13 ' A' ' 73' ' ' LEU . . . -114.46 136.44 53.01 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-N 115.158 -0.928 . . . . 73.430000000000007 112.532 -172.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 m -109.37 123.54 49.49 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.282 -1.377 . . . . 75.340000000000003 107.282 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 p -100.63 152.42 4.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 116.11 -0.495 . . . . 31.23 110.293 -173.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -142.13 140.08 32.36 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.691 -1.225 . . . . 73.040000000000006 107.691 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.96 136.32 49.42 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.34 0.59 . . . . 73.299999999999997 110.883 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mp -135.91 167.53 21.01 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.913 -1.143 . . . . 63.020000000000003 107.913 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -100.54 142.76 31.56 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.038 -1.468 . . . . 73.010000000000005 107.038 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.52 174.89 48.93 Favored Glycine 0 C--N 1.296 -1.681 0 C-N-CA 120.708 -0.758 . . . . 72.450000000000003 112.121 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.77 130.47 35.13 Favored 'General case' 0 C--O 1.179 -2.628 0 N-CA-C 108.188 -1.042 . . . . 51.039999999999999 108.188 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 13.64 -73.76 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 C-N-CA 128.241 2.616 . . . . 75.340000000000003 116.829 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 53.3 t -57.12 -37.75 72.43 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 124.151 0.98 . . . . 75.329999999999998 110.046 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 8.7 m-20 -86.18 124.4 32.54 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.601 -1.259 . . . . 62.5 107.601 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.4 t -93.83 -28.78 4.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-O 121.304 0.573 . . . . 72.439999999999998 111.717 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.6 tp -145.34 141.3 28.38 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.124 -0.695 . . . . 63.229999999999997 109.124 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.28 108.96 10.4 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.199 -1.408 . . . . 74.420000000000002 107.199 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -104.79 114.77 29.19 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.279 -1.378 . . . . 75.439999999999998 107.279 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 36.1 ttmt -101.12 132.64 46.49 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.341 0.657 . . . . 74.150000000000006 109.295 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -126.4 125.24 41.86 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.716 -0.475 . . . . 74.310000000000002 109.716 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 m -98.38 113.49 25.49 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.999 -1.482 . . . . 74.319999999999993 106.999 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.499 HD13 ' HB2' ' A' ' 54' ' ' ALA . 4.2 mm? -98.38 139.99 33.32 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.573 0.583 . . . . 75.409999999999997 112.573 -172.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HB2' ' HE2' ' A' ' 79' ' ' LYS . 42.9 tt0 -140.13 127.95 21.92 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 105.715 -1.957 . . . . 73.239999999999995 105.715 170.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.615 ' HD2' ' CE2' ' A' ' 52' ' ' PHE . 49.2 tttm -134.79 -176.91 4.39 Favored 'General case' 0 C--N 1.273 -2.744 0 N-CA-C 104.933 -2.247 . . . . 61.509999999999998 104.933 177.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.428 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -55.97 92.25 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 114.568 1.322 . . . . 73.510000000000005 114.568 -175.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.7 17.6 74.99 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 114.903 -1.044 . . . . 62.130000000000003 113.146 175.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 44.4 mtmt -140.09 143.99 36.57 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.419 -0.586 . . . . 72.120000000000005 109.419 -175.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 73' ' ' LEU . 33.6 ttmt -146.79 139.31 24.98 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 110.033 -0.358 . . . . 73.420000000000002 110.033 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.62 174.4 35.71 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 110.902 -0.879 . . . . 61.119999999999997 110.902 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.9 tp -119.56 134.46 63.05 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 108.106 -1.072 . . . . 74.430000000000007 108.106 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.2 t -123.61 115.59 45.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.432 0.634 . . . . 75.319999999999993 109.673 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.409 ' CD2' ' HG3' ' A' ' 70' ' ' LYS . 36.4 m170 -107.15 116.67 32.33 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.257 -0.883 . . . . 63.32 110.512 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.58 110.0 30.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.737 -0.838 . . . . 75.430000000000007 108.737 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -118.27 137.4 53.07 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.891 -0.506 . . . . 72.540000000000006 111.336 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.7 mt -106.37 118.76 37.48 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.112 -0.495 . . . . 73.230000000000004 109.944 -171.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.498 HH21 ' HB ' ' A' ' 6' ' ' VAL . 28.5 mtm105 -97.15 141.14 30.65 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.025 0.441 . . . . 73.510000000000005 110.096 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 64' ' ' CYS . 49.7 pttt -80.23 98.11 7.23 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 109.301 -0.629 . . . . 71.209999999999994 109.301 173.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.0 tt -69.22 112.01 3.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-O 122.513 1.149 . . . . 74.439999999999998 109.636 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.6 p -140.68 -171.4 3.22 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 113.35 -1.75 . . . . 51.020000000000003 107.723 -170.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.47 -5.0 53.83 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.593 0.711 . . . . 62.020000000000003 110.658 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -99.74 -29.25 12.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.547 -0.751 . . . . 54.25 109.169 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 84.9 m -121.27 92.87 48.76 Favored Pre-proline 0 N--CA 1.431 -1.377 0 CA-C-N 115.429 -0.805 . . . . 54.109999999999999 109.719 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -76.48 167.79 24.97 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.189 1.926 . . . . 73.040000000000006 110.976 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.24 123.34 12.31 Favored 'Trans proline' 0 C--O 1.251 1.157 0 C-N-CA 122.032 1.821 . . . . 62.420000000000002 110.194 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 t -86.68 157.57 3.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.462 -0.57 . . . . 73.430000000000007 109.462 -176.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.47 137.49 32.31 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.96 -0.564 . . . . 74.200000000000003 110.299 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -177.1 -170.43 39.52 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 108.76 -1.736 . . . . 74.439999999999998 108.76 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.502 ' HB2' ' HG2' ' A' ' 27' ' ' MET . 94.1 m-20 -71.63 140.01 49.54 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.187 -0.671 . . . . 62.140000000000001 109.187 178.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -98.63 119.7 37.81 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.019 0.438 . . . . 71.439999999999998 111.133 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 41.1 t -73.2 139.04 46.0 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.553 -0.906 . . . . 72.219999999999999 108.553 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 m -74.03 91.15 2.03 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.494 0.664 . . . . 73.519999999999996 110.374 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.459 ' CG1' HH21 ' A' ' 32' ' ' ARG . 66.7 t -89.57 136.59 23.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 114.748 -1.115 . . . . 65.150000000000006 109.897 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 93.4 mt -148.48 -88.74 0.08 Allowed 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.099 -0.955 . . . . 61.549999999999997 109.606 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -120.58 166.9 13.0 Favored 'General case' 0 C--N 1.262 -3.239 0 N-CA-C 107.006 -1.479 . . . . 64.219999999999999 107.006 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -44.71 -46.74 10.54 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 124.172 0.92 . . . . 74.329999999999998 112.761 -178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.04 -31.54 72.14 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.477 -0.783 . . . . 72.010000000000005 112.271 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -81.47 -36.9 28.77 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.112 -0.699 . . . . 75.230000000000004 109.112 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.415 ' O ' HG12 ' A' ' 113' ' ' ILE . 44.2 m-20 -63.61 -45.39 90.51 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.11 -0.95 . . . . 71.540000000000006 109.198 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 114' ' ' VAL . 7.0 tp -67.69 -36.91 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 120.335 -0.546 . . . . 60.439999999999998 110.951 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.26 -33.18 75.17 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.266 -0.642 . . . . 70.319999999999993 109.266 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 41.6 t -65.09 -38.93 92.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.677 -0.692 . . . . 60.229999999999997 110.248 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 109' ' ' ASP . 51.5 mm -67.69 -43.57 86.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.906 -0.405 . . . . 75.319999999999993 109.906 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 110' ' ' ILE . 83.7 t -60.43 -43.65 94.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.024 -0.535 . . . . 73.329999999999998 111.037 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -66.92 -31.35 71.88 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 120.767 -0.373 . . . . 41.43 110.38 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.64 -45.58 71.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.017 0.437 . . . . 75.140000000000001 110.809 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.4 mt -68.1 -44.13 84.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.545 -0.752 . . . . 72.439999999999998 109.461 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.1 -31.48 71.99 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 112.398 0.518 . . . . 62.43 112.398 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.35 -43.0 61.57 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 119.416 -0.914 . . . . 74.150000000000006 110.012 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 2.6 t -70.36 -41.26 73.35 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.6 0.714 . . . . 62.329999999999998 109.556 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 10.4 mp -74.61 -35.68 62.95 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.75 -0.659 . . . . 74.400000000000006 111.994 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.15 -14.77 52.85 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 119.544 -0.863 . . . . 44.200000000000003 113.033 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.53 -34.59 58.54 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 118.232 -1.387 . . . . 71.519999999999996 111.733 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.48 -153.93 39.16 Favored Glycine 0 C--N 1.295 -1.701 0 CA-C-N 114.726 -1.124 . . . . 71.140000000000001 115.752 172.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -51.39 103.77 0.07 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 125.088 1.355 . . . . 75.329999999999998 112.494 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.89 -178.74 5.96 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 106.883 -1.525 . . . . 75.219999999999999 106.883 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -110.13 139.17 45.56 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.453 -0.943 . . . . 54.210000000000001 108.453 172.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.8 t -155.5 -164.66 1.8 Allowed 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.874 -1.158 . . . . 73.120000000000005 107.874 -174.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -56.1 144.37 29.52 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.204 1.002 . . . . 62.119999999999997 109.913 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -80.34 88.9 5.53 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.436 0.636 . . . . 72.040000000000006 109.949 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -151.82 -164.87 2.08 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 105.352 -2.092 . . . . 73.120000000000005 105.352 173.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.522 ' O ' ' HD3' ' A' ' 134' ' ' PRO . . . 121.46 106.19 1.97 Allowed Glycine 0 CA--C 1.474 -2.479 0 N-CA-C 109.778 -1.329 . . . . 63.219999999999999 109.778 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -102.57 100.93 17.5 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-O 121.535 0.683 . . . . 60.25 111.772 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 132' ' ' GLY . 1.6 Cg_endo -81.88 85.72 1.66 Allowed 'Trans proline' 0 N--CA 1.43 -2.26 0 C-N-CA 122.162 1.908 . . . . 73.519999999999996 109.649 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 46.0 mm -87.85 110.31 34.06 Favored Pre-proline 0 N--CA 1.417 -2.102 0 N-CA-C 108.716 -0.846 . . . . 73.329999999999998 108.716 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.35 134.64 39.66 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 122.99 2.46 . . . . 70.420000000000002 111.959 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -127.48 112.39 21.07 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 107.532 -1.284 . . . . 75.239999999999995 107.532 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -68.12 -11.37 31.82 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.963 2.442 . . . . 74.450000000000003 113.658 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.47 123.25 40.07 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.869 -0.419 . . . . 74.219999999999999 109.869 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mp -125.52 89.66 3.08 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.028 -0.73 . . . . 62.549999999999997 109.028 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.93 151.31 12.1 Favored Glycine 0 C--N 1.304 -1.24 0 C-N-CA 120.545 -0.836 . . . . 62.229999999999997 111.549 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 2.5 pt? -96.43 -178.62 4.35 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.698 -0.482 . . . . 72.319999999999993 109.698 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 49' ' ' LYS . 22.8 t0 -130.29 112.13 13.04 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.18 -0.674 . . . . 63.32 109.18 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 24.2 m -64.04 117.47 7.11 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.297 -0.865 . . . . 41.130000000000003 112.75 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.1 m -162.28 93.57 0.87 Allowed 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.448 -1.316 . . . . 65.120000000000005 107.448 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -85.23 149.32 25.57 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.913 -1.143 . . . . 74.040000000000006 107.913 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.9 m -77.7 130.05 36.3 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.409 -0.96 . . . . 70.310000000000002 108.409 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.472 0 N-CA-C 109.895 -1.282 . . . . 41.32 109.895 -177.69 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 tpt . . . . . 0 CA--C 1.511 -0.524 0 N-CA-C 109.402 -0.592 . . . . 52.329999999999998 109.402 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -128.84 170.77 12.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.362 -0.607 . . . . 70.319999999999993 109.362 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.484 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 16.6 m-85 -124.18 146.93 48.37 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.832 -0.622 . . . . 74.319999999999993 110.694 177.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.645 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 0.4 OUTLIER -99.03 102.44 14.16 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 125.27 1.428 . . . . 71.219999999999999 108.246 178.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.1 t -85.0 113.13 23.03 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 107.526 -1.287 . . . . 71.340000000000003 107.526 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.442 HG13 HG22 ' A' ' 28' ' ' VAL . 60.0 t -107.26 107.78 23.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.882 -1.155 . . . . 74.239999999999995 107.882 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.9 tt -110.91 110.06 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-O 122.064 0.935 . . . . 73.540000000000006 109.466 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.406 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 45.6 mt -106.77 104.71 52.57 Favored Pre-proline 0 C--N 1.293 -1.879 0 CA-C-N 114.245 -1.343 . . . . 75.519999999999996 110.143 -174.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.693 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 5.9 Cg_exo -81.04 137.51 10.9 Favored 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 121.701 1.601 . . . . 73.109999999999999 108.463 170.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -139.27 156.59 46.95 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.001 -1.481 . . . . 73.219999999999999 107.001 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.458 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 35.7 m -104.58 126.47 51.69 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.397 -0.964 . . . . 73.120000000000005 108.397 175.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.523 ' CE1' ' HB3' ' A' ' 79' ' ' LYS 0.275 8.2 p90 -73.79 75.31 1.59 Allowed 'General case' 0 C--N 1.349 0.573 0 CA-C-O 122.723 1.249 . . . . 72.329999999999998 114.098 -176.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.635 ' NE2' ' HD2' ' A' ' 79' ' ' LYS . 50.3 m80 -128.46 111.41 13.26 Favored 'General case' 0 N--CA 1.414 -2.265 0 O-C-N 121.59 -0.694 . . . . 70.120000000000005 111.696 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -72.47 144.22 48.15 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.388 -1.278 . . . . 74.409999999999997 108.91 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -52.69 120.33 5.58 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 116.983 2.216 . . . . 73.319999999999993 116.983 -173.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.595 ' HB3' ' O ' ' A' ' 19' ' ' ASN . 9.5 t70 -100.45 168.22 9.88 Favored 'General case' 0 C--N 1.262 -3.203 0 CA-C-N 111.974 -2.376 . . . . 70.239999999999995 105.114 165.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -62.63 -32.84 73.94 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 122.63 0.372 . . . . 55.43 111.885 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -135.55 -35.68 0.8 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.901 0.704 . . . . 73.430000000000007 112.901 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.595 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 5.1 m-20 -95.84 -178.62 4.43 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.097 -0.501 . . . . 73.439999999999998 109.662 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 62.8 mtt 56.58 71.32 0.57 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 114.12 1.156 . . . . 71.510000000000005 114.12 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.423 ' OE2' ' HA ' ' A' ' 128' ' ' SER . 12.2 tt0 -165.72 116.45 1.05 Allowed 'General case' 0 N--CA 1.406 -2.658 0 N-CA-C 103.412 -2.811 . . . . 64.549999999999997 103.412 172.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.632 ' ND1' ' HB3' ' A' ' 127' ' ' ASN . 3.6 t60 -153.73 104.75 2.73 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-O 122.034 0.921 . . . . 62.43 110.77 171.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.5 mm -96.58 128.85 47.4 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.707 0 N-CA-C 104.076 -2.564 . . . . 75.150000000000006 104.076 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.693 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 59.3 m -107.81 159.06 31.82 Favored Pre-proline 0 C--N 1.288 -2.104 0 C-N-CA 119.812 -0.755 . . . . 72.120000000000005 110.426 -168.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.33 116.85 3.48 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.571 2.18 . . . . 73.150000000000006 112.741 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.52 128.87 5.55 Favored 'Trans proline' 0 C--O 1.256 1.39 0 C-N-CA 122.111 1.874 . . . . 74.349999999999994 111.501 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -91.44 126.26 36.47 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.723 -0.671 . . . . 74.219999999999999 110.594 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.449 HG11 ' HB ' ' A' ' 96' ' ' VAL . 94.6 t -123.14 115.24 45.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.555 -0.748 . . . . 53.43 108.994 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.475 HD11 ' H ' ' A' ' 101' ' ' CYS . 45.3 mm -125.14 102.47 10.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 109.664 -0.495 . . . . 52.399999999999999 109.664 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.645 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -110.1 80.39 0.27 Allowed Glycine 0 CA--C 1.474 -2.505 0 C-N-CA 119.84 -1.172 . . . . 64.310000000000002 112.92 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -165.3 20.69 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.06 -1.07 . . . . 74.109999999999999 110.304 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -103.08 133.39 48.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.99 -1.855 . . . . 73.140000000000001 105.99 -173.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.0 p -77.93 165.92 23.5 Favored 'General case' 0 N--CA 1.408 -2.526 0 N-CA-C 107.929 -1.137 . . . . 61.32 107.929 174.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.484 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 59.7 t80 -52.76 -43.92 66.13 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 123.333 0.653 . . . . 71.140000000000001 111.029 -174.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.01 -31.33 68.95 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.019 -0.991 . . . . 60.109999999999999 112.889 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -81.63 -34.36 12.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.216 0.531 . . . . 75.430000000000007 109.601 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.04 -45.43 88.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.672 -0.695 . . . . 61.229999999999997 110.012 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.3 mmt -69.85 -29.72 67.03 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.891 0.376 . . . . 74.450000000000003 110.313 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -67.68 -44.71 77.14 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 115.789 -0.641 . . . . 74.219999999999999 110.31 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 44' ' ' VAL . 7.9 tp -69.93 -39.91 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 119.709 -0.797 . . . . 73.120000000000005 109.738 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.31 -42.09 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 116.602 -0.272 . . . . 53.439999999999998 110.931 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.554 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 46.3 t-20 -64.44 -42.42 96.01 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.494 -0.558 . . . . 34.329999999999998 109.494 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.474 ' HA3' ' CE1' ' A' ' 106' ' ' PHE . . . -67.53 -40.46 90.93 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.588 -0.815 . . . . 42.109999999999999 112.058 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 40' ' ' ILE . 72.1 t -65.22 -41.36 91.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.53 -0.545 . . . . 62.340000000000003 109.53 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -53.71 -47.22 70.74 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.481 1.112 . . . . 65.099999999999994 110.92 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 42' ' ' ASN . 88.0 mtt180 -69.5 -37.21 77.11 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.333 -0.848 . . . . 73.209999999999994 110.645 -177.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.2 t -71.12 -36.01 61.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.217 -0.447 . . . . 51.119999999999997 110.649 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.56 -45.63 97.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 122.6 0.36 . . . . 64.019999999999996 110.921 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -70.94 -25.32 62.69 Favored 'General case' 0 C--O 1.209 -1.064 0 CA-C-O 121.02 0.438 . . . . 74.420000000000002 110.82 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.418 ' HB1' ' H ' ' A' ' 148' ' ' GLY . . . -83.6 -40.84 18.52 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.893 0.701 . . . . 63.130000000000003 112.893 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -92.23 -14.11 29.46 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 112.729 0.64 . . . . 74.150000000000006 112.729 -173.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -135.44 -175.71 4.03 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.505 0.669 . . . . 72.439999999999998 110.543 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.495 ' HA ' ' OD1' ' A' ' 143' ' ' ASP . 2.9 t-20 -113.53 100.62 8.64 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 103.487 -2.783 . . . . 73.099999999999994 103.487 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.72 153.74 28.49 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 114.07 1.137 . . . . 62.32 114.07 -167.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.6 m -126.73 118.25 24.33 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 105.56 -2.015 . . . . 52.439999999999998 105.56 168.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.9 p -99.96 118.74 47.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.482 0.658 . . . . 75.439999999999998 109.953 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HB2' ' HG3' ' A' ' 70' ' ' LYS . 39.2 mt-10 -114.83 122.23 45.72 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.569 -0.741 . . . . 61.32 109.075 -177.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.13 141.33 28.71 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.972 -0.381 . . . . 64.0 109.972 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.57 168.57 19.4 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.563 0.697 . . . . 53.009999999999998 109.481 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -106.24 127.0 52.92 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.179 -1.415 . . . . 74.310000000000002 107.179 174.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' A' ' 65' ' ' ASP . . . -72.83 176.51 43.04 Favored Glycine 0 N--CA 1.422 -2.273 0 CA-C-N 115.742 -0.663 . . . . 53.149999999999999 112.672 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' A' ' 65' ' ' ASP . 9.4 pt-20 -64.23 174.64 1.54 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.271 1.028 . . . . 73.420000000000002 110.146 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -49.49 -40.65 38.24 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.081 0.952 . . . . 63.229999999999997 111.736 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.18 -20.25 48.9 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.566 -1.197 . . . . 53.520000000000003 111.999 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.47 ' OD2' ' HB2' ' A' ' 85' ' ' LYS . 2.1 t70 -89.0 171.29 9.97 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.836 -0.54 . . . . 73.209999999999994 109.877 -174.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.7 t -114.19 -37.94 2.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 C-N-CA 123.857 0.863 . . . . 54.310000000000002 109.532 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.3 tp -167.3 131.57 1.89 Allowed 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.891 -0.595 . . . . 52.409999999999997 110.503 -171.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.28 133.68 52.56 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 107.41 -1.33 . . . . 72.120000000000005 107.41 -176.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -139.3 142.32 37.71 Favored 'General case' 0 C--N 1.28 -2.433 0 O-C-N 121.618 -0.676 . . . . 61.32 110.713 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HG3' ' HB2' ' A' ' 57' ' ' GLU . 14.4 ptmm? -121.64 122.69 40.17 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.376 0.608 . . . . 62.520000000000003 109.522 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -97.57 119.85 36.89 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 107.177 -1.416 . . . . 74.319999999999993 107.177 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.7 m -94.35 116.17 28.5 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.305 -1.369 . . . . 52.020000000000003 107.305 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.94 142.2 47.61 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-O 121.04 0.448 . . . . 64.120000000000005 110.913 -173.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 26.6 tt0 -150.41 100.49 2.88 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 107.936 -1.135 . . . . 73.129999999999995 107.936 168.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -102.75 90.4 3.8 Favored 'General case' 0 N--CA 1.417 -2.078 0 C-N-CA 118.959 -1.096 . . . . 54.210000000000001 108.39 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 55.51 67.58 0.99 Allowed 'General case' 0 CA--C 1.545 0.771 0 O-C-N 124.707 1.254 . . . . 70.099999999999994 111.385 171.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.62 -23.5 19.22 Favored Glycine 0 C--N 1.308 -1.021 0 CA-C-N 115.483 -0.781 . . . . 73.409999999999997 113.341 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 53.2 mtmt -84.44 101.12 11.78 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.261 -1.015 . . . . 74.129999999999995 108.261 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.635 ' HD2' ' NE2' ' A' ' 13' ' ' HIS . 42.0 mttp -103.73 134.11 47.6 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 123.843 0.715 . . . . 72.549999999999997 110.187 -172.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -171.8 169.46 42.53 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.074 -1.06 . . . . 52.539999999999999 112.825 177.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.1 mt -131.62 138.22 53.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.147 -1.427 . . . . 71.109999999999999 107.147 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.8 t -115.18 110.34 31.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 109.084 -0.71 . . . . 74.409999999999997 109.084 176.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 88.4 m-70 -97.27 105.83 18.05 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.664 -0.698 . . . . 74.230000000000004 109.827 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.2 t -101.29 115.44 43.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 107.927 -1.138 . . . . 72.540000000000006 107.927 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.47 ' HB2' ' OD2' ' A' ' 65' ' ' ASP . 21.7 ptmt -124.16 133.78 53.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.29 -0.633 . . . . 74.200000000000003 109.29 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.6 mt -107.33 112.91 25.97 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.863 -0.791 . . . . 70.519999999999996 108.863 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.472 ' HB2' ' HB2' ' A' ' 4' ' ' ASP . 45.5 mmm-85 -97.13 139.01 33.76 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.316 -0.994 . . . . 74.400000000000006 108.316 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 93' ' ' CYS . 21.8 pttm -92.06 98.98 11.89 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 120.208 -0.597 . . . . 74.450000000000003 111.464 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.2 tt -66.59 111.7 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 122.326 1.06 . . . . 73.129999999999995 109.494 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.3 p -145.67 -170.46 3.46 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.25 -1.341 . . . . 64.310000000000002 108.924 -169.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -72.73 -19.49 61.38 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.87 -1.159 . . . . 75.310000000000002 107.87 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.1 -36.84 17.88 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.253 -1.34 . . . . 73.239999999999995 109.556 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 86.3 m -122.36 125.43 26.53 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 113.463 0.912 . . . . 54.32 113.463 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.21 161.98 15.32 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.522 2.148 . . . . 75.450000000000003 110.905 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.12 142.99 89.34 Favored 'Trans proline' 0 C--O 1.262 1.71 0 C-N-CA 121.943 1.762 . . . . 71.439999999999998 109.667 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.449 ' HB ' HG11 ' A' ' 28' ' ' VAL . 13.7 t -87.98 159.42 3.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 109.576 -0.527 . . . . 71.200000000000003 109.576 -176.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -109.51 131.15 55.33 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.782 -0.821 . . . . 72.329999999999998 108.782 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -174.6 -160.76 23.26 Favored Glycine 0 CA--C 1.479 -2.17 0 N-CA-C 110.731 -0.948 . . . . 71.530000000000001 110.731 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -79.73 125.75 30.06 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.207 -0.664 . . . . 72.340000000000003 109.207 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -87.72 105.87 17.66 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.891 0.853 . . . . 75.209999999999994 110.761 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.475 ' H ' HD11 ' A' ' 29' ' ' ILE . 53.1 t -69.73 152.54 44.53 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.846 -1.525 . . . . 31.210000000000001 109.468 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.0 m -74.33 104.56 5.13 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.518 -0.919 . . . . 60.420000000000002 108.518 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.6 t -113.21 140.51 32.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 121.753 0.787 . . . . 74.439999999999998 110.518 -175.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.6 tp -149.76 -64.94 0.22 Allowed 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 114.452 -1.249 . . . . 75.150000000000006 108.164 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -158.42 162.04 37.55 Favored 'General case' 0 C--N 1.249 -3.787 0 CA-C-N 112.743 -2.026 . . . . 71.450000000000003 106.828 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.474 ' CE1' ' HA3' ' A' ' 43' ' ' GLY . 57.5 t80 -32.52 -55.03 0.34 Allowed 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 116.004 1.853 . . . . 53.200000000000003 116.004 -173.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.26 -28.13 69.52 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 113.669 0.988 . . . . 73.310000000000002 113.669 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -39.75 15.21 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.367 -1.346 . . . . 74.0 107.367 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 113' ' ' ILE . 11.9 m-20 -65.91 -46.51 78.02 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.603 -1.18 . . . . 74.019999999999996 108.629 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.428 HG13 HG22 ' A' ' 44' ' ' VAL . 16.2 tt -69.6 -25.86 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.536 -0.756 . . . . 73.209999999999994 110.504 -176.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -65.34 -49.92 67.56 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 107.025 -1.472 . . . . 60.340000000000003 107.025 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 3.4 t -63.29 -39.82 95.63 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.688 -1.142 . . . . 55.530000000000001 111.27 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 109' ' ' ASP . 41.4 mm -64.89 -46.91 90.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.048 -0.524 . . . . 74.019999999999996 111.368 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 92.6 t -69.99 -33.64 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 C-N-CA 120.184 -0.607 . . . . 73.310000000000002 110.173 -176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -66.4 -37.75 85.94 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.827 -0.624 . . . . 75.329999999999998 110.79 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.55 -41.03 80.36 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.064 0.459 . . . . 65.25 110.403 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.39 -45.7 95.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.671 -0.695 . . . . 71.409999999999997 109.186 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.6 -38.15 89.04 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 115.928 -0.578 . . . . 73.340000000000003 112.1 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -68.7 -40.21 80.13 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.602 -0.439 . . . . 72.310000000000002 110.632 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 42.8 t -59.22 -49.84 76.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.359 0.6 . . . . 62.219999999999999 109.433 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 10.5 mp -74.68 -14.84 60.79 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.603 -0.726 . . . . 74.129999999999995 112.427 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.26 -33.68 25.97 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 110.243 -0.28 . . . . 62.539999999999999 110.243 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.54 -34.84 46.89 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.311 0.577 . . . . 70.209999999999994 109.815 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.22 -136.35 51.03 Favored Glycine 0 CA--C 1.474 -2.521 0 CA-C-N 114.094 -1.412 . . . . 55.539999999999999 114.594 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.479 ' HB3' ' CD2' ' A' ' 13' ' ' HIS . 1.3 pm0 -73.66 38.72 0.1 Allowed 'General case' 0 C--N 1.262 -3.225 0 N-CA-C 114.934 1.457 . . . . 71.5 114.934 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 127' ' ' ASN . 48.5 mt -159.35 86.53 0.81 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 114.369 1.248 . . . . 71.400000000000006 114.369 -178.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.632 ' HB3' ' ND1' ' A' ' 22' ' ' HIS . 16.5 t-20 174.28 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.687 0.795 . . . . 74.420000000000002 110.78 166.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.423 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 45.0 t -78.12 125.52 29.48 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.596 -1.183 . . . . 75.319999999999993 110.497 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -173.83 89.15 0.07 Allowed 'General case' 0 C--O 1.247 0.964 0 N-CA-C 113.648 0.981 . . . . 72.349999999999994 113.648 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.0 tp 65.58 87.61 0.12 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.597 1.159 . . . . 63.299999999999997 113.93 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -104.01 115.76 31.02 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.178 -1.045 . . . . 75.040000000000006 108.178 175.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -151.38 46.56 0.6 Allowed Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 109.156 -1.578 . . . . 62.149999999999999 109.156 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -159.84 95.43 1.61 Allowed Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-N 115.511 -0.345 . . . . 72.400000000000006 110.138 -174.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -79.83 117.26 3.58 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.655 2.237 . . . . 72.430000000000007 110.62 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 48.0 mm -124.55 103.11 32.11 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-O 120.715 0.293 . . . . 43.140000000000001 111.521 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -77.43 162.93 30.35 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.479 2.119 . . . . 62.140000000000001 110.756 172.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -122.38 95.51 46.93 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-O 120.837 0.351 . . . . 62.240000000000002 110.494 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -73.7 -22.54 17.79 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.892 2.395 . . . . 74.019999999999996 112.492 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 53.5 tp -111.79 122.44 47.81 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.66 0.743 . . . . 62.409999999999997 112.469 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.5 mp -117.3 79.61 1.37 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.586 -1.635 . . . . 75.530000000000001 106.586 169.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.56 -146.3 11.34 Favored Glycine 0 N--CA 1.42 -2.374 0 C-N-CA 120.303 -0.951 . . . . 71.430000000000007 110.894 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.452 ' HB2' HD21 ' A' ' 53' ' ' ASN . 2.7 pt? -163.79 167.18 21.21 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.761 -0.829 . . . . 71.040000000000006 108.761 176.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.495 ' OD1' ' HA ' ' A' ' 53' ' ' ASN . 6.7 p-10 -97.8 175.25 6.23 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.134 -1.062 . . . . 73.409999999999997 108.134 177.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.3 m -144.33 61.06 1.35 Allowed 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 107.332 -1.358 . . . . 75.239999999999995 107.332 171.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 89.7 m -130.93 131.03 44.21 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.47 -1.241 . . . . 63.140000000000001 110.002 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.76 161.97 27.29 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.29 -1.004 . . . . 72.430000000000007 108.29 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.8 m -71.73 92.51 1.2 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.221 0.534 . . . . 63.32 110.404 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.418 ' H ' ' HB1' ' A' ' 50' ' ' ALA . . . . . . . . 0 N--CA 1.426 -1.982 0 N-CA-C 109.246 -1.542 . . . . 75.129999999999995 109.246 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.436 ' SD ' ' HE1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.504 -0.793 0 CA-C-O 120.807 0.337 . . . . 70.129999999999995 111.189 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -110.27 164.28 12.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.669 0.747 . . . . 51.549999999999997 111.986 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 11.3 m-85 -120.04 140.28 51.23 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.527 -1.215 . . . . 74.319999999999993 111.152 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.649 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 28.7 t70 -101.08 102.58 13.57 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 104.855 -2.276 . . . . 63.049999999999997 104.855 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.78 117.76 32.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.325 -0.852 . . . . 73.239999999999995 109.442 -172.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.19 116.72 52.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.028 -1.101 . . . . 74.519999999999996 108.028 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.409 HD13 HD12 ' A' ' 113' ' ' ILE . 10.3 tt -118.69 120.75 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 121.396 0.617 . . . . 74.25 109.732 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.493 HG12 ' HB3' ' A' ' 26' ' ' PRO . 5.5 mt -112.49 100.8 51.14 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 115.543 -0.753 . . . . 65.439999999999998 108.98 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.603 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 1.4 Cg_endo -85.53 120.53 2.11 Favored 'Trans proline' 0 N--CA 1.436 -1.87 0 N-CA-C 107.769 -1.666 . . . . 75.409999999999997 107.769 171.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -144.61 129.7 18.56 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 120.922 0.391 . . . . 70.340000000000003 110.431 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.653 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 37.5 m -73.08 120.39 18.63 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.65 -0.5 . . . . 62.100000000000001 109.65 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.601 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 2.7 p90 -61.52 110.89 1.6 Allowed 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 113.967 1.099 . . . . 72.109999999999999 113.967 -174.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -143.84 106.26 4.41 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 114.854 -1.066 . . . . 65.049999999999997 110.114 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -68.84 122.24 18.2 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.878 -1.897 . . . . 74.310000000000002 105.878 173.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.48 103.69 0.55 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 124.585 1.178 . . . . 73.349999999999994 109.77 -172.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 17' ' ' LYS . 14.0 t70 -89.1 -158.15 0.49 Allowed 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 114.02 -1.445 . . . . 55.420000000000002 110.492 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 23.3 tptm -72.46 -45.34 59.99 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.741 0.816 . . . . 74.150000000000006 111.694 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -132.62 -51.46 0.92 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.584 0.707 . . . . 51.100000000000001 110.249 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -96.36 -177.83 4.09 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 114.489 -1.232 . . . . 63.43 110.612 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 86.9 mtp 70.75 80.13 0.17 Allowed 'General case' 0 C--N 1.313 -0.99 0 O-C-N 124.572 1.17 . . . . 32.149999999999999 109.977 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.424 ' OE1' ' HA ' ' A' ' 127' ' ' ASN . 2.2 tm-20 -168.05 121.24 0.89 Allowed 'General case' 0 N--CA 1.403 -2.792 0 N-CA-C 105.083 -2.192 . . . . 70.530000000000001 105.083 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.45 ' NE2' ' HB3' ' A' ' 123' ' ' LYS . 18.5 t60 -168.42 84.28 0.17 Allowed 'General case' 0 C--N 1.282 -2.34 0 O-C-N 124.57 1.169 . . . . 75.230000000000004 110.334 165.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 131' ' ' GLU . 46.5 mm -103.17 136.05 37.72 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 N-CA-C 107.165 -1.42 . . . . 74.450000000000003 107.165 175.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 79.0 m -107.25 145.49 31.29 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 110.126 -0.324 . . . . 74.439999999999998 110.126 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 24' ' ' CYS . 52.5 Cg_exo -55.49 136.27 73.12 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 123.424 2.749 . . . . 71.340000000000003 112.873 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.493 ' HB3' HG12 ' A' ' 8' ' ' ILE . 74.5 Cg_endo -73.05 140.66 31.64 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.887 2.391 . . . . 63.340000000000003 112.394 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 99' ' ' ASN . 53.8 mtt -98.12 139.56 33.74 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-N 116.233 -0.44 . . . . 74.319999999999993 109.84 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.6 t -130.12 116.7 37.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 116.524 -0.307 . . . . 71.099999999999994 110.448 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.25 102.39 9.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 107.188 -1.412 . . . . 63.420000000000002 107.188 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.649 ' CA ' ' HA ' ' A' ' 4' ' ' ASP . . . -121.85 81.7 0.34 Allowed Glycine 0 N--CA 1.42 -2.372 0 C-N-CA 119.056 -1.545 . . . . 53.329999999999998 115.262 -175.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -153.64 15.82 0.51 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.24 -0.98 . . . . 71.329999999999998 110.803 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -102.07 136.43 41.91 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.745 -0.835 . . . . 72.430000000000007 108.745 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 p -74.05 168.31 19.78 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 106.595 -1.632 . . . . 73.129999999999995 106.595 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.562 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 73.9 t80 -61.62 -38.69 88.57 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 118.425 0.557 . . . . 41.130000000000003 110.735 -174.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -59.65 -49.26 78.44 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.486 -0.779 . . . . 71.129999999999995 111.209 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.1 mt -70.83 -38.74 73.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.647 -0.706 . . . . 72.5 109.308 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.401 ' HA ' HG22 ' A' ' 40' ' ' ILE . . . -65.94 -41.64 91.06 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.635 -0.711 . . . . 74.430000000000007 110.703 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 11.7 tpt -68.94 -40.83 78.73 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.839 -0.43 . . . . 52.329999999999998 109.839 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -74.21 -32.71 63.14 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 112.744 0.646 . . . . 70.109999999999999 112.744 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.557 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -74.68 -42.66 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.601 -0.889 . . . . 55.229999999999997 108.601 178.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.404 HG21 HD21 ' A' ' 86' ' ' LEU . 73.4 t -69.75 -38.78 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 120.956 -0.298 . . . . 71.109999999999999 110.7 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.549 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -73.96 -26.75 60.64 Favored 'General case' 0 C--O 1.201 -1.479 0 C-N-CA 119.8 -0.76 . . . . 73.409999999999997 110.474 177.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.407 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -66.2 -46.33 80.39 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.133 -1.187 . . . . 54.25 110.133 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 40' ' ' ILE . 96.2 t -58.24 -45.07 89.11 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 N-CA-C 108.523 -0.917 . . . . 71.319999999999993 108.523 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 42' ' ' ASN . 8.3 t70 -50.07 -49.27 51.89 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.646 1.578 . . . . 74.209999999999994 111.457 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 42' ' ' ASN . 45.4 mtt180 -67.36 -36.64 81.79 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.906 -1.043 . . . . 75.239999999999995 109.717 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 43' ' ' GLY . 60.9 t -71.72 -38.85 67.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 123.358 0.411 . . . . 61.310000000000002 110.695 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.455 HG23 HD11 ' A' ' 73' ' ' LEU . 70.3 mt -63.99 -46.1 94.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 C-N-CA 122.471 0.308 . . . . 52.310000000000002 110.614 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -78.68 -14.35 59.34 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.83 -0.748 . . . . 65.420000000000002 110.819 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.5 -49.27 10.1 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.948 -0.569 . . . . 61.119999999999997 111.126 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -91.8 -16.17 27.18 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 113.222 0.823 . . . . 74.219999999999999 113.222 -171.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.416 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 9.6 m-85 -129.09 -177.26 4.15 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.583 0.706 . . . . 74.25 110.281 -175.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 26.2 t-20 -109.81 108.23 18.48 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 104.352 -2.462 . . . . 73.120000000000005 104.352 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.66 157.97 45.27 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 115.963 -0.562 . . . . 71.239999999999995 112.202 -172.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 t -129.01 120.02 25.29 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.6 -1.63 . . . . 75.129999999999995 106.6 171.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.9 p -100.62 124.04 53.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.233 0.54 . . . . 73.340000000000003 110.612 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -122.73 146.92 47.07 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.791 -0.818 . . . . 75.239999999999995 108.791 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -119.68 127.67 53.1 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.955 0.883 . . . . 73.409999999999997 111.791 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.29 176.78 5.3 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.14 -1.43 . . . . 72.400000000000006 107.14 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -111.99 136.84 50.81 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.681 -0.859 . . . . 71.219999999999999 108.681 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.565 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -84.17 176.69 51.77 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 115.828 -0.624 . . . . 54.549999999999997 112.874 -175.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -74.68 133.04 42.13 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 123.328 0.651 . . . . 74.530000000000001 111.84 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t70 46.31 -84.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 126.298 1.839 . . . . 72.329999999999998 114.973 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.5 p -97.49 -1.6 43.78 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 113.556 0.947 . . . . 75.530000000000001 113.556 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.565 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 13.4 m-20 -76.96 117.78 18.89 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.659 -1.608 . . . . 75.310000000000002 106.659 172.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.0 t -85.31 -31.3 6.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-O 121.264 0.554 . . . . 52.329999999999998 112.235 -173.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 63.2 tp -148.67 133.91 18.38 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 109.409 -0.589 . . . . 60.130000000000003 109.409 -176.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.462 ' CE2' ' HD3' ' A' ' 85' ' ' LYS . 1.1 t80 -129.91 105.44 7.99 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.261 -1.385 . . . . 75.329999999999998 107.261 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -107.69 125.38 51.3 Favored 'General case' 0 C--N 1.281 -2.396 0 C-N-CA 120.191 -0.604 . . . . 74.340000000000003 111.732 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -103.0 115.14 30.03 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 125.201 1.4 . . . . 64.019999999999996 108.476 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 75.3 m-85 -102.56 118.04 36.0 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.606 -0.516 . . . . 74.099999999999994 109.606 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.0 m -87.87 123.15 32.33 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.804 -1.184 . . . . 71.25 107.804 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.455 HD11 HG23 ' A' ' 48' ' ' ILE . 4.3 mm? -111.14 138.46 47.55 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.972 0.909 . . . . 64.310000000000002 111.985 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 2.0 tm-20 -151.16 83.0 1.32 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.887 -1.051 . . . . 74.519999999999996 108.899 170.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -87.9 70.55 9.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.848 -0.797 . . . . 44.039999999999999 108.848 178.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 45.55 71.53 0.27 Allowed 'General case' 0 C--O 1.244 0.783 0 C-N-CA 125.255 1.422 . . . . 72.319999999999993 111.542 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.15 -24.1 33.08 Favored Glycine 0 C--N 1.304 -1.226 0 CA-C-N 115.466 -0.788 . . . . 45.32 112.207 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 99.0 mttt -88.53 103.13 15.6 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.417 -0.957 . . . . 71.420000000000002 108.417 175.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -106.78 146.96 30.24 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 120.307 -0.557 . . . . 72.420000000000002 110.515 -175.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . 177.72 177.42 46.52 Favored Glycine 0 CA--C 1.48 -2.148 0 C-N-CA 120.202 -0.999 . . . . 60.530000000000001 112.528 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 32.2 mt -132.22 145.19 35.09 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 106.796 -1.557 . . . . 73.019999999999996 106.796 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 100.0 t -122.5 109.22 23.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 108.208 -1.034 . . . . 53.530000000000001 108.208 172.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -95.05 106.54 18.55 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 123.868 0.867 . . . . 74.200000000000003 110.381 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.3 t -107.96 112.48 40.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.028 -0.73 . . . . 71.109999999999999 109.028 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.462 ' HD3' ' CE2' ' A' ' 68' ' ' TYR . 58.0 pttt -116.66 135.08 54.08 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 120.906 0.384 . . . . 63.030000000000001 110.867 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.404 HD21 HG21 ' A' ' 41' ' ' VAL . 56.3 mt -106.27 105.69 15.84 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.255 -1.387 . . . . 70.319999999999993 107.255 -175.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 33.8 ttt85 -98.02 118.29 34.28 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.366 -0.605 . . . . 72.340000000000003 109.366 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -70.54 104.01 2.66 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.232 -0.655 . . . . 74.530000000000001 109.232 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.2 tt -78.44 111.26 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 CA-C-O 122.415 1.102 . . . . 52.240000000000002 108.989 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.4 t -138.77 -177.87 5.06 Favored 'General case' 0 N--CA 1.401 -2.903 0 N-CA-C 105.989 -1.856 . . . . 73.049999999999997 105.989 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -75.12 -21.74 58.67 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 118.799 0.727 . . . . 73.340000000000003 110.691 -173.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -96.74 11.37 35.8 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.592 -1.185 . . . . 73.109999999999999 109.686 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 41.3 t -139.92 116.46 8.16 Favored Pre-proline 0 C--N 1.319 -0.739 0 O-C-N 121.177 -0.952 . . . . 63.549999999999997 112.096 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -79.61 131.23 9.23 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.756 2.304 . . . . 71.030000000000001 110.876 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.14 164.15 36.18 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 123.108 2.538 . . . . 75.430000000000007 111.648 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.89 156.82 3.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.726 -0.842 . . . . 71.439999999999998 108.726 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -107.93 140.68 40.7 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.449 -0.945 . . . . 71.400000000000006 108.449 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.58 -171.29 40.12 Favored Glycine 0 CA--C 1.471 -2.67 0 N-CA-C 109.064 -1.614 . . . . 75.310000000000002 109.064 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 27' ' ' MET . 6.9 t-20 -63.63 103.78 0.58 Allowed 'General case' 0 N--CA 1.409 -2.486 0 C-N-CA 123.814 0.846 . . . . 65.010000000000005 110.018 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -89.32 103.08 15.74 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.141 -1.059 . . . . 72.230000000000004 108.141 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 42.6 t -71.19 175.2 5.49 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.054 -0.975 . . . . 72.219999999999999 111.136 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.9 p -60.72 110.3 1.27 Allowed 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.245 1.018 . . . . 61.109999999999999 110.949 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.22 139.12 17.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.884 -0.784 . . . . 64.310000000000002 108.884 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.586 ' HG ' ' H ' ' A' ' 105' ' ' GLU . 15.8 tp -178.72 -159.47 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 104.53 -2.396 . . . . 61.539999999999999 104.53 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.586 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 43.0 mt-10 -81.39 171.61 14.55 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 118.614 0.643 . . . . 75.120000000000005 111.259 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' O ' HG22 ' A' ' 110' ' ' ILE . 1.2 t80 -36.13 -48.5 0.62 Allowed 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 127.59 2.356 . . . . 64.299999999999997 113.351 -173.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.69 -28.5 68.67 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 123.85 0.86 . . . . 74.439999999999998 112.449 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.451 ' HA ' ' NE ' ' A' ' 108' ' ' ARG . 0.8 OUTLIER -87.38 -40.83 14.07 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.348 -0.541 . . . . 73.329999999999998 110.279 -178.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.592 ' O ' HG12 ' A' ' 113' ' ' ILE 0.328 18.5 p-10 -80.52 -26.01 38.37 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 119.377 -0.929 . . . . 61.140000000000001 112.211 -174.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 106' ' ' PHE . 8.6 tp -64.55 -38.97 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 109.457 -0.572 . . . . 74.430000000000007 109.457 173.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.41 -43.32 86.09 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.311 -0.626 . . . . 54.100000000000001 109.311 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 42.9 t -58.5 -44.32 89.4 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.816 -1.084 . . . . 74.120000000000005 111.612 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 109' ' ' ASP . 43.4 mm -65.25 -41.39 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 120.923 -0.311 . . . . 74.239999999999995 110.591 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 110' ' ' ILE . 86.0 t -63.87 -42.87 97.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.544 -0.539 . . . . 64.340000000000003 109.544 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -61.47 -41.77 97.75 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.875 -0.602 . . . . 55.200000000000003 111.534 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.63 97.35 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 123.422 0.451 . . . . 54.210000000000001 111.444 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.3 mt -67.89 -44.79 85.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.165 -0.68 . . . . 72.329999999999998 109.165 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.92 -33.97 77.3 Favored 'General case' 0 C--O 1.211 -0.928 0 CA-C-N 115.702 -0.681 . . . . 70.450000000000003 111.64 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -69.97 -43.36 71.65 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.331 0.586 . . . . 72.310000000000002 110.64 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 5.3 t -70.22 -41.54 73.48 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.402 0.62 . . . . 62.539999999999999 109.594 -176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.422 HD23 ' HB3' ' A' ' 78' ' ' LYS . 9.5 mp -78.13 -15.7 58.62 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.503 -0.771 . . . . 74.200000000000003 111.77 -177.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.41 -38.25 22.17 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 121.034 -0.266 . . . . 51.100000000000001 111.031 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB3' ' NE2' ' A' ' 22' ' ' HIS . 23.1 tptm -62.79 -47.52 83.14 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.264 0.554 . . . . 64.340000000000003 110.103 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.64 -164.21 53.05 Favored Glycine 0 C--N 1.286 -2.229 0 CA-C-N 114.326 -1.306 . . . . 73.140000000000001 114.341 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -63.92 104.78 0.74 Allowed 'General case' 0 C--O 1.246 0.907 0 C-N-CA 124.057 0.943 . . . . 72.420000000000002 110.258 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -175.05 107.62 0.1 Allowed 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 106.434 -1.691 . . . . 64.230000000000004 106.434 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.424 ' HA ' ' OE1' ' A' ' 21' ' ' GLU . 3.0 t-20 -54.41 112.07 0.92 Allowed 'General case' 0 N--CA 1.469 0.521 0 O-C-N 124.154 0.908 . . . . 64.450000000000003 109.235 177.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 22.8 t -142.13 16.4 2.08 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.868 0.842 . . . . 41.310000000000002 110.846 -173.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -170.61 174.75 4.91 Favored 'General case' 0 C--N 1.271 -2.838 0 N-CA-C 107.383 -1.34 . . . . 72.140000000000001 107.383 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.2 tp -129.19 84.76 2.25 Favored 'General case' 0 N--CA 1.413 -2.288 0 O-C-N 121.677 -0.639 . . . . 74.140000000000001 109.942 176.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.539 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 18.4 mm-40 -116.0 85.86 2.37 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.173 -0.921 . . . . 72.549999999999997 110.415 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.54 62.43 3.08 Favored Glycine 0 N--CA 1.426 -1.981 0 CA-C-N 115.377 -0.828 . . . . 60.240000000000002 112.323 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -104.28 121.05 48.8 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 108.915 -0.772 . . . . 73.219999999999999 108.915 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.53 131.19 22.47 Favored 'Trans proline' 0 C--O 1.244 0.802 0 C-N-CA 122.493 2.129 . . . . 73.439999999999998 112.336 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.6 mm -126.14 102.32 27.63 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 108.582 -0.895 . . . . 73.519999999999996 108.582 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.58 132.09 18.37 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.356 2.038 . . . . 62.329999999999998 111.098 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 60.66 85.57 0.18 Allowed Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 124.094 0.957 . . . . 74.010000000000005 112.34 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -72.59 -27.06 15.86 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.251 1.967 . . . . 73.219999999999999 110.775 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.6 pp -131.63 132.53 44.11 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 107.604 -1.258 . . . . 73.349999999999994 107.604 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 24.6 tp -151.23 133.66 15.46 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.324 -0.991 . . . . 53.420000000000002 108.324 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 61.64 -160.34 29.17 Favored Glycine 0 C--O 1.254 1.398 0 O-C-N 123.985 0.803 . . . . 73.420000000000002 113.26 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 47.5 tp -161.23 79.98 0.6 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.433 -0.58 . . . . 52.25 109.433 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -97.59 91.1 5.26 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.627 -0.879 . . . . 74.420000000000002 108.627 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.1 m -107.89 74.49 0.95 Allowed 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 108.895 -0.78 . . . . 75.200000000000003 108.895 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 18.2 p -94.69 133.84 37.92 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.723 -1.126 . . . . 71.340000000000003 108.213 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 145' ' ' THR . 25.2 mmm180 78.36 158.8 0.18 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.944 0.897 . . . . 72.510000000000005 111.962 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.2 t -162.42 157.79 22.98 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 105.507 -2.034 . . . . 75.109999999999999 105.507 174.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.115 0 N-CA-C 110.026 -1.23 . . . . 51.219999999999999 110.026 -179.69 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.434 ' HE2' ' HB3' ' A' ' 1' ' ' MET . 62.0 mmm . . . . . 0 CA--C 1.494 -1.211 0 N-CA-C 111.965 0.357 . . . . 75.200000000000003 111.965 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -101.71 141.38 34.66 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.26 -1.015 . . . . 71.219999999999999 108.26 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 56.0 m-85 -118.06 142.79 47.03 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.64 -0.504 . . . . 63.219999999999999 109.64 174.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.627 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 32.0 t70 -104.31 115.58 30.64 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 124.475 1.11 . . . . 73.239999999999995 109.627 -172.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.82 117.32 48.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.917 -0.489 . . . . 45.530000000000001 109.861 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.506 HG23 HG22 ' A' ' 28' ' ' VAL . 7.3 p -111.52 124.27 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-O 121.357 0.599 . . . . 74.109999999999999 109.409 176.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 27' ' ' MET . 7.1 tt -123.41 118.27 53.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-O 121.556 0.693 . . . . 74.120000000000005 111.062 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.484 HG12 ' HB3' ' A' ' 26' ' ' PRO . 61.9 mt -106.61 111.77 63.86 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 115.267 -0.878 . . . . 71.030000000000001 109.838 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.509 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 3.3 Cg_endo -87.34 123.79 1.94 Allowed 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.029 1.819 . . . . 72.219999999999999 109.205 171.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -142.74 119.35 11.07 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.484 0.659 . . . . 72.200000000000003 111.076 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 22' ' ' HIS . 49.4 m -77.36 116.65 18.14 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.233 -0.44 . . . . 70.209999999999994 110.298 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.689 ' CE1' ' HB2' ' A' ' 79' ' ' LYS . 1.8 p90 -65.46 123.99 21.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.65 0.738 . . . . 75.219999999999999 112.035 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 39.4 m80 -139.71 146.39 39.54 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.951 -1.022 . . . . 73.439999999999998 110.299 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -82.13 104.89 12.79 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-O 122.443 1.116 . . . . 72.409999999999997 109.927 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -67.47 100.7 0.88 Allowed 'General case' 0 N--CA 1.398 -3.036 0 CA-C-N 113.201 -1.818 . . . . 61.329999999999998 109.165 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -87.31 -94.48 0.09 Allowed 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.474 -0.785 . . . . 72.129999999999995 111.885 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 1.8 tmtp? -112.77 -57.8 2.24 Favored 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 119.32 -0.952 . . . . 73.349999999999994 112.729 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -121.98 -26.53 4.76 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 118.975 -1.09 . . . . 62.340000000000003 112.901 -169.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -137.34 169.9 17.0 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.333 -0.617 . . . . 74.5 109.333 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.435 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 64.2 mtm 82.19 70.85 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 126.159 1.783 . . . . 44.439999999999998 111.226 -176.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -161.76 96.33 1.02 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 105.046 -2.205 . . . . 74.25 105.046 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 11' ' ' SER . 39.1 t60 -114.15 89.91 3.21 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 119.24 -0.984 . . . . 73.299999999999997 112.041 -171.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mm -100.99 131.12 49.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 106.529 -1.656 . . . . 71.129999999999995 106.529 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 71.4 m -107.68 130.34 22.95 Favored Pre-proline 0 C--N 1.292 -1.918 0 C-N-CA 119.927 -0.709 . . . . 72.129999999999995 109.099 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -42.62 134.43 5.04 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 124.037 3.158 . . . . 43.509999999999998 113.915 -177.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HB3' HG12 ' A' ' 8' ' ' ILE . 15.7 Cg_endo -59.29 136.77 74.46 Favored 'Trans proline' 0 C--O 1.256 1.393 0 C-N-CA 123.477 2.785 . . . . 75.409999999999997 114.073 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.534 ' HB2' HG23 ' A' ' 7' ' ' ILE . 24.8 mmt -96.52 131.45 43.11 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 105.401 -2.074 . . . . 73.420000000000002 105.401 172.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 6' ' ' VAL . 29.6 t -126.17 129.58 72.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 120.228 -0.589 . . . . 65.239999999999995 110.256 -175.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.3 mm -136.04 101.19 2.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 106.985 -1.487 . . . . 54.409999999999997 106.985 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.627 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -120.01 82.42 0.34 Allowed Glycine 0 CA--C 1.488 -1.604 0 C-N-CA 120.078 -1.058 . . . . 63.119999999999997 112.783 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -158.74 26.21 0.22 Allowed 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.982 -0.609 . . . . 75.209999999999994 111.46 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.56 HH22 HG12 ' A' ' 103' ' ' VAL . 21.3 mmt85 -118.04 141.97 47.9 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 107.828 -1.175 . . . . 74.230000000000004 107.828 -174.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.8 p -75.86 172.6 12.42 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 118.842 0.746 . . . . 73.120000000000005 109.481 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.532 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 60.1 t80 -55.19 -47.53 75.12 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.35 0.595 . . . . 65.049999999999997 112.139 -174.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.02 -40.01 78.9 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.343 -0.844 . . . . 63.329999999999998 111.197 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.72 -33.33 43.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.248 -0.433 . . . . 65.329999999999998 110.218 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.417 ' O ' HG22 ' A' ' 40' ' ' ILE . . . -65.28 -44.8 86.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.408 -0.36 . . . . 73.120000000000005 110.59 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.6 mtm -73.08 -33.34 65.57 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 118.912 -1.115 . . . . 74.209999999999994 111.06 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.11 -44.0 85.57 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.069 -0.514 . . . . 60.030000000000001 110.415 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 37' ' ' ALA . 8.5 tp -65.46 -38.92 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 109.807 -0.442 . . . . 71.219999999999999 109.807 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.448 HG21 HD21 ' A' ' 86' ' ' LEU . 96.8 t -69.29 -39.94 79.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 CA-C-N 116.213 -0.449 . . . . 65.209999999999994 110.196 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -67.84 -28.25 67.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.127 0.489 . . . . 72.019999999999996 110.183 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.43 -47.36 63.42 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.296 -1.121 . . . . 71.409999999999997 110.296 175.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 40' ' ' ILE . 92.9 t -62.7 -41.96 94.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.452 -0.573 . . . . 74.430000000000007 109.452 177.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -53.38 -53.05 56.71 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 125.265 1.426 . . . . 72.310000000000002 110.565 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.42 ' HA ' ' CD ' ' A' ' 49' ' ' LYS . 61.9 mtm180 -71.1 -23.77 62.17 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.511 -0.768 . . . . 75.219999999999999 112.523 -175.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 43' ' ' GLY . 94.3 t -78.2 -44.87 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 C-N-CA 120.522 -0.471 . . . . 70.239999999999995 110.47 175.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.429 HG22 ' HB2' ' A' ' 54' ' ' ALA . 54.9 mt -73.17 -33.77 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 120.537 -0.465 . . . . 72.439999999999998 111.456 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 13.3 ptmt -74.4 -16.22 60.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.391 0.615 . . . . 61.149999999999999 110.455 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 144' ' ' SER . . . -95.7 -49.79 5.21 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 115.318 -0.856 . . . . 64.209999999999994 111.081 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 t -77.07 -22.53 52.7 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 123.528 0.731 . . . . 64.319999999999993 112.649 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -127.7 -172.75 2.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.608 0.718 . . . . 64.140000000000001 110.8 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 18.6 t-20 -105.21 89.68 3.2 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 104.326 -2.472 . . . . 74.430000000000007 104.326 172.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' A' ' 49' ' ' LYS . . . -108.13 135.89 48.72 Favored 'General case' 0 N--CA 1.407 -2.599 0 CA-C-N 115.169 -0.923 . . . . 72.349999999999994 112.029 -172.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.5 m -115.6 110.73 19.62 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 106.171 -1.789 . . . . 54.149999999999999 106.171 172.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.85 118.72 46.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.54 -0.541 . . . . 72.019999999999996 109.54 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.56 ' HG3' ' HB2' ' A' ' 70' ' ' LYS . 9.2 pt-20 -120.88 122.32 40.0 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.123 -0.695 . . . . 73.430000000000007 109.123 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.449 ' HG2' ' HG2' ' A' ' 69' ' ' ARG . 42.7 mt-10 -95.28 130.44 42.04 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.814 -0.63 . . . . 75.140000000000001 111.37 -175.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.2 mp -125.52 176.5 6.8 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.437 -0.801 . . . . 72.209999999999994 109.324 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -105.27 139.14 40.36 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-O 121.198 0.523 . . . . 72.120000000000005 109.846 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.26 176.44 41.96 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 110.514 -1.034 . . . . 52.229999999999997 110.514 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.518 ' N ' ' HB2' ' A' ' 65' ' ' ASP . 26.7 mm-40 -65.51 -176.17 0.32 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 122.102 0.953 . . . . 65.010000000000005 111.67 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.69 -34.93 78.94 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.688 -1.142 . . . . 63.350000000000001 110.084 172.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.9 t -77.1 -22.06 53.31 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.591 -1.186 . . . . 62.539999999999999 108.997 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.518 ' HB2' ' N ' ' A' ' 62' ' ' GLU . 67.3 m-20 -93.53 172.46 8.25 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 109.024 -0.732 . . . . 74.319999999999993 109.024 177.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.1 t -117.7 -43.27 2.97 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 CA-C-O 121.513 0.673 . . . . 74.430000000000007 110.382 174.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.1 tp -157.34 149.1 22.28 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.73 -0.668 . . . . 65.230000000000004 109.724 -172.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.26 135.36 47.27 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.595 -0.891 . . . . 75.200000000000003 108.595 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.449 ' HG2' ' HG2' ' A' ' 58' ' ' GLU . 88.6 mtt180 -132.27 129.42 39.57 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.227 -0.296 . . . . 75.129999999999995 110.76 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.56 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . 6.4 mtpm? -105.55 116.56 32.15 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 105.615 -1.995 . . . . 73.430000000000007 105.615 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.425 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 71.6 m-85 -101.54 106.08 17.13 Favored 'General case' 0 C--N 1.263 -3.184 0 N-CA-C 107.678 -1.23 . . . . 74.120000000000005 107.678 174.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.3 m -91.93 112.44 24.37 Favored 'General case' 0 C--N 1.276 -2.628 0 N-CA-C 107.672 -1.233 . . . . 65.219999999999999 107.672 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.83 149.39 37.13 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.286 0.565 . . . . 65.340000000000003 111.023 -173.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 42.7 tt0 -150.25 98.26 2.65 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.991 -1.004 . . . . 74.439999999999998 109.8 168.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -105.91 88.66 2.86 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 115.872 -0.604 . . . . 65.239999999999995 109.674 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.295 5.7 pt-20 36.74 74.29 0.08 Allowed 'General case' 0 C--O 1.243 0.749 0 C-N-CA 125.825 1.65 . . . . 70.239999999999995 114.974 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.37 -23.91 34.37 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 113.604 -1.635 . . . . 71.219999999999999 112.47 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 57.9 mtmt -95.12 94.74 8.11 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 122.368 -0.489 . . . . 75.329999999999998 109.701 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.689 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 2.3 ptpp? -113.54 124.0 51.34 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.242 -0.89 . . . . 73.129999999999995 111.211 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.416 ' HA2' ' H ' ' A' ' 12' ' ' PHE . . . -173.04 172.49 45.16 Favored Glycine 0 CA--C 1.491 -1.411 0 C-N-CA 120.967 -0.635 . . . . 61.130000000000003 112.0 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.9 mt -121.65 145.99 27.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.552 -0.907 . . . . 61.350000000000001 108.552 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 95.6 t -119.94 110.34 28.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 108.512 -0.921 . . . . 63.420000000000002 108.512 174.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.518 ' CD2' ' HG2' ' A' ' 70' ' ' LYS . 33.0 m170 -94.94 107.85 19.89 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.816 -0.629 . . . . 73.230000000000004 110.196 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.14 118.49 53.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 115.792 -0.64 . . . . 74.0 109.565 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -111.82 142.39 44.25 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.203 -0.666 . . . . 65.430000000000007 109.203 173.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.448 HD21 HG21 ' A' ' 41' ' ' VAL . 92.5 mt -107.37 123.94 49.1 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 103.549 -2.759 . . . . 51.210000000000001 103.549 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 41.6 mtp-105 -112.84 155.92 23.81 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 109.267 -0.642 . . . . 74.25 109.267 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -98.06 105.49 17.64 Favored 'General case' 0 C--N 1.282 -2.346 0 C-N-CA 120.327 -0.549 . . . . 64.329999999999998 110.485 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 tt -82.81 110.17 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 107.749 -1.204 . . . . 71.109999999999999 107.749 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 m -145.85 -175.39 4.72 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 105.045 -2.206 . . . . 62.530000000000001 105.045 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -15.9 63.04 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 120.087 1.312 . . . . 71.329999999999998 110.458 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.07 -23.95 38.12 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.949 -1.023 . . . . 71.109999999999999 111.803 175.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 40.8 m -145.35 117.61 5.23 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 112.472 0.545 . . . . 64.439999999999998 112.472 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 93' ' ' CYS . 2.7 Cg_exo -73.59 158.49 47.4 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 122.622 2.215 . . . . 64.310000000000002 110.499 175.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.3 160.37 49.03 Favored 'Trans proline' 0 C--O 1.255 1.337 0 C-N-CA 122.789 2.326 . . . . 64.140000000000001 110.65 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 t -82.93 149.46 4.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 107.24 -1.393 . . . . 53.509999999999998 107.24 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -112.38 112.81 24.65 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 106.75 -1.574 . . . . 70.209999999999994 106.75 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -151.51 -157.62 7.97 Favored Glycine 0 CA--C 1.461 -3.309 0 C-N-CA 120.165 -1.017 . . . . 62.439999999999998 112.018 -174.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' A' ' 27' ' ' MET . 35.5 m-80 -76.58 104.23 6.98 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.798 -0.816 . . . . 65.25 108.798 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -83.11 112.32 19.7 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-O 121.651 0.739 . . . . 75.349999999999994 109.387 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.488 ' HB3' HG23 ' A' ' 103' ' ' VAL . 4.8 t -70.29 153.02 43.53 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.914 -1.513 . . . . 74.540000000000006 106.914 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.424 ' N ' ' SG ' ' A' ' 112' ' ' CYS . 15.5 m -69.84 77.63 0.46 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.426 1.107 . . . . 73.129999999999995 109.906 178.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.56 HG12 HH22 ' A' ' 32' ' ' ARG . 76.9 t -124.57 149.45 28.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 C-N-CA 125.429 1.491 . . . . 75.040000000000006 108.635 -173.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.2 mt -161.15 -82.61 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 125.625 1.57 . . . . 74.519999999999996 109.296 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -98.4 150.37 21.68 Favored 'General case' 0 C--N 1.262 -3.197 0 CA-C-N 114.109 -1.405 . . . . 75.340000000000003 108.948 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.518 ' HA ' ' HB3' ' A' ' 109' ' ' ASP . 74.6 t80 -46.34 -44.05 16.52 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.365 1.246 . . . . 70.219999999999999 114.365 -172.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -62.55 -35.61 79.99 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 112.587 0.588 . . . . 72.319999999999993 112.587 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -90.82 -30.7 16.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.441 0.639 . . . . 72.010000000000005 109.571 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.518 ' HB3' ' HA ' ' A' ' 106' ' ' PHE . 7.9 t0 -55.74 -55.15 35.7 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 125.731 1.613 . . . . 65.540000000000006 109.642 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.6 tp -59.78 -38.04 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 O-C-N 123.966 0.792 . . . . 63.049999999999997 110.865 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 40.3 mt-10 -69.5 -38.46 77.62 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 120.479 -0.488 . . . . 71.310000000000002 111.492 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 102' ' ' SER . 10.0 t -65.91 -40.77 91.78 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.0 -0.68 . . . . 44.229999999999997 109.36 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 117' ' ' ILE . 49.4 mm -64.41 -46.54 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 115.521 -0.763 . . . . 72.239999999999995 110.223 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 72.7 t -63.91 -41.88 93.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.52 -0.309 . . . . 64.030000000000001 110.732 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 111' ' ' GLU . 29.4 mtpp -67.19 -30.33 70.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 111.7 0.259 . . . . 75.230000000000004 111.7 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.37 -40.8 67.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.018 0.437 . . . . 53.329999999999998 110.298 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.57 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 83.0 mt -66.05 -45.78 89.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.137 -0.69 . . . . 73.409999999999997 109.137 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -57.57 -42.32 82.84 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.842 -0.617 . . . . 74.549999999999997 111.576 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -65.9 -41.9 90.91 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.539 -0.755 . . . . 74.400000000000006 110.288 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 15.1 t -70.17 -39.68 75.13 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.826 -0.435 . . . . 55.210000000000001 109.826 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 117' ' ' ILE . 61.4 mt -72.76 -37.39 67.68 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 116.423 -0.353 . . . . 73.420000000000002 111.359 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.89 -14.22 51.62 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 112.565 0.58 . . . . 61.340000000000003 112.565 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -66.63 -21.62 66.12 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.288 0.566 . . . . 74.439999999999998 112.432 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.88 -161.54 47.81 Favored Glycine 0 C--N 1.296 -1.681 0 CA-C-N 115.617 -0.72 . . . . 53.200000000000003 114.894 173.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.77 83.43 3.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.79 1.281 . . . . 65.099999999999994 112.498 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -128.17 123.26 33.9 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.544 -2.021 . . . . 73.25 105.544 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -76.13 126.04 30.25 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.429 -0.908 . . . . 73.140000000000001 111.753 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.3 t -135.82 97.39 3.63 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 105.714 -1.958 . . . . 72.200000000000003 105.714 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -90.7 103.78 16.44 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 114.628 -1.169 . . . . 75.019999999999996 110.783 -171.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.3 tp -149.08 172.9 14.02 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 107.713 -1.218 . . . . 65.030000000000001 107.713 -176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -70.71 109.65 5.06 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.186 0.517 . . . . 74.239999999999995 112.219 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -144.09 -161.9 9.17 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 107.076 -2.41 . . . . 63.420000000000002 107.076 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -163.81 75.62 1.73 Allowed Pre-proline 0 C--N 1.306 -1.315 0 CA-C-N 118.108 0.954 . . . . 75.219999999999999 109.927 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.95 92.94 0.33 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.841 2.361 . . . . 62.420000000000002 113.352 -176.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.516 ' HB ' ' HE3' ' A' ' 70' ' ' LYS . 47.5 mm -115.99 102.9 53.84 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 107.542 -1.281 . . . . 73.540000000000006 107.542 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.82 170.79 9.55 Favored 'Trans proline' 0 C--O 1.252 1.212 0 C-N-CA 123.744 2.963 . . . . 55.530000000000001 114.11 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.452 ' O ' HD22 ' A' ' 139' ' ' LEU . 21.8 t-20 -137.11 150.26 68.76 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 105.181 -2.155 . . . . 64.040000000000006 105.181 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.5 -0.06 6.96 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 122.253 1.969 . . . . 72.109999999999999 113.24 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.452 HD22 ' O ' ' A' ' 137' ' ' ASN . 3.4 mm? 71.82 113.09 0.06 Allowed 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.221 1.409 . . . . 72.329999999999998 112.602 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -138.01 98.32 3.61 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.27 -1.382 . . . . 75.019999999999996 107.27 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -170.47 175.79 44.24 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 109.722 -1.351 . . . . 75.420000000000002 109.722 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.4 tp -161.06 136.79 8.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 117.517 0.659 . . . . 54.039999999999999 109.348 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.44 110.58 0.8 Allowed 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 123.932 0.77 . . . . 74.340000000000003 110.479 176.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.459 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 7.6 m -115.42 84.67 2.13 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 106.846 -1.538 . . . . 54.310000000000002 106.846 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.5 m -67.11 -18.17 65.19 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.337 -0.847 . . . . 70.340000000000003 112.372 -172.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 67.47 -171.65 0.19 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.893 0.877 . . . . 73.120000000000005 108.847 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.1 t -81.77 97.7 8.09 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.956 0.884 . . . . 73.519999999999996 109.779 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.257 0 N-CA-C 108.854 -1.698 . . . . 71.430000000000007 108.854 -178.594 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.474 0 N-CA-C 106.803 -1.554 . . . . 73.239999999999995 106.803 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -138.63 163.24 32.6 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.433 0.635 . . . . 74.430000000000007 112.173 -172.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 46.2 m-85 -119.7 145.29 46.65 Favored 'General case' 0 C--O 1.251 1.144 0 C-N-CA 124.266 1.026 . . . . 74.409999999999997 110.616 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.604 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 30.6 t70 -115.44 111.23 20.47 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 125.542 1.537 . . . . 63.32 107.204 -175.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 p -96.65 127.87 48.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 122.119 -0.363 . . . . 65.340000000000003 110.916 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.577 HG23 HG22 ' A' ' 28' ' ' VAL . 4.8 p -117.9 127.48 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 115.923 -0.58 . . . . 60.310000000000002 111.177 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.429 HG23 ' HB2' ' A' ' 27' ' ' MET . 3.2 tt -115.62 112.86 41.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.473 -0.785 . . . . 72.409999999999997 109.698 176.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.436 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 3.3 mp -98.92 109.2 52.93 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 108.247 -1.02 . . . . 41.340000000000003 108.247 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 17.7 Cg_endo -93.9 138.6 1.27 Allowed 'Trans proline' 0 N--CA 1.436 -1.895 0 C-N-CA 122.193 1.928 . . . . 64.439999999999998 110.684 173.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -159.13 130.61 6.29 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 110.189 -0.3 . . . . 50.130000000000003 110.189 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.526 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.3 m -69.82 121.37 17.14 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.001 -0.74 . . . . 72.150000000000006 109.001 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.561 ' CE1' ' HD3' ' A' ' 79' ' ' LYS . 21.3 p90 -70.01 101.58 1.83 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 112.529 0.566 . . . . 64.239999999999995 112.529 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.482 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 54.4 m80 -146.65 151.34 37.08 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.991 -0.549 . . . . 74.099999999999994 111.77 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -80.41 119.44 23.11 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 106.905 -1.517 . . . . 73.230000000000004 106.905 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -62.04 104.41 0.46 Allowed 'General case' 0 N--CA 1.406 -2.654 0 O-C-N 124.527 1.142 . . . . 72.420000000000002 109.383 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -87.22 -155.02 0.26 Allowed 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 113.957 -1.474 . . . . 54.340000000000003 108.668 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -81.56 -56.88 3.74 Favored 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 121.45 -0.781 . . . . 74.400000000000006 112.412 -175.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -136.12 15.01 3.28 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.824 0.821 . . . . 63.119999999999997 110.207 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -148.57 157.34 43.4 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.919 -1.141 . . . . 65.120000000000005 107.919 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.482 ' CG ' ' HB3' ' A' ' 13' ' ' HIS . 41.4 ttp 63.53 62.31 0.95 Allowed 'General case' 0 C--N 1.348 0.519 0 CA-C-O 122.848 1.308 . . . . 62.009999999999998 109.658 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -148.3 96.05 2.55 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.688 -1.596 . . . . 62.149999999999999 107.562 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.502 ' CE1' ' HB2' ' A' ' 128' ' ' SER . 41.6 t60 -141.84 113.67 7.93 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.994 -1.083 . . . . 62.409999999999997 110.925 175.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.1 mm -126.93 126.91 69.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 106.394 -1.706 . . . . 73.450000000000003 106.394 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 46.6 m -107.68 149.85 39.46 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 112.264 0.468 . . . . 64.049999999999997 112.264 -171.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 33.3 Cg_endo -65.3 129.74 23.55 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.27 2.647 . . . . 75.25 112.367 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 20.1 Cg_exo -68.26 133.35 28.24 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.35 2.033 . . . . 75.120000000000005 112.199 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.429 ' HB2' HG23 ' A' ' 7' ' ' ILE . 25.0 mmt -86.96 131.32 34.13 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.67 -1.604 . . . . 74.219999999999999 106.67 174.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.577 HG22 HG23 ' A' ' 6' ' ' VAL . 19.0 t -127.64 127.91 69.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 109.503 -0.554 . . . . 62.539999999999999 109.503 -177.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.8 mm -126.65 114.4 37.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.561 -0.903 . . . . 74.439999999999998 108.561 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -127.87 82.14 0.34 Allowed Glycine 0 CA--C 1.48 -2.144 0 C-N-CA 119.06 -1.543 . . . . 50.210000000000001 114.531 -175.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -156.92 21.94 0.32 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.327 -0.936 . . . . 72.420000000000002 109.545 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.437 HH11 HD12 ' A' ' 40' ' ' ILE . 1.1 mmp_? -95.51 146.43 24.44 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.132 -1.433 . . . . 64.230000000000004 107.132 -172.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 p -85.07 175.6 8.92 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 105.947 -1.871 . . . . 72.299999999999997 105.947 168.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.491 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 76.8 t80 -60.41 -41.94 94.96 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 118.699 0.681 . . . . 72.120000000000005 110.695 -176.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -67.85 -41.58 82.72 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.48 -1.236 . . . . 63.340000000000003 111.197 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mm -74.01 -29.85 26.43 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 N-CA-C 109.613 -0.514 . . . . 71.150000000000006 109.613 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.407 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -63.42 -45.2 92.06 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.87 -0.605 . . . . 44.039999999999999 109.991 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.1 mmt -67.79 -39.46 84.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.225 -0.443 . . . . 73.420000000000002 110.713 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -69.43 -34.65 74.75 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.957 1.095 . . . . 65.109999999999999 113.957 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.52 ' O ' HG23 ' A' ' 44' ' ' VAL . 13.9 tt -70.46 -41.75 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 119.125 -1.03 . . . . 73.349999999999994 109.665 176.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 82.5 t -62.37 -44.1 98.85 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.369 0 N-CA-C 109.41 -0.589 . . . . 73.430000000000007 109.41 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -58.32 -41.84 85.42 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 123.119 0.568 . . . . 73.239999999999995 110.993 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.22 -43.55 92.79 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.62 -0.8 . . . . 74.25 111.401 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 40' ' ' ILE . 97.4 t -65.84 -41.32 89.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.31 -0.626 . . . . 71.010000000000005 109.31 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.93 -46.34 85.18 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 125.298 1.439 . . . . 63.310000000000002 110.717 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -64.8 -44.16 90.84 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.549 -1.205 . . . . 72.400000000000006 110.644 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.9 t -66.87 -38.95 82.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 116.266 -0.425 . . . . 65.340000000000003 110.759 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.487 HG23 HD11 ' A' ' 73' ' ' LEU . 66.1 mt -68.79 -41.87 82.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 121.029 -0.268 . . . . 74.319999999999993 111.675 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -80.39 -17.8 50.81 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 118.749 -1.18 . . . . 65.450000000000003 110.993 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.63 -43.02 8.48 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 112.371 0.508 . . . . 65.430000000000007 112.371 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.3 m -83.27 -16.13 47.52 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 112.801 0.667 . . . . 43.020000000000003 112.801 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -138.13 -174.49 3.81 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.097 0.475 . . . . 71.129999999999995 110.351 -174.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -103.78 105.86 16.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.014 -1.847 . . . . 74.450000000000003 106.014 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.67 136.4 40.9 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 112.948 0.722 . . . . 72.239999999999995 112.948 -174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -100.49 115.52 30.27 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.329 -1.73 . . . . 74.230000000000004 106.329 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 p -100.98 123.07 53.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.26 0.552 . . . . 64.329999999999998 111.437 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -130.67 119.75 22.88 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.107 -0.497 . . . . 72.439999999999998 110.772 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -82.51 137.41 34.63 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.014 -0.539 . . . . 61.340000000000003 110.173 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.4 mt -134.25 171.83 13.71 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.661 -0.866 . . . . 74.209999999999994 108.661 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -99.35 162.04 13.27 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.499 -0.556 . . . . 74.319999999999993 109.499 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.75 177.48 16.43 Favored Glycine 0 C--N 1.278 -2.681 0 N-CA-C 109.292 -1.523 . . . . 52.009999999999998 109.292 178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.509 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 12.8 pt-20 -65.84 179.48 0.87 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.437 -0.579 . . . . 72.140000000000001 109.437 175.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.04 -27.56 69.19 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 122.09 0.948 . . . . 73.530000000000001 111.474 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.8 t -77.42 -16.66 58.7 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.703 -1.135 . . . . 70.430000000000007 109.869 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.509 ' OD2' ' HG2' ' A' ' 62' ' ' GLU . 78.2 m-20 -101.24 157.72 16.57 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 108.436 -0.949 . . . . 74.209999999999994 108.436 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.471 HG21 ' CE2' ' A' ' 3' ' ' TYR . 36.9 t -104.56 -44.2 8.57 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-O 121.579 0.704 . . . . 73.409999999999997 110.314 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.1 tp -163.0 153.08 15.99 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.826 -1.176 . . . . 53.299999999999997 107.826 -174.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -130.08 128.34 41.69 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 106.873 -1.529 . . . . 75.450000000000003 106.873 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -123.43 108.51 12.77 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 107.351 -1.352 . . . . 73.530000000000001 107.351 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.439 ' HE3' ' HB3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -109.99 117.7 34.47 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.105 0.478 . . . . 71.140000000000001 110.218 -175.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -107.44 132.98 52.61 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.248 -0.649 . . . . 74.299999999999997 109.248 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.7 m -97.75 113.39 25.16 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 107.087 -1.449 . . . . 65.329999999999998 107.087 171.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.487 HD11 HG23 ' A' ' 48' ' ' ILE . 4.1 mm? -98.18 139.19 34.34 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 124.306 1.042 . . . . 73.329999999999998 113.51 -173.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -140.41 139.41 35.26 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-N 113.87 -1.514 . . . . 73.150000000000006 107.057 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -132.68 176.52 8.38 Favored 'General case' 0 C--N 1.263 -3.185 0 N-CA-C 102.686 -3.079 . . . . 75.25 102.686 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.3 0.0 OUTLIER -62.86 90.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 115.112 1.523 . . . . 73.329999999999998 115.112 -177.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.26 2.19 77.55 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 114.709 -1.132 . . . . 72.510000000000005 112.8 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 55.3 mttp -130.22 143.38 50.75 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.753 -0.832 . . . . 72.030000000000001 108.753 -174.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.561 ' HD3' ' CE1' ' A' ' 12' ' ' PHE . 14.8 ptpt -151.69 156.2 39.86 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 112.737 0.643 . . . . 62.439999999999998 112.737 -169.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -177.65 170.68 43.17 Favored Glycine 0 C--O 1.2 -2.004 0 CA-C-N 115.372 -0.831 . . . . 73.109999999999999 111.383 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.9 mt -115.75 138.14 47.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 107.684 -1.228 . . . . 74.329999999999998 107.684 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.6 t -115.99 110.37 31.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 109.003 -0.74 . . . . 70.200000000000003 109.003 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 31.2 m-70 -100.73 103.97 15.23 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.484 -0.78 . . . . 75.120000000000005 109.044 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.6 t -109.6 109.75 29.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.268 -0.641 . . . . 71.310000000000002 109.268 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -122.72 149.69 43.74 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 119.488 -0.885 . . . . 75.120000000000005 110.418 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.407 HD22 ' HB1' ' A' ' 37' ' ' ALA . 92.7 mt -99.16 126.54 44.95 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 107.736 -1.209 . . . . 75.049999999999997 107.736 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.5 ttt85 -115.95 134.52 54.89 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 108.273 -1.01 . . . . 75.219999999999999 108.273 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.501 ' HG2' HG23 ' A' ' 90' ' ' THR . 38.4 ttmt -81.06 98.3 7.92 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 116.295 -0.412 . . . . 73.109999999999999 111.482 -176.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.6 tt -75.04 111.4 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 122.235 1.017 . . . . 62.119999999999997 108.825 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.501 HG23 ' HG2' ' A' ' 88' ' ' LYS . 4.5 p -145.15 -171.21 3.61 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-N 114.943 -1.026 . . . . 64.219999999999999 108.941 -172.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -78.79 -4.55 49.97 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.967 0.889 . . . . 72.340000000000003 109.279 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -98.8 -23.34 15.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.312 -0.858 . . . . 70.099999999999994 109.607 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 96.9 m -138.46 118.05 9.71 Favored Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 112.145 0.424 . . . . 52.130000000000003 112.145 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.58 157.48 36.15 Favored 'Trans proline' 0 C--O 1.25 1.119 0 C-N-CA 122.037 1.825 . . . . 75.109999999999999 109.651 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.97 160.7 32.55 Favored 'Trans proline' 0 C--O 1.255 1.329 0 C-N-CA 123.074 2.516 . . . . 73.340000000000003 112.502 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 t -81.2 144.71 10.02 Favored 'Isoleucine or valine' 0 C--O 1.252 1.201 0 N-CA-C 108.493 -0.928 . . . . 74.150000000000006 108.493 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -97.24 85.89 3.79 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 121.953 0.882 . . . . 74.329999999999998 110.809 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -129.37 -158.61 9.59 Favored Glycine 0 N--CA 1.412 -2.959 0 N-CA-C 109.362 -1.495 . . . . 70.219999999999999 109.362 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.91 98.43 7.88 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 108.274 -1.01 . . . . 52.140000000000001 108.274 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 64.2 mtp85 -86.63 93.63 9.26 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 108.064 -1.087 . . . . 75.519999999999996 108.064 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 19.3 t -72.51 168.38 18.67 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 113.854 -1.521 . . . . 44.409999999999997 113.144 -170.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.4 m -73.53 105.9 5.08 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 124.726 1.21 . . . . 73.030000000000001 111.028 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.9 t -84.89 155.03 3.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.799 -1.092 . . . . 65.230000000000004 108.866 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.5 tp -150.35 -68.59 0.19 Allowed 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.686 1.231 . . . . 70.439999999999998 109.177 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.32 165.61 35.34 Favored 'General case' 1 C--N 1.237 -4.297 0 N-CA-C 103.224 -2.88 . . . . 55.43 103.224 178.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' O ' HG22 ' A' ' 110' ' ' ILE . 91.6 t80 -45.98 -36.39 5.52 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.781 1.03 . . . . 74.109999999999999 113.781 -173.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -58.12 -40.45 81.25 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 113.341 0.867 . . . . 73.420000000000002 113.341 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -88.2 -30.41 19.76 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 119.929 -0.708 . . . . 71.109999999999999 109.337 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.44 -47.02 83.6 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.932 -1.031 . . . . 70.25 109.379 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 106' ' ' PHE . 10.3 tp -69.0 -31.71 51.55 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 CA-C-N 116.14 -0.482 . . . . 74.329999999999998 109.826 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -63.81 -41.86 97.79 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.699 -0.482 . . . . 75.420000000000002 109.699 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 53.6 t -70.2 -40.22 74.72 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.001 -0.545 . . . . 45.43 110.178 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.07 -45.18 99.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.81 -0.632 . . . . 62.420000000000002 111.379 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.27 -41.76 92.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.618 0.247 . . . . 61.350000000000001 110.37 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -69.73 -23.79 63.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.464 0.542 . . . . 72.329999999999998 112.464 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.62 -43.94 58.32 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.972 -0.381 . . . . 74.209999999999994 109.972 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.15 -45.45 98.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.359 -0.608 . . . . 75.329999999999998 109.359 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -61.74 -38.23 87.19 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 116.059 -0.519 . . . . 74.329999999999998 111.541 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -64.11 -46.43 84.2 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 108.989 -0.745 . . . . 73.120000000000005 108.989 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 5.6 t -70.69 -29.88 66.3 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.387 -0.824 . . . . 55.420000000000002 111.25 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.29 -37.27 28.71 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.58 -0.7 . . . . 65.450000000000003 111.421 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . . . -76.78 -36.01 57.29 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 111.956 0.354 . . . . 52.210000000000001 111.956 -177.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -99.53 9.94 42.29 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 110.014 -0.365 . . . . 65.129999999999995 110.014 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.485 ' HA2' ' CD2' ' A' ' 22' ' ' HIS . . . -71.7 33.37 0.59 Allowed Glycine 0 C--N 1.334 0.469 0 N-CA-C 117.304 1.682 . . . . 60.109999999999999 117.304 -171.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.94 54.54 0.08 Allowed 'General case' 0 C--N 1.268 -2.96 0 N-CA-C 106.365 -1.717 . . . . 72.519999999999996 106.365 177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -155.62 134.58 12.08 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 104.258 -2.497 . . . . 34.399999999999999 104.258 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -69.25 93.62 0.64 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.244 1.021 . . . . 73.340000000000003 113.233 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.502 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 49.6 m -134.46 123.88 24.72 Favored 'General case' 0 N--CA 1.395 -3.18 0 N-CA-C 103.318 -2.845 . . . . 61.149999999999999 103.318 171.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -153.09 109.0 3.32 Favored 'General case' 0 N--CA 1.412 -2.357 0 C-N-CA 119.243 -0.983 . . . . 74.420000000000002 111.845 -171.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.5 tp -94.36 93.55 7.76 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.546 -2.02 . . . . 62.450000000000003 105.546 168.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -66.48 115.99 6.98 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.166 -0.924 . . . . 75.299999999999997 111.105 -172.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.47 170.59 26.77 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 114.069 -1.423 . . . . 75.010000000000005 114.135 -175.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -123.24 152.11 63.38 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.009 -0.737 . . . . 71.150000000000006 109.009 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.78 95.28 0.88 Allowed 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 121.843 1.695 . . . . 75.109999999999999 110.68 176.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.4 mm -83.67 121.75 76.37 Favored Pre-proline 0 N--CA 1.41 -2.429 0 N-CA-C 106.267 -1.753 . . . . 63.009999999999998 106.267 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -60.09 157.25 35.35 Favored 'Trans proline' 0 C--N 1.325 -0.697 0 C-N-CA 123.248 2.632 . . . . 64.120000000000005 111.692 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -122.28 85.48 47.18 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 109.344 -0.613 . . . . 60.119999999999997 109.344 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.47 ' HD2' ' OE1' ' A' ' 62' ' ' GLU . 12.1 Cg_exo -74.06 100.54 1.3 Allowed 'Trans proline' 0 N--CA 1.433 -2.08 0 C-N-CA 121.811 1.674 . . . . 65.120000000000005 110.905 175.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.02 136.6 35.22 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.069 -1.456 . . . . 72.219999999999999 107.069 171.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 66.28 104.35 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.156 0.983 . . . . 75.409999999999997 111.392 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -137.6 -65.12 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 110.437 -1.065 . . . . 74.230000000000004 110.437 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.8 tp -148.71 102.17 3.27 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.843 0.354 . . . . 43.43 110.835 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -114.57 -5.2 12.78 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.998 0.428 . . . . 73.099999999999994 109.928 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.5 m -59.97 108.38 0.76 Allowed 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 123.787 0.835 . . . . 53.009999999999998 113.187 -175.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.9 t -144.31 27.5 1.4 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.195 -1.409 . . . . 74.239999999999995 107.195 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.3 97.02 7.35 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 106.23 -1.767 . . . . 73.209999999999994 106.23 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 32.8 m 73.36 105.7 0.07 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.695 1.198 . . . . 70.109999999999999 111.372 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.144 0 N-CA-C 110.634 -0.986 . . . . 24.399999999999999 110.634 179.21 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.635 0 N-CA-C 105.66 -1.978 . . . . 74.25 105.66 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.01 139.07 32.05 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.327 0.584 . . . . 71.209999999999994 112.055 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.654 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 62.9 m-85 -125.93 137.07 53.68 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.001 -1.0 . . . . 74.25 109.333 176.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.481 ' OD1' ' HB ' ' A' ' 89' ' ' ILE . 4.9 m-20 -101.83 122.1 43.34 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.477 -0.783 . . . . 73.510000000000005 108.898 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 p -95.53 109.14 22.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 108.339 -0.986 . . . . 64.120000000000005 108.339 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 28' ' ' VAL . 61.0 t -102.96 106.28 19.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.921 -1.14 . . . . 70.129999999999995 107.921 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -105.67 118.48 53.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 CA-C-N 115.577 -0.738 . . . . 71.140000000000001 109.858 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.401 HG13 ' HB3' ' A' ' 26' ' ' PRO . 3.5 mp -106.18 108.18 61.22 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 107.927 -1.138 . . . . 74.120000000000005 107.927 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.648 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 28.5 Cg_endo -99.84 120.33 0.11 Allowed 'Trans proline' 0 N--CA 1.429 -2.314 0 C-N-CA 121.772 1.648 . . . . 74.299999999999997 110.908 171.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.713 ' HA ' ' SG ' ' A' ' 120' ' ' CYS . 0.7 OUTLIER -138.69 145.79 40.78 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.154 0.502 . . . . 64.400000000000006 109.901 174.06 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.598 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.6 p -81.76 129.99 34.91 Favored 'General case' 0 N--CA 1.398 -3.062 0 N-CA-C 107.468 -1.308 . . . . 60.439999999999998 107.468 175.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.505 ' CE1' ' HB3' ' A' ' 79' ' ' LYS 0.284 0.0 OUTLIER -73.95 80.63 1.67 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 115.003 1.483 . . . . 75.329999999999998 115.003 -169.143 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -91.12 151.61 20.92 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.444 -1.253 . . . . 75.109999999999999 112.445 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -104.43 -158.25 0.65 Allowed 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 106.152 -1.795 . . . . 75.140000000000001 106.152 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -128.66 110.72 12.47 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 110.042 -0.355 . . . . 70.5 110.042 172.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -91.79 -104.99 0.11 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.136 -0.69 . . . . 72.340000000000003 109.136 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -113.35 -54.37 2.62 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.474 -0.935 . . . . 74.340000000000003 108.474 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -134.75 -29.55 1.15 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.322 -1.308 . . . . 60.299999999999997 108.443 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -63.04 133.56 54.73 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.217 -1.031 . . . . 72.310000000000002 108.217 171.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 60.2 mtt 74.32 99.12 0.07 Allowed 'General case' 0 C--N 1.313 -0.983 0 O-C-N 124.126 0.891 . . . . 70.109999999999999 112.139 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -174.1 82.18 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 125.662 1.585 . . . . 73.310000000000002 107.867 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.471 ' ND1' ' HB2' ' A' ' 128' ' ' SER . 41.6 t60 -148.71 116.18 6.21 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-N 115.946 -0.57 . . . . 52.329999999999998 111.075 -175.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.9 mm -132.93 139.1 50.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.15 -1.426 . . . . 74.129999999999995 107.15 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 60.5 m -107.53 149.3 38.68 Favored Pre-proline 0 C--N 1.288 -2.087 0 N-CA-C 108.856 -0.794 . . . . 74.430000000000007 108.856 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 55.1 Cg_endo -69.29 147.76 66.59 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.655 2.237 . . . . 73.409999999999997 113.551 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 33.5 Cg_exo -64.45 136.69 51.83 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.117 2.544 . . . . 71.239999999999995 111.856 178.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.522 ' SD ' ' HB2' ' A' ' 101' ' ' CYS . 47.9 ttm -103.11 129.11 49.86 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.479 -0.934 . . . . 71.420000000000002 108.479 175.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 6' ' ' VAL . 58.9 t -120.76 132.39 70.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 116.338 -0.392 . . . . 74.540000000000006 110.265 -174.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.33 102.41 9.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 106.121 -1.807 . . . . 64.310000000000002 106.121 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -124.39 82.2 0.35 Allowed Glycine 0 C--N 1.285 -2.29 0 C-N-CA 120.025 -1.083 . . . . 60.340000000000003 114.587 -173.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -170.38 27.47 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.717 0.77 . . . . 73.400000000000006 109.276 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -105.04 154.0 20.71 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.765 -1.568 . . . . 74.329999999999998 106.765 -173.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.3 p -89.64 173.94 8.02 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 106.525 -1.657 . . . . 72.409999999999997 106.525 171.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.654 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 63.8 t80 -60.79 -46.15 91.64 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 118.603 0.638 . . . . 74.450000000000003 110.156 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.69 -42.3 95.42 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.569 -1.196 . . . . 62.140000000000001 111.567 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mm -69.66 -39.25 77.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 116.257 -0.429 . . . . 71.209999999999994 110.146 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.54 -44.7 81.68 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.857 -0.611 . . . . 61.109999999999999 110.077 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.6 mmt -65.88 -35.93 82.0 Favored 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 120.768 -0.373 . . . . 64.420000000000002 111.847 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.6 -41.61 92.6 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 120.555 -0.458 . . . . 63.0 111.509 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 44' ' ' VAL . 8.9 tt -71.96 -41.79 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 118.605 -1.238 . . . . 72.420000000000002 110.527 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.448 HG12 ' NH2' ' A' ' 69' ' ' ARG . 91.3 t -66.77 -38.37 81.38 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 CA-C-N 116.726 -0.216 . . . . 64.299999999999997 110.953 -177.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -67.47 -37.95 83.69 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.067 0.46 . . . . 73.430000000000007 110.277 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.464 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.72 -48.04 70.85 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.355 -0.926 . . . . 61.340000000000003 111.12 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 40' ' ' ILE . 92.0 t -64.81 -39.67 86.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.206 0.527 . . . . 73.510000000000005 109.78 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.07 -42.91 91.5 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.788 0.835 . . . . 74.109999999999999 112.117 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -79.63 -26.13 41.23 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 120.162 -0.615 . . . . 72.219999999999999 111.178 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 43' ' ' GLY . 79.5 t -70.03 -44.84 78.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 110.126 -0.324 . . . . 73.230000000000004 110.126 174.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 72.1 mt -65.1 -40.48 89.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 111.972 0.36 . . . . 75.319999999999993 111.972 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.415 ' HB2' ' OG ' ' A' ' 144' ' ' SER . 35.1 mtmm -80.27 -10.75 59.76 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.067 -1.053 . . . . 75.439999999999998 112.175 -176.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -98.81 -47.87 5.14 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.29 -0.414 . . . . 74.349999999999994 111.164 175.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.7 m -81.09 -18.12 47.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.629 0.603 . . . . 50.350000000000001 112.629 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.657 ' CE2' ' HD2' ' A' ' 75' ' ' LYS . 1.8 m-85 -127.68 175.2 8.48 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.333 -0.988 . . . . 73.319999999999993 108.333 -176.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.575 ' HA ' HD21 ' A' ' 142' ' ' LEU . 6.4 t-20 -105.03 91.7 3.91 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 105.716 -1.957 . . . . 52.310000000000002 105.716 174.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.558 ' HB2' HD13 ' A' ' 73' ' ' LEU . . . -132.25 136.39 46.94 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 112.998 0.74 . . . . 41.210000000000001 112.998 -172.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.556 ' OG ' ' HA ' ' A' ' 140' ' ' LEU . 23.3 t -94.46 159.77 14.95 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.856 -1.535 . . . . 53.049999999999997 106.856 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.0 130.9 55.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 120.909 0.385 . . . . 75.319999999999993 109.988 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -135.61 112.22 10.02 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.59 -0.522 . . . . 64.230000000000004 109.59 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -87.88 136.13 33.1 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.635 -0.426 . . . . 75.230000000000004 110.411 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.0 mt -133.59 171.65 13.81 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.436 -0.802 . . . . 74.310000000000002 108.898 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -85.37 143.78 28.43 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.329 -0.989 . . . . 44.240000000000002 108.329 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -96.67 175.43 31.46 Favored Glycine 0 N--CA 1.414 -2.777 0 N-CA-C 110.394 -1.082 . . . . 63.119999999999997 110.394 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.428 ' HG2' ' CG ' ' A' ' 65' ' ' ASP . 11.2 pt-20 -70.39 179.84 2.32 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 122.767 0.427 . . . . 73.439999999999998 110.03 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.4 -38.16 76.78 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.724 0.773 . . . . 72.319999999999993 112.795 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 76.9 m -83.78 -5.19 59.14 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.504 -0.771 . . . . 72.340000000000003 111.908 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 85' ' ' LYS . 13.4 m-20 -95.8 171.6 8.55 Favored 'General case' 0 CA--C 1.49 -1.365 0 CA-C-N 115.396 -0.82 . . . . 72.230000000000004 110.091 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.15 -42.65 3.58 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.447 0 CA-C-N 114.651 -1.159 . . . . 73.400000000000006 109.089 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.1 tp -163.21 151.77 14.12 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 106.901 -1.518 . . . . 74.329999999999998 106.901 -176.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.58 118.36 21.88 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.483 -1.673 . . . . 73.099999999999994 106.483 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.448 ' NH2' HG12 ' A' ' 41' ' ' VAL . 36.3 ttp180 -122.72 124.2 42.84 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.23 -0.988 . . . . 73.140000000000001 110.43 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -98.42 145.11 27.06 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 124.367 1.067 . . . . 72.439999999999998 108.986 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 95.4 m-85 -131.76 137.74 48.32 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.878 -1.156 . . . . 74.150000000000006 107.878 175.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 32.0 m -113.86 111.85 22.4 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.698 -0.853 . . . . 72.439999999999998 108.698 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 54' ' ' ALA . 4.2 mm? -96.9 139.96 32.16 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 113.273 0.842 . . . . 60.109999999999999 113.273 -171.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -143.85 89.75 2.08 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 105.038 -2.208 . . . . 54.399999999999999 105.038 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.657 ' HD2' ' CE2' ' A' ' 52' ' ' PHE . 63.9 tttm -105.34 96.34 6.45 Favored 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.766 -0.584 . . . . 71.349999999999994 109.632 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 13.6 pt-20 53.5 35.51 20.92 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.618 1.167 . . . . 72.5 113.092 173.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.54 -8.64 56.8 Favored Glycine 0 CA--C 1.506 -0.505 0 C-N-CA 121.165 -0.54 . . . . 74.439999999999998 112.764 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HE3' ' HA ' ' A' ' 122' ' ' ALA . 50.4 mtpt -98.86 102.72 14.55 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.392 -1.707 . . . . 62.119999999999997 106.392 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.505 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . 58.9 mttp -101.53 153.96 19.26 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.792 -0.64 . . . . 72.030000000000001 112.176 -174.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -173.04 176.58 45.78 Favored Glycine 0 N--CA 1.417 -2.596 0 N-CA-C 110.599 -1.0 . . . . 60.039999999999999 110.599 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.3 tt -133.78 149.36 30.68 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.039 0 N-CA-C 106.948 -1.501 . . . . 54.219999999999999 106.948 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 91.0 t -132.34 127.52 57.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.252 -0.648 . . . . 75.329999999999998 109.252 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -113.86 113.72 25.28 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.322 -0.621 . . . . 74.129999999999995 109.322 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.54 110.59 30.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.879 -0.786 . . . . 61.210000000000001 108.879 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.511 ' HB2' ' OD2' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -110.67 126.53 54.61 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.03 -1.1 . . . . 64.129999999999995 108.03 178.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.0 mt -100.22 125.94 46.45 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.995 -1.854 . . . . 60.039999999999999 105.995 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.456 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 70.1 mtp85 -112.36 141.8 45.64 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-O 121.091 0.472 . . . . 72.040000000000006 110.927 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -94.29 98.71 11.11 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 115.309 -0.86 . . . . 71.129999999999995 109.373 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.481 ' HB ' ' OD1' ' A' ' 4' ' ' ASP . 10.9 tt -65.38 111.72 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 122.44 1.114 . . . . 70.109999999999999 109.141 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.7 p -137.8 176.75 8.43 Favored 'General case' 0 N--CA 1.39 -3.44 0 CA-C-N 114.685 -1.143 . . . . 55.399999999999999 109.807 -174.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -71.38 -17.78 62.39 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.895 -1.048 . . . . 72.030000000000001 109.32 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -98.06 -32.12 11.79 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.665 -1.152 . . . . 73.530000000000001 110.817 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 42.3 m -133.69 108.46 11.96 Favored Pre-proline 0 N--CA 1.432 -1.349 0 N-CA-C 113.695 0.998 . . . . 74.299999999999997 113.695 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -90.4 144.92 4.03 Favored 'Trans proline' 0 N--CA 1.438 -1.785 0 C-N-CA 122.465 2.11 . . . . 32.420000000000002 111.236 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -82.87 158.93 15.97 Favored 'Trans proline' 0 C--O 1.255 1.37 0 C-N-CA 122.378 2.052 . . . . 74.239999999999995 111.518 172.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 t -98.73 150.13 5.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 105.252 -2.129 . . . . 75.409999999999997 105.252 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -107.13 146.31 31.43 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.788 0.804 . . . . 73.219999999999999 112.162 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -138.59 -147.58 5.17 Favored Glycine 0 CA--C 1.476 -2.344 0 CA-C-N 114.071 -1.422 . . . . 72.109999999999999 110.079 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -60.84 125.84 25.18 Favored 'General case' 0 C--N 1.288 -2.093 0 O-C-N 124.286 0.639 . . . . 74.340000000000003 110.007 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -97.7 131.43 44.25 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.213 0.53 . . . . 60.450000000000003 110.395 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.522 ' HB2' ' SD ' ' A' ' 27' ' ' MET . 44.3 t -73.35 154.91 39.89 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.558 -1.201 . . . . 64.400000000000006 109.919 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.3 t -80.96 74.97 7.94 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.519 -1.289 . . . . 64.319999999999993 107.519 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.94 140.05 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 114.866 -1.061 . . . . 75.420000000000002 109.803 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.9 tp -153.7 -121.87 0.03 OUTLIER 'General case' 0 C--N 1.257 -3.453 0 N-CA-C 103.866 -2.642 . . . . 74.239999999999995 103.866 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.62 168.59 10.07 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 107.817 -1.179 . . . . 63.240000000000002 107.817 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.457 ' O ' HG22 ' A' ' 110' ' ' ILE . 74.5 t80 -43.25 -36.64 1.87 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.57 1.148 . . . . 73.319999999999993 114.071 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -56.84 -37.63 71.53 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.707 0.803 . . . . 63.420000000000002 112.249 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -90.62 -34.69 15.37 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.687 -0.486 . . . . 75.319999999999993 109.687 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 26.0 m-20 -62.55 -46.87 86.37 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.15 -0.932 . . . . 74.519999999999996 110.613 -176.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 106' ' ' PHE . 9.1 tp -64.59 -39.75 86.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 N-CA-C 109.963 -0.384 . . . . 72.209999999999994 109.963 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.96 -41.5 82.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.774 -0.648 . . . . 75.219999999999999 110.671 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 7.8 t -63.0 -44.25 96.54 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.693 -0.685 . . . . 74.310000000000002 111.259 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 47.0 mm -68.25 -41.46 83.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.994 -0.372 . . . . 54.439999999999998 109.994 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 51.6 t -64.22 -43.06 97.23 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 CA-C-N 116.029 -0.532 . . . . 61.219999999999999 110.366 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -61.9 -40.47 95.56 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 122.826 0.45 . . . . 75.25 111.19 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.59 84.33 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.183 0.516 . . . . 70.329999999999998 111.412 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.415 ' O ' HD13 ' A' ' 121' ' ' LEU . 79.0 mt -71.3 -43.28 74.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.364 -0.606 . . . . 72.329999999999998 109.364 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 114' ' ' VAL . 1.7 tm-20 -62.63 -40.49 97.18 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.484 -0.78 . . . . 63.539999999999999 110.448 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.74 -36.78 76.12 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 120.069 -0.652 . . . . 74.319999999999993 110.669 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.713 ' SG ' ' HA ' ' A' ' 10' ' ' GLU . 10.8 t -67.96 -34.05 75.84 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.657 0.741 . . . . 75.099999999999994 109.665 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.3 mp -75.79 -35.34 60.12 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.474 -0.784 . . . . 73.319999999999993 111.247 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.477 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . . . -69.67 -33.77 73.02 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.991 0.424 . . . . 74.230000000000004 111.144 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -80.55 10.32 4.9 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.7 -0.682 . . . . 70.319999999999993 111.556 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -53.71 124.15 28.57 Favored Glycine 0 C--O 1.249 1.044 0 CA-C-N 116.111 -0.495 . . . . 50.25 112.817 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 68.04 57.98 0.48 Allowed 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 125.706 1.602 . . . . 74.310000000000002 112.259 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.2 mt -142.77 135.87 28.31 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.497 -1.229 . . . . 70.439999999999998 108.827 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -58.63 100.31 0.06 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.388 1.075 . . . . 71.239999999999995 112.0 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.471 ' HB2' ' ND1' ' A' ' 22' ' ' HIS . 58.2 m -155.55 105.83 2.47 Favored 'General case' 0 N--CA 1.422 -1.86 0 C-N-CA 124.416 1.086 . . . . 71.319999999999993 110.058 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm 68.5 103.06 0.05 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.855 1.262 . . . . 44.340000000000003 112.634 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . 0.289 0.6 OUTLIER -76.45 73.02 3.19 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 123.058 1.408 . . . . 51.43 112.83 176.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -134.28 151.49 51.3 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.308 -1.367 . . . . 71.340000000000003 107.308 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -119.76 142.18 16.09 Favored Glycine 0 N--CA 1.428 -1.866 0 C-N-CA 120.051 -1.071 . . . . 72.030000000000001 111.717 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.511 ' HE3' ' OE2' ' A' ' 10' ' ' GLU . 19.7 tptp -118.97 87.17 33.18 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 106.45 -1.685 . . . . 73.099999999999994 106.45 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -84.01 72.51 5.24 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.693 2.262 . . . . 61.119999999999997 112.699 -173.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.1 mt -128.5 100.6 22.17 Favored Pre-proline 0 N--CA 1.42 -1.972 0 CA-C-N 115.297 -0.865 . . . . 64.420000000000002 108.989 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -87.36 129.89 2.79 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.086 1.857 . . . . 64.519999999999996 110.234 172.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -120.66 102.77 44.44 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 109.149 -0.685 . . . . 63.149999999999999 109.149 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -86.66 -5.22 8.13 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.242 1.961 . . . . 73.109999999999999 112.651 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 tt -95.92 102.37 14.16 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 107.947 -1.131 . . . . 74.310000000000002 107.947 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.556 ' HA ' ' OG ' ' A' ' 55' ' ' SER 0.284 1.6 pp -125.16 115.32 20.26 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 113.081 0.771 . . . . 71.109999999999999 113.081 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -153.52 152.91 24.46 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.554 -1.018 . . . . 42.530000000000001 110.554 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.575 HD21 ' HA ' ' A' ' 53' ' ' ASN . 5.5 mp -126.99 143.65 51.23 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 117.072 0.436 . . . . 53.43 111.149 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -144.26 92.16 2.28 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.788 -0.642 . . . . 74.239999999999995 109.581 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' ' 49' ' ' LYS . 74.8 m -165.45 100.21 0.71 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.441 1.096 . . . . 73.019999999999996 109.074 178.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.8 t -82.4 67.55 8.47 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.774 0.797 . . . . 72.510000000000005 110.542 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.457 ' HG2' ' H ' ' A' ' 147' ' ' THR . 42.7 ttt180 62.23 -175.63 0.14 Allowed 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.239 -1.346 . . . . 65.299999999999997 110.71 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.457 ' H ' ' HG2' ' A' ' 146' ' ' ARG . 19.4 m -66.7 125.16 24.95 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.488 -0.56 . . . . 63.25 109.488 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.285 0 N-CA-C 109.028 -1.629 . . . . 62.049999999999997 109.028 -177.84 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.252 0 N-CA-C 106.764 -1.569 . . . . 72.140000000000001 106.764 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -120.45 128.89 53.59 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.905 0.383 . . . . 41.43 110.405 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.623 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 28.8 m-85 -117.69 148.95 41.51 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.395 0.617 . . . . 74.549999999999997 111.377 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.477 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 29.4 t70 -121.36 107.47 12.54 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.222 -2.14 . . . . 60.229999999999997 105.222 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -93.23 114.91 30.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 116.186 -0.461 . . . . 64.5 110.23 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.444 ' HB ' ' HG3' ' A' ' 85' ' ' LYS . 46.9 t -104.87 112.89 40.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 108.432 -0.951 . . . . 63.200000000000003 108.432 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.506 HG23 ' HB2' ' A' ' 27' ' ' MET . 3.7 tt -114.34 108.34 25.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.835 0.826 . . . . 75.25 108.847 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.9 mt -104.06 106.4 53.08 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 114.991 -1.004 . . . . 75.519999999999996 111.799 -171.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.584 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 7.1 Cg_endo -92.9 140.05 1.8 Allowed 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 122.419 2.079 . . . . 63.219999999999999 110.572 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -164.08 155.87 16.53 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 122.468 0.307 . . . . 71.140000000000001 110.76 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.9 m -91.57 135.19 34.04 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.707 -0.479 . . . . 52.009999999999998 109.707 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.15 68.65 10.0 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 113.551 0.945 . . . . 75.200000000000003 113.551 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -122.82 138.21 54.71 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.126 -1.064 . . . . 74.519999999999996 108.126 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.415 ' N ' ' HD2' ' A' ' 14' ' ' ARG . 9.0 mpt_? -82.39 134.98 35.25 Favored 'General case' 0 CA--C 1.475 -1.938 0 N-CA-C 108.998 -0.742 . . . . 73.200000000000003 108.998 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.432 ' HB3' HD22 ' A' ' 130' ' ' LEU . 7.1 t80 -62.67 110.44 1.72 Allowed 'General case' 0 N--CA 1.405 -2.702 0 O-C-N 124.688 1.242 . . . . 73.519999999999996 111.131 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.72 -99.31 0.06 Allowed 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 114.603 -1.18 . . . . 71.530000000000001 109.623 173.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -113.79 -58.45 2.15 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.033 0.444 . . . . 62.119999999999997 109.956 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -138.12 -51.91 0.6 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.085 0.945 . . . . 62.310000000000002 109.813 173.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -84.99 67.41 10.2 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.851 -1.068 . . . . 64.450000000000003 112.74 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 48.1 ttp 159.42 88.75 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.384 0 C-N-CA 128.169 2.588 . . . . 73.510000000000005 105.359 171.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 168.98 121.8 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.323 -2.103 . . . . 73.230000000000004 105.323 -173.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.474 ' HB2' ' H ' ' A' ' 125' ' ' GLU . 77.1 t60 -156.81 113.46 3.05 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.804 -0.758 . . . . 74.439999999999998 112.592 172.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.3 mm -113.64 132.5 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 N-CA-C 107.272 -1.381 . . . . 73.319999999999993 107.272 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 9.1 m -109.6 138.63 20.66 Favored Pre-proline 0 C--N 1.273 -2.723 0 N-CA-C 107.353 -1.351 . . . . 72.030000000000001 107.353 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -53.88 128.96 31.81 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 122.797 2.331 . . . . 70.409999999999997 112.427 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.88 130.43 26.0 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.489 2.126 . . . . 72.109999999999999 110.343 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.506 ' HB2' HG23 ' A' ' 7' ' ' ILE . 73.0 mtm -88.82 138.97 30.94 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 109.849 -0.426 . . . . 43.520000000000003 109.849 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.3 119.99 53.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.3 0.571 . . . . 74.430000000000007 110.04 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 30.6 mm -113.13 100.87 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 105.783 -1.932 . . . . 64.230000000000004 105.783 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -107.2 165.04 13.1 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 119.6 -1.286 . . . . 65.0 112.132 -176.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.6 t70 65.72 70.05 0.45 Allowed 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 125.339 1.456 . . . . 62.049999999999997 110.634 -175.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -138.34 136.05 35.99 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 105.364 -2.088 . . . . 75.349999999999994 105.364 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.6 p -77.95 163.73 25.73 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 106.558 -1.645 . . . . 63.020000000000003 106.558 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.623 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 74.7 t80 -59.13 -37.26 76.81 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.609 0.718 . . . . 71.430000000000007 110.393 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -63.56 -47.17 82.62 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.309 -1.314 . . . . 54.420000000000002 110.857 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.1 mt -73.13 -38.52 55.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.935 -0.765 . . . . 71.120000000000005 108.935 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.82 98.9 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.866 -1.061 . . . . 43.329999999999998 110.893 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.4 tpp -67.69 -39.9 84.39 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.624 -0.831 . . . . 75.319999999999993 110.545 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -70.52 -34.48 72.35 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 119.838 -0.745 . . . . 71.400000000000006 112.745 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 44' ' ' VAL . 7.0 tp -73.79 -43.01 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 119.484 -0.886 . . . . 42.520000000000003 110.57 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t -68.57 -39.65 80.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 121.249 -0.18 . . . . 63.219999999999999 111.159 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -70.51 -29.38 65.87 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.272 -0.64 . . . . 65.219999999999999 109.272 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.29 -47.54 78.89 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 110.42 -1.072 . . . . 71.549999999999997 110.42 174.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 40' ' ' ILE . 90.5 t -57.59 -46.06 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 109.146 -0.687 . . . . 73.239999999999995 109.146 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -55.86 -39.4 71.43 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 125.231 1.412 . . . . 75.010000000000005 113.108 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 46' ' ' ARG . 25.8 mtp180 -79.02 -31.04 44.53 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.305 -0.407 . . . . 74.319999999999993 111.2 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 43' ' ' GLY . 82.5 t -71.8 -38.06 64.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.289 -0.634 . . . . 63.439999999999998 109.289 176.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.5 mt -60.73 -46.6 95.69 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.852 0 CA-C-N 116.091 -0.504 . . . . 75.109999999999999 111.558 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.444 ' HD2' HD21 ' A' ' 142' ' ' LEU . 38.2 mtmm -76.7 -15.93 59.65 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.6 -0.84 . . . . 74.409999999999997 112.114 -178.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.4 -40.19 12.21 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.213 -0.449 . . . . 63.43 112.055 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 t -91.61 -20.61 21.46 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 112.463 0.542 . . . . 73.409999999999997 112.463 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -128.35 -179.97 5.31 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.6 0.714 . . . . 74.049999999999997 110.45 -174.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -105.54 106.52 17.06 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 104.155 -2.535 . . . . 71.319999999999993 104.155 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -118.2 135.63 54.13 Favored 'General case' 0 N--CA 1.404 -2.759 0 C-N-CA 119.533 -0.867 . . . . 64.439999999999998 113.114 -172.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.473 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 29.4 m -99.16 106.88 19.11 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 104.418 -2.438 . . . . 63.409999999999997 104.418 166.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 p -99.16 118.13 45.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.452 -0.944 . . . . 71.25 108.452 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -116.33 129.13 56.1 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.072 -0.967 . . . . 73.209999999999994 109.952 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -85.56 118.19 24.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.68 -0.691 . . . . 71.310000000000002 109.747 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mp -119.3 167.22 12.09 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 109.018 -0.734 . . . . 64.340000000000003 109.018 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -109.74 147.96 32.26 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 108.103 -1.073 . . . . 74.5 108.103 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.16 176.09 35.5 Favored Glycine 0 N--CA 1.407 -3.265 0 CA-C-N 115.512 -0.767 . . . . 73.150000000000006 112.725 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.453 ' N ' ' HB2' ' A' ' 65' ' ' ASP . 44.4 mt-10 -66.02 -173.33 0.18 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 124.893 1.277 . . . . 65.420000000000002 110.347 174.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -58.01 -44.7 87.42 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.462 0.648 . . . . 61.039999999999999 111.791 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 90.2 m -80.08 -23.45 41.3 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.6 -0.727 . . . . 34.409999999999997 111.757 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.453 ' HB2' ' N ' ' A' ' 62' ' ' GLU . 9.6 m-20 -90.87 123.23 34.23 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 119.342 -0.943 . . . . 73.430000000000007 111.013 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.7 t -84.43 -33.27 8.56 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 115.849 -0.614 . . . . 74.030000000000001 111.791 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.9 tp -151.58 139.9 20.39 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.441 -0.577 . . . . 73.030000000000001 109.441 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -130.8 121.41 25.31 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 107.622 -1.251 . . . . 62.329999999999998 107.622 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -118.72 123.66 45.42 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.665 -1.235 . . . . 70.5 107.665 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -103.63 109.96 21.85 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.268 -1.012 . . . . 72.209999999999994 108.268 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -96.43 119.17 34.44 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.01 -1.107 . . . . 62.229999999999997 108.01 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 16.9 m -98.95 115.93 30.02 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 106.527 -1.657 . . . . 55.539999999999999 106.527 174.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -108.59 151.04 26.66 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 113.537 0.94 . . . . 73.120000000000005 113.537 -170.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 36.6 tt0 -147.28 125.79 12.44 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 113.421 -1.718 . . . . 72.239999999999995 106.831 169.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -128.16 81.73 2.04 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 108.116 -1.068 . . . . 74.109999999999999 108.116 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 45.22 76.65 0.09 Allowed 'General case' 0 C--O 1.244 0.79 0 C-N-CA 126.239 1.816 . . . . 71.329999999999998 113.586 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.36 -23.18 28.78 Favored Glycine 0 C--N 1.309 -0.93 0 CA-C-N 115.777 -0.647 . . . . 52.210000000000001 112.933 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 14.2 mptt -96.01 129.42 43.28 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.551 -1.278 . . . . 65.329999999999998 107.551 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -145.97 138.49 25.53 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-O 121.132 0.492 . . . . 65.540000000000006 111.76 -173.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.3 179.76 42.28 Favored Glycine 0 CA--C 1.493 -1.285 0 N-CA-C 110.472 -1.051 . . . . 53.140000000000001 110.472 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 29.7 mt -120.1 145.96 25.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 109.404 -0.591 . . . . 70.239999999999995 109.404 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 83.8 t -126.45 112.64 30.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.716 -0.846 . . . . 72.510000000000005 108.716 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -98.87 107.54 20.0 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.309 -0.997 . . . . 75.239999999999995 108.309 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 44.0 t -102.58 110.47 29.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.696 -0.483 . . . . 74.099999999999994 109.696 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.444 ' HG3' ' HB ' ' A' ' 6' ' ' VAL . 8.1 ptpt -116.68 135.55 53.69 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 120.766 0.317 . . . . 72.0 110.677 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.1 mt -103.62 109.92 21.79 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 106.667 -1.605 . . . . 74.239999999999995 106.667 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.424 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 13.4 mtp180 -98.0 140.53 32.2 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 119.686 -0.806 . . . . 75.219999999999999 109.329 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -84.86 113.05 21.09 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 107.891 -1.151 . . . . 64.120000000000005 107.891 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 tt -87.26 111.64 22.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.79 -0.818 . . . . 71.540000000000006 108.79 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -128.18 174.59 9.13 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.505 -1.295 . . . . 72.129999999999995 107.505 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -78.2 0.16 26.12 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 120.282 -0.567 . . . . 75.030000000000001 112.322 -173.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -119.01 10.58 12.21 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.847 -0.615 . . . . 65.109999999999999 110.683 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.8 t -146.91 118.82 4.76 Favored Pre-proline 0 N--CA 1.446 -0.635 0 O-C-N 122.09 -0.381 . . . . 72.200000000000003 110.3 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.65 148.13 22.66 Favored 'Trans proline' 0 C--O 1.249 1.067 0 C-N-CA 123.209 2.606 . . . . 62.299999999999997 113.947 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.72 164.39 33.78 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 123.567 2.845 . . . . 64.439999999999998 110.217 175.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.5 t -100.51 156.48 4.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.742 -1.207 . . . . 72.200000000000003 107.742 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.89 116.34 24.96 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 122.024 0.916 . . . . 74.129999999999995 112.371 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -140.37 -160.5 8.34 Favored Glycine 0 N--CA 1.415 -2.748 0 N-CA-C 109.634 -1.387 . . . . 62.420000000000002 109.634 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -60.64 104.8 0.38 Allowed 'General case' 0 N--CA 1.398 -3.066 0 C-N-CA 124.792 1.237 . . . . 61.130000000000003 110.011 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -82.39 105.74 13.69 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 106.643 -1.614 . . . . 53.329999999999998 106.643 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.69 -179.23 5.21 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.421 -0.809 . . . . 72.5 109.207 -174.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.3 m -74.14 93.82 2.35 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.045 -0.724 . . . . 73.430000000000007 109.045 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.431 HG13 ' OD2' ' A' ' 109' ' ' ASP . 31.7 t -98.98 143.8 12.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.562 -0.903 . . . . 65.430000000000007 108.562 -177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.4 tp -161.57 -75.31 0.05 Allowed 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 122.133 0.968 . . . . 73.230000000000004 109.654 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -151.0 169.46 21.74 Favored 'General case' 0 C--N 1.259 -3.343 0 CA-C-N 112.945 -1.934 . . . . 72.230000000000004 108.193 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.426 ' O ' HG22 ' A' ' 110' ' ' ILE . 70.1 t80 -33.16 -63.47 0.23 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 115.559 1.689 . . . . 72.219999999999999 115.559 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.62 -42.62 93.1 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.914 0.709 . . . . 70.209999999999994 112.914 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.64 -36.18 62.88 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.256 -0.577 . . . . 54.520000000000003 109.714 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.552 ' O ' HG12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -64.88 -50.71 65.49 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 124.024 0.828 . . . . 63.43 110.134 177.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.509 HD13 ' HA ' ' A' ' 44' ' ' VAL . 7.6 tp -63.55 -36.25 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-O 120.914 0.388 . . . . 75.439999999999998 110.116 -176.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.37 -48.06 83.38 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.545 -0.752 . . . . 75.129999999999995 110.387 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 6.4 t -67.36 -36.31 81.13 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 116.065 -0.516 . . . . 62.299999999999997 109.782 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 109' ' ' ASP . 49.9 mm -64.89 -47.2 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.592 -0.731 . . . . 70.209999999999994 110.167 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 110' ' ' ILE . 77.0 t -63.39 -41.0 91.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-O 121.113 0.483 . . . . 64.349999999999994 110.174 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.33 -42.95 99.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.505 -0.77 . . . . 71.030000000000001 111.13 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.01 -38.06 79.03 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 123.191 0.307 . . . . 65.209999999999994 111.373 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.423 ' O ' HD13 ' A' ' 121' ' ' LEU . 77.8 mt -64.77 -45.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.543 -0.54 . . . . 65.530000000000001 109.543 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -71.75 -31.14 66.35 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 119.19 -1.004 . . . . 72.409999999999997 112.307 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.62 -43.75 88.6 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 109.156 -0.683 . . . . 74.109999999999999 109.156 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 52.1 t -58.66 -46.87 86.24 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.531 -0.758 . . . . 71.439999999999998 110.64 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.0 mp -73.26 -26.64 61.18 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.022 0.439 . . . . 73.230000000000004 111.811 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.68 -32.47 28.11 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 111.945 0.35 . . . . 72.349999999999994 111.945 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -87.73 9.93 19.96 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.486 0.55 . . . . 65.439999999999998 112.486 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -52.43 127.57 33.78 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.076 -0.511 . . . . 33.109999999999999 112.142 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.474 ' H ' ' HB2' ' A' ' 22' ' ' HIS 0.326 0.7 OUTLIER 86.2 22.32 0.07 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.742 1.617 . . . . 72.530000000000001 113.608 -178.086 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.2 mt -135.42 86.27 2.23 Favored 'General case' 0 C--N 1.264 -3.135 0 CA-C-N 112.861 -1.972 . . . . 61.149999999999999 106.603 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 22' ' ' HIS . 8.2 t30 -153.26 155.6 36.88 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.38 -0.528 . . . . 62.210000000000001 110.424 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 25.0 m -127.35 101.9 6.67 Favored 'General case' 0 N--CA 1.393 -3.317 0 N-CA-C 109.068 -0.716 . . . . 73.409999999999997 109.068 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 83.1 112.87 0.06 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.928 1.291 . . . . 74.430000000000007 113.433 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.432 HD22 ' HB3' ' A' ' 15' ' ' PHE . 31.3 tp -66.03 156.34 34.03 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 115.075 -0.966 . . . . 70.239999999999995 110.563 177.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -145.32 119.4 9.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.652 -1.24 . . . . 70.219999999999999 107.652 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.76 -167.81 46.71 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 120.61 -0.805 . . . . 71.409999999999997 111.607 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -138.68 137.92 20.93 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.771 -0.826 . . . . 74.239999999999995 108.771 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -49.3 124.19 11.41 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.728 2.952 . . . . 75.120000000000005 113.529 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 50.2 mm -87.84 128.83 52.73 Favored Pre-proline 0 N--CA 1.421 -1.902 0 N-CA-C 108.854 -0.795 . . . . 64.019999999999996 108.854 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.19 170.93 7.03 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 124.374 3.382 . . . . 72.209999999999994 114.081 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -151.51 157.05 34.95 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 108.24 -1.022 . . . . 72.420000000000002 108.24 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.93 -6.57 10.45 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 121.978 1.785 . . . . 74.120000000000005 111.129 175.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 55.5 tp 64.96 101.01 0.04 OUTLIER 'General case' 0 C--N 1.346 0.434 0 C-N-CA 124.789 1.236 . . . . 73.040000000000006 109.756 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.482 ' HG ' HD12 ' A' ' 142' ' ' LEU . 44.5 tp -118.92 117.29 28.43 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.948 -0.569 . . . . 52.240000000000002 110.338 -173.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -106.82 98.2 1.3 Allowed Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 109.913 -1.275 . . . . 74.219999999999999 109.913 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.482 HD12 ' HG ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -109.48 157.32 19.08 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.454 0.645 . . . . 63.32 111.59 -178.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -103.12 91.97 4.33 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.21 -0.663 . . . . 74.129999999999995 109.21 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 20.4 m -140.16 35.47 1.91 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 123.252 1.501 . . . . 72.519999999999996 108.037 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.5 m -97.24 84.88 3.56 Favored 'General case' 0 C--N 1.265 -3.075 0 CA-C-N 112.021 -2.354 . . . . 74.409999999999997 106.713 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -135.62 149.47 49.36 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.986 -1.006 . . . . 70.420000000000002 109.393 -173.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 55.5 m -146.18 150.13 35.26 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.357 -1.349 . . . . 73.310000000000002 107.357 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.528 0 C-N-CA 120.422 -0.894 . . . . 44.210000000000001 110.897 179.057 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HA ' ' HE3' ' A' ' 1' ' ' MET . 4.6 tpt . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.22 0.533 . . . . 74.010000000000005 110.282 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.49 157.71 16.98 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.164 -1.05 . . . . 44.450000000000003 108.164 175.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.609 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 73.4 m-85 -111.62 136.24 51.11 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.363 -0.977 . . . . 74.030000000000001 108.363 174.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 87' ' ' ARG . 30.4 t70 -113.15 114.29 26.58 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.967 -1.015 . . . . 63.229999999999997 108.491 -173.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -90.28 113.88 27.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 109.509 -0.552 . . . . 73.430000000000007 109.509 -174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.29 111.92 38.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 108.73 -0.841 . . . . 75.120000000000005 108.73 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.587 HG23 ' HB2' ' A' ' 27' ' ' MET . 4.5 tt -104.17 121.24 55.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 CA-C-N 115.754 -0.657 . . . . 75.329999999999998 110.26 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 19.8 mm -99.58 106.32 39.16 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 107.861 -1.163 . . . . 74.310000000000002 107.861 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 7' ' ' ILE . 18.4 Cg_endo -94.35 137.84 1.06 Allowed 'Trans proline' 0 N--CA 1.437 -1.836 0 C-N-CA 122.283 1.989 . . . . 73.329999999999998 111.432 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -146.89 154.98 41.94 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.155 -0.683 . . . . 64.310000000000002 109.155 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.522 ' OG ' ' HB3' ' A' ' 22' ' ' HIS . 90.0 p -79.85 156.1 27.52 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 107.296 -1.372 . . . . 73.230000000000004 107.296 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.481 ' HB3' ' CG ' ' A' ' 79' ' ' LYS . 53.7 t80 -81.63 76.89 8.53 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 109.16 -0.681 . . . . 75.239999999999995 109.16 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.412 ' CD2' ' HB3' ' A' ' 125' ' ' GLU . 71.5 m80 -150.82 101.96 2.95 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-N 114.761 -1.109 . . . . 75.450000000000003 110.439 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -88.1 155.77 19.62 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 106.863 -1.532 . . . . 74.120000000000005 106.863 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -55.82 99.84 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 115.527 1.677 . . . . 75.540000000000006 115.527 -173.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 17' ' ' LYS . 23.4 t70 -85.63 -152.23 0.16 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 113.088 -1.869 . . . . 52.219999999999999 106.799 172.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.438 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 9.3 tmtt? -69.82 -58.76 3.5 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.282 -1.007 . . . . 73.409999999999997 108.282 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -138.77 -51.78 0.56 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.514 -0.874 . . . . 72.519999999999996 112.451 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -90.12 55.2 3.02 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.581 1.326 . . . . 73.310000000000002 114.581 -166.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 61.1 mtt -162.85 90.74 0.71 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 125.682 1.593 . . . . 72.319999999999993 107.263 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -175.37 118.19 0.17 Allowed 'General case' 0 N--CA 1.424 -1.762 0 C-N-CA 124.741 1.217 . . . . 62.310000000000002 108.345 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.522 ' HB3' ' OG ' ' A' ' 11' ' ' SER . 10.8 t60 -169.78 110.92 0.44 Allowed 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.419 -0.81 . . . . 74.310000000000002 110.037 170.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.429 HG21 ' CA ' ' A' ' 132' ' ' GLY . 45.3 mm -112.19 139.69 35.54 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 105.04 -2.207 . . . . 70.319999999999993 105.04 175.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 50.9 m -108.17 145.85 32.32 Favored Pre-proline 0 C--N 1.274 -2.684 0 N-CA-C 109.008 -0.738 . . . . 75.519999999999996 109.008 -178.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.3 Cg_exo -60.88 150.43 83.48 Favored 'Trans proline' 0 C--O 1.248 0.99 0 C-N-CA 122.455 2.103 . . . . 63.5 112.072 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.516 ' HD3' ' OE1' ' A' ' 131' ' ' GLU . 22.9 Cg_exo -66.45 137.75 47.9 Favored 'Trans proline' 0 CA--C 1.503 -1.039 0 C-N-CA 122.998 2.465 . . . . 72.319999999999993 111.344 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.587 ' HB2' HG23 ' A' ' 7' ' ' ILE . 48.2 mtp -99.81 128.85 45.88 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 105.922 -1.881 . . . . 75.549999999999997 105.922 173.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.7 t -111.4 123.73 67.52 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 C-N-CA 119.786 -0.766 . . . . 53.539999999999999 109.373 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.2 mp -122.31 102.31 11.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.763 -1.569 . . . . 74.150000000000006 106.763 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.18 -169.01 14.21 Favored Glycine 0 C--N 1.276 -2.804 0 C-N-CA 119.225 -1.465 . . . . 75.299999999999997 114.178 -172.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.1 t70 57.37 43.26 23.58 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 123.043 1.402 . . . . 65.129999999999995 110.156 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -116.92 136.14 53.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 105.708 -1.96 . . . . 74.219999999999999 105.708 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 p -79.83 169.63 17.65 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 119.211 0.914 . . . . 75.030000000000001 108.645 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.609 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 68.0 t80 -57.48 -45.67 84.59 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 123.188 0.595 . . . . 74.430000000000007 111.573 -172.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -66.87 -42.15 86.09 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 114.735 -1.12 . . . . 74.409999999999997 110.725 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.7 mt -72.97 -36.86 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 115.325 -0.852 . . . . 72.299999999999997 109.865 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.434 ' HA ' HG22 ' A' ' 40' ' ' ILE . . . -64.06 -41.16 97.46 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.954 -0.566 . . . . 73.030000000000001 110.324 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.2 ttm -70.3 -37.95 74.89 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 120.139 -0.624 . . . . 62.0 110.819 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -73.12 -36.0 66.64 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.428 0.899 . . . . 72.420000000000002 113.428 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 37' ' ' ALA . 11.6 tt -68.31 -40.87 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 119.842 -0.743 . . . . 72.409999999999997 109.28 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.4 t -65.42 -43.82 94.56 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.864 0 N-CA-C 109.57 -0.53 . . . . 72.340000000000003 109.57 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -59.42 -39.24 82.86 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.595 0.358 . . . . 72.329999999999998 111.82 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.8 -44.0 95.37 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.714 -0.755 . . . . 74.109999999999999 111.369 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 40' ' ' ILE . 56.6 t -71.06 -39.09 74.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.378 -0.601 . . . . 61.420000000000002 109.378 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.441 ' OD2' HG21 ' A' ' 56' ' ' VAL . 14.1 t70 -56.68 -46.93 80.85 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.752 1.621 . . . . 64.450000000000003 109.966 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -64.73 -40.56 95.52 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.157 -0.929 . . . . 75.140000000000001 109.917 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.1 t -66.77 -39.29 83.32 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 CA-C-N 116.311 -0.404 . . . . 62.229999999999997 111.139 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 52' ' ' PHE . 72.9 mt -69.44 -40.74 80.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 110.66 -0.126 . . . . 73.209999999999994 110.66 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -71.92 -30.79 65.72 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.337 -0.545 . . . . 74.25 110.607 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.2 -45.66 11.8 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 112.545 0.572 . . . . 73.349999999999994 112.545 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.5 m -85.44 -20.01 30.44 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.885 0.698 . . . . 73.209999999999994 112.885 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 48' ' ' ILE . 6.4 m-85 -123.15 157.08 33.74 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-O 121.145 0.498 . . . . 72.519999999999996 109.683 -175.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 45.1 t30 -85.86 87.35 7.4 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 104.367 -2.457 . . . . 60.030000000000001 104.367 172.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -133.5 136.25 44.95 Favored 'General case' 0 N--CA 1.397 -3.112 0 CA-C-N 115.434 -0.803 . . . . 72.310000000000002 111.975 -173.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.419 ' OG ' ' HB ' ' A' ' 72' ' ' THR . 41.0 p -95.8 122.77 38.94 Favored 'General case' 0 N--CA 1.404 -2.731 0 N-CA-C 106.727 -1.582 . . . . 62.0 106.727 171.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.441 HG21 ' OD2' ' A' ' 45' ' ' ASP . 3.2 p -99.68 119.34 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.712 0 N-CA-C 108.126 -1.065 . . . . 71.310000000000002 108.126 177.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.471 ' HG2' HD22 ' A' ' 139' ' ' LEU . 28.3 mt-10 -117.61 112.28 20.33 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 114.12 -1.4 . . . . 53.299999999999997 108.584 -174.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -94.21 122.36 36.66 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.406 0.622 . . . . 72.129999999999995 111.464 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mp -121.94 178.11 5.02 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 115.197 -0.91 . . . . 54.329999999999998 109.193 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -95.61 140.8 29.91 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.325 -0.852 . . . . 61.149999999999999 108.748 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.12 175.69 41.57 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 115.574 -0.739 . . . . 54.539999999999999 113.089 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -72.52 174.87 6.85 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 123.995 0.918 . . . . 70.420000000000002 108.595 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -49.73 -41.33 43.39 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 124.613 1.165 . . . . 72.109999999999999 113.034 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.01 -8.54 57.88 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.124 -0.944 . . . . 70.010000000000005 111.644 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -99.15 159.08 15.23 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 107.667 -1.234 . . . . 74.209999999999994 107.667 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.75 -37.64 3.67 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.638 0 CA-C-O 121.57 0.7 . . . . 74.030000000000001 110.212 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.7 tp -156.88 144.24 18.9 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.798 -1.186 . . . . 73.120000000000005 107.798 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -131.32 107.12 8.73 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.857 -0.794 . . . . 74.230000000000004 108.857 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -116.19 129.33 56.25 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.017 -1.073 . . . . 74.430000000000007 111.262 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -109.32 128.89 55.45 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.532 -0.758 . . . . 53.109999999999999 109.447 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -105.91 134.72 48.58 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 107.255 -1.387 . . . . 63.229999999999997 107.255 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.559 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 30.6 m -109.18 107.3 17.53 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 106.578 -1.638 . . . . 62.229999999999997 106.578 173.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.66 140.13 41.16 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 120.954 0.407 . . . . 52.149999999999999 111.865 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 44.3 tt0 -147.81 86.82 1.6 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.627 -0.715 . . . . 74.299999999999997 109.073 168.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -95.91 104.0 15.91 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.922 -0.581 . . . . 72.25 110.556 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 56.9 34.81 25.43 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.804 0.69 . . . . 74.150000000000006 112.46 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.94 -7.88 57.47 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 120.754 -0.736 . . . . 55.539999999999999 113.086 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 53.4 mtpt -92.37 102.11 14.59 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.108 -1.071 . . . . 73.200000000000003 108.108 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.642 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -102.09 138.19 39.37 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.576 -0.738 . . . . 75.420000000000002 111.21 -173.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.441 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . -164.03 164.48 36.55 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.438 -0.411 . . . . 54.43 112.751 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 34.0 mm -120.13 134.63 63.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 105.584 -2.006 . . . . 74.200000000000003 105.584 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.6 t -127.57 120.3 54.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.879 -0.513 . . . . 62.310000000000002 110.25 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 67.1 m-70 -105.62 104.14 13.8 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.328 -0.619 . . . . 65.099999999999994 109.328 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.3 t -100.11 110.59 27.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 109.669 -0.493 . . . . 74.140000000000001 109.669 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -112.55 140.54 47.22 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.042 0.449 . . . . 72.510000000000005 110.406 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.2 mt -97.78 125.7 42.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 105.831 -1.915 . . . . 70.540000000000006 105.831 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 4' ' ' ASP . 22.9 mmm180 -104.55 141.54 36.23 Favored 'General case' 0 C--N 1.273 -2.761 0 N-CA-C 108.017 -1.105 . . . . 73.510000000000005 108.017 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -90.0 98.04 11.54 Favored 'General case' 0 C--N 1.279 -2.48 0 C-N-CA 119.294 -0.962 . . . . 63.439999999999998 108.958 172.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.3 tt -74.13 112.31 10.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 121.261 -0.899 . . . . 61.25 110.39 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 93' ' ' CYS . 0.8 OUTLIER -142.34 177.14 8.46 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.084 -1.08 . . . . 62.149999999999999 108.084 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -77.99 -13.83 59.74 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 118.774 0.715 . . . . 61.140000000000001 111.119 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -109.02 9.82 26.31 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.124 -0.943 . . . . 62.310000000000002 110.156 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.408 ' HB3' ' OG1' ' A' ' 90' ' ' THR . 42.1 t -147.84 102.07 3.66 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 109.075 -0.713 . . . . 74.439999999999998 109.075 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.56 139.65 25.77 Favored 'Trans proline' 0 C--O 1.252 1.224 0 C-N-CA 122.429 2.086 . . . . 60.539999999999999 113.851 -174.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.62 161.07 28.08 Favored 'Trans proline' 0 N--CA 1.439 -1.71 0 C-N-CA 122.45 2.1 . . . . 70.319999999999993 108.78 173.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.3 t -91.68 157.92 2.92 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.559 0 N-CA-C 107.232 -1.396 . . . . 73.420000000000002 107.232 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -109.82 133.48 53.1 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.09 -1.078 . . . . 71.239999999999995 108.09 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -155.52 -144.88 4.03 Favored Glycine 0 N--CA 1.413 -2.867 0 C-N-CA 119.842 -1.171 . . . . 72.5 112.244 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -64.9 127.01 29.81 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 113.456 -1.372 . . . . 53.229999999999997 109.521 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -77.11 99.33 5.33 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.549 -1.278 . . . . 74.349999999999994 107.549 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 44.1 t -79.96 152.59 29.43 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 115.404 -0.816 . . . . 72.239999999999995 109.565 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.8 m -76.6 86.4 3.28 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.232 -1.025 . . . . 63.119999999999997 108.232 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.469 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 28.8 t -115.51 138.0 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 110.515 -174.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 103' ' ' VAL . 25.6 mt -170.55 -49.98 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 126.556 1.943 . . . . 54.140000000000001 110.948 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.6 142.37 17.8 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 113.996 -1.456 . . . . 75.530000000000001 107.537 -172.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -32.96 -44.43 0.11 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.145 2.178 . . . . 74.200000000000003 116.552 -170.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -54.84 -53.72 51.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.373 0.606 . . . . 73.25 112.567 -175.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -80.72 -30.14 36.31 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.989 -0.55 . . . . 71.049999999999997 110.041 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.94 -47.88 81.33 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.944 -1.026 . . . . 75.420000000000002 109.477 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.7 tt -65.53 -37.0 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.552 -0.295 . . . . 52.310000000000002 110.523 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.28 -48.32 82.25 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 109.655 -0.498 . . . . 73.109999999999999 109.655 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 21.5 t -62.81 -39.25 93.71 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.514 -0.767 . . . . 70.129999999999995 111.632 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 75.9 mt -70.18 -45.71 74.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 120.505 -0.478 . . . . 74.439999999999998 110.846 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.6 t -70.19 -38.86 75.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.264 -0.574 . . . . 64.209999999999994 110.72 -176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -74.53 -22.05 59.22 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 112.291 0.478 . . . . 75.200000000000003 112.291 -176.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.439 ' HB3' ' SD ' ' A' ' 27' ' ' MET . . . -83.04 -37.69 23.56 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 119.073 -1.051 . . . . 63.299999999999997 110.486 175.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 81.6 mt -62.48 -45.37 98.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 108.968 -0.752 . . . . 55.549999999999997 108.968 175.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -54.4 -43.64 71.63 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 123.575 0.75 . . . . 60.450000000000003 112.382 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 22.5 mm-40 -65.7 -44.11 87.13 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.818 0.699 . . . . 74.450000000000003 110.93 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 36.5 t -62.4 -40.94 98.15 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.198 0.523 . . . . 43.0 110.163 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 117' ' ' ILE . 70.6 mt -71.82 -29.14 64.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.977 -0.556 . . . . 74.019999999999996 110.656 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.08 -31.81 39.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 112.727 0.64 . . . . 74.540000000000006 112.727 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 119' ' ' GLU . 72.3 mmtt -65.56 -40.25 92.62 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 119.841 -0.743 . . . . 63.520000000000003 109.933 -177.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.62 -154.3 50.76 Favored Glycine 0 C--N 1.291 -1.966 0 CA-C-N 114.44 -1.254 . . . . 63.219999999999999 114.798 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.412 ' HB3' ' CD2' ' A' ' 13' ' ' HIS . 9.2 pt-20 -63.8 133.12 52.86 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 124.703 1.201 . . . . 61.109999999999999 112.799 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp 74.03 80.23 0.12 Allowed 'General case' 0 C--O 1.244 0.795 0 C-N-CA 124.983 1.313 . . . . 50.130000000000003 111.783 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -161.38 165.96 28.13 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.106 -1.072 . . . . 71.319999999999993 108.106 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.5 m -41.97 128.16 3.47 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.075 1.75 . . . . 64.030000000000001 114.753 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 129' ' ' LYS . 1.2 pptp? -145.8 142.37 28.81 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.348 -0.982 . . . . 52.149999999999999 108.348 173.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 46.0 tp -158.0 25.96 0.26 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.326 1.06 . . . . 75.25 108.457 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.516 ' OE1' ' HD3' ' A' ' 26' ' ' PRO . 14.3 pt-20 -177.37 -171.81 0.35 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.326 -1.307 . . . . 73.099999999999994 107.749 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.429 ' CA ' HG21 ' A' ' 23' ' ' ILE . . . 131.28 151.15 6.9 Favored Glycine 0 N--CA 1.431 -1.64 0 O-C-N 123.868 0.73 . . . . 50.219999999999999 112.551 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -143.35 70.24 17.83 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 107.167 -1.42 . . . . 64.5 107.167 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.73 104.85 1.87 Allowed 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 122.466 2.111 . . . . 52.109999999999999 111.468 -173.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 7.4 tp -127.31 102.07 24.2 Favored Pre-proline 0 N--CA 1.42 -1.971 0 CA-C-O 121.823 0.82 . . . . 62.310000000000002 110.919 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.95 160.66 27.14 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.707 2.271 . . . . 73.319999999999993 111.537 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -162.87 125.69 1.73 Allowed Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 108.523 -0.917 . . . . 74.340000000000003 108.523 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -69.05 -15.82 40.05 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.746 2.298 . . . . 75.239999999999995 112.657 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.471 HD22 ' HG2' ' A' ' 57' ' ' GLU . 25.2 tp 71.51 153.33 0.12 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.132 1.373 . . . . 53.009999999999998 111.46 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.3 tp -68.41 122.04 17.58 Favored 'General case' 0 C--O 1.249 1.046 0 N-CA-C 108.464 -0.939 . . . . 64.430000000000007 108.464 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.71 77.98 1.55 Allowed Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 115.716 -0.674 . . . . 34.039999999999999 112.656 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 tt -116.18 101.59 8.85 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 104.963 -2.236 . . . . 64.439999999999998 104.963 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -88.94 158.32 18.09 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.191 0.519 . . . . 65.329999999999998 110.616 -175.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.4 m -114.25 98.97 7.26 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 115.508 -0.769 . . . . 64.319999999999993 109.105 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 87.3 m -98.56 88.65 4.15 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.694 -1.224 . . . . 72.430000000000007 107.694 173.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -108.88 137.4 46.87 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.043 -1.435 . . . . 74.409999999999997 109.488 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.2 m -84.42 81.98 8.59 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 108.365 -0.976 . . . . 53.340000000000003 108.365 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.349 0 N-CA-C 109.806 -1.318 . . . . 42.43 109.806 -178.781 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptm . . . . . 0 CA--C 1.515 -0.388 0 N-CA-C 109.375 -0.602 . . . . 65.239999999999995 109.375 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HE3' ' HA ' ' A' ' 31' ' ' ASP . 87.5 tttt -122.3 136.96 54.99 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.072 0.463 . . . . 73.299999999999997 111.499 -173.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.586 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 19.2 m-85 -117.24 152.44 34.82 Favored 'General case' 0 C--O 1.251 1.169 0 C-N-CA 125.0 1.32 . . . . 73.010000000000005 109.338 173.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.631 ' OD1' ' HA3' ' A' ' 30' ' ' GLY . 24.6 t70 -123.67 108.77 12.93 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.581 -1.637 . . . . 55.450000000000003 106.581 -177.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.44 127.05 48.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.195 0.522 . . . . 62.119999999999997 111.927 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 85' ' ' LYS . 4.8 p -115.15 121.66 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.621 0 N-CA-C 108.156 -1.053 . . . . 75.340000000000003 108.156 176.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.486 HG23 ' CG ' ' A' ' 27' ' ' MET . 1.9 tt -122.2 123.48 68.95 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 CA-C-N 115.392 -0.822 . . . . 73.099999999999994 109.878 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.54 ' CG1' ' HB2' ' A' ' 83' ' ' HIS . 40.2 pt -108.06 118.59 52.27 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.864 -0.607 . . . . 53.049999999999997 110.463 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.498 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 11.5 Cg_endo -90.94 142.7 3.21 Favored 'Trans proline' 0 N--CA 1.431 -2.152 0 C-N-CA 122.153 1.902 . . . . 72.019999999999996 109.726 170.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -151.41 146.95 26.32 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 108.909 -0.774 . . . . 72.5 108.909 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.614 ' OG ' ' HB3' ' A' ' 22' ' ' HIS . 86.5 p -90.4 143.9 26.32 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.302 -1.37 . . . . 72.420000000000002 107.302 175.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.542 ' CE1' ' HB2' ' A' ' 79' ' ' LYS 0.351 1.6 p90 -80.61 87.5 5.76 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 118.098 -1.441 . . . . 74.230000000000004 113.189 178.379 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -130.14 99.53 5.09 Favored 'General case' 0 N--CA 1.414 -2.271 0 CA-C-N 113.729 -1.578 . . . . 63.210000000000001 110.833 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.92 118.05 9.86 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 122.305 1.05 . . . . 63.340000000000003 109.395 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.54 ' HA ' ' O ' ' A' ' 20' ' ' MET . 56.1 t80 -60.71 111.62 1.69 Allowed 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 112.208 -2.269 . . . . 74.019999999999996 111.074 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -85.69 -105.04 0.06 Allowed 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 113.433 -1.712 . . . . 73.25 110.218 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -112.35 -57.31 2.29 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.451 0.644 . . . . 72.540000000000006 110.627 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -124.92 -23.28 4.31 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.497 -0.774 . . . . 75.540000000000006 109.909 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -103.07 157.41 17.01 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.554 -0.748 . . . . 52.310000000000002 111.654 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.54 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 83.1 mtp 72.96 76.7 0.14 Allowed 'General case' 0 C--O 1.209 -1.038 0 O-C-N 124.829 1.331 . . . . 71.439999999999998 114.085 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -161.2 99.39 1.19 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.305 -0.998 . . . . 73.109999999999999 108.305 171.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.614 ' HB3' ' OG ' ' A' ' 11' ' ' SER . 47.0 t60 -136.63 93.04 2.82 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.651 -0.87 . . . . 72.219999999999999 108.651 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.421 HG13 ' HA ' ' A' ' 130' ' ' LEU . 52.2 mm -109.01 138.53 35.73 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 106.126 -1.805 . . . . 71.430000000000007 106.126 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 62.9 m -106.81 122.73 40.79 Favored Pre-proline 0 C--N 1.273 -2.736 0 C-N-CA 120.278 -0.569 . . . . 53.350000000000001 110.078 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -49.55 143.35 21.66 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.976 3.117 . . . . 50.43 113.733 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.85 133.05 55.75 Favored 'Trans proline' 0 CA--C 1.509 -0.727 0 C-N-CA 123.792 2.995 . . . . 73.129999999999995 113.051 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.486 ' CG ' HG23 ' A' ' 7' ' ' ILE . 22.1 ptp -106.07 141.55 37.25 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.652 -1.611 . . . . 74.409999999999997 106.652 172.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.443 HG22 HG23 ' A' ' 6' ' ' VAL . 39.8 t -133.86 127.75 52.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 120.229 -0.588 . . . . 51.210000000000001 110.91 -169.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.408 HD13 ' O ' ' A' ' 28' ' ' VAL . 45.3 mm -129.17 103.8 9.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.715 -1.217 . . . . 75.319999999999993 107.715 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.631 ' HA3' ' OD1' ' A' ' 4' ' ' ASP . . . -123.04 88.91 0.41 Allowed Glycine 0 N--CA 1.419 -2.461 0 C-N-CA 118.919 -1.61 . . . . 72.420000000000002 113.618 -175.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.461 ' HA ' ' HE3' ' A' ' 2' ' ' LYS . 5.9 p-10 -165.52 29.29 0.05 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.991 0.901 . . . . 74.349999999999994 109.118 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -118.32 136.98 53.39 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-N 115.572 -0.74 . . . . 74.340000000000003 109.21 -170.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.4 p -76.31 169.66 17.8 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 106.765 -1.568 . . . . 65.150000000000006 106.765 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.586 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 84.8 t80 -59.0 -39.21 81.15 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.465 0.65 . . . . 63.219999999999999 110.758 -177.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.15 -50.31 72.38 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.144 -1.389 . . . . 72.109999999999999 110.755 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.3 mt -69.99 -37.19 71.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.5 -0.555 . . . . 63.43 109.5 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -65.17 -42.1 94.01 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.612 -0.722 . . . . 70.329999999999998 110.8 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.6 tpp -69.76 -41.15 75.57 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 120.103 -0.639 . . . . 41.25 110.16 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.4 -38.03 80.92 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 112.489 0.552 . . . . 73.019999999999996 112.489 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 44' ' ' VAL . 14.4 tt -69.52 -39.39 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 119.516 -0.874 . . . . 72.25 110.114 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 37' ' ' ALA . 96.7 t -67.95 -40.41 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 120.544 -0.462 . . . . 55.539999999999999 109.964 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -69.55 -25.91 64.24 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.77 0.319 . . . . 72.209999999999994 111.559 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.59 -46.51 39.3 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 110.541 -1.024 . . . . 73.049999999999997 110.541 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 48' ' ' ILE . 86.3 t -61.1 -42.62 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 109.21 -0.663 . . . . 64.530000000000001 109.21 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -49.92 -52.36 33.87 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 125.912 1.685 . . . . 52.32 111.057 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -68.28 -35.19 77.48 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.773 -1.103 . . . . 73.310000000000002 110.387 -175.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 91.6 t -71.73 -36.56 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 116.075 -0.511 . . . . 62.43 111.253 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 44' ' ' VAL . 60.4 mt -68.35 -38.76 79.89 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.959 0 N-CA-C 109.541 -0.54 . . . . 74.450000000000003 109.541 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -66.62 -33.84 76.55 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.803 0.335 . . . . 74.209999999999994 111.682 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.99 -25.5 34.7 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.452 0.538 . . . . 60.049999999999997 112.452 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.9 m -99.48 -23.96 14.93 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.164 0.801 . . . . 75.120000000000005 113.164 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -133.24 -172.52 2.96 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.792 0.806 . . . . 73.439999999999998 111.6 -173.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -106.93 100.25 9.77 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 104.287 -2.486 . . . . 71.319999999999993 104.287 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -114.69 144.49 43.36 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 113.343 0.868 . . . . 72.319999999999993 113.343 -169.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -123.68 112.15 17.04 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.798 -1.556 . . . . 73.109999999999999 106.798 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -100.55 137.2 28.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.127 0.489 . . . . 74.310000000000002 109.993 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -136.32 117.96 14.96 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.223 -1.029 . . . . 73.340000000000003 108.223 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -97.65 129.25 44.75 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.55 -0.86 . . . . 71.120000000000005 111.366 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.2 mp -122.51 177.44 5.41 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.744 -1.116 . . . . 32.399999999999999 108.072 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -101.58 161.83 13.35 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.389 -1.337 . . . . 73.040000000000006 107.389 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.39 176.63 19.7 Favored Glycine 0 N--CA 1.413 -2.85 0 N-CA-C 111.052 -0.819 . . . . 53.530000000000001 111.052 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.48 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 11.9 pt-20 -65.23 -178.33 0.47 Allowed 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 123.403 0.681 . . . . 61.109999999999999 110.418 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -50.13 -38.45 39.15 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 114.442 1.275 . . . . 43.32 114.442 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 44.0 t -92.96 -0.93 57.11 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 121.687 0.756 . . . . 75.340000000000003 110.558 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.524 ' OD1' ' HG2' ' A' ' 87' ' ' ARG . 88.0 m-20 -100.75 152.82 20.03 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-N 115.974 -0.557 . . . . 74.349999999999994 110.077 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -113.45 -24.89 3.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-O 121.288 0.566 . . . . 50.140000000000001 111.893 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.433 ' HB3' HD12 ' A' ' 86' ' ' LEU . 57.2 tp -154.36 141.73 19.63 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 109.141 -0.688 . . . . 73.129999999999995 109.141 177.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -130.34 102.13 6.06 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 106.655 -1.609 . . . . 73.549999999999997 106.655 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -111.24 124.63 52.61 Favored 'General case' 0 C--N 1.281 -2.38 0 C-N-CA 119.436 -0.906 . . . . 64.140000000000001 109.642 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -105.74 143.27 34.13 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.284 -0.636 . . . . 73.109999999999999 109.284 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.489 ' HB3' HD11 ' A' ' 73' ' ' LEU . 87.6 m-85 -127.88 126.26 41.22 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.384 -0.969 . . . . 72.450000000000003 108.384 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.0 m -103.28 117.0 33.52 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.112 -1.81 . . . . 65.209999999999994 106.112 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 71' ' ' TYR . 0.7 OUTLIER -122.55 144.31 49.17 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.415 0.626 . . . . 75.5 112.393 -170.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.5 ' OE2' ' HG ' ' A' ' 140' ' ' LEU . 22.2 mt-10 -147.55 160.4 42.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.574 1.178 . . . . 63.420000000000002 111.134 171.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -154.29 157.44 38.68 Favored 'General case' 0 C--N 1.258 -3.409 0 N-CA-C 102.327 -3.212 . . . . 75.040000000000006 102.327 165.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -53.06 99.59 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.994 0.902 . . . . 52.520000000000003 112.726 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.72 0.51 56.46 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.401 -0.818 . . . . 71.219999999999999 112.648 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 95.6 mttt -134.33 108.55 8.26 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.047 -1.094 . . . . 40.409999999999997 108.047 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 16.5 ptpt -131.64 132.66 44.19 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.397 0.517 . . . . 71.340000000000003 112.397 -174.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -170.87 177.27 43.99 Favored Glycine 0 C--O 1.215 -1.036 0 C-N-CA 119.955 -1.117 . . . . 65.430000000000007 113.819 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.0 mt -129.22 148.81 33.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 106.884 -1.524 . . . . 62.539999999999999 106.884 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.25 123.86 51.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.634 -0.506 . . . . 55.210000000000001 109.634 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.54 ' HB2' ' CG1' ' A' ' 8' ' ' ILE . 11.9 m170 -110.7 112.44 24.32 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.641 -0.503 . . . . 73.329999999999998 109.641 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.47 114.51 42.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.514 -0.921 . . . . 74.120000000000005 108.514 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.495 ' HB3' HG13 ' A' ' 6' ' ' VAL . 59.9 tttp -115.72 118.28 32.63 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.958 -1.127 . . . . 74.420000000000002 107.958 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.433 HD12 ' HB3' ' A' ' 67' ' ' LEU . 90.5 mt -98.16 114.63 26.9 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 107.232 -1.395 . . . . 74.120000000000005 107.232 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.524 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 76.0 mtp85 -102.42 139.62 37.78 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.581 0.705 . . . . 71.519999999999996 110.073 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -90.71 98.27 11.68 Favored 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 115.089 -0.96 . . . . 73.439999999999998 108.49 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 tt -75.14 110.81 10.49 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-O 122.824 1.297 . . . . 70.209999999999994 109.173 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.1 p -123.31 -170.81 2.18 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 113.773 -1.558 . . . . 74.310000000000002 107.744 -174.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -82.63 -0.46 47.21 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.672 -0.862 . . . . 75.230000000000004 108.672 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -112.51 -5.05 14.07 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.974 -1.012 . . . . 72.140000000000001 110.18 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.2 m -137.97 113.97 9.15 Favored Pre-proline 0 C--N 1.311 -1.087 0 C-N-CA 123.202 0.601 . . . . 75.129999999999995 110.814 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.48 163.34 29.79 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 122.015 1.81 . . . . 64.049999999999997 110.552 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.96 163.2 29.32 Favored 'Trans proline' 0 C--O 1.247 0.952 0 C-N-CA 122.885 2.39 . . . . 63.030000000000001 112.048 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 t -93.41 156.54 3.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.582 -0.896 . . . . 71.430000000000007 108.582 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -106.41 141.54 37.55 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.272 -1.01 . . . . 72.510000000000005 108.272 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.42 -163.83 31.51 Favored Glycine 0 N--CA 1.419 -2.466 0 C-N-CA 120.149 -1.024 . . . . 55.109999999999999 111.714 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -69.58 139.23 53.68 Favored 'General case' 0 N--CA 1.417 -2.124 0 C-N-CA 125.205 1.402 . . . . 75.239999999999995 107.921 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -102.59 123.54 46.5 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 119.655 -0.818 . . . . 72.439999999999998 111.803 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.1 t -79.34 137.92 37.5 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.311 -1.366 . . . . 71.530000000000001 107.311 172.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.5 m -75.33 95.47 3.21 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.647 0.737 . . . . 63.25 110.191 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.431 HG13 ' CG ' ' A' ' 109' ' ' ASP . 57.7 t -97.89 147.55 6.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.778 -1.101 . . . . 45.219999999999999 109.369 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 47.1 tp -149.56 -74.1 0.17 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.289 -0.869 . . . . 70.420000000000002 109.56 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -143.56 151.41 40.18 Favored 'General case' 0 C--N 1.258 -3.385 0 N-CA-C 106.831 -1.544 . . . . 54.100000000000001 106.831 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.467 ' O ' HG22 ' A' ' 110' ' ' ILE . 79.9 t80 -35.78 -42.08 0.24 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.512 1.671 . . . . 72.349999999999994 115.512 -172.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -55.26 -47.75 74.99 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 122.804 0.442 . . . . 71.530000000000001 112.015 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.89 -34.22 30.11 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 107.672 -1.232 . . . . 60.219999999999999 107.672 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.431 ' CG ' HG13 ' A' ' 103' ' ' VAL . 26.2 m-20 -62.37 -46.8 87.0 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.476 -0.784 . . . . 74.349999999999994 110.218 -176.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 106' ' ' PHE . 8.5 tp -65.56 -41.36 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 115.571 -0.74 . . . . 73.310000000000002 110.612 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -26.37 60.32 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 120.285 -0.566 . . . . 72.340000000000003 111.572 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 12.0 t -68.26 -48.01 66.21 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 116.585 -0.28 . . . . 71.209999999999994 110.382 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.73 -42.93 93.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.216 -0.447 . . . . 72.319999999999993 110.087 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 70.9 t -64.65 -40.9 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 116.207 -0.451 . . . . 73.450000000000003 110.306 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -61.55 -44.09 97.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.351 -0.386 . . . . 74.430000000000007 111.355 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.49 -35.64 75.76 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.847 0.356 . . . . 33.409999999999997 111.573 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.46 ' O ' HD13 ' A' ' 121' ' ' LEU . 80.8 mt -69.33 -44.57 80.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 109.587 -0.523 . . . . 72.439999999999998 109.587 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -60.37 -45.22 94.3 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.886 -0.783 . . . . 63.219999999999999 108.886 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 44.5 mt-10 -68.57 -33.74 74.6 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 112.081 0.4 . . . . 64.219999999999999 112.081 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 9' ' ' PRO . 30.3 t -67.42 -31.3 71.41 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.417 0.627 . . . . 60.210000000000001 109.818 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.462 ' HG ' ' C ' ' A' ' 79' ' ' LYS . 9.0 mp -81.33 -37.84 27.69 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 121.151 0.501 . . . . 71.549999999999997 110.812 176.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.4 -16.71 41.76 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 115.579 1.696 . . . . 75.430000000000007 115.579 -175.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 62.9 mttm -75.81 -3.88 37.52 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 119.884 1.22 . . . . 75.340000000000003 113.603 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.07 -157.45 20.08 Favored Glycine 0 N--CA 1.422 -2.263 0 C-N-CA 119.943 -1.122 . . . . 74.329999999999998 113.429 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 20' ' ' MET . 10.0 pt-20 -102.93 30.77 4.57 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.421 -0.889 . . . . 73.129999999999995 111.214 -174.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.9 mt -138.56 104.02 5.02 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 114.674 -1.148 . . . . 71.010000000000005 113.723 -171.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 t30 179.46 96.54 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.791 1.636 . . . . 71.209999999999994 106.682 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.6 m -59.26 172.22 0.65 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 125.278 1.431 . . . . 61.109999999999999 114.603 -171.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 57.2 tptt 83.77 93.6 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.683 1.993 . . . . 72.540000000000006 111.742 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.421 ' HA ' HG13 ' A' ' 23' ' ' ILE . 94.2 mt -76.04 81.48 2.89 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.218 -0.901 . . . . 73.120000000000005 111.163 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -105.76 11.89 31.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 123.765 1.745 . . . . 74.420000000000002 107.974 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -137.76 145.82 17.52 Favored Glycine 0 N--CA 1.413 -2.849 0 N-CA-C 105.044 -3.223 . . . . 72.109999999999999 105.044 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -121.15 93.8 48.83 Favored Pre-proline 0 C--N 1.286 -2.18 0 CA-C-N 117.982 0.891 . . . . 64.439999999999998 109.084 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.69 120.33 7.7 Favored 'Trans proline' 0 C--O 1.244 0.776 0 C-N-CA 122.868 2.379 . . . . 65.430000000000007 113.634 -171.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.9 tp -127.55 104.23 21.74 Favored Pre-proline 0 N--CA 1.428 -1.533 0 CA-C-N 115.302 -0.863 . . . . 73.5 110.634 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -67.6 132.62 27.53 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 121.789 1.659 . . . . 61.219999999999999 110.672 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -96.09 163.01 21.91 Favored Pre-proline 0 C--N 1.306 -1.306 0 CA-C-N 116.368 -0.378 . . . . 63.039999999999999 110.39 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.09 -25.09 77.12 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.741 2.294 . . . . 70.120000000000005 111.335 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 80.4 mt -85.8 104.04 15.12 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 105.747 -1.946 . . . . 55.450000000000003 105.747 173.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.5 ' HG ' ' OE2' ' A' ' 74' ' ' GLU . 13.8 tp -132.74 150.24 52.18 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.081 -1.081 . . . . 75.200000000000003 108.081 -171.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.459 ' HA3' ' HB2' ' A' ' 74' ' ' GLU . . . -81.89 84.09 1.5 Allowed Glycine 0 CA--C 1.503 -0.68 0 C-N-CA 121.167 -0.54 . . . . 71.109999999999999 112.35 -173.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.413 HD23 ' H ' ' A' ' 142' ' ' LEU . 1.9 pt? -84.5 32.11 0.51 Allowed 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 123.074 0.549 . . . . 72.150000000000006 112.018 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -104.78 162.37 13.37 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.846 0.832 . . . . 73.319999999999993 111.444 -176.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.7 t -151.62 46.94 0.8 Allowed 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 104.364 -2.458 . . . . 75.310000000000002 104.364 172.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.2 m -75.83 94.82 3.38 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 112.699 -2.046 . . . . 73.329999999999998 108.626 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -94.3 90.36 6.26 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.364 -0.835 . . . . 75.329999999999998 109.387 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.1 p -80.73 126.88 31.85 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-O 121.814 0.816 . . . . 73.230000000000004 112.434 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.663 0 N-CA-C 107.645 -2.182 . . . . 73.129999999999995 107.645 177.571 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.428 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 2.0 mmt . . . . . 0 CA--C 1.506 -0.732 0 CA-C-O 121.367 0.603 . . . . 71.439999999999998 112.194 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -126.18 143.77 51.01 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.671 -1.233 . . . . 55.43 107.671 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 11.8 m-85 -114.7 145.34 42.16 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 122.002 0.906 . . . . 72.099999999999994 112.778 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.666 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 35.4 t70 -106.12 100.89 10.41 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 127.026 2.131 . . . . 64.239999999999995 105.541 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -92.42 124.6 44.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.638 -0.664 . . . . 54.140000000000001 109.334 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.9 t -113.51 119.05 59.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.288 -1.004 . . . . 73.239999999999995 108.288 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.536 HG23 ' HB2' ' A' ' 27' ' ' MET . 7.7 tt -114.29 116.55 52.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 121.504 0.669 . . . . 61.140000000000001 109.391 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 83' ' ' HIS . 20.7 mt -106.61 106.72 58.58 Favored Pre-proline 0 C--N 1.3 -1.551 0 CA-C-N 115.56 -0.745 . . . . 72.219999999999999 110.056 -175.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.536 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 25.3 Cg_endo -95.42 137.22 0.74 Allowed 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.507 2.138 . . . . 73.420000000000002 111.185 173.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -158.55 137.45 11.29 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 121.845 -0.534 . . . . 71.409999999999997 111.065 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -84.5 106.92 16.45 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.21 -0.45 . . . . 50.409999999999997 109.853 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.629 ' CE1' ' HB2' ' A' ' 79' ' ' LYS . 2.0 p90 -63.26 106.98 0.97 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.103 1.149 . . . . 64.219999999999999 114.103 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 73.7 m80 -142.24 156.36 45.3 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.96 -1.018 . . . . 74.319999999999993 108.704 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -98.26 120.68 39.1 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 108.0 -1.111 . . . . 71.430000000000007 108.0 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -60.04 111.08 1.36 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 124.754 1.284 . . . . 75.349999999999994 110.603 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.07 -100.53 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.576 -1.193 . . . . 72.299999999999997 108.355 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -113.19 -60.31 1.9 Allowed 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 106.862 -1.533 . . . . 75.5 106.862 167.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.457 ' HA ' ' OE1' ' A' ' 21' ' ' GLU . 7.2 p-80 -138.5 34.56 2.26 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 113.797 -1.547 . . . . 74.25 110.005 175.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -135.29 152.61 51.66 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 106.619 -1.622 . . . . 61.310000000000002 106.619 -178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.461 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 0.0 OUTLIER 60.99 58.09 2.38 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.512 1.149 . . . . 62.520000000000003 110.009 -175.239 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 18' ' ' HIS . 7.4 pt-20 -141.06 88.22 2.16 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 113.47 -1.695 . . . . 64.5 110.684 -176.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -128.75 104.65 7.75 Favored 'General case' 0 C--N 1.285 -2.22 0 O-C-N 121.68 -0.638 . . . . 72.420000000000002 109.456 174.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.6 mm -116.51 136.68 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.733 0 N-CA-C 107.02 -1.474 . . . . 70.430000000000007 107.02 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 70.2 m -108.38 145.63 31.94 Favored Pre-proline 0 C--N 1.281 -2.397 0 N-CA-C 107.335 -1.357 . . . . 73.430000000000007 107.335 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.42 152.01 33.9 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 121.902 1.734 . . . . 63.119999999999997 112.451 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.02 125.2 17.49 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.631 2.221 . . . . 64.439999999999998 111.261 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.536 ' HB2' HG23 ' A' ' 7' ' ' ILE . 38.9 mtt -95.56 134.45 38.41 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.454 -1.684 . . . . 23.440000000000001 106.454 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -131.33 136.86 56.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.383 -0.527 . . . . 65.230000000000004 110.954 -168.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.4 mp -133.65 109.17 12.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.201 -1.037 . . . . 72.129999999999995 108.201 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.666 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -119.08 81.19 0.32 Allowed Glycine 0 C--N 1.3 -1.465 0 C-N-CA 119.209 -1.472 . . . . 42.329999999999998 115.137 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -176.06 31.03 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 124.555 1.142 . . . . 53.5 112.268 172.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.42 ' NH1' HG11 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -109.65 133.23 53.36 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 106.228 -1.767 . . . . 71.329999999999998 106.228 -179.185 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 p -75.13 161.48 29.36 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 119.471 1.032 . . . . 72.25 109.509 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.575 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 61.9 t80 -58.89 -43.63 90.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.499 0.666 . . . . 74.150000000000006 111.263 -173.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -70.08 -34.96 73.82 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.841 -1.072 . . . . 73.140000000000001 112.098 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.5 -35.79 17.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.404 -0.591 . . . . 42.229999999999997 109.404 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.8 -45.72 93.31 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-N 115.497 -0.774 . . . . 51.030000000000001 109.997 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 18.4 mmt -62.99 -38.11 89.87 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 116.504 -0.316 . . . . 70.109999999999999 111.249 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -65.54 -45.26 84.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.396 -0.365 . . . . 63.200000000000003 111.035 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.463 ' O ' HG23 ' A' ' 44' ' ' VAL . 10.4 tt -71.79 -39.73 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 119.146 -1.022 . . . . 65.299999999999997 110.541 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 83.5 t -67.8 -33.73 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 121.133 -0.227 . . . . 63.409999999999997 110.615 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -67.83 -40.94 83.7 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.86 -0.422 . . . . 75.219999999999999 109.86 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.34 -45.05 92.34 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-N 115.64 -0.709 . . . . 62.32 111.342 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 40' ' ' ILE . 69.7 t -61.7 -42.7 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.012 0.434 . . . . 74.519999999999996 109.875 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.56 -46.21 80.85 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 124.306 1.042 . . . . 72.239999999999995 111.225 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -71.54 -35.32 70.62 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.059 -0.973 . . . . 71.340000000000003 110.323 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 43' ' ' GLY . 97.7 t -67.73 -40.6 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 121.051 -0.259 . . . . 75.030000000000001 110.445 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 44' ' ' VAL . 74.8 mt -64.15 -39.6 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.958 0.409 . . . . 74.200000000000003 109.9 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -74.89 -19.28 60.21 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 115.973 -0.558 . . . . 75.319999999999993 111.321 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.72 -14.74 16.54 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 112.874 0.694 . . . . 73.319999999999993 112.874 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 m -108.23 -23.42 11.94 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 112.429 0.529 . . . . 70.409999999999997 112.429 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -133.97 177.93 7.35 Favored 'General case' 0 CA--C 1.484 -1.564 0 CA-C-O 121.461 0.648 . . . . 72.150000000000006 110.069 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.534 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 38.4 t30 -98.93 95.89 7.47 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 104.938 -2.245 . . . . 72.019999999999996 104.938 175.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -117.41 135.25 54.02 Favored 'General case' 0 N--CA 1.402 -2.859 0 CA-C-N 115.427 -0.806 . . . . 44.43 112.408 -173.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.4 m -109.72 121.26 44.82 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 106.812 -1.551 . . . . 64.219999999999999 106.812 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.35 128.82 51.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-O 121.294 0.568 . . . . 74.219999999999999 110.539 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -122.37 112.33 17.96 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.879 -1.526 . . . . 71.209999999999994 106.879 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.16 119.13 34.09 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.814 0.34 . . . . 53.399999999999999 110.818 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.48 174.4 6.57 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.291 0.567 . . . . 62.130000000000003 109.824 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -95.98 155.18 16.86 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.2 -1.408 . . . . 64.420000000000002 107.2 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.66 175.73 24.6 Favored Glycine 0 C--N 1.277 -2.749 0 C-N-CA 120.519 -0.848 . . . . 73.150000000000006 112.891 -176.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.51 ' HB3' ' OD2' ' A' ' 65' ' ' ASP . 11.6 tp10 -65.91 177.05 1.42 Allowed 'General case' 0 C--O 1.21 -1.025 0 C-N-CA 124.735 1.214 . . . . 72.140000000000001 108.813 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -45.25 -49.11 12.69 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 113.813 1.042 . . . . 74.420000000000002 113.813 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 76.8 m -82.03 -15.07 54.86 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.758 -0.655 . . . . 75.209999999999994 111.712 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 12.3 m-20 -98.87 118.09 34.85 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.1 -0.64 . . . . 73.219999999999999 110.618 -176.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.0 t -80.73 -36.21 15.47 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.508 0 CA-C-N 116.062 -0.517 . . . . 61.200000000000003 112.272 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.8 tp -146.48 140.68 26.4 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.896 -1.15 . . . . 75.439999999999998 107.896 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.79 102.01 6.13 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 107.374 -1.343 . . . . 65.519999999999996 107.374 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -109.43 114.53 28.25 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.83 0.824 . . . . 63.009999999999998 110.372 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -98.49 139.33 34.39 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.811 -1.086 . . . . 72.420000000000002 109.012 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.84 128.48 51.7 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 107.257 -1.386 . . . . 71.329999999999998 107.257 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.3 m -103.42 119.17 38.37 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 106.78 -1.563 . . . . 75.409999999999997 106.78 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.57 137.71 44.07 Favored 'General case' 0 CA--C 1.495 -1.156 0 CA-C-O 121.084 0.468 . . . . 61.240000000000002 112.182 -173.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -142.45 83.55 1.83 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.145 -1.428 . . . . 74.109999999999999 107.145 173.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -85.62 66.79 9.83 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.063 -0.517 . . . . 75.409999999999997 109.831 -177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 51.56 64.1 1.98 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.507 -1.224 . . . . 74.5 111.427 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.93 -11.8 62.39 Favored Glycine 0 C--N 1.314 -0.667 0 C-N-CA 120.666 -0.778 . . . . 74.109999999999999 112.856 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -108.64 107.7 18.28 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.38 -1.341 . . . . 64.109999999999999 107.38 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.629 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -121.63 142.65 49.92 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 113.14 0.793 . . . . 70.239999999999995 113.14 -165.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.98 171.29 43.77 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.967 -0.56 . . . . 41.409999999999997 111.877 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.4 mt -116.53 147.0 20.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.759 -1.2 . . . . 75.329999999999998 107.759 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.3 t -130.18 110.44 19.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.588 -0.893 . . . . 71.530000000000001 108.588 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.502 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 38.6 m-70 -98.89 106.32 18.57 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.294 -0.632 . . . . 63.299999999999997 109.294 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.6 t -104.66 109.87 28.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.603 -0.888 . . . . 64.340000000000003 108.603 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -119.76 139.44 52.3 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.61 -0.515 . . . . 71.099999999999994 109.61 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.7 mt -102.52 106.22 16.9 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 107.385 -1.339 . . . . 74.120000000000005 107.385 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 60.0 ttt-85 -98.05 141.55 30.86 Favored 'General case' 0 C--N 1.263 -3.17 0 N-CA-C 108.843 -0.799 . . . . 64.340000000000003 108.843 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -93.59 108.35 20.08 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 109.346 -0.613 . . . . 73.0 109.346 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 tt -83.15 116.12 26.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.29 0.567 . . . . 73.420000000000002 109.68 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.8 p -115.79 -172.04 2.09 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 107.957 -1.127 . . . . 72.409999999999997 107.957 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -87.76 -13.2 42.97 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.464 0.65 . . . . 73.109999999999999 109.977 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -95.49 -38.23 10.54 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.919 -1.037 . . . . 65.430000000000007 109.63 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 49.3 t -101.52 104.3 33.25 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 109.465 -0.568 . . . . 63.039999999999999 109.465 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.85 146.97 33.96 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.219 2.612 . . . . 70.129999999999995 113.017 -176.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.16 162.18 27.45 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 123.782 2.988 . . . . 73.239999999999995 113.447 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 t -92.22 159.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 107.339 -1.356 . . . . 61.340000000000003 107.339 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.48 141.34 48.66 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.316 -0.624 . . . . 53.420000000000002 109.316 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.09 -169.9 41.41 Favored Glycine 0 CA--C 1.467 -2.927 0 N-CA-C 108.762 -1.735 . . . . 64.510000000000005 108.762 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.511 ' HB3' ' HG2' ' A' ' 27' ' ' MET . 4.4 t-20 -56.31 111.0 0.86 Allowed 'General case' 0 N--CA 1.426 -1.634 0 O-C-N 124.234 0.608 . . . . 72.450000000000003 109.788 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -87.16 126.17 34.63 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 108.344 -0.984 . . . . 74.219999999999999 108.344 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.11 151.97 44.87 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.305 -0.861 . . . . 51.329999999999998 110.435 -175.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.9 m -78.93 81.92 5.17 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.523 0.677 . . . . 74.549999999999997 109.766 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.531 HG13 ' OD2' ' A' ' 109' ' ' ASP . 49.3 t -80.74 143.72 11.86 Favored 'Isoleucine or valine' 0 C--O 1.251 1.137 0 CA-C-N 114.705 -1.134 . . . . 54.310000000000002 109.64 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -154.67 -67.98 0.13 Allowed 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.44 -1.319 . . . . 70.430000000000007 107.44 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -158.6 163.06 37.32 Favored 'General case' 1 C--N 1.24 -4.189 0 CA-C-N 112.54 -2.118 . . . . 64.030000000000001 105.62 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -39.35 -43.12 1.14 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.336 1.606 . . . . 73.0 115.336 -172.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -60.36 -49.76 76.29 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.025 0.379 . . . . 71.120000000000005 112.025 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -74.71 -33.87 62.48 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.295 -0.562 . . . . 71.329999999999998 110.645 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.531 ' OD2' HG13 ' A' ' 103' ' ' VAL . 0.9 OUTLIER -62.29 -48.37 80.2 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.387 -0.824 . . . . 64.439999999999998 110.423 178.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 10.5 tp -66.68 -37.99 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 120.711 -0.396 . . . . 65.209999999999994 110.452 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -63.58 -42.21 98.31 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.685 -0.406 . . . . 74.140000000000001 110.44 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 2.7 t -63.59 -41.32 98.36 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.164 -0.471 . . . . 73.120000000000005 111.907 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.424 ' O ' HG13 ' A' ' 117' ' ' ILE . 47.6 mm -70.54 -45.19 75.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 121.085 -0.246 . . . . 44.310000000000002 110.644 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.496 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 70.7 t -64.69 -42.91 96.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.333 -0.394 . . . . 72.129999999999995 110.912 -177.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.57 -27.35 62.14 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.173 -0.611 . . . . 53.149999999999999 111.163 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.18 84.8 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.47 -0.567 . . . . 14.15 109.47 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 113' ' ' ILE . 72.4 mt -63.8 -45.8 96.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.398 -0.819 . . . . 72.140000000000001 109.184 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 114' ' ' VAL . 80.6 mt-10 -60.71 -40.35 91.97 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 116.276 -0.42 . . . . 72.510000000000005 111.283 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -70.43 -35.22 73.26 Favored 'General case' 0 C--O 1.202 -1.438 0 C-N-CA 120.632 -0.427 . . . . 74.439999999999998 111.149 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 8.1 t -73.54 -37.15 65.68 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.196 -0.602 . . . . 73.140000000000001 110.483 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.3 mp -77.58 -42.67 34.38 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.866 -0.734 . . . . 71.329999999999998 111.211 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.29 -19.88 29.22 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 116.29 1.959 . . . . 65.019999999999996 116.29 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.4 30.4 mttp -59.63 -47.76 84.33 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 116.73 2.122 . . . . 72.200000000000003 116.73 -172.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 155.34 149.84 5.41 Favored Glycine 0 C--N 1.264 -3.431 0 C-N-CA 119.405 -1.378 . . . . 63.439999999999998 113.017 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -83.17 48.78 1.43 Allowed 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 124.424 1.09 . . . . 71.530000000000001 111.128 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.5 tp 176.95 101.85 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 125.2 1.4 . . . . 71.230000000000004 109.67 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 34.6 t30 177.41 113.34 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.668 1.187 . . . . 71.420000000000002 109.665 174.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.9 m 55.58 94.84 0.02 OUTLIER 'General case' 0 N--CA 1.421 -1.917 0 C-N-CA 125.824 1.65 . . . . 50.210000000000001 114.539 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -82.03 114.5 20.64 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 115.044 -0.98 . . . . 72.420000000000002 110.424 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 98.8 mt -128.68 -174.9 3.37 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.989 -1.856 . . . . 74.230000000000004 105.989 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.61 120.38 16.14 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.648 -0.501 . . . . 74.409999999999997 109.648 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -133.08 160.47 23.91 Favored Glycine 0 CA--C 1.482 -1.982 0 N-CA-C 109.533 -1.427 . . . . 62.109999999999999 109.533 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.404 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 3.0 mppt? -110.49 109.28 58.25 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 117.366 0.583 . . . . 74.329999999999998 110.254 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.83 112.07 3.3 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 121.849 1.699 . . . . 75.209999999999994 109.139 174.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.422 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 49.6 mm -106.9 110.15 63.47 Favored Pre-proline 0 N--CA 1.421 -1.89 0 CA-C-N 116.32 -0.4 . . . . 74.010000000000005 110.354 -176.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 135' ' ' ILE . 55.8 Cg_endo -74.01 150.04 42.71 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.294 1.996 . . . . 61.030000000000001 109.304 170.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.1 m120 66.03 87.44 0.12 Allowed Pre-proline 0 C--N 1.32 -0.703 0 C-N-CA 124.073 0.949 . . . . 74.329999999999998 111.672 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -81.85 -10.96 11.5 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.558 2.172 . . . . 71.439999999999998 111.658 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 66.03 100.32 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 124.851 1.26 . . . . 74.420000000000002 111.167 -176.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.7 mp -86.34 69.6 10.44 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 121.444 0.64 . . . . 62.32 109.427 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.63 -36.55 58.41 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 115.185 -0.916 . . . . 55.310000000000002 111.078 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.8 tt 66.64 94.14 0.07 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.922 1.289 . . . . 72.129999999999995 109.075 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -130.62 109.68 10.83 Favored 'General case' 0 CA--C 1.469 -2.155 0 CA-C-N 114.491 -1.231 . . . . 73.310000000000002 109.558 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 66.6 m -161.88 71.84 0.37 Allowed 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.213 -1.403 . . . . 54.229999999999997 107.213 174.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.4 m -78.65 86.71 4.61 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.566 -0.743 . . . . 61.409999999999997 109.249 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -169.83 132.88 1.18 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.378 -1.712 . . . . 72.030000000000001 106.378 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.6 m -88.22 98.4 11.55 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.943 -0.762 . . . . 73.209999999999994 108.943 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.459 0 N-CA-C 109.672 -1.371 . . . . 62.329999999999998 109.672 -178.665 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 N-CA-C 107.022 -1.473 . . . . 74.400000000000006 107.022 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 98.3 mttt -88.06 155.29 19.88 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.673 0.749 . . . . 63.25 112.195 -178.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.632 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 7.6 m-85 -122.95 151.86 41.4 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.957 -1.02 . . . . 74.239999999999995 111.856 178.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.61 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 32.3 t70 -103.32 101.55 11.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 105.753 -1.943 . . . . 70.129999999999995 105.753 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -90.41 120.91 40.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.643 0.735 . . . . 73.140000000000001 109.335 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.0 t -110.69 112.39 40.35 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 107.664 -1.236 . . . . 71.530000000000001 107.664 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.522 HG23 ' HB3' ' A' ' 27' ' ' MET . 4.7 tt -120.08 108.83 24.19 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 CA-C-O 121.938 0.875 . . . . 74.430000000000007 109.903 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.0 mt -110.27 117.25 51.82 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-N 114.799 -1.091 . . . . 73.549999999999997 108.553 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.604 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 44.6 Cg_endo -93.67 140.25 1.55 Allowed 'Trans proline' 0 N--CA 1.431 -2.171 0 C-N-CA 121.51 1.473 . . . . 73.530000000000001 110.728 171.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.55 124.49 8.61 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.187 0.518 . . . . 74.329999999999998 111.054 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.577 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 57.4 m -67.51 114.64 6.33 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 122.108 -0.37 . . . . 71.310000000000002 110.143 177.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 2.7 p90 -57.39 115.17 2.55 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 113.726 1.009 . . . . 64.129999999999995 113.726 -176.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 71.0 m80 -146.45 162.79 37.5 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 114.275 -1.329 . . . . 64.409999999999997 108.324 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -133.63 149.5 51.58 Favored 'General case' 0 N--CA 1.401 -2.896 0 N-CA-C 104.945 -2.243 . . . . 71.430000000000007 104.945 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -61.12 115.93 4.15 Favored 'General case' 0 N--CA 1.413 -2.316 0 O-C-N 124.214 0.946 . . . . 74.450000000000003 110.806 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -91.27 -159.31 0.62 Allowed 'General case' 0 C--N 1.266 -3.064 0 N-CA-C 105.504 -2.036 . . . . 72.409999999999997 105.504 172.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -70.64 -52.84 18.57 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 119.466 1.03 . . . . 64.430000000000007 110.599 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -136.16 5.47 3.02 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.546 0.689 . . . . 52.420000000000002 110.511 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -125.82 170.95 11.1 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.486 -0.561 . . . . 75.150000000000006 109.486 -175.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.401 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 57.9 mtt 66.2 85.19 0.14 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.86 1.264 . . . . 65.150000000000006 113.347 175.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -161.73 98.72 1.11 Allowed 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.854 -1.165 . . . . 70.530000000000001 107.854 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -149.62 134.21 17.61 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.919 -0.488 . . . . 73.519999999999996 111.391 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.2 mp -128.86 144.72 37.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 104.572 -2.381 . . . . 72.349999999999994 104.572 172.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.604 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 37.4 m -107.15 160.0 27.99 Favored Pre-proline 0 C--N 1.277 -2.547 0 N-CA-C 108.584 -0.895 . . . . 52.109999999999999 108.584 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.89 119.81 7.1 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.228 2.619 . . . . 71.129999999999995 114.182 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.59 125.14 10.35 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.64 2.227 . . . . 62.420000000000002 110.925 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.522 ' HB3' HG23 ' A' ' 7' ' ' ILE . 39.0 tpp -101.15 128.19 47.36 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.899 -1.149 . . . . 70.400000000000006 107.899 -175.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.7 t -129.31 129.34 67.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.449 -0.574 . . . . 72.109999999999999 109.449 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.409 HD11 ' H ' ' A' ' 101' ' ' CYS . 38.7 mm -134.39 106.59 8.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.062 0.458 . . . . 74.430000000000007 110.684 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -104.47 81.12 0.32 Allowed Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 119.875 -1.155 . . . . 61.219999999999999 112.091 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -170.04 31.12 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.895 0.855 . . . . 41.200000000000003 111.023 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 -124.61 133.94 53.09 Favored 'General case' 0 C--O 1.201 -1.457 0 N-CA-C 107.667 -1.235 . . . . 72.209999999999994 107.667 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 2.3 p -84.44 155.25 22.32 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 118.524 0.602 . . . . 73.319999999999993 110.553 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.632 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 90.3 t80 -48.9 -53.74 18.3 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 124.464 1.106 . . . . 72.120000000000005 113.315 -172.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 25.5 m-20 -70.18 -35.43 73.96 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.749 -1.114 . . . . 73.109999999999999 111.06 -174.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.8 mt -76.28 -38.23 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 109.619 -0.512 . . . . 71.109999999999999 109.619 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.01 -44.96 95.61 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.716 -0.675 . . . . 43.310000000000002 110.414 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.8 ttm -66.45 -38.38 87.24 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 119.968 -0.693 . . . . 65.519999999999996 110.674 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 35' ' ' ASP . 55.9 mm-40 -67.82 -40.14 83.85 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.494 -0.482 . . . . 65.129999999999995 111.752 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 44' ' ' VAL . 14.6 tt -73.38 -38.36 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 119.464 -0.894 . . . . 73.340000000000003 110.736 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.87 -39.23 84.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 110.193 -0.299 . . . . 64.400000000000006 110.193 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -71.31 -16.59 62.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.031 0.443 . . . . 65.109999999999999 111.822 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.79 -43.47 6.79 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 110.233 -1.147 . . . . 74.530000000000001 110.233 173.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 40' ' ' ILE . 77.4 t -59.8 -38.26 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.045 -1.095 . . . . 62.149999999999999 108.045 177.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -51.09 -50.08 59.44 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 126.051 1.74 . . . . 72.439999999999998 111.069 176.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -67.26 -38.19 84.74 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.753 -0.832 . . . . 73.319999999999993 108.753 -177.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -62.32 -45.4 98.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.07 -0.514 . . . . 72.230000000000004 110.696 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 44' ' ' VAL . 61.6 mt -69.42 -38.35 76.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.912 0.386 . . . . 73.219999999999999 110.397 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -79.58 -14.29 58.93 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.245 0.545 . . . . 74.439999999999998 112.263 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.65 -38.46 7.9 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.722 -0.611 . . . . 65.310000000000002 112.009 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -84.72 -14.08 49.42 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.663 0.744 . . . . 70.140000000000001 110.377 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -141.19 -175.58 4.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.58 -1.267 . . . . 65.120000000000005 107.58 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -106.78 100.1 9.63 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 105.609 -1.997 . . . . 63.409999999999997 105.609 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -129.46 136.04 49.4 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-O 121.194 0.521 . . . . 74.25 111.952 -175.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.507 ' OG ' ' HA2' ' A' ' 141' ' ' GLY . 5.5 p -116.87 127.57 54.4 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.725 -1.213 . . . . 71.030000000000001 107.725 175.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 p -101.03 119.1 48.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 119.805 -0.758 . . . . 72.219999999999999 111.77 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -95.91 111.11 23.19 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.806 -1.924 . . . . 70.010000000000005 105.806 171.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -103.24 108.51 19.75 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 122.069 0.937 . . . . 73.519999999999996 112.315 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mp -111.85 177.56 4.61 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.888 -1.506 . . . . 74.120000000000005 109.422 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -94.42 161.82 14.07 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.427 -0.953 . . . . 63.450000000000003 108.427 177.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.1 176.52 24.66 Favored Glycine 0 C--N 1.285 -2.298 0 N-CA-C 110.345 -1.102 . . . . 54.149999999999999 110.345 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -65.19 -179.47 0.58 Allowed 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 116.973 0.386 . . . . 73.120000000000005 110.126 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -52.05 -31.9 32.1 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 113.273 0.842 . . . . 74.400000000000006 113.273 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 51.8 t -87.67 -15.6 36.71 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.765 -0.652 . . . . 74.230000000000004 111.463 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.501 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 11.5 m-20 -105.64 156.81 17.9 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-O 121.244 0.545 . . . . 73.329999999999998 110.141 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.6 t -112.22 -31.94 2.17 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 120.497 -0.481 . . . . 74.530000000000001 111.857 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 57.3 tp -151.15 138.64 19.55 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.071 -0.652 . . . . 53.009999999999998 109.764 -176.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.2 104.18 6.91 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.392 -0.596 . . . . 73.329999999999998 109.392 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -104.62 116.58 32.3 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.482 -0.932 . . . . 72.319999999999993 108.482 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -98.72 110.27 22.9 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.669 -1.234 . . . . 75.230000000000004 107.669 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -94.93 123.04 38.17 Favored 'General case' 0 C--N 1.264 -3.122 0 N-CA-C 109.713 -0.477 . . . . 64.5 109.713 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 29.9 m -94.26 122.38 36.74 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.452 -1.314 . . . . 65.200000000000003 107.452 176.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.47 136.78 50.15 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 114.391 1.256 . . . . 73.340000000000003 114.391 -172.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -133.62 135.68 44.35 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.91 -1.885 . . . . 74.519999999999996 105.91 170.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.546 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 80.1 tttt -139.82 172.62 12.52 Favored 'General case' 0 C--N 1.27 -2.886 0 N-CA-C 104.422 -2.436 . . . . 71.510000000000005 104.422 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.469 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 8.2 pt-20 -47.2 87.67 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.907 0.883 . . . . 74.140000000000001 112.942 176.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.32 19.16 78.63 Favored Glycine 0 N--CA 1.432 -1.623 0 CA-C-N 115.175 -0.921 . . . . 61.240000000000002 112.482 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 59.2 mmtt -127.86 156.43 42.58 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.725 -1.583 . . . . 74.310000000000002 106.725 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -156.85 140.77 16.21 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 123.262 0.351 . . . . 74.329999999999998 110.349 -178.164 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -170.5 177.46 43.66 Favored Glycine 0 C--O 1.205 -1.692 0 C-N-CA 120.113 -1.041 . . . . 71.120000000000005 113.432 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.403 HG13 ' HB3' ' A' ' 12' ' ' PHE . 60.8 mt -123.79 151.5 28.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 106.493 -1.669 . . . . 75.120000000000005 106.493 175.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.1 t -134.64 109.9 12.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.324 -0.991 . . . . 63.25 108.324 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -89.4 104.22 16.79 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.693 -0.484 . . . . 72.230000000000004 109.693 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.2 t -105.13 109.81 28.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.385 -0.969 . . . . 72.219999999999999 108.385 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 18.1 pttp -122.68 144.22 49.28 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 120.111 -0.635 . . . . 65.439999999999998 110.014 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.4 mt -105.81 109.47 21.44 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 107.226 -1.398 . . . . 52.240000000000002 107.226 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.524 ' HD3' ' OD2' ' A' ' 4' ' ' ASP . 36.6 ttt180 -98.51 141.34 31.48 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.4 -0.963 . . . . 61.409999999999997 108.4 -177.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -85.01 111.18 19.48 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 120.346 -0.542 . . . . 75.420000000000002 109.925 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.9 tt -74.47 112.13 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-O 122.168 0.985 . . . . 71.510000000000005 108.993 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -135.31 -177.95 4.89 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 106.235 -1.765 . . . . 73.239999999999995 106.235 -171.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -80.91 -13.75 58.63 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.472 1.13 . . . . 64.319999999999993 108.987 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -79.34 -33.39 43.09 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 113.849 -1.523 . . . . 71.25 108.474 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 95.9 m -129.76 94.22 32.44 Favored Pre-proline 0 N--CA 1.439 -1.002 0 CA-C-N 115.209 -0.905 . . . . 74.239999999999995 110.403 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.6 153.39 43.86 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 122.529 2.153 . . . . 51.520000000000003 112.269 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.34 138.48 60.85 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.171 2.581 . . . . 53.130000000000003 111.762 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.4 t -97.27 153.26 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.307 -0.997 . . . . 73.219999999999999 108.307 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -105.64 92.27 4.11 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 108.364 -0.976 . . . . 71.140000000000001 108.364 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -109.96 -149.67 12.68 Favored Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 109.741 -1.344 . . . . 61.149999999999999 109.741 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -72.9 118.27 15.64 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 107.426 -1.324 . . . . 25.350000000000001 107.426 172.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -94.78 121.6 36.54 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.519 0.676 . . . . 71.129999999999995 109.201 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.409 ' H ' HD11 ' A' ' 29' ' ' ILE . 20.8 t -69.37 151.48 46.11 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.673 -1.149 . . . . 74.209999999999994 110.261 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 m -77.34 88.74 3.74 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.75 -0.833 . . . . 51.039999999999999 108.75 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -106.0 148.29 10.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 114.924 -1.035 . . . . 65.219999999999999 110.976 -172.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.0 tp -157.83 -61.45 0.08 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.628 1.204 . . . . 74.150000000000006 107.887 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -146.43 167.2 24.22 Favored 'General case' 0 C--N 1.256 -3.475 0 CA-C-N 112.243 -2.253 . . . . 71.219999999999999 108.192 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.55 ' O ' HG22 ' A' ' 110' ' ' ILE . 63.8 t80 -46.59 -49.17 19.33 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 124.627 1.204 . . . . 71.140000000000001 113.611 -175.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -58.73 -28.93 66.32 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.061 0.458 . . . . 74.329999999999998 112.063 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -87.11 -40.44 14.65 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 116.323 -0.399 . . . . 72.239999999999995 111.366 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.455 ' O ' HG12 ' A' ' 113' ' ' ILE 0.367 4.5 p30 -78.26 -28.34 47.7 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 118.788 -1.165 . . . . 73.299999999999997 112.954 -176.113 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 106' ' ' PHE . 8.2 tp -67.59 -40.3 83.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 109.482 -0.562 . . . . 72.019999999999996 109.482 175.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -66.91 -41.01 87.85 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 108.95 -0.759 . . . . 75.219999999999999 108.95 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 8.5 t -64.19 -41.87 96.9 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.13 -0.941 . . . . 74.540000000000006 111.744 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 109' ' ' ASP . 35.8 mm -68.16 -42.0 84.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 120.494 0.188 . . . . 61.399999999999999 110.596 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 93.1 t -67.03 -41.23 87.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.396 -0.594 . . . . 73.420000000000002 109.396 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -60.6 -39.91 89.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.936 -0.574 . . . . 71.140000000000001 110.964 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.45 98.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.86 0.362 . . . . 73.109999999999999 110.711 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 77.3 mt -68.8 -43.52 82.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.326 -0.62 . . . . 73.0 109.326 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -58.25 -46.18 86.45 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 123.817 0.847 . . . . 61.229999999999997 111.618 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -69.86 -36.05 75.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.533 -0.758 . . . . 65.109999999999999 109.464 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 52.7 t -65.21 -47.2 77.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.699 -0.682 . . . . 53.219999999999999 110.193 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.3 mp -68.88 -30.41 68.91 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.157 -0.474 . . . . 73.200000000000003 111.596 -177.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.12 -35.32 56.35 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.66 -0.7 . . . . 72.140000000000001 111.128 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -87.05 -12.93 45.8 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.52 0.676 . . . . 75.319999999999993 110.781 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.35 60.51 4.51 Favored Glycine 0 C--N 1.304 -1.203 0 CA-C-N 115.306 -0.861 . . . . 70.120000000000005 113.265 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -130.54 108.35 9.88 Favored 'General case' 0 C--N 1.268 -2.973 0 C-N-CA 124.733 1.213 . . . . 74.140000000000001 108.479 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.7 mp 66.51 -178.65 0.2 Allowed 'General case' 0 C--O 1.242 0.702 0 O-C-N 124.265 0.978 . . . . 71.319999999999993 110.917 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -62.89 127.79 32.88 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.512 -1.292 . . . . 74.319999999999993 107.512 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.7 m -127.1 161.18 29.06 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 109.04 -0.726 . . . . 72.319999999999993 109.04 -176.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.464 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 22.3 ttmm -80.38 77.63 7.13 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 122.499 1.142 . . . . 51.310000000000002 112.332 -178.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 129' ' ' LYS . 20.6 mt -171.21 54.15 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 129.893 3.277 . . . . 62.530000000000001 103.511 174.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -75.29 175.88 7.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.353 -2.203 . . . . 51.020000000000003 111.37 -173.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 138.95 -137.53 8.72 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 108.787 -1.725 . . . . 62.020000000000003 108.787 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -116.99 110.64 41.44 Favored Pre-proline 0 C--N 1.305 -1.357 0 CA-C-N 117.088 0.444 . . . . 71.019999999999996 110.087 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.61 173.71 13.87 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.563 2.175 . . . . 75.310000000000002 110.79 176.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 46.5 mm -111.22 102.76 53.77 Favored Pre-proline 0 N--CA 1.432 -1.359 0 CA-C-O 121.164 0.507 . . . . 75.299999999999997 110.075 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -88.18 138.84 4.19 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 123.017 2.478 . . . . 60.329999999999998 112.073 172.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.465 ' HB3' ' HD2' ' A' ' 138' ' ' PRO . 16.3 m120 -136.78 173.73 5.22 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 107.521 -1.288 . . . . 64.209999999999994 107.521 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 137' ' ' ASN . 23.5 Cg_endo -66.58 -18.01 53.58 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 121.535 1.49 . . . . 74.439999999999998 112.333 174.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.9 mp 73.65 102.14 0.07 Allowed 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.539 1.136 . . . . 74.430000000000007 112.51 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.1 mt -112.64 101.54 9.67 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.173 -1.417 . . . . 73.310000000000002 107.173 173.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.507 ' HA2' ' OG ' ' A' ' 55' ' ' SER . . . -127.68 4.73 7.05 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.478 -0.868 . . . . 74.010000000000005 113.21 -175.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.1 mp -89.17 76.06 7.75 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.275 1.036 . . . . 65.340000000000003 112.313 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -143.07 31.87 1.38 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 104.319 -2.475 . . . . 73.120000000000005 104.319 175.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.3 m -41.42 111.08 0.19 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 111.621 -2.536 . . . . 73.409999999999997 114.752 -172.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.3 p -128.98 147.69 50.88 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.045 -1.094 . . . . 75.109999999999999 108.045 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -146.32 141.86 27.69 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.216 0.532 . . . . 75.019999999999996 111.553 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 49.2 m -145.07 101.55 3.64 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.281 -1.007 . . . . 64.109999999999999 108.281 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.04 0 N-CA-C 109.503 -1.439 . . . . 31.219999999999999 109.503 -179.789 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.1 mmm . . . . . 0 CA--C 1.499 -1.002 0 CA-C-O 121.011 0.434 . . . . 64.140000000000001 110.291 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -99.56 143.47 29.76 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.976 -0.556 . . . . 74.219999999999999 109.962 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.608 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 21.0 m-85 -116.49 141.04 48.7 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.62 -0.718 . . . . 74.409999999999997 110.008 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.659 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 33.2 t70 -111.92 108.63 18.05 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 125.418 1.487 . . . . 43.520000000000003 109.988 -174.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 p -88.87 116.04 29.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 115.894 -0.594 . . . . 71.120000000000005 109.962 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.21 116.8 50.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.412 -1.329 . . . . 73.439999999999998 107.412 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.491 HG23 ' HB3' ' A' ' 27' ' ' MET . 4.9 tt -121.32 115.86 47.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-O 121.305 0.574 . . . . 43.030000000000001 110.551 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.8 tt -110.42 110.3 58.02 Favored Pre-proline 0 C--N 1.298 -1.668 0 CA-C-N 116.028 -0.533 . . . . 74.120000000000005 110.298 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.566 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 72.4 Cg_endo -91.62 147.4 3.35 Favored 'Trans proline' 0 N--CA 1.435 -1.952 0 C-N-CA 122.301 2.001 . . . . 64.299999999999997 110.112 173.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.61 177.66 9.83 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.933 -0.766 . . . . 64.140000000000001 108.933 177.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.47 ' HB2' ' HB3' ' A' ' 22' ' ' HIS . 52.1 m -122.6 104.29 9.25 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 109.019 -0.734 . . . . 53.350000000000001 109.019 173.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 24.0 p90 -49.56 95.61 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 115.131 1.53 . . . . 73.049999999999997 115.131 -176.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.498 ' CE1' ' HB3' ' A' ' 125' ' ' GLU . 76.6 m80 -145.85 168.89 19.71 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.42 -0.809 . . . . 74.310000000000002 109.299 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.75 147.23 46.57 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 104.322 -2.473 . . . . 73.049999999999997 104.322 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -70.43 93.36 0.87 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 123.77 0.669 . . . . 65.120000000000005 109.265 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.5 -84.28 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.212 -0.904 . . . . 71.150000000000006 110.529 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -107.61 -59.91 1.77 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.61 -0.515 . . . . 64.299999999999997 109.61 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -138.06 -52.43 0.62 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.066 -1.087 . . . . 73.239999999999995 108.066 173.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.462 HD22 HD21 ' A' ' 126' ' ' LEU . 14.7 m120 -74.97 174.92 8.65 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 113.114 -1.857 . . . . 60.219999999999999 111.083 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.464 ' HB3' ' HB3' ' A' ' 13' ' ' HIS . 4.5 mpp? 74.0 72.16 0.11 Allowed 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 124.881 1.363 . . . . 74.5 108.567 -175.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 5.1 pt-20 -148.84 93.29 2.09 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 113.804 -1.544 . . . . 65.439999999999998 109.249 -171.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 125' ' ' GLU . 19.0 t60 -160.96 107.47 1.45 Allowed 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.143 -1.423 . . . . 55.539999999999999 113.616 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -123.34 136.63 59.33 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 105.27 -2.122 . . . . 73.109999999999999 105.27 172.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 64.0 m -108.3 153.73 41.78 Favored Pre-proline 0 C--N 1.294 -1.83 0 O-C-N 123.109 0.256 . . . . 72.409999999999997 110.791 -176.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.2 Cg_exo -65.83 143.18 72.51 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 123.244 2.629 . . . . 64.099999999999994 113.849 -178.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 7.4 Cg_exo -74.97 130.45 13.31 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.905 2.403 . . . . 61.210000000000001 112.002 176.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.491 ' HB3' HG23 ' A' ' 7' ' ' ILE . 50.3 ttm -92.42 135.3 34.15 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.941 -1.133 . . . . 64.519999999999996 107.941 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 83.9 t -131.09 116.4 33.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 O-C-N 123.238 0.337 . . . . 71.420000000000002 110.786 -171.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.2 mm -129.2 106.06 13.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 120.638 0.256 . . . . 71.430000000000007 111.357 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -112.83 80.91 0.28 Allowed Glycine 0 CA--C 1.476 -2.396 0 C-N-CA 120.27 -0.966 . . . . 72.450000000000003 112.139 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -144.33 1.58 1.08 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.648 0.981 . . . . 51.100000000000001 113.648 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -107.33 134.57 50.2 Favored 'General case' 0 C--N 1.285 -2.204 0 O-C-N 121.025 -1.047 . . . . 71.150000000000006 108.304 -172.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 p -74.65 164.48 26.53 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 107.569 -1.271 . . . . 61.229999999999997 107.569 173.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.608 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 82.1 t80 -55.3 -45.48 76.24 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 120.789 0.328 . . . . 75.209999999999994 111.848 -173.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.85 -39.24 93.24 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.272 -0.876 . . . . 43.210000000000001 111.498 -176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.9 mm -74.31 -43.19 50.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.754 -0.832 . . . . 74.120000000000005 108.754 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 40' ' ' ILE . . . -61.92 -43.38 98.95 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 115.539 -0.755 . . . . 74.109999999999999 111.074 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.3 tpt -68.81 -38.0 79.6 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.972 -0.291 . . . . 61.340000000000003 110.871 -175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -84.36 -21.43 30.89 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 118.905 -1.118 . . . . 74.219999999999999 112.594 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.507 ' O ' HG23 ' A' ' 44' ' ' VAL . 17.6 tt -82.6 -40.25 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 C-N-CA 119.005 -1.078 . . . . 73.25 109.78 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.36 -36.28 71.3 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.876 0 C-N-CA 121.095 -0.242 . . . . 71.340000000000003 110.439 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -64.05 -31.98 73.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.147 0.499 . . . . 71.25 110.158 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -69.41 -44.78 63.27 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.714 -0.955 . . . . 52.219999999999999 110.714 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 40' ' ' ILE . 63.3 t -60.14 -44.93 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.282 -0.636 . . . . 73.409999999999997 109.282 177.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.8 -43.42 80.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.848 1.259 . . . . 70.430000000000007 110.862 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -68.96 -38.5 79.44 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.478 -0.783 . . . . 65.209999999999994 109.78 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 43' ' ' GLY . 92.9 t -66.41 -42.27 90.17 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.361 0 CA-C-N 116.513 -0.312 . . . . 73.409999999999997 110.674 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.458 ' CG2' HD11 ' A' ' 73' ' ' LEU . 72.7 mt -66.81 -41.81 88.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 121.287 0.565 . . . . 61.119999999999997 110.496 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -78.22 -11.38 59.92 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.499 -0.773 . . . . 71.319999999999993 110.583 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.9 -41.94 5.06 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 113.192 0.812 . . . . 72.430000000000007 113.192 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.5 m -91.03 -6.44 53.9 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.583 0.586 . . . . 64.439999999999998 112.583 -175.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -136.47 168.91 18.56 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 108.33 -0.989 . . . . 74.140000000000001 108.33 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 17.6 t-20 -96.15 100.17 11.84 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 105.588 -2.004 . . . . 73.439999999999998 105.588 176.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.19 136.23 55.01 Favored 'General case' 0 N--CA 1.408 -2.542 0 C-N-CA 120.079 -0.648 . . . . 75.040000000000006 112.626 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.485 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 11.6 m -99.45 106.46 18.51 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 103.737 -2.69 . . . . 60.439999999999998 103.737 167.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.439 ' CG2' ' HD2' ' A' ' 69' ' ' ARG . 5.1 p -99.86 121.76 50.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-O 121.661 0.743 . . . . 45.420000000000002 111.419 -171.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -116.25 135.93 53.46 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.293 -0.867 . . . . 75.019999999999996 109.505 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.483 ' HB3' ' NH1' ' A' ' 69' ' ' ARG . 8.5 pt-20 -98.78 136.36 38.93 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.382 -0.372 . . . . 74.120000000000005 110.025 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.6 mt -142.02 175.41 9.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.234 0.54 . . . . 64.409999999999997 111.021 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.37 161.78 13.44 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.466 -1.679 . . . . 72.329999999999998 106.466 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.569 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -114.69 175.22 15.93 Favored Glycine 0 C--N 1.284 -2.306 0 C-N-CA 119.714 -1.231 . . . . 61.409999999999997 113.061 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -93.53 134.05 36.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 123.07 0.548 . . . . 74.019999999999996 111.19 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 52.17 -88.67 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.629 1.714 . . . . 70.200000000000003 115.629 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 73.9 m -89.26 -12.96 39.21 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.546 -0.752 . . . . 53.340000000000003 112.069 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.569 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 14.0 m-20 -69.24 125.87 28.02 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.799 -1.186 . . . . 70.129999999999995 107.799 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.4 t -92.53 -31.8 4.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 121.279 0.561 . . . . 72.129999999999995 110.491 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.2 tp -151.76 145.22 24.84 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.124 -1.065 . . . . 71.25 108.124 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -130.12 122.21 27.83 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 107.938 -1.134 . . . . 74.420000000000002 107.938 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.483 ' NH1' ' HB3' ' A' ' 58' ' ' GLU . 22.0 tpp180 -120.1 119.07 32.24 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.406 -1.331 . . . . 74.439999999999998 107.406 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -108.83 136.26 48.68 Favored 'General case' 0 C--N 1.282 -2.327 0 C-N-CA 123.624 0.77 . . . . 73.510000000000005 109.215 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -126.31 131.87 51.76 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.329 -0.619 . . . . 74.409999999999997 109.329 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 18.6 m -103.02 109.51 21.08 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.663 -1.606 . . . . 72.150000000000006 106.663 172.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.458 HD11 ' CG2' ' A' ' 48' ' ' ILE . 3.3 mm? -98.67 140.51 32.78 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 113.027 0.751 . . . . 52.520000000000003 113.027 -172.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 44.0 mt-10 -135.71 95.9 3.33 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.279 -1.328 . . . . 65.430000000000007 108.493 171.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -92.08 76.36 5.41 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.082 -1.822 . . . . 72.0 106.082 179.066 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.333 0.7 OUTLIER 30.45 76.92 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.917 1.687 . . . . 75.409999999999997 115.417 -175.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.76 -23.51 35.44 Favored Glycine 0 C--O 1.236 0.273 0 C-N-CA 121.333 -0.46 . . . . 52.530000000000001 112.415 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 61.5 mttp -98.47 144.39 27.87 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 105.301 -2.111 . . . . 74.430000000000007 105.301 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 5.3 ptpp? -145.59 150.52 36.52 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 120.216 -0.594 . . . . 73.450000000000003 109.929 -168.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . 171.82 156.2 11.82 Favored Glycine 0 C--N 1.309 -0.951 0 C-N-CA 120.53 -0.843 . . . . 72.450000000000003 112.79 175.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 27.4 mt -103.57 139.22 25.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.504 -0.924 . . . . 63.409999999999997 108.504 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.3 t -118.53 116.45 51.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.342 -0.984 . . . . 74.420000000000002 108.342 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -104.34 109.5 21.37 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.568 -0.901 . . . . 74.120000000000005 108.568 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.08 119.53 55.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.028 -0.73 . . . . 74.239999999999995 109.028 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -121.47 140.24 52.43 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.23 -0.655 . . . . 63.409999999999997 109.23 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.0 mt -106.48 109.75 21.75 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.148 -1.427 . . . . 75.519999999999996 107.148 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -97.05 148.28 23.16 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-O 121.788 0.804 . . . . 73.239999999999995 111.014 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 88' ' ' LYS . 36.9 ttpt -92.18 105.5 17.7 Favored 'General case' 0 C--N 1.259 -3.352 0 CA-C-N 114.83 -1.077 . . . . 73.319999999999993 108.613 175.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 tt -91.34 112.34 25.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.412 0.625 . . . . 53.310000000000002 109.384 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.3 p -131.94 -171.01 2.52 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.815 -0.63 . . . . 74.430000000000007 109.993 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.47 -14.34 46.37 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.755 0.788 . . . . 62.32 108.905 176.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -90.41 -39.87 12.39 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.968 -1.015 . . . . 65.140000000000001 109.708 176.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 42.5 t -85.5 132.61 44.23 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 109.538 -0.541 . . . . 65.040000000000006 109.538 176.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 93' ' ' CYS . 5.4 Cg_exo -77.33 117.1 4.27 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.877 2.384 . . . . 72.239999999999995 111.88 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.34 122.31 11.12 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.836 2.357 . . . . 75.230000000000004 111.717 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.7 t -88.9 157.68 3.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 107.636 -1.246 . . . . 74.25 107.636 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -122.76 161.5 23.82 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.59 -0.893 . . . . 72.239999999999995 108.59 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -173.68 -166.24 31.63 Favored Glycine 0 CA--C 1.458 -3.486 0 N-CA-C 106.718 -2.553 . . . . 61.140000000000001 106.718 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 27' ' ' MET . 3.2 t-20 -56.01 102.98 0.09 Allowed 'General case' 0 N--CA 1.409 -2.49 0 O-C-N 124.411 0.712 . . . . 71.200000000000003 109.584 176.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -85.66 114.15 22.42 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.943 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 41.7 t -78.53 141.26 38.29 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.422 -1.325 . . . . 53.25 107.422 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.5 m -64.79 117.32 7.34 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.399 -0.963 . . . . 30.210000000000001 108.399 177.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.7 t -76.01 141.26 16.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.445 0.64 . . . . 74.310000000000002 110.539 -172.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.539 ' HG ' ' H ' ' A' ' 105' ' ' GLU . 15.2 tp -161.7 -159.46 0.62 Allowed 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.053 -2.203 . . . . 72.310000000000002 105.053 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.539 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 36.3 mt-10 -89.14 173.05 8.65 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 119.134 0.879 . . . . 61.509999999999998 112.038 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.489 ' O ' HG22 ' A' ' 110' ' ' ILE . 71.6 t80 -32.82 -58.05 0.36 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.517 1.927 . . . . 74.420000000000002 116.201 -171.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -68.64 -21.54 64.46 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 113.052 0.76 . . . . 72.420000000000002 113.052 -170.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -87.73 -42.39 12.65 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 119.671 -0.812 . . . . 75.310000000000002 111.001 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 113' ' ' ILE 0.262 17.1 p-10 -77.94 -30.08 50.29 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 118.684 -1.206 . . . . 60.039999999999999 111.783 -175.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 106' ' ' PHE . 16.5 tt -69.65 -38.78 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 119.225 -0.99 . . . . 72.319999999999993 109.829 175.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.25 -36.51 83.2 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 109.154 -0.684 . . . . 64.319999999999993 109.154 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 43.5 t -60.17 -45.49 92.9 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.798 -0.637 . . . . 61.240000000000002 109.703 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 109' ' ' ASP . 46.4 mm -61.28 -46.27 96.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 122.954 0.501 . . . . 74.150000000000006 109.891 175.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 110' ' ' ILE . 80.9 t -61.38 -42.77 95.01 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 CA-C-N 115.608 -0.723 . . . . 64.329999999999998 109.996 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 115' ' ' LYS . 37.3 mmtm -67.64 -32.19 72.71 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 112.139 0.422 . . . . 53.340000000000003 112.139 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.99 -39.37 83.28 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.284 -0.566 . . . . 71.109999999999999 110.044 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.5 mt -69.92 -47.12 71.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.856 -0.611 . . . . 72.200000000000003 110.11 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -64.7 -40.53 95.53 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 116.253 -0.431 . . . . 71.409999999999997 110.987 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.67 -17.72 58.97 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 120.298 -0.561 . . . . 65.340000000000003 112.154 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 27.4 t -78.24 -48.14 16.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.144 -1.058 . . . . 72.439999999999998 108.144 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 11.2 mp -69.37 -36.74 77.13 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.502 -0.772 . . . . 53.310000000000002 111.918 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.93 -13.57 53.13 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 114.002 1.112 . . . . 74.310000000000002 114.002 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -74.93 -12.39 60.34 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.255 -0.978 . . . . 74.519999999999996 110.893 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.92 169.01 42.29 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 115.113 -0.949 . . . . 55.340000000000003 111.12 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.498 ' HB3' ' CE1' ' A' ' 13' ' ' HIS . 0.7 OUTLIER -83.98 51.87 2.16 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 122.152 -0.616 . . . . 52.329999999999998 112.04 -178.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.462 HD21 HD22 ' A' ' 19' ' ' ASN . 89.4 mt -137.19 80.41 1.81 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.918 -1.037 . . . . 74.340000000000003 112.338 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.6 t30 177.93 100.62 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.097 1.359 . . . . 73.200000000000003 109.751 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 63.9 m -67.07 119.38 11.91 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.692 0.758 . . . . 62.310000000000002 112.337 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -158.13 136.82 11.23 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 102.235 -3.246 . . . . 63.219999999999999 102.235 173.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -150.0 108.63 3.83 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 119.148 0.885 . . . . 63.5 113.243 -175.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.18 92.99 0.51 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 104.4 -2.445 . . . . 50.439999999999998 104.4 173.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 147.86 176.82 21.75 Favored Glycine 0 C--N 1.289 -2.071 0 N-CA-C 107.831 -2.108 . . . . 72.349999999999994 107.831 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -148.08 108.85 3.7 Favored Pre-proline 0 C--N 1.302 -1.497 0 CA-C-N 118.087 0.943 . . . . 73.420000000000002 110.025 -177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.98 110.7 1.78 Allowed 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 122.498 2.132 . . . . 65.120000000000005 112.033 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 48.1 mm -116.17 100.68 53.69 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 108.322 -0.992 . . . . 72.040000000000006 108.322 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.34 130.28 8.01 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 122.867 2.378 . . . . 44.109999999999999 112.366 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -126.97 120.59 22.67 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 107.029 -1.471 . . . . 74.209999999999994 107.029 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.93 61.82 5.68 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 122.777 2.318 . . . . 75.200000000000003 113.669 -175.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.5 tp -95.44 53.77 1.52 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.495 -1.668 . . . . 72.319999999999993 106.495 174.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.47 HD23 ' H ' ' A' ' 140' ' ' LEU . 2.5 pt? -85.45 151.1 24.23 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 113.285 -1.78 . . . . 73.540000000000006 111.052 -173.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 104.99 -20.46 38.37 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.703 -0.76 . . . . 52.32 111.967 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 30.7 tp -76.19 85.35 3.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 122.152 0.977 . . . . 72.129999999999995 109.668 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -120.94 147.55 45.3 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.426 -1.716 . . . . 72.109999999999999 108.929 -173.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 67.9 p -124.53 93.68 3.98 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.414 -0.958 . . . . 64.129999999999995 108.414 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 40.7 m -63.18 106.32 0.85 Allowed 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.631 0.729 . . . . 74.439999999999998 111.656 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -137.78 115.62 11.48 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.05 -1.093 . . . . 72.430000000000007 108.05 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.3 t -131.51 128.85 40.21 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.389 0.614 . . . . 74.129999999999995 109.99 175.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.509 0 N-CA-C 108.333 -1.907 . . . . 53.210000000000001 108.333 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 mtm . . . . . 0 CA--C 1.494 -1.185 0 N-CA-C 108.808 -0.812 . . . . 65.530000000000001 108.808 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -92.87 145.42 24.4 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.659 -0.497 . . . . 62.219999999999999 109.659 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.615 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 21.9 m-85 -112.48 142.68 44.73 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 121.564 0.697 . . . . 73.549999999999997 111.466 177.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.676 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 31.9 t70 -111.26 102.66 11.05 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 105.793 -1.929 . . . . 73.099999999999994 105.793 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.65 119.3 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 CA-C-O 122.087 0.946 . . . . 62.520000000000003 110.865 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.419 HG13 HG22 ' A' ' 28' ' ' VAL . 45.9 t -105.99 116.58 50.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-N 114.083 -1.417 . . . . 73.230000000000004 107.848 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.528 HG23 ' HB3' ' A' ' 27' ' ' MET . 6.2 tt -115.3 114.85 47.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 CA-C-O 121.348 0.594 . . . . 75.450000000000003 109.614 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mp -104.0 106.61 53.88 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 108.936 -0.764 . . . . 70.030000000000001 108.936 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.631 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 2.0 Cg_endo -84.87 139.16 7.29 Favored 'Trans proline' 0 N--CA 1.44 -1.646 0 C-N-CA 121.964 1.776 . . . . 65.540000000000006 109.199 172.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -157.78 133.65 9.26 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.056 0.455 . . . . 74.329999999999998 110.524 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.479 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 48.7 m -84.26 118.56 24.26 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.588 -0.523 . . . . 51.32 109.588 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 79' ' ' LYS . 3.7 p90 -61.77 109.84 1.35 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.257 1.206 . . . . 63.350000000000001 114.257 -174.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -139.29 128.65 24.18 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.494 -0.776 . . . . 74.019999999999996 111.416 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -81.37 104.09 11.58 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 105.68 -1.97 . . . . 73.510000000000005 105.68 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 20' ' ' MET . 49.3 t80 -45.99 103.0 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 O-C-N 125.84 1.963 . . . . 74.200000000000003 109.662 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.25 -103.96 0.1 Allowed 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.134 -1.393 . . . . 73.310000000000002 113.688 -173.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -111.96 -58.99 2.05 Favored 'General case' 0 N--CA 1.434 -1.256 0 O-C-N 122.041 -0.412 . . . . 63.530000000000001 110.61 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -136.62 -36.76 0.7 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.405 -0.591 . . . . 74.400000000000006 109.405 176.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -102.04 163.25 12.35 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.766 -1.198 . . . . 74.340000000000003 107.766 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 1.8 mpt? 72.73 80.17 0.14 Allowed 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 124.28 1.032 . . . . 74.200000000000003 110.389 -173.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 178.03 132.4 0.07 Allowed 'General case' 0 N--CA 1.407 -2.605 0 N-CA-C 104.042 -2.577 . . . . 72.519999999999996 104.042 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 67.2 t60 179.41 92.37 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.804 0 O-C-N 124.336 1.023 . . . . 73.299999999999997 112.275 174.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.439 ' HB ' HD11 ' A' ' 130' ' ' LEU . 49.1 mm -100.88 139.82 21.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 N-CA-C 105.692 -1.966 . . . . 55.310000000000002 105.692 171.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.631 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 42.0 m -106.58 153.92 40.31 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 109.708 -0.479 . . . . 71.409999999999997 109.708 -174.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 42.6 Cg_endo -68.75 151.1 74.61 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 122.812 2.341 . . . . 73.120000000000005 112.718 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 13.4 Cg_exo -72.63 151.55 52.51 Favored 'Trans proline' 0 C--O 1.255 1.356 0 C-N-CA 123.178 2.586 . . . . 70.109999999999999 114.107 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.557 ' SD ' ' HB3' ' A' ' 99' ' ' ASN . 2.4 tpt -114.56 134.99 54.62 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 104.606 -2.368 . . . . 74.409999999999997 104.606 176.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.419 HG22 HG13 ' A' ' 6' ' ' VAL . 92.0 t -130.73 130.43 64.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 119.088 0.858 . . . . 73.239999999999995 110.731 -176.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.8 mm -124.1 102.51 11.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 106.961 -1.496 . . . . 73.239999999999995 106.961 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -126.31 81.13 0.36 Allowed Glycine 0 CA--C 1.476 -2.344 0 C-N-CA 117.586 -2.245 . . . . 63.509999999999998 114.198 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -161.15 18.45 0.12 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.438 -0.881 . . . . 62.43 111.372 176.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -115.25 134.14 55.4 Favored 'General case' 0 C--O 1.2 -1.514 0 N-CA-C 108.209 -1.034 . . . . 71.329999999999998 108.209 -171.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -72.88 163.38 28.22 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.13 -1.063 . . . . 72.519999999999996 108.13 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.615 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 83.0 t80 -52.09 -47.97 64.95 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.936 0.494 . . . . 62.030000000000001 112.092 -172.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.68 -40.66 92.98 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.176 -0.92 . . . . 73.439999999999998 111.302 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.4 mt -76.25 -37.88 32.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.343 -0.614 . . . . 63.240000000000002 109.343 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.6 99.74 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.483 -0.78 . . . . 53.420000000000002 110.008 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -67.26 -36.35 81.41 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.251 -0.431 . . . . 64.439999999999998 110.066 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -68.64 -42.51 77.92 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.23 -0.441 . . . . 73.319999999999993 110.888 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 44' ' ' VAL . 8.1 tp -71.1 -37.52 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.277 -0.569 . . . . 64.120000000000005 110.337 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.9 t -67.09 -37.19 78.79 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 N-CA-C 109.808 -0.441 . . . . 52.399999999999999 109.808 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.12 -33.54 76.27 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 109.643 -0.503 . . . . 74.319999999999993 109.643 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.22 -43.71 78.79 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 111.42 -0.672 . . . . 64.140000000000001 111.42 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 40' ' ' ILE . 99.4 t -62.03 -46.1 97.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.747 -0.835 . . . . 73.329999999999998 108.747 177.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -53.85 -46.27 71.19 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 125.498 1.519 . . . . 74.530000000000001 110.927 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -66.86 -41.08 87.93 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 114.391 -1.277 . . . . 71.409999999999997 110.316 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 88.8 t -71.25 -35.0 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 116.036 -0.529 . . . . 62.439999999999998 110.005 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 64.8 mt -65.12 -45.84 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 110.091 -0.337 . . . . 55.32 110.091 175.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -62.78 -35.4 79.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.21 0.448 . . . . 61.420000000000002 112.21 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.32 -33.74 22.01 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 113.445 0.905 . . . . 73.340000000000003 113.445 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -97.03 -16.32 20.62 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 113.564 0.95 . . . . 61.539999999999999 113.564 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -128.16 -177.02 3.98 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.204 -0.665 . . . . 72.109999999999999 109.204 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -107.76 100.25 9.65 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 103.719 -2.697 . . . . 65.209999999999994 103.719 171.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.05 144.95 30.62 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 114.759 1.392 . . . . 50.219999999999999 114.759 -168.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.426 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 1.9 m -123.34 103.47 8.52 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 103.983 -2.599 . . . . 60.399999999999999 103.983 169.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 p -100.66 119.26 48.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-O 121.649 0.738 . . . . 71.140000000000001 111.351 -174.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -120.0 122.45 41.18 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.383 -0.826 . . . . 74.209999999999994 111.469 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -89.25 140.97 28.94 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.802 -0.444 . . . . 73.219999999999999 109.802 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 mp -136.49 172.42 13.04 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.106 -1.442 . . . . 74.239999999999995 107.106 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.49 147.81 24.47 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.255 -0.578 . . . . 73.420000000000002 109.716 176.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.44 148.79 41.09 Favored Glycine 0 C--N 1.293 -1.835 0 CA-C-N 115.29 -0.868 . . . . 32.539999999999999 111.137 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.92 132.74 34.33 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-O 121.158 0.504 . . . . 63.119999999999997 110.789 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.0 t70 52.31 -84.14 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 126.137 1.775 . . . . 74.439999999999998 113.681 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.5 t -110.54 -0.55 17.31 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.171 0.51 . . . . 51.310000000000002 111.786 -176.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 23.1 m-20 -74.24 138.21 43.52 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 106.664 -1.606 . . . . 74.329999999999998 106.664 172.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.8 t -93.81 -29.93 4.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 112.698 0.629 . . . . 53.210000000000001 112.698 -173.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.3 tp -150.29 140.24 21.94 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 108.669 -0.863 . . . . 73.230000000000004 108.669 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -130.68 133.7 46.31 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 107.054 -1.461 . . . . 74.200000000000003 107.054 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -137.05 120.34 16.84 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.492 -1.299 . . . . 73.150000000000006 107.492 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -111.94 118.09 34.53 Favored 'General case' 0 N--CA 1.413 -2.294 0 C-N-CA 118.828 -1.149 . . . . 74.030000000000001 108.612 175.068 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.43 ' HB3' HD11 ' A' ' 73' ' ' LEU . 13.0 m-85 -94.11 125.68 38.89 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 114.658 -1.155 . . . . 73.209999999999994 108.624 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 19.5 m -100.06 113.99 27.0 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.78 -1.563 . . . . 74.109999999999999 106.78 175.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.43 HD11 ' HB3' ' A' ' 71' ' ' TYR . 0.8 OUTLIER -120.41 152.4 37.97 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 113.538 0.94 . . . . 55.240000000000002 113.538 -170.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -135.32 140.81 45.4 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.222 -1.808 . . . . 72.430000000000007 106.807 170.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.549 ' HG2' ' OE1' ' A' ' 76' ' ' GLU . 51.6 tttm -139.47 -178.64 5.48 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 104.988 -2.227 . . . . 75.099999999999994 104.988 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.549 ' OE1' ' HG2' ' A' ' 75' ' ' LYS 0.26 0.0 OUTLIER -59.87 86.25 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 115.233 1.568 . . . . 70.120000000000005 115.233 -177.568 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.15 19.33 67.28 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 114.798 -1.092 . . . . 64.129999999999995 111.263 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 44.7 mtpt -132.74 135.9 46.03 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.306 -0.998 . . . . 73.409999999999997 108.306 -176.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -137.94 138.65 39.19 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.982 -0.747 . . . . 74.439999999999998 108.982 -175.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 11' ' ' SER . . . -174.04 172.12 45.06 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 119.414 -1.374 . . . . 63.420000000000002 113.612 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.5 mt -124.43 143.68 37.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 106.996 -1.483 . . . . 71.230000000000004 106.996 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 97.4 t -124.03 110.1 24.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.085 -0.709 . . . . 62.439999999999998 109.085 177.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -94.15 104.18 16.21 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.002 -0.545 . . . . 74.409999999999997 109.648 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.3 t -105.62 115.07 46.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 109.245 -0.65 . . . . 75.329999999999998 109.245 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -125.34 134.94 52.02 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.019 -0.673 . . . . 71.439999999999998 110.185 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.8 mp -112.1 108.1 17.26 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 109.115 -0.698 . . . . 64.349999999999994 109.115 -173.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.529 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 12.3 ptp180 -102.14 151.42 22.2 Favored 'General case' 0 CA--C 1.468 -2.196 0 C-N-CA 119.333 -0.947 . . . . 74.519999999999996 112.28 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -84.29 98.45 10.0 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.885 -1.052 . . . . 62.43 109.557 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.458 HD12 ' HB3' ' A' ' 95' ' ' PRO . 6.3 tt -74.11 114.95 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-O 122.16 0.981 . . . . 72.340000000000003 109.959 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.5 p -133.04 -171.84 2.78 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 107.695 -1.224 . . . . 62.200000000000003 107.695 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -83.03 -5.83 59.25 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.235 0.54 . . . . 54.399999999999999 110.093 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -98.91 -39.93 8.33 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.989 -0.745 . . . . 73.120000000000005 108.989 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 62.7 m -104.35 120.69 49.88 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 116.494 -0.321 . . . . 74.319999999999993 111.615 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.37 142.79 19.07 Favored 'Trans proline' 0 CA--C 1.555 1.569 0 C-N-CA 123.069 2.512 . . . . 70.420000000000002 113.859 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.458 ' HB3' HD12 ' A' ' 89' ' ' ILE . 66.9 Cg_endo -73.69 164.72 34.1 Favored 'Trans proline' 0 C--O 1.248 1.025 0 C-N-CA 124.016 3.144 . . . . 75.310000000000002 111.883 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.5 t -101.11 159.67 3.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 107.989 -1.115 . . . . 75.540000000000006 107.989 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -112.66 111.5 22.35 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.185 0.517 . . . . 73.349999999999994 110.7 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -128.49 -163.5 11.31 Favored Glycine 0 CA--C 1.487 -1.712 0 N-CA-C 110.462 -1.055 . . . . 74.510000000000005 110.462 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.557 ' HB3' ' SD ' ' A' ' 27' ' ' MET . 2.6 t-20 -75.19 140.91 43.6 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 122.446 0.298 . . . . 64.540000000000006 110.37 177.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -83.92 97.69 9.38 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 122.083 0.944 . . . . 64.409999999999997 110.581 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.19 151.99 44.77 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 113.422 -1.717 . . . . 63.43 108.978 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -76.83 93.27 3.7 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.839 0.828 . . . . 75.099999999999994 110.69 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.25 146.16 6.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 114.923 -1.035 . . . . 73.310000000000002 109.866 -175.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.7 mt -156.9 -90.8 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 126.116 1.766 . . . . 75.319999999999993 107.934 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.44 173.72 11.23 Favored 'General case' 0 C--N 1.255 -3.515 0 N-CA-C 105.944 -1.873 . . . . 75.209999999999994 105.944 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.464 ' O ' HG22 ' A' ' 110' ' ' ILE . 90.6 t80 -33.01 -46.39 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.682 1.734 . . . . 64.140000000000001 115.682 -172.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -56.1 -55.39 33.62 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 123.087 0.555 . . . . 74.150000000000006 112.204 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -78.83 -30.86 45.51 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.818 -0.628 . . . . 74.510000000000005 109.49 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.431 ' O ' HG12 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -65.76 -49.16 69.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.259 -0.882 . . . . 62.229999999999997 110.425 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 106' ' ' PHE . 9.9 tp -68.3 -35.76 72.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 121.365 0.603 . . . . 74.120000000000005 109.498 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -65.11 -44.68 87.97 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 115.205 -0.907 . . . . 75.409999999999997 110.12 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 27.0 t -67.55 -39.32 84.97 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 123.448 0.468 . . . . 63.5 110.974 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.569 ' O ' HG12 ' A' ' 117' ' ' ILE . 44.4 mm -66.01 -45.09 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 116.494 -0.321 . . . . 74.219999999999999 110.593 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.77 -35.5 74.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 N-CA-C 109.88 -0.415 . . . . 74.430000000000007 109.88 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 119' ' ' GLU . 60.1 tttp -60.1 -47.11 87.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.652 -0.703 . . . . 73.150000000000006 110.28 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.42 95.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.167 -0.47 . . . . 72.439999999999998 110.958 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 113' ' ' ILE . 43.0 mm -66.84 -44.03 89.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.742 -0.466 . . . . 61.340000000000003 109.742 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.78 -36.59 83.98 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.973 -0.558 . . . . 74.140000000000001 112.288 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 54.5 mm-40 -68.45 -45.54 72.21 Favored 'General case' 0 C--O 1.221 -0.441 0 O-C-N 123.727 0.642 . . . . 65.400000000000006 110.034 176.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 44.6 t -56.63 -46.27 81.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.938 -0.574 . . . . 72.299999999999997 111.233 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.7 mp -78.6 -19.86 51.77 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.26 -0.576 . . . . 74.129999999999995 111.777 -177.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.63 -29.8 41.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.053 0.454 . . . . 70.400000000000006 109.928 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -83.13 -1.97 54.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.884 -0.598 . . . . 73.430000000000007 111.032 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -53.86 131.1 43.99 Favored Glycine 0 C--O 1.245 0.808 0 N-CA-C 110.814 -0.915 . . . . 71.329999999999998 110.814 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 73.9 74.66 0.12 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.63 1.172 . . . . 74.120000000000005 109.937 -171.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.1 tp -131.88 149.22 52.51 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 106.141 -1.8 . . . . 74.329999999999998 106.141 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -81.31 104.49 11.8 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 119.026 -1.069 . . . . 52.450000000000003 110.839 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.5 t -151.19 171.88 16.69 Favored 'General case' 0 N--CA 1.409 -2.52 0 N-CA-C 103.996 -2.594 . . . . 72.120000000000005 103.996 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.68 123.57 8.68 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.19 -0.604 . . . . 62.229999999999997 112.421 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.439 HD11 ' HB ' ' A' ' 23' ' ' ILE . 2.1 pt? -161.24 -157.64 0.52 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.636 -1.616 . . . . 74.400000000000006 106.636 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -98.89 93.41 6.02 Favored 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 120.052 -0.659 . . . . 73.340000000000003 111.724 176.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.21 159.11 37.5 Favored Glycine 0 C--O 1.249 1.05 0 CA-C-N 115.146 -0.933 . . . . 52.310000000000002 111.904 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -98.94 131.19 25.96 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 112.475 0.546 . . . . 44.439999999999998 112.475 -176.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.78 156.48 63.2 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.275 1.983 . . . . 74.409999999999997 108.403 168.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.59 101.41 54.21 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.712 -0.477 . . . . 73.420000000000002 109.712 -175.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -79.1 131.7 10.02 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 N-CA-C 107.849 -1.635 . . . . 74.420000000000002 107.849 168.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -81.65 117.0 66.54 Favored Pre-proline 0 C--N 1.296 -1.724 0 C-N-CA 119.847 -0.741 . . . . 62.25 111.282 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.53 -24.77 25.78 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.344 2.03 . . . . 42.25 111.589 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 82.4 mt 58.72 67.23 0.95 Allowed 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 123.024 1.392 . . . . 62.210000000000001 109.862 -175.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 68.2 tp -148.56 115.32 6.0 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 112.76 -2.018 . . . . 72.129999999999995 106.311 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -177.2 -129.69 1.28 Allowed Glycine 0 N--CA 1.419 -2.499 0 C-N-CA 119.38 -1.39 . . . . 61.539999999999999 111.918 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.7 mp 63.88 28.88 14.66 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.702 0.763 . . . . 75.510000000000005 109.301 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -85.84 98.81 10.97 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.428 -1.323 . . . . 71.340000000000003 107.428 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.8 m -93.21 147.92 22.48 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-N 115.165 -0.925 . . . . 74.219999999999999 111.421 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -148.48 170.06 18.87 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 106.978 -1.49 . . . . 72.310000000000002 106.978 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -139.16 98.53 3.54 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.401 -0.963 . . . . 63.130000000000003 108.401 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 62.9 m -150.34 142.76 24.36 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.643 -0.873 . . . . 72.340000000000003 108.643 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.212 0 N-CA-C 109.073 -1.611 . . . . 61.210000000000001 109.073 -179.676 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 CA--C 1.489 -1.392 0 N-CA-C 108.305 -0.998 . . . . 75.230000000000004 108.305 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.67 153.47 51.08 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.043 -1.095 . . . . 74.510000000000005 108.043 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.495 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 14.4 m-85 -112.95 145.67 40.38 Favored 'General case' 0 C--N 1.283 -2.313 0 C-N-CA 123.387 0.675 . . . . 75.209999999999994 109.508 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.644 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 15.7 t70 -103.08 110.67 22.69 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.532 -1.285 . . . . 73.140000000000001 107.532 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -93.11 111.46 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 CA-C-O 121.897 0.856 . . . . 74.230000000000004 108.721 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 27' ' ' MET . 4.8 p -109.29 110.97 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.76 0 CA-C-N 114.778 -1.101 . . . . 73.209999999999994 109.284 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.678 HG23 ' HB2' ' A' ' 27' ' ' MET . 4.3 tt -103.93 125.36 58.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.868 -1.06 . . . . 52.329999999999998 110.372 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.2 mt -118.93 103.31 48.27 Favored Pre-proline 0 N--CA 1.425 -1.723 0 CA-C-N 115.52 -0.764 . . . . 60.310000000000002 109.275 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.555 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 3.1 Cg_exo -82.39 140.58 10.89 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.175 1.917 . . . . 75.439999999999998 109.582 173.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -156.97 114.27 3.12 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.949 0.881 . . . . 71.329999999999998 110.677 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 m -80.42 128.39 33.52 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.811 -0.632 . . . . 62.539999999999999 109.619 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.482 ' HD2' ' CD1' ' A' ' 81' ' ' ILE . 2.2 p90 -59.18 105.18 0.31 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 114.632 1.345 . . . . 71.530000000000001 114.632 -175.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -141.14 106.73 5.08 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.395 -1.275 . . . . 73.540000000000006 109.538 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -69.08 159.14 33.44 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 106.86 -1.533 . . . . 72.430000000000007 106.86 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -82.91 92.16 7.26 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.012 -1.075 . . . . 72.349999999999994 110.462 176.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.547 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 16.9 t70 -66.76 -102.0 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.76 -1.109 . . . . 74.329999999999998 109.43 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -113.32 -60.36 1.89 Allowed 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 108.269 -1.011 . . . . 63.340000000000003 108.269 171.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -139.5 -53.08 0.54 Allowed 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.677 0.751 . . . . 74.109999999999999 112.205 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -86.1 74.47 10.07 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.376 -0.829 . . . . 73.120000000000005 111.109 -174.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.547 ' SD ' ' HB2' ' A' ' 16' ' ' ASP . 53.0 ttm 173.87 93.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.719 2.007 . . . . 74.349999999999994 105.614 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 10.0 pt-20 -176.16 115.99 0.13 Allowed 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.082 -1.451 . . . . 63.43 107.082 -175.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -157.44 98.23 1.67 Allowed 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 119.326 -0.95 . . . . 73.310000000000002 111.429 172.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.4 mm -120.05 131.04 73.49 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 105.832 -1.914 . . . . 55.399999999999999 105.832 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 73.5 m -107.47 129.03 24.82 Favored Pre-proline 0 C--N 1.293 -1.885 0 C-N-CA 119.764 -0.775 . . . . 64.239999999999995 110.745 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 53.8 Cg_exo -56.17 146.15 72.58 Favored 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 123.217 2.612 . . . . 63.530000000000001 112.537 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 49.6 Cg_exo -57.8 145.11 91.88 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 123.684 2.922 . . . . 50.340000000000003 114.265 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.678 ' HB2' HG23 ' A' ' 7' ' ' ILE . 62.9 mtp -103.41 131.13 50.75 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 104.994 -2.224 . . . . 64.219999999999999 104.994 173.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.6 t -120.66 123.23 69.9 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 O-C-N 123.133 0.27 . . . . 74.150000000000006 110.355 -173.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.68 107.5 15.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 107.389 -1.338 . . . . 72.209999999999994 107.389 176.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . -127.13 81.77 0.35 Allowed Glycine 0 CA--C 1.475 -2.429 0 C-N-CA 118.019 -2.039 . . . . 75.540000000000006 115.416 -173.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -174.38 37.92 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.979 0.895 . . . . 74.049999999999997 111.126 173.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -113.7 133.34 55.39 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 106.423 -1.695 . . . . 33.219999999999999 106.423 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 p -76.71 163.49 26.78 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 119.139 0.881 . . . . 72.340000000000003 109.089 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.495 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 63.2 t80 -52.55 -43.32 65.11 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 123.758 0.823 . . . . 74.239999999999995 111.689 -174.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -68.14 -40.23 82.47 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.008 -0.996 . . . . 72.400000000000006 111.331 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.2 mm -73.65 -39.35 53.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.131 -0.692 . . . . 65.439999999999998 109.131 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.78 95.14 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.936 -1.029 . . . . 74.329999999999998 110.331 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.1 mmt -65.67 -36.04 82.5 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.495 -0.482 . . . . 74.129999999999995 111.287 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -68.42 -43.58 76.88 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 120.634 -0.426 . . . . 74.409999999999997 111.285 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 44' ' ' VAL . 13.7 tt -70.32 -39.33 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 C-N-CA 119.826 -0.75 . . . . 44.130000000000003 110.464 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.3 -45.09 99.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-N 116.737 -0.21 . . . . 74.209999999999994 110.868 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -68.44 -32.59 72.71 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 119.977 -0.689 . . . . 53.450000000000003 111.4 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -69.78 -46.05 55.29 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 110.983 -0.847 . . . . 74.010000000000005 110.983 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 40' ' ' ILE . 69.0 t -62.35 -41.11 90.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.729 -0.471 . . . . 63.409999999999997 109.729 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.448 ' CG ' HH21 ' A' ' 69' ' ' ARG . 16.4 t70 -58.48 -46.67 86.19 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.919 -1.037 . . . . 61.530000000000001 110.346 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -40.77 96.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.633 -0.712 . . . . 64.409999999999997 110.817 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 43' ' ' GLY . 98.3 t -63.75 -43.22 97.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.531 -0.304 . . . . 74.25 111.067 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.8 mt -69.9 -39.59 77.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.561 0.219 . . . . 73.319999999999993 110.922 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -74.92 -24.72 58.55 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 120.903 0.382 . . . . 74.340000000000003 110.912 -175.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.39 -42.15 9.94 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 112.502 0.556 . . . . 25.219999999999999 112.502 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.1 m -83.9 -17.93 39.12 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.199 0.523 . . . . 74.329999999999998 111.737 -174.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -134.58 179.34 6.35 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 121.533 0.682 . . . . 60.450000000000003 109.995 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.547 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 26.7 t-20 -98.8 102.66 14.47 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.007 -1.849 . . . . 75.25 106.007 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -133.98 135.94 43.8 Favored 'General case' 0 N--CA 1.412 -2.357 0 C-N-CA 119.595 -0.842 . . . . 72.420000000000002 112.446 -175.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.9 m -102.1 111.89 24.34 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 105.24 -2.133 . . . . 74.150000000000006 105.24 171.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.415 HG21 ' OD1' ' A' ' 45' ' ' ASP . 7.4 p -100.64 142.74 15.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 120.699 0.285 . . . . 62.539999999999999 110.778 -174.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.46 ' HB2' ' ND2' ' A' ' 137' ' ' ASN . 10.0 tp10 -139.88 151.74 45.89 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.634 -0.876 . . . . 73.239999999999995 108.634 175.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -125.63 106.46 9.75 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.983 0.897 . . . . 61.32 110.068 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -99.08 172.49 7.36 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.854 -1.067 . . . . 72.219999999999999 109.148 -175.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -109.03 137.84 46.3 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.059 -0.518 . . . . 72.230000000000004 109.687 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.494 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -98.29 176.83 30.65 Favored Glycine 0 C--N 1.294 -1.784 0 CA-C-N 115.196 -0.911 . . . . 60.200000000000003 112.671 -174.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.72 166.74 8.36 Favored 'General case' 0 C--O 1.19 -2.047 0 N-CA-C 107.388 -1.338 . . . . 65.109999999999999 107.388 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -42.6 -39.77 2.46 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 115.311 1.597 . . . . 72.430000000000007 115.311 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 51.5 t -73.71 -29.64 62.38 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.082 0.468 . . . . 63.200000000000003 111.518 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.494 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 8.0 m-20 -98.26 115.17 27.82 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.545 -0.909 . . . . 63.240000000000002 108.545 -176.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.0 t -83.67 -32.57 8.96 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 N-CA-C 113.29 0.848 . . . . 74.340000000000003 113.29 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.1 tp -148.79 140.8 23.85 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.238 -1.023 . . . . 73.439999999999998 108.238 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -129.72 126.11 37.49 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.962 -1.495 . . . . 75.530000000000001 106.962 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.448 HH21 ' CG ' ' A' ' 45' ' ' ASP . 10.8 tpt180 -113.73 138.8 49.74 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 107.529 -1.286 . . . . 65.540000000000006 107.529 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -123.96 130.64 52.92 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.981 -1.118 . . . . 52.219999999999999 107.981 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -125.56 115.82 20.78 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.234 -0.654 . . . . 70.0 109.234 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 39.5 m -88.26 110.3 20.63 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.974 -1.121 . . . . 74.329999999999998 107.974 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.0 142.23 28.47 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.13 0.572 . . . . 74.239999999999995 112.317 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 36.7 tt0 -144.32 93.9 2.5 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.917 -1.038 . . . . 63.140000000000001 109.041 171.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.539 ' HG2' ' H ' ' A' ' 76' ' ' GLU . 49.8 tttt -99.53 -176.04 3.17 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 105.968 -1.864 . . . . 64.0 105.968 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.539 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 8.6 pt-20 -48.83 91.26 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.092 1.357 . . . . 70.140000000000001 113.271 177.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.24 17.27 68.0 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.188 -0.914 . . . . 62.32 113.414 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . 53.7 mtmt -138.78 122.41 17.44 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.48 -0.933 . . . . 73.140000000000001 108.48 -177.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -145.24 145.58 31.35 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 120.698 0.285 . . . . 72.540000000000006 111.298 -173.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.92 171.9 41.81 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 110.47 -1.052 . . . . 71.530000000000001 110.47 -176.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.482 ' CD1' ' HD2' ' A' ' 12' ' ' PHE . 3.7 mp -105.03 143.87 15.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 117.888 0.844 . . . . 72.099999999999994 109.669 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.4 t -119.6 110.27 28.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.967 -0.753 . . . . 73.319999999999993 108.967 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -93.89 131.3 39.45 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 124.006 0.922 . . . . 74.439999999999998 110.017 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.14 109.92 18.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.235 -1.024 . . . . 63.32 108.235 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -118.45 146.27 44.61 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.936 -1.106 . . . . 54.439999999999998 111.338 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.5 mt -105.52 107.89 19.12 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.502 -1.296 . . . . 73.549999999999997 107.502 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 37.3 ptt180 -103.84 135.89 44.54 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.403 -0.962 . . . . 74.129999999999995 108.403 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -76.73 108.34 9.68 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.447 0.641 . . . . 73.549999999999997 110.81 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 tt -82.82 111.42 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.276 1.036 . . . . 74.420000000000002 108.564 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 91' ' ' GLU . 3.6 m -144.53 -171.95 3.71 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 104.27 -2.493 . . . . 73.319999999999993 104.27 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.512 ' H ' HG22 ' A' ' 90' ' ' THR . 3.8 mp0 -60.82 -24.34 65.78 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 119.112 0.869 . . . . 74.5 111.765 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -76.45 -39.92 52.0 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.544 -0.753 . . . . 73.540000000000006 110.665 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 73.9 m -119.21 89.87 40.61 Favored Pre-proline 0 N--CA 1.431 -1.4 0 CA-C-N 116.459 -0.337 . . . . 73.109999999999999 110.627 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.24 152.75 56.17 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 121.809 1.673 . . . . 65.329999999999998 110.575 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.96 141.98 91.24 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.213 2.608 . . . . 44.140000000000001 113.317 -175.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.25 155.62 16.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 106.619 -1.622 . . . . 54.009999999999998 106.619 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.92 144.97 27.36 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 120.958 0.409 . . . . 74.439999999999998 110.183 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -157.24 -159.74 9.7 Favored Glycine 0 CA--C 1.464 -3.14 0 N-CA-C 107.992 -2.043 . . . . 45.039999999999999 107.992 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.474 ' HB3' ' HA ' ' A' ' 27' ' ' MET . 9.1 t-20 -69.45 108.99 3.99 Favored 'General case' 0 N--CA 1.395 -3.206 0 N-CA-C 107.652 -1.24 . . . . 70.420000000000002 107.652 171.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -83.29 109.62 17.41 Favored 'General case' 0 N--CA 1.416 -2.164 0 N-CA-C 107.894 -1.15 . . . . 74.409999999999997 107.894 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 36.7 t -69.32 156.74 38.3 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.856 -1.066 . . . . 65.109999999999999 109.723 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -79.43 94.58 5.58 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.982 -1.118 . . . . 61.049999999999997 107.982 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.7 t -96.31 129.96 45.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.339 -0.846 . . . . 63.43 110.297 -172.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 mp -139.64 -90.42 0.19 Allowed 'General case' 0 C--N 1.269 -2.905 0 CA-C-N 114.746 -1.116 . . . . 71.010000000000005 108.569 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -139.41 163.14 33.29 Favored 'General case' 0 C--N 1.251 -3.684 0 CA-C-N 113.587 -1.642 . . . . 70.409999999999997 106.873 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -34.35 -49.99 0.4 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.284 1.433 . . . . 52.240000000000002 114.843 -172.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 111' ' ' GLU . 27.9 tt0 -61.08 -46.5 90.41 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.095 0.406 . . . . 63.25 112.095 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -78.08 -31.16 50.02 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.494 -0.321 . . . . 61.329999999999998 110.555 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.417 ' O ' HG12 ' A' ' 113' ' ' ILE . 2.3 m-20 -66.43 -45.99 77.99 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.324 -0.853 . . . . 71.010000000000005 110.127 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.2 tp -63.35 -38.08 81.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 116.558 -0.292 . . . . 74.230000000000004 110.729 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 107' ' ' GLU . 44.9 mt-10 -60.14 -46.13 90.7 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.835 -0.431 . . . . 63.420000000000002 109.835 177.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 18.6 t -61.5 -41.1 96.78 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.497 -0.774 . . . . 71.099999999999994 111.137 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 117' ' ' ILE . 46.3 mm -65.42 -46.33 90.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.312 -0.404 . . . . 75.010000000000005 110.377 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 80.1 t -64.88 -39.97 87.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.158 -0.474 . . . . 73.010000000000005 110.554 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -67.46 -32.28 73.02 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 116.366 -0.379 . . . . 71.219999999999999 111.252 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.53 -34.67 53.87 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 120.641 0.258 . . . . 61.229999999999997 111.338 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 113' ' ' ILE . 82.4 mt -64.17 -48.12 87.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.791 -1.189 . . . . 71.430000000000007 107.791 174.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -62.77 -29.73 70.91 Favored 'General case' 0 C--O 1.192 -1.933 0 CA-C-N 115.447 -0.797 . . . . 72.450000000000003 111.633 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -67.59 -35.55 79.19 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.234 0.54 . . . . 54.219999999999999 109.795 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 4.5 t -84.47 -31.15 24.7 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.143 0.973 . . . . 75.349999999999994 109.537 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 9.6 mp -78.54 -39.34 38.16 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.859 -0.609 . . . . 72.219999999999999 111.98 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.67 -15.55 44.95 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 114.826 1.417 . . . . 42.520000000000003 114.826 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HD3' ' HA ' ' A' ' 123' ' ' LYS 0.346 34.0 mmtp -84.14 -3.93 58.45 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 116.271 1.952 . . . . 62.130000000000003 116.271 -175.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.33 -163.45 53.92 Favored Glycine 0 C--O 1.215 -1.075 0 C-N-CA 120.442 -0.885 . . . . 62.210000000000001 113.44 173.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 0.1 OUTLIER -92.1 88.63 6.6 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-O 121.86 0.838 . . . . 63.049999999999997 112.823 -177.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 127' ' ' ASN . 6.2 tt -161.84 140.65 9.52 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 105.996 -1.853 . . . . 70.420000000000002 105.996 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.443 ' N ' HD23 ' A' ' 126' ' ' LEU . 6.3 t30 78.16 113.27 0.07 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.251 1.204 . . . . 73.099999999999994 114.251 177.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.2 p -144.0 104.52 4.15 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 114.76 -1.109 . . . . 72.340000000000003 108.267 173.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -107.42 32.56 4.57 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.993 0.901 . . . . 72.129999999999995 110.464 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.0 tp -171.72 135.15 0.85 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 113.717 -1.583 . . . . 65.400000000000006 107.14 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.09 105.91 18.14 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.236 -1.764 . . . . 73.340000000000003 106.236 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -145.59 154.39 25.9 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 110.546 -1.022 . . . . 70.310000000000002 110.546 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -114.68 105.3 53.61 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 109.905 -0.406 . . . . 73.129999999999995 109.905 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.22 121.3 8.28 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.502 2.135 . . . . 51.350000000000001 110.68 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.4 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 49.3 mm -104.89 102.94 38.38 Favored Pre-proline 0 N--CA 1.436 -1.128 0 N-CA-C 109.074 -0.713 . . . . 74.129999999999995 109.074 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 135' ' ' ILE . 37.5 Cg_endo -67.26 143.32 63.92 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.449 2.099 . . . . 71.129999999999995 110.352 175.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.46 ' ND2' ' HB2' ' A' ' 57' ' ' GLU . 27.2 p-10 -101.78 135.4 19.75 Favored Pre-proline 0 C--N 1.298 -1.641 0 C-N-CA 120.019 -0.672 . . . . 61.539999999999999 110.131 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.72 -52.37 2.4 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.347 2.031 . . . . 71.239999999999995 110.654 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 55.4 tp 66.18 123.1 0.02 OUTLIER 'General case' 0 C--O 1.242 0.677 0 C-N-CA 125.532 1.533 . . . . 72.540000000000006 112.517 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.0 tp -84.66 78.31 9.88 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.22 -1.4 . . . . 71.140000000000001 107.22 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -121.07 122.77 5.32 Favored Glycine 0 N--CA 1.412 -2.935 0 CA-C-N 114.903 -1.044 . . . . 62.43 111.63 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 142' ' ' LEU . 1.9 pt? -123.91 27.33 7.27 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.662 -1.607 . . . . 50.539999999999999 106.662 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -95.6 93.15 6.98 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.77 -1.559 . . . . 75.420000000000002 111.019 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.8 m -125.92 93.35 3.8 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.067 -1.457 . . . . 73.129999999999995 107.067 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.7 t -153.99 138.71 17.01 Favored 'General case' 0 N--CA 1.411 -2.382 0 N-CA-C 108.152 -1.055 . . . . 70.430000000000007 108.152 -176.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.52 100.93 4.64 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 106.366 -1.716 . . . . 71.310000000000002 106.366 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.5 t -138.29 135.68 35.7 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.543 -0.91 . . . . 72.450000000000003 108.543 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.489 0 N-CA-C 107.453 -2.259 . . . . 74.109999999999999 107.453 -175.267 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 tmm? . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 107.816 -1.179 . . . . 61.409999999999997 107.816 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -110.93 165.72 11.63 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.821 0.819 . . . . 71.340000000000003 113.193 -169.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 34' ' ' TYR . 7.5 m-85 -121.65 145.81 47.62 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.684 -1.144 . . . . 71.430000000000007 110.28 177.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.442 ' OD1' ' HA3' ' A' ' 30' ' ' GLY . 32.4 t70 -115.13 120.75 40.84 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.762 -1.57 . . . . 73.450000000000003 106.762 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -99.91 116.78 43.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 109.63 -0.507 . . . . 63.130000000000003 109.63 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.42 ' HB ' ' CG ' ' A' ' 85' ' ' LYS . 46.6 t -108.48 117.46 54.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 107.862 -1.162 . . . . 60.409999999999997 107.862 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.503 HG23 ' HB2' ' A' ' 27' ' ' MET . 7.7 tt -117.95 123.09 71.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 121.376 0.608 . . . . 62.420000000000002 110.306 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.2 mp -114.27 98.24 48.04 Favored Pre-proline 0 N--CA 1.422 -1.849 0 CA-C-N 115.648 -0.705 . . . . 44.509999999999998 109.138 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.696 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 5.8 Cg_exo -81.49 130.36 6.95 Favored 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 122.009 1.806 . . . . 74.230000000000004 107.427 171.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.37 131.08 12.36 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.285 0.564 . . . . 72.099999999999994 110.697 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -73.53 122.17 21.77 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 107.672 -1.233 . . . . 54.409999999999997 107.672 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.495 ' HD1' ' O ' ' A' ' 12' ' ' PHE 0.255 0.1 OUTLIER -68.02 105.68 2.11 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.981 0.896 . . . . 63.020000000000003 113.08 -175.256 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -126.75 126.29 43.19 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 113.942 1.09 . . . . 74.120000000000005 113.942 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -76.64 129.18 36.02 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 103.171 -2.9 . . . . 73.5 103.171 165.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.65 111.46 9.86 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-O 121.602 0.715 . . . . 73.319999999999993 110.026 -169.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.57 -164.17 0.61 Allowed 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 114.36 -1.291 . . . . 32.539999999999999 107.967 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -100.88 -29.9 11.97 Favored 'General case' 0 N--CA 1.411 -2.381 0 O-C-N 121.499 -0.751 . . . . 72.209999999999994 110.745 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.1 t60 -135.05 -51.08 0.77 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 118.776 -1.169 . . . . 65.430000000000007 113.357 -175.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -122.22 139.08 54.19 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 109.358 -0.608 . . . . 72.140000000000001 109.358 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . 0.303 59.3 mtm 96.64 73.35 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 126.338 1.855 . . . . 65.019999999999996 111.295 -175.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -156.41 94.07 1.46 Allowed 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 112.696 -2.047 . . . . 42.539999999999999 107.44 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -142.17 120.55 12.37 Favored 'General case' 0 CA--C 1.47 -2.116 0 O-C-N 121.577 -0.702 . . . . 71.540000000000006 109.462 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.419 HG13 ' H ' ' A' ' 132' ' ' GLY . 41.6 mm -133.05 143.67 38.72 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.799 0 N-CA-C 104.225 -2.509 . . . . 74.349999999999994 104.225 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.696 ' HB2' ' O ' ' A' ' 9' ' ' PRO . 60.5 m -107.77 150.1 39.82 Favored Pre-proline 0 C--N 1.274 -2.7 0 N-CA-C 109.989 -0.374 . . . . 73.420000000000002 109.989 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 27.0 Cg_exo -65.29 142.5 73.26 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.239 2.626 . . . . 63.32 114.255 -176.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 31.8 Cg_exo -63.06 126.49 18.05 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 123.104 2.536 . . . . 41.119999999999997 110.994 175.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.503 ' HB2' HG23 ' A' ' 7' ' ' ILE . 84.3 mtp -101.23 145.29 29.03 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.333 -0.988 . . . . 60.140000000000001 108.333 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 62.2 t -130.76 121.21 49.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.417 -0.586 . . . . 65.25 109.417 -178.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.6 mp -131.14 102.18 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.772 0 N-CA-C 106.205 -1.776 . . . . 72.049999999999997 106.205 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.442 ' HA3' ' OD1' ' A' ' 4' ' ' ASP . . . -117.53 -172.75 16.09 Favored Glycine 0 C--N 1.269 -3.146 0 C-N-CA 119.902 -1.142 . . . . 55.030000000000001 112.773 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.45 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 9.0 t70 71.7 67.6 0.15 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 125.636 1.574 . . . . 71.140000000000001 110.515 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.515 HH22 ' CG1' ' A' ' 103' ' ' VAL . 3.8 mpt_? -140.25 143.92 36.21 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 104.818 -2.29 . . . . 74.25 104.818 172.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 t -78.53 -179.71 6.56 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.78 -1.168 . . . . 62.149999999999999 108.07 174.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.455 ' HB2' ' CE1' ' A' ' 3' ' ' TYR . 88.3 t80 -55.98 -52.91 62.5 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 123.094 0.558 . . . . 70.349999999999994 112.394 -174.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 46.2 m-20 -68.04 -39.9 82.96 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.008 -0.997 . . . . 64.310000000000002 110.136 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.0 mt -65.03 -38.32 82.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.305 -0.861 . . . . 75.25 109.925 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.16 -42.47 88.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.791 -0.448 . . . . 72.129999999999995 109.791 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 24.0 mmt -64.77 -41.32 95.95 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.037 -0.529 . . . . 74.099999999999994 110.825 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 35' ' ' ASP . 40.1 mt-10 -66.27 -40.29 90.02 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 112.337 0.495 . . . . 73.349999999999994 112.337 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 44' ' ' VAL . 15.0 tt -72.58 -41.49 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 119.198 -1.001 . . . . 74.450000000000003 110.609 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.433 HG21 HD21 ' A' ' 86' ' ' LEU . 92.6 t -72.15 -37.15 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 120.468 -0.493 . . . . 62.219999999999999 111.309 -177.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -74.31 -23.89 59.14 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.611 -0.436 . . . . 74.219999999999999 111.057 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.87 -45.93 40.24 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.196 -1.161 . . . . 32.140000000000001 110.196 175.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 40' ' ' ILE . 61.5 t -63.3 -41.97 94.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 N-CA-C 108.981 -0.748 . . . . 75.319999999999993 108.981 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.68 -52.34 31.76 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 125.372 1.469 . . . . 65.25 110.793 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -63.93 -40.25 96.02 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.789 -1.096 . . . . 71.310000000000002 110.732 -177.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.93 -36.62 74.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.215 -0.448 . . . . 72.420000000000002 110.592 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.4 mt -67.62 -43.74 86.69 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.171 0 N-CA-C 109.901 -0.407 . . . . 73.420000000000002 109.901 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -74.26 -15.75 60.97 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.628 0.603 . . . . 75.109999999999999 112.628 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.76 -33.99 13.38 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 112.177 0.436 . . . . 45.130000000000003 112.177 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -96.52 -19.21 19.27 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.258 0.551 . . . . 72.040000000000006 112.359 -176.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.416 ' CD2' ' HD2' ' A' ' 75' ' ' LYS . 22.4 m-85 -137.23 -176.36 4.36 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.686 -1.227 . . . . 71.310000000000002 107.686 -176.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.403 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 36.6 t30 -107.49 117.78 34.99 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.985 -1.487 . . . . 73.109999999999999 106.985 174.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 72' ' ' THR . . . -138.24 134.98 35.09 Favored 'General case' 0 N--CA 1.405 -2.71 0 C-N-CA 119.892 -0.723 . . . . 72.230000000000004 110.934 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.6 m -108.18 120.04 41.21 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 105.754 -1.943 . . . . 73.030000000000001 105.754 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.32 127.36 53.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.185 0.517 . . . . 64.129999999999995 110.767 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -121.72 116.6 24.82 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.748 -1.205 . . . . 64.140000000000001 107.748 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' A' ' 69' ' ' ARG . 42.1 mt-10 -100.49 118.18 36.17 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 120.872 0.368 . . . . 72.319999999999993 111.634 -177.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mp -121.32 178.13 4.9 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.69 -0.855 . . . . 62.219999999999999 108.69 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -87.59 149.61 24.21 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.746 -0.835 . . . . 75.549999999999997 108.746 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' HA3' ' HB2' ' A' ' 65' ' ' ASP . . . -92.35 175.17 37.47 Favored Glycine 0 C--N 1.292 -1.908 0 N-CA-C 110.316 -1.114 . . . . 71.109999999999999 110.316 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -92.5 133.81 35.57 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 118.079 0.939 . . . . 74.209999999999994 112.749 -175.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.3 t70 59.26 -76.59 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.918 1.687 . . . . 62.109999999999999 114.53 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.9 t -119.38 5.53 11.16 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.425 0.631 . . . . 72.430000000000007 110.748 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.508 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 65.3 m-20 -81.43 124.17 29.2 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.943 -1.873 . . . . 73.150000000000006 105.943 173.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.8 t -83.75 -37.15 13.0 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 112.457 0.54 . . . . 74.5 112.457 -173.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 59.2 tp -142.18 137.85 31.13 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 109.169 -0.678 . . . . 64.409999999999997 109.169 -175.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.06 103.59 6.85 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.097 -1.446 . . . . 70.230000000000004 107.097 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.461 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 8.2 ptp180 -107.67 119.81 40.46 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 122.047 0.927 . . . . 74.420000000000002 111.226 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -98.71 108.69 21.44 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 113.704 -1.589 . . . . 74.340000000000003 108.036 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.413 ' CE1' ' HD3' ' A' ' 69' ' ' ARG . 89.0 m-85 -97.21 131.38 44.0 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.882 -0.784 . . . . 74.319999999999993 108.882 176.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 15.4 m -96.13 118.58 32.99 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.662 -1.607 . . . . 53.100000000000001 106.662 173.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.24 134.74 47.84 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 112.976 0.732 . . . . 73.510000000000005 112.976 -173.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 53' ' ' ASN . 51.6 mm-40 -136.45 137.04 40.01 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.155 -1.384 . . . . 75.519999999999996 108.105 174.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.577 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -141.79 85.88 1.96 Allowed 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.141 -1.429 . . . . 62.210000000000001 107.141 175.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.278 15.5 pt-20 32.95 69.62 0.12 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.919 1.687 . . . . 75.230000000000004 114.572 -174.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.19 -23.33 35.18 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.035 -0.984 . . . . 52.219999999999999 112.565 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.539 ' N ' ' HE3' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -85.88 124.25 32.14 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.064 -1.828 . . . . 74.209999999999994 106.064 178.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -132.2 146.51 52.07 Favored 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 120.057 -0.657 . . . . 71.420000000000002 111.745 -172.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.24 176.56 38.61 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.196 -0.911 . . . . 73.049999999999997 111.174 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 72' ' ' THR . 9.4 tp -129.47 138.0 55.44 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 106.668 -1.604 . . . . 73.420000000000002 106.668 178.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 62.1 t -125.44 110.32 24.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.467 -0.771 . . . . 63.240000000000002 110.083 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -96.92 106.36 18.67 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 123.838 0.855 . . . . 73.140000000000001 110.411 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.461 ' HB ' ' HG3' ' A' ' 69' ' ' ARG . 24.2 t -107.09 115.46 48.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.048 -0.723 . . . . 72.150000000000006 109.048 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.42 ' CG ' ' HB ' ' A' ' 6' ' ' VAL . 18.3 ptpt -110.45 140.42 44.71 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.819 -0.437 . . . . 70.140000000000001 109.819 177.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.433 HD21 HG21 ' A' ' 41' ' ' VAL . 44.4 mt -107.8 108.02 19.04 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 105.399 -2.074 . . . . 72.430000000000007 105.399 178.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 43.9 ttt85 -97.81 133.13 42.74 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 109.057 -0.72 . . . . 72.439999999999998 109.057 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -79.34 112.82 16.95 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.42 -0.955 . . . . 72.299999999999997 108.42 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.5 tt -91.08 111.44 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-O 122.373 1.082 . . . . 74.310000000000002 109.023 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.6 m -133.53 172.6 12.51 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 105.206 -2.146 . . . . 53.539999999999999 105.206 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -64.55 -20.89 66.5 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 118.872 0.76 . . . . 70.140000000000001 110.485 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -94.48 -5.83 45.27 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.039 -0.982 . . . . 74.340000000000003 111.59 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 70.3 m -133.32 109.52 12.51 Favored Pre-proline 0 C--N 1.314 -0.94 0 O-C-N 122.124 -0.36 . . . . 73.019999999999996 111.046 -175.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.56 138.86 24.79 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.143 1.895 . . . . 53.420000000000002 112.387 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.95 164.66 33.9 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 123.414 2.742 . . . . 51.340000000000003 111.13 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.7 t -94.11 155.7 3.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.988 -0.745 . . . . 72.549999999999997 108.988 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -106.19 122.08 45.48 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.512 -0.767 . . . . 70.209999999999994 109.086 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -158.13 -159.65 9.74 Favored Glycine 0 CA--C 1.468 -2.85 0 N-CA-C 110.229 -1.148 . . . . 54.0 110.229 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -76.29 93.0 3.36 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-O 121.828 0.823 . . . . 54.25 111.375 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 62.9 ttt180 -73.89 122.01 21.84 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.252 -1.34 . . . . 72.109999999999999 108.037 177.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 38.7 t -88.97 163.79 15.4 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.896 -0.722 . . . . 73.329999999999998 109.846 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.7 m -75.31 107.75 7.63 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 122.934 0.494 . . . . 75.340000000000003 109.902 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.515 ' CG1' HH22 ' A' ' 32' ' ' ARG . 36.5 t -85.01 135.91 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-O 122.132 0.967 . . . . 70.450000000000003 110.277 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.0 mt -153.18 -163.84 1.78 Allowed 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 104.805 -2.294 . . . . 73.099999999999994 104.805 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -54.05 145.93 15.76 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 118.405 0.548 . . . . 75.219999999999999 111.406 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.428 ' O ' HG22 ' A' ' 110' ' ' ILE . 13.9 t80 -32.91 -48.57 0.21 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.425 2.29 . . . . 75.230000000000004 113.707 -173.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.564 ' O ' ' HG3' ' A' ' 111' ' ' GLU . 43.3 tt0 -57.4 -43.87 84.05 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 112.349 0.5 . . . . 62.299999999999997 112.349 -176.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 -72.09 -31.4 66.04 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.145 -0.622 . . . . 61.409999999999997 111.501 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -71.38 -44.7 64.46 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.879 -1.055 . . . . 74.200000000000003 108.412 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 106' ' ' PHE . 12.7 tt -68.37 -36.79 76.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 C-N-CA 120.479 -0.489 . . . . 74.099999999999994 110.681 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 107' ' ' GLU . 52.6 mt-10 -61.56 -35.94 79.22 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.874 0.368 . . . . 74.140000000000001 110.064 176.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 44.5 t -64.98 -43.44 92.62 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.005 -0.543 . . . . 75.439999999999998 109.953 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.6 mm -64.58 -46.66 91.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.513 -0.767 . . . . 73.430000000000007 110.301 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 110' ' ' ILE . 92.3 t -63.29 -39.2 84.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.456 -0.338 . . . . 73.319999999999993 110.53 -177.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -62.64 -38.7 91.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.052 0.453 . . . . 74.120000000000005 110.4 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.89 -42.32 90.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.132 -0.486 . . . . 71.030000000000001 110.326 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.78 -42.75 93.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.008 -0.542 . . . . 75.209999999999994 110.569 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 114' ' ' VAL . 52.8 mt-10 -61.12 -44.81 96.77 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 121.319 -0.152 . . . . 75.129999999999995 110.618 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -65.07 -46.59 80.55 Favored 'General case' 0 C--O 1.181 -2.502 0 C-N-CA 119.685 -0.806 . . . . 72.439999999999998 110.336 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 2.7 t -68.84 -22.71 64.21 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.324 0.583 . . . . 61.310000000000002 111.616 -172.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 8.2 mp -81.96 -47.1 13.12 Favored 'General case' 0 N--CA 1.428 -1.553 0 O-C-N 121.999 -0.438 . . . . 55.310000000000002 111.473 174.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.16 -25.59 31.71 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.855 0.687 . . . . 51.100000000000001 112.855 -172.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -102.65 9.92 38.98 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.431 -1.322 . . . . 44.439999999999998 107.431 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.11 57.35 2.75 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 114.445 -1.252 . . . . 61.210000000000001 115.329 -174.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -173.26 98.5 0.12 Allowed 'General case' 0 C--N 1.272 -2.765 0 C-N-CA 125.233 1.413 . . . . 72.25 107.228 172.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.81 -178.38 4.85 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 115.598 -0.728 . . . . 71.129999999999995 110.022 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -134.1 159.46 40.78 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 126.02 1.728 . . . . 71.120000000000005 106.467 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.8 t 63.56 34.66 12.37 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 122.033 0.921 . . . . 72.400000000000006 110.996 177.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.453 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 1.9 mmpt? -122.69 107.54 12.06 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.594 -1.185 . . . . 70.519999999999996 111.004 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.6 tp -65.42 144.79 56.84 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.349 -0.841 . . . . 63.229999999999997 109.308 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.4 165.66 13.83 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.167 -0.924 . . . . 74.010000000000005 112.232 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.419 ' H ' HG13 ' A' ' 23' ' ' ILE . . . -120.56 -74.3 0.38 Allowed Glycine 0 N--CA 1.42 -2.368 0 N-CA-C 105.232 -3.147 . . . . 73.239999999999995 105.232 170.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -117.97 119.49 33.59 Favored Pre-proline 0 N--CA 1.427 -1.605 0 N-CA-C 106.82 -1.548 . . . . 62.030000000000001 106.82 170.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.7 106.43 1.98 Allowed 'Trans proline' 0 N--CA 1.446 -1.285 0 N-CA-C 107.598 -1.732 . . . . 73.340000000000003 107.598 172.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 49.3 mm -112.27 102.12 53.43 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 120.825 -0.35 . . . . 71.319999999999993 111.184 -174.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.57 132.72 7.97 Favored 'Trans proline' 0 N--CA 1.436 -1.878 0 C-N-CA 122.001 1.801 . . . . 75.040000000000006 107.695 167.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -136.79 98.73 10.58 Favored Pre-proline 0 C--N 1.289 -2.037 0 C-N-CA 119.287 -0.965 . . . . 63.039999999999999 108.99 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.76 75.93 4.54 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 122.314 2.009 . . . . 74.219999999999999 112.867 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.495 HD21 HG21 ' A' ' 72' ' ' THR . 2.2 pp -143.53 162.03 36.92 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.399 -0.819 . . . . 60.509999999999998 111.016 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.77 97.95 6.89 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.016 -0.735 . . . . 62.140000000000001 109.016 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.12 129.79 41.13 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 111.329 -0.708 . . . . 62.119999999999997 111.329 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.6 tt -123.98 98.3 5.73 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.685 -0.858 . . . . 73.030000000000001 108.685 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -141.08 139.82 34.09 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.463 -0.79 . . . . 61.549999999999997 110.495 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 t -147.46 47.27 1.12 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.378 1.085 . . . . 73.340000000000003 108.611 175.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 20.9 p -88.89 116.57 27.27 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 107.781 -1.192 . . . . 71.129999999999995 107.781 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 50.2 ttp85 -53.06 112.11 0.8 Allowed 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.765 0.826 . . . . 62.0 111.952 -172.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.2 m -80.95 120.48 24.81 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.479 -0.782 . . . . 74.450000000000003 109.967 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.422 0 N-CA-C 109.829 -1.309 . . . . 73.549999999999997 109.829 178.282 . . . . . . . . 0 0 . 1 stop_ save_